Citrus Sinensis ID: 036122
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 457 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.993 | 0.793 | 0.659 | 1e-180 | |
| F4I114 | 714 | Probable serine/threonine | no | no | 0.820 | 0.525 | 0.706 | 1e-161 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.730 | 0.651 | 0.513 | 2e-97 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.713 | 0.645 | 0.525 | 6e-97 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.776 | 0.684 | 0.487 | 9e-96 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.708 | 0.631 | 0.521 | 2e-95 | |
| Q9NYV4 | 1490 | Cyclin-dependent kinase 1 | yes | no | 0.706 | 0.216 | 0.454 | 4e-76 | |
| Q3MJK5 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.706 | 0.217 | 0.451 | 8e-76 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.706 | 0.216 | 0.451 | 9e-76 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.706 | 0.217 | 0.451 | 1e-75 |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 632 bits (1631), Expect = e-180, Method: Compositional matrix adjust.
Identities = 314/476 (65%), Positives = 374/476 (78%), Gaps = 22/476 (4%)
Query: 1 MGCVCGKG----------DRRSSPVNRRGSERASVTVTVSSGAVVSGNVVRLGKERARAE 50
MGCV G+ +SS + +VT S+G V++ +V + E A +
Sbjct: 1 MGCVFGREAATTTTAEAKQAKSSKASSGVVVVGESSVTKSNG-VIADDVEKKKNEEANGD 59
Query: 51 TEK-----NRRHTGDFGP----PERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFE 101
E+ +RR + P P + + GWPSWL G+A+ W PR+A+TFE
Sbjct: 60 KERKSSKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFE 119
Query: 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
K+DKIGQGTYSNVYKA+D+LTGKIVALKKVRFDNLEPESVKFMAREILVLR+LDHPNV+K
Sbjct: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVK 179
Query: 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
LEGLVTSRMSCSLYLVF+YM+HDLAGLA+ VKFSE +VKC M+QL+SGLEHCH+ GVL
Sbjct: 180 LEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVL 239
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVG 281
HRDIKGSNLLID+ G+LKIADFGLAT +DP K+PMTSRVVTLWYR PELLLGAT YGVG
Sbjct: 240 HRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVG 299
Query: 282 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341
+DLWSAGCILAELLAG+PIMPGRTEVEQLHKI+KLCGSPSE+YWKK K + ++KP++P
Sbjct: 300 IDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREP 359
Query: 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPP 401
YKR I ETFKDFP SSLPLI+ LLSI+P++R TA+AAL SEFF +EPYACEP+ LPKYPP
Sbjct: 360 YKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYPP 419
Query: 402 SKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
SKE+D K R+EE RRQR S KA DGA++ RHRDR+ RA+PAPEANAE+Q+N+D
Sbjct: 420 SKEIDAKRRDEETRRQRAAS-KAQG-DGARKNRHRDRSNRALPAPEANAELQSNVD 473
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 567 bits (1462), Expect = e-161, Method: Compositional matrix adjust.
Identities = 269/381 (70%), Positives = 322/381 (84%), Gaps = 6/381 (1%)
Query: 76 GWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN 135
GWPSWL +VAG+AI W PR+A++FEKL+KIGQGTYS+VYKARDL T ++VALKKVRF N
Sbjct: 139 GWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKVRFAN 198
Query: 136 LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK 195
++P+SV+FMAREI++LR+LDHPNV+KLEGL+TSR+S S+YL+FEYMEHDLAGLA+ G+
Sbjct: 199 MDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGIN 258
Query: 196 FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255
FSE Q+KCYMKQLL GLEHCH+ GVLHRDIKGSNLL+D++ LKI DFGLA FY KQ
Sbjct: 259 FSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQ 318
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
P+TSRVVTLWYRPPELLLG+T YGV VDLWS GCILAEL GKPIMPGRTEVEQLHKIFK
Sbjct: 319 PLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFK 378
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
LCGSPSEEYWK SKLP+AT+FKPQQPYKRC+AETFK PSS+L L+E LL+++PD RGT
Sbjct: 379 LCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTT 438
Query: 376 TAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRH 435
+AL SEFF T P A +PSSLPKY P KE+DVK +EEEA+R++ S K N +K+V
Sbjct: 439 ASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQN---DSKQV-- 493
Query: 436 RDRAGRAIPAPEANAEIQTNL 456
R +A+PAP++NAE T++
Sbjct: 494 -SRESKAVPAPDSNAESLTSI 513
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (913), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 184/358 (51%), Positives = 240/358 (67%), Gaps = 24/358 (6%)
Query: 82 MAVAG------DAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN 135
MAVA D W R + FEKL++IG+GTY VY A++ T +IVALKK+R DN
Sbjct: 1 MAVAAPGQLNLDESPSWGSRSVDCFEKLEQIGEGTYGQVYMAKETETNEIVALKKIRMDN 60
Query: 136 LEPESVKFMA-REILVLRKLDHPNVIKLEGLVTS---------------RMSCSLYLVFE 179
E E A REI +L+KL H NVI+L+ +VTS + S+Y+VFE
Sbjct: 61 -EREGFPITAIREIKILKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFE 119
Query: 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILK 239
YM+HDL GLA G++F+ PQ+KCYM+QLL+GL +CH N VLHRDIKGSNLLIDN+G LK
Sbjct: 120 YMDHDLTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLK 179
Query: 240 IADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP 299
+ADFGLA + +T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL GKP
Sbjct: 180 LADFGLARSFSSDHNGNLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKP 239
Query: 300 IMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSL 358
I+ G+ E EQL KIF+LCG+P E W +K+P FKPQ+P KR + E+FK F +L
Sbjct: 240 ILTGKNEPEQLSKIFELCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHAL 299
Query: 359 PLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARR 416
L+E +L++DP R +A AL++E+F T+P C+P SLPKY S E K + ++ R+
Sbjct: 300 DLLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQ 357
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (910), Expect = 6e-97, Method: Compositional matrix adjust.
Identities = 184/350 (52%), Positives = 237/350 (67%), Gaps = 24/350 (6%)
Query: 92 WTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILV 150
W R + FEKL++IG+GTY VY A+++ TG+IVALKK+R DN E E A REI +
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 151 LRKLDHPNVIKLEGLVTS--------------RMSCSLYLVFEYMEHDLAGLAACQGVKF 196
L+KL H NVI+L+ +VTS + +Y+VFEYM+HDL GLA G++F
Sbjct: 77 LKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 197 SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256
+ PQ+KCYMKQLL+GL +CH N VLHRDIKGSNLLIDN+G LK+ADFGLA Y
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL 316
+T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL KPI+PG+ E EQL+KIF+L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKNEQEQLNKIFEL 256
Query: 317 CGSPSEEYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
CGSP E+ W SK+P FKP +P KR + E F+ F +L L+E +L +DP R +A
Sbjct: 257 CGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKMLVLDPAQRISA 316
Query: 376 TAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLR-------EEEARRQR 418
AL++E+F T+P C+P SLP Y S E K + EE A+RQ+
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQQRQNEEAAKRQK 366
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 9e-96, Method: Compositional matrix adjust.
Identities = 188/386 (48%), Positives = 246/386 (63%), Gaps = 31/386 (8%)
Query: 82 MAVAG------DAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN 135
MAVA D W R + FEKL++IG+GTY VY AR+ T +IVALKK+R DN
Sbjct: 1 MAVAAPGQLNLDESPSWGSRSVDCFEKLEQIGEGTYGQVYMARETETQEIVALKKIRMDN 60
Query: 136 LEPESVKFMA-REILVLRKLDHPNVIKLEGLVTS---------------RMSCSLYLVFE 179
E E A REI +L+KL H NVI+L+ +VTS + S+Y+VFE
Sbjct: 61 -EREGFPITAIREIKILKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFE 119
Query: 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILK 239
YM+HDL GLA G++F+ PQ+KCYMKQLL+GL +CH N VLHRDIKGSNLLIDN+G LK
Sbjct: 120 YMDHDLTGLADRPGMRFTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLK 179
Query: 240 IADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP 299
+ADFGLA + +T+RV+TLWYRPPELLLG+T YG VD+WS GCI AELL GKP
Sbjct: 180 LADFGLARSFSNDHNGNLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKP 239
Query: 300 IMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSL 358
I+PG+ E EQL KIF +CG+P E W +K+P FKP + KR + E FK F +L
Sbjct: 240 ILPGKNEPEQLSKIFDVCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLAL 299
Query: 359 PLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQR 418
L+E +L++DP R +A AL++E+F ++P C+P SLPKY S E K + ++ R
Sbjct: 300 DLLEKMLTLDPAQRISAQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMR--- 356
Query: 419 GLSGKANAVDGAKRVRHRDRAGRAIP 444
+A+ ++ +H GR P
Sbjct: 357 ----QADEAAKRQKTQHPQPHGRLPP 378
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 350 bits (897), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 178/341 (52%), Positives = 230/341 (67%), Gaps = 17/341 (4%)
Query: 92 WTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILV 150
W R + FEKL++IG+GTY VY A+++ TG+IVALKK+R DN E E A REI +
Sbjct: 18 WGSRSVDCFEKLEQIGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREGFPITAIREIKI 76
Query: 151 LRKLDHPNVIKLEGLVTS--------------RMSCSLYLVFEYMEHDLAGLAACQGVKF 196
L+KL H NVI L+ +VTS + +Y+VFEYM+HDL GLA G++F
Sbjct: 77 LKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDLTGLADRPGLRF 136
Query: 197 SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256
+ PQ+KCYMKQLL+GL +CH N VLHRDIKGSNLLIDN+G LK+ADFGLA Y
Sbjct: 137 TVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGLARSYSHDHTGN 196
Query: 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL 316
+T+RV+TLWYRPPELLLGAT YG +D+WS GCI AELL GKPI+PG+TE EQL+KI++L
Sbjct: 197 LTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKTENEQLNKIYEL 256
Query: 317 CGSPSEEYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
CGSP E W SK+P K +P KR + E ++ F +L L+E +L +DP R A
Sbjct: 257 CGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKMLVLDPSQRICA 316
Query: 376 TAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARR 416
AL++E+F T+P C+P SLP Y S E K + ++ R
Sbjct: 317 KDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMRH 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9NYV4|CDK12_HUMAN Cyclin-dependent kinase 12 OS=Homo sapiens GN=CDK12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 285 bits (730), Expect = 4e-76, Method: Compositional matrix adjust.
Identities = 154/339 (45%), Positives = 204/339 (60%), Gaps = 16/339 (4%)
Query: 91 DWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REIL 149
DW R + F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 718 DWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIK 776
Query: 150 VLRKLDHPNVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLAACQGVKFSEPQV 201
+LR+L H +V+ ++ +VT + + YLVFEYM+HDL GL V FSE +
Sbjct: 777 ILRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 836
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261
K +MKQL+ GLE+CH LHRDIK SN+L++N G +K+ADFGLA Y+ +P T++V
Sbjct: 837 KSFMKQLMEGLEYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKV 896
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS 321
+TLWYRPPELLLG Y +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 897 ITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPC 956
Query: 322 EEYWKKS-KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
W KLP KP++ Y+R + E F PS++L L++ +L++DP R TA L
Sbjct: 957 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQ 1016
Query: 381 SEFF-NTEPYACEPSSLPKYPPSKEMDVKLREEEARRQR 418
S+F + E P LP + E+ K R RRQR
Sbjct: 1017 SDFLKDVELSKMAPPDLPHWQDCHELWSKKR----RRQR 1051
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q3MJK5|CDK12_RAT Cyclin-dependent kinase 12 OS=Rattus norvegicus GN=Cdk12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (727), Expect = 8e-76, Method: Compositional matrix adjust.
Identities = 153/339 (45%), Positives = 204/339 (60%), Gaps = 16/339 (4%)
Query: 91 DWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REIL 149
DW R + F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 714 DWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIK 772
Query: 150 VLRKLDHPNVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLAACQGVKFSEPQV 201
+LR+L H +V+ ++ +VT + + YLVFEYM+HDL GL V FSE +
Sbjct: 773 ILRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 832
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261
K +MKQL+ GL++CH LHRDIK SN+L++N G +K+ADFGLA Y+ +P T++V
Sbjct: 833 KSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKV 892
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS 321
+TLWYRPPELLLG Y +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 893 ITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPC 952
Query: 322 EEYWKKS-KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
W KLP KP++ Y+R + E F PS++L L++ +L++DP R TA L
Sbjct: 953 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQ 1012
Query: 381 SEFF-NTEPYACEPSSLPKYPPSKEMDVKLREEEARRQR 418
S+F + E P LP + E+ K R RRQR
Sbjct: 1013 SDFLKDVELSKMAPPDLPHWQDCHELWSKKR----RRQR 1047
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors (By similarity). Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (727), Expect = 9e-76, Method: Compositional matrix adjust.
Identities = 153/339 (45%), Positives = 205/339 (60%), Gaps = 16/339 (4%)
Query: 91 DWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REIL 149
DW R + F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 719 DWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIK 777
Query: 150 VLRKLDHPNVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLAACQGVKFSEPQV 201
+LR+L H +V+ ++ +VT + + YLVFEYM+HDL GL V FSE +
Sbjct: 778 ILRQLIHRSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 837
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261
K +MKQL+ GL++CH LHRDIK SN+L++N G +K+ADFGLA Y+ +P T++V
Sbjct: 838 KSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKV 897
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS 321
+TLWYRPPELLLG Y +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 898 ITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPC 957
Query: 322 EEYWKKS-KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
W KLP KP++ Y+R + E F PS++L L++ +L++DP R TA L
Sbjct: 958 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQ 1017
Query: 381 SEFF-NTEPYACEPSSLPKYPPSKEMDVKLREEEARRQR 418
S+F + E +P LP + E+ K R RRQR
Sbjct: 1018 SDFLKDVELSKMDPPDLPHWQDCHELWSKKR----RRQR 1052
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 284 bits (727), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 153/339 (45%), Positives = 204/339 (60%), Gaps = 16/339 (4%)
Query: 91 DWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REIL 149
DW R + F+ + IG+GTY VYKA+D TG++VALKKVR DN E E A REI
Sbjct: 714 DWGKRCVDKFDIIGIIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIK 772
Query: 150 VLRKLDHPNVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLAACQGVKFSEPQV 201
+LR+L H +V+ ++ +VT + + YLVFEYM+HDL GL V FSE +
Sbjct: 773 ILRQLVHQSVVNMKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 832
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261
K +MKQL+ GL++CH LHRDIK SN+L++N G +K+ADFGLA Y+ +P T++V
Sbjct: 833 KSFMKQLMEGLDYCHKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKV 892
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS 321
+TLWYRPPELLLG Y +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 893 ITLWYRPPELLLGEERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPC 952
Query: 322 EEYWKKS-KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
W KLP KP++ Y+R + E F PS++L L++ +L++DP R TA L
Sbjct: 953 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQ 1012
Query: 381 SEFF-NTEPYACEPSSLPKYPPSKEMDVKLREEEARRQR 418
S+F + E P LP + E+ K R RRQR
Sbjct: 1013 SDFLKDVELSKMAPPDLPHWQDCHELWSKKR----RRQR 1047
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 457 | ||||||
| 118483184 | 586 | unknown [Populus trichocarpa] | 0.989 | 0.771 | 0.808 | 0.0 | |
| 255540111 | 2299 | DNA binding protein, putative [Ricinus c | 0.975 | 0.193 | 0.803 | 0.0 | |
| 224136278 | 551 | predicted protein [Populus trichocarpa] | 0.916 | 0.760 | 0.851 | 0.0 | |
| 224122126 | 538 | predicted protein [Populus trichocarpa] | 0.892 | 0.758 | 0.877 | 0.0 | |
| 357464961 | 570 | hypothetical protein MTR_3g098760 [Medic | 0.908 | 0.728 | 0.837 | 0.0 | |
| 356516507 | 559 | PREDICTED: probable serine/threonine-pro | 0.888 | 0.726 | 0.858 | 0.0 | |
| 356508849 | 559 | PREDICTED: probable serine/threonine-pro | 0.960 | 0.785 | 0.780 | 0.0 | |
| 356511524 | 555 | PREDICTED: probable serine/threonine-pro | 0.949 | 0.781 | 0.756 | 0.0 | |
| 225456439 | 587 | PREDICTED: probable serine/threonine-pro | 0.995 | 0.775 | 0.755 | 0.0 | |
| 356527598 | 555 | PREDICTED: probable serine/threonine-pro | 0.967 | 0.796 | 0.748 | 0.0 |
| >gi|118483184|gb|ABK93496.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1978), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/475 (80%), Positives = 410/475 (86%), Gaps = 23/475 (4%)
Query: 1 MGCVCGKG---DRRSSPVNR---RGSERASVTVTVSSGAVVSGNVVRLGKERARAETEKN 54
MGCV GK DR+S V+ R S+ V VT S A V ++ +E+A T+K
Sbjct: 1 MGCVLGKPASRDRQSREVSSDRDRSSDEPPVDVTGSVNAAV-----KVKREKATTSTQKQ 55
Query: 55 R--RHTGDF------GPPERRRPHSES----QQGWPSWLMAVAGDAIRDWTPRRANTFEK 102
RHTGDF G ERRRP E QQGWPSWLMAVAGDAI +WTPRRANTFEK
Sbjct: 56 NAARHTGDFPAVDVQGTTERRRPRPEVSLCYQQGWPSWLMAVAGDAIGEWTPRRANTFEK 115
Query: 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
LDKIGQGTYSNVYKARDL+TGKIVALKKVRFDNLEPESVKFMAREILVLR+LDHPNV+KL
Sbjct: 116 LDKIGQGTYSNVYKARDLITGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVLKL 175
Query: 163 EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
EGLVTSRMSCSLYLVFEYMEHDLAGLAA +GVKF+EPQ+KCYMKQLLSG+EHCHN+GVLH
Sbjct: 176 EGLVTSRMSCSLYLVFEYMEHDLAGLAARRGVKFTEPQIKCYMKQLLSGIEHCHNHGVLH 235
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGV 282
RDIKGSNLLIDN+GILKIADFGLATFYDP K PMTSRVVTLWYRPPELLLGATYYG GV
Sbjct: 236 RDIKGSNLLIDNEGILKIADFGLATFYDPDRKVPMTSRVVTLWYRPPELLLGATYYGAGV 295
Query: 283 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342
DLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY
Sbjct: 296 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 355
Query: 343 KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPS 402
KRCI ETFKDFP+S+LPLIETLLS+DPD+R TATAALNSEFF TEPYACEPSSLPKYPPS
Sbjct: 356 KRCIVETFKDFPTSALPLIETLLSVDPDDRVTATAALNSEFFTTEPYACEPSSLPKYPPS 415
Query: 403 KEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
KE+DVKLR+EEARRQRGL GK NAVDGA++ R RDRAG AIPAPEANAE NLD
Sbjct: 416 KELDVKLRDEEARRQRGLGGKGNAVDGARKTRIRDRAGWAIPAPEANAENPANLD 470
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540111|ref|XP_002511120.1| DNA binding protein, putative [Ricinus communis] gi|223550235|gb|EEF51722.1| DNA binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1956), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 381/474 (80%), Positives = 402/474 (84%), Gaps = 28/474 (5%)
Query: 1 MGCVCGK----GDRRS----SPVNRRGSERASVTVTVSSGAVVSGNVVRLGKERARAETE 52
MGCV GK GDRRS SP R S S TVT GAV V R KER +A
Sbjct: 1 MGCVIGKTTTAGDRRSRAVGSPNRGRSSGDTSATVT---GAV--NAVTRNKKERQKA--- 52
Query: 53 KNRRHTGDFGPPERRRPHSES---------QQGWPSWLMAVAGDAIRDWTPRRANTFEKL 103
R+ GDF QQGWPSWLMAVAGDAI DWTPRRANTFEKL
Sbjct: 53 ---RNAGDFHTDVLTAERRRPRPPEPVLGYQQGWPSWLMAVAGDAIGDWTPRRANTFEKL 109
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
DKIGQGTYSNVYKARDL+TGKIVALKKVRFDNLEPESVKFMAREILVLR+LDHPNV+KLE
Sbjct: 110 DKIGQGTYSNVYKARDLITGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVLKLE 169
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
GLVTSRMSCSLYLVFEYM+HDLAGLAACQGVKF+E Q+KCY+KQLL+GLEHCH GVLHR
Sbjct: 170 GLVTSRMSCSLYLVFEYMDHDLAGLAACQGVKFNEAQIKCYVKQLLAGLEHCHKRGVLHR 229
Query: 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVD 283
DIKGSNLLIDN+G+LKIADFGLATF+DP K PMTSRVVTLWYRPPELLLGATYY VGVD
Sbjct: 230 DIKGSNLLIDNEGVLKIADFGLATFFDPERKVPMTSRVVTLWYRPPELLLGATYYSVGVD 289
Query: 284 LWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYK 343
LWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYK
Sbjct: 290 LWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYK 349
Query: 344 RCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSK 403
RCIAETFKDFP +SLPL+ETLLSIDPDNRGTAT ALNSEFFNTEP ACEPSSLPKYPPSK
Sbjct: 350 RCIAETFKDFPPASLPLVETLLSIDPDNRGTATTALNSEFFNTEPRACEPSSLPKYPPSK 409
Query: 404 EMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
EMDVKLREEEARRQ+GL GK+NAVDGA+RV+ RDR GRAIP PEANAEI +N+D
Sbjct: 410 EMDVKLREEEARRQKGLGGKSNAVDGARRVKIRDRVGRAIPVPEANAEIPSNVD 463
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136278|ref|XP_002322289.1| predicted protein [Populus trichocarpa] gi|222869285|gb|EEF06416.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 755 bits (1949), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/431 (85%), Positives = 390/431 (90%), Gaps = 12/431 (2%)
Query: 39 VVRLGKERARAETEKNR--RHTGDF------GPPERRRPHSES----QQGWPSWLMAVAG 86
V++ +E+A T+K RHTGDF G ERRRP E QQGWPSWLMAVAG
Sbjct: 5 AVKVKREKATTSTQKQNAARHTGDFPAVDVQGTTERRRPRPEVSLCYQQGWPSWLMAVAG 64
Query: 87 DAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAR 146
DAI +WTPRRANTFEKLDKIGQGTYSNVYKARDL+TGKIVALKKVRFDNLEPESVKFMAR
Sbjct: 65 DAIGEWTPRRANTFEKLDKIGQGTYSNVYKARDLITGKIVALKKVRFDNLEPESVKFMAR 124
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMK 206
EILVLR+LDHPNV+KLEGLVTSRMSCSLYLVFEYMEHDLAGLAA +GVKF+EPQ+KCYMK
Sbjct: 125 EILVLRRLDHPNVLKLEGLVTSRMSCSLYLVFEYMEHDLAGLAARRGVKFTEPQIKCYMK 184
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
QLLSG+EHCHN+GVLHRDIKGSNLLIDN+GILKIADFGLATFYDP K PMTSRVVTLWY
Sbjct: 185 QLLSGIEHCHNHGVLHRDIKGSNLLIDNEGILKIADFGLATFYDPDRKVPMTSRVVTLWY 244
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
RPPELLLGATYYG GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK
Sbjct: 245 RPPELLLGATYYGAGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 304
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386
KSKLPNATLFKPQQPYKRCI ETFKDFP+S+LPLIETLLS+DPD+R TATAALNSEFF T
Sbjct: 305 KSKLPNATLFKPQQPYKRCIVETFKDFPTSALPLIETLLSVDPDDRVTATAALNSEFFTT 364
Query: 387 EPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAP 446
EPYACEPSSLPKYPPSKE+DVKLR+EEARRQRGL GK NAVDGA++ R RDRAG AIPAP
Sbjct: 365 EPYACEPSSLPKYPPSKELDVKLRDEEARRQRGLGGKGNAVDGARKTRIRDRAGWAIPAP 424
Query: 447 EANAEIQTNLD 457
EANAE NLD
Sbjct: 425 EANAENPANLD 435
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122126|ref|XP_002318759.1| predicted protein [Populus trichocarpa] gi|222859432|gb|EEE96979.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1937), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/418 (87%), Positives = 383/418 (91%), Gaps = 10/418 (2%)
Query: 50 ETEKNRRHTGDF------GPPERRRPHSES----QQGWPSWLMAVAGDAIRDWTPRRANT 99
+ +K R TGDF G ERRRP E+ QQGWPSWLMAVAGDAI DWTPRRANT
Sbjct: 5 QRQKATRDTGDFQVEDVQGGTERRRPRPEASLKCQQGWPSWLMAVAGDAIGDWTPRRANT 64
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
FEKLDKIGQGTYSNVYKARDL+TGKIVALKKVRFDNLEPESVKFMAREILVLR+LDHPNV
Sbjct: 65 FEKLDKIGQGTYSNVYKARDLITGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNV 124
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
+K+EGLVTSRMSCSLYLVFEYMEHDLAGL A QGVKF+EPQVKCYM QLLSGLEHCHN+
Sbjct: 125 LKIEGLVTSRMSCSLYLVFEYMEHDLAGLVARQGVKFTEPQVKCYMTQLLSGLEHCHNHR 184
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
VLHRDIKGSNLLI+NDG+LKIADFGLATFYDP K PMTSRVVTLWYRPPELLLGAT YG
Sbjct: 185 VLHRDIKGSNLLINNDGVLKIADFGLATFYDPDRKVPMTSRVVTLWYRPPELLLGATSYG 244
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339
V VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ
Sbjct: 245 VSVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 304
Query: 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKY 399
QPYKRCIAETFKDFP+SSLPLIETLLSIDPD+R TATAALNSEFF TEPYACEPSSLPKY
Sbjct: 305 QPYKRCIAETFKDFPASSLPLIETLLSIDPDDRVTATAALNSEFFTTEPYACEPSSLPKY 364
Query: 400 PPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
PPSKE+DVKLR+EEARRQRGLSGKANAVDGA+RVR RDR GRAIPAPEANAE NLD
Sbjct: 365 PPSKELDVKLRDEEARRQRGLSGKANAVDGARRVRIRDRPGRAIPAPEANAENPANLD 422
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464961|ref|XP_003602762.1| hypothetical protein MTR_3g098760 [Medicago truncatula] gi|355491810|gb|AES73013.1| hypothetical protein MTR_3g098760 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 738 bits (1906), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/431 (83%), Positives = 393/431 (91%), Gaps = 16/431 (3%)
Query: 35 VSGNVVRLGKERARAETEKNRRHTGDFG----PPERRRPH----SESQQGWPSWLMAVAG 86
V+ NVVR+ E +KNR HTGDF ERR+P S +QQGWPSWLMAVAG
Sbjct: 31 VTNNVVRV------RERQKNR-HTGDFPVNLPALERRKPMLDPLSVNQQGWPSWLMAVAG 83
Query: 87 DAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAR 146
+AI DWTPRRAN+FEKL KIGQGTYSNVYKA+DL+TGKIVALKKVRFDNLEPESVKFMAR
Sbjct: 84 EAIGDWTPRRANSFEKLAKIGQGTYSNVYKAKDLVTGKIVALKKVRFDNLEPESVKFMAR 143
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMK 206
EILVLRKLDHPNV+KLEGLVTSRMSCSLYLVFEYMEHDLAGL+A QGVKF+EPQVKC+MK
Sbjct: 144 EILVLRKLDHPNVVKLEGLVTSRMSCSLYLVFEYMEHDLAGLSAGQGVKFTEPQVKCFMK 203
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
QLLSGLEHCH+ GVLHRDIKGSNLLIDN+GILKIADFGLATFY+P KQ MTSRVVTLWY
Sbjct: 204 QLLSGLEHCHSRGVLHRDIKGSNLLIDNEGILKIADFGLATFYNPNKKQSMTSRVVTLWY 263
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
RPPELLLGAT+YGVG+DLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP+EEYW+
Sbjct: 264 RPPELLLGATFYGVGIDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPAEEYWR 323
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386
K KLPNAT+FKPQQPYKRCI+ETFKDFP SSLPLI++LL+IDPD RGTA+AALN EFF T
Sbjct: 324 KHKLPNATIFKPQQPYKRCISETFKDFPPSSLPLIDSLLAIDPDRRGTASAALNHEFFTT 383
Query: 387 EPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAP 446
EPYACEPSSLPKYPPSKE+DVK+R+EEARRQ+ L+GKANAVDGAKRVR R+R GRAIPAP
Sbjct: 384 EPYACEPSSLPKYPPSKELDVKMRDEEARRQKALNGKANAVDGAKRVRARER-GRAIPAP 442
Query: 447 EANAEIQTNLD 457
EANAEIQTNLD
Sbjct: 443 EANAEIQTNLD 453
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516507|ref|XP_003526935.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/416 (85%), Positives = 386/416 (92%), Gaps = 10/416 (2%)
Query: 50 ETEKNRRHTGDFG----PPERRRPHSE----SQQGWPSWLMAVAGDAIRDWTPRRANTFE 101
E E+NR HTGDF ERR+P + +QQGWPSWLMAVAG+AI DWTPRRANTFE
Sbjct: 39 EKERNR-HTGDFPGTLPAAERRKPRLDPCAVTQQGWPSWLMAVAGEAIGDWTPRRANTFE 97
Query: 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
KL KIGQGTYSNVYKARDL+TGKIVALKKVRFDNLEPESVKFMAREILVLR+LDHPNV+K
Sbjct: 98 KLAKIGQGTYSNVYKARDLVTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVK 157
Query: 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
LEGLVTSRMSCSLYLVFEYMEHDLAGLAA QGVKF+EPQVKC+MKQLLSGLEHCH+ GVL
Sbjct: 158 LEGLVTSRMSCSLYLVFEYMEHDLAGLAAGQGVKFTEPQVKCFMKQLLSGLEHCHSRGVL 217
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVG 281
HRDIKGSNLLIDN+GILKIADFGLATFYDP +KQ MTSRVVTLWYRPPELLLGAT YGVG
Sbjct: 218 HRDIKGSNLLIDNEGILKIADFGLATFYDPKIKQAMTSRVVTLWYRPPELLLGATVYGVG 277
Query: 282 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341
+DLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW+K +LPNAT+FKPQQP
Sbjct: 278 IDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWRKYRLPNATIFKPQQP 337
Query: 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPP 401
YKRCI ET+KDFP SSLPLIETLL+IDPD+R TA+AALNSEFF TEPYACEPSSLPKYPP
Sbjct: 338 YKRCILETYKDFPPSSLPLIETLLAIDPDDRCTASAALNSEFFTTEPYACEPSSLPKYPP 397
Query: 402 SKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
SKE+DVKLR+EEARRQ+ L+GKA+AVDGAK+VR R+R GRA+PAPEANAEIQTNLD
Sbjct: 398 SKELDVKLRDEEARRQKALNGKASAVDGAKKVRVRER-GRAVPAPEANAEIQTNLD 452
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508849|ref|XP_003523166.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 726 bits (1873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/470 (78%), Positives = 400/470 (85%), Gaps = 31/470 (6%)
Query: 1 MGCV----CGKGDRRSSPVNRRGSERASVTVTVSSGAVVSGNVVRLGKERARAETEKNRR 56
MGCV G GD+R RR +R +GAV GN +E+ R R
Sbjct: 1 MGCVLGTPAGAGDQRL----RRSEKR--------NGAVDEGNNAVGLREKER------NR 42
Query: 57 HTGDFG----PPERRRPHSE----SQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQ 108
HTGDF P RR+P + +QQGWPSWLMAVAG+AI DWTPRRANTFEKL KIGQ
Sbjct: 43 HTGDFPGTLPAPGRRKPRLDPCAVTQQGWPSWLMAVAGEAIGDWTPRRANTFEKLAKIGQ 102
Query: 109 GTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTS 168
GTYSNVYKARDL+TGKIVALKKVRFDNLEPESVKFMAREILVLR+LDHPNV+KLEGLVTS
Sbjct: 103 GTYSNVYKARDLVTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVKLEGLVTS 162
Query: 169 RMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGS 228
RMSCSLYLVFEYMEHDLAGLAA QGVKF+EPQVKC+MKQLLSGLEHCH+ GVLHRDIKGS
Sbjct: 163 RMSCSLYLVFEYMEHDLAGLAAGQGVKFTEPQVKCFMKQLLSGLEHCHSRGVLHRDIKGS 222
Query: 229 NLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAG 288
NLLIDN+GILKIADFGLATFYDP +KQ MTSRVVTLWYRPPELLLGAT YGVG+DLWSAG
Sbjct: 223 NLLIDNEGILKIADFGLATFYDPKIKQAMTSRVVTLWYRPPELLLGATVYGVGIDLWSAG 282
Query: 289 CILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAE 348
CILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW+K +LPNAT+FKPQQPYKRCI E
Sbjct: 283 CILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWRKYRLPNATIFKPQQPYKRCILE 342
Query: 349 TFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVK 408
T+KDFP SSLPLIETLL+IDP++RGTA+A LNSEFF TEPYACEPSSLPKYPPSKE+DVK
Sbjct: 343 TYKDFPPSSLPLIETLLAIDPEDRGTASATLNSEFFTTEPYACEPSSLPKYPPSKELDVK 402
Query: 409 LREEEARRQRGLSGKANAVDGAKR-VRHRDRAGRAIPAPEANAEIQTNLD 457
LR+EEARRQ+ L+GKA+AVDGAK+ GRA+PAPEANAEIQTNLD
Sbjct: 403 LRDEEARRQKALNGKASAVDGAKKVRVRERERGRAVPAPEANAEIQTNLD 452
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356511524|ref|XP_003524475.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 714 bits (1843), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/469 (75%), Positives = 387/469 (82%), Gaps = 35/469 (7%)
Query: 1 MGCVCGK----GDRRSSPVNRRGSERASVTVTVSSGAVVSGNVVRLGKERARAETEKNRR 56
MGC GK GDRR S A SG G A+ ++
Sbjct: 1 MGCALGKPADAGDRRRH-----------------STATTSG-----GHNPAKVREKQKPL 38
Query: 57 HTGDFG----PPERRRPH----SESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQ 108
H G+ PERRRP + S QGWP WLMAVAGDAIRDWTPRRANTFEKL KIGQ
Sbjct: 39 HAGELSGVIPAPERRRPRLDSFTASHQGWPPWLMAVAGDAIRDWTPRRANTFEKLAKIGQ 98
Query: 109 GTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTS 168
GTYSNVYKA+DL++GKIVALKKVRFDN+E ESVKFMAREILVLR+LDHPNV+KLEGLVTS
Sbjct: 99 GTYSNVYKAKDLVSGKIVALKKVRFDNVEAESVKFMAREILVLRRLDHPNVVKLEGLVTS 158
Query: 169 RMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGS 228
R+S SLYLVFEYMEHDLAGL+A GVKFSEPQVKCYMKQLLSGLEHCH+ GVLHRDIKGS
Sbjct: 159 RISSSLYLVFEYMEHDLAGLSAAVGVKFSEPQVKCYMKQLLSGLEHCHSRGVLHRDIKGS 218
Query: 229 NLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAG 288
NLLIDN+GILKIADFGLATF+DP K PMTSRVVTLWYRPPELLLG+T YGVGVDLWSAG
Sbjct: 219 NLLIDNEGILKIADFGLATFFDPKKKHPMTSRVVTLWYRPPELLLGSTSYGVGVDLWSAG 278
Query: 289 CILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAE 348
CILAELLAGKP MPGRTEVEQLHKIFKLCGSPS+EYWKK +LPNATL+KPQQPYKR I E
Sbjct: 279 CILAELLAGKPTMPGRTEVEQLHKIFKLCGSPSDEYWKKYRLPNATLYKPQQPYKRNILE 338
Query: 349 TFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVK 408
TFKDFPSSSLPLIETLL+IDPD+RGT +AALNSEFF TEPYACEPS+LPKYPP+KE+D+K
Sbjct: 339 TFKDFPSSSLPLIETLLAIDPDDRGTTSAALNSEFFTTEPYACEPSNLPKYPPTKELDIK 398
Query: 409 LREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
LR+EEARRQ+ LSGK NAVDGA+RVR R+R G AIP PEAN EIQ N+D
Sbjct: 399 LRDEEARRQKALSGKTNAVDGARRVRVRER-GLAIPGPEANVEIQNNVD 446
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456439|ref|XP_002284341.1| PREDICTED: probable serine/threonine-protein kinase At1g54610 [Vitis vinifera] gi|297734482|emb|CBI15729.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 712 bits (1839), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/470 (75%), Positives = 387/470 (82%), Gaps = 15/470 (3%)
Query: 1 MGCVCGKGDRRSSPVNRRGSERASVTVTVSSGA--VVSGNVVRLGKERARAETEKNRRHT 58
MGCV K R P S+R +S+ VV G + G E AR +
Sbjct: 1 MGCVQSKRASRDDPSAAGESDRQRELEELSNALKNVVKGR--KEGMEVARGVEREKVTRA 58
Query: 59 GDFGPPERRRPHSE----SQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNV 114
GD ERRRP E SQ+GWPSWL+ GD I+DWTPR AN+FEKLDKIGQGTYSNV
Sbjct: 59 GDSPATERRRPRPEPYLRSQRGWPSWLLDALGDGIQDWTPRCANSFEKLDKIGQGTYSNV 118
Query: 115 YKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174
YKARDL+TGKIVALKKVRFDNL PESVKFM REILVLRKL+HPNVIKLEGLVTSRMSCSL
Sbjct: 119 YKARDLITGKIVALKKVRFDNLGPESVKFMGREILVLRKLNHPNVIKLEGLVTSRMSCSL 178
Query: 175 YLVFEYMEHDLAGL-------AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKG 227
YLVFEYMEHDLAGL + QG KF+EPQVKC+MKQLLSGLEHCHN GVLHRDIKG
Sbjct: 179 YLVFEYMEHDLAGLVGHGSYLSTSQGRKFTEPQVKCFMKQLLSGLEHCHNQGVLHRDIKG 238
Query: 228 SNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSA 287
SNLLI+N+GILKIADFGLATF+DP ++PMTSRVVTLWYRPPELLLGATYYGVGVDLWSA
Sbjct: 239 SNLLINNEGILKIADFGLATFFDPDRRRPMTSRVVTLWYRPPELLLGATYYGVGVDLWSA 298
Query: 288 GCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIA 347
GCILAELL GKPIMPGRTEVEQ+HKIFKLCGSPSEEYWKKSKLP+AT+FKPQQPYKRC+A
Sbjct: 299 GCILAELLGGKPIMPGRTEVEQVHKIFKLCGSPSEEYWKKSKLPHATIFKPQQPYKRCVA 358
Query: 348 ETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDV 407
E FKDFP SSLPLIE LLSIDPD+RGTAT+ALNSEFF TEPYACEPSSLPK PP+KE+DV
Sbjct: 359 EAFKDFPCSSLPLIEALLSIDPDDRGTATSALNSEFFTTEPYACEPSSLPKCPPTKEIDV 418
Query: 408 KLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
+EARRQRG+SGKAN VDG +RVR RDR GRA+PAPEANAE+Q NLD
Sbjct: 419 IKLRDEARRQRGVSGKANVVDGNRRVRARDRGGRAVPAPEANAELQANLD 468
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356527598|ref|XP_003532395.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 691 bits (1784), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/461 (74%), Positives = 380/461 (82%), Gaps = 19/461 (4%)
Query: 1 MGCVCGKGDRRSSPVNRRGSERASVTVTVSSGAVVSGNVVRLGKERARAETEKNRRHTGD 60
MGC GK P + G T T S G N V++ R + + +G
Sbjct: 1 MGCKLGK------PADA-GDRLRHNTATTSGG----NNAVKV---REKQKPPDAGELSGV 46
Query: 61 FGPPERRR----PHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYK 116
PERR + S QGWP WLMAVAGD+I DWTPRRANTFEKL KIGQGTYSNVYK
Sbjct: 47 IPAPERRTLRLDSFTASHQGWPPWLMAVAGDSIGDWTPRRANTFEKLAKIGQGTYSNVYK 106
Query: 117 ARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176
A+DL++GKIVALKKVRFDNLE ESVKFMAREILVLR+LDHPNV+KLEGLVTSR+S S+YL
Sbjct: 107 AKDLVSGKIVALKKVRFDNLEAESVKFMAREILVLRRLDHPNVVKLEGLVTSRISSSIYL 166
Query: 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236
VFEYMEHDLAGL+A GVKFSEPQVKCYMKQLLSGLEHCH+ GVLHRDIKGSNLLIDN+G
Sbjct: 167 VFEYMEHDLAGLSASVGVKFSEPQVKCYMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNEG 226
Query: 237 ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA 296
ILKIADFGLATF+DP K PMTSRVVTLWYRPPELLLG+T YGVGVDLWS GCILAELL
Sbjct: 227 ILKIADFGLATFFDPKQKHPMTSRVVTLWYRPPELLLGSTSYGVGVDLWSVGCILAELLT 286
Query: 297 GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSS 356
GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK +LPNA L+KPQQPYKR ETFKDFPSS
Sbjct: 287 GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKYRLPNAALYKPQQPYKRNTLETFKDFPSS 346
Query: 357 SLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARR 416
SLPLIETLL+IDPD+RG+ +AALNSEFF T PYACEPS+LPKYPP+KE+D+KLR+E+ARR
Sbjct: 347 SLPLIETLLAIDPDDRGSTSAALNSEFFTTVPYACEPSNLPKYPPTKELDIKLRDEKARR 406
Query: 417 QRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
Q+ LSGK NAVDGA+RVR R+R G A PAPEAN EIQ NLD
Sbjct: 407 QKALSGKTNAVDGARRVRVRER-GLADPAPEANVEIQNNLD 446
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 457 | ||||||
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 1.0 | 0.787 | 0.705 | 4e-177 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.901 | 0.719 | 0.718 | 3.4e-164 | |
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.814 | 0.536 | 0.742 | 2.9e-159 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.820 | 0.525 | 0.708 | 2.2e-150 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.870 | 0.537 | 0.647 | 4.2e-143 | |
| TAIR|locus:2096199 | 593 | AT3G05050 [Arabidopsis thalian | 0.901 | 0.694 | 0.656 | 6.8e-143 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.835 | 0.593 | 0.678 | 1.4e-142 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.829 | 0.617 | 0.660 | 1e-139 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.888 | 0.580 | 0.619 | 3.6e-137 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.824 | 0.531 | 0.637 | 4.8e-133 |
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1720 (610.5 bits), Expect = 4.0e-177, P = 4.0e-177
Identities = 333/472 (70%), Positives = 379/472 (80%)
Query: 1 MGCVCGK---GDRRSS-------PVNRRGSERXXXXXXXXXXXXXXXXXXRLGKERARAE 50
MGCV K GD+R P + R +E + K+ +
Sbjct: 1 MGCVLCKESTGDKRKHNNPDEPPPADLRNTEDLPSSSSTTTAAISVEIGEKKKKDLDSIQ 60
Query: 51 TEKNRR--HTGDFGPPERRRPHSE--SQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKI 106
+ RR HTGDF RRP + +GWP WL+A GD+I+D TPRRA T+EKL+KI
Sbjct: 61 IQPERRTWHTGDFSAGSSRRPGMSLRTPEGWPPWLIAACGDSIKDLTPRRATTYEKLEKI 120
Query: 107 GQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLV 166
GQGTYSNVYKA+DLL+GKIVALKKVRFDNLE ESVKFMAREILVLR+L+HPNVIKL+GLV
Sbjct: 121 GQGTYSNVYKAKDLLSGKIVALKKVRFDNLEAESVKFMAREILVLRRLNHPNVIKLQGLV 180
Query: 167 TSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIK 226
TSR+SCSLYLVFEYMEHDL+GLAA QG+KF PQVKC+MKQLLSGLEHCH+ GVLHRDIK
Sbjct: 181 TSRVSCSLYLVFEYMEHDLSGLAATQGLKFDLPQVKCFMKQLLSGLEHCHSRGVLHRDIK 240
Query: 227 GSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWS 286
GSNLLIDNDGILKIADFGLATFYDP KQ MTSRVVTLWYRPPELLLGAT YG GVDLWS
Sbjct: 241 GSNLLIDNDGILKIADFGLATFYDPKQKQTMTSRVVTLWYRPPELLLGATSYGTGVDLWS 300
Query: 287 AGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCI 346
AGCI+AELLAGKP+MPGRTEVEQLHKIFKLCGSPS+ YWKK +LPNATLFKPQ PYKRC+
Sbjct: 301 AGCIMAELLAGKPVMPGRTEVEQLHKIFKLCGSPSDSYWKKYRLPNATLFKPQHPYKRCV 360
Query: 347 AETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMD 406
AE F F SS+ L+ETLL+IDP +RGT+T+ALNSEFF TEP C+PSSLPKYPPSKE++
Sbjct: 361 AEAFNGFTPSSVHLVETLLTIDPADRGTSTSALNSEFFTTEPLPCDPSSLPKYPPSKELN 420
Query: 407 VKLREEEARRQRGLSGKANAVDGAKRVRHR-DRAGRAIPAPEANAEIQTNLD 457
VKLR+EE RRQ+GL+GK + +DGA+R+R+R DR GRAIPAPEANAE Q NLD
Sbjct: 421 VKLRDEELRRQKGLAGKGSGIDGARRIRYRGDRTGRAIPAPEANAESQANLD 472
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1598 (567.6 bits), Expect = 3.4e-164, P = 3.4e-164
Identities = 299/416 (71%), Positives = 351/416 (84%)
Query: 44 KERARAETEKNR--RHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFE 101
KER ++ ++ R + P + + GWPSWL G+A+ W PR+A+TFE
Sbjct: 60 KERKSSKGDRRRSTKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEALNGWVPRKADTFE 119
Query: 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
K+DKIGQGTYSNVYKA+D+LTGKIVALKKVRFDNLEPESVKFMAREILVLR+LDHPNV+K
Sbjct: 120 KIDKIGQGTYSNVYKAKDMLTGKIVALKKVRFDNLEPESVKFMAREILVLRRLDHPNVVK 179
Query: 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
LEGLVTSRMSCSLYLVF+YM+HDLAGLA+ VKFSE +VKC M+QL+SGLEHCH+ GVL
Sbjct: 180 LEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFSESEVKCLMRQLISGLEHCHSRGVL 239
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVG 281
HRDIKGSNLLID+ G+LKIADFGLAT +DP K+PMTSRVVTLWYR PELLLGAT YGVG
Sbjct: 240 HRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPMTSRVVTLWYRAPELLLGATDYGVG 299
Query: 282 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341
+DLWSAGCILAELLAG+PIMPGRTEVEQLHKI+KLCGSPSE+YWKK K + ++KP++P
Sbjct: 300 IDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLCGSPSEDYWKKGKFTHGAIYKPREP 359
Query: 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPP 401
YKR I ETFKDFP SSLPLI+ LLSI+P++R TA+AAL SEFF +EPYACEP+ LPKYPP
Sbjct: 360 YKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASAALKSEFFTSEPYACEPADLPKYPP 419
Query: 402 SKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
SKE+D K R+EE RRQR S KA DGA++ RHRDR+ RA+PAPEANAE+Q+N+D
Sbjct: 420 SKEIDAKRRDEETRRQRAAS-KAQG-DGARKNRHRDRSNRALPAPEANAELQSNVD 473
|
|
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1524 (541.5 bits), Expect = 2.9e-159, Sum P(2) = 2.9e-159
Identities = 286/385 (74%), Positives = 331/385 (85%)
Query: 76 GWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN 135
GWP WL +VAG+AIR W PRRA++FEKLDKIGQGTYSNVY+ARDL KIVALKKVRFDN
Sbjct: 110 GWPPWLASVAGEAIRGWVPRRADSFEKLDKIGQGTYSNVYRARDLDQKKIVALKKVRFDN 169
Query: 136 LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK 195
LEPESV+FMAREI +LR+LDHPN+IKLEGLVTSRMSCSLYLVFEYMEHDLAGLA+ +K
Sbjct: 170 LEPESVRFMAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIK 229
Query: 196 FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255
FSE QVKCY++QLL GL+HCH+ GVLHRDIKGSNLLIDN G+LKIADFGLA+F+DP Q
Sbjct: 230 FSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQ 289
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
P+TSRVVTLWYRPPELLLGAT YG VDLWSAGCILAEL AGKPIMPGRTEVEQLHKIFK
Sbjct: 290 PLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFK 349
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
LCGSP+E+YW KS+LP+AT+FKP QPYKR + ETFK+FP +L L+ETLLS++PD+RGTA
Sbjct: 350 LCGSPTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTA 409
Query: 376 TAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRH 435
TAAL SEFF+T P C+PSSLPKYPPSKE+D ++R+EE+RRQ G G + RH
Sbjct: 410 TAALKSEFFSTRPLPCDPSSLPKYPPSKELDARMRDEESRRQVG---------GNRDQRH 460
Query: 436 RDRAG----RAIPAPEANAEIQTNL 456
++R G RAIPAP+ANAE+ ++
Sbjct: 461 QERRGTKESRAIPAPDANAELVASM 485
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1450 (515.5 bits), Expect = 2.2e-150, Sum P(2) = 2.2e-150
Identities = 270/381 (70%), Positives = 323/381 (84%)
Query: 76 GWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN 135
GWPSWL +VAG+AI W PR+A++FEKL+KIGQGTYS+VYKARDL T ++VALKKVRF N
Sbjct: 139 GWPSWLASVAGEAINGWIPRKADSFEKLEKIGQGTYSSVYKARDLETNQLVALKKVRFAN 198
Query: 136 LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK 195
++P+SV+FMAREI++LR+LDHPNV+KLEGL+TSR+S S+YL+FEYMEHDLAGLA+ G+
Sbjct: 199 MDPDSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGIN 258
Query: 196 FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255
FSE Q+KCYMKQLL GLEHCH+ GVLHRDIKGSNLL+D++ LKI DFGLA FY KQ
Sbjct: 259 FSEAQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQ 318
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
P+TSRVVTLWYRPPELLLG+T YGV VDLWS GCILAEL GKPIMPGRTEVEQLHKIFK
Sbjct: 319 PLTSRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFK 378
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
LCGSPSEEYWK SKLP+AT+FKPQQPYKRC+AETFK PSS+L L+E LL+++PD RGT
Sbjct: 379 LCGSPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTT 438
Query: 376 TAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRH 435
+AL SEFF T P A +PSSLPKY P KE+DVK +EEEA+R++ S K N D +K+V
Sbjct: 439 ASALESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQN--D-SKQV-- 493
Query: 436 RDRAGRAIPAPEANAEIQTNL 456
R +A+PAP++NAE T++
Sbjct: 494 -SRESKAVPAPDSNAESLTSI 513
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1399 (497.5 bits), Expect = 4.2e-143, P = 4.2e-143
Identities = 261/403 (64%), Positives = 324/403 (80%)
Query: 55 RRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNV 114
+R + P + R + GWPSWL++VAG+++ DW PRRANTFEKL+KIGQGTYS+V
Sbjct: 170 KRGSSIVSPKDAER--KQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEKIGQGTYSSV 227
Query: 115 YKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174
Y+ARDLL KIVALKKVRFD + ESVKFMAREI+V+R+LDHPNV+KLEGL+T+ +S SL
Sbjct: 228 YRARDLLHNKIVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAPVSSSL 287
Query: 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN 234
YLVFEYM+HDL GL++ GVKF+EPQVKCYM+QLLSGLEHCH+ GVLHRDIKGSNLLID+
Sbjct: 288 YLVFEYMDHDLLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSNLLIDS 347
Query: 235 DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL 294
G+LKIADFGLATF+DP +TS VVTLWYRPPELLLGA++YGVGVDLWS GCIL EL
Sbjct: 348 KGVLKIADFGLATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGCILGEL 407
Query: 295 LAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFP 354
AGKPI+PG+TEVEQLHKIFKLCGSP+E YW+K KLP++ FK PY+R ++E FKDFP
Sbjct: 408 YAGKPILPGKTEVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEMFKDFP 467
Query: 355 SSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEA 414
+S L L+ETLLSIDPD+R +A AL SE+F T+P+AC+PS+LPKYPPSKE+D K+R+E
Sbjct: 468 ASVLSLLETLLSIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEIDAKMRDEAK 527
Query: 415 RRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNLD 457
R+Q + K D R+ H +R + +P +AN + ++
Sbjct: 528 RQQPMRAEKQERQDSMTRISH-ER--KFVPPVKANNSLSMTME 567
|
|
| TAIR|locus:2096199 AT3G05050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1397 (496.8 bits), Expect = 6.8e-143, P = 6.8e-143
Identities = 281/428 (65%), Positives = 327/428 (76%)
Query: 44 KERARAETE-KNRRHTGD---FGPPERRRPHSES----QQ---GWPSWLMAVAGDAIRDW 92
KE TE K R+ G+ PP+ RR + +Q GWPSWL V G+A+ W
Sbjct: 71 KENGFVVTEAKERKSKGERKRSKPPDPRRSNPPKNLLGEQVAAGWPSWLSEVCGEALSGW 130
Query: 93 TPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLR 152
PR+A++FEK+DKIG GTYSNVYKA+D LTG IVALKKVR D E ES+KFMAREIL+LR
Sbjct: 131 LPRKADSFEKIDKIGSGTYSNVYKAKDSLTGNIVALKKVRCDVNERESLKFMAREILILR 190
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
+LDHPNVIKLEGLVTSRMS SLYLVF YM+HDLAGLAA +KF+E QVKCYMKQLLSGL
Sbjct: 191 RLDHPNVIKLEGLVTSRMSSSLYLVFRYMDHDLAGLAASPEIKFTEQQVKCYMKQLLSGL 250
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELL 272
EHCHN GVLHRDIKGSNLLID+ G+L+I DFGLATF+D +Q MT+RVVTLWYR PELL
Sbjct: 251 EHCHNRGVLHRDIKGSNLLIDDGGVLRIGDFGLATFFDASKRQEMTNRVVTLWYRSPELL 310
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332
G Y VGVDLWSAGCILAELLAG+ IMPGR EVEQLH+I+KLCGSPSEEYWKK +LP+
Sbjct: 311 HGVVEYSVGVDLWSAGCILAELLAGRAIMPGRNEVEQLHRIYKLCGSPSEEYWKKIRLPS 370
Query: 333 A---TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389
KP YKR I E +KDF +L L++TLL++DP R TAT L S+FF TEP
Sbjct: 371 THKHAHHKPLPQYKRRIREVYKDFSPEALSLLDTLLALDPAERQTATDVLMSDFFTTEPL 430
Query: 390 ACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEAN 449
AC+PS LPKYPPSKE+D K R+EE RRQR + KA G +R+R R+RA RA+PAPEAN
Sbjct: 431 ACQPSDLPKYPPSKEIDAKRRDEEYRRQRE-ARKAQGESG-RRMRPRERAPRAMPAPEAN 488
Query: 450 AEIQTNLD 457
AE Q+N+D
Sbjct: 489 AENQSNID 496
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1394 (495.8 bits), Expect = 1.4e-142, P = 1.4e-142
Identities = 262/386 (67%), Positives = 316/386 (81%)
Query: 64 PERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTG 123
PE +E GWP+WL++VAG+A+ +WTPRRA+TFEKL+KIGQGTYS+VYKARDL
Sbjct: 101 PETVSKEAELAAGWPAWLVSVAGEALVNWTPRRASTFEKLEKIGQGTYSSVYKARDLTNN 160
Query: 124 KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH 183
KIVALK+VRFD + ESVKFMAREI+V+R+LDHPNV+KLEGL+T+ +S SLYLVFEYM+H
Sbjct: 161 KIVALKRVRFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDH 220
Query: 184 DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243
DL GLA+ G+KFSEPQVKCYM+QLLSGL HCH+ GVLHRDIKGSNLLID++G+LKIADF
Sbjct: 221 DLVGLASIPGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADF 280
Query: 244 GLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPG 303
GLATF+DP P+TSRVVTLWYRPPELLLGA +YGVGVDLWS GCIL EL +GKPI+ G
Sbjct: 281 GLATFFDPQNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAG 340
Query: 304 RTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIET 363
+TEVEQLHKIFKLCGSP+E+YW+K KLP + F+P PY R +AE FKD P++ L L+E
Sbjct: 341 KTEVEQLHKIFKLCGSPTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEA 400
Query: 364 LLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGK 423
LLSIDPD RG+A AL SE+F TEP+AC+PSSLPKYPPSKE+D K+R++ A+RQR K
Sbjct: 401 LLSIDPDRRGSAARALESEYFRTEPFACDPSSLPKYPPSKEIDAKIRDD-AKRQRPTQEK 459
Query: 424 ANAVDGAKRVRHRDRAGRAIPAPEAN 449
D R H +R + IP +AN
Sbjct: 460 HERQDSQTRRSH-ER--KLIPPVKAN 482
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1345 (478.5 bits), Expect = 1.0e-139, Sum P(2) = 1.0e-139
Identities = 251/380 (66%), Positives = 306/380 (80%)
Query: 76 GWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN 135
GWP WL +VAG+AI+ W PRRA++FEKLDKIGQGTYS VYKARDL TGKIVA+KKVRF N
Sbjct: 117 GWPYWLTSVAGEAIKGWVPRRADSFEKLDKIGQGTYSIVYKARDLETGKIVAMKKVRFAN 176
Query: 136 LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK 195
++PESV+FMAREI +LRKLDHPNV+KL+ LVTS++S SL+LVFEYMEHDL+GLA GVK
Sbjct: 177 MDPESVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLSGLALRPGVK 236
Query: 196 FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255
F+EPQ+KC+MKQLL GLEHCH+ G+LHRDIKGSNLL++NDG+LKI DFGLA+FY P Q
Sbjct: 237 FTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASFYKPDQDQ 296
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
P+TSRVVTLWYR PELLLG+T YG +DLWS GCILAEL KPIMPGRTEVEQ+HKIFK
Sbjct: 297 PLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVEQMHKIFK 356
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
LCGSPSEE+W +K P AT +KPQ PYKR + ETFK+ SSSL L++ LLS++P+ R +A
Sbjct: 357 LCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVEPEKRCSA 416
Query: 376 TAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKR-VR 434
++ L SEFF TEP C SSLPKYPPSKE+D K+R+EEA+R++ + K + +R +R
Sbjct: 417 SSTLLSEFFTTEPLPCHISSLPKYPPSKELDAKVRDEEAKRKKAEAVKWRGHESVRRGLR 476
Query: 435 HRDRAGRAIPAPEANAEIQT 454
I + +N + T
Sbjct: 477 DSKVTPEFIASGNSNVSLTT 496
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1343 (477.8 bits), Expect = 3.6e-137, P = 3.6e-137
Identities = 257/415 (61%), Positives = 314/415 (75%)
Query: 42 LGKERARAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFE 101
LG E RA + R G R + GWP+WL VAG+AI W P R++ FE
Sbjct: 67 LGSESGRASDSLSFR----LGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFE 122
Query: 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
KL+KIGQGTYSNV++A + TG+IVALKKVRFDN EPESVKFMAREIL+LR+L+HPN+IK
Sbjct: 123 KLEKIGQGTYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNIIK 182
Query: 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
LEGL+TS++SC++ LVFEYMEHDL GL + +KF+ PQ+KCYMKQLLSGL+HCH+ GV+
Sbjct: 183 LEGLITSKLSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVM 242
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPELLLGATYYG 279
HRDIKGSNLL+ N+GILK+ADFGLA F + K+P+TSRVVTLWYRPPELLLGAT YG
Sbjct: 243 HRDIKGSNLLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYG 302
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339
VDLWS GC+ AELL GKPI+ GRTEVEQLHKIFKLCGSP E+YWKKSKLP+A LFKPQ
Sbjct: 303 ASVDLWSVGCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQ 362
Query: 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKY 399
Q Y C+ ET KD + + LIETLLSIDP RGTA++AL S++F T+P+AC+PSSLP Y
Sbjct: 363 QTYDSCLRETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFTTKPFACDPSSLPIY 422
Query: 400 PPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQT 454
PPSKE+D K R+E AR++ +G+ +D K R R AP+ + +T
Sbjct: 423 PPSKEIDTKHRDEAARKKISGNGR-RGIDPRKPSRKAHSFNRL--APDVRHQTET 474
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1304 (464.1 bits), Expect = 4.8e-133, P = 4.8e-133
Identities = 243/381 (63%), Positives = 298/381 (78%)
Query: 76 GWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN 135
GWP+WL VAG+AI W P R++ FEKL+KIGQGTYS+V++AR+ TG+IVALKKVRFDN
Sbjct: 107 GWPAWLSNVAGEAIHGWVPFRSDAFEKLEKIGQGTYSSVFRARETETGRIVALKKVRFDN 166
Query: 136 LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK 195
EPESV+FMAREIL+LRKL+HPN+IKLEG+VTS++SCS++LVFEYMEHDL GL + +
Sbjct: 167 FEPESVRFMAREILILRKLNHPNIIKLEGIVTSKLSCSIHLVFEYMEHDLTGLLSSPDID 226
Query: 196 FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP-GLK 254
F+ PQ+KCYMKQLLSGL+HCH GV+HRDIKGSNLL++N+GILK+ADFGLA F + G K
Sbjct: 227 FTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSNLLVNNEGILKVADFGLANFCNASGNK 286
Query: 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIF 314
QP+TSRVVTLWYRPPELLLGAT YG VDLWS GC+ AELL GKP++ GRTEVEQLHKIF
Sbjct: 287 QPLTSRVVTLWYRPPELLLGATEYGASVDLWSVGCVFAELLIGKPVLQGRTEVEQLHKIF 346
Query: 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFK--DFPSSSLPLIETLLSIDPDNR 372
KLCGSP E+YWKKSKLP+A LFKPQQ Y C+ ET K + + LIETLLSI P R
Sbjct: 347 KLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRETLKLKGLSDADINLIETLLSIQPHKR 406
Query: 373 GTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKR 432
GTA+ AL S++F ++P+AC+PSSLP Y PSKE+D K RE+ R++ +G+ + K
Sbjct: 407 GTASTALVSQYFTSKPFACDPSSLPVYSPSKEIDAKHREDTTRKKISGNGR-RGTESRKP 465
Query: 433 VRHRDRAGRAIPAPEANAEIQ 453
R + PA + Q
Sbjct: 466 TRKPPAFAKLAPAEDVRHHSQ 486
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 457 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-162 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-127 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-120 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-113 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-109 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-107 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-107 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-101 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-99 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-95 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-92 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-91 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-91 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-89 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-88 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-85 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-84 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-83 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-79 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-79 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-78 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-77 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-76 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-76 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-75 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-75 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-74 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-73 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-66 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-64 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-64 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-63 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-63 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-62 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-62 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-62 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-61 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-61 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-61 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-60 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-59 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-57 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-55 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-55 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-54 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-52 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-52 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-51 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-51 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-50 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-50 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-49 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-48 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-48 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-47 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-47 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-45 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-45 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-43 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-42 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-41 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-40 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-40 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-40 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-39 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-38 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-37 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-37 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-35 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-30 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-30 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-30 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-27 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-27 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-26 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-25 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-24 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-23 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-22 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-22 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-20 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-20 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-20 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-20 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-19 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-19 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-18 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-18 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-18 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-18 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-17 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-17 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-17 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-16 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-14 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-14 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-14 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-09 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-08 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 9e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 458 bits (1180), Expect = e-162
Identities = 163/287 (56%), Positives = 210/287 (73%), Gaps = 2/287 (0%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+EK+ +IG+GTY VYKAR+ TG++VALKK+R +N + REI +L+KL HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
++L+ +VTS+ S+Y+VFEYM+HDL GL VKF+E Q+KCYMKQLL GL++ H+NG
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
+LHRDIKGSN+LI+NDG+LK+ADFGLA Y T+RV+TLWYRPPELLLGAT YG
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYG 180
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLFKP 338
VD+WS GCILAEL GKPI G TE+EQL KIF+LCGSP++E W SKLP KP
Sbjct: 181 PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240
Query: 339 QQPYKRCIAETFKDFPSSS-LPLIETLLSIDPDNRGTATAALNSEFF 384
++PYKR + E FK S L L++ LL++DP R +A AL E+F
Sbjct: 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 368 bits (948), Expect = e-127
Identities = 129/287 (44%), Positives = 183/287 (63%), Gaps = 7/287 (2%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
+EKL+K+G+GTY VYKARD TG+IVALKK+R DN E E + A REI +L++L HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPN 59
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
++KL ++ + LYLVFEY + DL + S +K M QLL GL +CH++
Sbjct: 60 IVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
+LHRD+K N+LI+ DG+LK+ADFGLA + L+ T VVTLWYR PE+LLG+ +Y
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTLWYRAPEILLGSKHY 176
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLFK 337
VD+WS GCI AE++ GKP+ PG +E++QL KIF++ G+P+EE W +KLP+
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P+ P K + + + L+ +L +P R +A AL +F
Sbjct: 237 PKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 352 bits (905), Expect = e-120
Identities = 135/303 (44%), Positives = 194/303 (64%), Gaps = 11/303 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE--PESVKFMA-REILVLRKLDH 156
+EK K+G+GTY+ VYKARD TG+IVA+KK++ + + + F A REI +L++L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
PN+I L + + + + LVFE+ME DL + + + + +K YM L GLE+ H
Sbjct: 62 PNIIGLLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFY-DPGLKQPMTSRVVTLWYRPPELLLGA 275
+N +LHRD+K +NLLI +DG+LK+ADFGLA + P K MT +VVT WYR PELL GA
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGA 177
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNAT 334
+YGVGVD+WS GCI AELL P +PG ++++QL KIF+ G+P+EE W + LP+
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPS 394
FKP P + + F +L L++ LL+++P+ R TA AL +F+ +P PS
Sbjct: 238 EFKPFPPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS 295
Query: 395 SLP 397
LP
Sbjct: 296 QLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 334 bits (859), Expect = e-113
Identities = 153/310 (49%), Positives = 200/310 (64%), Gaps = 8/310 (2%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRK 153
R FEKL++IG+GTY VY+ARD +G+IVALKKVR DN E + + + REI +L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLN 62
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
L HPN+++L+ +V + S++LV EY E DLA L FSE QVKC M QLL GL+
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELL 272
+ H N ++HRD+K SNLL+ + G LKIADFGLA T+ P +PMT +VVTLWYR PELL
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP--AKPMTPKVVTLWYRAPELL 180
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLP 331
LG T Y +D+W+ GCILAELLA KP++PG++E+EQL I +L G+P+E W S LP
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240
Query: 332 NATLFK-PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390
F P+QPY + F + L L+ LL DP R TA AL S +F +P
Sbjct: 241 LVGKFTLPKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299
Query: 391 CEPSSLPKYP 400
CEP +P +P
Sbjct: 300 CEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 324 bits (832), Expect = e-109
Identities = 141/296 (47%), Positives = 188/296 (63%), Gaps = 10/296 (3%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRK 153
R + +EKL++I +GTY VY+ARD TG+IVALKK++ + E E + REI +L K
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPITSLREINILLK 60
Query: 154 LDHPNVIKL-EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
L HPN++ + E +V S + +Y+V EY+EHDL L F + +VKC M QLLSG+
Sbjct: 61 LQHPNIVTVKEVVVGSNLD-KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELL 272
H H+N +LHRD+K SNLL++N GILKI DFGLA Y LK P T VVTLWYR PELL
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELL 178
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLP 331
LGA Y +D+WS GCI AELL KP+ PG++E++QL+KIFKL G+P+E+ W S+LP
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238
Query: 332 NATLFKPQ-QPYKRCIAETFKDFPSS--SLPLIETLLSIDPDNRGTATAALNSEFF 384
A PY + + + F S L+ LL+ DP R +A AL +F
Sbjct: 239 GAKKKTFTKYPYNQ-LRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 321 bits (824), Expect = e-107
Identities = 139/303 (45%), Positives = 182/303 (60%), Gaps = 19/303 (6%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
+E L K+G+GT+ VYKAR + TG++VALKK+ N E + A REI +L+KL HPN
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKHPN 68
Query: 159 VIKLEGLV------TSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
V+ L + + R S+Y+V YM+HDL+GL VK +E Q+KCYM QLL G+
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM----------TSRVV 262
+ H N +LHRDIK +N+LIDN GILKIADFGLA YD P T+ VV
Sbjct: 129 NYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188
Query: 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322
T WYRPPELLLG Y VD+W GC+ AE+ +PI+ G+++++QLH IFKLCG+P+E
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTE 248
Query: 323 EYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381
E W LP Y R + E F L L+ LLS+DP R TA+ AL
Sbjct: 249 ETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308
Query: 382 EFF 384
+F
Sbjct: 309 PYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 320 bits (821), Expect = e-107
Identities = 145/302 (48%), Positives = 191/302 (63%), Gaps = 11/302 (3%)
Query: 92 WTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILV 150
W R + F+ + +IG+GTY VYKARD TG++VALKKVR DN E E A REI +
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKI 59
Query: 151 LRKLDHPNVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLAACQGVKFSEPQVK 202
LR+L+H N++ L+ +VT + + YLVFEYM+HDL GL V FSE +K
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262
+MKQLL GL +CH LHRDIK SN+L++N G +K+ADFGLA Y+ +P T++V+
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322
TLWYRPPELLLG YG +D+WS GCIL EL KPI E+ QL I +LCGSP
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
Query: 323 EYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381
W KLP KP++ Y+R + E F P+ +L L++ +L++DP R TA ALNS
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299
Query: 382 EF 383
+
Sbjct: 300 PW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 303 bits (779), Expect = e-101
Identities = 143/300 (47%), Positives = 182/300 (60%), Gaps = 14/300 (4%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDH 156
+ +EKL KIGQGT+ V+KAR T +IVALKKV +N E E A REI +L+ L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKH 70
Query: 157 PNVIKL------EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLS 210
NV+ L + +R S YLVFE+ EHDLAGL + + VKF+ ++K MK LL+
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLN 130
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQP--MTSRVVTLWYR 267
GL + H N +LHRD+K +N+LI DGILK+ADFGLA F +P T+RVVTLWYR
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
PPELLLG YG +D+W AGCI+AE+ PIM G TE QL I +LCGS + E W
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250
Query: 328 -SKLPNATLFKPQQPYKRCIAETFKDFPSS--SLPLIETLLSIDPDNRGTATAALNSEFF 384
KL + Q KR + E K + +L LI+ LL +DP R A ALN +FF
Sbjct: 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 298 bits (766), Expect = 2e-99
Identities = 129/287 (44%), Positives = 177/287 (61%), Gaps = 6/287 (2%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++KL KIG+GTY VYKARD LTG+IVA+KK++ K REI +L++L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
IKL + + LYLVFE+M+ DL L + E +K Y+ QLL GL CH++G
Sbjct: 61 IKLLDVFRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
+LHRD+K NLLI+ +G+LK+ADFGLA +F P +P T VVT WYR PELLLG Y
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGY 176
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLFK 337
VD+WS GCI AELL+ +P+ PG++E++QL KIF+ G+P E W K + L F
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ + + F + +L L+ +L DP R TA AL +F
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 288 bits (740), Expect = 2e-95
Identities = 122/290 (42%), Positives = 163/290 (56%), Gaps = 7/290 (2%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
++ L +IG+G + V+KA+D TG+ VALKKV LE REI L+ HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
V+KL L LV EYM DL+ + + E QVK YM+ LL G+ + H N
Sbjct: 61 VVKL--LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
G++HRD+K +NLLI DG+LKIADFGLA + + + +V T WYR PELL GA Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLP--NATL 335
GVDLW+ GCI AELL G P+ PG ++EQL +F+ G+P+EE W + LP N
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
F +P + E F D +L L++ LL DP R +A AL +F
Sbjct: 239 FPESKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 6e-92
Identities = 114/287 (39%), Positives = 161/287 (56%), Gaps = 35/287 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+E L+K+G+G++ VY ARD TGK+VA+K ++ ++ + + + REI +L+KL HPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59
Query: 160 IKLEG-LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
++L LYLV EY E DL L + + SE + + Y++Q+LS LE+ H+
Sbjct: 60 VRLYDVFEDED---KLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFYLRQILSALEYLHS 115
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
G++HRD+K N+L+D DG +K+ADFGLA DPG K +T+ V T Y PE+LLG
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KG 172
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
YG VD+WS G IL ELL GKP PG +QL ++FK G P +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFP------------ 217
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P + I+ KD I LL DP+ R TA AL FF
Sbjct: 218 ---PPEWDISPEAKDL-------IRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 279 bits (715), Expect = 1e-91
Identities = 121/296 (40%), Positives = 172/296 (58%), Gaps = 20/296 (6%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE---PESVKFMAREILVLRKLD- 155
+E+L +IG+G Y VYKARDL TG+ VALKKVR E P S REI +L++L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLES 57
Query: 156 --HPNVIKL----EGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQL 208
HPN+++L G T R L LVFE+++ DLA L+ C +K M+QL
Sbjct: 58 FEHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP 268
L G++ H++ ++HRD+K N+L+ +DG +KIADFGLA Y + +TS VVTLWYR
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRA 174
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328
PE+LL ++Y VD+WS GCI AEL +P+ G +E +QL KIF + G PSEE W ++
Sbjct: 175 PEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233
Query: 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ F P R + L L++ +L+ +P R +A AL +F
Sbjct: 234 VSLPRSSFPSYTP--RSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 276 bits (709), Expect = 8e-91
Identities = 126/290 (43%), Positives = 186/290 (64%), Gaps = 12/290 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
++K++KIG+GTY VYKARD LTG+IVALKK+R + E E V A REI +L++L+HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPN 59
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+++L +V S LYLVFE+++ DL + + P +K Y+ QLL G+ +CH+
Sbjct: 60 IVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+ VLHRD+K NLLID +G LK+ADFGLA + ++ T VVTLWYR PE+LLG+
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGSRQ 176
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLF 336
Y VD+WS GCI AE++ +P+ PG +E++QL +IF+ G+P E+ W + LP+ +
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD---Y 233
Query: 337 KPQQP--YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
KP P ++ +++ + L L+ +L DP R +A AAL +F
Sbjct: 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 274 bits (702), Expect = 4e-89
Identities = 123/325 (37%), Positives = 186/325 (57%), Gaps = 32/325 (9%)
Query: 100 FEKLDK-IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK-----------FMA-R 146
+ + +G+GTY V KA D LTGKIVA+KKV+ + + K F R
Sbjct: 10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMK 206
E+ ++ ++ H N++ L + + LV + M DL + + ++ +E QVKC +
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVDRK-IRLTESQVKCILL 126
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY-------------DPGL 253
Q+L+GL H +HRD+ +N+ I++ GI KIADFGLA Y
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
++ MTS+VVTLWYR PELL+GA Y VD+WS GCI AELL GKP+ PG E++QL +I
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
Query: 314 FKLCGSPSEEYW-KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR 372
F+L G+P+E+ W + KLP T F P++P + + F + ++ L+++LL ++P R
Sbjct: 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKP--KDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 373 GTATAALNSEFFNTEPYACEPSSLP 397
+A AL E+F ++P C+PS LP
Sbjct: 305 ISAKEALKHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 7e-88
Identities = 107/287 (37%), Positives = 150/287 (52%), Gaps = 29/287 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+E L K+G G++ VYKA+ TGKIVA+K ++ + + + + REI +LR+L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
++L LYLV EY E DL + +G SE + K Q+L GLE+ H+N
Sbjct: 61 VRLIDAFED--KDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
G++HRD+K N+L+D +G++KIADFGLA +T+ V T WY PE+LLG Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK-LCGSPSEEYWKKSKLPNATLFK 337
G VD+WS G IL ELL GKP G ++QL I + L + K S
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS--------- 227
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+E KD I+ L+ DP R TA L +F
Sbjct: 228 -------SGSEEAKDL-------IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 262 bits (671), Expect = 4e-85
Identities = 126/292 (43%), Positives = 179/292 (61%), Gaps = 16/292 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
F+K++KIG+GTY VYKAR+ LTG++VALKK+R D E E V A REI +L++L+HPN
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIREISLLKELNHPN 60
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
++KL ++ + LYLVFE++ DL + A P +K Y+ QLL GL CH+
Sbjct: 61 IVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+ VLHRD+K NLLI+ +G +K+ADFGLA + ++ T VVTLWYR PE+LLG Y
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKY 177
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLF 336
Y VD+WS GCI AE++ + + PG +E++QL +IF+ G+P E W + LP+ +
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD---Y 234
Query: 337 KPQQPYKRCIAETFKDF----PSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
KP P + + F L+ +L DP+ R +A AAL FF
Sbjct: 235 KPSFP--KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 4e-84
Identities = 117/326 (35%), Positives = 171/326 (52%), Gaps = 23/326 (7%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
IG G Y V A D TG+ VA+KK+ FD+L K + REI +LR L H N+I L
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHENIIGLL 65
Query: 164 GLVTSRMSCS---LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
++ +Y+V E ME DL + ++ ++ ++ Q+L GL++ H+ V
Sbjct: 66 DILRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANV 124
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
+HRD+K SN+L++++ LKI DFGLA D K +T VVT WYR PELLL ++ Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
+D+WS GCI AELL KP+ PGR ++QL+ I ++ G+PSEE K A +
Sbjct: 185 TKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLK 244
Query: 339 QQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT------EPYA 390
P K+ +++ F ++ L+E +L DP R TA AL + EP A
Sbjct: 245 SLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVA 304
Query: 391 CEPSSLPKYPPSKEMDVKLREEEARR 416
P + D +L EEE +
Sbjct: 305 KPPFDFDFFD-----DDELTEEELKE 325
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 3e-83
Identities = 125/289 (43%), Positives = 177/289 (61%), Gaps = 10/289 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + E V A REI +L++L H N
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKN 60
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+++L ++ S L LVFEY + DL +C G VK +M QLL GL CH+
Sbjct: 61 IVRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNG-DIDPEIVKSFMFQLLKGLAFCHS 117
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+ VLHRD+K NLLI+ +G LK+ADFGLA + ++ ++ VVTLWYRPP++L GA
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKL 176
Query: 278 YGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATL 335
Y +D+WSAGCI AEL AG+P+ PG +QL +IF+L G+P+EE W SKLP+
Sbjct: 177 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ + K S+ L++ LL +P R +A AL +F
Sbjct: 237 YPMYPATTSLVNVVPKLN-STGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 6e-79
Identities = 113/291 (38%), Positives = 175/291 (60%), Gaps = 14/291 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKV--RFDNLEPESVKFMAREILVLRKL-DH 156
++ + ++G GT+ +VY AR+ TG++VA+KK+ +F + E E + RE+ LRKL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEH 57
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHC 215
PN++KL+ + R + LY VFEYME +L L +G FSE ++ + Q+L GL H
Sbjct: 58 PNIVKLKEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H +G HRD+K NLL+ ++KIADFGLA + P T V T WYR PE+LL +
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS--RPPYTDYVSTRWYRAPEILLRS 173
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPNAT 334
T Y VD+W+ GCI+AEL +P+ PG +E++QL+KI + G+P+++ W + KL +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 335 LFK-PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
F+ PQ + + + ++ LI+ +L DP R TA+ AL +F
Sbjct: 234 GFRFPQFAPTS-LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 7e-79
Identities = 126/297 (42%), Positives = 176/297 (59%), Gaps = 15/297 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDH-P 157
+EKL+KIG+GTY VYKARD TGK+VALKK R + ++ E + A REI +L+ L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSESI 61
Query: 158 NVIKL---EGLVTSRMSCSLYLVFEYMEHDLA----GLAACQGVKFSEPQVKCYMKQLLS 210
+++L E + SLYLVFEY++ DL G +K +M QLL
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLATFYDPGLKQPMTSRVVTLWYRPP 269
G+ HCH +GV+HRD+K NLL+D G+LKIAD GL + +K T +VTLWYR P
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-YTHEIVTLWYRAP 180
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-S 328
E+LLG+T+Y VD+WS GCI AE+ +P+ PG +E++QL IFKL G+P+E+ W S
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240
Query: 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
KL + F +P ++ D L L++ +L DP R +A AAL +F+
Sbjct: 241 KLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 2e-78
Identities = 117/291 (40%), Positives = 175/291 (60%), Gaps = 14/291 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE--PESVKFMAREILVLRKLDHP 157
F++L+K+G+GTY+ VYK R+ TG+IVALK++ D E P + REI ++++L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHE 58
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEP--QVKCYMKQLLSGLEHC 215
N+++L ++ + L LVFEYM+ DL GV+ + VK + QLL G+ C
Sbjct: 59 NIVRLHDVIHTE--NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLG 274
H N VLHRD+K NLLI+ G LK+ADFGLA F P ++ VVTLWYR P++LLG
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEVVTLWYRAPDVLLG 174
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNA 333
+ Y +D+WS GCI+AE++ G+P+ PG +QL KIF++ G+P+E W S+LP
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P+ P + + + F + L+ LL ++P+ R +A AL +F
Sbjct: 235 KPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 3e-77
Identities = 122/292 (41%), Positives = 180/292 (61%), Gaps = 15/292 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
+ K++KIG+GTY VYK R+ TG+IVA+KK+R ++ E E V A REI +L++L HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPN 60
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQ-VKCYMKQLLSGLEHCH 216
++ L+ ++ LYL+FE++ DL L + ++ + + VK Y+ Q+L G+ CH
Sbjct: 61 IVCLQDVLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
+ VLHRD+K NLLIDN G++K+ADFGLA F P + T VVTLWYR PE+LLG+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGS 176
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNAT 334
Y VD+WS G I AE+ KP+ G +E++QL +IF++ G+P+E+ W + LP+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD-- 234
Query: 335 LFKPQQP--YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+K P K + K+ L L+E +L DP R +A ALN +F
Sbjct: 235 -YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 1e-76
Identities = 112/316 (35%), Positives = 160/316 (50%), Gaps = 30/316 (9%)
Query: 99 TFEKLDKIGQGTYSNVYKAR--DLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLD 155
+E IG+GTY VYKA+ + GK A+KK + D + + A REI +LR+L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL----AACQGVKFSEPQVKCYMKQLLSG 211
H NV+ L + S+YL+F+Y EHDL + + V VK + Q+L+G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 212 LEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFYDPGLKQPMTSR--VVTLW 265
+ + H+N VLHRD+K +N+L+ G++KI D GLA ++ LK VVT+W
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIFKL 316
YR PELLLGA +Y +D+W+ GCI AELL +PI GR +QL +IF++
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 317 CGSPSEEYW----KKSKLPNATLFKPQQPYKRC----IAETFKDFPSSSLPLIETLLSID 368
G+P+E+ W K + + Y E K S L+ LL D
Sbjct: 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300
Query: 369 PDNRGTATAALNSEFF 384
P R TA AL +F
Sbjct: 301 PTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 5e-76
Identities = 123/290 (42%), Positives = 183/290 (63%), Gaps = 9/290 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
+EK++KIG+GTY VYKARD +T + +ALKK+R + E E V A REI +L+++ H N
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHGN 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+++L+ +V S LYLVFEY++ DL + + + +K Y+ Q+L G+ +CH+
Sbjct: 63 IVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 218 NGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ VLHRD+K NLLID LK+ADFGLA + ++ T VVTLWYR PE+LLG+
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT-FTHEVVTLWYRAPEILLGSR 179
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATL 335
+Y VD+WS GCI AE++ KP+ PG +E+++L KIF++ G+P+EE W + LP+
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
P+ P K +A + + L+ +L +DP R TA AAL E+F
Sbjct: 240 AFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 238 bits (610), Expect = 3e-75
Identities = 129/337 (38%), Positives = 181/337 (53%), Gaps = 36/337 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFD---NLEPESVKFMAREILVLRKL-D 155
+E L K+G+G Y V+KA D T ++VALKK+ FD N F REI+ L++L D
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGD 65
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDL-----AGLAACQGVKFSEPQVKCY-MKQLL 209
HPN++KL ++ + +YLVFEYME DL A + E K Y M QLL
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL--------EDVHKRYIMYQLL 117
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA----TFYDPGLKQPMTSRVVTLW 265
L++ H+ V+HRD+K SN+L+++D +K+ADFGLA + +T V T W
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
YR PE+LLG+T Y GVD+WS GCIL E+L GKP+ PG + + QL KI ++ G PS E
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 326 K--KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN--- 380
+ KS L ++ + E +L L++ LL +P+ R TA AL
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297
Query: 381 -SEFFNTEPYACEPSSL-PKYPPSKEMDVKLREEEAR 415
++F N EP P P + +VKL E R
Sbjct: 298 VAQFHNPSD---EPVLPYPITIPLDD-NVKLSVAEYR 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 4e-75
Identities = 119/305 (39%), Positives = 169/305 (55%), Gaps = 32/305 (10%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKL 154
+ T++KLDK+G+G+Y+ VYK R LTG++VALK++R + E F A RE +L+ L
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFTAIREASLLKDL 60
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
H N++ L ++ ++ + L LVFEY++ DL G S V+ ++ QLL GL +
Sbjct: 61 KHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--------TFYDPGLKQPMTSRVVTLWY 266
CH VLHRD+K NLLI G LK+ADFGLA T+ ++ VVTLWY
Sbjct: 119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY---------SNEVVTLWY 169
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCGSPSEEYW 325
RPP++LLG+T Y +D+W GCI E+ G+P+ PG T+V +QLHKIF++ G+P+EE W
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 326 KK-SKLPNATLFKPQQ-----PYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379
S P FKP P D L L +P R +A A+
Sbjct: 230 PGVSSNPE---FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
Query: 380 NSEFF 384
+F
Sbjct: 287 KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 234 bits (600), Expect = 2e-74
Identities = 106/290 (36%), Positives = 154/290 (53%), Gaps = 5/290 (1%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
N +E L +G+G Y V K R+ TG+IVA+KK + + + K RE+ VLR+L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
N++ L R LYLVFEY+E L L V+ Y+ QLL + +CH+
Sbjct: 61 NIVNL--KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+ ++HRDIK N+L+ G+LK+ DFG A P+T V T WYR PELL+G T
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCG--SPSEEYWKKSKLPNATL 335
YG VD+W+ GCI+AELL G+P+ PG ++++QL+ I K G PS + S A +
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238
Query: 336 FKPQQPYKRCIAETF-KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P+ + + S +L ++ L +DP R T L +F
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 5e-73
Identities = 114/289 (39%), Positives = 161/289 (55%), Gaps = 17/289 (5%)
Query: 103 LDKIGQGTYSNVYKARDLLTGKIVALK--KVRFDNLEPESVKFMAREILVLRKL-DHPNV 159
L KIG+GT+S V KA+ TGK A+K K F +LE + REI LR+L HPN+
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNI 60
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
++L ++ R + L LVFE M+ +L L + E +VK YM QLL L+H H NG
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 220 VLHRDIKGSNLLIDNDGILKIADFG-LATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
+ HRDIK N+LI +D ILK+ADFG Y K P T + T WYR PE LL YY
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCRGIYS---KPPYTEYISTRWYRAPECLLTDGYY 176
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL--- 335
G +D+W+ GC+ E+L+ P+ PG E++Q+ KI + G+P E KK + +
Sbjct: 177 GPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKSRHMNYN 235
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
F ++ + + + + L L++ LL+ DPD R TA AL +F
Sbjct: 236 FPSKKG--TGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 6e-66
Identities = 119/294 (40%), Positives = 170/294 (57%), Gaps = 19/294 (6%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
T+ KLDK+G+GTY+ V+K R LT +VALK++R ++ E + RE+ +L+ L H N
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHAN 64
Query: 159 VIKLEGLV-TSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
++ L ++ T R L LVFEY++ DL G S VK +M QLL GL +CH
Sbjct: 65 IVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+LHRD+K NLLI+ G LK+ADFGLA K ++ VVTLWYRPP++LLG+T
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLGSTE 180
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
Y +D+W GCIL E+ G+P+ PG T E+LH IF+L G+P+EE W P T +
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW-----PGITSNE 235
Query: 338 -------PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
PQ + I + + + L+ +LL + +R +A AAL +F
Sbjct: 236 EFRSYLFPQYRAQPLINHAPR-LDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 1e-64
Identities = 115/291 (39%), Positives = 163/291 (56%), Gaps = 7/291 (2%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
+ T+ KLDK+G+GTY+ VYK R LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
H N++ L ++ + S L LVFEY++ DL G + VK ++ QLL GL +C
Sbjct: 63 HANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H VLHRD+K NLLI+ G LK+ADFGLA K ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YSNEVVTLWYRPPDILLGS 179
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
T Y +D+W GCI E+ G+P+ PG T EQLH IF++ G+P+EE W L N
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW-PGILSNEEF 238
Query: 336 FKPQQP--YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P C+ S L+ LL + R +A A+ +F
Sbjct: 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 209 bits (534), Expect = 1e-64
Identities = 101/294 (34%), Positives = 152/294 (51%), Gaps = 19/294 (6%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+EKL KIG+G+Y V+K R+ TG+IVA+KK +P K REI +L++L HPN+
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
+ L + R L+LVFEY +H + E +K + Q L + CH +
Sbjct: 63 VNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
+HRD+K N+LI G +K+ DFG A T V T WYR PELL+G T YG
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGP-GDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGS---------PSEEYWKKSKL 330
VD+W+ GC+ AELL G+P+ PG+++V+QL+ I K G + +++K +
Sbjct: 180 PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239
Query: 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P +P + F + S +L ++ L +DP R + L +F
Sbjct: 240 PEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 1e-63
Identities = 117/329 (35%), Positives = 170/329 (51%), Gaps = 28/329 (8%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLD 155
+ ++ L +G G Y V A D TG+ VA+KK+ F + K RE+ +L+ +D
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72
Query: 156 HPNVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSG 211
H NVI L + T S +YLV M DL + CQ K S+ ++ + Q+L G
Sbjct: 73 HENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRG 130
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
L++ H+ G++HRD+K SN+ ++ D LKI DFGLA D MT V T WYR PE+
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 186
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
+L +Y VD+WS GCI+AELL GK + PG ++QL +I L G+P EE +K
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 332 NATLFKPQQPY-KRCIAETFKD-FPSSS---LPLIETLLSIDPDNRGTATAALNSEFFNT 386
+A + P + FK+ F ++ + L+E +L +DPD R TA AL +
Sbjct: 247 SARNYIQSLPQMPKK---DFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL-- 301
Query: 387 EPYAC---EPSSLPKYPPSKEMDVKLREE 412
Y EP + P Y S E +E
Sbjct: 302 AEYHDPEDEPVA-PPYDQSFESRDLTVDE 329
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 2e-63
Identities = 79/191 (41%), Positives = 114/191 (59%), Gaps = 6/191 (3%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGL 165
+G+G + VY ARD TGK VA+K ++ ++ + + REI +L+KL+HPN++KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 166 VTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRD 224
LYLV EY E L L K SE ++ + Q+L GLE+ H+NG++HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 225 IKGSNLLIDND-GILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVD 283
+K N+L+D+D G +K+ADFGL+ K + + V T Y PE+LLG YY D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 284 LWSAGCILAEL 294
+WS G IL EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 3e-62
Identities = 109/296 (36%), Positives = 173/296 (58%), Gaps = 19/296 (6%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDH 156
+E L +G+G+Y V K + TG+IVA+KK ++ + + VK +A REI +L++L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRH 59
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
N++ L + R LYLVFE+++H DL G+ S +V+ Y+ Q+L G+
Sbjct: 60 ENLVNL--IEVFRRKKRLYLVFEFVDHTVLDDLE--KYPNGLDES--RVRKYLFQILRGI 113
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPEL 271
E CH++ ++HRDIK N+L+ G++K+ DFG A T PG + T V T WYR PEL
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPEL 171
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE---EYWKKS 328
L+G T YG VD+W+ GC++ E+L G+P+ PG ++++QL+ I K G+ E ++K+
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231
Query: 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
L A + P+ + + F L L + L IDPD+R +++ L+ EFF
Sbjct: 232 PL-FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 6e-62
Identities = 108/332 (32%), Positives = 158/332 (47%), Gaps = 29/332 (8%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKV--RFDNLEPESVKFMAREILVLRKLDH 156
++ ++ IG G Y V A D +GK VA+KK+ FD P K RE+ +LR H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKH 63
Query: 157 PNVIKLEGLVTSRMS--CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
N+I + ++ + +Y+V + ME DL + +E ++ ++ QLL GL++
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKY 122
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP---MTSRVVTLWYRPPEL 271
H+ V+HRD+K SNLL++ D L+I DFG+A + MT V T WYR PEL
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS--- 328
LL Y +D+WS GCI AE+L + + PG+ V QL I + GSPSEE +
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242
Query: 329 -------KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381
LP K P+ + F +L L+ +L DP+ R T AL
Sbjct: 243 RVRKYIQNLPR----KQPVPWS----KIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294
Query: 382 EFFNTEPY-ACEPSSLPKYPPSKEMDVKLREE 412
F EP+ P + E RE+
Sbjct: 295 PFLAQYHDPDDEPTCPPPFDFDFEAIELSREQ 326
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 9e-62
Identities = 118/309 (38%), Positives = 165/309 (53%), Gaps = 27/309 (8%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
IG+G Y V A++ T + VA+KK+ FDN K REI +LR LDH NVI ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI--DAKRTLREIKLLRHLDHENVIAIK 70
Query: 164 GLV--TSRMSCS-LYLVFEYMEHDLAGLAACQGVKFSEP----QVKCYMKQLLSGLEHCH 216
++ R + + +Y+V+E M+ DL Q ++ S+ + ++ QLL GL++ H
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLH-----QIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
+ VLHRD+K SNLL++ + LKI DFGLA T + G MT VVT WYR PELLL
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNC 183
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
+ Y +D+WS GCI AELL KP+ PG+ V QL I +L GSPSEE + A
Sbjct: 184 SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243
Query: 336 FKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF------NTE 387
+ PY ++ A F ++ L+E +L DP R T AL + + E
Sbjct: 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDE 303
Query: 388 PYACEPSSL 396
P P S
Sbjct: 304 PVCQTPFSF 312
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-61
Identities = 111/297 (37%), Positives = 168/297 (56%), Gaps = 15/297 (5%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
+ T+ KL+K+G+GTY+ V+K R LT +VALK++R ++ E + RE+ +L+ L
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLK 62
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
H N++ L +V + S L LVFEY++ DL G S VK ++ Q+L GL +C
Sbjct: 63 HANIVTLHDIVHTDKS--LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H VLHRD+K NLLI+ G LK+ADFGLA K ++ VVTLWYRPP++LLG+
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-YSNEVVTLWYRPPDVLLGS 179
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW------KKSK 329
+ Y +D+W GCI E+ +G+P+ PG T ++LH IF+L G+P+EE W + K
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386
N +KPQ + + + L+ L + R +A A+ +F +
Sbjct: 240 NYNFPKYKPQP-----LINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 7e-61
Identities = 112/292 (38%), Positives = 158/292 (54%), Gaps = 12/292 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL---DH 156
+E + +IG G Y VYKARD +G VALK VR E RE+ +L++L DH
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 157 PNVIKLEGL-VTSRM--SCSLYLVFEYMEHDL-AGLAACQGVKFSEPQVKCYMKQLLSGL 212
PN+++L + TSR + LVFE+++ DL L +K M+Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELL 272
+ H N ++HRD+K N+L+ + G +K+ADFGLA Y + +T VVTLWYR PE+L
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVL 179
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332
L +TY VD+WS GCI AE+ KP+ G +E +QL KIF L G P E+ W +
Sbjct: 180 LQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP 238
Query: 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
F P+ P R + + S L+ +L+ +P R +A AL FF
Sbjct: 239 RGAFSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (512), Expect = 9e-61
Identities = 112/340 (32%), Positives = 171/340 (50%), Gaps = 37/340 (10%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA----REILVLRKL 154
++ L IG+G Y V A TG VA+KK+ P + REI +LR+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILRRF 60
Query: 155 DHPNVIKLEGLVTSRMSCSL---YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSG 211
H N+I + ++ S Y+V E ME DL L Q S ++ ++ Q+L G
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ--HLSNDHIQYFLYQILRG 118
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP--MTSRVVTLWYRPP 269
L++ H+ VLHRD+K SNLL++ + LKI DFGLA DP +T V T WYR P
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329
E++L + Y +D+WS GCILAE+L+ +P+ PG+ + QL+ I + G+PS+E
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238
Query: 330 LPNA-----TL-FKPQQPYKRCIAETFKDFP---SSSLPLIETLLSIDPDNRGTATAALN 380
A +L FKP+ P+ + FP +L L++ +L+ +P R T AL
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKL-------FPNADPKALDLLDKMLTFNPHKRITVEEALA 291
Query: 381 SEFFNTEPY---ACEPSSLPKYPPSKEMDVKLREEEARRQ 417
+ E Y + EP + +P E+ L +E+ +
Sbjct: 292 HPYL--EQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKEL 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 2e-60
Identities = 112/303 (36%), Positives = 161/303 (53%), Gaps = 14/303 (4%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
N + L +G G + V ARD LTG+ VA+KK+ P K RE+ +L+ L H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQ-VKCYMKQLLSGLEHCH 216
N+I L + S + +Y V E + DL L + + E Q ++ ++ Q+L GL++ H
Sbjct: 70 NIISLSDIFISPLE-DIYFVTELLGTDLHRLLTSRPL---EKQFIQYFLYQILRGLKYVH 125
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ GV+HRD+K SN+LI+ + LKI DFGLA DP MT V T +YR PE++L
Sbjct: 126 SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIMLTWQ 181
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
Y V VD+WSAGCI AE+L GKP+ PG+ V Q I L G+P ++ N F
Sbjct: 182 KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241
Query: 337 KPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPS 394
P +E FK+ S++ L+E +L DP R +A AL + PY +P+
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL--APYH-DPT 298
Query: 395 SLP 397
P
Sbjct: 299 DEP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 5e-60
Identities = 117/298 (39%), Positives = 167/298 (56%), Gaps = 20/298 (6%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLD 155
A ++ L+K+G+G+Y+ VYK + G++VALK + E V F A RE +L+ L
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLK 61
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
H N++ L ++ ++ + L VFEYM DLA V+ +M QLL GL +
Sbjct: 62 HANIVLLHDIIHTKET--LTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD-PGLKQPMTSRVVTLWYRPPELLLG 274
H +LHRD+K NLLI G LK+ADFGLA P Q +S VVTLWYRPP++LLG
Sbjct: 120 HGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLG 177
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKK-SKLPN 332
AT Y +D+W AGCI E+L G+P PG ++V EQL KI+ + G P+E+ W SKLPN
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237
Query: 333 ATLFKPQQPYKRCIAETFKDF------PSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+KP+ + C + + P + L +L + P +R +A AL +F
Sbjct: 238 ---YKPEW-FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 3e-59
Identities = 89/289 (30%), Positives = 139/289 (48%), Gaps = 32/289 (11%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
+ + + +G+G++ +VY A D TG+++A+K V E ++ + REI +L L HPN
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 159 VIKLEGLVTSRMSCSLYLVFEYM-EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+++ G +L + EY+ L+ L G K EP ++ Y +Q+L GL + H+
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHS 119
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGAT 276
NG++HRDIKG+N+L+D+DG++K+ADFG A T V T ++ PE++ G
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-E 178
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKLPNATL 335
YG D+WS GC + E+ GKP L+KI P +P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE--------IPE--- 227
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
++E KDF + L DP R TA L F
Sbjct: 228 ---------HLSEEAKDF-------LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 8e-57
Identities = 115/310 (37%), Positives = 169/310 (54%), Gaps = 34/310 (10%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKL 154
+A+++EKL+K+G+G+Y+ VYK + + GK+VALK +R E E F A RE +L+ L
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGL 60
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
H N++ L ++ ++ + L LVFEY+ DL VK ++ QLL GL +
Sbjct: 61 KHANIVLLHDIIHTKET--LTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY 118
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
H +LHRD+K NLLI + G LK+ADFGLA ++ VVTLWYRPP++LLG
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLG 177
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKK-SKLPN 332
+T Y +D+W GCI E++ G PG +++ QL +IF + G+P+E+ W LP+
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237
Query: 333 ATLFKPQQPYKRCIAETFKDFPSSSL--------------PLIETLLSIDPDNRGTATAA 378
FKP E F + +L L LL P NR +A AA
Sbjct: 238 ---FKP---------ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA 285
Query: 379 LNSEFFNTEP 388
L+ E+F+ P
Sbjct: 286 LSHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 7e-55
Identities = 115/327 (35%), Positives = 173/327 (52%), Gaps = 27/327 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ L +G G+ V+ A D K VA+KK+ +P+SVK REI ++R+LDH N+
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNI 64
Query: 160 IKLEGLVTSRMS------------CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQ 207
+K+ ++ S S+Y+V EYME DLA + QG SE + +M Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE-QG-PLSEEHARLFMYQ 122
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGL--KQPMTSRVVTL 264
LL GL++ H+ VLHRD+K +N+ I+ D +LKI DFGLA DP K ++ +VT
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
WYR P LLL Y +D+W+AGCI AE+L GKP+ G E+EQ+ I + EE
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 325 WKK--SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382
+ + +P+ +P +R + + +L +E +L+ +P +R TA AL
Sbjct: 243 RNELLNVIPSFVRNDGGEP-RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHP 301
Query: 383 FFNTEPYAC---EPSSLPKYPPSKEMD 406
+ Y+C EP SL + E+D
Sbjct: 302 YM--SCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 7e-55
Identities = 115/325 (35%), Positives = 175/325 (53%), Gaps = 16/325 (4%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
+ L ++G G Y +V A D TG+ VA+KK+ K RE+ +L+ + H N
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 159 VIKLEGLVTSRMSC----SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
VI L + TS +S YLV YM+ DL + G SE +V+ + Q+L GL++
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKI---MGHPLSEDKVQYLVYQMLCGLKY 132
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
H+ G++HRD+K NL ++ D LKI DFGLA D MT VVT WYR PE++L
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILN 188
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
+Y VD+WS GCI+AE+L GK + G+ ++QL +I K+ G P E+ +K + A
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248
Query: 335 LF---KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391
+ P+ P ++ + F ++ L+E +L +D D R TAT AL +F++ A
Sbjct: 249 SYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDAD 307
Query: 392 EPSSLPKYPPSKEMDVKLREEEARR 416
E + Y S E + KL +E ++
Sbjct: 308 EETEQQPYDDSLENE-KLSVDEWKK 331
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 1e-54
Identities = 104/299 (34%), Positives = 151/299 (50%), Gaps = 17/299 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLT--GKIVALKKVR--FDNLEPESVKFMAREILVLRKL- 154
+E + ++GQG Y V AR+ T + VA+KK+ F K RE+ +LR
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFR 59
Query: 155 DHPNVIKLEGL--VTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
H N+ L + V LYL E ME DL + G ++ + ++ Q+L GL
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGL 118
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP---MTSRVVTLWYRPP 269
++ H+ VLHRD+K NLL++ D LKI DFGLA + + MT V T WYR P
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329
E++L Y +D+WS GCILAELL KP+ G+ V+QL++I ++ G+P EE +
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238
Query: 330 LPNATLF---KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
P A + P P K F + +L L+E LL+ DP R + AL +
Sbjct: 239 SPKAQNYIRSLPNIPKKP-FESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 2e-54
Identities = 120/299 (40%), Positives = 167/299 (55%), Gaps = 25/299 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTG-KIVALKKVRFDNLEPESVKFMAREILVLRKLD--- 155
+E + +IG+G Y V+KARDL G + VALK+VR E RE+ VLR L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 156 HPNVIKLEGLVT-SRM--SCSLYLVFEYMEHDLAGLAACQGVKFSEPQV-----KCYMKQ 207
HPNV++L + T SR L LVFE+++ DL K EP V K M Q
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD----KVPEPGVPTETIKDMMFQ 118
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYR 267
LL GL+ H++ V+HRD+K N+L+ + G +K+ADFGLA Y + +TS VVTLWYR
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYR 176
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
PE+LL ++Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P EE W +
Sbjct: 177 APEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235
Query: 328 S-KLP-NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
LP A K QP ++ + D L+ L+ +P R +A +AL+ +F
Sbjct: 236 DVALPRQAFHSKSAQPIEKFVT----DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 2e-52
Identities = 93/285 (32%), Positives = 138/285 (48%), Gaps = 34/285 (11%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
FE L+KIG+G + VYKAR TGK VA+K ++ + E + + EI +L+K HPN+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNI 59
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+K G + L++V E+ L L +E Q+ K+LL GLE+ H+N
Sbjct: 60 VKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
G++HRDIK +N+L+ +DG +K+ DFGL+ + + V T ++ PE++ G Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT--KARNTMVGTPYWMAPEVING-KPY 174
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
D+WS G EL GKP ++ L KI G P L N
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPP--------GLRN------ 219
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
P K + FKDF ++ L +P+ R TA L F
Sbjct: 220 --PEKWS--DEFKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 4e-52
Identities = 82/295 (27%), Positives = 129/295 (43%), Gaps = 48/295 (16%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+E + +IG+G++ VY R GK+ LK++ N+ + + E+ +L+KL+HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 160 IKL-EGLVTSRMSCSLYLVFEYMEH-DLAGL---AACQGVKFSEPQVKCYMKQLLSGLEH 214
IK E L +V EY + DL+ +G F E Q+ + QL L++
Sbjct: 62 IKYYESFEEK---GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLL 273
H+ +LHRDIK N+ + ++G++K+ DFG++ + VV T +Y PEL
Sbjct: 119 LHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELCQ 176
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y D+WS GC+L EL K G +E KI
Sbjct: 177 NKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI-------------------- 215
Query: 334 TLFKPQQPYKRCIAETFKDFP---SSSL-PLIETLLSIDPDNRGTATAALNSEFF 384
+ + P SS L L+ +LL DP+ R + L S F
Sbjct: 216 ------------LKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 6e-52
Identities = 111/330 (33%), Positives = 165/330 (50%), Gaps = 25/330 (7%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++ L +G G Y +V A D TG VA+KK+ K RE+ +L+ + H NV
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 160 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
I L + T S +YLV M DL + CQ K ++ V+ + Q+L GL++
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI 136
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H+ ++HRD+K SNL ++ D LKI DFGLA D MT V T WYR PE++L
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNW 192
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
+Y VD+WS GCI+AELL G+ + PG ++QL I +L G+P E KK +A
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252
Query: 336 FKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF------NTE 387
+ K A F ++ L+E +L +D D R TA AL +F + E
Sbjct: 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 312
Query: 388 PYACEPSSLPKYPPSKEMDVKLREEEARRQ 417
P A +P + S+++ + +E +
Sbjct: 313 PVA-DP--YDQSFESRDLLI----DEWKSL 335
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-51
Identities = 111/316 (35%), Positives = 170/316 (53%), Gaps = 28/316 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHP 157
++ + IG+G+Y V A D TG+ VA+KK+ F+++ ++ + + REI +LR L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHP 59
Query: 158 NVIKLEGLV---TSRMSCSLYLVFEYMEHDLAGLAACQGVK----FSEPQVKCYMKQLLS 210
++++++ ++ + R +Y+VFE ME DL Q +K + + ++ QLL
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLH-----QVIKANDDLTPEHHQFFLYQLLR 114
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSRVVTLWYRP 268
L++ H V HRD+K N+L + D LKI DFGLA F D T V T WYR
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 269 PELLLGATY--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
PEL G+ + Y +D+WS GCI AE+L GKP+ PG+ V QL I L G+PS E
Sbjct: 175 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 327 KSKLPNATLF----KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382
+ + A + + +QP ++ F + +L L+E LL+ DP +R TA AL
Sbjct: 234 RVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291
Query: 383 FFNTEPYAC-EPSSLP 397
+F EPS+ P
Sbjct: 292 YFKGLAKVEREPSAQP 307
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 176 bits (446), Expect = 7e-51
Identities = 93/329 (28%), Positives = 142/329 (43%), Gaps = 40/329 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFD-NLEPESVKFMAREILVLRKLDHP- 157
+ L K+G+G++ VY ARD K+VALK + + + V+ REI +L L+HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLAAC--QGVKFSEPQVKCYMKQLLSGLEH 214
N++KL SLYLV EY++ L L + SE + + Q+LS LE+
Sbjct: 59 NIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 215 CHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPG-----LKQPMTSRVVTLWYRP 268
H+ G++HRDIK N+L+D + ++K+ DFGLA + ++ V T Y
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 269 PELLLGAT--YYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIFKLCGSPSEE 323
PE+LLG + Y D+WS G L ELL G P G Q KI +PS
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
P + ++ L++ LL+ DP NR ++++ L+ +
Sbjct: 237 SPLSPSNP-------------------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 384 FNTEPYACEPSSLPKYPPSKEMDVKLREE 412
S P
Sbjct: 278 LAHLKLKESDLSDLLKPDDSAPLRLSLPP 306
|
Length = 384 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 9e-51
Identities = 110/319 (34%), Positives = 170/319 (53%), Gaps = 22/319 (6%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVL 151
P R ++ L +G G Y +V A D + VA+KK+ F +L + RE+ +L
Sbjct: 14 PER---YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY--RELRLL 68
Query: 152 RKLDHPNVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQ 207
+ + H NVI L + T S +YLV M DL + CQ K S+ V+ + Q
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQ 126
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYR 267
LL GL++ H+ G++HRD+K SN+ ++ D L+I DFGLA D MT V T WYR
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYR 182
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
PE++L +Y VD+WS GCI+AELL GK + PG ++QL +I ++ G+PS E KK
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242
Query: 328 SKLPNATLFKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
+A + P+ ++ + + F+ ++ L+E +L +D D R +A+ AL +F+
Sbjct: 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS 302
Query: 386 TEPYACEPSSLPKYPPSKE 404
+P P+ P E
Sbjct: 303 QYH---DPEDEPEAEPYDE 318
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 1e-50
Identities = 110/293 (37%), Positives = 157/293 (53%), Gaps = 12/293 (4%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDH 156
N FE L +G+G Y V K R T +IVA+KK + D+ E E VK RE+ +LR L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQ 59
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
N+++L+ R LYLVFEY+E ++ L +V+ Y+ QL+ + CH
Sbjct: 60 ENIVELKEAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
N ++HRDIK NLLI ++ +LK+ DFG A G T V T WYR PELLLGA
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGS-PSEE---YWKKSKLPN 332
YG VD+WS GCIL EL G+P+ PG +E++QL I K+ G P+E+ ++ +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF-- 234
Query: 333 ATLFKPQQPYKRCIAETFKDFPSS-SLPLIETLLSIDPDNRGTATAALNSEFF 384
L P + + + + S L L++ LL ++P +R LN F
Sbjct: 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 2e-50
Identities = 110/323 (34%), Positives = 170/323 (52%), Gaps = 13/323 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ L ++G G Y V A D TG VA+KK+ K RE+ +L+ + H NV
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 160 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
I L + T +S YLV +M DL L + K SE +++ + Q+L GL++
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYI 134
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H G++HRD+K NL ++ D LKI DFGLA D MT VVT WYR PE++L
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPEVILNW 190
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
+Y VD+WS GCI+AE+L GKP+ G ++QL +I K+ G+PS+E+ +K + +A
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250
Query: 336 FKPQQP--YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
+ + P K+ + ++ ++E +L +D ++R TA AL +F +
Sbjct: 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDE 310
Query: 394 SSLPKYPPSKEMDVKLREEEARR 416
+ P Y S + +V EE +R
Sbjct: 311 TEAPPYDDSFD-EVDQSLEEWKR 332
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 7e-50
Identities = 77/199 (38%), Positives = 119/199 (59%), Gaps = 10/199 (5%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
D IG+G + VYK +L TG VA+K++ + ++ E++K + +EI +L+ L HPN++K
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 164 GLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
G + + S SLY++ EY E+ L + G F E V Y+ Q+L GL + H GV+H
Sbjct: 66 GSIET--SDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL--GATYYGV 280
RDIK +N+L DG++K+ADFG+AT + + S V T ++ PE++ GA+
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIEMSGAS---T 178
Query: 281 GVDLWSAGCILAELLAGKP 299
D+WS GC + ELL G P
Sbjct: 179 ASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 114/314 (36%), Positives = 170/314 (54%), Gaps = 38/314 (12%)
Query: 105 KIGQGTYSNVYKAR--DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
K+G+GTY +VYKA+ D + ALK++ + + REI +LR+L HPNVI L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISL 63
Query: 163 EGLVTSRMSCSLYLVFEYMEHDL--------AGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
+ + S ++L+F+Y EHDL A A + V+ VK + Q+L G+ +
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 215 CHNNGVLHRDIKGSNLLIDNDGI----LKIADFGLATFYDPGLK--QPMTSRVVTLWYRP 268
H N VLHRD+K +N+L+ +G +KIAD G A ++ LK + VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIFKLCGS 319
PELLLGA +Y +D+W+ GCI AELL +PI R E +QL +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 320 PSEEYWKK-SKLP-NATLFKP--QQPYKRC----IAETFKDFP-SSSLPLIETLLSIDPD 370
P+++ W+ K+P ++TL K + Y C E K P S + L++ LL++DP
Sbjct: 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPI 303
Query: 371 NRGTATAALNSEFF 384
R T+ A+ +F
Sbjct: 304 KRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 6e-48
Identities = 112/316 (35%), Positives = 167/316 (52%), Gaps = 42/316 (13%)
Query: 105 KIGQGTYSNVYKAR--DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
K+G+GTY +VYKA+ D K ALK++ + + REI +LR+L HPNVI L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIAL 63
Query: 163 EGLVTSRMSCSLYLVFEYMEHDL--------AGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
+ + S ++L+F+Y EHDL A A + ++ VK + Q+L G+ +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 215 CHNNGVLHRDIKGSNLLIDNDGI----LKIADFGLATFYDPGLK--QPMTSRVVTLWYRP 268
H N VLHRD+K +N+L+ +G +KIAD G A ++ LK + VVT WYR
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIFKLCGS 319
PELLLGA +Y +D+W+ GCI AELL +PI R E +QL +IF + G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243
Query: 320 PSEEYWKK-SKLPNATLFKPQQPYKRCI---------AETFKDFPSSSL-PLIETLLSID 368
P+++ W+ K+P Q+ ++R E K P S + L++ LL++D
Sbjct: 244 PADKDWEDIRKMPEYPTL--QKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301
Query: 369 PDNRGTATAALNSEFF 384
P R T+ AL +F
Sbjct: 302 PTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 7e-48
Identities = 101/284 (35%), Positives = 150/284 (52%), Gaps = 15/284 (5%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHPNVIK-L 162
IG G + V+ D GK VALKK+ F NL S K + RE+ +L H NV+ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 163 EGLVTSRMSC--SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
+ L + +Y+V E M+ DL + S VK ++ Q+L GL++ H+ G+
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGV 280
LHRDIK NLL++++ +LKI DFGLA +P + MT VVT +YR PE+L+G+ +Y
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 281 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLPNATLFKP 338
VD+WS GCI AELL + + ++ ++QL I L G+PS E + L P
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP 244
Query: 339 QQPYKRCIAETFK---DFPSSSLPLIETLLSIDPDNRGTATAAL 379
+P + + ++ L+ +L DPD R +A AL
Sbjct: 245 HKP--PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 93/298 (31%), Positives = 132/298 (44%), Gaps = 57/298 (19%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKV--RFDNLEPESVKFMAREILVLRKLD 155
+ F+ IG+G++S V A++ T K A+K + R E + VK++ E VL +L+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLN 59
Query: 156 -HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
HP +IKL T + +LY V EY + +L G E + Y ++L LE
Sbjct: 60 GHPGIIKLYY--TFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK---------------QPMT 258
+ H+ G++HRD+K N+L+D D +KI DFG A DP +
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 259 SR----VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIF 314
R V T Y PELL G DLW+ GCI+ ++L GKP G E KI
Sbjct: 177 RRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235
Query: 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR 372
KL EY P +FP + LIE LL +DP +R
Sbjct: 236 KL------EY----SFPP-------------------NFPPDAKDLIEKLLVLDPQDR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 5e-47
Identities = 98/289 (33%), Positives = 132/289 (45%), Gaps = 38/289 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
E++ +GQG+ VYK R TGKI ALKK+ D + E K + RE+ LR + P V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYV 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+K G + +V EYM+ LA L G K EP + +Q+L GL++ H
Sbjct: 62 VKCYGAFYK--EGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTK 118
Query: 219 -GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
++HRDIK SNLLI++ G +KIADFG++ + L Q T V T+ Y PE + G
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGE-S 176
Query: 278 YGVGVDLWSAGCILAELLAGK-PIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
Y D+WS G L E GK P +P E + I C P
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPP------------- 220
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
P P + E F+DF I L DP R +A L F
Sbjct: 221 ---PSLPAEEFSPE-FRDF-------ISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-45
Identities = 103/332 (31%), Positives = 168/332 (50%), Gaps = 38/332 (11%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHP 157
++ L IG G V A D +TG+ VA+KK+ F N K RE+++++ ++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHK 75
Query: 158 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVK--FSEPQVKCYMKQLLSG 211
N+I L + T + S +YLV E M+ +L CQ ++ ++ + Q+L G
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANL-----CQVIQMDLDHERMSYLLYQMLCG 130
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
++H H+ G++HRD+K SN+++ +D LKI DFGLA G MT VVT +YR PE+
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 188
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
+LG Y VD+WS GCI+ E++ G + PG ++Q +KI + G+PS+E+ + + P
Sbjct: 189 ILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ-P 246
Query: 332 NATLFKPQQPYKRCIAETFKD-FPSSSLP----------------LIETLLSIDPDNRGT 374
+ +P + +F++ FP P L+ +L IDP+ R +
Sbjct: 247 TVRNYVENRP--KYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304
Query: 375 ATAALNSEFFNTEPYACEPSSLPKYPPSKEMD 406
AL + N E + P P +D
Sbjct: 305 VDDALQHPYINVWYDPSEVEAPPPAPYDHSID 336
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-45
Identities = 92/302 (30%), Positives = 135/302 (44%), Gaps = 41/302 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++ L+KIG+G VYKA D TGK VA+KK+R E + EIL+++ HPN+
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNI 77
Query: 160 IKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
+ LV L++V EYM+ L + V+ +EPQ+ +++L GLE+ H
Sbjct: 78 VDYYDSYLV---GDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ V+HRDIK N+L+ DG +K+ADFG A K S V T ++ PE++
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-KSKRNSVVGTPYWMAPEVIKR-K 191
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
YG VD+WS G + E+ G+P P L +F + T
Sbjct: 192 DYGPKVDIWSLGIMCIEMAEGEP--P-YLREPPLRALFLI----------------TTKG 232
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSL 396
P + FKDF + L DP+ R +A L F AC
Sbjct: 233 IPPLKNPEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFLKK---ACPKEEF 282
Query: 397 PK 398
Sbjct: 283 AP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 5e-43
Identities = 89/291 (30%), Positives = 143/291 (49%), Gaps = 38/291 (13%)
Query: 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
++ +KIG GT+ VY A +L TG+++A+K++R + +P+++K +A E+ VL L HPN++
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 161 KLEGLVTSRMSCSLYLVFEY-MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
K G+ R +Y+ EY L L G E ++ Y QLL GL + H++G
Sbjct: 63 KYYGVEVHREK--VYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHG 119
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL----WYRPPELLLGA 275
++HRDIK +N+ +D++G++K+ DFG A M V +L Y PE++ G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 276 TYYGVG--VDLWSAGCILAELLAGKPIMPGRTEVEQLHKI-FKLCGSPSEEYWKKSKLPN 332
G G D+WS GC++ E+ GK E++ +I F +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVGAGH------------ 223
Query: 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
KP P ++ KDF ++ L DP R TA+ L F
Sbjct: 224 ----KPPIPDSLQLSPEGKDF-------LDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 154 bits (389), Expect = 1e-42
Identities = 109/336 (32%), Positives = 166/336 (49%), Gaps = 37/336 (11%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+++L IG G V A D + G VA+KK+ K RE+++L+ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 160 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGV--KFSEPQVKCYMKQLLSGLE 213
I L + T + S +YLV E M+ +L CQ + + ++ + Q+L G++
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANL-----CQVIHMELDHERMSYLLYQMLCGIK 137
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H H+ G++HRD+K SN+++ +D LKI DFGLA MT VVT +YR PE++L
Sbjct: 138 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM--MTPYVVTRYYRAPEVIL 195
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK--SKLP 331
G Y VD+WS GCI+ EL+ G I G ++Q +K+ + G+PS E+ + +
Sbjct: 196 GMGYKE-NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254
Query: 332 NATLFKPQQPYKRCIAETFKD--FPSSS----------LPLIETLLSIDPDNRGTATAAL 379
N +PQ P E F D FPS S L+ +L IDPD R + AL
Sbjct: 255 NYVENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313
Query: 380 NSEFFNT--EPYACEPSSLPKYPPSKEMDVKLREEE 413
+ +P E PP + D +L E E
Sbjct: 314 RHPYITVWYDPAEAEA------PPPQIYDAQLEERE 343
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 86/292 (29%), Positives = 131/292 (44%), Gaps = 55/292 (18%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
+G+G++ V R TGK+ A+K ++ ++ + V+ E +L +++HP ++KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 165 LVTSRMSCS------LYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+ LYLV EY +L + +G +FSE + + Y +++ LE+ H+
Sbjct: 59 ------HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHS 111
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
G+++RD+K N+L+D DG +K+ DFGLA G + + T Y PE+LLG
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLLGKG 169
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
YG VD WS G +L E+L GKP E KI K L
Sbjct: 170 -YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI------------LKDPL------ 210
Query: 337 KPQQPYKRCIAETFKDFPSSSL-PLIETLLSIDPDNR-GTATAAL--NSEFF 384
F +F S LI LL DP R G+ A FF
Sbjct: 211 ------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 91/287 (31%), Positives = 144/287 (50%), Gaps = 46/287 (16%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDN---LEPESVKFMAREILVLRKLDHPNVIKL 162
+G G++ +VY+ +L G A+K+V + E+VK + +EI +L KL HPN+++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 163 EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
G T R +LY+ E + LA L G F EP ++ Y +Q+L GLE+ H+ +
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT-----SRVVTLWYRPPELLLGAT 276
HRDIKG+N+L+D +G++K+ADFG+A KQ + S + ++ PE++
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMA-------KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
YG+ D+WS GC + E+ GKP +++E + +FK+ S LP
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKE--------LP----- 221
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
P +++ KDF I L DP R TA L F
Sbjct: 222 ----PIPDHLSDEAKDF-------ILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 93/290 (32%), Positives = 142/290 (48%), Gaps = 39/290 (13%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKV--------RFDNLEPESVKFMAREILVLRKLDHP 157
IG+GTY VY A ++ TG+++A+K+V R D+ + + VK + EI L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
N+++ G T+ S++L EY+ G +F E V+ + +Q+L GL + H+
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGL----ATFYDPGLKQPMTSRVVTLWYRPPELLL 273
G+LHRD+K NLL+D DGI KI+DFG+ YD Q M+ + W P +
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDN--DQNMSMQGSVFWMAPEVIHS 184
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
+ Y VD+WS GC++ E+ AG+ P E E + +FKL K P
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKL--------GNKRSAP-- 231
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
P P + + +L + +I+PDNR TA L F
Sbjct: 232 ----PIPP------DVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 99/326 (30%), Positives = 162/326 (49%), Gaps = 27/326 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++ L IG G V A D + + VA+KK+ K RE+++++ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 160 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVK--FSEPQVKCYMKQLLSGLE 213
I L + T + S +Y+V E M+ +L CQ ++ ++ + Q+L G++
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANL-----CQVIQMELDHERMSYLLYQMLCGIK 140
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H H+ G++HRD+K SN+++ +D LKI DFGLA G MT VVT +YR PE++L
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
G Y VD+WS GCI+ E++ G + PG ++Q +K+ + G+P E+ KK +
Sbjct: 199 GMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257
Query: 334 TLFKPQQPYK-RCIAETFKD--FP----------SSSLPLIETLLSIDPDNRGTATAALN 380
T + + Y + F D FP S + L+ +L ID R + AL
Sbjct: 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317
Query: 381 SEFFNTEPYACEPSSLPKYPPSKEMD 406
+ N E + P P K++D
Sbjct: 318 HPYINVWYDPSEAEAPPPKIPDKQLD 343
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 107/338 (31%), Positives = 168/338 (49%), Gaps = 41/338 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++ L IG G V A D + + VA+KK+ K RE+++++ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 160 IKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVK--FSEPQVKCYMKQLLSGLE 213
I L + T + S +YLV E M+ +L CQ ++ ++ + Q+L G++
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANL-----CQVIQMELDHERMSYLLYQMLCGIK 133
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H H+ G++HRD+K SN+++ +D LKI DFGLA G MT VVT +YR PE++L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
G Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ KK + P
Sbjct: 192 GMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ-PTV 249
Query: 334 TLFKPQQPYKRCIAETF-KDFPSSSLP---------------LIETLLSIDPDNRGTATA 377
+ +P + TF K FP S P L+ +L IDP R +
Sbjct: 250 RNYVENRP--KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 378 ALNSEFFNT--EPYACEPSSLPKYPPSKEMDVKLREEE 413
AL + N +P E PP + D +L E E
Sbjct: 308 ALQHPYINVWYDPAEVEA------PPPQIYDKQLDERE 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 74/223 (33%), Positives = 117/223 (52%), Gaps = 11/223 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+E L+ IG+G++ V K R GKI+ K++ + N+ + + + E+ +LR+L HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGL-AACQGVK--FSEPQVKCYMKQLLSGLEHC 215
++ + R + +LY+V EY E DLA L C+ + E + + QLL L C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 216 HN-----NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
HN N VLHRD+K +N+ +D + +K+ DFGLA + V T +Y PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS-SFAKTYVGTPYYMSPE 180
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
L +Y D+WS GC++ EL A P R +++ KI
Sbjct: 181 QLNHMSYDEKS-DIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 5e-38
Identities = 78/242 (32%), Positives = 116/242 (47%), Gaps = 31/242 (12%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK---FMAREILVLRKLDHPNVIKL 162
I +G Y V+ A+ TG I A+K ++ ++ ++ R+IL + P V+KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS--QAQSPYVVKL 58
Query: 163 -EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
+ +LYLV EY+ DLA L G E + Y+ +++ LE+ H+NG+
Sbjct: 59 YYSFQGKK---NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGI 114
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT---------SRVV-TLWYRPPE 270
+HRD+K N+LID++G LK+ DFGL+ GL + R+V T Y PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKV---GLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI------FKLCGSPSEEY 324
++LG + VD WS GCIL E L G P G T E I + S+E
Sbjct: 172 VILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEA 230
Query: 325 WK 326
Sbjct: 231 ID 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 75/207 (36%), Positives = 113/207 (54%), Gaps = 15/207 (7%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDH 156
F+ KIG+G +S VYKA LL G++VALKKV+ F+ ++ ++ + +EI +L++LDH
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 157 PNVIK-LEGLVTSRMSCSLYLVFEYMEH-DLAGL---AACQGVKFSEPQVKCYMKQLLSG 211
PNVIK L + + L +V E + DL+ + Q E + Y QL S
Sbjct: 62 PNVIKYLASFIENNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT--SRVVTLWYRPP 269
LEH H+ ++HRDIK +N+ I G++K+ D GL F+ + S V T +Y P
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTPYYMSP 175
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLA 296
E + Y D+WS GC+L E+ A
Sbjct: 176 ERIHENG-YNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 7e-37
Identities = 107/317 (33%), Positives = 157/317 (49%), Gaps = 23/317 (7%)
Query: 95 RRANTFEKL-DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
R N KL + IG G++ VY+A + T + VA+KKV D ++ RE+L+++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKN 115
Query: 154 LDHPNVIKL------EGLVTSRMSCSLYLVFEYME---HDLAGLAACQGVKFSEPQVKCY 204
L+H N+I L E + + L +V E++ H A VK Y
Sbjct: 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLY 175
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVVT 263
QL L + H+ + HRD+K NLLID N LK+ DFG A G Q S + +
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG--QRSVSYICS 233
Query: 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323
+YR PEL+LGAT Y +DLWS GCI+AE++ G PI G++ V+QL +I ++ G+P+E+
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293
Query: 324 YWKKSKLPNATLFKPQQPYKRCIAETF-KDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382
K+ PN K + + + F K P ++ I L +P R AL
Sbjct: 294 QLKEMN-PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 383 FFNTEPYACEPSSLPKY 399
FF+ C LPKY
Sbjct: 353 FFDDLRDPC--IKLPKY 367
|
Length = 440 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 44/302 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F L+ IG+G++ VYKA D T ++VA+K + + E E ++ + +EI L + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
K G L+++ EY L K E + ++++L GLE+ H
Sbjct: 62 TKYYGSFLKG--SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE 117
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPELLLGA 275
G +HRDIK +N+L+ +G +K+ADFG++ L M+ R V T ++ PE++
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVSG----QLTSTMSKRNTFVGTPFWMAPEVIKQ- 172
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
+ Y D+WS G EL G+P + + L I K
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN------------------- 213
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSS 395
P ++ FKDF + L+ DP R +A L +F A + S
Sbjct: 214 -NPPSLEGNKFSKPFKDF-------VSLCLNKDPKERPSAKELLKHKFIKK---AKKTSY 262
Query: 396 LP 397
L
Sbjct: 263 LT 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-35
Identities = 84/301 (27%), Positives = 128/301 (42%), Gaps = 48/301 (15%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE--PESVKFMAREILVLRKLD 155
+ +E ++ IG G + VY A L + VA+K++ +LE SV + +E+ + + +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSG 211
HPNV+K L+LV Y+ D+ + +G E + +K++L G
Sbjct: 58 HPNVVKYYTSFVVGDE--LWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKG 114
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGL-ATFYDPGLKQPMTSRVV--TLWYRP 268
LE+ H+NG +HRDIK N+L+ DG +KIADFG+ A+ D G + + T +
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328
PE++ Y D+WS G EL G P S
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAA--PY------------------------S 208
Query: 329 KLPNA-----TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
K P TL P +K + S +I L DP R TA L +F
Sbjct: 209 KYPPMKVLMLTLQND--PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
Query: 384 F 384
F
Sbjct: 267 F 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 81/263 (30%), Positives = 123/263 (46%), Gaps = 16/263 (6%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKK-VRFDNLEPESVKFMAREILVLRKLDHPN 158
FE L IG+G + V + T K+ A+K + +E SV+ + E +L++L+HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG---LAACQGVKFSEPQVKCYMKQLLSGLEHC 215
++ L + + ++YLV + + L G Q VKFSE QVK ++ +++ LE+
Sbjct: 62 LVNLW--YSFQDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H+ G++HRDIK N+L+D G + I DF +AT P TS T Y PE+L
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQ 174
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPG--RTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y V VD WS G E L GK G RT +Q+ + W +
Sbjct: 175 -GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233
Query: 334 TLFKPQQPYKR--CIAETFKDFP 354
+ P KR + K+ P
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 80/293 (27%), Positives = 140/293 (47%), Gaps = 45/293 (15%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
F+ L+K+G+G+Y +VYKA TG++VA+K V + E ++ + +EI +L++ D P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSP 58
Query: 158 NVIKLEGLVTSRMSCS-LYLVFEYMEHDLAG-----LAACQGVKFSEPQVKCYMKQLLSG 211
++K G S + L++V ME+ AG + +E ++ + Q L G
Sbjct: 59 YIVKYYG---SYFKNTDLWIV---MEYCGAGSVSDIMKITNKT-LTEEEIAAILYQTLKG 111
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
LE+ H+N +HRDIK N+L++ +G K+ADFG++ + + + + T ++ PE+
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-RNTVIGTPFWMAPEV 170
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
+ Y D+WS G E+ GKP P +++ + IF + P L
Sbjct: 171 IQEIGYNNK-ADIWSLGITAIEMAEGKP--P-YSDIHPMRAIFMIPNKPPP------TLS 220
Query: 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ + P+ F DF ++ L DP+ R +A L F
Sbjct: 221 DPEKWSPE----------FNDF-------VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 85/300 (28%), Positives = 138/300 (46%), Gaps = 58/300 (19%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+E + +IG GTY +VYKARD+ TG++VA+K ++ + + + + +EI +L++ HPN+
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNI 62
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG-----------VKFSEPQVKCYMKQL 208
+ G R L++V EY C G SE Q+ ++
Sbjct: 63 VAYFGSYLRRDK--LWIVMEY----------CGGGSLQDIYQVTRGPLSELQIAYVCRET 110
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLW 265
L GL + H G +HRDIKG+N+L+ DG +K+ADFG++ L + R + T +
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSA----QLTATIAKRKSFIGTPY 166
Query: 266 YRPPELLLGATY--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323
+ PE+ Y D+W+ G EL +P M ++ + +F + S+
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM---FDLHPMRALFLI----SKS 219
Query: 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
+ KL + + P F DF I+ L+ DP R TAT L F
Sbjct: 220 NFPPPKLKDKEKWSPV----------FHDF-------IKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 75/231 (32%), Positives = 127/231 (54%), Gaps = 20/231 (8%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES-------VKFMAREILVLRKLDHPN 158
IG G++ +VY + +G+++A+K+V ++ S + +AREI +L++L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+++ G +S + L + EY+ +A L G F E V+ +++Q+L GL + HN
Sbjct: 68 IVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQILKGLNYLHN 124
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGL-----ATFYDPGLKQPMTSRVVTLWYRPPELL 272
G++HRDIKG+N+L+DN G +KI+DFG+ A S ++++ PE +
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE-V 183
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323
+ T Y D+WS GC++ E+L GK P + QL IFK+ + S E
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-32
Identities = 82/262 (31%), Positives = 130/262 (49%), Gaps = 28/262 (10%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES---VKFMAREILVLRKLDHPNVIKL 162
+GQG + VY D+ TG+ +A+K+V FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 163 EGLVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
G + + S+++ EYM D +E + Y +Q+L G+E+ H+N
Sbjct: 70 YGCLRDDETLSIFM--EYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSN 123
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFG----LATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
++HRDIKG+N+L D+ G +K+ DFG L T G M S T ++ PE++ G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG--TGMKSVTGTPYWMSPEVISG 181
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
YG D+WS GC + E+L KP E E + IFK+ P+ +LP+
Sbjct: 182 EG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN-----PQLPSHV 232
Query: 335 LFKPQQPYKRCIAETFKDFPSS 356
+ +R E K PS+
Sbjct: 233 SPDARNFLRRTFVENAKKRPSA 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 85/307 (27%), Positives = 129/307 (42%), Gaps = 57/307 (18%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-D 155
FE ++ IG+GTY VYKAR TG++VA+K + ++ + + + E +LRK +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM---DIIEDEEEEIKEEYNILRKYSN 61
Query: 156 HPNVIKLEGLVTSRMSCS----LYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQ 207
HPN+ G + L+LV E DL +G + E + +++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTL 264
L GL + H N V+HRDIKG N+L+ + +K+ DFG++ L + R + T
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIGTP 177
Query: 265 WYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIFKL 316
++ PE++ Y D+WS G EL GKP + P R L KI
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKI--- 230
Query: 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT 376
P P TL P+ K+ F DF I L + + R
Sbjct: 231 ---PRN--------PPPTLKSPENWSKK-----FNDF-------ISECLIKNYEQRPFME 267
Query: 377 AALNSEF 383
L F
Sbjct: 268 ELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 77/233 (33%), Positives = 125/233 (53%), Gaps = 26/233 (11%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRF----DNLEPESVKFMAREILVLRKLDHPNVIK 161
+G G +S+ Y+ARD+ TG ++A+K+V + + + E V+ + +EI ++ +L+HP++I+
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK----FSEPQVKCYMKQLLSGLEHCHN 217
+ G +L++ E+M AG + + F E + Y +QLL GL + H
Sbjct: 68 MLGATCEDSHFNLFV--EWM----AGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 218 NGVLHRDIKGSNLLIDNDG-ILKIADFGLA-----TFYDPGLKQPMTSRVVTLWYRPPEL 271
N ++HRD+KG+NLLID+ G L+IADFG A G Q + T+ + PE+
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ--GQLLGTIAFMAPEV 179
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC---GSPS 321
L G YG D+WS GC++ E+ KP L IFK+ +PS
Sbjct: 180 LRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-31
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 25/230 (10%)
Query: 100 FEKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
E K+G+G + VYK T VA+K ++ E E +F+ E +++KL
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLS 59
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL-----AGLAACQGVKFSEPQVKCYMKQLL 209
HPN+++L G+ T LY+V EYM DL G K + + Q+
Sbjct: 60 HPNIVRLLGVCTQGEP--LYIVTEYMPGGDLLDFLRK-----HGEKLTLKDLLQMALQIA 112
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTL-WYR 267
G+E+ + +HRD+ N L+ + ++KI+DFGL+ Y+ + + + W
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM- 171
Query: 268 PPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIFK 315
PE L + D+WS G +L E+ L +P PG + E L +
Sbjct: 172 APESLKDGKFT-SKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F+ L K+G+G+Y +VYK + L + ALK+V ++ + + EI +L ++HPN+
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYME-HDLAGL---AACQGVKFSEPQVKCYMKQLLSGLEHC 215
I + L +V EY DL+ + E ++ QLL GL+
Sbjct: 62 ISYKE--AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLG 274
H +LHRD+K +N+L+ + ++KI D G++ LK+ M + T Y PE+ G
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTPHYMAPEVWKG 175
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
Y D+WS GC+L E+ P R+ + +K+
Sbjct: 176 -RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 21/212 (9%)
Query: 104 DKIGQGTYSNVYKA--RDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
K+G+G + VYK + VA+K ++ D E E F+ +E V++KL HPNV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPNVV 59
Query: 161 KLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGV-------KFSEPQVKCYMKQLLSG 211
+L G+ T LYLV EYME DL L + V S + + Q+ G
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS--RVVTLWYRPP 269
+E+ + +HRD+ N L+ D ++KI+DFGL+ + ++ W P
Sbjct: 118 MEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-AP 176
Query: 270 ELLLGATYYGVGVDLWSAGCILAEL--LAGKP 299
E L + D+WS G +L E+ L P
Sbjct: 177 ESLKDGI-FTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 6e-30
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 101 EKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
K+G+G + VYK VA+K ++ D E + +F+ RE ++RKLDH
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDH 60
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSGLEH 214
PN++KL G+ T L +V EYM DL L + + S + + Q+ G+E+
Sbjct: 61 PNIVKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF-YDPGLKQPMTSRVVTLWYRPPELLL 273
+ +HRD+ N L+ + ++KI+DFGL+ YD + ++ W PE L
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLK 177
Query: 274 GATYYGVGVDLWSAGCILAELL 295
+ D+WS G +L E+
Sbjct: 178 EGK-FTSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 101/325 (31%), Positives = 137/325 (42%), Gaps = 77/325 (23%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLE-PESVKFMA-REILVLRKLDH 156
FE + IG+G + V+ RD TG++ A+K +R D ++ + A R+IL D
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA--DADS 60
Query: 157 PNVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLL 209
P ++KL S LYLV EYM DL L + V F E + Y+ +L+
Sbjct: 61 PWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELV 111
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD------------------- 250
L+ H G +HRDIK N+LID DG +K+ADFGL +
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 251 ------PGLKQPMT---SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIM 301
KQ S V T Y PE+L G T YG+ D WS G IL E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 302 PGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLI 361
T E +KI WK+S L P P ++ LI
Sbjct: 231 YSDTLQETYNKIIN---------WKES------LRFPPDP----------PVSPEAIDLI 265
Query: 362 ETLLSIDPDNR-GTATAALNSEFFN 385
LL DP++R G+ + FF
Sbjct: 266 CRLL-CDPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-29
Identities = 87/296 (29%), Positives = 139/296 (46%), Gaps = 45/296 (15%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK-FMAREILVLR 152
P++ T + +KIGQG VY A D+ TG+ VA+K++ NL+ + K + EILV+R
Sbjct: 17 PKKKYT--RFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMR 71
Query: 153 KLDHPNVIKLEGLVTSRMSC-SLYLVFEYMEHDLAGLAACQGVK---FSEPQVKCYMKQL 208
+ HPN++ + S + L++V EY LAG + V E Q+ ++
Sbjct: 72 ENKHPNIVNY---LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCREC 124
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP 268
L LE H+N V+HRDIK N+L+ DG +K+ DFG P + ++ V T ++
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMA 183
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328
PE++ YG VD+WS G + E++ G+P + L+ I
Sbjct: 184 PEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------- 227
Query: 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
AT P+ ++ F+DF + L +D + RG+A L F
Sbjct: 228 ----ATNGTPELQNPEKLSAIFRDFLNRC-------LEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 101 EKLDKIGQGTYSNVYKARDLLTGKI------VALKKVRFDNLEPESVKFMAREILVLRKL 154
K+G+G + VYK + L GK VA+K ++ D E + +F+ RE ++RKL
Sbjct: 2 TLGKKLGEGAFGEVYKGK--LKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKL 58
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSGL 212
DHPNV+KL G+ T LY+V EYME DL L + K S + + Q+ G+
Sbjct: 59 DHPNVVKLLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGM 115
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL-WYRPPEL 271
E+ + +HRD+ N L+ + ++KI+DFGL+ + + W PE
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APES 174
Query: 272 LLGATYYGVGVDLWSAGCILAELL 295
L + D+WS G +L E+
Sbjct: 175 LKEGKFT-SKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-28
Identities = 91/292 (31%), Positives = 134/292 (45%), Gaps = 54/292 (18%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGL 165
+G+GTY VY ARDL T +A+K++ + V+ + EI + L H N+++ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG- 72
Query: 166 VTSRMSCSLYLVFE-YMEHDLAG-LAACQGVKF-----SEPQVKCYMKQLLSGLEHCHNN 218
S S F+ +ME G L+A K+ +E + Y KQ+L GL++ H+N
Sbjct: 73 -----SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 219 GVLHRDIKGSNLLIDN-DGILKIADFG----LATFYDPGLKQPMTSRVV-TLWYRPPELL 272
++HRDIKG N+L++ G++KI+DFG LA G+ P T TL Y PE++
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-----GI-NPCTETFTGTLQYMAPEVI 181
Query: 273 -LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
G YG D+WS GC + E+ GKP P F G P +K
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKP--P-----------FIELGEPQAAMFK----- 223
Query: 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
+FK ++ K+F I DPD R +A L F
Sbjct: 224 -VGMFKIHPEIPESLSAEAKNF-------ILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 29/263 (11%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAR---EILVLRKLDHPNVIKL 162
+GQG + VY D+ TG+ +A K+V+FD PE+ K ++ EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 163 EGLVTSRMSCSLYLVFEYM-----EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
G + R +L + EYM + L A +E + Y +Q+L G+ + H+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-----LTESVTRKYTRQILEGMSYLHS 124
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFG----LATFYDPGLKQPMTSRVVTLWYRPPELLL 273
N ++HRDIKG+N+L D+ G +K+ DFG L T G + S T ++ PE++
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG--IRSVTGTPYWMSPEVIS 182
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
G YG D+WS GC + E+L KP E E + IFK+ P+ +LP+
Sbjct: 183 GEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-----NPQLPSH 233
Query: 334 TLFKPQQPYKRCIAETFKDFPSS 356
+ + + CI + PS+
Sbjct: 234 I-SEHARDFLGCIFVEARHRPSA 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 28/213 (13%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDH 156
+ FE + +G G++ V R +GK ALK + ++ + V+ + E +L+ + H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LAACQGVKFSEPQVKCYMKQLLS 210
P ++ L G + + +LYLV EY + G L +F EP + Y Q++
Sbjct: 61 PFLVNLYG--SFQDDSNLYLVMEY----VPGGELFSHLRKSG--RFPEPVARFYAAQVVL 112
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW----Y 266
LE+ H+ +++RD+K NLL+D+DG +KI DFG A R TL Y
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG--------RTYTLCGTPEY 164
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKP 299
PE++L YG VD W+ G ++ E+LAG P
Sbjct: 165 LAPEIILSKG-YGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 7e-27
Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+E + KIG+G++ +Y A+ + +K++ + + + +E+++L K+ HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHN 217
+ + + + L++V EY + DL Q GV FSE Q+ + Q+ GL+H H+
Sbjct: 62 VTF--FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 218 NGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+LHRDIK N+ + +G + K+ DFG+A + ++ T V T +Y PE+
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC-VGTPYYLSPEICQNRP 178
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
Y D+WS GC+L EL K G + QL + K+C F
Sbjct: 179 YNN-KTDIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKICQG---------------YF 219
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P P +F LI L + P +R + T+ L F
Sbjct: 220 APISP----------NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 75/228 (32%), Positives = 118/228 (51%), Gaps = 23/228 (10%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES---VKFMAREILVLRKLDHPNVIKL 162
+GQG + VY D TG+ +A+K+V+FD PE+ V + EI +L+ L H +++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 163 EGLVTSRMSCSLYLVFEYM-----EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
G + M +L + E+M + L A +E + Y +Q+L G+ + H+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-----LTENVTRKYTRQILEGVSYLHS 124
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFG----LATFYDPGLKQPMTSRVVTLWYRPPELLL 273
N ++HRDIKG+N+L D+ G +K+ DFG L T G M S T ++ PE++
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG--MKSVTGTPYWMSPEVIS 182
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS 321
G YG D+WS GC + E+L KP E E + IFK+ P+
Sbjct: 183 GEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 3e-26
Identities = 84/257 (32%), Positives = 122/257 (47%), Gaps = 36/257 (14%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
KIG+G +S VY+A LL G VALKKV+ FD ++ ++ +EI +L++L+HPNVIK
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 164 GLVTSRMSCSLYLVFEYMEH-DLAGLA---ACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
L +V E + DL+ + Q E V Y QL S LEH H+
Sbjct: 69 ASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
V+HRDIK +N+ I G++K+ D GL F+ S V T +Y PE + Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPE-RIHENGYN 184
Query: 280 VGVDLWSAGCILAELLAGK----------------------PIMPGRTEVEQLHKIFKLC 317
D+WS GC+L E+ A + P +P E+L ++ +C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 244
Query: 318 GSPSEEYWKKSKLPNAT 334
+P E K P+ T
Sbjct: 245 INPDPE-----KRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 65/203 (32%), Positives = 103/203 (50%), Gaps = 10/203 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPN 158
F L +IG G++ VY ARD+ T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
I+ +G + +LV EY + + E ++ L GL + H++
Sbjct: 77 TIEYKGCYLREHTA--WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT-- 276
+HRDIK N+L+ G +K+ADFG A+ L P S V T ++ PE++L
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSAS-----LVSPANSFVGTPYWMAPEVILAMDEG 189
Query: 277 YYGVGVDLWSAGCILAELLAGKP 299
Y VD+WS G EL KP
Sbjct: 190 QYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 14/206 (6%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH--- 156
+++L+ IG+G Y VY+ + + TG++VALK + D + + V + RE+ +L +L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 157 PNVIKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
PN+ K G L R L+++ EY E + L +E + ++++L L+
Sbjct: 62 PNITKYYGSYLKGPR----LWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALK 115
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ H GV+HRDIK +N+L+ N G +K+ DFG+A + + T V T ++ PE++
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVIT 174
Query: 274 GATYYGVGVDLWSAGCILAELLAGKP 299
YY D+WS G + E+ G P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 59/201 (29%), Positives = 106/201 (52%), Gaps = 6/201 (2%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ K+ KIG+G++ + GK +K++ + P+ + +E+ VL + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DL-AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
++ + + + +LY+V +Y E DL + A +GV F E Q+ + Q+ L+H H+
Sbjct: 62 VQYQE--SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+LHRDIK N+ + DG +K+ DFG+A + ++ T + T +Y PE+ Y
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRPY 178
Query: 278 YGVGVDLWSAGCILAELLAGK 298
D+W+ GC+L E+ K
Sbjct: 179 NNKS-DIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 71/203 (34%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLDHPN 158
L I +G + +VY A+ TG A+K ++ ++ + +VK R I++++ + P
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVK-AERAIMMIQG-ESPY 58
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
V KL S+ LYLV EY+ D A L G E K Y+ +++ G+E H
Sbjct: 59 VAKLYYSFQSKDY--LYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQ 115
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGAT 276
G++HRDIK NLLID G LK+ DFGL+ GL + V T Y PE +LG
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN---GL---ENKKFVGTPDYLAPETILGVG 169
Query: 277 YYGVGVDLWSAGCILAELLAGKP 299
+ D WS GC++ E L G P
Sbjct: 170 DDKMS-DWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 74/208 (35%), Positives = 113/208 (54%), Gaps = 21/208 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPN 158
F+ KIG+G +S VY+A LL K VALKKV+ F+ ++ ++ + +EI +L++L+HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 159 VIK-LEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKC--------YMKQL 208
VIK L+ + L +V E + DL+ Q +K+ + Q + Y QL
Sbjct: 64 VIKYLDSFIEDN---ELNIVLELADAGDLS-----QMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP 268
S +EH H+ V+HRDIK +N+ I G++K+ D GL F+ S V T +Y
Sbjct: 116 CSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMS 174
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLA 296
PE + Y D+WS GC+L E+ A
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 87/290 (30%), Positives = 141/290 (48%), Gaps = 43/290 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK-FMAREILVLRKLDHPN 158
+ + +KIGQG VY A D+ TG+ VA++++ NL+ + K + EILV+R+ +PN
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPN 78
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK---FSEPQVKCYMKQLLSGLEHC 215
++ L + + L++V EY LAG + V E Q+ ++ L LE
Sbjct: 79 IVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLG 274
H+N V+HRDIK N+L+ DG +K+ DFG P +Q S +V T ++ PE++
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTR 190
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
YG VD+WS G + E++ G+P + L+ I G+P
Sbjct: 191 KA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTP-------------- 234
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ Q P K ++ F+DF + L +D + RG+A L +F
Sbjct: 235 --ELQNPEK--LSAIFRDF-------LNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 6e-25
Identities = 84/289 (29%), Positives = 136/289 (47%), Gaps = 41/289 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK-FMAREILVLRKLDHPN 158
+ + +KIGQG VY A D+ TG+ VA+K++ NL+ + K + EILV+R+ +PN
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPN 77
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK---FSEPQVKCYMKQLLSGLEHC 215
++ L + + L++V EY LAG + V E Q+ ++ L L+
Sbjct: 78 IVNY--LDSYLVGDELWVVMEY----LAGGSLTDVVTETCMDEGQIAAVCRECLQALDFL 131
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H+N V+HRDIK N+L+ DG +K+ DFG P + ++ V T ++ PE++
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRK 190
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
YG VD+WS G + E++ G+P + L+ I AT
Sbjct: 191 A-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATN 230
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P+ ++ F+DF + L +D D RG+A L F
Sbjct: 231 GTPELQNPERLSAVFRDF-------LNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
FE L+KIG+G++ V+K ++ A+K++ + + E VL KLD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 160 IK-LEGLVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
I+ E + L +V EY E H L L +G E QV + Q+L GL H
Sbjct: 62 IRYYESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPELL 272
H+ +LHRDIK NL +D +KI D G+A + V T +Y PEL
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI---VGTPYYLSPELC 173
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
Y D+W+ G +L E GK + + KI +
Sbjct: 174 EDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 20/224 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
E L ++G G V K TGKI+A+K +R + + K + RE+ +L K + P +
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAA----CQGVKFSEPQVKCYMKQLLSGLEHC 215
+ G + + + + EYM D L QG E + +L GL +
Sbjct: 62 VGFYGAFYN--NGDISICMEYM--DGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYL 116
Query: 216 HNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
H ++HRD+K SN+L+++ G +K+ DFG++ L + + V T Y PE + G
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFVGTSSYMAPERIQG 173
Query: 275 ATYYGVGVDLWSAGCILAELLAGK-----PIMPGRTEVEQLHKI 313
Y V D+WS G L EL G+ P E L I
Sbjct: 174 -NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 86/323 (26%), Positives = 140/323 (43%), Gaps = 52/323 (16%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPN 158
F L +IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L+KL HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
I+ G + +LV EY + L E ++ L GL + H++
Sbjct: 77 TIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT-- 276
++HRD+K N+L+ G++K+ DFG A+ + P V T ++ PE++L
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP--SEEYWKKSKLPNAT 334
Y VD+WS G EL KP + + L+ I + SP +W
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPALQSGHW--------- 239
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPS 394
+E F++F S L I P +R T+ L F E
Sbjct: 240 ------------SEYFRNFVDSCLQKI-------PQDRPTSEVLLKHRFVLRE------- 273
Query: 395 SLPKYPPSKEMDVKLREEEARRQ 417
PP+ MD+ R ++A R+
Sbjct: 274 ----RPPTVIMDLIQRTKDAVRE 292
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 77/232 (33%), Positives = 109/232 (46%), Gaps = 19/232 (8%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDH 156
F+ L ++GQG Y V+ A+ TG+IVALK+++ L V+ + E +L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
++KL L + LYL EY+ D L GV SE + YM ++ ++
Sbjct: 61 EWLVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDAL 117
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H G +HRD+K N LID G +K+ DFGL+ G+ S V + Y PE+L G
Sbjct: 118 HELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRG- 172
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
Y VD WS GC+L E L G P G T E + YWK+
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 80/288 (27%), Positives = 130/288 (45%), Gaps = 42/288 (14%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGL 165
+G G + VYKA+ TG A K ++ ++ E E FM EI +L + HPN++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKHPNIVGL--Y 68
Query: 166 VTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRD 224
L+++ E+ + L + +EPQ++ +Q+L L H++ V+HRD
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 225 IKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPELLLGATY---- 277
+K N+L+ DG +K+ADFG++ K + R + T ++ PE++ T+
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSA----KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
Y D+WS G L EL +P P E+ + + K+ S TL +
Sbjct: 185 YDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEP-----------PTLDQ 230
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
P + +F DF S L DPD+R TA L F +
Sbjct: 231 P-----SKWSSSFNDFLKSC-------LVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 82/285 (28%), Positives = 140/285 (49%), Gaps = 36/285 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F KL++IG+G++ V+K D T ++VA+K + + E E ++ + +EI VL + D P V
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
K G + L+++ EY+ A L + F E Q+ +K++L GL++ H+
Sbjct: 65 TKYYG--SYLKGTKLWIIMEYLGGGSA-LDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
+HRDIK +N+L+ G +K+ADFG+A D +K+ + V T ++ PE++ + Y
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSA-Y 178
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
D+WS G EL G+ P +++ + +F + K TL
Sbjct: 179 DSKADIWSLGITAIELAKGE---PPNSDMHPMRVLFLI-----------PKNNPPTLTGE 224
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
++ FK+F I+ L+ DP R TA L +F
Sbjct: 225 -------FSKPFKEF-------IDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 81/305 (26%), Positives = 136/305 (44%), Gaps = 52/305 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ KIG+G+ V A D TG+ VA+KK+ D + + + + E++++R HPN+
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 160 IKLEG--LVTSRMSCSLYLVFEYMEHDLAGLAACQGV---KFSEPQVKCYMKQLLSGLEH 214
+++ LV L++V E++E G A V + +E Q+ +L L
Sbjct: 79 VEMYSSYLVGDE----LWVVMEFLE----GGALTDIVTHTRMNEEQIATVCLAVLKALSF 130
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPEL 271
H GV+HRDIK ++L+ +DG +K++DFG + + + R V T ++ PE
Sbjct: 131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA----QVSKEVPRRKSLVGTPYWMAPE- 185
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
++ YG VD+WS G ++ E++ G+P Y+ + L
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEP-----------------------PYFNEPPLQ 222
Query: 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391
+ P K + K P ++ +L DP R TA LN F A
Sbjct: 223 AMKRIRDNLPPK--LKNLHKVSPRLR-SFLDRMLVRDPAQRATAAELLNHPFLAK---AG 276
Query: 392 EPSSL 396
PSS+
Sbjct: 277 PPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 75/284 (26%), Positives = 115/284 (40%), Gaps = 38/284 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ + +G+G + R +V K+V L + + EI++L L HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
I +L + EY L + +G F E V Y+ Q++S + + H
Sbjct: 62 IAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGAT 276
G+LHRDIK N+ + G++K+ DFG++ G + M VV T +Y PEL G
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
Y D+W+ GC+L ELL L + F +P K
Sbjct: 178 -YNFKSDIWALGCVLYELLT-------------LKRTFD-ATNPLNLVVK---------- 212
Query: 337 KPQQPYKRCIAETFKDFPSSSL-PLIETLLSIDPDNRGTATAAL 379
+ SS L L+ +LL DP+ R TA L
Sbjct: 213 -----IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVR----FDNLEPESVKFMAREILVLRKLDHPNVIK 161
+G G + V + + ALK V+ + + E + E +L + +HP ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 162 LEGLVTSRMSCSLYLVFEYME--------HDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
L T + +Y++ EY D F E + Y+ ++ E
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRDRG--------LFDEYTARFYIACVVLAFE 107
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELL 272
+ HN G+++RD+K NLL+D++G +K+ DFG A G K T T Y PE++
Sbjct: 108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEII 164
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKP 299
L Y VD WS G +L ELL G+P
Sbjct: 165 LNKG-YDFSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 102 KLDKIGQGTYSNVYKAR-DLL---TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ ++G+G + V R D L TG+ VA+K + E F REI +LR LDH
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF-EREIEILRTLDHE 66
Query: 158 NVIKLEGLVTSRMSCSLYLVFEY-----MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
N++K +G+ SL L+ EY + L + + ++ + Q+ G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGM 122
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG-----LKQPMTSRVVTLWYR 267
++ + +HRD+ N+L++++ ++KI+DFGLA +K+P S + WY
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY- 179
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELL 295
PE L + + D+WS G L EL
Sbjct: 180 APECLRTSKFSSAS-DVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 7e-24
Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 19/210 (9%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPN 158
FE + +IG GTY +VYKAR++ TG++ A+K ++ LEP E + +EI++++ H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGV-----KFSEPQVKCYMKQLLSGLE 213
++ G R L++ E+ G + Q + SE Q+ ++ L GL
Sbjct: 68 IVAYFGSYLRRDK--LWICMEF-----CGGGSLQDIYHVTGPLSESQIAYVSRETLQGLY 120
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ H+ G +HRDIKG+N+L+ ++G +K+ADFG++ + + S + T ++ PE+
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-RKSFIGTPYWMAPEVAA 179
Query: 274 GATYYGVG--VDLWSAGCILAELLAGKPIM 301
G D+W+ G EL +P M
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-24
Identities = 85/289 (29%), Positives = 139/289 (48%), Gaps = 41/289 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK-FMAREILVLRKLDHPN 158
+ + +KIGQG V+ A D+ TG+ VA+K++ NL+ + K + EILV+++L +PN
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPN 77
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK---FSEPQVKCYMKQLLSGLEHC 215
++ L + + L++V EY LAG + V E Q+ ++ L LE
Sbjct: 78 IVNF--LDSFLVGDELFVVMEY----LAGGSLTDVVTETCMDEAQIAAVCRECLQALEFL 131
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H N V+HRDIK N+L+ DG +K+ DFG P + ++ V T ++ PE++
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRK 190
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
YG VD+WS G + E++ G+P + L+ I G+P
Sbjct: 191 A-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP--------------- 233
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ Q P K ++ F+DF + L +D + RG+A L F
Sbjct: 234 -ELQNPEK--LSPIFRDF-------LNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 3e-23
Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 10/217 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPN 158
F L +IG G++ VY ARD+ T ++VA+KK+ + + E + + +E+ L+++ HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
I+ +G + +LV EY + L E ++ L GL + H++
Sbjct: 87 SIEYKGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT-- 276
++HRDIK N+L+ G +K+ADFG A+ + P S V T ++ PE++L
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSAS-----IASPANSFVGTPYWMAPEVILAMDEG 199
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
Y VD+WS G EL KP + + L+ I
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-23
Identities = 73/239 (30%), Positives = 117/239 (48%), Gaps = 28/239 (11%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES---VKFMAREILVLRKLDHPNVIKL 162
+G+G + VY D TG+ +A+K+V FD E+ V + EI +L+ L H +++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 163 EGLVTSRMSCSLYLVFEYM-----EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
G + L + EYM + L A +E + Y +Q+L G+ + H+
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-----LTENVTRRYTRQILQGVSYLHS 124
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFG----LATFYDPGLKQPMTSRVVTLWYRPPELLL 273
N ++HRDIKG+N+L D+ G +K+ DFG + T G + S T ++ PE++
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG--IKSVTGTPYWMSPEVIS 182
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332
G YG D+WS C + E+L KP E E + IFK+ P+ K LP+
Sbjct: 183 GEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPT-----KPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 21/213 (9%)
Query: 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
E++++IG G VYK TG++ ALK V + N E + + REI +LR ++HPNV+
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICREIEILRDVNHPNVV 135
Query: 161 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKF-SEPQVKCYMKQLLSGLEHCHNNG 219
K + + + ++ E+M+ + +G E + +Q+LSG+ + H
Sbjct: 136 KCHDMFDH--NGEIQVLLEFMDG-----GSLEGTHIADEQFLADVARQILSGIAYLHRRH 188
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM---TSRVVTLWYRPPEL----L 272
++HRDIK SNLLI++ +KIADFG++ L Q M S V T+ Y PE L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRI----LAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 273 LGATYYGVGVDLWSAGCILAELLAGK-PIMPGR 304
Y G D+WS G + E G+ P GR
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 9e-23
Identities = 66/201 (32%), Positives = 111/201 (55%), Gaps = 8/201 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F KL+KIG+G++ V+K D T K+VA+K + + E E ++ + +EI VL + D P V
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
K G + L+++ EY+ A L + E Q+ ++++L GL++ H+
Sbjct: 65 TKYYG--SYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
+HRDIK +N+L+ G +K+ADFG+A D +K+ + V T ++ PE ++ + Y
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQSAY 178
Query: 279 GVGVDLWSAGCILAELLAGKP 299
D+WS G EL G+P
Sbjct: 179 DSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 9e-23
Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 45/285 (15%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREIL---- 149
+T+E ++ IG+GTY VYK + G + A+K L+P + + EI
Sbjct: 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDP--ISDVDEEIEAEYN 70
Query: 150 VLRKL-DHPNVIKLEGLVTSRMSCS---LYLVFEY-----MEHDLAGLAACQGVKFSEPQ 200
+L+ L +HPNV+K G+ L+LV E + + GL C G + E
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAM 129
Query: 201 VKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR 260
+ + L GL+H HNN ++HRD+KG+N+L+ +G +K+ DFG++ + TS
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 261 VVTLWYRPPELLLGATY---YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC 317
W P + Y Y D+WS G EL G P + V+ L KI
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI---- 245
Query: 318 GSPSEEYWKKSKLPNATLFKPQQPYK-------RCIAETFKDFPS 355
+ P TL P++ + +C+ + F+ PS
Sbjct: 246 ----------PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS 280
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 20/228 (8%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPNVIKLEG 164
+G+G + V + TGK+ A KK+ L+ + MA E +L K+ ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 165 LVTSRMSCSLYLV--------FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
++ L + + G F E + Y Q++ GLEH H
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--------FPEARAIFYAAQIICGLEHLH 112
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+++RD+K N+L+D+ G ++I+D GLA + + + R T Y PE+L G
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAV--ELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
Y VD ++ GC L E++AG+ R E + ++ + + EY
Sbjct: 171 -YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 18/220 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRF-DNLEPESVKFMAREILVLRKLDHPN 158
E++ +G GT+ V+ RD ++ ALK + + + + + + E VL+++ HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+I+L T LY++ EY+ +L G +FS Y +++ LE+ H+
Sbjct: 63 IIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHS 119
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW----YRPPELLL 273
+++RD+K N+L+D +G +K+ DFG A + + R TL Y PE ++
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEYLAPE-VI 170
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
+ + VD W+ G ++ E+L G P KI
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 89/329 (27%), Positives = 131/329 (39%), Gaps = 99/329 (30%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDH 156
+ FE + IG+G + V + TG I A+KK+R + LE E V + E +L + D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 157 PNVIKLEGLVTSRMSCS------LYLVFEY----------MEHDLAGLAACQGVKFSEPQ 200
P V+K + S LYL+ EY M+ D F+E +
Sbjct: 61 PWVVK--------LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT----------FTEEE 102
Query: 201 VKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLAT---------FYD- 250
+ Y+ + + ++ H G +HRDIK NLL+D G +K++DFGL T FY
Sbjct: 103 TRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 251 -----PG-----LKQPMTS-RVVTLW----------------YRPPELLLGATYYGVGVD 283
P + +PM+S R W Y PE+ L T Y D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECD 221
Query: 284 LWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYK 343
WS G I+ E+L G P E KI WK+ TL P +
Sbjct: 222 WWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN---------WKE------TLQFPDEVP- 265
Query: 344 RCIAETFKDFPSSSLPLIETLLSIDPDNR 372
++ KD LI+ L + + R
Sbjct: 266 --LSPEAKD-------LIKRLC-CEAERR 284
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 86/316 (27%), Positives = 130/316 (41%), Gaps = 35/316 (11%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDH 156
F+ +G+G + V R+ TG I A+K ++ L E+V F E +L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
P + +L + +LYLV EY DL L +F E + Y+ +L+ +
Sbjct: 61 PWIPQL--QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL-- 273
H G +HRDIK N+LID G +K+ADFG A V T Y PE+L
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 274 ---GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330
G YGV D WS G I E++ G+ T + + I + + K
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF-----QRFLK---- 229
Query: 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390
F P+ P ++ F D LI++LL R FF+ +
Sbjct: 230 -----F-PEDPK---VSSDFLD-------LIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272
Query: 391 CEPSSLPKYPPSKEMD 406
+SLP + P+ + D
Sbjct: 273 NIRNSLPPFVPTLKSD 288
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 64/204 (31%), Positives = 112/204 (54%), Gaps = 14/204 (6%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F KL++IG+G++ VYK D T ++VA+K + + E E ++ + +EI VL + D P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK---FSEPQVKCYMKQLLSGLEHCH 216
+ G + L+++ EY L G +A +K E + ++++L GL++ H
Sbjct: 65 TRYYG--SYLKGTKLWIIMEY----LGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
+ +HRDIK +N+L+ G +K+ADFG+A D +K+ + V T ++ PE ++
Sbjct: 119 SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPE-VIKQ 175
Query: 276 TYYGVGVDLWSAGCILAELLAGKP 299
+ Y D+WS G EL G+P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 80/292 (27%), Positives = 142/292 (48%), Gaps = 43/292 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPN 158
+E + ++G GTY +VYKAR+L TG++ A+K ++ LEP + + +EI ++++ H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCN 67
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGV-----KFSEPQVKCYMKQLLSGLE 213
++ G SR L++ EY G + Q + SE Q+ ++ L GL
Sbjct: 68 IVAYFGSYLSREK--LWICMEY-----CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLA 120
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ H+ G +HRDIKG+N+L+ ++G +K+ADFG+A + + S + T ++ PE+
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-RKSFIGTPYWMAPEVAA 179
Query: 274 GATYYGVG--VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
G D+W+ G EL +P M ++ + +F + S+ ++ KL
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPM---FDLHPMRALFLM----SKSNFQPPKLK 232
Query: 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
+ T + TF +F ++ L+ +P R TA L F
Sbjct: 233 DKTKWSS----------TFHNF-------VKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 8e-22
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 10/217 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPN 158
F L +IG G++ VY A + T ++VA+KK+ + + E + + +E+ L++L HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
I+ +G + +LV EY + L E ++ L GL + H++
Sbjct: 83 TIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT-- 276
++HRDIK N+L+ G +K+ADFG A+ P S V T ++ PE++L
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
Y VD+WS G EL KP + + L+ I
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 72/245 (29%), Positives = 119/245 (48%), Gaps = 21/245 (8%)
Query: 89 IRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMARE 147
I D P ++T+E ++ IG+GTY V+K + G A+K + +++ E + E
Sbjct: 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAE 64
Query: 148 ILVLRKL-DHPNVIKLEGLVTSRMSCS---LYLVFEYME----HDLAGLAACQGVKFSEP 199
+L+ L DHPNV+K G+ + + L+LV E DL +G + EP
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 200 QVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259
+ + + L GL+H H N +HRD+KG+N+L+ +G +K+ DFG++ + TS
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 260 RVVTLWYRPP----ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
W P E L +T Y D+WS G EL G P + ++ + +FK
Sbjct: 185 VGTPFWMAPEVIACEQQLDST-YDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFK 240
Query: 316 LCGSP 320
+ +P
Sbjct: 241 IPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+L ++G+G +V K R TG I ALK + D P+ K + RE+ + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSP 59
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
++K G S S+ + EY E + +G + E + + +L GL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ H+ ++HRDIK SN+L+ G +K+ DFG++ + T T +Y PE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTF-TGTSFYMAPERIQ 176
Query: 274 GATYYGVGVDLWSAGCILAELLAGK-PIMP 302
G Y + D+WS G L E+ + P P
Sbjct: 177 GKP-YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES---VKFMAREILVLRKLDH 156
+ L +G+G++ + + + + A+K++R P+S V+ +E ++L K+ H
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKH 57
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
PN++ + + LY+V EY + + + +G F E + + Q+ G++H
Sbjct: 58 PNIVAFKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT---SRVVTLWYRPPEL 271
H VLHRDIK N+ + +G +K+ DFG A L P + V T +Y PPE+
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPPEI 171
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLC-GSPSEEYWKKSK 329
Y D+WS GCIL EL K P + + I K+C GS
Sbjct: 172 WENMPYNNKS-DIWSLGCILYELCTLKHPFQANSWK----NLILKVCQGS-------YKP 219
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLS 366
LP+ ++ + I + FK P S P T+LS
Sbjct: 220 LPSHYSYELRS----LIKQMFKRNPRSR-PSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-20
Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 42/301 (13%)
Query: 90 RDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREIL 149
RD P +E + ++G G + VYKA++ TG + A K + + E E +M EI
Sbjct: 6 RDLDPN--EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIE 61
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH---DLAGLAACQGVKFSEPQVKCYMK 206
+L +HP ++KL G L+++ E+ D L +G+ EPQ++ +
Sbjct: 62 ILATCNHPYIVKLLGAFY--WDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICR 117
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
Q+L L++ H+ ++HRD+K N+L+ DG +K+ADFG++ L Q S + T ++
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRDSFIGTPYW 176
Query: 267 RPPELLLGATY----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322
PE+++ T Y D+WS G L E+ I P E+ + + K+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIA----- 228
Query: 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382
KS+ P TL +P + + F+DF ++T L P+ R +A L
Sbjct: 229 ----KSEPP--TLSQPSK-----WSMEFRDF-------LKTALDKHPETRPSAAQLLEHP 270
Query: 383 F 383
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 85/294 (28%), Positives = 136/294 (46%), Gaps = 46/294 (15%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+E + ++G G + VYKA++ TG + A K + D E ++ EI +L DHPN+
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVI--DTKSEEELEDYMVEIDILASCDHPNI 64
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGV------KFSEPQVKCYMKQLLSGLE 213
+KL L +L+++ E+ AG A V +EPQ++ KQ L L
Sbjct: 65 VKL--LDAFYYENNLWILIEF----CAG-GAVDAVMLELERPLTEPQIRVVCKQTLEALN 117
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ H N ++HRD+K N+L DG +K+ADFG++ + Q S + T ++ PE+++
Sbjct: 118 YLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVM 176
Query: 274 GATY----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329
T Y D+WS G L E+ I P E+ + + K+ KS+
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIA---------KSE 224
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
P TL +P + + FKDF ++ L + D R T T L F
Sbjct: 225 PP--TLAQPSR-----WSSEFKDF-------LKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-20
Identities = 87/306 (28%), Positives = 129/306 (42%), Gaps = 44/306 (14%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMAREILVLRKL-DHPNVIK 161
IG+G + VY R TGK+ A+K K R + E++ R +L L D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 162 LEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
+ L + + M DL + GV FSE +++ Y +++ GLEH HN V
Sbjct: 62 MS--YAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGV 280
++RD+K +N+L+D G ++I+D GLA D K+P S V T Y PE+L Y
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYMAPEVLQKGVAYDS 175
Query: 281 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQ 340
D +S GC+L +LL G SP ++ K K +
Sbjct: 176 SADWFSLGCMLFKLLRGH--------------------SPFRQHKTKDKHEIDRMTLTMA 215
Query: 341 PYKRCIAETFKDFPSSSLPLIETLLSIDPDNR-----GTATAALNSEFFNTEPYACEPSS 395
E F L+E LL D + R A FF + + +
Sbjct: 216 V------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDW--QMVF 267
Query: 396 LPKYPP 401
L KYPP
Sbjct: 268 LQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 23/220 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR----FDNLEPESVKFMAREILVLRKLD 155
F L +G+G + V A TG++ A+K ++ E ES+ R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
HP ++ L + + V EY DL + FSEP+ Y ++ GL++
Sbjct: 61 HPFLVNLFACFQT--EDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM--TSRVVTLWYRP---- 268
H N +++RD+K NLL+D +G +KIADFGL K+ M R T P
Sbjct: 117 LHENKIVYRDLKLDNLLLDTEGFVKIADFGLC-------KEGMGFGDRTSTFCGTPEFLA 169
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 308
PE+L + Y VD W G ++ E+L G+ PG E E
Sbjct: 170 PEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 5e-20
Identities = 64/208 (30%), Positives = 105/208 (50%), Gaps = 23/208 (11%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDN-----LEPESVKFMAREILVLRKLDHPNVI 160
+G+G Y VY G+++A+K+V D E E K + E+ +L+ L H N++
Sbjct: 8 LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEK-LQEEVDLLKSLKHVNIV 65
Query: 161 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK----FSEPQVKCYMKQLLSGLEHCH 216
+ G + S+++ F + G + + EP Y KQ+L G+ + H
Sbjct: 66 QYLGTCLDDNTISIFMEF------VPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFG----LATFYDPGLKQPMTSRVV-TLWYRPPEL 271
NN V+HRDIKG+N+++ +GI+K+ DFG LA G M + T ++ PE
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE- 178
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKP 299
++ + YG D+WS GC + E+ GKP
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 58/313 (18%)
Query: 107 GQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLV 166
++ K + T +VA+KK+ D+ E +K + +EI+ R+L HPN++ V
Sbjct: 11 EDLMIVHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YV 65
Query: 167 TSRMSCS-LYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
TS + S LY+V M + DL +G E + +K +L+ L++ H+ G +
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSKGFI 123
Query: 222 HRDIKGSNLLIDNDGILKIA-----------DFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
HR +K S++L+ DG + ++ +D S V L + PE
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP-----KSSVKNLPWLSPE 178
Query: 271 LL----LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP------ 320
+L G Y D++S G EL G +P + + K+ G+
Sbjct: 179 VLQQNLQG---YNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCLLDK 233
Query: 321 -------SEEYWKKSKLPNAT-LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR 372
+S + PY R +E F F +E L DP++R
Sbjct: 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQF-------VELCLQRDPESR 286
Query: 373 GTATAALNSEFFN 385
+A+ LN FF
Sbjct: 287 PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 7e-20
Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTG-KIVALKKVRFDNLE--------PESVKFMAREIL 149
+ L+ +G G + VYK R G ++ALK++ N +S+ + E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 150 VLRK-LDHPNVIK-----LEGLVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEP 199
++++ L HPN+++ LE LY+V + +E + + +F+E
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEN-------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113
Query: 200 QVKCYMKQLLSGLEHCHNNG-VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258
++ Q++ L + H ++HRD+ +N+++ D + I DFGLA P K +T
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LT 171
Query: 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP 299
S V T+ Y PE++ YG D+W+ GCIL ++ +P
Sbjct: 172 SVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 69/213 (32%), Positives = 107/213 (50%), Gaps = 12/213 (5%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLR-KLDHPNVIKLE 163
+G+G++ V+ A T + A+K ++ D L + V+ E VL +HP + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 164 GLVTSRMSCSLYLVFEYMEH-DLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
T + +L+ V EY+ DL + +C KF P+ Y +++ GL+ H+ G++
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGATYYGV 280
+RD+K N+L+D DG +KIADFG+ + L T T Y PE+LLG Y
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQK-YNT 175
Query: 281 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
VD WS G +L E+L G+ G E E I
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK---- 161
IG+GT+ VY+ R T +I A+K + S K + + V + N++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL--------SKKEIVAKKEVAHTIGERNILVRTLL 52
Query: 162 -----LEGLVTSRMSCS-LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
+ GL S + S LYLV +YM + +FSE + K Y+ +L+ LEH
Sbjct: 53 DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLL 273
H +++RD+K N+L+D G + + DFGL+ L T+ T Y PE+LL
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLL 169
Query: 274 GATYYGVGVDLWSAGCILAELLAG 297
Y VD WS G ++ E+ G
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 42/228 (18%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMARE--ILVLRKLDHPNVIKL 162
+G+G++ V A T ++ A+K ++ D L+ + V+ E +L L HP
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHP----- 56
Query: 163 EGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCYMKQLLSG 211
+T SC L+ V EY M H + +F EP+ + Y +++ G
Sbjct: 57 --FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ------RSGRFDEPRARFYAAEIVLG 108
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW------ 265
L+ H G+++RD+K N+L+D++G +KIADFG+ K+ + V T
Sbjct: 109 LQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGTPD 161
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
Y PE+L YG VD W+ G +L E+LAG+ G E E I
Sbjct: 162 YIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+EK+ +G+G + V+ R K+V +K++ + + + E VL+ L HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 160 IK-LEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVK-FSEPQVKCYMKQLLSGLEHCH 216
I+ E + +L +V EY LA + E + + Q+L L H H
Sbjct: 62 IEYYENFL---EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118
Query: 217 NNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
+LHRD+K N+L+D + ++KI DFG++ K + V T Y PEL G
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGK 176
Query: 276 TYYGVGVDLWSAGCILAELLAGK 298
Y D+W+ GC+L EL + K
Sbjct: 177 P-YNQKSDIWALGCVLYELASLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 68/217 (31%), Positives = 107/217 (49%), Gaps = 21/217 (9%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
A FE ++ +G GTY VYK R + TG++ A+K + E E +K +EI +L+K H
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSH 61
Query: 157 -PNVIKLEGLVTSR----MSCSLYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQ 207
N+ G + M L+LV E+ DL + +G E + ++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 119
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYR 267
+L GL H H + V+HRDIKG N+L+ + +K+ DFG++ D + + T + T ++
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWM 178
Query: 268 PPELLL-----GATYYGVGVDLWSAGCILAELLAGKP 299
PE++ AT Y DLWS G E+ G P
Sbjct: 179 APEVIACDENPDAT-YDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 75/258 (29%), Positives = 108/258 (41%), Gaps = 48/258 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPN 158
F K+ IG G + V R + T + A+K +R D L + E +L + D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
V+KL + + +LY V +Y+ D+ L G+ F E + Y+ +L +E H
Sbjct: 63 VVKL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHK 119
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT---------FYDPG---------------- 252
G +HRDIK N+LID DG +K+ DFGL T +Y G
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 253 -LKQPMT----------------SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295
+ + S V T Y PE+LL T Y D WS G IL E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEML 238
Query: 296 AGKPIMPGRTEVEQLHKI 313
G+P T E K+
Sbjct: 239 VGQPPFLADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 18/225 (8%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHP 157
F L +G+G++ V A T ++ A+K ++ D ++ + V+ E VL D P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 158 NVIKLEGLVTSRMSC-----SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
+T SC LY V EY+ Q KF EPQ Y ++ GL
Sbjct: 61 P------FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGL 114
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPE 270
H G+++RD+K N+++D++G +KIADFG+ + +T+R T Y PE
Sbjct: 115 FFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE 171
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
++ YG VD W+ G +L E+LAG+P G E E I +
Sbjct: 172 -IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 8/232 (3%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHP 157
TF +G+G + V + TGK+ A KK+ ++ + MA E +L K++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
V+ L ++ + L LV M DL + F E + Y ++ GLE
Sbjct: 61 FVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H +++RD+K N+L+D+ G ++I+D GLA G + + RV T+ Y PE++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYMAPEVVKNE 176
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
Y D W GC++ E++ GK R E + ++ + EEY +K
Sbjct: 177 R-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 7e-19
Identities = 75/285 (26%), Positives = 137/285 (48%), Gaps = 33/285 (11%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
E KIG+G+ V AR+ +G+ VA+K + D + + + + E++++R H NV
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNV 80
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
+++ + + L+++ E+++ Q + +E Q+ + +L L + H+ G
Sbjct: 81 VEM--YKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG 137
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
V+HRDIK ++L+ DG +K++DFG + + S V T ++ PE ++ T YG
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPE-VISRTPYG 195
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339
VD+WS G ++ E++ G+P + V+ + +L SP KL NA P
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP------PKLKNAHKISP- 245
Query: 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+DF +E +L+ +P R TA L+ F
Sbjct: 246 ---------VLRDF-------LERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-19
Identities = 63/197 (31%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 105 KIGQGTYSNVYKARD---LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
++G+G++ VY +D + ++ LK++ L P +E +L KLDHP ++K
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 162 LEGLVTSRMSCSLYLVFEYME-HDL-AGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHN 217
R + ++ EY E DL L + G SE QV + QLL G+ + H
Sbjct: 67 FHASFLERDA--FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+LHRD+K N+ + N+ +LKI DFG++ G T+ T +Y PE L
Sbjct: 125 RRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL-MGSCDLATTFTGTPYYMSPE-ALKHQG 181
Query: 278 YGVGVDLWSAGCILAEL 294
Y D+WS GCIL E+
Sbjct: 182 YDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 69/198 (34%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMAREILVLRKL-DHPNVIK 161
IG+G + VY R TGK+ A+K K R + E++ R +L L D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 162 LE-GLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
+ T C + + M DL + GV FSE +++ Y +++ GLEH HN
Sbjct: 62 MTYAFHTPDKLC---FILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRF 117
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
V++RD+K +N+L+D G ++I+D GLA D K+P S V T Y PE+L T Y
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYMAPEVLQKGTAYD 174
Query: 280 VGVDLWSAGCILAELLAG 297
D +S GC+L +LL G
Sbjct: 175 SSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 59/195 (30%), Positives = 105/195 (53%), Gaps = 7/195 (3%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
KIG+G+ V A + TGK VA+KK+ D + + + + E++++R H NV+ +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 165 LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRD 224
+ + L++V E++E A + +E Q+ +L L + HN GV+HRD
Sbjct: 87 --SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 225 IKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDL 284
IK ++L+ +DG +K++DFG + + S V T ++ PE ++ YG VD+
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPE-VISRLPYGTEVDI 201
Query: 285 WSAGCILAELLAGKP 299
WS G ++ E++ G+P
Sbjct: 202 WSLGIMVIEMIDGEP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 23/225 (10%)
Query: 88 AIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMARE 147
A+RD A FE ++ +G GTY VYK R + TG++ A+K + E E +K E
Sbjct: 10 ALRD----PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---E 62
Query: 148 ILVLRKLDH-PNVIKLEGLVTSRMSC----SLYLVFEYMEH----DLAGLAACQGVKFSE 198
I +L+K H N+ G + L+LV E+ DL + +G E
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL--VKNTKGNALKE 120
Query: 199 PQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258
+ +++L GL H H + V+HRDIKG N+L+ + +K+ DFG++ D + + T
Sbjct: 121 DWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 180
Query: 259 SRVVTLWYRPPELLL----GATYYGVGVDLWSAGCILAELLAGKP 299
+ T ++ PE++ Y D+WS G E+ G P
Sbjct: 181 F-IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 8/232 (3%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHP 157
TF + +G+G + V + TGK+ A K++ ++ + MA E +L K++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHC 215
V+ L ++ + L LV M DL G F E + Y ++L GLE
Sbjct: 61 FVVNLAYAYETKDA--LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H ++RD+K N+L+D+ G ++I+D GLA G + + RV T+ Y PE +L
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPE-VLNN 175
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
Y + D W GC++ E++ G+ GR E + ++ + E Y K
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 70/224 (31%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
F L +G+G++ V A T ++ A+K ++ D ++ + V+ E VL P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 159 VIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLAACQGV-KFSEPQVKCYMKQLLSG 211
+T SC LY V EY+ DL + Q V KF EP Y ++ G
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIG 113
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPP 269
L H+ G+++RD+K N+++D +G +KIADFG+ + T+R T Y P
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIAP 170
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
E++ YG VD W+ G +L E+LAG+P G E E I
Sbjct: 171 EIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 8/204 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNL--EPESVKFMAREILVLRKL 154
FE L +G G Y V+ R + TGK+ A+K ++ L + ++V+ E VL +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 155 -DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
P ++ L + L+L+ +Y+ Q FSE +V+ Y +++ LE
Sbjct: 62 RQSPFLVTLH--YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H H G+++RDIK N+L+D++G + + DFGL+ + K+ S T+ Y PE++
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 274 GATYYGVGVDLWSAGCILAELLAG 297
G +G VD WS G ++ ELL G
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 9/205 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNL--EPESVKFMAREILVLRKL 154
FE L +G G Y V+ R + GK+ A+K ++ + + ++ + E VL +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 155 DH-PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
P ++ L + L+L+ +Y+ Q F+E +V+ Y+ +++ L+
Sbjct: 62 RRCPFLVTLHYAFQT--DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H H G+++RDIK N+L+D++G + + DFGL+ + ++ S T+ Y PE++
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 274 GATY-YGVGVDLWSAGCILAELLAG 297
G + + VD WS G + ELL G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-18
Identities = 67/260 (25%), Positives = 110/260 (42%), Gaps = 34/260 (13%)
Query: 147 EILVLRKLDHPNVIKL-EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYM 205
E ++L+ ++HP+VI++ + LV+ ++C +V + DL + Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TL 264
KQ+L GL + H ++HRD+K N+ I++ + I D G A F + P + T+
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTV 220
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA----------GKPIMPGRTEVEQLHKIF 314
PE+L Y D+WSAG +L E+LA P ++ L KI
Sbjct: 221 ETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279
Query: 315 KLCGSPSEEYWKKSKLPNATLFKP--------QQPYKR--CIAETFKDFPSSSLPLIETL 364
EE+ + P + L + +QPY R C + P L+ +
Sbjct: 280 STLKVHPEEF---PRDPGSRLVRGFIEYASLERQPYTRYPCFQRV--NLPIDGEFLVHKM 334
Query: 365 LSIDPDNRGTATAALNSEFF 384
L+ D R +A LN F
Sbjct: 335 LTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-18
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 30/212 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
FE + +G G++ V A+ TG+ A+K ++ L+ + V+ +A+E +L +L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 159 VIKLEGLVTSRMSCS------LYLVFEY-MEHDLAGLAACQGVKFSEPQVKCYMKQLLSG 211
++ M CS +Y + E+ + +L G +F K Y +L+
Sbjct: 80 IVN--------MMCSFQDENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLA 130
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW----YR 267
E+ H+ +++RD+K NLL+DN G +K+ DFG A + + R TL Y
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRTFTLCGTPEYL 182
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKP 299
PE ++ + +G VD W+ G +L E +AG P
Sbjct: 183 APE-VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 88/330 (26%), Positives = 132/330 (40%), Gaps = 61/330 (18%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES-VKFMAREILVLRKLDHPNVIKLEG 164
IG+G++ V + R T +I ALK +R ++ S V E VL +++ P ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 165 LVTSRMSCSLYLVFEYME-----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
S LYLV ++ H L + +F + + Y +LL LE+ H
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQ-----REGRFDLSRARFYTAELLCALENLHKFN 113
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW----YRPPELLLGA 275
V++RD+K N+L+D G + + DFGL L + T Y PELLLG
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCK-----LNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
Y VD W+ G +L E+L G P E KI
Sbjct: 169 GYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL--------------------- 206
Query: 336 FKPQQPYKRCIAETFKD-FPSSSLPLIETLLSIDPDNR---GTATAALNSEFFNTEPYA- 390
Q+P + F D F + L+ LLS DP R A N FF+ +
Sbjct: 207 ---QEPLR------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKK 257
Query: 391 -CEPSSLPKYPPSKE--MDVKLREEEARRQ 417
P + P+ +D +EE R+
Sbjct: 258 LLMKGIQPPFKPAVSSAIDTSNFDEEFTRE 287
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 9e-18
Identities = 64/230 (27%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR + E+ K+G G + V+ T K VA+K ++ + PE+ +E +++K
Sbjct: 4 PRESLKLER--KLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQIMKK 57
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSG 211
L H +++L + + +Y+V EYM L L + +G K PQ+ Q+ G
Sbjct: 58 LRHDKLVQLYAVCSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF-----YDP--GLKQPMTSRVVTL 264
+ + + +HRD+ N+L+ + + KIADFGLA Y G K P+
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK------ 169
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
W P G + + D+WS G +L E++ G+ PG T E L ++
Sbjct: 170 WTAPEAANYGR--FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 76/264 (28%), Positives = 115/264 (43%), Gaps = 52/264 (19%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRF-DNLEPESVKFMAREILVLRKLDHPN 158
F K+ +G G + V AR + T + A+K +R D L V + E +L + D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
V++L + + +LY V +Y+ D+ L G+ F E + Y+ +L +E H
Sbjct: 63 VVRL--YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHK 119
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT---------FYDPG--LKQ----------- 255
G +HRDIK N+LID DG +K+ DFGL T +Y G ++Q
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 256 -----------PMTSR-------------VVTLWYRPPELLLGATYYGVGVDLWSAGCIL 291
P+ R V T Y PE+LL Y + D WS G IL
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVIL 238
Query: 292 AELLAGKPIMPGRTEVEQLHKIFK 315
E+L G+P +T +E K+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 8/232 (3%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHP 157
TF + +G+G + V + TGK+ A KK+ ++ + MA E +L K++
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHC 215
V+ L ++ + L LV M DL G F E + Y ++ GLE
Sbjct: 61 FVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H +++RD+K N+L+D+ G ++I+D GLA G Q + RV T+ Y PE++
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPEVVKNE 176
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
Y D W+ GC+L E++AG+ R + + ++ +L EEY +K
Sbjct: 177 R-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 103 LDKIGQGTYSNVYKAR-DLL---TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
+ ++G+G + +V R D L TG++VA+KK++ E ++ REI +L+ L H N
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDN 66
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
++K +G+ S +L LV EY+ + L + ++ Y Q+ G+E+ +
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT-------FYDPGLKQPMTSRVVTLWYRPPE 270
+HRD+ N+L++++ +KI DFGL +Y +++P S + WY P
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK--VREPGESPI--FWYAPES 182
Query: 271 LLLGATYYGVGVDLWSAGCILAEL 294
L + + V D+WS G +L EL
Sbjct: 183 --LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 58/195 (29%), Positives = 104/195 (53%), Gaps = 7/195 (3%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
KIG+G+ V A +GK+VA+KK+ D + + + + E++++R H NV+++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 165 LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRD 224
+ + L++V E++E A + +E Q+ +L L H GV+HRD
Sbjct: 85 --SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 225 IKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDL 284
IK ++L+ +DG +K++DFG + + S V T ++ PE L+ YG VD+
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPE-LISRLPYGPEVDI 199
Query: 285 WSAGCILAELLAGKP 299
WS G ++ E++ G+P
Sbjct: 200 WSLGIMVIEMVDGEP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNL--EPESVKFMAREILVLRKL 154
FE L +G G Y V+ R + +GK+ A+K ++ + + ++ + E VL +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 155 DH-PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
P ++ L + L+L+ +Y+ Q +F E +V+ Y +++ LE
Sbjct: 62 RQSPFLVTLH--YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H H G+++RDIK N+L+D++G + + DFGL+ + + S T+ Y P+++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 274 GA-TYYGVGVDLWSAGCILAELLAG 297
G + VD WS G ++ ELL G
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
+ +G G VYKA LLT +I+A+K + D + E K + E+ +L K D P +I
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 163 EG--LVTSRMS-CSLYLVFEYMEH---DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
G V +R+S C+ E+M+ D+ K E + ++ GL +
Sbjct: 65 YGAFFVENRISICT-----EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW 112
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ +LHRD+K SN+L++ G +K+ DFG++T + + V T Y PE + G
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQ 169
Query: 277 YYGVGVDLWSAGCILAELLAGK 298
YG+ D+WS G EL G+
Sbjct: 170 -YGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 9/207 (4%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKV-RFDNLEPESVKFMAREILVLRKL 154
+A ++ + IG+G + V R + K+ A+K + +F+ ++ F E ++
Sbjct: 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
+ P V++L + LY+V EYM DL L + V E K Y +++ L+
Sbjct: 101 NSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFYTAEVVLALD 156
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H+ G++HRD+K N+L+D G LK+ADFG D + V T Y PE+L
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216
Query: 274 ---GATYYGVGVDLWSAGCILAELLAG 297
G YYG D WS G L E+L G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 100 FEKLDKIGQGTYSNV----YKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
+K+ +G+G + V Y + TG++VA+K ++ + ++ +EI +L+ L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLY 64
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEH 214
H N++K +G + + L L+ EY+ L L K + Q+ + +Q+ G+ +
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG-----LKQPMTSRVVTLWYRPP 269
H+ +HRD+ N+L+DND ++KI DFGLA G +++ S V WY
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV--FWYAVE 180
Query: 270 ELLLGATYYGVGVDLWSAGCILAELL 295
L Y D+WS G L ELL
Sbjct: 181 CLKENKFSY--ASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
+KIG+G + +VYK L VA+K R KF+ +E +L++ DHPN++KL
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLL-------SGLEHCH 216
G+ + +Y+V E + G + ++ + ++ +K+LL +G+E+
Sbjct: 59 GVCVQKQP--IYIVMELV----PGGSLLTFLRKKKNRLT--VKKLLQMSLDAAAGMEYLE 110
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL--KQPMTSRVVTLWYRPPELLLG 274
+ +HRD+ N L+ + +LKI+DFG++ + G+ ++ W P L G
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 275 ATYYGVGVDLWSAGCILAELLAG 297
Y D+WS G +L E +
Sbjct: 171 R--YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 23/210 (10%)
Query: 100 FEKLDKIGQGTYSNV----YKARDLLTGKIVALKKVRFDNLEPES----VKFMAREILVL 151
+++ +G+G + V Y TG+ VA+K +L+PES + + +EI +L
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEIL 60
Query: 152 RKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLS 210
R L H N++K +G+ T + L+ E++ L K + Q Y Q+
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICK 120
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGL--ATFYDPG---LKQPMTSRVVTLW 265
G+++ + +HRD+ N+L++++ +KI DFGL A D +K + S V W
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FW 178
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELL 295
Y PE L+ + +Y + D+WS G L ELL
Sbjct: 179 Y-APECLIQSKFY-IASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKV-RFDNLEPESVKFMAREILVLRKL 154
+A F+ + IG+G + V R + ++ A+K + +F+ ++ F E ++
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100
Query: 155 DHPNVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQ 207
+ +++L + LY+V EYM DL L + + E + Y +
Sbjct: 101 NSEWIVQLH--------YAFQDDKYLYMVMEYMPGGDLVNLMSNYDI--PEKWARFYTAE 150
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP-GLKQPMTSRVVTLWY 266
++ L+ H+ G +HRD+K N+L+D G LK+ADFG D G+ + T+ V T Y
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDY 209
Query: 267 RPPELLL---GATYYGVGVDLWSAGCILAELLAGKP 299
PE+L G YYG D WS G L E+L G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF--MAREILVLRKLDHPN 158
E LD++G+G Y +VYK TG +A+K++R LE + KF + E+ +L K P
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR---LELDESKFNQIIMELDILHKAVSPY 60
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHD-----LAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
++ G + ++Y+ EYM+ AG A +G+ E ++ ++ GL+
Sbjct: 61 IVDFYGAFF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGI--PEDVLRRITYAVVKGLK 116
Query: 214 HC---HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
HN ++HRD+K +N+L++ +G +K+ DFG++ L + + + Y PE
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK---TNIGCQSYMAPE 171
Query: 271 LLLGAT-----YYGVGVDLWSAGCILAELLAGKPIMPGRT 305
+ Y V D+WS G + E+ G+ P T
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 92/326 (28%), Positives = 145/326 (44%), Gaps = 47/326 (14%)
Query: 103 LDKIGQGTYSNVYKARDLL---TGKIVALK-------KVRFDNLEPESVKFMAREILVLR 152
L +GQG++ V+ R + G++ A+K KVR D + + M R+IL
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVR-DRVRTK----MERDILA-- 53
Query: 153 KLDHPNVIKL------EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMK 206
+++HP ++KL EG LYL+ +++ + V F+E VK Y+
Sbjct: 54 EVNHPFIVKLHYAFQTEG--------KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
+L L+H H+ G+++RD+K N+L+D +G +K+ DFGL+ K+ S T+ Y
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY-SFCGTVEY 164
Query: 267 RPPELL--LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL-CGSPSEE 323
PE++ G T D WS G ++ E+L G G+ E + I K G P
Sbjct: 165 MAPEVVNRRGHTQ---SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFL 221
Query: 324 YWKKSKLPNATLFKPQQPYKRCIA-----ETFKDFPSSSLPLIETLL--SIDPDNRGTAT 376
+ L A LFK + P R A E K P S L I P +
Sbjct: 222 SPEAQSLLRA-LFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVG 279
Query: 377 AALNSEFFNTEPYACEPSSLPKYPPS 402
++ +F+ E + P P PPS
Sbjct: 280 RPDDTFYFDPEFTSRTPKDSPGIPPS 305
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 6e-17
Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 31/232 (13%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
R N +E + KIG G + V+ + T + K + + L+ + E+ V+R+L
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK 70
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLA-GLAACQGV--KFSEPQVKCYMKQLLSG 211
H N+++ ++ + LY++ E+ + DL+ + C + K E + +QLL
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHA 130
Query: 212 LEHCHN-----NG--VLHRDIKGSNLL-----------------IDNDGILKIADFGLAT 247
L +CHN NG VLHRD+K N+ ++ I KI DFGL+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 248 FYDPGLKQPMTSRVVTLWYRPPELLLGAT-YYGVGVDLWSAGCILAELLAGK 298
+ G++ S V T +Y PELLL T Y D+W+ GCI+ EL +GK
Sbjct: 191 --NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 72/231 (31%), Positives = 106/231 (45%), Gaps = 28/231 (12%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRK 153
FE + I G Y VY R T + A+KK+ NL + + V F+ R+IL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDILTFA- 58
Query: 154 LDHPNVIKLEG-LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSG 211
++P V+ + T R C +V EY+E D A L G + + Y + +
Sbjct: 59 -ENPFVVSMFCSFETKRHLC---MVMEYVEGGDCATLLKNIGALPVD-MARMYFAETVLA 113
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLAT-------------FYDPGLKQPMT 258
LE+ HN G++HRD+K NLLI + G +K+ DFGL+ + ++ +
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 259 SRVV-TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 308
+V T Y PE++L YG VD W+ G IL E L G G T E
Sbjct: 174 KQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 7e-17
Identities = 72/264 (27%), Positives = 121/264 (45%), Gaps = 26/264 (9%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
+IG G + V+ L K VA+K +R + E E V+ KL HP +++L G
Sbjct: 11 EIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHPKLVQLYG 66
Query: 165 LVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
+ T R + LVFE+MEH L+ Q KFS+ + + G+ + ++ V+HR
Sbjct: 67 VCTER--SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 224 DIKGSNLLIDNDGILKIADFGLATF-YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGV 282
D+ N L+ + ++K++DFG+ F D ++ W P Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK--YSSKS 182
Query: 283 DLWSAGCILAELLA-GKPIMPGRTE---VEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
D+WS G ++ E+ + GK R+ VE ++ F+L K +L + ++++
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY---------KPRLASQSVYEL 233
Query: 339 QQPYKRCIAETFKDFPSSSLPLIE 362
Q C E +D PS SL L +
Sbjct: 234 MQ---HCWKERPEDRPSFSLLLHQ 254
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 10/216 (4%)
Query: 87 DAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKV-RFDNLEPESVKFMA 145
+ IRD +A +E + IG+G + V R T K+ A+K + +F+ ++ F
Sbjct: 33 NKIRDLR-MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 146 REILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCY 204
E ++ + P V++L + LY+V EYM DL L + V E + Y
Sbjct: 92 EERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV--PEKWARFY 147
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
+++ L+ H+ G +HRD+K N+L+D G LK+ADFG + + V T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 265 WYRPPELLL---GATYYGVGVDLWSAGCILAELLAG 297
Y PE+L G YYG D WS G L E+L G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-17
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVK--FMAREILVLRKLDHPNVIKL 162
+G+G++ V A T + A+K ++ D LE + V+ + R +L L +HP + L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLAL-AWEHPFLTHL 61
Query: 163 EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
T + L+ V EY+ +F E + + Y +++ GL+ H G+++
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV------TLWYRPPELLLGAT 276
RD+K N+L+D DG +KIADFG+ K+ M T Y PE+L G
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC-------KENMNGEGKASTFCGTPDYIAPEILKGQK 172
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
Y VD WS G +L E+L G+ G E E I
Sbjct: 173 -YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 79/311 (25%), Positives = 123/311 (39%), Gaps = 62/311 (19%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKV-RFDNLEPESVKFMAREILVLRKLDHPN 158
F+K+ +G+G V+ R TGK+ ALK + + + ++ VK + E +L LDHP
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEY-MEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCH 216
+ L + + L LV +Y +L L Q G SE + Y ++L LE+ H
Sbjct: 63 LPTLYA--SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM------------------- 257
G+++RD+K N+L+ G + ++DF L+ D
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 258 ---------TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 308
S V T Y PE++ G +G VD W+ G +L E+L G G E
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
Query: 309 QLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSID 368
I K K+ P ++ + +D LI LL D
Sbjct: 240 TFSNILK----------KEVTFPG----------SPPVSSSARD-------LIRKLLVKD 272
Query: 369 PDNR-GTATAA 378
P R G+ A
Sbjct: 273 PSKRLGSKRGA 283
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLE- 163
+G+GT+ V R+ TG+ A+K +R + + + V E VL+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
T C V EY + F+E + + Y +++S LE+ H+ V++R
Sbjct: 63 AFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVG 281
DIK NL++D DG +KI DFGL G+ T + T Y PE+L YG
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDND-YGRA 175
Query: 282 VDLWSAGCILAELLAGK 298
VD W G ++ E++ G+
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 23/203 (11%)
Query: 106 IGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
IG G + V + R L GK VA+K ++ + + + + F+ E ++ + DHPN+I+L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNIIRL 70
Query: 163 EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
EG+VT + ++ EYME+ L KF+ Q+ ++ + SG+++ +
Sbjct: 71 EGVVTKSRP--VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 222 HRDIKGSNLLIDNDGILKIADFGL--------ATFYDPGLKQPMTSRVVTLWYRPPELLL 273
HRD+ N+L++++ + K++DFGL AT+ G K P+ W P +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI------RWTAPEAIAY 182
Query: 274 GATYYGVGVDLWSAGCILAELLA 296
+ D+WS G ++ E+++
Sbjct: 183 RK--FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 16/179 (8%)
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCY 204
E V+ KL HPN+++L G+ T + +++V EYM + L L +G K +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDM 105
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
+ +E+ +NG +HRD+ N L+ D ++K++DFGLA + L TS T
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTK 162
Query: 265 W---YRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTE---VEQLHKIFKL 316
+ + PPE+ + + D+WS G ++ E+ + GK + VE + ++L
Sbjct: 163 FPVKWAPPEVFDYSRFSSKS-DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 79/291 (27%), Positives = 120/291 (41%), Gaps = 56/291 (19%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDH 156
+ FE L IG+G + V + TG I A+K +R D LE E V + E +L + D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
V+K+ + + +LYL+ E++ + SE + Y+ + + ++ H
Sbjct: 61 AWVVKM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLAT---------FY---------DPGLKQPMT 258
G +HRDIK NLL+D G +K++DFGL T FY D + +
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178
Query: 259 SRVVTLW----------------YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP 302
R W Y PE+ + T Y D WS G I+ E+L G P
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 303 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDF 353
T E K+ WK++ +F P+ P I+E KD
Sbjct: 238 SETPQETYRKVMN---------WKET-----LVFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 52/200 (26%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 106 IGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
IG G + V + R L GK VA+K ++ E + F++ E ++ + DHPN+I L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQFDHPNIIHL 70
Query: 163 EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
EG+VT S + ++ E+ME+ L +F+ Q+ ++ + +G+++ +
Sbjct: 71 EGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFY-----DPGLKQPMTSRVVTLWYRPPELLLGAT 276
HRD+ N+L++++ + K++DFGL+ F DP + ++ W P +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--R 186
Query: 277 YYGVGVDLWSAGCILAELLA 296
+ D+WS G ++ E+++
Sbjct: 187 KFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 122 TGKIVALKKVRFDNLEPE-SVKFMAREILVLRKLDHPNVIKL--EGLVTSRMSCSLYLVF 178
TG VA+K +R D E E RE + +L HPN++ L G + L+ VF
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAVF 58
Query: 179 EYME-HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI 237
EY+ L + A G + + M Q+L L HN G++HRD+K N+++ G+
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGR-LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 238 ---LKIADFGLATFYDPGLKQPMTSRVV-------TLWYRPPELLLGATYYGVGVDLWSA 287
K+ DFG+ T PG++ + + T Y PE L G DL++
Sbjct: 118 RPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAW 175
Query: 288 GCILAELLAGKPIMPGRTEVEQLHK 312
G I E L G+ ++ G + E L++
Sbjct: 176 GLIFLECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-16
Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 30/236 (12%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR + + + K+G G + V+ K VA+K ++ + PES E +++K
Sbjct: 4 PR--ESLQLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMKK 57
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSG 211
L H +++L +V+ +Y+V EYM L L +G P + Q+ +G
Sbjct: 58 LRHDKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAG 114
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD-------PGLKQPMTSRVVTL 264
+ + +HRD++ +N+L+ + + KIADFGLA + G K P+
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK------ 168
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIFKL 316
W P L G + + D+WS G +L EL+ G+ P M R +EQ+ + +++
Sbjct: 169 WTAPEAALYGR--FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 76/289 (26%), Positives = 121/289 (41%), Gaps = 56/289 (19%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPN 158
FE L IG+G + V + TG + A+K +R D LE E V + E +L + D
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
V+K+ +++ LYL+ E++ + +E + + Y+ + + ++ H
Sbjct: 63 VVKMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLAT---------FY---------DPGLKQPMTSR 260
G +HRDIK NLL+D+ G +K++DFGL T FY D + + R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 261 VVTLWYR----------------PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR 304
W R PE+ + Y + D WS G I+ E+L G P
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSE 239
Query: 305 TEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDF 353
T E K+ WK++ +F P+ P I+E KD
Sbjct: 240 TPQETYKKVMN---------WKET-----LIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLE- 163
+G+GT+ V R+ TGK A+K ++ + + + V E VL+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 164 GLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
T C V EY +L + + V FSE + + Y +++S L + H+ V++
Sbjct: 63 SFQTHDRLC---FVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVVY 118
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGV 280
RD+K NL++D DG +KI DFGL G+ T + T Y PE+L YG
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDND-YGR 174
Query: 281 GVDLWSAGCILAELLAGK 298
VD W G ++ E++ G+
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 69/262 (26%), Positives = 118/262 (45%), Gaps = 27/262 (10%)
Query: 145 AREILVLRKLDHPNVIKLEGLVT-SRMSCSLYLVFEYMEHDL-AGLAACQGVKFSEPQVK 202
A E +LR ++HP++I+L+G T ++ +C L+ + DL LAA + + + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKRNIAICD--IL 185
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262
+ +L +++ H N ++HRDIK N+ I++ G + + DFG A F
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG------KPIMPGRTEVE-QLHKIFK 315
T+ PE LL YG VD+WSAG +L E+ K + G + + Q+ I +
Sbjct: 246 TIATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIR 304
Query: 316 LCGSPSEEYWKKSKLPNATLFK---------PQQPYKRCIAETFKDFPSSSLPLIETLLS 366
G+ E+ A L + ++P R + + P LI +L+
Sbjct: 305 RSGTHPNEFPID---AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLA 361
Query: 367 IDPDNRGTATAALNSEFFNTEP 388
D +R +A A L+ F P
Sbjct: 362 FDAHHRPSAEALLDFAAFQDIP 383
|
Length = 391 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 7e-16
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
K+G G Y VY+ VA+K ++ D +E V+ +E V++++ HPN+++L G
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 165 LVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYM-KQLLSGLEHCHNNGVL 221
+ T Y++ E+M + L L C + V YM Q+ S +E+ +
Sbjct: 70 VCT--REPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYD-------PGLKQPMTSRVVTLWYRPPELLLG 274
HRD+ N L+ + ++K+ADFGL+ G K P+ W P L
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAYN 180
Query: 275 ATYYGVGVDLWSAGCILAEL 294
+ + D+W+ G +L E+
Sbjct: 181 K--FSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 65/230 (28%), Positives = 107/230 (46%), Gaps = 27/230 (11%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR + E K+GQG + V+ T + VA+K ++ + PE+ +E V++K
Sbjct: 4 PRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKK 57
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSG 211
L H +++L +V+ +Y+V EYM L L G PQ+ Q+ SG
Sbjct: 58 LRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 114
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD-------PGLKQPMTSRVVTL 264
+ + +HRD++ +N+L+ + + K+ADFGLA + G K P+
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------ 168
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
W P L G + + D+WS G +L EL G+ PG E L ++
Sbjct: 169 WTAPEAALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 77/259 (29%), Positives = 110/259 (42%), Gaps = 54/259 (20%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRF-DNLEPESVKFMAREILVLRKLDHPN 158
F K+ +G G + V A + T + A+K +R D L V + E +L + D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
V+KL + + LY V +Y+ D+ L V F E + Y+ +L +E H
Sbjct: 63 VVKLYYSFQDKDN--LYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHK 119
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT---------FYDPG---------------- 252
G +HRDIK N+LID DG +K+ DFGL T +Y G
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 253 ------------LKQPMT---------SRVVTLWYRPPELLLGATYYGVGVDLWSAGCIL 291
L+Q T S V T Y PE+LL Y + D WS G IL
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVIL 238
Query: 292 AELLAGKP--IMPGRTEVE 308
E+L G+P + P TE +
Sbjct: 239 FEMLVGQPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVK--FMAREILVLRKLDHPNVIKL 162
+G+G++ V A T ++ A+K ++ D L+ + V + IL L HP
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHP----- 56
Query: 163 EGLVTSRMSC-----SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+T+ C L+ V EY+ + KF EP+ + Y ++ L H
Sbjct: 57 --FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGA 275
+GV++RD+K N+L+D +G K+ADFG+ G+ +T+ T Y PE +L
Sbjct: 115 HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPE-ILQE 170
Query: 276 TYYGVGVDLWSAGCILAELLAGKP 299
YG VD W+ G ++ E++AG+P
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEG 164
+G+GT+ V R+ +GK A+K ++ + + + V E VL+ HP + L+
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK- 61
Query: 165 LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRD 224
+ + L V EY+ + FSE + + Y +++S L++ H+ +++RD
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 225 IKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVGV 282
+K NL++D DG +KI DFGL G+ T + T Y PE+L YG V
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDND-YGRAV 176
Query: 283 DLWSAGCILAELLAGK 298
D W G ++ E++ G+
Sbjct: 177 DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 22/226 (9%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
+ IG+G + V + TG+ VA+K ++ D + F+ E V+ KL H N+++L
Sbjct: 12 EIIGEGEFGAVLQGE--YTGQKVAVKNIKCD---VTAQAFLE-ETAVMTKLHHKNLVRLL 65
Query: 164 GLVTSRMSCSLYLVFEYMEH-DLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
G++ + LY+V E M +L +G S Q+ + + G+E+ + ++
Sbjct: 66 GVI---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVG 281
HRD+ N+L+ DG+ K++DFGLA G+ S++ W P L +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKWTAPEALKHKK--FSSK 177
Query: 282 VDLWSAGCILAELL----AGKPIMPGRTEVEQLHKIFKLCGSPSEE 323
D+WS G +L E+ A P M + E + K +++ P E
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--EPPEG 221
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 57/202 (28%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 102 KLDK-IGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
K++K IG G + V R L GK VA+K ++ E + F++ E ++ + DHP
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHP 65
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
N+I LEG+VT S + +V EYME+ L +F+ Q+ ++ + SG+++
Sbjct: 66 NIIHLEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFY--DPGLKQPMTSRVVTLWYRPPELLLG 274
+ G +HRD+ N+L++++ + K++DFGL+ DP + + + PE +
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIA 182
Query: 275 ATYYGVGVDLWSAGCILAELLA 296
+ D+WS G ++ E+++
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 55/190 (28%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 143 FMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEP--- 199
+ EIL L +L+H N++K+E ++ R + Y++ + + DL + + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 200 -QVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258
Q + MKQLL +E+ H+ ++HRDIK N+ ++ DG + + DFG A ++ +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP----GRTEVEQLHKIF 314
V T+ PE+L G Y + D+WS G IL ++L+ P G +QL KI
Sbjct: 327 GWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKII 384
Query: 315 KLCGSPSEEY 324
EE+
Sbjct: 385 DSLSVCDEEF 394
|
Length = 501 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 50/276 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILV-LRKLDHPN 158
E ++++G+G Y V K R + TG I+A+K++R + + K + ++ + +R +D P
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDCPY 61
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGL---AACQGVKFSEPQVKCYMKQLLSGLEHC 215
+ G + +++ E M+ L +G+ E + ++ LE+
Sbjct: 62 TVTFYGALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 216 HNN-GVLHRDIKGSNLLIDNDGILKIADFG--------LATFYDPGLKQPMTSRVVTLWY 266
H+ V+HRD+K SN+LI+ +G +K+ DFG +A D G K Y
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----------Y 169
Query: 267 RPPELL---LGATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSPSE 322
PE + L Y V D+WS G + EL G+ P +T +QL ++ + PS
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EPS- 225
Query: 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSL 358
+LP F P+ F+DF + L
Sbjct: 226 -----PQLPAEK-FSPE----------FQDFVNKCL 245
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLE 163
IG+G+Y+ V R T +I A+K V+ + + + E + ++ E V + +HP ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
+ L+ V EY+ + K E + Y ++ L + H G+++R
Sbjct: 63 SCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVG 281
D+K N+L+D++G +K+ D+G+ GL+ T+ T Y PE+L G YG
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEILRGED-YGFS 176
Query: 282 VDLWSAGCILAELLAGK 298
VD W+ G ++ E++AG+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 3e-15
Identities = 62/225 (27%), Positives = 110/225 (48%), Gaps = 27/225 (12%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR T + + K+G G + V+ K VA+K ++ ++ PE+ F+A E ++++
Sbjct: 4 PR--ETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMKQ 57
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSG 211
L HP +++L +VT +Y++ EYME+ + L +G+K + ++ Q+ G
Sbjct: 58 LQHPRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEG 114
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP-------GLKQPMTSRVVTL 264
+ +HRD++ +N+L+ KIADFGLA + G K P+
Sbjct: 115 MAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK------ 168
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVE 308
W P + G + + D+WS G +L E++ G+ PG T E
Sbjct: 169 WTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKAR--DLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR N E + IGQG + V++AR LL + +VA+K ++ + F RE
Sbjct: 3 PR--NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 59
Query: 149 LVLRKLDHPNVIKLEGL-VTSRMSCSLYLVFEYME--------------------HDLAG 187
++ + DHPN++KL G+ + C L+FEYM H +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116
Query: 188 LAACQGVK--FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGL 245
C S + C KQ+ +G+ + +HRD+ N L+ + ++KIADFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176
Query: 246 A-TFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA 296
+ Y + + + + + PPE + Y D+W+ G +L E+ +
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 24/226 (10%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ + L K+G G + V++ T VA+K ++ ++P+ F+ E +++KL HP
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKD--FL-AEAQIMKKLRHP 61
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
+I+L + T + +Y+V E M++ L L G PQ+ Q+ SG+ +
Sbjct: 62 KLIQLYAVCT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL 119
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD-------PGLKQPMTSRVVTLWYRP 268
+HRD+ N+L+ + I K+ADFGLA G K P+ W P
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK------WTAP 173
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
L + + D+WS G +L E++ G+ PG T E L ++
Sbjct: 174 EAALYNR--FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 6e-15
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 18/230 (7%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALK----KVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
IG+G++ V A+ L GK A+K K+ + E + + MA ++L+ + HP ++
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNVLLKNVKHPFLVG 60
Query: 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
L + + + LY V +++ + F EP+ + Y ++ S L + H+ ++
Sbjct: 61 LH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYG 279
+RD+K N+L+D+ G + + DFGL G+ Q T+ T Y PE++ Y
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQ----LHKIFKLCGSPSEEYW 325
VD W G +L E+L G P R E LHK L S W
Sbjct: 176 T-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 12/215 (5%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMARE--ILVLRKLDHPNVIKL 162
+G+G++ V AR +G++ A+K ++ D L+ + V+ E IL L + +HP + +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 163 EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
+ L+ V E++ + +F E + + Y ++ S L H+ G+++
Sbjct: 62 --YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGV 280
RD+K N+L+D++G K+ADFG+ G+ T+ T Y PE +L YG
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGP 175
Query: 281 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
VD W+ G +L E+L G E + I
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 54/178 (30%), Positives = 81/178 (45%), Gaps = 29/178 (16%)
Query: 196 FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255
F EP+ Y Q++SGLEH H +++RD+K N+L+DNDG ++I+D GLA G +
Sbjct: 94 FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG-QS 152
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
T + PELL G Y VD ++ G L E++A + P R E++
Sbjct: 153 KTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARG--PFRARGEKV----- 204
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKD-FPSSSLPLIETLLSIDPDNR 372
+ +L L T+ D F +S E LL+ DP+ R
Sbjct: 205 ----------ENKELKQRILNDSV---------TYPDKFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 26/228 (11%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
F L +G+G++ V A T ++ A+K ++ D ++ + V+ E VL P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 159 VIKLEGLVTSRMSC-----SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
+T SC LY V EY+ Q +F EP Y ++ GL
Sbjct: 62 ------FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW------YR 267
H+ G+++RD+K N+++D++G +KIADFG+ K+ M V T Y
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENMWDGVTTKTFCGTPDYI 168
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
PE ++ YG VD W+ G +L E+LAG+ G E E I +
Sbjct: 169 APE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 88/334 (26%), Positives = 140/334 (41%), Gaps = 47/334 (14%)
Query: 105 KIGQG--TYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
+IG+G ++VY AR TG +V ++ +N E +K + E+++ HPN++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 163 EGLVTSRMSCSLYLVFEYMEHDLAG--LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
+ T+ L+++ +M + A L SE + + L GL + H NG
Sbjct: 65 WTVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY 122
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLATFY---DPGLKQ------PMTSRVVTLWYRPPEL 271
+HR+IK S++LI DG++ ++ GL+ Y G K P S V W PEL
Sbjct: 123 IHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS-PEL 179
Query: 272 LLGATY-YGVGVDLWSAGCILAELLAGK-PIMP-GRTEVEQLHKIFKLCGSPSEEYWKKS 328
L Y Y V D++S G EL G+ P RT++ L K+ SP +
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSP----LDIT 234
Query: 329 KLP--NATLFKPQQPYKRCIAETF-------------------KDFPSSSLPLIETLLSI 367
P + + Q I E+ K F + L+E L
Sbjct: 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQ 294
Query: 368 DPDNRGTATAALNSEFFNTEPYACEPSSLPKYPP 401
DP+ R +A++ L+ FF + S L PP
Sbjct: 295 DPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 25/223 (11%)
Query: 106 IGQGTYSNVYKARDLL---TGKIVA---LKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+G+G Y V++ R + TGKI A LKK + ++ A E +L + HP +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPFI 62
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+ L + + LYL+ EY+ +L +G+ F E Y+ ++ LEH H
Sbjct: 63 VDL--IYAFQTGGKLYLILEYLSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQQ 119
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV------TLWYRPPELL 272
G+++RD+K N+L+D G +K+ DFGL K+ + V T+ Y PE+L
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLC-------KESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
+ + +G VD WS G ++ ++L G P + + KI K
Sbjct: 173 MRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 59/224 (26%), Positives = 105/224 (46%), Gaps = 26/224 (11%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGL 165
+G+G + V+K L VA+K + D + +KF++ E +L++ DHPN++KL G+
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIGV 60
Query: 166 VTSRMSCSLYLVFE---------YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
T R +Y+V E ++ L Q VKF+ +G+ +
Sbjct: 61 CTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAA--------AGMAYLE 110
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ +HRD+ N L+ + +LKI+DFG++ D G+ + + + + PE L
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNYG 169
Query: 277 YYGVGVDLWSAGCILAELLA----GKPIMPGRTEVEQLHKIFKL 316
Y D+WS G +L E + P M + EQ+ K +++
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGL 165
+G+G+Y V R GK +KK+ N K +E +L +L HPN+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI------ 61
Query: 166 VTSRMS-----CSLYLVFEYMEH-DL-AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
V R S LY+V + E DL L +G E QV + Q+ L++ H
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGATY 277
+LHRD+K N+ + I+K+ D G+A + + M S ++ T +Y PEL
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKP- 178
Query: 278 YGVGVDLWSAGCILAEL 294
Y D+W+ GC + E+
Sbjct: 179 YNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 51/194 (26%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE-SVKFMAREILVLRKLDHPNVIKL 162
++IG+G + V+ R VA+K R + L P+ KF+ +E +L++ HPN+++L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFL-QEARILKQYSHPNIVRL 58
Query: 163 EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
G+ T + +Y+V E ++ D +G + ++ ++ +G+E+ + +
Sbjct: 59 IGVCTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM--TSRVVTLWYRPPELLLGATYYG 279
HRD+ N L+ +LKI+DFG++ + G+ ++ W P L G Y
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR--YS 174
Query: 280 VGVDLWSAGCILAE 293
D+WS G +L E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 5e-14
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 16/225 (7%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDHPNVIKLE 163
IG+G++ V A+ G A+K ++ + + E MA ++L+ L HP ++ L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
+ + + LY V +Y+ + F EP+ + Y ++ S + + H+ +++R
Sbjct: 63 --YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVG 281
D+K N+L+D+ G + + DFGL G++ T+ T Y PE+L Y
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRT 176
Query: 282 VDLWSAGCILAELLAGKPIMPGRTEVEQ-----LHKIFKLCGSPS 321
VD W G +L E+L G P R +V Q LHK +L G +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 10/217 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F K+G G + V++ VA+K ++ D+L + +E+ L++L H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHL 64
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
I L + + +Y++ E ME LA L + +G + Q+ G+ +
Sbjct: 65 ISLFAVCSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+HRD+ N+L+ D + K+ADFGLA + ++ W P G
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-- 180
Query: 278 YGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
+ D+WS G +L E+ G+ PG E +I
Sbjct: 181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 69/267 (25%), Positives = 107/267 (40%), Gaps = 58/267 (21%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDH 156
F + IG+G + V + TGKI A+K + + + + + + E VL + D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVK---FSEPQVKCYMKQLLSGL 212
P V+ L + + + LYL+ E++ DL + +K FSE + YM + + +
Sbjct: 61 PWVVSL--YYSFQDAQYLYLIMEFLPGGDLMTML----IKYDTFSEDVTRFYMAECVLAI 114
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLAT-FY----DPGLKQPMTSRVVT---- 263
E H G +HRDIK N+LID G +K++DFGL+T F+ ++ + +
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 264 ---------------------LW----------------YRPPELLLGATYYGVGVDLWS 286
W Y PE+ L YG D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWS 233
Query: 287 AGCILAELLAGKPIMPGRTEVEQLHKI 313
G I+ E L G P E KI
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 10/210 (4%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAR-EILVLRKLDHPNVIKLEG 164
+G+G + V + TGK+ A KK+ L+ +S + MA E +L K++ P ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 165 LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSE-PQVKCYMKQLLSGLEHCHNNGVLH 222
S+ L LV M DL G + E +V Y Q+ G+ H H+ +++
Sbjct: 61 AFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGV 282
RD+K N+L+D+ G +++D GLA G + +T R T Y PE+L Y V
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGTNGYMAPEILKEEP-YSYPV 175
Query: 283 DLWSAGCILAELLAGKPIMPGRTEVEQLHK 312
D ++ GC + E++AG+ P + E++ K
Sbjct: 176 DWFAMGCSIYEMVAGR--TPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 25/219 (11%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
K+GQG + V+ T K VA+K ++ + PE+ +E +++KL H ++ L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYA 68
Query: 165 LVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
+V+ +Y+V E+M L L G PQ+ Q+ G+ + +H
Sbjct: 69 VVSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYD-------PGLKQPMTSRVVTLWYRPPELLLGA 275
RD++ +N+L+ ++ + KIADFGLA + G K P+ W P L G
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYGR 179
Query: 276 TYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
+ + D+WS G +L EL+ G+ PG E L ++
Sbjct: 180 --FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDHPNVIKLE 163
IG+G++ V A+ GK A+K ++ + + E MA ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
+ + + LY V +Y+ + F EP+ + Y ++ S L + H+ +++R
Sbjct: 63 --YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVG 281
D+K N+L+D+ G + + DFGL G++ T+ T Y PE+L Y
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRT 176
Query: 282 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
VD W G +L E+L G P R E I
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+ IG+G + +V G+ VA+K ++ D+ ++ F+A E V+ L HPN++
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLV 63
Query: 161 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSE-PQVKCYMKQLLSGLEHCHNN 218
+L G+V LY+V EYM L +G Q + + G+E+
Sbjct: 64 QLLGVVLQ--GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
+HRD+ N+L+ D + K++DFGLA + Q + ++ W P L +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQD-SGKLPVKWTAPEALREKK--F 176
Query: 279 GVGVDLWSAGCILAELLA 296
D+WS G +L E+ +
Sbjct: 177 STKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLD-HPNVIKLE 163
IG+G+Y+ V R +I A+K V+ + + + E + ++ E V + +P ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 164 GL--VTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
TSR L+LV EY+ + K E + Y ++ L H G++
Sbjct: 63 SCFQTTSR----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYG 279
+RD+K N+L+D DG +K+ D+G+ GL T+ T Y PE+L G YG
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILRGEE-YG 174
Query: 280 VGVDLWSAGCILAELLAGK 298
VD W+ G ++ E++AG+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLE 163
IG+G+Y+ V T +I A+K ++ + + + E + ++ E V +HP ++ L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 164 GL--VTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
SR L+ V E++ + K E + Y ++ L H G++
Sbjct: 63 SCFQTESR----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYG 279
+RD+K N+L+D +G +K+ D+G+ G++ T+ T Y PE+L G YG
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGED-YG 174
Query: 280 VGVDLWSAGCILAELLAGK 298
VD W+ G ++ E++AG+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 8/232 (3%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHP 157
TF +G+G + V + TGK+ A KK+ ++ + MA E +L K++
Sbjct: 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVK-FSEPQVKCYMKQLLSGLEHC 215
V+ L +L LV M DL G F E + Y +L GLE
Sbjct: 61 FVVSLA--YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
+++RD+K N+L+D+ G ++I+D GLA G + + RV T+ Y PE++
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRVGTVGYMAPEVINNE 176
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
Y D W GC++ E++ G+ R E + ++ + EEY +K
Sbjct: 177 K-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 71/240 (29%), Positives = 102/240 (42%), Gaps = 47/240 (19%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKK-VRFDNLEPESVKFMAREILVLRKLDH 156
N E L +IG GT VYK R TG ++A+K+ R N E M ++ VL+ D
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDC 73
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAAC---------QGV------KFSEPQV 201
P ++K G + VF ME ++ C + K + V
Sbjct: 74 PYIVKCYGYFITDSD-----VFICMEL----MSTCLDKLLKRIQGPIPEDILGKMTVAIV 124
Query: 202 KC--YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM-- 257
K Y+K+ +GV+HRD+K SN+L+D G +K+ DFG++ L
Sbjct: 125 KALHYLKE---------KHGVIHRDVKPSNILLDASGNVKLCDFGISGR----LVDSKAK 171
Query: 258 TSRVVTLWYRPPELLLGATY---YGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKI 313
T Y PE + Y + D+WS G L EL G+ P +TE E L KI
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 48/149 (32%), Positives = 72/149 (48%), Gaps = 6/149 (4%)
Query: 147 EILVLRKLDHPNVIKLEGL-VTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYM 205
E +LR+L HP V+ L + V ++C LV DL + QV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TL 264
+QLLS +++ H G++HRDIK N+L++ + + DFG A F P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAE 293
PE+L G Y VD+WSAG ++ E
Sbjct: 327 DTNAPEVLAGDPYTPS-VDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-13
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 27/225 (12%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR + EK K+G G + V+ A K VA+K ++ ++ SV+ E V++
Sbjct: 4 PRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSM---SVEAFLAEANVMKT 57
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSG 211
L H ++KL +VT +Y++ E+M L L + +G K P++ + Q+ G
Sbjct: 58 LQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD-------PGLKQPMTSRVVTL 264
+ +HRD++ +N+L+ + KIADFGLA + G K P+
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------ 168
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVE 308
W P + G+ + + D+WS G +L E++ G+ PG + E
Sbjct: 169 WTAPEAINFGS--FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 55/187 (29%), Positives = 92/187 (49%), Gaps = 26/187 (13%)
Query: 126 VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD- 184
VA+K + + E F+ E V+ KL HP +++L G+ T + LY+V E+ME+
Sbjct: 31 VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQLYGVCTQQKP--LYIVTEFMENGC 85
Query: 185 -LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243
L L QG K S+ + + + G+E+ N +HRD+ N L+ + G++K++DF
Sbjct: 86 LLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDF 144
Query: 244 GLATFY-------DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA 296
G+ + G K P+ + PPE+ + Y D+WS G ++ E+
Sbjct: 145 GMTRYVLDDEYTSSSGAKFPVK-------WSPPEVFN-FSKYSSKSDVWSFGVLMWEVFT 196
Query: 297 -GKPIMP 302
GK MP
Sbjct: 197 EGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 52/214 (24%), Positives = 92/214 (42%), Gaps = 34/214 (15%)
Query: 106 IGQGTYSNVYKA--RDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+G+G + V+ L +VA+K ++ + ++ K RE +L H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 161 KLEGLVTSRMSCSLYLVFEYMEH-DL----------AGLAACQGVK---FSEPQVKCYMK 206
K G+ T +VFEYMEH DL A + Q+
Sbjct: 72 KFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA------TFYDPGLKQPMTSR 260
Q+ SG+ + + +HRD+ N L+ D ++KI DFG++ +Y G
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVG-----GHT 184
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL 294
++ + + PPE ++ + D+WS G +L E+
Sbjct: 185 MLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 66/234 (28%), Positives = 114/234 (48%), Gaps = 19/234 (8%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
+ + FEK+ ++G G V+K +G I+A K + + ++P + RE+ VL + +
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECN 61
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAAC--QGVKFSEPQVKCYMKQLLSGL 212
P ++ G S S+ MEH D L + + E + ++ GL
Sbjct: 62 SPYIVGFYGAFYSDGEISIC-----MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 116
Query: 213 EHC-HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
+ + ++HRD+K SN+L+++ G +K+ DFG++ + S V T Y PE
Sbjct: 117 TYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPER 173
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIF--KLCGSPSE 322
L G T+Y V D+WS G L E+ G+ PI P + ++L +F + G P+E
Sbjct: 174 LQG-THYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAE 224
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEG 164
+G+GT+ V ++ TG+ A+K ++ + + + V E VL+ HP + L+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61
Query: 165 LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHR 223
+ + L V EY + FSE + + Y +++S L++ H+ V++R
Sbjct: 62 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVG 281
D+K NL++D DG +KI DFGL G+K T + T Y PE+L YG
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDND-YGRA 176
Query: 282 VDLWSAGCILAELLAGK 298
VD W G ++ E++ G+
Sbjct: 177 VDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 71/244 (29%), Positives = 116/244 (47%), Gaps = 13/244 (5%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLR-KLDHPNVIKLE 163
+G+G++ V A G+ A+K ++ D L + V+ E VL ++P + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 164 GLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
T + L+ V E++ DL +G +F + Y +++ GL+ H+ G+++
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIY 119
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGV 282
RD+K N+++D DG +KIADFG+ G ++ T Y PE+L G Y V
Sbjct: 120 RDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGTPDYIAPEILQGLK-YTFSV 177
Query: 283 DLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW--KKSKLPNATLFKPQQ 340
D WS G +L E+L G+ G E E I +P W K+SK LF+ +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESI--RVDTPHYPRWITKESKDILEKLFE-RD 234
Query: 341 PYKR 344
P +R
Sbjct: 235 PTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 12/216 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
FEKL ++G G V K +G I+A K + + ++P + RE+ VL + + P +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN- 218
+ G S S+ + E+M+ + + E + +L GL +
Sbjct: 62 VGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM-TSRVVTLWYRPPELLLGATY 277
++HRD+K SN+L+++ G +K+ DFG++ L M S V T Y PE L G T+
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQG-TH 174
Query: 278 YGVGVDLWSAGCILAELLAGK-PI-MPGRTEVEQLH 311
Y V D+WS G L E+ G+ PI P E+E +
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 11/217 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
FE++ ++G G V K + +G I+A K + + ++P + RE+ VL + + P +
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYI 65
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC-HNN 218
+ G S S+ + E+M+ + + E + +L GL + +
Sbjct: 66 VGFYGAFYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
++HRD+K SN+L+++ G +K+ DFG++ + S V T Y PE L G T+Y
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG-THY 179
Query: 279 GVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIF 314
V D+WS G L EL G+ PI P + ++L IF
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 38/220 (17%)
Query: 103 LDKIGQGTYSNVYKARDLLTGK-------IVALKKVRFDNLEPESVKFMAREILVLRKLD 155
L+++G+G + VYK LTG VA+K ++ +N EP+ + +E ++ L
Sbjct: 10 LEELGEGAFGKVYKGE--LTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQ 66
Query: 156 HPNVIKLEGLVT-SRMSCSLYLVFEYMEH--------------DLAGLAACQGVK--FSE 198
HPN++ L G+ T + +C L FEY+ H D+ + + VK
Sbjct: 67 HPNIVCLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 199 PQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPM 257
Q+ +G+E+ ++ +HRD+ N L+ +KI+DFGL+ Y +
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 258 TSRVVTLWYRPPELLLGATYYG---VGVDLWSAGCILAEL 294
+ ++ + + PPE +L YG D+WS G +L E+
Sbjct: 184 SKSLLPVRWMPPEAIL----YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 24/214 (11%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
K+G G + V+ + K VA+K ++ + SV+ E +++ L H +++L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYA 68
Query: 165 LVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
+VT +Y++ EYM L L + +G K P++ + Q+ G+ + +H
Sbjct: 69 VVTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYD-------PGLKQPMTSRVVTLWYRPPELLLGA 275
RD++ +N+L+ + KIADFGLA + G K P+ W P + G+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFGS 180
Query: 276 TYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVE 308
+ + D+WS G +L E++ GK PG + +
Sbjct: 181 --FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 196 FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255
F E +V Q++ L+ H+ ++HRD+K +N+ + GI+K+ DFG + Y +
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 256 PMTSRVV-TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIF 314
+ S T +Y PE L Y D+WS G IL ELL LH+ F
Sbjct: 226 DVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLT-------------LHRPF 271
Query: 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT 374
K PS+ ++ L+ P+ ++ K L++ LLS +P R T
Sbjct: 272 K---GPSQR-----EIMQQVLYGKYDPFPCPVSSGMK-------ALLDPLLSKNPALRPT 316
Query: 375 ATAALNSEFF 384
L++EF
Sbjct: 317 TQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 47/197 (23%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 106 IGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
IG G + V++ + G+ VA+K ++ E + F++ E ++ + H N+I+L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIRL 71
Query: 163 EGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
EG+VT ++ EYME+ L +FS Q+ ++ + +G+++ + +
Sbjct: 72 EGVVTKFKP--AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFY--DPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
HRD+ N+L++++ K++DFGL+ DP + + + + PE + +
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRKFT 188
Query: 280 VGVDLWSAGCILAELLA 296
D+WS G ++ E+++
Sbjct: 189 SASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 10/213 (4%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDHPNVIKLE 163
IG+G++ V AR K A+K ++ + + E M+ ++L+ + HP ++ L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
+ + + LY V +Y+ + F EP+ + Y ++ S L + H+ +++R
Sbjct: 63 --FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVG 281
D+K N+L+D+ G + + DFGL ++ T+ T Y PE+L Y
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQP-YDRT 176
Query: 282 VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIF 314
VD W G +L E+L G P R E I
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 9/159 (5%)
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYM- 205
E V+ KL H +++L G+ T + +Y+V EYM + + K +P M
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF-YDPGLKQPMTSRVVTL 264
K + G+ + + +HRD+ N L+D+ G +K++DFGL+ + D + S+
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMP 302
W PPE+LL + + D+W+ G ++ E+ + GK MP
Sbjct: 167 W-SPPEVLLYSKFSSKS-DVWAFGVLMWEVYSLGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 46/248 (18%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
A + L +IG+G + V K +G I+A+K++R E E + + +V+R D
Sbjct: 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFS----EPQVKCYMKQLLS-- 210
P ++K G + C ++ E M+ L KF E +++L
Sbjct: 63 PYIVKFYGALFREGDC--WICMELMDISLD--------KFYKYVYEVLKSVIPEEILGKI 112
Query: 211 ------GLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGL--------ATFYDPGLKQ 255
L + ++HRD+K SN+L+D +G +K+ DFG+ A D G +
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCR- 171
Query: 256 PMTSRVVTLWYRPPELLL--GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHK 312
P Y PE + Y V D+WS G L E+ GK P V +QL +
Sbjct: 172 P---------YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQ 222
Query: 313 IFKLCGSP 320
+ K G P
Sbjct: 223 VVK--GDP 228
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 32/222 (14%)
Query: 94 PRRANT-----FEKLDKIGQGTYSNV----YKARDLLTGKIVALKKVRFDNLEPESVKFM 144
P+R N F + +G G++ V YK D I +K + ++ + V +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI--IKQKQVDHV 78
Query: 145 AREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LAACQGVKFSEPQVK 202
E +L ++HP + L G + + LYLV E++ + G + K V
Sbjct: 79 FSERKILNYINHPFCVNLYG--SFKDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVG 133
Query: 203 C-YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261
C Y Q++ E+ + +++RD+K NLL+D DG +K+ DFG A D +R
Sbjct: 134 CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD--------TRT 185
Query: 262 VTLWYRP----PELLLGATYYGVGVDLWSAGCILAELLAGKP 299
TL P PE+LL +G D W+ G + E+L G P
Sbjct: 186 YTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 100 FEKLDKIGQGTYSNVYKAR---DLLTGKI-VALKKVRFDNLEPESVKFMAREILVLRKLD 155
EK+ +G G + VYK + KI VA+K +R + P++ K + E V+ +D
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVD 67
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLS----- 210
HP+V++L G+ +S + L+ + M C + + LL+
Sbjct: 68 HPHVVRLLGIC---LSSQVQLITQLMPL------GCLLDYVRNHKDNIGSQYLLNWCVQI 118
Query: 211 --GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS--RVVTLWY 266
G+ + ++HRD+ N+L+ +KI DFGLA D K+ +V W
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELL 295
+L Y D+WS G + EL+
Sbjct: 179 ALESILHRI--YTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 23/221 (10%)
Query: 102 KLDKI-GQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
KL KI G+G + +V + + D K VA+K ++ D ++ E ++ DH
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 157 PNVIKLEGLVTSRMSC-----SLYLVFEYMEHD------LAGLAACQGVKFSEPQVKCYM 205
PNV+KL G V S ++ +M+H L K + +M
Sbjct: 61 PNVMKLIG-VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPG-LKQPMTSRVVT 263
+ G+E+ N +HRD+ N ++ D + +ADFGL+ Y +Q +++
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPG 303
W L Y D+W+ G + E+ G+ PG
Sbjct: 180 KWIAIES--LADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 65/233 (27%), Positives = 108/233 (46%), Gaps = 34/233 (14%)
Query: 106 IGQGTYSNVYK--ARDLL---TGKI-VALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+G G + VY+ A D+L +G I VA+K +R + E +F+ E ++ +HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPNI 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLL-------- 209
+KL G+ ++ Y++ E ME L+ L + +F P + +K+LL
Sbjct: 62 VKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVAK 117
Query: 210 --SGLEHCHNNGVLHRDIKGSNLLI-----DNDGILKIADFGLAT-FYDPGLKQPMTSRV 261
LE H +HRD+ N L+ D D ++KI DFGLA Y + +
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
+ + + PE LL + D+WS G ++ E+L G+ P E L +
Sbjct: 175 LPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 27/217 (12%)
Query: 104 DKIGQGTYSNVYKARDLLTG--KIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVI 160
D IG+G + V KAR G A+K+++ + + + A E+ VL KL HPN+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 161 KLEGLVTSRMSCSLYLVFEYMEH---------------DLA-GLAACQGVKFSEPQVKCY 204
L G R LYL EY H D A +A S Q+ +
Sbjct: 72 NLLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
+ G+++ +HRD+ N+L+ + + KIADFGL+ + +K+ M R+
Sbjct: 130 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVR 188
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKP 299
W L + Y D+WS G +L E+ L G P
Sbjct: 189 WMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 56/231 (24%), Positives = 104/231 (45%), Gaps = 33/231 (14%)
Query: 92 WTPRRANTFEKLDKIGQGTYSNVYK--ARDLLTGKI---VALKKVRFDNLEPESVKFMAR 146
W R + ++GQG++ VY+ A+ ++ G+ VA+K V + E ++F+
Sbjct: 1 WELPR-EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN- 58
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAAC-----QGVKFSEP 199
E V+++ + +V++L G+V+ +V E M DL L + P
Sbjct: 59 EASVMKEFNCHHVVRLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 200 QVKCYMK---QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA------TFYD 250
++ +++ ++ G+ + +HRD+ N ++ D +KI DFG+ +Y
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR 176
Query: 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKP 299
G K + R W P L G + D+WS G +L E+ LA +P
Sbjct: 177 KGGKGLLPVR----WMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 8/220 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKV-RFDNLEPESVKFMAREILVLRKLDHPN 158
FE L IG+G + V + TG++ A+K + +++ L+ E VL D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEY-MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+ L + LYLV +Y + DL L + + E + Y+ +++ ++ H
Sbjct: 63 ITNLHYAFQDENN--LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL---- 273
G +HRDIK N+L+D +G +++ADFG V T Y PE+L
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
G YG D WS G + E+L G+ + VE KI
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 42/149 (28%), Positives = 72/149 (48%), Gaps = 13/149 (8%)
Query: 104 DKIGQGTYSNVYKAR-DLLTGKI--VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
K+G G++ V + GK+ VA+K ++ D L F+ +E ++ LDH N+I
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 161 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCH 216
+L G+V ++ L +V E L L F + Y Q+ +G+ +
Sbjct: 60 RLYGVV---LTHPLMMVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGL 245
+ +HRD+ N+L+ +D +KI DFGL
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGL 143
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 10/222 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKV-RFDNLEPESVKFMAREILVLRKLDHPN 158
FE L IG+G + V + K+ A+K + +++ L+ E VL D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEY-MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+ L + +LYLV +Y + DL L + + E + Y+ +++ ++ H
Sbjct: 63 ITTLH--YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFG-LATFYDPGLKQPMTSRVVTLWYRPPELLL--- 273
+HRDIK N+L+D +G +++ADFG + G Q + V T Y PE+L
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA-VGTPDYISPEILQAME 179
Query: 274 -GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIF 314
G YG D WS G + E+L G+ + VE KI
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFM--AREILVLRKLDHPNVIKL 162
I +G + VY R K+ A+K V+ D + V + R+ L L K P ++ L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHL 69
Query: 163 EGLVTSRMSCS-LYLVFEYM-EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
S S + +YLV EY+ D+ L G F E Y+ ++ L++ H +G+
Sbjct: 70 ---YYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGI 125
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLA 246
+HRD+K N+LI N+G +K+ DFGL+
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
R E + +G G +V K + + TG ++A KKV + K + RE+ ++ +
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECR 61
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
P ++ G + + + + E+M+ L + G + ++ GL +
Sbjct: 62 SPYIVSFYGAFLNENNICMCM--EFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTY 118
Query: 215 CHN-NGVLHRDIKGSNLLIDNDGILKIADFGLA---------TFYDPGLKQPMTSRVVTL 264
+N + ++HRDIK SN+L+++ G +K+ DFG++ TF V T
Sbjct: 119 LYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF------------VGTS 166
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGK 298
Y PE + G Y V D+WS G + EL GK
Sbjct: 167 TYMSPERIQGGK-YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 10/221 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKV-RFDNLEPESVKFMAREILVLRKLDHPN 158
FE + IG+G + V + T +I A+K + +++ L+ E VL D
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEY-MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+ L + LYLV +Y + DL L + + E + Y+ +++ + H
Sbjct: 63 ITTLH--YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFG-LATFYDPGLKQPMTSRVVTLWYRPPELLL--- 273
+HRDIK N+L+D +G +++ADFG G Q + V T Y PE+L
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA-VGTPDYISPEILQAME 179
Query: 274 -GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
G YG D WS G + E+L G+ + VE KI
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 60/231 (25%), Positives = 100/231 (43%), Gaps = 36/231 (15%)
Query: 94 PRRANTFEKLDKIGQGTYSNV----------YKARDLLTGKI------VALKKVRFDNLE 137
PR+ TF+ +K+G+G + V + +D VA+K +R D +
Sbjct: 3 PRKRLTFK--EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 138 PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME----------HDLAG 187
F+ +EI ++ +L PN+I+L L S L ++ EYME H+
Sbjct: 61 NARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 188 LAACQGVKFSEPQVKCYMK-QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
A V +M Q+ SG+++ + +HRD+ N L+ + +KIADFG++
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 247 TFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295
G + R V W +LLG + D+W+ G L E+L
Sbjct: 178 RNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 24/158 (15%)
Query: 105 KIGQGTYSNVYKA--RDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
IG+G + +VY+ KI VA+K + KF+ E ++R+ DHP+++K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 162 LEGLVTSRMSCSLYLVFE---------YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
L G++T +++V E Y++ + L + + Y QL + L
Sbjct: 72 LIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTAL 120
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250
+ + +HRDI N+L+ + +K+ DFGL+ + +
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 36/227 (15%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK--FMAREILVLRKLDHP 157
++ + IG+G VY A D + + VALKK+R D E +K F+ RE + L HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHP 62
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYME-----HDLAGLAACQGVKFSEPQVKCYMKQLLS-- 210
++ + + + +Y Y+E L + + + E K + LS
Sbjct: 63 GIVPVYSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIF 119
Query: 211 -----GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF----------YDPGLKQ 255
+E+ H+ GVLHRD+K N+L+ G + I D+G A F D +
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 256 PMTSR-------VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295
S V T Y PE LLG D+++ G IL ++L
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 40/235 (17%)
Query: 103 LDK-IGQGTYSNVYKARDL-LTGK----IVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
L K +G+G + V KA L G+ VA+K ++ +N ++ + E +L++++H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNH 62
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHD-------LAGLAACQGVKFSEPQVKCY----- 204
P+VIKL G + L L+ EY ++ + + + Y
Sbjct: 63 PHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 205 -----MKQLLS-------GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYD 250
M L+S G+++ ++HRD+ N+L+ +KI+DFGL+ + +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPG 303
+ R+ W L Y D+WS G +L E+ L G P PG
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 19/185 (10%)
Query: 125 IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH- 183
+VA+K +R D + F+ +EI ++ +L +PN+I+L G+ S L ++ EYME+
Sbjct: 46 LVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEYMENG 102
Query: 184 DLAGLAACQGV--KFSE----PQVK----CYMK-QLLSGLEHCHNNGVLHRDIKGSNLLI 232
DL + + + F+ P V YM Q+ SG+++ + +HRD+ N L+
Sbjct: 103 DLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
Query: 233 DNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVGVDLWSAGCI 290
N +KIADFG++ G + R V W +LLG + D+W+ G
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVT 220
Query: 291 LAELL 295
L E+
Sbjct: 221 LWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 45/196 (22%), Positives = 91/196 (46%), Gaps = 10/196 (5%)
Query: 106 IGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
+G G + + + L K VA+ +R + + F+A E L L + DH N+++L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRL 71
Query: 163 EGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
EG++T ++ +V EYM + L + Q+ + L SG+++ G +
Sbjct: 72 EGVITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129
Query: 222 HRDIKGSNLLIDNDGILKIADFG-LATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGV 280
H+ + +L+++D + KI+ F L + M+ + LW P + ++
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH--HFSS 187
Query: 281 GVDLWSAGCILAELLA 296
D+WS G ++ E+++
Sbjct: 188 ASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 46/158 (29%), Positives = 67/158 (42%), Gaps = 13/158 (8%)
Query: 146 REILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEP----QV 201
REI +L+ + H +I L + R ++ +V + DL V S P Q
Sbjct: 135 REIDILKTISHRAIINL--IHAYRWKSTVCMVMPKYKCDLFTY-----VDRSGPLPLEQA 187
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT-SR 260
++LL L + H G++HRD+K N+ +D + DFG A D P
Sbjct: 188 ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGK 298
TL PELL Y D+WSAG +L E+
Sbjct: 248 SGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 9e-10
Identities = 72/274 (26%), Positives = 115/274 (41%), Gaps = 50/274 (18%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTG-KIVALKKVRFDNLEPESVKFMAREILVLRKL-DH 156
FE D IG+G + V +A G K+ A K+ + + A E+ VL KL H
Sbjct: 5 KFE--DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEY---------------MEHDLAGLAACQGV--KFSEP 199
PN+I L G +R LY+ EY +E D A A G +
Sbjct: 63 PNIINLLGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPA-FAKEHGTASTLTSQ 119
Query: 200 QVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259
Q+ + + +G+++ +HRD+ N+L+ + KIADFGL+ + +K+ M
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-G 178
Query: 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIFKLC 317
R+ W L + Y D+WS G +L E+ L G P C
Sbjct: 179 RLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP----------------YC 220
Query: 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFK 351
G E ++ KLP ++ ++P + C E ++
Sbjct: 221 GMTCAELYE--KLPQG--YRMEKP-RNCDDEVYE 249
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 53/205 (25%), Positives = 101/205 (49%), Gaps = 17/205 (8%)
Query: 106 IGQGTYSNVYKAR---DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
+G+G + +V +A+ + + + VA+K ++ D ++ RE +++ DHPNVIKL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 163 EGL-VTSRMSCSL---YLVFEYMEH-DLAG--LAACQGVK-FSEPQVKC--YMKQLLSGL 212
G+ + SR L ++ +M+H DL L + G + F+ P +M + SG+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPE 270
E+ + +HRD+ N +++ + + +ADFGL+ G +Q S++ W
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186
Query: 271 LLLGATYYGVGVDLWSAGCILAELL 295
L Y D+W+ G + E++
Sbjct: 187 --LADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 86/341 (25%), Positives = 135/341 (39%), Gaps = 61/341 (17%)
Query: 101 EKLDKIGQG--TYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
E L IG+G V AR TG+ V ++++ + E V F+ E+ V + +HPN
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK--FSEPQVKCYMKQLLSGLEHCH 216
++ + L++V +M + A C SE + ++ +L L++ H
Sbjct: 61 IVPYRATFIA--DNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH 118
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFY---DPGLKQ------PMTSRVVTLWYR 267
+ G +HR +K S++LI DG K+ GL + + G + P S V W
Sbjct: 119 HMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGK-PI--MPGRTEVEQLHKIFKLCGS----- 319
P L Y D++S G EL G P MP T++ + KL G+
Sbjct: 177 PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA-TQM----LLEKLNGTVPCLL 231
Query: 320 -----PSEEYWKK----------------SKLPNATLFKPQQPYKRCIAETFKDFPSSSL 358
P+EE K S + PY R + F F
Sbjct: 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF----- 286
Query: 359 PLIETLLSIDPDNRGTATAALNSEFF-NTEPYACEPSSLPK 398
+E L +PD R +A+ LN FF + A E +LP+
Sbjct: 287 --VEQCLQRNPDARPSASTLLNHSFFKQIKRRASE--ALPE 323
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGL 165
IG+G + +V G VA+K ++ D + F+A E V+ +L H N+++L G+
Sbjct: 14 IGKGEFGDVMLGD--YRGNKVAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 166 VTSRMSCSLYLVFEYM-EHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
+ LY+V EYM + L +G V + +K + + +E+ N +H
Sbjct: 68 IVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEAMEYLEANNFVH 125
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGV 282
RD+ N+L+ D + K++DFGL + Q T ++ W P L +
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD-TGKLPVKWTAPEALR--EKKFSTKS 180
Query: 283 DLWSAGCILAELLA-GK---PIMPGRTEVEQLHKIFKL 316
D+WS G +L E+ + G+ P +P + V ++ K +K+
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 126 VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-D 184
VA+K +R D + F+ +E+ +L +L PN+ +L G+ T L ++ EYME+ D
Sbjct: 49 VAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTV--DPPLCMIMEYMENGD 105
Query: 185 L---------AGLAACQGVKFSEPQVKCYM-KQLLSGLEHCHNNGVLHRDIKGSNLLIDN 234
L K YM Q+ SG+ + + +HRD+ N L+
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 235 DGILKIADFGL------ATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAG 288
+ +KIADFG+ + +Y + P+ R W +LLG + D+W+ G
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGK--FTTKSDVWAFG 219
Query: 289 CILAELL 295
L E+L
Sbjct: 220 VTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 62/244 (25%), Positives = 94/244 (38%), Gaps = 51/244 (20%)
Query: 106 IGQGTYSNVYKARDLLTG---KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
+G G + +V K L+ VA+K ++ K RE V+ +LDHP +++L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 163 EGLVTSRMSCSLYLVFEYMEHDLAGLAAC-----QGVKFSEPQVKCYMKQLLSG---LEH 214
G+ LV E LA L + + +K Q+ G LE
Sbjct: 62 IGVCKGEPLM---LVME-----LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-------TFY--DPGLKQPMTSRVVTLW 265
H +HRD+ N+L+ N KI+DFG++ +Y + P+ W
Sbjct: 114 KH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------W 164
Query: 266 YRPPELLLGATYYGV---GVDLWSAGCILAELLA--GKPI--MPGRTEVEQLHKIFKLCG 318
Y P + YG D+WS G L E + KP M G + L +L
Sbjct: 165 YAPECI-----NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-P 218
Query: 319 SPSE 322
P E
Sbjct: 219 RPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 51/216 (23%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 103 LDKIGQGTYSNVYKARDLLTG----KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
++++G+ + +YK L G ++VA+K ++ D P+ +E ++ +L HPN
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPN 68
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQ------GVKFSEP-QVKCYMK---- 206
++ L G+VT + ++FEY+ DL + G E VK +
Sbjct: 69 IVCLLGVVTQEQP--VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 207 -----QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSR 260
Q+ +G+E+ ++ +H+D+ N+LI +KI+D GL+ Y +
Sbjct: 127 LHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA 296
++ + + PPE ++ + D+WS G +L E+ +
Sbjct: 187 LLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 4e-09
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 25/215 (11%)
Query: 104 DKIGQGTYSNVY--KARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
D+IG G + V +A ++ V +K++R E + F+ +E+ R+L+HPNV++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQ 59
Query: 162 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMK---QLLSGLEHCH 216
G S LV E+ DL L + +G+ Q + ++ SGL H
Sbjct: 60 CLGQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPEL---- 271
+H D+ N + D +KI D+GLA Y V L + PEL
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 272 ---LLGA--TYYGVGVDLWSAGCILAEL--LAGKP 299
LL T ++WS G + EL A +P
Sbjct: 178 GQDLLPKDQTKKS---NIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 65/240 (27%), Positives = 103/240 (42%), Gaps = 41/240 (17%)
Query: 106 IGQGTYSNVYKAR----DLLTGKI-VALKKVRFDNLEPESVKFMAREILVLRKL-DHPNV 159
+G+G + V KA D VA+K ++ D E + ++ E+ +++ + H N+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNI 78
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHD-----------LAGLAACQGVKFSEPQVKCY---- 204
I L G+ T LY+V EY H A+ + E +
Sbjct: 79 INLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 205 -MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA------TFYDPGLKQPM 257
Q+ G+E + +HRD+ N+L+ D ++KIADFGLA +Y ++
Sbjct: 137 FAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY----RKTT 192
Query: 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIFK 315
R+ W P L Y D+WS G +L E+ L G P PG VE+L K+ K
Sbjct: 193 NGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 33/228 (14%)
Query: 106 IGQGTYSNVYKA----RDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+G G + VY+ RD ++ VA+K + E + F+ E L++ K +H N++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMSKFNHQNIV 72
Query: 161 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLL-------SGL 212
+L G+ R+ +++ E M DL + P MK LL G
Sbjct: 73 RLIGVSFERLP--RFILLELMAGGDLKSFLRENRPRPERPSS-LTMKDLLFCARDVAKGC 129
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDG---ILKIADFGLA------TFYDPGLKQPMTSRVVT 263
++ N +HRDI N L+ G + KIADFG+A ++Y G + + +
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK--- 186
Query: 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310
+ PPE L + D+WS G +L E+ + G PGRT E +
Sbjct: 187 --WMPPEAFLDGIFTS-KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 105 KIGQGTYSNVYKAR--DLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++G+G + V+ A +LL + +VA+K ++ + E F RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTVLQHQHI 69
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH------------DLAGLAACQGV---KFSEPQVKCY 204
++ G+ T L +VFEYM H D LA + V + + Q+
Sbjct: 70 VRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA------TFYDPGLKQPMT 258
Q+ SG+ + + +HRD+ N L+ ++KI DFG++ +Y G + +
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295
R + PPE +L + D+WS G +L E+
Sbjct: 188 IR-----WMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 49/245 (20%)
Query: 106 IGQGTYSNVYKARDLLTGK-------IVALKKVRFDNLEPESVKFMAREILVLRKL-DHP 157
+G+G + V A L K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 158 NVIKLEGLVTSRMSCSLYLVFEY-----------------MEH--DLAGLAACQGVKFSE 198
N+I L G T LY++ EY ME+ D+A + Q + F +
Sbjct: 82 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ-MTFKD 138
Query: 199 PQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA------TFYDPG 252
V C Q+ G+E+ + +HRD+ N+L+ + ++KIADFGLA +Y
Sbjct: 139 -LVSC-TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY--- 193
Query: 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQL 310
K+ R+ W P L Y D+WS G ++ E+ L G P PG VE+L
Sbjct: 194 -KKTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFTLGGSP-YPG-IPVEEL 248
Query: 311 HKIFK 315
K+ K
Sbjct: 249 FKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 106 IGQGTYSNVYKARDLLTGKI---VALKKV-RFDNLEPESVKFMAREILVLRKLDHPNVIK 161
IG+G + VY + + A+K + R +LE V+ +E ++++ HPNV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVLS 60
Query: 162 LEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMK---QLLSGLEHCHN 217
L G+ L +V YM+H DL + P VK + Q+ G+E+ +
Sbjct: 61 LLGICLPSEGSPL-VVLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLAS 116
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTL---WYRPPELLL 273
+HRD+ N ++D +K+ADFGLA YD L W L
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL-- 174
Query: 274 GATY-YGVGVDLWSAGCILAELLA-GKPIMP 302
T + D+WS G +L EL+ G P P
Sbjct: 175 -QTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 53/222 (23%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTG-----KIVALKKVRFDNLEPESVKFMAREILVLR 152
+T ++++G+ + VYK T + VA+K ++ D E + E ++
Sbjct: 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRS 63
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQ------GVKFSEPQVKCYM 205
+L HPN++ L G+VT S+ +F Y H DL + G + VK +
Sbjct: 64 RLQHPNIVCLLGVVTKEQPLSM--IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTL 121
Query: 206 K---------QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGL-ATFYDPGLKQ 255
+ Q+ +G+E ++ V+H+D+ N+L+ + +KI+D GL Y +
Sbjct: 122 EPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 256 PMTSRVVTL-WYRPPELLLGATYYGVGVDLWSAGCILAELLA 296
M + ++ + W P ++ G + + D+WS G +L E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 49/210 (23%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 105 KIGQGTYSNVYKAR--DLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++G+G + V+ A +L + +VA+K ++ + + K RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DASDNARKDFHREAELLTNLQHEHI 69
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQG------------VKFSEPQVKCYMK 206
+K G+ L +VFEYM+H DL G + ++ Q+ +
Sbjct: 70 VKFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLW 265
Q+ +G+ + + +HRD+ N L+ + ++KI DFG++ Y + ++ +
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELL 295
+ PPE ++ + D+WS G +L E+
Sbjct: 188 WMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 40/117 (34%), Positives = 58/117 (49%), Gaps = 16/117 (13%)
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA------TFYDPGLKQPMTSR 260
Q+ G+E+ + +HRD+ N+L+ D ++KIADFGLA +Y K+ R
Sbjct: 148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KKTTNGR 203
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIFK 315
+ W P L Y D+WS G +L E+ L G P PG VE+L K+ K
Sbjct: 204 LPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFTLGGSP-YPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 27/213 (12%)
Query: 105 KIGQGTYSNVYKAR--DLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++G+G + V+ A +L K +VA+K ++ L K RE +L L H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHI 69
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGV---------------KFSEPQVKC 203
+K G+ L +VFEYM+H DL G + Q+
Sbjct: 70 VKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 204 YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVV 262
Q+ SG+ + + +HRD+ N L+ + ++KI DFG++ Y + ++
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295
+ + PPE ++ + D+WS G IL E+
Sbjct: 188 PIRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 30/204 (14%)
Query: 113 NVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172
NV K R LL VA+K +R D + F+ +E+ +L +L PN+I+L G+
Sbjct: 40 NVRKGRPLL----VAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--ED 92
Query: 173 SLYLVFEYMEH-DL------------------AGLAACQGVKFSEPQVKCYMKQLLSGLE 213
L ++ EYME+ DL A A S + Q+ SG++
Sbjct: 93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPEL 271
+ + +HRD+ N L+ + +KIADFG++ G + R V W +
Sbjct: 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 272 LLGATYYGVGVDLWSAGCILAELL 295
L+G + D+W+ G L E+L
Sbjct: 213 LMGK--FTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 11/207 (5%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTG---KIVALKKVRFDNLEPESVKFMAREILVLR 152
+ KL +G G + V+K + G KI K D ++ + + +L +
Sbjct: 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMG 64
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKC-YMKQLLSG 211
LDH +++L G+ SL LV + Q +PQ + Q+ G
Sbjct: 65 SLDHAYIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVT--LWYRPP 269
+ + + ++HR++ N+L+ +D I++IADFG+A P K+ S T W
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLA 296
+L G Y D+WS G + E+++
Sbjct: 182 SILFGR--YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 40/117 (34%), Positives = 58/117 (49%), Gaps = 16/117 (13%)
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA------TFYDPGLKQPMTSR 260
Q+ G+E+ + +HRD+ N+L+ D ++KIADFGLA +Y K+ R
Sbjct: 142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY----KKTTNGR 197
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIFK 315
+ W P L Y D+WS G +L E+ L G P PG VE+L K+ K
Sbjct: 198 LPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 61/243 (25%), Positives = 104/243 (42%), Gaps = 45/243 (18%)
Query: 106 IGQGTYSNVYKARDLLTGK-------IVALKKVRFDNLEPESVKFMAREILVLRKLD-HP 157
+G+G + V +A K VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 158 NVIKLEGLVTSRMSCSLYLVFEY-----------------MEHDLAGLAACQGVKFSEPQ 200
N+I L G+ T LY++ EY ++ + +
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 201 VKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA------TFYDPGLK 254
V C Q+ G+E+ + +HRD+ N+L+ D ++KIADFGLA +Y K
Sbjct: 137 VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY----K 191
Query: 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHK 312
+ R+ W P L Y D+WS G ++ E+ L G P PG VE+L K
Sbjct: 192 KTSNGRLPVKWMAPEALF--DRVYTHQSDVWSFGILMWEIFTLGGSP-YPG-IPVEELFK 247
Query: 313 IFK 315
+ +
Sbjct: 248 LLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 59/230 (25%), Positives = 93/230 (40%), Gaps = 36/230 (15%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL-EG 164
+G G V A+ + G+ A+K V + + E+ L D +++K E
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 165 LVTS-----RMSCSLYLVFEYMEH-DLAGLAACQGVK--------FSEPQVKCYMKQLLS 210
+ LV +Y DL Q +K F E + Q+L
Sbjct: 100 FAKKDPRNPENVLMIALVLDYANAGDLR-----QEIKSRAKTNRTFREHEAGLLFIQVLL 154
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY------DPGLKQPMTSRVVT- 263
+ H H+ ++HRDIK +N+L+ ++G++K+ DFG + Y D G T V
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214
Query: 264 -LWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 312
+W R P Y D++S G +L ELL K G E +HK
Sbjct: 215 EIWRRKP--------YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 34/277 (12%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-----ESVKFMAREI 148
PR +F K +G G + V +A K A+ KV L+P E M+ E+
Sbjct: 33 PRNNLSFGKT--LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-EL 89
Query: 149 LVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQ-VKCYM 205
++ L +H N++ L G T + + ++ EY + DL + F + + +
Sbjct: 90 KIMSHLGNHENIVNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS 147
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSRVVT 263
Q+ G+ + +HRD+ N+L+ + I+KI DFGLA D +R+
Sbjct: 148 YQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 264 LWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIFKLCGSPS 321
W P + Y D+WS G +L E+ L P PG + +K+ K
Sbjct: 208 KWMAPESIFNCV--YTFESDVWSYGILLWEIFSLGSNP-YPGMPVDSKFYKLIK------ 258
Query: 322 EEYWKKSKLPNATLFKPQQPY---KRCIAETFKDFPS 355
E ++ ++ P + Y K C P+
Sbjct: 259 -EGYRMAQ----PEHAPAEIYDIMKTCWDADPLKRPT 290
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 5e-08
Identities = 75/292 (25%), Positives = 118/292 (40%), Gaps = 55/292 (18%)
Query: 104 DKIGQGTYSNVYKARDLLTG-KIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIK 161
D IG+G + V KAR G ++ A K + + + A E+ VL KL HPN+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 162 LEGLVTSRMSCSLYLVFEY---------------MEHDLAGLAACQGV--KFSEPQVKCY 204
L G R LYL EY +E D A A S Q+ +
Sbjct: 61 LLGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPA-FAIANSTASTLSSQQLLHF 117
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
+ G+++ +HRD+ N+L+ + + KIADFGL+ + +K+ M R+
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVR 176
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIFKLCGSPSE 322
W L + Y D+WS G +L E+ L G P CG
Sbjct: 177 WMAIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------YCGMTCA 218
Query: 323 EYWKKSKLPNATLFKPQQPYKRCIAETF-------KDFPSSSLPLIETLLSI 367
E ++ KLP ++ ++P C E + ++ P + L+S+
Sbjct: 219 ELYE--KLPQG--YRLEKP-LNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 30/73 (41%), Positives = 42/73 (57%)
Query: 201 VKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR 260
+K M+Q+L+GL H G++HRDIK NLL+ DG +KI DFG A G+
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYG 370
Query: 261 VVTLWYRPPELLL 273
++ Y PPE L+
Sbjct: 371 MLDPRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 36/142 (25%), Positives = 65/142 (45%), Gaps = 7/142 (4%)
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
PN++ L + S S ++LV ++ E + + E VK + +++ L+ H
Sbjct: 45 PNMVCLHKYIVSEDS--VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALH 102
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
G++ RD+ +N+L+D+ G +++ F + + + Y PE + G +
Sbjct: 103 REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE-VGGIS 157
Query: 277 YYGVGVDLWSAGCILAELLAGK 298
D WS G IL ELL GK
Sbjct: 158 EETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 5/104 (4%)
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSR 260
CY Q+ G+E + +HRD+ N+L+ + ++KI DFGLA + DP + +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPG 303
+ W P + Y + D+WS G +L E+ + G PG
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 8e-08
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 32/205 (15%)
Query: 105 KIGQGTYSNVYKA--RDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
++G G + V K + + K VA+K ++ DN +P + RE V+++LD+P ++++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 163 EGLVTSRMSCSLYLVFEYMEHDLAGLAAC-----QGVKFSEPQVKCYMKQLLSGLEHCHN 217
G+ + S LV E LA L + +E + + Q+ G+++
Sbjct: 62 IGICEAE---SWMLVME-----LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE 113
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLA-------TFYDPGLKQPMTSRVVTLWYRPPE 270
+HRD+ N+L+ KI+DFGL+ +Y K + WY P
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY----KAKTHGKWPVKWYAPEC 169
Query: 271 LLLGATYYGVG--VDLWSAGCILAE 293
+ YY D+WS G ++ E
Sbjct: 170 M----NYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 34/116 (29%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSR 260
CY Q+ G+E + +HRD+ N+L+ + ++KI DFGLA + DP + ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFK 315
+ W P + Y D+WS G +L E+ + G PG E+ + K
Sbjct: 238 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 59/243 (24%), Positives = 108/243 (44%), Gaps = 31/243 (12%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPES-VKFMAREILVL 151
+ +++ +G G + VYK + G+ V + K+ + P++ V+FM E L++
Sbjct: 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIM 63
Query: 152 RKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLS 210
+DHP++++L G+ +S ++ LV + M H L + + Q+
Sbjct: 64 ASMDHPHLVRLLGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD--------PGLKQPMTSRVV 262
G+ + ++HRD+ N+L+ + +KI DFGLA + G K P+ +
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 263 T-LWYRPPELLLGATYYGVGVDLWSAGCILAELL--AGKPI--MPGRTEVEQLHKIFKLC 317
+ YR + D+WS G + EL+ GKP +P R + L K +L
Sbjct: 181 ECIHYRK---------FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231
Query: 318 GSP 320
P
Sbjct: 232 QPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 70/222 (31%), Positives = 98/222 (44%), Gaps = 45/222 (20%)
Query: 109 GTYSNVY--KARD---LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
G + V K + L KI+ K F+ +EP + M D+PN IKL
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKN--FNAIEPMVHQLMK---------DNPNFIKLY 75
Query: 164 GLVTSRMSCSLYLVFEYM-EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
VT+ L+ +Y+ + DL L +G K SE +VK ++QL+ L H + ++H
Sbjct: 76 YSVTT--LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIH 132
Query: 223 RDIKGSNLLID--NDGILKIADFGLA------TFYDPGLKQPMTSRVVTLWYRPPELLLG 274
DIK N+L D D I + D+GL + YD G TL Y PE + G
Sbjct: 133 NDIKLENVLYDRAKDRI-YLCDYGLCKIIGTPSCYD-G----------TLDYFSPEKIKG 180
Query: 275 ATYYGVGVDLWSAGCILAELLAGK-PIMPGRTE---VEQLHK 312
Y V D W+ G + ELL GK P E +E L K
Sbjct: 181 HN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 37/272 (13%)
Query: 106 IGQGTYSNVYKAR---DLLTGK-----IVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+G+G + V+ A+ G + AL+K + +NL+ E RE+ + RKL H
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE----FRRELDMFRKLSHK 68
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYME-HDL--------AGLAACQGVKFSEPQVKCYMKQL 208
NV++L GL R + Y++ EY + DL + + S Q Q+
Sbjct: 69 NVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ--PMTSRVVTLWY 266
G++H N +HRD+ N L+ + +K++ L+ D + + + ++ L +
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRW 184
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
PE + + D+WS G ++ E+ G+ G ++ E L+++ + E
Sbjct: 185 LAPEAVQ-EDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL----QAGKLELP 239
Query: 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSS 357
P+ L+K RC A KD PS S
Sbjct: 240 VPEGCPS-RLYKLMT---RCWAVNPKDRPSFS 267
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTG---KI-VALKKVRFDNLEPESVKFMAREILVLRKLD 155
F+K+ +G G + VYK + G KI VA+K++R + P++ K + E V+ +D
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 67
Query: 156 HPNVIKLEG--------LVTSRM--SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYM 205
+P+V +L G L+T M C L V E+ + + +
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD------------NIGSQYLLNWC 115
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK--QPMTSRVVT 263
Q+ G+ + ++HRD+ N+L+ +KI DFGLA K +V
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELL 295
W E +L Y D+WS G + EL+
Sbjct: 176 KWM-ALESILHRIYTHQS-DVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 103 LDKIGQGTYSNVYK--ARDLLTGKI---VALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
L ++GQG++ VY+ ARD++ G+ VA+K V E ++F+ E V++
Sbjct: 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCH 69
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKC--YMKQLLS---- 210
+V++L G+V S+ +L +V E M H DL + + +++++
Sbjct: 70 HVVRLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 127
Query: 211 ---GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGL------ATFYDPGLKQPMTSRV 261
G+ + + +HRD+ N ++ +D +KI DFG+ +Y G K + R
Sbjct: 128 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKP 299
W P L G + D+WS G +L E+ LA +P
Sbjct: 187 ---WMAPESLKDGV--FTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 7/105 (6%)
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSR 260
Y Q+ G+E + +HRD+ N+L+ + ++KI DFGLA + DP + +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPG 303
+ W P + Y D+WS G +L E+ L P PG
Sbjct: 237 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASP-YPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 46/192 (23%), Positives = 88/192 (45%), Gaps = 17/192 (8%)
Query: 126 VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY----LVFEYM 181
VA+K ++ ++ E + +++ DHPNV++L G+ + Y ++ +M
Sbjct: 29 VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88
Query: 182 EH-DL------AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN 234
+H DL + L C ++ VK +M + SG+E+ + +HRD+ N +++
Sbjct: 89 KHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGMEYLSSKSFIHRDLAARNCMLNE 147
Query: 235 DGILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILA 292
+ + +ADFGL+ G +Q +++ W L Y D+WS G +
Sbjct: 148 NMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES--LADRVYTTKSDVWSFGVTMW 205
Query: 293 ELLA-GKPIMPG 303
E+ G+ PG
Sbjct: 206 EIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 24/108 (22%), Positives = 47/108 (43%), Gaps = 4/108 (3%)
Query: 144 MAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKC 203
RE+ +L+ L + + L + YL+ E++E G + + + +
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE----GETLDEVSEEEKEDIAE 93
Query: 204 YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251
+ +LL+ L + H D+ N+L+D+ IL I D+ A + P
Sbjct: 94 QLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 38/209 (18%)
Query: 152 RKLDHPNVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKFSEPQVKCYMK---Q 207
R L HPN+++ G + LVFEY E DL + + Q+ + +
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE 107
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWY 266
+ +G+ H H + LH D+ N + +D +K+ D+G+ + Y + + V L +
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 267 RPPEL-------LLGA--TYYGVGVDLWSAGCILAELL--AGKPIMPGRTEVEQLHKIFK 315
PEL L+ A T ++W+ G L EL A +P ++ E L+ + K
Sbjct: 168 LAPELVGEFHGGLITAEQTKPS---NVWALGVTLWELFENAAQP-YSHLSDREVLNHVIK 223
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQ--QPY 342
++ K LFKPQ PY
Sbjct: 224 ------DQQVK--------LFKPQLELPY 238
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 37/211 (17%)
Query: 102 KLDK-IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILV---------- 150
K+DK IG G + VY+ + I + +NLE E+ + E LV
Sbjct: 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET---IVMETLVYNNIYDIDKI 71
Query: 151 -----LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME------HDLAGLAACQGVKFSEP 199
+ +DH + K G S C +Y F +E ++ C ++
Sbjct: 72 ALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKC----KNKK 126
Query: 200 QVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259
+K MK +L+ LE+ H +G+ H DIK N+++D + I D+G+A+ + K S
Sbjct: 127 LIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186
Query: 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCI 290
+ +R G YY G+D + C+
Sbjct: 187 KEQKDLHR------GTLYYA-GLDAHNGACV 210
|
Length = 294 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 30/215 (13%)
Query: 108 QGTYSNVYKA--RDLLTGKI--VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
+GT+ ++ D GK V +K V+ D+ V + +E +L L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSHQNILPI- 73
Query: 164 GLVTSRMSCSLYLVFEYMEH----------DLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
V ++++ YM L Q + S Q+ Q+ G+
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQIACGMS 131
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP----- 268
+ H GV+H+DI N +ID + +KI D L+ P + RP
Sbjct: 132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE----NRPVKWMA 187
Query: 269 PELLLGATYYGVGVDLWSAGCILAEL--LAGKPIM 301
E L+ Y D+WS G +L EL L P +
Sbjct: 188 LESLVNKEYSSAS-DVWSFGVLLWELMTLGQTPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 7/155 (4%)
Query: 100 FEKLDKIGQGTYSNVYK---ARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
+K+ +G G + VYK D KI KV +N P++ K + E V+ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
P V +L G+ ++ ++ LV + M + L + + + Q+ G+ +
Sbjct: 69 PYVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250
++HRD+ N+L+ + +KI DFGLA D
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 46/165 (27%), Positives = 64/165 (38%), Gaps = 24/165 (14%)
Query: 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC 317
T+ V T YR PE++LG + D+WS GCI+ EL GK + +E LH + K
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361
Query: 318 GSPSEEYWKKSKLPNATLF-----------KPQQPYKRCIAETFKDFPSSSL--PLIETL 364
G E+ + A L P+ + A ++ L LI L
Sbjct: 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL 421
Query: 365 LSIDPDNRGTATAALNSEFFNTEPYAC----EPSSLPKYPPSKEM 405
L D R LN+ T PY E P YP ++ M
Sbjct: 422 LHYDRQKR------LNARQMTTHPYVLKYYPECRQHPNYPDNRSM 460
|
Length = 467 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 46/186 (24%), Positives = 83/186 (44%), Gaps = 24/186 (12%)
Query: 126 VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD- 184
VA+K ++ +N E M RE ++ +LD+P ++++ G+ + +L LV E
Sbjct: 25 VAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE---ALMLVMEMASGGP 80
Query: 185 LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244
L + + + + V M Q+ G+++ +HRD+ N+L+ N KI+DFG
Sbjct: 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFG 140
Query: 245 LA-------TFYDP--GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295
L+ ++Y K P+ WY P + + D+WS G + E
Sbjct: 141 LSKALGADDSYYKARSAGKWPLK------WYAPECINFRK--FSSRSDVWSYGITMWEAF 192
Query: 296 A--GKP 299
+ KP
Sbjct: 193 SYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 48/225 (21%), Positives = 85/225 (37%), Gaps = 27/225 (12%)
Query: 106 IGQGTYSNVYKAR------DLLTGKIVALKKVRFDNLEPESVKFMA--REILVLRKLDHP 157
+GQGT++N+YK + G + V L + +A ++ +L H
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKV-LGSDHRDSLAFFETASLMSQLSHK 61
Query: 158 NVIKLEGLVTSRMSCSLY-LVFEYMEH---DLAGLAACQGVKFSEPQVKCY-MKQLLSGL 212
+++KL G+ +V EY++ D+ V K KQL S L
Sbjct: 62 HLVKLYGV----CVRDENIMVEEYVKFGPLDVFLHREKNNVSLH---WKLDVAKQLASAL 114
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL----WYRP 268
+ + ++H ++ G N+L+ G L DPG+ + SR + W P
Sbjct: 115 HYLEDKKLVHGNVCGKNILVARYG-LNEGYVPFIKLSDPGIPITVLSREERVERIPWIAP 173
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQLHK 312
+ G + D WS G L E+ + + + E+
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF 218
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 12/150 (8%)
Query: 105 KIGQGTYSNVYKAR---DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
+IG G + V ++V +K++R E +KF+ E R L H N+++
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLE-EAQPYRSLQHSNLLQ 59
Query: 162 LEGLVTSRMSCSLYLVFEYME-HDLAG-LAACQGVKFSEPQVKCYMK---QLLSGLEHCH 216
G T LV E+ DL G L +C+ + P + ++ GL H H
Sbjct: 60 CLGQCTE--VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
N +H D+ N L+ D +KI D+GL+
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 30/217 (13%)
Query: 105 KIGQGTYSNVYK--ARDLLTGKI---VALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++GQG++ VY+ A+ ++ + VA+K V E ++F+ E V+++ + +V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGL-----AACQGVKFSEPQVKCYMKQLL----S 210
++L G+V S+ +L ++ DL + P M Q+
Sbjct: 72 VRLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGL------ATFYDPGLKQPMTSRVVTL 264
G+ + + N +HRD+ N ++ D +KI DFG+ +Y G K + R
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKP 299
W P L G + D+WS G +L E+ LA +P
Sbjct: 187 WMSPESLKDGV--FTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 5/103 (4%)
Query: 204 YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSRV 261
+ Q+ G+E + +HRD+ N+L+ I+KI DFGLA +D ++ +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPG 303
W P + Y D+WS G +L E+ + G PG
Sbjct: 302 PVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 32/112 (28%), Positives = 52/112 (46%), Gaps = 5/112 (4%)
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSRVVTL 264
Q+ G++ + +HRD+ N+L+ + + KI DFGLA D +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFK 315
W P + Y V D+WS G +L E+ + GK PG + +K+ K
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK 329
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 21/158 (13%)
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSRVVTL 264
Q+ +G+E + +HRD+ N+LI ++KI DFGLA D ++ +
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKIFKLCGSPSE 322
W P + Y D+WS G +L E+ L G P P EQ + + +
Sbjct: 307 WMAPESIF--NNLYTTLSDVWSFGILLWEIFTLGGTP-YPELPMNEQFY-------NAIK 356
Query: 323 EYWKKSKLPNATLFKPQQPY---KRCIAETFKDFPSSS 357
++ +K +A+ + Y ++C E F+ P S
Sbjct: 357 RGYRMAKPAHAS----DEIYEIMQKCWEEKFEIRPDFS 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 38/168 (22%), Positives = 65/168 (38%), Gaps = 32/168 (19%)
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMS--CSLYLVFEY-----------MEHDLAGLAACQG 193
EI LR++D N++K+ G + + L L+ EY E DL
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDL-------- 119
Query: 194 VKFSEPQVKCYMK-QLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251
+ K M GL + + ++++ + L+ + LKI GL
Sbjct: 120 ----SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI--- 172
Query: 252 GLKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGK 298
L P V + Y ++L + Y + D++S G +L E+ GK
Sbjct: 173 -LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 26/77 (33%), Positives = 37/77 (48%), Gaps = 8/77 (10%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGL 165
I +G YK + + G +K++ N P S EI + KL HPN++KL GL
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS------EIADMGKLQHPNIVKLIGL 751
Query: 166 VTSRMSCSLYLVFEYME 182
S YL+ EY+E
Sbjct: 752 CRSEKGA--YLIHEYIE 766
|
Length = 968 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 9e-04
Identities = 17/44 (38%), Positives = 26/44 (59%), Gaps = 1/44 (2%)
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLAT 247
M+Q+L L+ H+ G++HRD+K N++ G KI D G A
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSRVVTL 264
Q+ G+ + +HRD+ N+L+ + I KI DFGLA D +R+
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFK 315
W P + Y D+WS G +L E+ + G PG + +K+ K
Sbjct: 282 WMAPESIF--NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 46/225 (20%), Positives = 83/225 (36%), Gaps = 76/225 (33%)
Query: 86 GDAIRDWTPRRANTFEKLDK-------IGQGTYSNVYKARDLLTGKIVALKKVRFD---- 134
G I + F + + I Q V++A L +G+ VA+K R
Sbjct: 118 GRPIEEL-------FSEFEPEPIASASIAQ-----VHRAV-LKSGEEVAVKVQRPGIRER 164
Query: 135 -NLEPESVKFMAREI----LVLRKLDHPNVIK-------------LEGLVTSRM------ 170
+ + ++ +AR I R+LD V+ E R
Sbjct: 165 IEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFKD 224
Query: 171 SCSLY-------------LVFEYME----HDLAGLAACQGV---KFSEPQVKCYMKQLLS 210
+Y L E+++ D+A L + G+ + +E V+ +++QLL
Sbjct: 225 DPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQLL- 282
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255
+G H D N+L+ +DG + + DFG+ DP ++
Sbjct: 283 ------RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKFRR 321
|
Length = 517 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 457 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.48 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.77 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.41 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.19 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.01 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.96 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.83 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.72 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.64 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.63 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.56 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.38 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.12 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.91 | |
| PLN02236 | 344 | choline kinase | 96.77 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.76 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.75 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.29 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.6 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.49 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.38 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.29 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.15 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 95.12 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.03 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-80 Score=595.31 Aligned_cols=380 Identities=68% Similarity=1.149 Sum_probs=355.2
Q ss_pred CCCCCCCchhhHhhhcccccccCCcCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHH
Q 036122 71 SESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILV 150 (457)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~ 150 (457)
.....+||.|+....++++..|.++..+.|+.+++||+|.||.||+|++..+|+.||+|+++.+...........+||.|
T Consensus 90 ~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~I 169 (560)
T KOG0600|consen 90 EQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKI 169 (560)
T ss_pred hhhhccCccccccccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHH
Confidence 34578999999999999999999999999999999999999999999999999999999999998888888889999999
Q ss_pred HHhcCCCCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q 036122 151 LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNL 230 (457)
Q Consensus 151 l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 230 (457)
|++|+||||++|.++.+....+.+|+|+|||+++|..++...+..|++.+++.|+.||+.||+|||++||+|||||.+||
T Consensus 170 Lr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNi 249 (560)
T KOG0600|consen 170 LRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNI 249 (560)
T ss_pred HHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccce
Confidence 99999999999999999987789999999999999999888888999999999999999999999999999999999999
Q ss_pred EecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHH
Q 036122 231 LIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 310 (457)
Q Consensus 231 Ll~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~ 310 (457)
|||.+|.+||+|||||+++.......+++.+.|.||+|||+|+|...|+.++|+||.||||.||++|+|+|+|.++.+++
T Consensus 250 Lidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl 329 (560)
T KOG0600|consen 250 LIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL 329 (560)
T ss_pred EEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence 99999999999999999998887778999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
.+|+++||+|.+++|+..++|.+..+++.+++++.+.+.++.+++.+.+|+..||..||.+|.||.++|+|+||...+.+
T Consensus 330 ~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~ 409 (560)
T KOG0600|consen 330 HKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLP 409 (560)
T ss_pred HHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCChhhhhhhhHHHHHHhhhccCCCCccccccccccccccCCCcCCcccccchhccC
Q 036122 391 CEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPEANAEIQTNL 456 (457)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 456 (457)
|+|..+|.|++..+.+.+.++++.+++.+..++ .+...+.++..++.|++.++++...+.
T Consensus 410 ~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~------~~~~~~~~~~~r~~p~~~~~~~~~~~~ 469 (560)
T KOG0600|consen 410 CDPSSLPKYPPSHELDAKRRREQKRRNKGGASK------RRIRERGDRGSRAIPAQPANAESQASP 469 (560)
T ss_pred CCcccCCCCCcchhHHHHHHHHHhhcccccccc------cccccccccccCCCCCCCCCHHHhccc
Confidence 999999999999999999999988877732221 111222377899999999998776543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-63 Score=456.33 Aligned_cols=310 Identities=44% Similarity=0.750 Sum_probs=272.7
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
+..++|+.+++|++|.||.||+|+++.+++.||+|.++.+......--.-.+||.+|.+++|||||.+-++.....-+.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 44688999999999999999999999999999999998765322222235689999999999999999999987777789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+|||||++++...+.....+|...+++.++.|++.||+|||.+.|+|||||++|+|+++.|.+||+|||+|+.++.. .
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~ 231 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-L 231 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-c
Confidence 999999999999988888889999999999999999999999999999999999999999999999999999988754 3
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.+++..+.|.||+|||+++|...|+.++|+||+|||+.||++++|.|+|....+++.+|++.+|.|++..|+........
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~ 311 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV 311 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence 56788899999999999999999999999999999999999999999999999999999999999999999986544433
Q ss_pred -cC-CCCCCcccchhcccCC--CCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCCCCCCCCCCCChhhh
Q 036122 335 -LF-KPQQPYKRCIAETFKD--FPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMD 406 (457)
Q Consensus 335 -~~-~~~~~~~~~~~~~~~~--~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~ 406 (457)
.. .+.+++ ..+...|.. +++...+|+..+|.+||.+|.||+|+|.|.||...|.++.|..+|.||...+.+
T Consensus 312 k~~~f~~~py-n~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~~~ 386 (419)
T KOG0663|consen 312 KKMTFSEHPY-NNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSEQQ 386 (419)
T ss_pred hccccCCCCc-hhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccccc
Confidence 22 233332 333444444 458999999999999999999999999999999999999999999998775543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-61 Score=431.52 Aligned_cols=296 Identities=43% Similarity=0.759 Sum_probs=262.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|..+++||+|.||.||+|++..+|+.||||+++..+..........+||+.|+.++|+||+.|+++|.. ...+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~--~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH--KSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC--CCceEEE
Confidence 47999999999999999999999999999999999876655555567799999999999999999999977 5668999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
+|||+.+|...+..+...|+..+++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.+... ..
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-~~ 158 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-IQ 158 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc-cc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999998875433 33
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc-CCCCcccC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPNATLF 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~~ 336 (457)
+..+.|.||+|||.+.|...|+..+||||.|||+.||+-|.|.|+|.++.+++..|++.+|+|.++.|+.. .+|....+
T Consensus 159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~ 238 (318)
T KOG0659|consen 159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI 238 (318)
T ss_pred ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence 44588999999999999999999999999999999999999999999999999999999999999999864 45555444
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPK 398 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~ 398 (457)
+.. | .......+...++++.||+.+||.+||.+|+|+.|+|+|+||++.|.++.+..+|.
T Consensus 239 ~~~-P-~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~ 298 (318)
T KOG0659|consen 239 QQF-P-KPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPI 298 (318)
T ss_pred hcC-C-CCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcC
Confidence 311 0 11223377888999999999999999999999999999999999888887776653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-61 Score=464.89 Aligned_cols=287 Identities=39% Similarity=0.682 Sum_probs=259.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|.++++||.|.||.||+|+.+.+|..||||.++......+..-. .||+..|++|+ |||||+|.+++.+... .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 47899999999999999999999999999999999876655444333 47999999999 9999999999988543 899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+|||||+.+|..++..++..|++..++.|+.||++||+|+|++|++|||+||||||+..+..+||+|||+|+..... .
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk--p 164 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK--P 164 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC--C
Confidence 99999999999999999999999999999999999999999999999999999999998899999999999977543 6
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh-cCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~ 334 (457)
+.+.++.|.||+|||+|+...+|+.++|||++|||++|+.+-+|+|+|.++.+++.+|++++|+|..+.|.. ..+...-
T Consensus 165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m 244 (538)
T KOG0661|consen 165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM 244 (538)
T ss_pred CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence 788999999999999999999999999999999999999999999999999999999999999999999987 4444445
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+...+.....+...++..++++.+||.+||.+||.+||||+|+|+||||+..
T Consensus 245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 55555555566777788899999999999999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-60 Score=431.22 Aligned_cols=286 Identities=35% Similarity=0.591 Sum_probs=252.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+.|+.+.++|+|+||+||+|+++.||+.||||++.-...++...+-..+|+++|++|+|+|+|.|+++|.. ...++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--krklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--KRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--cceeEEE
Confidence 46899999999999999999999999999999997665555666667899999999999999999999977 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
+|||+...+..+.....-++...++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+.. .....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY 158 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence 99999999988887777799999999999999999999999999999999999999999999999999998863 23567
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc-CCCCcc-c
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPNAT-L 335 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~-~ 335 (457)
+.++.|.||+|||.+.|...|+..+|||++||++.||++|.|.|+|..+.+++..|...+|...+...... ..+-.. .
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 88999999999999999888999999999999999999999999999999999999999998877654432 122221 1
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.-|...-...+...+++++..+.||++.||..||.+|++.+|+|.||||+.
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 123344455567778888999999999999999999999999999999965
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-60 Score=450.72 Aligned_cols=263 Identities=32% Similarity=0.489 Sum_probs=225.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh-----HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-----ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||+++...... .....+.+|++||++|+|||||+++++|.. .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--P 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--C
Confidence 466888999999999999999999999999999998765432 123346799999999999999999999988 5
Q ss_pred ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC---CcEEEeeccCccc
Q 036122 172 CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND---GILKIADFGLATF 248 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~ 248 (457)
...|+||||++|+-+....-.++.+.+...+.+++||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 6689999999987776666677789999999999999999999999999999999999999866 7899999999998
Q ss_pred cCCCCCCCcccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhh
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~ 325 (457)
.+.. ..+.+.|||+.|.|||++.+. ..+..++|+||+|||||.+++|.+||.+..... ..++|.+.-...-...|
T Consensus 329 ~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 329 SGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred cccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 7633 667889999999999999754 335568999999999999999999998765444 66777665444333333
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
..+++++++||++||..||++|||++|+|+||||+..+
T Consensus 407 -------------------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 407 -------------------------DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -------------------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 44889999999999999999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=450.01 Aligned_cols=257 Identities=30% Similarity=0.479 Sum_probs=230.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.+|...+.||+|||+.||.+++..+|+.||+|++.+... .....+.+.+||+|.++|+|||||+++++|++ ...+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 679999999999999999999999999999999987544 34456778999999999999999999999998 678999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|.|+|..+.+..+..+.+.++|.+++.+++||+.||.|||+++|+|||||..|+||+++.+|||+|||||..+..+. ..
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ER 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cc
Confidence 99999988777777788899999999999999999999999999999999999999999999999999999887553 33
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
..+.+|||.|+|||++.... ++..+||||+|||||.||+|+|||...+..+.+.+|...-..
T Consensus 175 k~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~----------------- 236 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS----------------- 236 (592)
T ss_pred cceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc-----------------
Confidence 46689999999999998666 799999999999999999999999999999999998553211
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....++.++.+||.+||+.||.+|||++++|.|+||+..
T Consensus 237 ------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 237 ------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred ------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence 123588999999999999999999999999999999553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-57 Score=423.71 Aligned_cols=257 Identities=30% Similarity=0.452 Sum_probs=225.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++.+.++.||+|..|+||+++|+.+++.+|+|++.. ..+....+++.+|++++++.+|||||.+||.|..... .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 4578889999999999999999999999999999944 4577778899999999999999999999999998543 6999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+++.++.+....+.++|.....++.+|++||.|||+ ++||||||||+||||+..|.|||||||.++.+...
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999998887777776789999999999999999999995 89999999999999999999999999999987644
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR-----TEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
...+.+||..|||||.+.+.. |+.++||||||+.++||++|+.||... +..+.+..|+. .+++.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP~------- 301 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPPR------- 301 (364)
T ss_pred hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCCC-------
Confidence 457889999999999999887 899999999999999999999999874 44555555533 22111
Q ss_pred CCcccCCCCCCcccchhcccC-CCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFK-DFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
... .+++++++||..||++||.+|+|+.|+|+|||+++.
T Consensus 302 ------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 302 ------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred ------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 112 388999999999999999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-57 Score=421.24 Aligned_cols=291 Identities=37% Similarity=0.586 Sum_probs=251.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEe---cCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTS---RMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---~~~~~ 173 (457)
...|..++.||.|+||.|+.+.++.+|+.||||++..........++..+|+++|++++|+||+.+.+++.. ..-..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 346777899999999999999999999999999997544456677888999999999999999999998876 23456
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC-
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG- 252 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~- 252 (457)
+|+|+|+|+.+|...+.. +..|++..+..++.||+.||.|+|+.+|+||||||+|+|++.+..+||+|||+|+..+..
T Consensus 101 vYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 999999998877776654 445999999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....++..+.|.||.|||++.....|+.++||||+|||+.||++|++.|+|.+..+++..|...+|+|.++.+.......
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 22345788999999999999988889999999999999999999999999999999999999999999998887655333
Q ss_pred cccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 333 ATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 333 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
+..+ ...+..+..+...++..++.+.||+++||..||.+|+|++|+|+||||....
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 2221 1112224456788899999999999999999999999999999999998853
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-56 Score=419.68 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=230.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|+++++||+|+||+||.++.+.+++.||+|++++...- ....+.+..|..||.+++||+||.++..|++ ...+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kLy 101 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKLY 101 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeEE
Confidence 57899999999999999999999999999999999876543 3456778899999999999999999766666 67899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+|+||+.|+.+...+++.+.|+|..++.|+.+|+.||.|||++|||||||||+||||+.+|+++|+|||+++..-.. ..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~ 180 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD 180 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence 99999999888888888889999999999999999999999999999999999999999999999999999854322 23
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
...+.+||+.|||||++.+.. |+.++|+||||+++|||++|.+||.+.+.....++|.+.-..
T Consensus 181 ~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~---------------- 243 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP---------------- 243 (357)
T ss_pred ccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC----------------
Confidence 445689999999999999887 899999999999999999999999999999999988653110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc----CHHHHhcCCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp----ta~elL~hp~f~~~~~~ 390 (457)
....-++.++++||+.+|..||++|. .+.++-+||||....|.
T Consensus 244 ------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 244 ------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred ------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 01122788999999999999999995 68999999999987765
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=411.79 Aligned_cols=290 Identities=40% Similarity=0.742 Sum_probs=251.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeeeEEecC----Cc
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN-VIKLEGLVTSRM----SC 172 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~----~~ 172 (457)
..|..+++||+|+||+||+|+++.+|+.||+|+++.+...+..-....+|+.+|++|+|+| ||+|++++.... ..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 5688899999999999999999999999999999877543222334578999999999999 999999998732 13
Q ss_pred eEEEEEecccCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 173 SLYLVFEYMEHDLAGLAACQG---VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
.+++||||++.++...+.... ..++...++.+++||+.||+|||+++|+||||||+||||+++|.+||+|||+|+.+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 789999999999888776655 35788899999999999999999999999999999999999999999999999976
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc-
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS- 328 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~- 328 (457)
.-.. ...+..++|.+|+|||++.|...|+...||||+|||++||+++++.|++..+.+++..|++.+|+|+++.|+..
T Consensus 171 ~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 171 SIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred cCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 5222 33677889999999999999988999999999999999999999999999999999999999999999999864
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.++......+.......+....+...++..+|+..||+++|.+|.|+..+|.||||+..+
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 344444433444335566677777788999999999999999999999999999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-55 Score=425.55 Aligned_cols=264 Identities=35% Similarity=0.499 Sum_probs=231.2
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCc
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 172 (457)
+..++|...+.||+|+|++|++|+++.+++.||||++.+..+- ...++.+.+|-.+|.+| .||.|++|+..|.+ +.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EE 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--cc
Confidence 4468999999999999999999999999999999999876543 34456788899999999 79999999766665 77
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+|+||++++.+..++.+-+.|++..++.|+.||+.||+|||++|||||||||+||||+.||++||+|||.|+.+.+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 89999999998655555556678999999999999999999999999999999999999999999999999999987543
Q ss_pred CCC------------CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 036122 253 LKQ------------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP 320 (457)
Q Consensus 253 ~~~------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~ 320 (457)
... ...+.+||..|++||+|.... .++.+|||+||||||+|+.|.|||.+.++.-+.++|+.+-..+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF 306 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC
Confidence 221 125689999999999998766 7899999999999999999999999999999999998764332
Q ss_pred ChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 321 SEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
.++|++.+.|||+++|..||.+|+|++||-+||||.+..|.
T Consensus 307 -----------------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~ 347 (604)
T KOG0592|consen 307 -----------------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWE 347 (604)
T ss_pred -----------------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChh
Confidence 24688999999999999999999999999999999998765
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-55 Score=409.71 Aligned_cols=282 Identities=40% Similarity=0.648 Sum_probs=241.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc---e
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC---S 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---~ 173 (457)
.-.|...+.+|.|+||.||+|....+++.||||+.-.+..- -.+|+.+|+.++|||||+|..+|....+. .
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 34688899999999999999999999999999998655422 23699999999999999999888765444 4
Q ss_pred EEEEEecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-CcEEEeeccCcccc
Q 036122 174 LYLVFEYMEHDLAGLAAC---QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLATFY 249 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~ 249 (457)
+.+|||||+.++...+.. .+..++...++-+..||++||.|||+.||+||||||+|+|+|.+ |.+||||||.|+.+
T Consensus 97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 568999999988776654 35679999999999999999999999999999999999999965 99999999999998
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.++ .+..++..|..|+|||.+.|...|+.+.||||.|||+.||+-|++.|+|.+..+++..|++.+|.|+.+......
T Consensus 177 ~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 766 455788899999999999999999999999999999999999999999999999999999999999988765432
Q ss_pred CCCcccCCCCCCcccchhc-ccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAE-TFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
++...+...+.....+.+ ..+..++++.+|+.++|.++|.+|.|+.|+|.||||+.-
T Consensus 255 -~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 255 -PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred -cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 222233323222333333 557789999999999999999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-54 Score=418.96 Aligned_cols=277 Identities=32% Similarity=0.478 Sum_probs=236.7
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..++|+++..||+|+||.||+|+.+.||+.||+|++++... ....+..+..|..+|...++|+||+|+..|.+ ...+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~L 216 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYL 216 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCee
Confidence 47899999999999999999999999999999999987654 46677888999999999999999999777766 7789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC---
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP--- 251 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~--- 251 (457)
||||||++|+-..-++.+...|++..++.|+.+++.|+..||+.|+|||||||+|+|||..|++||+||||+.-+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999876666666677899999999999999999999999999999999999999999999999999853311
Q ss_pred --------------------CCCC-----------------------CcccccccCccCchHhhhCCcCCCccchhhhHH
Q 036122 252 --------------------GLKQ-----------------------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAG 288 (457)
Q Consensus 252 --------------------~~~~-----------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG 288 (457)
.... ...+.+|||.|||||++.+.. |+..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHH
Confidence 0000 012568999999999999888 89999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh-cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccC
Q 036122 289 CILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSI 367 (457)
Q Consensus 289 ~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~ 367 (457)
|||||||.|.|||.+.+..++..+|... .. ...| .-..++++++|||.+||.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw---------r~~l~fP-----------------~~~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNW---------RETLKFP-----------------EEVDLSDEAKDLITRLLC- 428 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHH---------hhhccCC-----------------CcCcccHHHHHHHHHHhc-
Confidence 9999999999999999999999999763 21 0111 012366899999999999
Q ss_pred CCCCCcC---HHHHhcCCCCCCCCCCCCCCCCCCCCCC
Q 036122 368 DPDNRGT---ATAALNSEFFNTEPYACEPSSLPKYPPS 402 (457)
Q Consensus 368 dP~~Rpt---a~elL~hp~f~~~~~~~~~~~~~~~~~~ 402 (457)
||++|.- ++||-+||||+...|.......|++.|.
T Consensus 429 d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~ 466 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQ 466 (550)
T ss_pred CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCC
Confidence 9999975 9999999999999988766666666664
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=401.81 Aligned_cols=262 Identities=30% Similarity=0.497 Sum_probs=229.3
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
..++|.+.++||.|+||+||+|+++.++..||||.+....+.....+-+..|+.+|+.++|||||++++++.. .+.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEE
Confidence 3578999999999999999999999999999999999888888888889999999999999999999999988 56899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC------CcEEEeeccCcccc
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND------GILKIADFGLATFY 249 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~------~~vkl~DFGla~~~ 249 (457)
||||||.|+.+..+..+.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999987777777777789999999999999999999999999999999999999865 46999999999998
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.+. ....+.+|++.|||||++.... |+.|+|+||+|+|+|+|++|++||...+..+.+..+.+.-..
T Consensus 166 ~~~--~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~---------- 232 (429)
T KOG0595|consen 166 QPG--SMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI---------- 232 (429)
T ss_pred Cch--hHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc----------
Confidence 754 3456789999999999998666 899999999999999999999999999998887755331100
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
+......+++...+|+...|+.+|..|.+..+-+.|+++...+
T Consensus 233 ----------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 233 ----------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ----------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 0111123567778999999999999999999999999998754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-54 Score=389.81 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=232.2
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..++|+++..||.|+||.|.+++++.+|..||+|++++... ...+++...+|..+|+.+.||+++++++.+.+ ...+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~l 119 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNL 119 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeE
Confidence 35789999999999999999999999999999999987643 44566778899999999999999999887776 6789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||++|+.+..++.+.++|++..++.++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 99999999988887877878999999999999999999999999999999999999999999999999999997753
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
...+.||||.|+|||++...+ |+.++|+|||||++|||+.|.+||...+...+.++|.+.--.
T Consensus 197 -rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--------------- 259 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--------------- 259 (355)
T ss_pred -cEEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc---------------
Confidence 346789999999999999877 899999999999999999999999999999999999764211
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCC-----cCHHHHhcCCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR-----GTATAALNSEFFNTEPYAC 391 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R-----pta~elL~hp~f~~~~~~~ 391 (457)
...-+++++++||+.+|+.|-.+| ....++..||||++..|..
T Consensus 260 --------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 260 --------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred --------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 123478999999999999999999 3577899999999987753
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=390.07 Aligned_cols=286 Identities=26% Similarity=0.399 Sum_probs=241.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++.|++-++||+|.|+.||++.+..+|+.+|+|+++.........+.+.+|+.|.+.|+|||||+|++.+.. ....|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEE
Confidence 578999999999999999999999999999999998877766677889999999999999999999988876 678899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~~ 253 (457)
|+|+|.|+.+..-+-....++|..+-.+++||+.+|.|+|.+||||||+||+|+|+-. ..-+||+|||+|..+..
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~-- 165 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND-- 165 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence 9999998655443333356899999999999999999999999999999999999963 34699999999998873
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......+|||.|||||++...+ |+..+|||+.|||||-|+.|.+||.+.+.....++|.+.-...+..
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~---------- 234 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSP---------- 234 (355)
T ss_pred ccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCc----------
Confidence 35567789999999999998777 8999999999999999999999999999999999987754433332
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCCCCCCCCCCCChhhhhhhhHHH
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEE 413 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (457)
.++.+++++++||++||..||.+|+|+.|+|+|||+.+-. .........+...++++..
T Consensus 235 ---------------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~------~~As~~H~~dtvd~lrkfN 293 (355)
T KOG0033|consen 235 ---------------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE------RVASAIHRQDTVDCLKKFN 293 (355)
T ss_pred ---------------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH------HHHHHhhhHHHHHHHHHhh
Confidence 3456899999999999999999999999999999998631 1111222344456667666
Q ss_pred HHHhh
Q 036122 414 ARRQR 418 (457)
Q Consensus 414 ~~~~~ 418 (457)
++|+-
T Consensus 294 arRKL 298 (355)
T KOG0033|consen 294 ARRKL 298 (355)
T ss_pred HHHHH
Confidence 66654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-54 Score=387.26 Aligned_cols=250 Identities=30% Similarity=0.496 Sum_probs=217.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..+|+++++||.|.||+||++++..+|..||.|.++.+..+....+.+..|+.+|++|+|||||+++++-..+....++|
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 46799999999999999999999999999999999998888888899999999999999999999988544444556999
Q ss_pred EEecccCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 177 VFEYMEHDLAGLAA----CQGVKFSEPQVKCYMKQLLSGLEHCHN--NG--VLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 177 v~E~~~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~--~~--ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
|||||.++-+..+. .....++|..+|+++.|++.||.++|. .+ |+||||||.||+|+.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999976544433 345679999999999999999999999 44 99999999999999999999999999998
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
+.... ....+.+|||.||+||.+.+.+ |++++||||+||++|||+.-++||.+.+-.+..++|.+.-.+|-..
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~----- 250 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD----- 250 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH-----
Confidence 87543 4457789999999999999887 8999999999999999999999999998888888886643222110
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta 375 (457)
..++.++..||..|+..||+.||+.
T Consensus 251 ----------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 251 ----------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred ----------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 2367788999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=407.80 Aligned_cols=257 Identities=31% Similarity=0.511 Sum_probs=223.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE---PESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 172 (457)
.+.|.+.+.||+|+||+|++|++..+|..||+|++...... ....+.+.+|+.++++++ ||||+++++++.. ..
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~~ 93 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--PT 93 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--CC
Confidence 57899999999999999999999999999999988765221 133456778999999999 9999999999988 45
Q ss_pred eEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-CcEEEeeccCccccC
Q 036122 173 SLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLATFYD 250 (457)
Q Consensus 173 ~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~~ 250 (457)
.+|+||||+.| ++++.+.. .+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 69999999998 55555555 7789999999999999999999999999999999999999999 999999999999874
Q ss_pred CCCCCCcccccccCccCchHhhhCCc-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLLGAT-YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.......+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+......+|.+...
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~----------- 240 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF----------- 240 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc-----------
Confidence 2335677889999999999999877 667999999999999999999999999888777777644211
Q ss_pred CCCcccCCCCCCcccchhcccCCC-CCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDF-PSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....+ ++++.+||++||..||.+|+|+.+++.||||+.
T Consensus 241 ------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 241 ------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 111234 889999999999999999999999999999997
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=396.24 Aligned_cols=283 Identities=40% Similarity=0.703 Sum_probs=234.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.++||.|+||+||+|++..++..||+|+++..... .....+.+|+.++++++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 46799999999999999999999999999999999754322 223456789999999999999999999876 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+++++...+...+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~~ 159 (288)
T cd07871 81 VFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KT 159 (288)
T ss_pred EEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-cc
Confidence 99999998877776666668999999999999999999999999999999999999999999999999997653221 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc-c-
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA-T- 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~- 334 (457)
.....+++.|+|||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+....+.+..+.|+....... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 34457899999999998766689999999999999999999999999999999999999999999998876432211 0
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
...+.. ...........+++++++||++||++||.+|||++|+|+||||
T Consensus 240 ~~~~~~-~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQY-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCcc-CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 001111 0111223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=414.34 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=231.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFD-NLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
+-|.+.+.||.|+.|.|.+|+|..||+.+|||++.+. .........+++||.||+.+.|||++++|++++. ..++|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lyl 89 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYL 89 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEE
Confidence 5578899999999999999999999999999999876 4444455678999999999999999999999988 678999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|.||++++-+.++.-..++|++.++.++++||+.|+.|+|..+|+||||||+|+||+..+++||+|||+|..-.++ ..
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--kl 167 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KL 167 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC--cc
Confidence 9999998877777777778999999999999999999999999999999999999999999999999999876544 45
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
..+.||++.|.|||++.|.+|.+.++||||+|||||.||||+.||.+.+....+.++.+...
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f------------------ 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF------------------ 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc------------------
Confidence 66789999999999999999999999999999999999999999998888888888865321
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
+....+++++++||.+||..||++|+|.+|++.|||+.+.+-
T Consensus 230 -----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 230 -----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 223458999999999999999999999999999999998543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=350.02 Aligned_cols=286 Identities=41% Similarity=0.733 Sum_probs=253.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
..|...++||+|.||+||++++..+++.||+|.++.+..+...-....+|+-+|+.|+|.|||+++++... +..+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc--CceeEEe
Confidence 35778899999999999999999999999999999877655544567789999999999999999998876 6779999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
+|||..++...+...++.++.+.++.++.|+++||.|+|++++.||||||.|.||+.+|.+||+|||+++.++-.. .-.
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv-rcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eee
Confidence 9999999988888888899999999999999999999999999999999999999999999999999999776432 223
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhc-CCCCccc
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPNATL 335 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~ 335 (457)
+..+.|.+|.+|.++.|...|+...|+||-|||+.|+.. |+|.|++.+..+++.+|+..+|.|.++.|+.. ++|....
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 445779999999999999999999999999999999986 79999999999999999999999999999864 4444332
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
-|..+....++...+.+.+..+||++.+|..+|.+|++++++|+||||...
T Consensus 239 -yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 -YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 244444566788889999999999999999999999999999999999863
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=391.00 Aligned_cols=284 Identities=37% Similarity=0.602 Sum_probs=232.2
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||.||+|++..+++.||+|++............+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 47999999999999999999999999999999998665444455678889999999999999999998876 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++++..+......+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99999988887766666799999999999999999999999999999999999999999999999999987654333333
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC-CCcc-c
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-PNAT-L 335 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~-~ 335 (457)
....||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..+....+..+...+..... +... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 4567899999999998766 78999999999999999999999999888888888877777766655442110 0000 0
Q ss_pred CCCC-CCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 336 FKPQ-QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 336 ~~~~-~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
..+. .............++.++.+||++||++||++|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 000111122234578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=388.42 Aligned_cols=277 Identities=27% Similarity=0.336 Sum_probs=235.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||.|.-|+||++....++..+|+|++.+..+. .....+.+.|.+||+.++||.++.||+.++. +...|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec--cceeE
Confidence 57899999999999999999999999999999999876553 5556778889999999999999999999987 67899
Q ss_pred EEEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC--
Q 036122 176 LVFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP-- 251 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~-- 251 (457)
+|||||+|+-+..++++ ++.|++..++.|+.+|+.||+|||.+|||+|||||+||||.++|++.|+||.|+.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 99999998766555443 56799999999999999999999999999999999999999999999999999743210
Q ss_pred -------------------------------C-C---------------------CCCcccccccCccCchHhhhCCcCC
Q 036122 252 -------------------------------G-L---------------------KQPMTSRVVTLWYRPPELLLGATYY 278 (457)
Q Consensus 252 -------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~l~~~~~~ 278 (457)
. . .....+.+||-.|+|||++.|.. .
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-H 312 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-H 312 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-C
Confidence 0 0 01123568999999999999888 7
Q ss_pred CccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcH
Q 036122 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSL 358 (457)
Q Consensus 279 ~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (457)
+.++|+|+|||++|||+.|..||.|.+..+++.+|...--.++ ..+.++..++
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp---------------------------~~~~vs~~ak 365 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP---------------------------EEPEVSSAAK 365 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC---------------------------CCCcchhHHH
Confidence 9999999999999999999999999999999988854211110 1124668899
Q ss_pred HHHHHhccCCCCCCcC----HHHHhcCCCCCCCCCCCCCCCCCCCCCCh
Q 036122 359 PLIETLLSIDPDNRGT----ATAALNSEFFNTEPYACEPSSLPKYPPSK 403 (457)
Q Consensus 359 ~Li~~~L~~dP~~Rpt----a~elL~hp~f~~~~~~~~~~~~~~~~~~~ 403 (457)
|||+++|.+||.+|.. |+||-+||||++..|+......|++.|..
T Consensus 366 DLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~ 414 (459)
T KOG0610|consen 366 DLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKP 414 (459)
T ss_pred HHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCc
Confidence 9999999999999999 99999999999999997777777766553
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=400.49 Aligned_cols=256 Identities=34% Similarity=0.503 Sum_probs=227.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|.+.+.||+|.||.||+|+.+.+.+.||||.+.+........+.+.+|++|+++|+|||||.++++|+. ..++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEE
Confidence 57999999999999999999999999999999999887777778889999999999999999999999988 6789999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
.||+.|++... +..++.++|++++.++.+++.||.|||+++|+|||+||.|||+..+|.+|+||||+|+....+ ....
T Consensus 80 te~a~g~L~~i-l~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vl 157 (808)
T KOG0597|consen 80 TEYAVGDLFTI-LEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVL 157 (808)
T ss_pred ehhhhhhHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceee
Confidence 99999966554 455668999999999999999999999999999999999999999999999999999977643 3455
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
++..|||.|||||++.+.. |+..+|+||||||+|||++|+|||......+..+.|..-.-.+
T Consensus 158 tsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----------------- 219 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----------------- 219 (808)
T ss_pred eeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC-----------------
Confidence 6778999999999998766 8999999999999999999999999887777777775421111
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....++.+.+|++.+|.+||.+|+|-.++|.|||+++.
T Consensus 220 ------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 220 ------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ------------cccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 12467888999999999999999999999999999874
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=391.08 Aligned_cols=288 Identities=36% Similarity=0.636 Sum_probs=230.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEE
Confidence 47899999999999999999999999999999999754322 222346789999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.+++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 159 (303)
T cd07869 81 VFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHT 159 (303)
T ss_pred EEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-Ccc
Confidence 9999999988877766667999999999999999999999999999999999999999999999999999754322 122
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhcCC-CCcc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSKL-PNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~ 334 (457)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+..+....+.+....|..... +...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (303)
T cd07869 160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239 (303)
T ss_pred CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 3446789999999999876668889999999999999999999998754 4567778888888887777654321 1100
Q ss_pred cCCCCCCcccchhccc--CCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETF--KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
...........+...+ ..+++.+.+||.+||+.||++|||+.|+|+||||+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0000000011111111 12457889999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=394.08 Aligned_cols=264 Identities=33% Similarity=0.492 Sum_probs=224.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh------------HHHHHHHHHHHHHHhcCCCCceeEee
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP------------ESVKFMAREILVLRKLDHPNVIKLEG 164 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~------------~~~~~~~~E~~~l~~l~hpniv~l~~ 164 (457)
.++|++.+.||+|.||.|.+|++..+++.||||++.+..... ...+...+||.||++|+|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 689999999999999999999999999999999996543211 12357889999999999999999999
Q ss_pred eEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 165 LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 165 ~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
+..+.....+|||+|||..+-..........|++.+++.|+++++.||.|||.+|||||||||+|+||+++|+|||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 99998889999999999976655444333339999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCC----CCCcccccccCccCchHhhhC---CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 036122 245 LATFYDPGL----KQPMTSRVVTLWYRPPELLLG---ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC 317 (457)
Q Consensus 245 la~~~~~~~----~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~ 317 (457)
.+..+..+. .......+|||.|+|||.+.+ ..+.+.+.||||+||+||.|+.|+.||.+....+...+|.+..
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 998763221 122345789999999999987 3446788999999999999999999999999999999886531
Q ss_pred CCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
-.. ...+++.+.++|||.+||.+||++|+++.++-.|||....
T Consensus 336 L~f---------------------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEF---------------------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccC---------------------------CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 111 1123567889999999999999999999999999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-51 Score=387.31 Aligned_cols=262 Identities=28% Similarity=0.472 Sum_probs=211.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.++...+.||+|+||+||++.+..+|..+|||.+....... .+.+.+|+.+|.+|+|||||+++|.........++|+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45788899999999999999999999999999998763222 6778999999999999999999997555322368999
Q ss_pred EecccCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-CCcEEEeeccCccccCC--CC
Q 036122 178 FEYMEHDLAGLAACQGV-KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLATFYDP--GL 253 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~--~~ 253 (457)
|||+.++.+..+....+ .|++..++.+.+||+.||.|||++||||+||||+||||+. ++.+||+|||++..... ..
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999866655555443 7999999999999999999999999999999999999999 79999999999987763 22
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
........||+.|||||++.......+++|||||||++.||+||.+||... .+....++......
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~------------- 239 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED------------- 239 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC-------------
Confidence 223446789999999999985332345999999999999999999999874 22222222221100
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
........+++++++||..||..||++||||+++|.|||.++.
T Consensus 240 -----------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 240 -----------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -----------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0012234588899999999999999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=381.79 Aligned_cols=270 Identities=26% Similarity=0.410 Sum_probs=222.9
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
....|++.++||.|..++||+|+...+++.||||++..+..+.+ .+.+.+|+..|+.++||||++++..|.. +..+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv--~~~LW 100 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV--DSELW 100 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe--cceeE
Confidence 35789999999999999999999999999999999998876655 7889999999999999999999888877 67899
Q ss_pred EEEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 176 LVFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+||.||.++....+... ..-+.|..+..|++++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+-...
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999987544444332 2349999999999999999999999999999999999999999999999999887553322
Q ss_pred CCC---cccccccCccCchHhhh-CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 254 KQP---MTSRVVTLWYRPPELLL-GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 254 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... ....+||++|||||+++ ....|+.|+||||||+...||.+|..||........+-.-.+ +.|+.-.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~pp~~~----- 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--NDPPTLL----- 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CCCCCcc-----
Confidence 111 14568999999999954 444599999999999999999999999998887766544322 2222000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+..+.++..++.+|..||++||.+||||+++|.|+||+..
T Consensus 254 ------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 254 ------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred ------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 0111223446688899999999999999999999999999999975
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=404.61 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=228.5
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCc
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~ 172 (457)
...++|.++++||+|.||+|+++..+.+++.||||+++++.. ..+.++....|..|+...+ ||.++.|+..|.. ..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~ 442 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KE 442 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CC
Confidence 347899999999999999999999999999999999998764 6677788888999998886 9999999888877 67
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
++|+||||+.|+.. ....+...|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..--
T Consensus 443 ~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~- 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG- 520 (694)
T ss_pred eEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-
Confidence 89999999998873 3344456799999999999999999999999999999999999999999999999999985431
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....++.+||+.|||||++.+.. |+.++|+|||||+|||||.|.+||.+.+..+....|...-
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--------------- 584 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--------------- 584 (694)
T ss_pred CCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---------------
Confidence 224567789999999999999877 8999999999999999999999999999999988885421
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYA 390 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~ 390 (457)
......++.++.++|+++|+.||++|.. ++++.+||||+...|.
T Consensus 585 --------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 585 --------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred --------------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 0112347889999999999999999987 4789999999998765
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=392.50 Aligned_cols=290 Identities=34% Similarity=0.527 Sum_probs=231.9
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---CceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~ 175 (457)
+|++.+.||+|+||.||+|++..+|..||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999999999999999998754333344456789999999999999999999876432 23589
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC--
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL-- 253 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-- 253 (457)
+||||+++++...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCCCCHHHHHH-hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999988776554 34469999999999999999999999999999999999999999999999999998543221
Q ss_pred CCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
........||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.++...+.......
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 1122446789999999998752 347899999999999999999999999999888888888888888776654422111
Q ss_pred cccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 333 ATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
.... .............++.+++.+.+||.+||+.||++|||++|+|+||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000 00000111233445677889999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=406.01 Aligned_cols=284 Identities=33% Similarity=0.530 Sum_probs=227.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec------C
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR------M 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 170 (457)
..+|.+.+.||+|+||.||+|.+..+++.||||++..+. ....+|+.+|+.++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 468999999999999999999999999999999886432 2234799999999999999998876432 1
Q ss_pred CceEEEEEecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCc
Q 036122 171 SCSLYLVFEYMEHDLAGLAA---CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLA 246 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla 246 (457)
...+++||||+++++...+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 23477999999998765543 2455799999999999999999999999999999999999999654 7999999999
Q ss_pred cccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 247 TFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
+.+... .......||+.|+|||++.+...|+.++|||||||++|||++|.+||.+.+..+.+.++.+.++.+..+.+.
T Consensus 219 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 876433 223456789999999999876668999999999999999999999999999999999999999998877665
Q ss_pred hcCCCCcccCCCCCCcccchhccc-CCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETF-KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
... +..............+...+ ...++++.+||.+||++||.+|||+.|+|+||||+....
T Consensus 297 ~~~-~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 297 EMN-PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred Hhc-hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 321 11111110000111111222 346788999999999999999999999999999987543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=382.13 Aligned_cols=281 Identities=40% Similarity=0.665 Sum_probs=226.4
Q ss_pred CCccccceeeccCceEEEEEEEcC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeeeEEe---cC
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL-TGKIVALKKVRFDNLEPESVKFMAREILVLRKL---DHPNVIKLEGLVTS---RM 170 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---~~ 170 (457)
.+|++.+.||+|+||+||+|++.. +|..||+|+++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 369999999999999999999854 568899999976544333334456677777766 69999999998853 12
Q ss_pred CceEEEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
...+++||||+.+++...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 3568999999998877766543 345899999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.++.+.+.++....+.+....|+...
T Consensus 161 ~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 161 SFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred cCC--cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 433 2234557899999999997665 7899999999999999999999999999999999999988887776665421
Q ss_pred -CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 330 -LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 330 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
++.. .+... ....+....+++++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 238 ~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQ-AFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccch-hccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 1111 11110 1112333446788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=399.34 Aligned_cols=281 Identities=30% Similarity=0.534 Sum_probs=230.4
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-C-----CCceeEeeeEEecCCc
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-H-----PNVIKLEGLVTSRMSC 172 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~ 172 (457)
+|++++.||+|+||.|.+|.+..|++.||||+++.. .....+-..|+.+|..|+ | -|||+++++|.. .+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cc
Confidence 689999999999999999999999999999999754 344455667999999997 3 489999999988 56
Q ss_pred eEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC--cEEEeeccCcccc
Q 036122 173 SLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG--ILKIADFGLATFY 249 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~--~vkl~DFGla~~~ 249 (457)
++|||+|+++.+|..++..+. ..|+...++.++.||+.||.+||+.||||+|||||||||.+-+ .|||+|||+|...
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 899999999999988887654 3589999999999999999999999999999999999998543 7999999999876
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... ..+++.+..|+|||+++|.+ |+.+.||||||||+.||++|.|+|+|.+..+++..|.+.+|.|+...+....
T Consensus 342 ~q~----vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 342 SQR----VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred CCc----ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 432 23678899999999999988 8999999999999999999999999999999999999999999988876432
Q ss_pred CCCcccCC----CC----------------------------CC-cccchhcccC-CCCCCcHHHHHHhccCCCCCCcCH
Q 036122 330 LPNATLFK----PQ----------------------------QP-YKRCIAETFK-DFPSSSLPLIETLLSIDPDNRGTA 375 (457)
Q Consensus 330 ~~~~~~~~----~~----------------------------~~-~~~~~~~~~~-~~~~~~~~Li~~~L~~dP~~Rpta 375 (457)
-....... +. .+ ....+...+. .-...+.|||++||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 11100000 00 00 0011111111 112356899999999999999999
Q ss_pred HHHhcCCCCCCCCC
Q 036122 376 TAALNSEFFNTEPY 389 (457)
Q Consensus 376 ~elL~hp~f~~~~~ 389 (457)
.|+|+||||.+...
T Consensus 497 ~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 497 AQALNHPFLTGTSL 510 (586)
T ss_pred HHHhcCcccccccc
Confidence 99999999996543
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=384.83 Aligned_cols=303 Identities=48% Similarity=0.792 Sum_probs=249.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++|+||+++++++.......+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 57899999999999999999999999999999999765433333334567999999999999999999987654567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.+++...+......+++.++..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++....... ..
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~ 164 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KP 164 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CC
Confidence 99999988777766555679999999999999999999999999999999999999999999999999998765332 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC-CCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-PNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~ 335 (457)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|+.... +....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccccc
Confidence 23345688899999998766678999999999999999999999999999999999999999888777764321 11111
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYP 400 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~~~~ 400 (457)
+.........+...+..+++++.+||.+||+.||++|||++++|+||||++.+.++.+..+|.+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred ccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 11111111223334455788999999999999999999999999999999998888888877664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=397.17 Aligned_cols=257 Identities=28% Similarity=0.506 Sum_probs=222.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
...|....+||+|+.|.||.++...+++.||||++....... .+-+.+|+.+|+..+|+|||.+++.|.. .+.+|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEE
Confidence 356888999999999999999999999999999998765433 3558899999999999999999988877 467999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||||+|+.+.++.... .++|.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 348 VMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred EEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 99999997776665544 499999999999999999999999999999999999999999999999999998865543 4
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.++.+||+.|||||++.... |++++||||||++++||+-|.|||-..+....+..|.. -|.|.-
T Consensus 426 R~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l-------------- 489 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL-------------- 489 (550)
T ss_pred cccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc--------------
Confidence 56789999999999998777 89999999999999999999999998777666666533 222211
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....+++.+++||.+||+.||++|+||.|||+||||+.
T Consensus 490 -----------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 490 -----------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred -----------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 122458899999999999999999999999999999965
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=366.05 Aligned_cols=261 Identities=31% Similarity=0.435 Sum_probs=227.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL------EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
+.|...+.||.|..++|.+|.++.+|+.+|+|++..... ..+..+...+|+.||+++ .||||+.+.++|..
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 567888999999999999999999999999999975322 122345567899999998 59999999999987
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...+++|+|+|+.+.+.+++.....++|...+.|++|++.|+.|||.++||||||||+|||++++.++||+|||+|+.+.
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 67899999999988887777777789999999999999999999999999999999999999999999999999999887
Q ss_pred CCCCCCcccccccCccCchHhhh-----CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLL-----GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
++ ......+|||+|+|||.+. +.+.|+..+|+|++|||||-|+.|.|||-.....-.+..|.+.-..+.
T Consensus 175 ~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~---- 248 (411)
T KOG0599|consen 175 PG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR---- 248 (411)
T ss_pred Cc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC----
Confidence 76 4567889999999999985 344588899999999999999999999987777777777776543333
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
++.+.+++...+|||.+||+.||.+|+|++|+|+||||.+.
T Consensus 249 ---------------------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 249 ---------------------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ---------------------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 24456789999999999999999999999999999999653
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=383.46 Aligned_cols=288 Identities=36% Similarity=0.663 Sum_probs=236.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||.||+|++..+++.||+|.++..... .....+.+|+.++++++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEE
Confidence 46899999999999999999999999999999999765432 223346689999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+++++...+...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cc
Confidence 99999998887776666678999999999999999999999999999999999999999999999999997653221 12
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc-c
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT-L 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~ 335 (457)
.....+|+.|+|||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+...++.+..+.|+........ .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 234567899999999987666889999999999999999999999999999999999999999988888654321110 0
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
...............+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000001111223456788999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=395.22 Aligned_cols=288 Identities=34% Similarity=0.513 Sum_probs=233.1
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC---ceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS---CSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~~~ 175 (457)
+|++.+.||+|+||.||++.+..+|+.||||++..........+.+.+|+.+++.++|+||+++++++..... ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999986543344455678899999999999999999999876321 2689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.+++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999999887766543 457999999999999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC--c
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN--A 333 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~ 333 (457)
......+|+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+.+.+|.+..+.+....... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 34456789999999999876668899999999999999999999999999999999999999988776543211000 0
Q ss_pred ccCCC-CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKP-QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~-~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+ ..+............++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00000 0000111112234567889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=368.48 Aligned_cols=295 Identities=38% Similarity=0.623 Sum_probs=237.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG----KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
...|+.++.||+|.||.||+|....++ +.+|||.++............-+|+.+++.|+||||+.|..++... +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 357999999999999999999655443 3799999986633222223456899999999999999999988775 56
Q ss_pred eEEEEEecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC----CcEEEeecc
Q 036122 173 SLYLVFEYMEHDLAGLAACQ----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND----GILKIADFG 244 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DFG 244 (457)
.+++++||.+++|+..+... ...++...++.|+.||+.|+.|||++=|+||||||.||||..+ |.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 79999999999998876553 3468999999999999999999999999999999999999987 899999999
Q ss_pred CccccCCCCCCC--cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC---------hHHHHHHH
Q 036122 245 LATFYDPGLKQP--MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT---------EVEQLHKI 313 (457)
Q Consensus 245 la~~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~---------~~~~~~~i 313 (457)
+++.+....... ....+.|.||+|||+++|...|+.++|||+.|||+.||+|-.|.|.+.. ..+++.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 999886544322 2345679999999999999999999999999999999999999998753 45789999
Q ss_pred HHhcCCCChhhhhhc-CCCCcccC--CCC-CCc----ccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 314 FKLCGSPSEEYWKKS-KLPNATLF--KPQ-QPY----KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 314 ~~~~~~~~~~~~~~~-~~~~~~~~--~~~-~~~----~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
++++|.|.++.|+.. +.|..... ..+ .-+ ...+....+.-++...+|+.+||++||-+|+|++++|+|+||.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~ 341 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT 341 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence 999999999999864 34433110 000 000 1112223344466799999999999999999999999999999
Q ss_pred CCCCCCC
Q 036122 386 TEPYACE 392 (457)
Q Consensus 386 ~~~~~~~ 392 (457)
..+.+..
T Consensus 342 ~d~lpp~ 348 (438)
T KOG0666|consen 342 EDPLPPL 348 (438)
T ss_pred cCCCCCC
Confidence 9865533
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=389.57 Aligned_cols=285 Identities=32% Similarity=0.529 Sum_probs=228.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC----c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----C 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 172 (457)
.++|++.+.||+|+||.||++.+..+|..||+|++............+.+|+.+++.++||||+++++++..... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 478999999999999999999999999999999997655445556678899999999999999999998865321 3
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 579999999998776553 24889999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC---
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK--- 329 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--- 329 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.+..+.+..+++....
T Consensus 177 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 177 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred --ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 2234567899999999998766 7899999999999999999999999999888888888888888776654321
Q ss_pred ------CCCcccCCCCCCccc----chhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 330 ------LPNATLFKPQQPYKR----CIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 330 ------~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+............. .........++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 000000000000000 0011112346788999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=395.65 Aligned_cols=280 Identities=25% Similarity=0.330 Sum_probs=219.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||.||+|++..+++.||+|.... ..+.+|+.+|++|+|||||++++++.. ....++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEE
Confidence 4689999999999999999999999999999997532 235789999999999999999999877 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++.+++...+.. ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 161 v~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999999887766554 3468999999999999999999999999999999999999999999999999997543322233
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR-------TEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.....||+.|+|||++.+.. ++.++|||||||++|||++|..||... +...++..+....|.++.++.....
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 34567999999999998766 799999999999999999999776543 2345677777777766544321100
Q ss_pred CCCcc------cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 330 LPNAT------LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 330 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
..... ......+...........++.++.+||.+||++||++|||++|+|+||||+..+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 00000 000000000111112234677899999999999999999999999999998854
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-48 Score=375.04 Aligned_cols=281 Identities=38% Similarity=0.657 Sum_probs=226.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeeeEEec---CCc
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL---DHPNVIKLEGLVTSR---MSC 172 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~---~~~ 172 (457)
+|++.+.||+|+||+||+|++..+|+.||+|.++...........+.+|+.+++.+ +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48899999999999999999999999999999976433322223455677777665 799999999987642 234
Q ss_pred eEEEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
.+++||||+.+++...+... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 58999999998877766543 23589999999999999999999999999999999999999999999999999986643
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
. .......+|..|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....|......
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 161 Q--MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred c--ccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 2 2234457899999999998766 799999999999999999999999999999999999988888777666542111
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
....+.+ .....+....+.++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 238 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSP--RGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCC--CCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1111111 11122344556788889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=388.47 Aligned_cols=285 Identities=31% Similarity=0.520 Sum_probs=229.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|.+.+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999999999999999999765444455567788999999999999999998876422 23
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 5799999999987766542 4889999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC--
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-- 330 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 330 (457)
.......+|..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+...++....+.+..+.+.....
T Consensus 180 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 180 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred --CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 2234567899999999998766 78999999999999999999999999999999999999888887766554211
Q ss_pred -------CCcccCCCCCCc----ccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 331 -------PNATLFKPQQPY----KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 331 -------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+....+...... ...........+..+++||.+||+.||.+|||++|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 111100000000 000111112235678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=385.53 Aligned_cols=263 Identities=34% Similarity=0.502 Sum_probs=227.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 174 (457)
...|++.+.||.|.||.||+|+++.+|+.+|+|++.+.... ......+.+|+.+|+++. |||||.++++|.+ ...+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeE
Confidence 46799999999999999999999999999999999876543 234567889999999998 9999999999998 5689
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC----CcEEEeeccCccccC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND----GILKIADFGLATFYD 250 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~~~ 250 (457)
++|||++.|+.+....... .+++..+..++.||+.++.|||+.||+||||||+|+|+... +.+|++|||++....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999976554443333 39999999999999999999999999999999999999743 589999999999887
Q ss_pred CCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
. .......+||+.|+|||++.+.. |+..+||||+||++|.|++|.+||.+.+..+...+|...-..+.
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~--------- 258 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT--------- 258 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC---------
Confidence 6 35567889999999999998766 89999999999999999999999999998888887765433222
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
.+.|.+++..+.+||+.||..||.+|+|+.++|+|||++.....
T Consensus 259 ----------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 259 ----------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred ----------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 23456789999999999999999999999999999999986433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=379.11 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=217.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.++++++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEE
Confidence 368999999999999999999999999999999975432 22344668899999999999999999988876 568999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.++.+..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---- 154 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---- 154 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence 9999988655555555667999999999999999999999999999999999999999999999999999865432
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....-
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~------------------ 215 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL------------------ 215 (291)
T ss_pred cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc------------------
Confidence 23457899999999998766 78999999999999999999999998887777666643210
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYA 390 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~ 390 (457)
.....+++.+.+||++||+.||.+|++ ++++++||||+...+.
T Consensus 216 -----------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 216 -----------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 011235678899999999999999995 9999999999875543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=384.96 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=217.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.++++++||||+++++++.. ...+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 94 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVY 94 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEE
Confidence 4789999999999999999999999999999999975432 22345668899999999999999999999877 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999988666555555667999999999999999999999999999999999999999999999999999866432
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+.... .
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~--~--------------- 232 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--L--------------- 232 (329)
T ss_pred -cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--c---------------
Confidence 23457899999999998766 7899999999999999999999999887776666553310 0
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYA 390 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~ 390 (457)
.....++..+.+||.+||+.||.+|++ +++++.||||++..+.
T Consensus 233 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 233 ------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 001225677899999999999999997 7999999999875443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=373.42 Aligned_cols=255 Identities=28% Similarity=0.489 Sum_probs=231.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
..+|++.+.||+|.||.|-+|++...|+.||||.|+++.. +.+..-.+.+||+||+.|+||||+.+|++|.. .+.+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN--kdKIv 129 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN--KDKIV 129 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC--CceEE
Confidence 4689999999999999999999989999999999998876 45566789999999999999999999999988 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||||..++.+..+....+.|++.+++.+++||..|+.|+|.++++|||||.+|||||.++++||+|||++..+... .
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--K 207 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc--c
Confidence 99999998877777777788999999999999999999999999999999999999999999999999999988654 5
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
..++++|++-|.+||++.|.++-++.+|-|||||+||.|+.|..||.|.+......+|...-..
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr---------------- 271 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR---------------- 271 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc----------------
Confidence 6788999999999999999998899999999999999999999999999998888888553211
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
-+.-|+++.-||+.||-.||++|.|++++-.|-|.+
T Consensus 272 --------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 272 --------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred --------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 123567889999999999999999999999999986
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=373.18 Aligned_cols=282 Identities=41% Similarity=0.709 Sum_probs=232.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||+|++..+|+.||+|.+............+.+|+.++++++||||+++++++.+ ...+|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 4888999999999999999999999999999997654443344567789999999999999999999876 56799999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||+++++...+......+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++....... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYS 157 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcC
Confidence 999998888776666679999999999999999999999999999999999999999999999999998654322 2223
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcccC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNATLF 336 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~ 336 (457)
...++..|+|||++.+...++.++|||||||++|+|+||..| |.+.+..+.+..++..++.+....|.... .+... .
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK-P 236 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc-c
Confidence 456789999999998766678999999999999999998765 67777788888898888888777765422 22211 1
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.+..+....+.+..+.+++++.+||.+||+.||.+|||++++|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111112222344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=382.64 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=212.1
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEeccc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.++++++||||+++++++.. ...+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 23344567789999999999999999998877 568999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc
Q 036122 183 HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262 (457)
Q Consensus 183 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 262 (457)
++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~g 157 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceec
Confidence 8766666666668999999999999999999999999999999999999999999999999998753221 122344679
Q ss_pred cCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCc
Q 036122 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342 (457)
Q Consensus 263 t~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (457)
|+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+.....
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (323)
T cd05571 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI------------------------ 212 (323)
T ss_pred CccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 99999999998766 79999999999999999999999988777666555432100
Q ss_pred ccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 343 KRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 343 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
.....+++++.+||++||+.||++|| ++.++|+||||+...+
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 01134678899999999999999999 8999999999988644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=381.52 Aligned_cols=265 Identities=29% Similarity=0.416 Sum_probs=220.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.++..++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEE
Confidence 3699999999999999999999999999999999764322 2344567889999999999999999998877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~ 154 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y 154 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence 999998876666666666799999999999999999999999999999999999999999999999999986543 2
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+....+........
T Consensus 155 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------------- 218 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--------------- 218 (333)
T ss_pred cCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------------
Confidence 34567899999999998775 89999999999999999999999998887777666543211000
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
.+. .......+++++.+||.+||..+|.+|||+.++++||||....+.
T Consensus 219 ~~~------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 219 RPV------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred CCC------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 000 000013467889999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=373.03 Aligned_cols=287 Identities=39% Similarity=0.684 Sum_probs=235.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~l 81 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTL 81 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEE
Confidence 46899999999999999999999999999999999755322 223446689999999999999999999876 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.+++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~ 160 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KT 160 (301)
T ss_pred EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cc
Confidence 99999998887776666679999999999999999999999999999999999999999999999999997653221 12
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc-cc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA-TL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~ 335 (457)
.....+++.|+|||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+....+.+....|+....... ..
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 23346789999999998766678899999999999999999999999999999999999988888887764311110 00
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.........+.......+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0001111122223345678889999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=370.25 Aligned_cols=283 Identities=40% Similarity=0.709 Sum_probs=230.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||+|++..++..||+|++............+.+|+.++++++||||+++++++.. +..+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 4888999999999999999999999999999997654444444667889999999999999999999887 56799999
Q ss_pred ecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 179 EYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 179 E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||+.+++...+... +..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RV 157 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-cc
Confidence 99998776665432 2568999999999999999999999999999999999999999999999999997654321 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||++.+...++.++|||||||++|+|+||++||.+.+..+.+..+....+.+....|+..........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 23446789999999987766578899999999999999999999999988888888888888777777654221111000
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
................+++++.+||.+||+.||++|||+.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000111122333455688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=375.40 Aligned_cols=278 Identities=37% Similarity=0.656 Sum_probs=216.5
Q ss_pred cceeeccCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 103 LDKIGQGTYSNVYKARDL--LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
..+||+|+||+||+|+++ .+++.||+|.+...... ..+.+|+.+|++++||||+++++++.......+|+||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999965 46789999998654322 336689999999999999999999877666779999999
Q ss_pred ccCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----cCCCcEEEeeccCccc
Q 036122 181 MEHDLAGLAACQ--------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATF 248 (457)
Q Consensus 181 ~~~~l~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~~ 248 (457)
+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 82 AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred cCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 998876655422 2358999999999999999999999999999999999999 4567999999999987
Q ss_pred cCCCCC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhc
Q 036122 249 YDPGLK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIFKLC 317 (457)
Q Consensus 249 ~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---------~~~~~~i~~~~ 317 (457)
...... .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+... ..++..++..+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 643321 1223467899999999998766689999999999999999999999975442 46678888999
Q ss_pred CCCChhhhhhcC-CCCcccC----C----CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 318 GSPSEEYWKKSK-LPNATLF----K----PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 318 ~~~~~~~~~~~~-~~~~~~~----~----~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
+.+....|.... .+..... . ........+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 988887776532 1111000 0 00000011111122345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=382.70 Aligned_cols=285 Identities=32% Similarity=0.532 Sum_probs=228.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|.+.+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 47899999999999999999999999999999999765545555667788999999999999999999886532 23
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+++++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 5799999999987765532 4889999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC--
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-- 330 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 330 (457)
.......||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.+.++.+..+.+....-
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 173 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred --cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 2234567899999999998766 78999999999999999999999999998888888888888877666543210
Q ss_pred -------CCcccCC-CC---CCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 331 -------PNATLFK-PQ---QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 331 -------~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+...... +. ..............+..+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0000000 00 000000011122345678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-48 Score=385.71 Aligned_cols=264 Identities=26% Similarity=0.377 Sum_probs=215.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++++.||+|+||+||+|.+..+++.||||+++.... .......+.+|+.++.+++|+||+++++.+.+ ...+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEE
Confidence 478999999999999999999999999999999975432 23445678889999999999999999998877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC--
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-- 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 254 (457)
||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 79 IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred EEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999876665655566899999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCC
Q 036122 255 --------------------------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP 302 (457)
Q Consensus 255 --------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~ 302 (457)
......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCC
Confidence 0112457999999999998766 7899999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCC---CCcCHHHHh
Q 036122 303 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPD---NRGTATAAL 379 (457)
Q Consensus 303 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~---~Rpta~elL 379 (457)
+.+..+...++....... ..| ....+++++.+||.+|+. +|. .||+++|++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------~~p-----------------~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~ 291 (363)
T cd05628 238 SETPQETYKKVMNWKETL--------IFP-----------------PEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK 291 (363)
T ss_pred CCCHHHHHHHHHcCcCcc--------cCC-----------------CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence 988877777665321100 000 011367789999999875 555 468999999
Q ss_pred cCCCCCCCCCC
Q 036122 380 NSEFFNTEPYA 390 (457)
Q Consensus 380 ~hp~f~~~~~~ 390 (457)
+||||++..|.
T Consensus 292 ~hp~f~~~~~~ 302 (363)
T cd05628 292 TNPFFEGVDWE 302 (363)
T ss_pred CCCCCCCCCHH
Confidence 99999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=381.79 Aligned_cols=285 Identities=34% Similarity=0.556 Sum_probs=230.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|++++.||.|+||+||+|.+..+++.||||++............+.+|+.++++++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46899999999999999999999999999999999765433344556778999999999999999998875421 24
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|++||++++++..... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~- 170 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD- 170 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC-
Confidence 579999999877765443 34699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.+.......
T Consensus 171 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 171 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 23456789999999999876568999999999999999999999999999888888888888887766654321111
Q ss_pred cccCC--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFK--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...+. ........+...+...++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00000 00000111233344567778999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=373.52 Aligned_cols=261 Identities=24% Similarity=0.398 Sum_probs=212.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.|+..+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.++++++|+||+++++++.. ...+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 378899999999999999999999999999998765432 2233457789999999999999999988876 5679999
Q ss_pred EecccCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHDLAGLAAC--QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||++++.+..... ....+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||++...... .
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E 156 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence 99999765543332 2346899999999999999999999999999999999999999999999999999865432 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||..|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.......+........
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------------- 221 (285)
T ss_pred eecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--------------
Confidence 234557899999999998766 79999999999999999999999987765443333322211110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
......+++++.+||++||+.||.+||| ++++++||||++..+
T Consensus 222 -----------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 222 -----------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred -----------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence 0122357888999999999999999997 999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-48 Score=386.99 Aligned_cols=264 Identities=29% Similarity=0.434 Sum_probs=217.2
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEE
Confidence 479999999999999999999999999999999976432 23445667889999999999999999998887 568999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC-
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ- 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 255 (457)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+......
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999998766666555667999999999999999999999999999999999999999999999999998754321100
Q ss_pred ------------------------------------CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCC
Q 036122 256 ------------------------------------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP 299 (457)
Q Consensus 256 ------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~ 299 (457)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCC
Confidence 111346899999999997766 7899999999999999999999
Q ss_pred CCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC---HH
Q 036122 300 IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT---AT 376 (457)
Q Consensus 300 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~ 376 (457)
||.+.+..+....+....... ..+ ....+++++.+||++||. +|.+|++ +.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~--------~~~-----------------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~ 291 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETL--------QFP-----------------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVN 291 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCcc--------CCC-----------------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence 999888777666654311000 000 011367889999999997 9999998 99
Q ss_pred HHhcCCCCCCCCCC
Q 036122 377 AALNSEFFNTEPYA 390 (457)
Q Consensus 377 elL~hp~f~~~~~~ 390 (457)
|+|+||||+...+.
T Consensus 292 ~ll~h~~~~~~~~~ 305 (364)
T cd05599 292 EIKSHPFFKGVDWE 305 (364)
T ss_pred HHhcCCCcCCCCHH
Confidence 99999999986553
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=348.98 Aligned_cols=255 Identities=32% Similarity=0.446 Sum_probs=224.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|-||.||+|+.+.++-.||+|++.+.... .....++.+|++|-+.|+||||+++|++|.+ ...+|
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riy 98 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIY 98 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec--cceeE
Confidence 57899999999999999999999999999999999766543 2334578899999999999999999999988 67899
Q ss_pred EEEecccCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 176 LVFEYMEHDLAGLAAC--QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
|++||...+.+...+. ...++++.....++.|++.||.|+|..+|+||||||+|+|++..|.+||+|||.+.....
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-- 176 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 176 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC--
Confidence 9999998765544444 566799999999999999999999999999999999999999999999999999976542
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
....+.+||..|.+||+..+.. ++..+|+|++|++.||++.|.+||...+..+.+++|.+.--.
T Consensus 177 -~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~-------------- 240 (281)
T KOG0580|consen 177 -NKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLK-------------- 240 (281)
T ss_pred -CCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcccc--------------
Confidence 3446789999999999998877 799999999999999999999999999988899888664211
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
....++.++.|||.+||.++|.+|.+..|++.|||+..
T Consensus 241 ---------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 ---------------FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ---------------CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 11347889999999999999999999999999999975
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=381.98 Aligned_cols=258 Identities=25% Similarity=0.336 Sum_probs=217.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC-cEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG-KIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g-~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++.+.||+|+||.||+|.+..++ ..||+|++..... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 106 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYL 106 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCEE
Confidence 468999999999999999999876554 6899999875432 23345668899999999999999999999987 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 999999988666656656667999999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.....||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+.......+.....
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 245 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII---------------- 245 (340)
T ss_pred --cceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 23467899999999998765 78999999999999999999999998887776666643210
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
.....+++.+.+||++||+.||++|+ |++++++||||++..|.
T Consensus 246 -------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 246 -------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 01123677889999999999999995 89999999999986554
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-50 Score=380.68 Aligned_cols=256 Identities=29% Similarity=0.456 Sum_probs=220.2
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
..|..++.||+|.||.||+|.+..+++.||||++..+.. ...+..+++|+.+|.+++++||.++|+.|.. +..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-~deIediqqei~~Ls~~~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-EDEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc-chhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHH
Confidence 468888999999999999999999999999999988754 3445778899999999999999999999888 6779999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
||||.|+........+..+.+.++..++++++.||.|||.++.+|||||+.||||..+|.+||+|||.+..........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 9999998777777777777999999999999999999999999999999999999999999999999998776554433
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
.+.+||+.|||||++.+.. |+.++||||||++.+||++|.||+......-.+-.|- ..
T Consensus 169 ~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp---k~------------------ 226 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP---KS------------------ 226 (467)
T ss_pred ccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc---CC------------------
Confidence 7789999999999999655 8999999999999999999999998766522221110 00
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
..| ..-.++++.+++||..||.+||+.||||.++|+|+|++.
T Consensus 227 -~PP------~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 227 -APP------RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -CCC------ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 000 111268889999999999999999999999999999987
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=385.24 Aligned_cols=263 Identities=28% Similarity=0.380 Sum_probs=213.3
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.++++++||||+++++++.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 58899999999999999999999999999999976432 34455678899999999999999999999887 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC---
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK--- 254 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~--- 254 (457)
|||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||++..+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99998866655555566799999999999999999999999999999999999999999999999999764311000
Q ss_pred -------------------------------------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHH
Q 036122 255 -------------------------------------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCIL 291 (457)
Q Consensus 255 -------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl 291 (457)
......+||+.|+|||++.+.. ++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il 238 (381)
T cd05626 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVIL 238 (381)
T ss_pred ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHH
Confidence 0012357999999999998766 78999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccC--CC
Q 036122 292 AELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSI--DP 369 (457)
Q Consensus 292 ~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~--dP 369 (457)
|||++|.+||...+..+...++....... .. .....+++++.+||.+||.. +|
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~-----------------~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 239 FEMLVGQPPFLAPTPTETQLKVINWENTL--------HI-----------------PPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred HHHHhCCCCCcCCCHHHHHHHHHcccccc--------CC-----------------CCCCCCCHHHHHHHHHHccCcccc
Confidence 99999999999887766655553211000 00 01124678899999997655 44
Q ss_pred CCCcCHHHHhcCCCCCCCCC
Q 036122 370 DNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 370 ~~Rpta~elL~hp~f~~~~~ 389 (457)
..|+|++++++||||+...+
T Consensus 294 ~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 294 LGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred cCCCCHHHHhcCcccCCCCh
Confidence 55999999999999988654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=355.92 Aligned_cols=294 Identities=47% Similarity=0.769 Sum_probs=242.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec------C
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR------M 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~ 170 (457)
.+.|+.+.+||+|.||.||+|+...+|+.||+|++-.++.....-....+|+.+|..|+|+|++.++++|... .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4678999999999999999999999999999998765443322223456899999999999999999887532 2
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...+|+||.+|++++...+.....+|+..++.+++.+++.||.|+|.+.|+|||+|++|+||+.+|.+||+|||+++.+.
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 34589999999999988887777789999999999999999999999999999999999999999999999999998764
Q ss_pred CC---CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 251 PG---LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 251 ~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
.. .....+..+.|.+|++||.+.|...|+++.|||+-|||+.||+|+.|.|.++++..++..|..+||+...+.|+.
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 22 233456778899999999999999999999999999999999999999999999999999999999999999986
Q ss_pred cC-CCCcccC--CCC-CCcccchhcccCCC--CCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 328 SK-LPNATLF--KPQ-QPYKRCIAETFKDF--PSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 328 ~~-~~~~~~~--~~~-~~~~~~~~~~~~~~--~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
.. +|-.... .|. ....+.+....+-+ .+++.||+..||..||.+|++++++|.|.||..++.+
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 43 2222111 110 00011122222211 5688999999999999999999999999999987544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=374.97 Aligned_cols=252 Identities=30% Similarity=0.412 Sum_probs=210.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcE-EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~-vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..+.+.+.||.|+||+||+|. ..|+. ||+|++..........+.|.+|+.+|.+|+|||||+++|+|..... .++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~-~~~i 117 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG-SLCI 117 (362)
T ss_pred HHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-ceEE
Confidence 455667779999999999997 56666 9999998766555557889999999999999999999999987432 6899
Q ss_pred EEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCEEecCCC-cEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNG-VLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~ 252 (457)
||||++++.+..+... ...++...+..|+.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999998877766655 678999999999999999999999999 99999999999999998 9999999999876533
Q ss_pred CCCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
. ...+...||+.|||||++.+. ..|+.++||||||++||||+||..||.+....+....+......|
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp----------- 265 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP----------- 265 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 2 334557899999999999852 448999999999999999999999999998855555543221111
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++.+..||..|+..||.+||+..+++.
T Consensus 266 ----------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 ----------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 111237888999999999999999999988874
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=383.76 Aligned_cols=264 Identities=32% Similarity=0.467 Sum_probs=219.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|.+.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.++..++|+||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEE
Confidence 4799999999999999999999999999999999764322 2445678889999999999999999988876 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC---
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL--- 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~--- 253 (457)
||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 79 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 79 VMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 99999876555555555679999999999999999999999999999999999999999999999999998664332
Q ss_pred -------------------------CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 036122 254 -------------------------KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 308 (457)
Q Consensus 254 -------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~ 308 (457)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 11233457899999999998775 7999999999999999999999999888777
Q ss_pred HHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-HHHHhcCCCCCCC
Q 036122 309 QLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-ATAALNSEFFNTE 387 (457)
Q Consensus 309 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-a~elL~hp~f~~~ 387 (457)
...++....... .+ .....+++++.+||.+||. ||.+|++ ++++|+||||+..
T Consensus 238 ~~~~i~~~~~~~--------~~-----------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 238 TYNKIINWKESL--------RF-----------------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHHHhccCCcc--------cC-----------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 666664311100 00 0112268889999999997 9999999 9999999999986
Q ss_pred CCC
Q 036122 388 PYA 390 (457)
Q Consensus 388 ~~~ 390 (457)
.+.
T Consensus 292 ~~~ 294 (350)
T cd05573 292 DWE 294 (350)
T ss_pred CHH
Confidence 654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=385.35 Aligned_cols=263 Identities=29% Similarity=0.426 Sum_probs=213.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|.+++.||+|+||.||++.+..+|+.||||++..... .......+.+|+.++++++||||+++++++.+ ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEE
Confidence 378999999999999999999999999999999875432 23445678899999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC--
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-- 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 254 (457)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999998765555555566799999999999999999999999999999999999999999999999999963321000
Q ss_pred -----------C---------------------------------CcccccccCccCchHhhhCCcCCCccchhhhHHHH
Q 036122 255 -----------Q---------------------------------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCI 290 (457)
Q Consensus 255 -----------~---------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~v 290 (457)
. .....+||+.|+|||++.+.. ++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchh
Confidence 0 001246899999999998766 7999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCC
Q 036122 291 LAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPD 370 (457)
Q Consensus 291 l~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~ 370 (457)
+|||++|.+||.+.+..+....+....... .++ ....++.++.+||.+||. +|.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------~~p-----------------~~~~~s~~~~dli~~lL~-~~~ 291 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETL--------YFP-----------------DDIHLSVEAEDLIRRLIT-NAE 291 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCcc--------CCC-----------------CCCCCCHHHHHHHHHHhc-CHh
Confidence 999999999999888777666654311000 000 012367788999999998 777
Q ss_pred CC---cCHHHHhcCCCCCCCCC
Q 036122 371 NR---GTATAALNSEFFNTEPY 389 (457)
Q Consensus 371 ~R---pta~elL~hp~f~~~~~ 389 (457)
+| +|+.|+|+||||+...+
T Consensus 292 ~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 292 NRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred hcCCCCCHHHHhcCCCcCCCCH
Confidence 65 59999999999987544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=380.25 Aligned_cols=266 Identities=28% Similarity=0.373 Sum_probs=218.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|.+.+.||+|+||+||++.+..+|+.||+|+++.... .......+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEE
Confidence 469999999999999999999999999999999986533 33445678899999999999999999988876 567999
Q ss_pred EEecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++.+..+. .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 99999875544444 43467999999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccCchHhhhC-----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 256 PMTSRVVTLWYRPPELLLG-----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
......||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+.++....... ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------~~ 230 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL--------KF 230 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc--------CC
Confidence 2334578999999999863 3347889999999999999999999999888777766664321000 00
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 391 (457)
.....+++++.+||..||. ||.+|||++++++||||+...+..
T Consensus 231 -----------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 231 -----------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 0112467889999999998 999999999999999999865543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=387.14 Aligned_cols=280 Identities=24% Similarity=0.312 Sum_probs=218.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC------CCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH------PNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~~~ 170 (457)
.++|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.++| .+|+.+++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~- 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE- 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-
Confidence 578999999999999999999999999999999996432 222345567777777754 4588888888653
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCC-------------
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDG------------- 236 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~------------- 236 (457)
...+|+|||+++++++..+... ..+++.++..++.||+.||.|||+ .|||||||||+||||+.++
T Consensus 204 ~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 4578999999988887766543 579999999999999999999998 5999999999999998765
Q ss_pred ---cEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036122 237 ---ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313 (457)
Q Consensus 237 ---~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i 313 (457)
.+||+|||++.... ...+..+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+
T Consensus 283 ~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCc----cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 49999999886432 2234568999999999998776 899999999999999999999999999999999999
Q ss_pred HHhcCCCChhhhhhcCCCCcc-------cCCCCCCcccchhcc-----cC--CCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 314 FKLCGSPSEEYWKKSKLPNAT-------LFKPQQPYKRCIAET-----FK--DFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-----~~--~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
.+.+|.++..++......... ...+... ...+... +. ...+.+.|||.+||++||.+|||++|+|
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTD-PKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCC-HHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 999998877654322111000 0000000 0000000 00 0134577999999999999999999999
Q ss_pred cCCCCCCC
Q 036122 380 NSEFFNTE 387 (457)
Q Consensus 380 ~hp~f~~~ 387 (457)
+||||++.
T Consensus 437 ~Hp~~~~~ 444 (467)
T PTZ00284 437 THPYVLKY 444 (467)
T ss_pred cCcccccc
Confidence 99999874
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=383.57 Aligned_cols=263 Identities=29% Similarity=0.401 Sum_probs=214.0
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.++++++|+||+++++.+.+ ...+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 58999999999999999999999999999999975432 23445678899999999999999999999887 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC----
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL---- 253 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~---- 253 (457)
|||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 9999886555555555679999999999999999999999999999999999999999999999999975331000
Q ss_pred ------------------------------------------CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHH
Q 036122 254 ------------------------------------------KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCIL 291 (457)
Q Consensus 254 ------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl 291 (457)
.......+||+.|+|||++.+.. ++.++|||||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil 238 (382)
T cd05625 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVIL 238 (382)
T ss_pred cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHH
Confidence 00012347899999999998766 78999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC
Q 036122 292 AELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN 371 (457)
Q Consensus 292 ~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 371 (457)
|||++|++||.+.+..+...++........ ......+++++.+||.+|+ .||.+
T Consensus 239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~p~~~~~s~~~~~li~~l~-~~p~~ 292 (382)
T cd05625 239 YEMLVGQPPFLAQTPLETQMKVINWQTSLH-------------------------IPPQAKLSPEASDLIIKLC-RGPED 292 (382)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHccCCCcC-------------------------CCCcccCCHHHHHHHHHHc-cCHhH
Confidence 999999999998887766665543111000 0011346888999999987 59999
Q ss_pred CcC---HHHHhcCCCCCCCCCC
Q 036122 372 RGT---ATAALNSEFFNTEPYA 390 (457)
Q Consensus 372 Rpt---a~elL~hp~f~~~~~~ 390 (457)
|++ ++++++||||+...+.
T Consensus 293 R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 293 RLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred cCCCCCHHHHhcCCCcCCcChH
Confidence 997 9999999999886543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=372.82 Aligned_cols=250 Identities=30% Similarity=0.415 Sum_probs=209.6
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD 184 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~ 184 (457)
||+|+||.||+|++..+++.||+|++..... .......+.+|+.++++++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975422 33445667889999999999999999988876 56799999999987
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccC
Q 036122 185 LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264 (457)
Q Consensus 185 l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~ 264 (457)
.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 665555556679999999999999999999999999999999999999999999999999998543221 2234457899
Q ss_pred ccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCccc
Q 036122 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKR 344 (457)
Q Consensus 265 ~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (457)
.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 158 ~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------------------------- 209 (312)
T cd05585 158 EYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--------------------------- 209 (312)
T ss_pred ccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------------------------
Confidence 999999998766 7999999999999999999999999887776665553210
Q ss_pred chhcccCCCCCCcHHHHHHhccCCCCCCc---CHHHHhcCCCCCCCC
Q 036122 345 CIAETFKDFPSSSLPLIETLLSIDPDNRG---TATAALNSEFFNTEP 388 (457)
Q Consensus 345 ~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp---ta~elL~hp~f~~~~ 388 (457)
......+++++.+||.+||..||.+|| ++.++|.||||....
T Consensus 210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 011134678899999999999999997 589999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=372.67 Aligned_cols=259 Identities=27% Similarity=0.508 Sum_probs=234.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.+-|.+.+.||+|.|.+|-+|+|.-+|..||||++.+..++.-....+.+|+..|+.++|||||+||++... +..+||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEE
Confidence 467999999999999999999999999999999999888877777788899999999999999999999877 678999
Q ss_pred EEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-CCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+|+-++ ++.+++.....-+.|..+++|+.||+.|+.|+|+..+|||||||+||++. .-|-|||+|||++..+.++
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-- 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-- 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--
Confidence 9999987 67777777777799999999999999999999999999999999998775 6789999999999998877
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
...++.+|+..|.|||+++|..|..+++||||||||||-|++|++||...++.+.+.+|+..-++
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--------------- 237 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--------------- 237 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc---------------
Confidence 55788899999999999999998889999999999999999999999999999999998764322
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
....++.+.+|||..||..||.+|.|++++..|+|++...
T Consensus 238 --------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 238 --------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred --------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 2234678899999999999999999999999999999754
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=374.78 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=211.1
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEeccc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
+.||+|+||.||++++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 23445677889999999999999999988876 567999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc
Q 036122 183 HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262 (457)
Q Consensus 183 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 262 (457)
++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+|
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 157 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG 157 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence 8766666656667999999999999999999999999999999999999999999999999998754221 122344578
Q ss_pred cCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCc
Q 036122 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342 (457)
Q Consensus 263 t~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (457)
|+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+....
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~------------------------- 211 (328)
T cd05593 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED------------------------- 211 (328)
T ss_pred CcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC-------------------------
Confidence 99999999998766 7899999999999999999999998877766555442210
Q ss_pred ccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 343 KRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 343 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
......+++++.+||++||..||++|+ ++.|+++||||....|
T Consensus 212 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 212 ----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred ----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 001134678899999999999999997 8999999999987544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=381.20 Aligned_cols=267 Identities=24% Similarity=0.360 Sum_probs=219.5
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..++|++.+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~ 118 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYL 118 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEE
Confidence 35789999999999999999999999999999999975322 22334557789999999999999999988876 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999987655555443 3589999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccccccCccCchHhhhCC---cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGA---TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
......+||+.|+|||++.+. ..++.++|||||||++|||++|.+||.+.+......++........
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------- 267 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---------- 267 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC----------
Confidence 233456799999999998753 2378899999999999999999999999887777666643210000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC--CcCHHHHhcCCCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN--RGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~ 390 (457)
......++.++.+||++||+.+|.+ |+|++++++||||+...|.
T Consensus 268 ---------------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 268 ---------------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred ---------------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 0011246788999999999999998 9999999999999986554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=376.38 Aligned_cols=264 Identities=28% Similarity=0.398 Sum_probs=209.2
Q ss_pred CccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCc
Q 036122 99 TFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNL--EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 172 (457)
+|++.+.||+|+||+||++++. .+++.||+|++..... .....+.+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4889999999999999999864 4789999999975322 223345678899999999 59999999988876 56
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 79999999998655555555567999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.........||+.|+|||++.+...++.++|||||||++|||+||..||...........+.......
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~------------ 226 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC------------ 226 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC------------
Confidence 33333456799999999999876557889999999999999999999997543221111111100000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
. ......+++.+.+||.+||+.||++|| +++++++||||+...+
T Consensus 227 ----~---------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 227 ----D---------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred ----C---------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0 011124677889999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=373.86 Aligned_cols=253 Identities=27% Similarity=0.392 Sum_probs=211.9
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEeccc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
+.||+|+||.||++++..+|..||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 23345567789999999999999999998877 567999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc
Q 036122 183 HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262 (457)
Q Consensus 183 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 262 (457)
++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ........|
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 157 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 157 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccC
Confidence 8766666666667999999999999999999999999999999999999999999999999998753221 122334578
Q ss_pred cCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCc
Q 036122 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342 (457)
Q Consensus 263 t~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (457)
|+.|+|||++.+.. ++.++|||||||++|||++|..||...+.......+.....
T Consensus 158 t~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~------------------------ 212 (323)
T cd05595 158 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------------------ 212 (323)
T ss_pred CcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 99999999997765 78999999999999999999999988877766665532100
Q ss_pred ccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 343 KRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 343 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
.....+++++.+||.+||+.||.+|+ ++.++++||||.+..|
T Consensus 213 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 213 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 01134678899999999999999998 9999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=361.42 Aligned_cols=285 Identities=41% Similarity=0.689 Sum_probs=236.0
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||+|.+..+|..||+|++............+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 5889999999999999999998899999999998765545555678899999999999999999999877 56789999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||+.+++...+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++............
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99966676666555567999999999999999999999999999999999999999999999999999876544322344
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC-CCcccCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-PNATLFK 337 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~ 337 (457)
...++..|+|||++.+...++.++|||||||++|+|++|.++|.+.++.+.+..+....+.+....|+.... +......
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 567899999999987666578999999999999999999999999999899999988888887776664321 1111111
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
........+...++..+..+.+||.+||+.||++|||++++|+||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 111111123345567788999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=383.13 Aligned_cols=264 Identities=28% Similarity=0.379 Sum_probs=213.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|++++|+||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEE
Confidence 369999999999999999999999999999999865322 22334567889999999999999999998877 568999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC---
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL--- 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~--- 253 (457)
||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 99999886665555556679999999999999999999999999999999999999999999999999975321000
Q ss_pred ---------------------------------------CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHH
Q 036122 254 ---------------------------------------KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL 294 (457)
Q Consensus 254 ---------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~el 294 (457)
.......+||+.|+|||++.+.. ++.++|||||||++|||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeeh
Confidence 00012357999999999998766 78999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-
Q 036122 295 LAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG- 373 (457)
Q Consensus 295 ltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp- 373 (457)
++|++||.+.+..+...++....... .......+++++.+||.+|+ .+|.+|+
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETTL-------------------------HIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCccc-------------------------cCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 99999999888776655543211000 00011346788899999977 5999999
Q ss_pred --CHHHHhcCCCCCCCCCC
Q 036122 374 --TATAALNSEFFNTEPYA 390 (457)
Q Consensus 374 --ta~elL~hp~f~~~~~~ 390 (457)
|+.++++||||+...+.
T Consensus 292 ~~t~~ell~h~~~~~~~~~ 310 (376)
T cd05598 292 KNGADEIKAHPFFKGIDFA 310 (376)
T ss_pred CCCHHHHhCCCCcCCCCHH
Confidence 99999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=362.52 Aligned_cols=287 Identities=46% Similarity=0.776 Sum_probs=235.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||.|+||.||+|.+..+++.||+|.++...........+.+|+.++++++||||+++++++.......+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46799999999999999999999989999999999865544333445678999999999999999999987754478999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~ 162 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KP 162 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cc
Confidence 99999987777666555569999999999999999999999999999999999999999999999999998664332 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~ 335 (457)
.....+++.|+|||.+.+...++.++||||||+++|+|++|.+||...+..+.+.++...++.+....|.... ++....
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 3345678899999998776657889999999999999999999999999999999999999988888776532 222111
Q ss_pred CCCCCCcccchhcccCC--CCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 336 FKPQQPYKRCIAETFKD--FPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~--~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
..........+...++. +++.+.+||++||+.||++|||+.|+|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 11111111122333444 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=377.70 Aligned_cols=266 Identities=26% Similarity=0.357 Sum_probs=216.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||++++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLY 119 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEE
Confidence 5789999999999999999999999999999999975322 23334567789999999999999999998877 56899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+..+.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999876555554433 5899999999999999999999999999999999999999999999999999876533222
Q ss_pred CcccccccCccCchHhhhCCc---CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 256 PMTSRVVTLWYRPPELLLGAT---YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....+||+.|+|||++.+.. .++.++|||||||++|+|++|.+||.+.+......++........ .
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~-- 268 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN--------F-- 268 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC--------C--
Confidence 334567999999999997542 378899999999999999999999999888777766644211100 0
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC--CcCHHHHhcCCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN--RGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~ 390 (457)
.....++..+.+||..||..++.+ |+|++|+++||||+...+.
T Consensus 269 ---------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 269 ---------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred ---------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 011236778899999999866654 8999999999999885443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=369.51 Aligned_cols=284 Identities=23% Similarity=0.317 Sum_probs=216.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||++++..+|..||+|++.... .......+.+|+.+|++++||||+++++++.. ...+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999997643 34455678899999999999999999999887 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++.+..+......+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 157 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---
Confidence 999999876666666666799999999999999999999986 6999999999999999999999999999765332
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc-CCCCc-
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS-KLPNA- 333 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~- 333 (457)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+....+...........+... ..+..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 223457899999999998765 799999999999999999999999877665543322111100000000000 00000
Q ss_pred -c----cCCCCCCccc-------chhc-----ccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 -T----LFKPQQPYKR-------CIAE-----TFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 -~----~~~~~~~~~~-------~~~~-----~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. ......+... .... ....+++++++||.+||++||++|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0 0000000000 0000 012356788999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=375.05 Aligned_cols=259 Identities=29% Similarity=0.445 Sum_probs=230.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|..++++|+|+||.+++++++..++.|++|.+..............+|+.+++++.|||||.+.+.|... ++.++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEE
Confidence 3689999999999999999999999999999999998887666666788999999999999999999998873 445999
Q ss_pred EEecccCCHHHHHHh-c-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAAC-Q-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~-~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||+||+|+.+...+. . +..|+++.+..|+.||+.|+.|||+++|+|||||+.|||++.++.|||+|||+|+...+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999876554433 3 4679999999999999999999999999999999999999999999999999999887653
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
....+.+||+.||+||++.+.+ |+.++|||||||++|||++-+++|.+.+......+|++....|-
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl------------- 226 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL------------- 226 (426)
T ss_pred hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC-------------
Confidence 3557789999999999998877 89999999999999999999999999999999999988654332
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
...++.++..||+.||..+|+.||++.++|.+|.++.
T Consensus 227 ---------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 227 ---------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ---------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 2346788999999999999999999999999999873
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=370.19 Aligned_cols=268 Identities=25% Similarity=0.324 Sum_probs=214.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||+||++++..+++.||+|++.... ........+.+|+.++..++|+||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEE
Confidence 47999999999999999999999999999999997532 233345568889999999999999999998877 568999
Q ss_pred EEecccCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+.++.+. .+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 99999875444 44333567999999999999999999999999999999999999999999999999999765433222
Q ss_pred CcccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 256 PMTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF----------- 227 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc-----------
Confidence 2233568999999999863 2347889999999999999999999999887776666553311000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC--CcCHHHHhcCCCCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN--RGTATAALNSEFFNTEPYAC 391 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~~ 391 (457)
.+......++.++.+||++||..++++ |+++.++|+||||....+..
T Consensus 228 -------------~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 276 (331)
T cd05597 228 -------------QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276 (331)
T ss_pred -------------cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHH
Confidence 011122347888999999999765554 88999999999998865543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=371.08 Aligned_cols=254 Identities=26% Similarity=0.377 Sum_probs=211.0
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEeccc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
+.||+|+||.||++.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 469999999999999999999999999976432 23344567789999999999999999988877 567999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 183 HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 183 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
++.+.........+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||+++..... ........
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFC 157 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Cccccccc
Confidence 87766666666679999999999999999999997 79999999999999999999999999998754222 12233457
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (325)
T cd05594 158 GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI----------------------- 213 (325)
T ss_pred CCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 899999999998766 78999999999999999999999988877666555422100
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
.....+++++.+||++||+.||++|+ ++.++|+||||.+..+.
T Consensus 214 ------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 214 ------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 01123677889999999999999997 99999999999975443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=365.92 Aligned_cols=277 Identities=37% Similarity=0.654 Sum_probs=213.5
Q ss_pred ceeeccCceEEEEEEEcC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLL--TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~--~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
.+||+|+||.||+|++.. ++..||+|.+...... ..+.+|+.++++++||||+++++++.......+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 579999999999998654 5678999998654322 3467899999999999999999998766567889999999
Q ss_pred cCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----cCCCcEEEeeccCcccc
Q 036122 182 EHDLAGLAACQ--------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFY 249 (457)
Q Consensus 182 ~~~l~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~~~ 249 (457)
++++...+... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 99877665321 2358899999999999999999999999999999999999 56679999999999876
Q ss_pred CCCCC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcC
Q 036122 250 DPGLK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIFKLCG 318 (457)
Q Consensus 250 ~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---------~~~~~~i~~~~~ 318 (457)
..... .......+|+.|+|||++.+...++.++|||||||++|||+||.+||..... ...+.+++..++
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 43322 1223457899999999998766689999999999999999999999975432 355677888888
Q ss_pred CCChhhhhhcCC-CCcccCC-----C---CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 319 SPSEEYWKKSKL-PNATLFK-----P---QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 319 ~~~~~~~~~~~~-~~~~~~~-----~---~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.+....|..... +...... . ...............+..+++||.+||+.||.+|||++|+|+||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 888777765321 1100000 0 0000000111112235568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=378.29 Aligned_cols=265 Identities=28% Similarity=0.383 Sum_probs=216.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++++.||+|+||.||++.+..+++.||+|+++.... .......+.+|+.++..++|+||+++++.+.. ...+|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 468999999999999999999999999999999975322 33445678889999999999999999998876 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC--
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-- 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 254 (457)
||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 79 v~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 79 IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred EEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999876665555566799999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCC
Q 036122 255 --------------------------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP 302 (457)
Q Consensus 255 --------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~ 302 (457)
......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCC
Confidence 0012357999999999998766 7899999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc---CHHHHh
Q 036122 303 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG---TATAAL 379 (457)
Q Consensus 303 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp---ta~elL 379 (457)
+.+..+...++....... .. .....+++++.+||.+|+. ||.+|+ ++++++
T Consensus 238 ~~~~~~~~~~i~~~~~~~--------~~-----------------p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 238 SETPQETYRKVMNWKETL--------VF-----------------PPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCHHHHHHHHHcCCCce--------ec-----------------CCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 888877766654310000 00 0011267789999999874 999998 589999
Q ss_pred cCCCCCCCCCCC
Q 036122 380 NSEFFNTEPYAC 391 (457)
Q Consensus 380 ~hp~f~~~~~~~ 391 (457)
+||||++..|..
T Consensus 292 ~hp~f~~~~~~~ 303 (360)
T cd05627 292 SHPFFEGVDWGH 303 (360)
T ss_pred cCCCCCCCCHHH
Confidence 999999876643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.39 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=210.6
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||+||+|+++.+++.||||++..... .......+..|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999975432 223445667788888876 69999999998877 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
+++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccccc
Confidence 987666666566679999999999999999999999999999999999999999999999999987542221 2234457
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (320)
T cd05590 158 GTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------------------- 213 (320)
T ss_pred cCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC-----------------------
Confidence 899999999998665 78999999999999999999999999888777766643110
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCH------HHHhcCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA------TAALNSEFFNTEPY 389 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta------~elL~hp~f~~~~~ 389 (457)
.....++.++.+||++||+.||.+|+++ +++++||||+...+
T Consensus 214 ------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 214 ------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred ------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 0112367788999999999999999998 99999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=360.22 Aligned_cols=289 Identities=43% Similarity=0.736 Sum_probs=233.7
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE---PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
+|++.+.||+|+||.||+|.+..+|+.||||.+...... ......+..|+.++++++|+||+++++++.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 478889999999999999999889999999999865433 2334557789999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.+++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-R 157 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-c
Confidence 999999666655554433379999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~ 334 (457)
......+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.++.+.+.++...++.+....|.... ++...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 22334568889999998765557899999999999999999999999999888888888888887777665422 11111
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACE 392 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~ 392 (457)
.. ...........+...+..+.+||.+||..||++|||+.|+|.||||++.+.+..
T Consensus 238 ~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EF--KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cc--cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 11 111111223344566788999999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=356.85 Aligned_cols=281 Identities=38% Similarity=0.621 Sum_probs=227.2
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEEEE
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
|++.+.||+|+||.||+|.+..+++.||+|+++......... ...+|+.++.++. |+||+++++++.+.....+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 677899999999999999999999999999987643332222 3347899999885 99999999999875446799999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||++++++..+......+++.++..++.||+.||.|||+.|++|+||||+||+++. +.+||+|||++...... ....
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~ 156 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYT 156 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcC
Confidence 99999888877665567999999999999999999999999999999999999999 99999999999866432 2223
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
...++..|+|||++.+...++.++|||||||++|||++|.+||.+.+..+....+....+.+...............+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 45678999999988665557889999999999999999999999999888888888888877765533222111111111
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......+......++.++.+||.+||+.||++|||++++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111222333345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=369.03 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=213.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCC-CceeEeeeEEecCCceEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHP-NVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~~l 176 (457)
+|++++.||+|+||.||+|++..+++.||||++..... .......+..|+.++..+.|+ +|+.+++++.. ...+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 58899999999999999999999999999999976432 233455677899999999765 57888888776 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 99999886665555555679999999999999999999999999999999999999999999999999987432111 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
....+||+.|+|||++.+.. ++.++|||||||++|+|+||++||.+.+..+.+..+.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (324)
T ss_pred eeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------------
Confidence 33457899999999998766 78999999999999999999999998888777766643110
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH-----HHHhcCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA-----TAALNSEFFNTEPY 389 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~hp~f~~~~~ 389 (457)
.....+++++.+||.+||..||.+|++. +++++||||....|
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 219 -----------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0112467788999999999999999986 89999999987544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=355.23 Aligned_cols=283 Identities=35% Similarity=0.601 Sum_probs=226.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++|+||+++++++.. ...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 46899999999999999999999899999999987554333334567889999999999999999999877 5678999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++++..+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++........ ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DY 157 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cc
Confidence 99999998887776666799999999999999999999999999999999999999999999999999987654321 22
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh---cCCCCcc
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK---SKLPNAT 334 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~ 334 (457)
....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......... ..... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 236 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK-G 236 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc-c
Confidence 3446788999999988755578999999999999999999999998888777766665554433221110 00000 0
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
...+...........+.+++..+.+||.+||+.||++|||+.|+|.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00111111112233456778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=368.63 Aligned_cols=256 Identities=26% Similarity=0.391 Sum_probs=210.9
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHH---HhcCCCCceeEeeeEEecCCceEE
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVL---RKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
|++++.||+|+||.||+|.+..+|+.||||+++.... .....+.+.+|+.++ +.++||||+++++++.. ...+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 6788999999999999999999999999999975432 223345566676655 56789999999999877 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.++.+...... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~ 156 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GD 156 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CC
Confidence 99999998766555443 46999999999999999999999999999999999999999999999999998753221 12
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~----------------- 218 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV----------------- 218 (324)
T ss_pred cccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------------
Confidence 234567899999999998765 78999999999999999999999999887777666543110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
.....+++.+.+||.+||+.||.+|| ++.++++||||+...+
T Consensus 219 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 219 ------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 01124677889999999999999999 7999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=368.55 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=211.2
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|++..+++.||+|++..... .......+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 469999999999999999999999999976432 233445567789998876 79999999999887 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
+++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-ccccccc
Confidence 987665555556679999999999999999999999999999999999999999999999999987543221 2234457
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+.....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~----------------------- 213 (321)
T cd05591 158 GTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV----------------------- 213 (321)
T ss_pred cCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 899999999998766 78999999999999999999999999888877776643110
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCc-------CHHHHhcCCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-------TATAALNSEFFNTEPYA 390 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-------ta~elL~hp~f~~~~~~ 390 (457)
.....+++++.+||.+||+.||++|+ +++++++||||....|.
T Consensus 214 ------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 214 ------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred ------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 00123577889999999999999999 99999999999875443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=360.82 Aligned_cols=282 Identities=42% Similarity=0.769 Sum_probs=228.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++++.||.|+||.||+|++..+|+.||||++............+.+|+.++++++||||+++++++.. ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEe
Confidence 4888999999999999999999999999999987654444444568889999999999999999999876 56799999
Q ss_pred ecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 179 EYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 179 E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
||+.+++...+... ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTY 157 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-ccc
Confidence 99987776655433 3568999999999999999999999999999999999999999999999999998654322 222
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcccC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNATLF 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~ 336 (457)
....++..|+|||++.+...++.++|||||||++|+|+||+.||.+.+..+.+.++++..+.+....|+... ++.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 334568899999988776656889999999999999999999999999888888888888888776664321 1111100
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.+. ..........+.+++++.+||.+||+.||.+|||++++|.||||
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 238 FPK-WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccc-ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 011 01111223345677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=359.54 Aligned_cols=288 Identities=48% Similarity=0.865 Sum_probs=235.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM------ 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 170 (457)
.++|++.+.||+|+||.||+|.+..+|+.||+|+++...........+.+|+.++++++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 57899999999999999999999999999999999865433334456778999999999999999999886632
Q ss_pred --CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 171 --SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 171 --~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
...+|+||||+++++...+......+++.++..++.||+.||.|||+.||+|+||||+||++++++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 236899999999988777665555799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.............++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+.++.+....|+..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 65443333334456888999999876555788999999999999999999999999988999999988888877666542
Q ss_pred C-CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 329 K-LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 329 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
. .+..............+...+..++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 2 1111111111112223334455678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=366.47 Aligned_cols=259 Identities=26% Similarity=0.372 Sum_probs=214.1
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 176 (457)
+|++.+.||+|+||.||+|++..+++.||||++..... .......+..|..++..+ +|++|+++++++.. ...+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 58889999999999999999999999999999986532 223344566788888877 58899999888876 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 99999876555555555679999999999999999999999999999999999999999999999999997543211 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....||+.|+|||++.+.. ++.++|||||||++|||+||++||.+.+..+....+.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred cccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 34467899999999998766 79999999999999999999999999888777776643210
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYA 390 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~ 390 (457)
.....+++++.+||.+||+.||.+|++ ..++++||||+...|.
T Consensus 219 -----------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 219 -----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred -----------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 011246778899999999999999998 4899999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=367.05 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=210.0
Q ss_pred cceeeccCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 103 LDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++.||+|+||.||++++. .+++.||+|+++.... .......+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEE
Confidence 367999999999999864 4788999999975432 22233557789999999999999999998877 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Ccc
Confidence 9999987666666666679999999999999999999999999999999999999999999999999987543221 223
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+....+..+.....
T Consensus 158 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~------------------- 217 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL------------------- 217 (323)
T ss_pred cccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 3457899999999998765 78999999999999999999999998887776666543110
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
.....+++.+.+||++||+.||++|| +++++++||||....+
T Consensus 218 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 218 ----------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 01134677889999999999999999 8999999999987543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=369.05 Aligned_cols=259 Identities=28% Similarity=0.405 Sum_probs=207.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|+.++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEE
Confidence 467899999999999999999999999999999986543 33445678899999999999999999999876 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.++.+.. ...+.+..+..++.||+.||.|||++||+||||||+||||++++.+||+|||+++...... ..
T Consensus 150 v~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 224 (353)
T PLN00034 150 LLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP 224 (353)
T ss_pred EEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence 999999865532 2246788889999999999999999999999999999999999999999999998764322 22
Q ss_pred cccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 257 MTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....+||..|+|||++.. ..+++.++|||||||++|||++|+.||......+....+.......
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 292 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ------------ 292 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC------------
Confidence 345678999999998743 2335678999999999999999999997443322222211110000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.......++.++.+||.+||+.||++|||+.|+|+||||....
T Consensus 293 -------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 -------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0011234677899999999999999999999999999998853
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=364.79 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=206.8
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHh-cCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRK-LDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|++..+++.||+|+++.... .......+..|..++.. ++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999976432 22333445567777765 489999999998876 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
+++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence 887666555556679999999999999999999999999999999999999999999999999997543222 2234567
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+.... +
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~--------------------- 213 (316)
T cd05592 158 GTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--P--------------------- 213 (316)
T ss_pred CCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C---------------------
Confidence 899999999998766 7899999999999999999999999988777666553210 0
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCH-HHHhcCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA-TAALNSEFFNTEPY 389 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-~elL~hp~f~~~~~ 389 (457)
.....++.++.+||.+||+.||.+||++ .++++||||....+
T Consensus 214 ------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 214 ------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 0112367788999999999999999986 58889999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=372.30 Aligned_cols=266 Identities=26% Similarity=0.358 Sum_probs=216.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.. ...+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~ 119 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY 119 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence 5799999999999999999999999999999999875322 23334567789999999999999999998876 56899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~ 198 (371)
T cd05622 120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198 (371)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence 99999987655555443 35899999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccCchHhhhCCc---CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 256 PMTSRVVTLWYRPPELLLGAT---YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~---~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....+||+.|+|||++.+.. .++.++|||||||++|||++|.+||.+.+......++........
T Consensus 199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----------- 267 (371)
T cd05622 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------- 267 (371)
T ss_pred cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc-----------
Confidence 334567999999999997532 378899999999999999999999999887777666643211000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC--CcCHHHHhcCCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN--RGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~ 390 (457)
......++..+.+||..||..++.+ |++++++++||||++..+.
T Consensus 268 --------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 268 --------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred --------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 0012357888999999999844443 7899999999999886553
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.39 Aligned_cols=288 Identities=47% Similarity=0.823 Sum_probs=233.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM------ 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 170 (457)
.++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999999999999998765433333345678999999999999999998875432
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...+|+||||+.+++...+......+++..+..++.||+.||.|||++||+|+||||+|||+++++.+||+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 23579999999998887776666679999999999999999999999999999999999999999999999999998654
Q ss_pred CCCC----------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 036122 251 PGLK----------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP 320 (457)
Q Consensus 251 ~~~~----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~ 320 (457)
.... ...+...+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+.....+.++...+.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 3211 112334678899999998776557899999999999999999999999999999999999988887
Q ss_pred ChhhhhhcC-CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 321 SEEYWKKSK-LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 321 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
....|.... ++..............+...+..+.+.+.+||.+||+.||.+|||+.++|.||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 776665432 2211111111111222334455677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=355.46 Aligned_cols=284 Identities=38% Similarity=0.676 Sum_probs=226.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.++++++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEE
Confidence 46899999999999999999999889999999998754322 122345689999999999999999999876 568999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.+++...+......+++..++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~ 159 (291)
T cd07844 81 VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KT 159 (291)
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-cc
Confidence 99999988877666555678999999999999999999999999999999999999999999999999987543221 11
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhcCCCC-cc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSKLPN-AT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~ 334 (457)
.....++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+..+.+..+.+..+.|....... ..
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 2233568899999998765557889999999999999999999998766 567778888888888877776532111 11
Q ss_pred cCCCCCCcccchhcccCCCC--CCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFP--SSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~--~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
...........+......++ .++.+||.+||+.||++|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 11100001111223333444 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=366.72 Aligned_cols=267 Identities=24% Similarity=0.308 Sum_probs=214.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||++++..+++.||+|++.... ........+.+|+.++..++|+||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEE
Confidence 47899999999999999999999999999999986432 122334557889999999999999999988876 567999
Q ss_pred EEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+.++.+ ..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999987544 444443567999999999999999999999999999999999999999999999999999765433222
Q ss_pred CcccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 256 PMTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||...+..+.+.++.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----------- 227 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc-----------
Confidence 2334578999999999863 3347889999999999999999999999888777776664311000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC--CcCHHHHhcCCCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN--RGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~ 390 (457)
.+......+++++.+||++||..++.+ |++++++++||||++..|.
T Consensus 228 -------------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 228 -------------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred -------------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 011122457888999999999776555 7899999999999986543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=358.60 Aligned_cols=256 Identities=27% Similarity=0.381 Sum_probs=205.0
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD 184 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~ 184 (457)
||+|+||+||++.+..+|+.||+|++...... ......+..|+.+++.++|+||+++++++.. ...+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 79999999999999999999999999754332 2234567789999999999999999988876 56799999999886
Q ss_pred HHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccc
Q 036122 185 LAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR 260 (457)
Q Consensus 185 l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 260 (457)
.+..... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ......
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-cccccc
Confidence 5544332 34569999999999999999999999999999999999999999999999999998664332 122345
Q ss_pred cccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCC
Q 036122 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQ 340 (457)
Q Consensus 261 ~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (457)
.||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+........
T Consensus 158 ~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 217 (280)
T cd05608 158 AGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS------------------- 217 (280)
T ss_pred CCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-------------------
Confidence 7899999999998766 78999999999999999999999987543322222211110000
Q ss_pred CcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 341 PYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
......+++.+.+|+.+||+.||++|| |++++++||||+...+.
T Consensus 218 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 218 ------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 011234778899999999999999999 89999999999986544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=358.83 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=212.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+|++.+.||+|+||+||++.+..+++.||+|++...... ......+.+|+.+++.++||||+++++.+.. ...+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 488899999999999999999899999999999754332 2223456789999999999999999998876 4679999
Q ss_pred EecccCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHDLAGLAA-CQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~-~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||+.++.+.... .. ...+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~ 156 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--E 156 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--C
Confidence 9999876554333 22 346999999999999999999999999999999999999999999999999999865432 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--------------
Confidence 223457899999999998765 78999999999999999999999988766554444332211000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
......++..+.+||.+||..||.+|| +++++++||||....+.
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 222 -----------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred -----------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 011234677889999999999999999 99999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=364.40 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=206.6
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|++..+|+.||+|+++.... .......+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 469999999999999999999999999976432 122334566788888754 89999999998877 56899999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ........
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccC
Confidence 98665555555667999999999999999999999999999999999999999999999999998743221 12234567
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+....+.... +
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--~--------------------- 213 (316)
T cd05620 158 GTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--P--------------------- 213 (316)
T ss_pred CCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C---------------------
Confidence 899999999998766 7899999999999999999999999887766665542210 0
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCH-HHHhcCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA-TAALNSEFFNTEPY 389 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-~elL~hp~f~~~~~ 389 (457)
.....++.++.+||++||+.||++|+++ +++++||||+...+
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 214 ------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 0112366788999999999999999998 58889999988644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=354.28 Aligned_cols=282 Identities=38% Similarity=0.716 Sum_probs=230.4
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||.|++|.||+|++..+|..||||+++..... .....+.+|+.++++++|+||+++++++.. ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEE
Confidence 588999999999999999999999999999999765432 223456789999999999999999999887 56789999
Q ss_pred ecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 179 EYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 179 E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||+++++...+.... ..+++..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++........ .
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 78 EYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred ecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 999998777665443 4689999999999999999999999999999999999999999999999999986543221 2
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....++..|++||++.+...++.++|||||||++|+|++|.+||.+.+..+...++.+....+....|...........
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 23456788999999987766578899999999999999999999999999999999998888888777764431111100
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
..............+.+++.+.++|.+||+.||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 001101111223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=356.46 Aligned_cols=286 Identities=42% Similarity=0.726 Sum_probs=227.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCC---ce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMS---CS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~---~~ 173 (457)
++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.+. |+||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999999999999999998765433333456778999999995 6999999988865321 23
Q ss_pred EEEEEecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-CCcEEEeeccCccc
Q 036122 174 LYLVFEYMEHDLAGLAACQ----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLATF 248 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~ 248 (457)
.|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 7999999999877665443 245899999999999999999999999999999999999998 89999999999986
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
+.... .......+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|...
T Consensus 161 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 161 FSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred cCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 54321 12233456889999999877665789999999999999999999999999988888888888887776665432
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
.........+.. .........+.+++++.+||.+||..||.+|||++|+|.||||+
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQW-KPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcc-cchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 111100000100 01112334456889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=355.80 Aligned_cols=286 Identities=41% Similarity=0.753 Sum_probs=231.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 57999999999999999999998899999999987654433444567889999999999999999999876 5689999
Q ss_pred EecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-CCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||+++++........ ..+++..+..++.||+.||.|||+++|+|+||+|+||+++. ++.+||+|||++....... .
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 9999988777665433 33688899999999999999999999999999999999985 5679999999997654321 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~ 334 (457)
......+++.|+|||++.+...++.++|||||||++|+|+||.+||...+..+.+.+++...+.+....|.... ++...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK 238 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence 22345678999999998776557889999999999999999999999998888888888888888887776421 22211
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...+... ........+.+++.+.++|.+||+.||++||++.++|.||||...
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 239 SAFPKWP-PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhcccCC-CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 1111101 112223345678899999999999999999999999999999874
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=367.63 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=210.7
Q ss_pred cceeeccCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 103 LDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
++.||+|+||.||++++. .+|+.||+|++............+.+|+.++++++||||+++++++.. ...+|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEc
Confidence 367999999999999763 578999999998654433344567789999999999999999999877 567999999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccc
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 259 (457)
|+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceec
Confidence 99876555555555679999999999999999999999999999999999999999999999999998654321 22344
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (457)
..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 158 ~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~--------------------- 215 (318)
T cd05582 158 FCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL--------------------- 215 (318)
T ss_pred ccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 67899999999998765 78899999999999999999999998887777666543110
Q ss_pred CCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
.....+++.+.+||++||+.||++||| +++++.||||+...+
T Consensus 216 --------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 216 --------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 011236778899999999999999999 788999999987543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=365.69 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=207.6
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREIL-VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||+||+|++..+|+.||||++..... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCC
Confidence 469999999999999999999999999975432 1222334445544 5678999999999988876 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ........
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFC 157 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcccccc
Confidence 98766666666668999999999999999999999999999999999999999999999999998753221 12234457
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (323)
T cd05575 158 GTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------ 212 (323)
T ss_pred CChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 899999999998766 7899999999999999999999999888777666654310
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCH----HHHhcCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA----TAALNSEFFNTEPY 389 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~hp~f~~~~~ 389 (457)
....+.+++.+.+||++||+.||.+||++ .+++.||||....+
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 -----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 01123467889999999999999999997 69999999987554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=365.18 Aligned_cols=267 Identities=23% Similarity=0.295 Sum_probs=214.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|.+.+.||+|+||.||++++..+++.||+|++.... ........+.+|+.++..++|+||+++++++.. ...+|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 47999999999999999999999999999999987532 223334557789999999999999999998876 568999
Q ss_pred EEecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 99999876554444 33567999999999999999999999999999999999999999999999999999866433222
Q ss_pred CcccccccCccCchHhhhCC----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 256 PMTSRVVTLWYRPPELLLGA----TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+...++.......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~----------- 227 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF----------- 227 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc-----------
Confidence 22345789999999998752 236889999999999999999999999887776666554311000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC--CcCHHHHhcCCCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN--RGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~ 390 (457)
.+.....++++++.+||.+||..++.+ |++++++++||||+...|.
T Consensus 228 -------------~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 228 -------------QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred -------------cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 011123457888999999999976655 5799999999999986554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=376.81 Aligned_cols=277 Identities=23% Similarity=0.300 Sum_probs=210.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|+|||++++++.. ....++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 4579999999999999999999999999999996432 224679999999999999999998877 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC-
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ- 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 255 (457)
|||++.+++...+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 238 v~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 238 VLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 9999998888877666667999999999999999999999999999999999999999999999999999866432211
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCC-CCCCC------hHHHHHHHHHhcCCCChhhhh--
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPI-MPGRT------EVEQLHKIFKLCGSPSEEYWK-- 326 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~p-f~~~~------~~~~~~~i~~~~~~~~~~~~~-- 326 (457)
......||+.|+|||++.+.. ++.++|||||||+||||++|..+ |.... ....+.++++..+....++..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 123457899999999998766 79999999999999999998754 43321 123344444433221111100
Q ss_pred ------hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 327 ------KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 327 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
...........+. ........+..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPA--YTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCc--cCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000000 000011122346778999999999999999999999999999975
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=367.82 Aligned_cols=280 Identities=24% Similarity=0.306 Sum_probs=216.7
Q ss_pred cCCccccceeeccCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL--LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..+|.+++.||+|+||.||+|... .++..||+|.+... ....+|+.+|++++|||||++++++.. ...+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW--KSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee--CCEE
Confidence 457999999999999999999754 35678999987643 224579999999999999999998876 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+|||++.+++...+ .....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 162 ~lv~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 999999998887766 4455799999999999999999999999999999999999999999999999999986643322
Q ss_pred C-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 255 Q-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 255 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
. ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.. ....+..+.+.++..+.++......
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 1 223457899999999998766 7899999999999999999999997654 3456677777666544333211000
Q ss_pred C------Cc-ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 331 P------NA-TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 331 ~------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
. .. ....+.......+ .-..++.++.+||++||..||++|||+.|+|.||||++.++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVI--RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hHHHHHHhhcccccCCccccchh--hccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 0 00 0000000000000 01245778899999999999999999999999999987543
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=369.53 Aligned_cols=277 Identities=24% Similarity=0.313 Sum_probs=211.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..+|++++.||+|+||.||+|++..++..||+|+..... ...|+.++++++|+||+++++++.. ....++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 134 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCM 134 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEE
Confidence 457999999999999999999999999999999854321 3468999999999999999999887 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.+++...+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 212 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PA 212 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cc
Confidence 9999999888887777778999999999999999999999999999999999999999999999999999754322 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCC-CCCCCCC---------hHHHHHHHHHhcCCCChhhhh
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGK-PIMPGRT---------EVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~-~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~ 326 (457)
.....||+.|+|||++.+.. ++.++|||||||++|||+++. ++|.... ....+..+...++..+..+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 213 FLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred cccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 23457899999999998766 799999999999999999864 5554322 123344444444443333221
Q ss_pred hcCCCCcc---c--CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 327 KSKLPNAT---L--FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 327 ~~~~~~~~---~--~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
........ . .....+...........++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 00000000 0 000011111111122356788899999999999999999999999999985
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=364.42 Aligned_cols=285 Identities=32% Similarity=0.554 Sum_probs=227.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++............+.+|+.++++++|+||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46899999999999999999999999999999998755444455566778999999999999999999886432 23
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+.+++...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 5799999999887766543 2899999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
. ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||...+......++...++.+..+++.......
T Consensus 172 ~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 172 F--MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred C--CCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 1 233456789999999998766 7899999999999999999999999999888899999989988876654422110
Q ss_pred cccCC--CC---CCcccc---------hhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFK--PQ---QPYKRC---------IAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~--~~---~~~~~~---------~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..... +. .++... ........++.+.+||.+||+.||++|||+.|+|.||||+.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 00000 00 000000 000112345678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=362.92 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=210.0
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||+||+|.+..+++.||||+++.... .......+.+|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999986432 233445677899999888 69999999999877 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccccee
Confidence 987666565566679999999999999999999999999999999999999999999999999987532211 2223457
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 158 g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~----------------------- 213 (318)
T cd05570 158 GTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV----------------------- 213 (318)
T ss_pred cCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 899999999998766 78999999999999999999999998877666655532100
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCH-----HHHhcCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA-----TAALNSEFFNTEPY 389 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~hp~f~~~~~ 389 (457)
.....++..+.+||++||..||.+|||+ .+++.||||+...+
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 214 ------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred ------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0112367788999999999999999999 99999999988544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.70 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=204.0
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|++..+++.||+|+++.... .......+.+|+.++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 469999999999999999999999999986533 233456678899999998 69999999999877 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
+++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCcccccc
Confidence 98665555555567999999999999999999999999999999999999999999999999998743211 12234467
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE--------VEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+.+.... .
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-----------~----- 220 (329)
T cd05588 158 GTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE-----------K----- 220 (329)
T ss_pred CCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----------C-----
Confidence 899999999998766 78999999999999999999999963211 1111111000 0
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC------HHHHhcCCCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT------ATAALNSEFFNTEPY 389 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt------a~elL~hp~f~~~~~ 389 (457)
.......++..+.+||++||+.||.+|+| ++++++||||....|
T Consensus 221 ------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 221 ------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 00011246778899999999999999987 799999999987544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=354.09 Aligned_cols=285 Identities=56% Similarity=0.971 Sum_probs=236.4
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++|+||+++++++........++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 67889999999999999999989999999999876433444456788999999999999999999988743367999999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccc
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 259 (457)
|+++++...+......+++.+++.++.||+.||.|||+.|++|+||||+|||+++++.+||+|||++...........+.
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccc
Confidence 99988777766555679999999999999999999999999999999999999999999999999998765443223344
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcccCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNATLFKP 338 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~ 338 (457)
..++..|+|||.+.+...++.++||||||+++|+|++|.+||...+....+..+.+.++.+....|.... +.......+
T Consensus 161 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd07840 161 RVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKP 240 (287)
T ss_pred cccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccc
Confidence 5678899999988765557899999999999999999999999999888999999988888777765432 112222223
Q ss_pred CCCcccchhcccCCC-CCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 339 QQPYKRCIAETFKDF-PSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~-~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......+...+... ++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 241 KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 333333344445554 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=353.97 Aligned_cols=284 Identities=35% Similarity=0.617 Sum_probs=227.2
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEE
Confidence 46899999999999999999998899999999987654443445667889999999999999999999876 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||+.++++..+......+++.++..++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9999998887776666669999999999999999999999999999999999999999999999999998664332 223
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC-CC-ccc
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL-PN-ATL 335 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~-~~~ 335 (457)
....++..|+|||++.+...++.++|||||||++|+|++|++||...+..+....+....+............ +. ...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 4456789999999998765578899999999999999999999998887777777776655443222111000 00 000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
..+............+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0111111112223456788899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=355.40 Aligned_cols=288 Identities=47% Similarity=0.722 Sum_probs=227.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM------ 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 170 (457)
.++|++.++||+|+||.||+|.+..+++.||||.+............+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46799999999999999999999999999999998765433333345668999999999999999999886532
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
....|+||||+.+++...+......+++.+++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 23579999999998877776666679999999999999999999999999999999999999999999999999998664
Q ss_pred CCCC---CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 251 PGLK---QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 251 ~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
.... .......++..|+|||++.+...++.++||||||+++|+|++|.+||.+.+.......+...++..+.+.|+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3221 1123346788999999987765578899999999999999999999999988888888888888777666554
Q ss_pred cCCCCc-ccCCCCCCcccchhccc--CCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 328 SKLPNA-TLFKPQQPYKRCIAETF--KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 328 ~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
...... ................. ...++.+.+||.+||..||.+|||++++|+||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 311110 00000000000111111 1135677899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=348.14 Aligned_cols=273 Identities=26% Similarity=0.393 Sum_probs=231.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|..+++||+|.||+|-+|+.+.+|+.||||+++++.. ..+.+.....|-.+|+..+||.+..|...|.. ...+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlC 244 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLC 244 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEE
Confidence 6889999999999999999999999999999999987653 45666777889999999999999998766665 67899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||..|+.+...+.+...|++...+.+..+|+.||.|||+++||+||||.+|+|++.+|++||+|||+++.-- ....
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~ 323 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGD 323 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc-cccc
Confidence 999999998777777777789999999999999999999999999999999999999999999999999997432 1224
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
...+.+|||.|+|||++.... |+.++|+|.+||+||||++|+.||...+.......|...- .
T Consensus 324 t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed----------~------- 385 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED----------L------- 385 (516)
T ss_pred eeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh----------c-------
Confidence 457789999999999998766 8999999999999999999999999988877766664321 0
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCCCC--CCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYACE--PSSLPKYPPS 402 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~~~--~~~~~~~~~~ 402 (457)
.....++++++.|+..+|.+||.+|.. +.|+.+|+||....|... ..-.|++.|.
T Consensus 386 ------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPq 447 (516)
T KOG0690|consen 386 ------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQ 447 (516)
T ss_pred ------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCC
Confidence 112358899999999999999999975 899999999999877532 2234445444
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=362.65 Aligned_cols=253 Identities=24% Similarity=0.412 Sum_probs=203.6
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.++.++ +||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999986532 234455677899998877 79999999999877 56899999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcccccc
Confidence 98766655555667999999999999999999999999999999999999999999999999999753221 12234467
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC--------hHHHH-HHHHHhcCCCChhhhhhcCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT--------EVEQL-HKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~--------~~~~~-~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ....+ ..+...
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------------- 220 (329)
T cd05618 158 GTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------------- 220 (329)
T ss_pred CCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------------
Confidence 899999999998766 7899999999999999999999995311 11111 111100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC------HHHHhcCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT------ATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt------a~elL~hp~f~~~~~ 389 (457)
.......++..+.+||++||+.||.+|+| ++++++||||+...|
T Consensus 221 -------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 221 -------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 00112346677899999999999999998 589999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=352.53 Aligned_cols=257 Identities=26% Similarity=0.478 Sum_probs=215.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.-|.++++||+|+||.||++.|+.+|+.+|||.+..+ ...+.+.+|+.||++++.|++|++||.|.. ...+|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCceEee
Confidence 4589999999999999999999999999999998754 345678899999999999999999998877 4679999
Q ss_pred EecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+- +..+.+..++++|++.++..+++.-+.||+|||...-+|||||..||||+.+|+.||+|||.|..+.+.. ..
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 999985 5666677788899999999999999999999999999999999999999999999999999998764332 33
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
..+..||+.|||||++..-. |+.++||||||+...||..|+|||..-.. +..|+-....|++.+.
T Consensus 186 RNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPPTF~----------- 250 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPPTFK----------- 250 (502)
T ss_pred hCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCCCCC-----------
Confidence 45678999999999998655 88999999999999999999999975443 2333333222222110
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.....+.++-|+|++||.++|++|-||.++++|||+++.+
T Consensus 251 ------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 251 ------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 0112466778899999999999999999999999999864
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=360.30 Aligned_cols=258 Identities=28% Similarity=0.395 Sum_probs=212.7
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 176 (457)
+|+..+.||+|+||+||+|+++.+|+.||+|++..... .......+..|+.++..+. |++|+++++++.. ...+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 47888999999999999999999999999999976432 2334456778899998886 5677888888776 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-cc
Confidence 99999986666565566679999999999999999999999999999999999999999999999999987543221 12
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~------------------ 218 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV------------------ 218 (323)
T ss_pred ccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 23456899999999998765 78999999999999999999999998887777666643210
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
.....++.++.+|+.+||+.||.+|++ .+++++||||+...|
T Consensus 219 -----------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 219 -----------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred -----------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 011246778899999999999999997 579999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=350.86 Aligned_cols=285 Identities=35% Similarity=0.624 Sum_probs=231.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||.||+|.+..+++.||+|+++...........+.+|+.++++++|+||+++++++.. ...+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 36899999999999999999999999999999987654444555778899999999999999999999987 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++++..+......+++.++..++.||+.||.|||+++++|+||+|+||++++++.+||+|||++...........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 99999988877766666799999999999999999999999999999999999999999999999999987654433244
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC-CcccC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP-NATLF 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~ 336 (457)
....++..|+|||++.+...++.++||||||+++|+|++|.+||.+.+..+.+..+...++......+...... .....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 55678899999999987745889999999999999999999999988888877777777776655443322110 00000
Q ss_pred C-CCCCcccchhccc-CCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 K-PQQPYKRCIAETF-KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~-~~~~~~~~~~~~~-~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
. +.......+...+ ..+++++.+||++||..||++|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 0000011112222 2358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=359.63 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=206.6
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHh-cCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRK-LDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|++..+++.||||+++.... .......+..|..++.. ++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999976432 12233445667888876 489999999999877 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
+++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeeec
Confidence 886665555555679999999999999999999999999999999999999999999999999987532211 2234457
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... .+
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~--------------------- 213 (316)
T cd05619 158 GTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP--------------------- 213 (316)
T ss_pred CCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC---------------------
Confidence 899999999998766 789999999999999999999999988876666554221 00
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCHH-HHhcCCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT-AALNSEFFNTEPYA 390 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~-elL~hp~f~~~~~~ 390 (457)
.....++.++.+||.+||+.||++||++. ++++||||+...+.
T Consensus 214 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 214 ------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred ------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 00123567789999999999999999996 89999999886543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.92 Aligned_cols=253 Identities=25% Similarity=0.371 Sum_probs=206.7
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHH-HHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREIL-VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||+||+|++..+|+.||+|++..... .......+..|.. +++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCC
Confidence 469999999999999999999999999975422 2233344555554 5677999999999988876 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~ 157 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFC 157 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCccccc
Confidence 98766666666678999999999999999999999999999999999999999999999999998753221 12234567
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+...++....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------ 212 (325)
T cd05604 158 GTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------ 212 (325)
T ss_pred CChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 899999999998766 7899999999999999999999999888776666553310
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCH----HHHhcCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA----TAALNSEFFNTEPY 389 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~hp~f~~~~~ 389 (457)
....+.++..+.+||++||+.||.+||++ .+++.||||....+
T Consensus 213 -----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 213 -----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred -----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 00113466778899999999999999976 59999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=351.36 Aligned_cols=281 Identities=43% Similarity=0.795 Sum_probs=227.9
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
|++.+.||.|++|.||+|.+..+|..||+|++............+.+|+.++++++||||+++++++.. ....|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEe
Confidence 678899999999999999999999999999998665444444567789999999999999999999876 578999999
Q ss_pred cccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 180 YMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 180 ~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
|+++++...+.... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~ 157 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYT 157 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccC
Confidence 99877666554433 368999999999999999999999999999999999999999999999999997654322 1223
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcccCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNATLFK 337 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~ 337 (457)
...++..|+|||++.+...++.++|||||||++|+|++|.+||...+....+.++.+..+.+....|.... ++......
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF 237 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence 34568899999988766557889999999999999999999999998888888888888888777664421 11111111
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
+... ..........+++.+.+||.+||+.||.+|||++|++.||||
T Consensus 238 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 238 PKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1100 111223356678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=350.21 Aligned_cols=284 Identities=38% Similarity=0.613 Sum_probs=222.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
+.+|.+++.||+|+||.||+|.+..+|..||+|++...... .....+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEE
Confidence 47899999999999999999999999999999998754322 222346689999999999999999999876 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.++++..+......+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++...... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-QT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC-CC
Confidence 99999988887776655678899999999999999999999999999999999999999999999999997543221 12
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhcC-CCCcc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT-EVEQLHKIFKLCGSPSEEYWKKSK-LPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~ 334 (457)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+ ..+.+.++....+.|....+.... ++...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 2334578999999998765557889999999999999999999997654 446677777777777666554321 11111
Q ss_pred cCCCCCCcccchhcccC--CCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 335 LFKPQQPYKRCIAETFK--DFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~--~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
...............+. ..+.++.+||.+||..||.+|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000000111111111 125678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.76 Aligned_cols=289 Identities=33% Similarity=0.536 Sum_probs=229.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---Cce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~ 173 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.++++++|+||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 468999999999999999999999999999999986432 2233455778999999999999999998876532 235
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||+++++...+. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 89999999988776553 3469999999999999999999999999999999999999999999999999998654321
Q ss_pred CC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 254 KQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 254 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.. ......||..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+...++.+..+.+......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 11 1233568999999999876555789999999999999999999999998888888888888888776665432211
Q ss_pred CcccCC--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 332 NATLFK--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 332 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
....+. ........+....+.+++++.+||.+||+.||++|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 110000 000111112233456788999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-47 Score=393.07 Aligned_cols=277 Identities=28% Similarity=0.376 Sum_probs=235.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|.+++.||+|+||.|.+++++.+++.||+|++++-.. .......|..|..+|..-+.+-|+.++..|.+ ..++|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LY 151 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLY 151 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceE
Confidence 5789999999999999999999999999999999976322 23444668899999999999999999877766 78899
Q ss_pred EEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
+||||++|| ++.++...+ ++++..+++|+..|+.||+.||+.|+|||||||+|||||..|++||+|||.+-.+..+..
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999875 555554444 899999999999999999999999999999999999999999999999999988887666
Q ss_pred CCcccccccCccCchHhhhC---C-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 255 QPMTSRVVTLWYRPPELLLG---A-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~---~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
-.....+|||.|++||+|.. + ..|+..+|+||+||++|||+.|..||...+-.+++.+|+..-.. ..+
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~--------l~F 302 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKES--------LSF 302 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhh--------cCC
Confidence 66777899999999999952 2 45899999999999999999999999999999999999764100 000
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC---HHHHhcCCCCCCCCCCCCCCCCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT---ATAALNSEFFNTEPYACEPSSLPKYPPS 402 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~hp~f~~~~~~~~~~~~~~~~~~ 402 (457)
| ...++|+++++||+++|. +|+.|.. ++++-.||||.+.+|.--....|++.|.
T Consensus 303 P-----------------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 303 P-----------------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred C-----------------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 0 112489999999999885 7898888 9999999999999996555566666664
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=365.42 Aligned_cols=252 Identities=26% Similarity=0.382 Sum_probs=205.0
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc---CCCCceeEeeeEEecCCceEEEEEecc
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL---DHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
||+|+||+||+|++..+|+.||+|++..... .......+..|..++..+ +||||+++++++.. ...+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999975432 122333455677777665 69999999988877 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 886665555566679999999999999999999999999999999999999999999999999987543221 2234567
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+..... .++
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------~~~---------- 217 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV----------RFP---------- 217 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC----------CCC----------
Confidence 899999999998766578999999999999999999999998877766655532100 000
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCc----CHHHHhcCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRG----TATAALNSEFFNTEP 388 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp----ta~elL~hp~f~~~~ 388 (457)
...+++++.+||++||+.||.+|| ++.++++||||....
T Consensus 218 --------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 218 --------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred --------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 013677889999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.94 Aligned_cols=296 Identities=41% Similarity=0.747 Sum_probs=236.7
Q ss_pred cCCcccc-ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH------------HHHHHHHHHHHHHhcCCCCceeEe
Q 036122 97 ANTFEKL-DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE------------SVKFMAREILVLRKLDHPNVIKLE 163 (457)
Q Consensus 97 ~~~y~~~-~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~------------~~~~~~~E~~~l~~l~hpniv~l~ 163 (457)
.++|..+ +.||.|+||+||+|.+..+++.||||++........ ....+.+|+.++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 3567654 669999999999999999999999999875432211 012467899999999999999999
Q ss_pred eeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeec
Q 036122 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 164 ~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
+++.. ...+++||||+.+++...+. ....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+||
T Consensus 87 ~~~~~--~~~~~lv~e~~~~~l~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 87 DVYVE--GDFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEEec--CCcEEEEEeccccCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99876 56799999999987776654 3456999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCC-------------CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHH
Q 036122 244 GLATFYDPG-------------LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 310 (457)
Q Consensus 244 Gla~~~~~~-------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~ 310 (457)
|++...... .........++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999765411 0111223456889999999987665789999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhhhhcC-CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 311 HKIFKLCGSPSEEYWKKSK-LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
..+....+.+....|+... ++....+... ............+..+.+||.+||+.||++|||++|+|.||||+..+.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~ 321 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPR--KPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcC--CcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCC
Confidence 9999998888877665432 1111111111 112233345567888999999999999999999999999999999877
Q ss_pred CCCCCCCC
Q 036122 390 ACEPSSLP 397 (457)
Q Consensus 390 ~~~~~~~~ 397 (457)
++.+...|
T Consensus 322 ~~~~~~~~ 329 (335)
T PTZ00024 322 PCDPSQLP 329 (335)
T ss_pred CCCcccCC
Confidence 76665544
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=360.71 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=206.5
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHH-HHHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREI-LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||+||+|++..+++.||+|++...... ......+..|. .+++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCC
Confidence 4699999999999999999999999999754321 12223334444 45688999999999998877 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......+
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~ 157 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC 157 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence 98766666666667999999999999999999999999999999999999999999999999999754221 12234567
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (325)
T cd05602 158 GTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------ 212 (325)
T ss_pred CCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC------------------------
Confidence 899999999998766 7899999999999999999999999888777766654310
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCHH----HHhcCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT----AALNSEFFNTEPY 389 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~----elL~hp~f~~~~~ 389 (457)
....+.+++.+.+||.+||+.||.+|+++. ++++|+||....|
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 213 -----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred -----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 011235778899999999999999999876 8999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=377.29 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=217.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC-----
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----- 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 171 (457)
.++|.+.+.||+|+||+||+|++..+|+.||||++............+.+|+.++..++|+||+++++.+.....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 478999999999999999999999999999999998776666667778899999999999999999877654221
Q ss_pred -ceEEEEEecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 172 -CSLYLVFEYMEHDLAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 172 -~~~~lv~E~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
..+++||||+.++.+..... ....+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls 190 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccC
Confidence 24789999998754443332 2346999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 247 TFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 247 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
+.+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------- 262 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------- 262 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-------
Confidence 86643211 2234467899999999998766 79999999999999999999999998887776665533110
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
......+++++.+||..||+.||.+|||+.++|+|||++.
T Consensus 263 ---------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 ---------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 0112346788999999999999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=358.75 Aligned_cols=283 Identities=24% Similarity=0.371 Sum_probs=213.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.++||+|+||.||++.+..++..+|+|++.... .......+.+|+.++++++|+||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEE
Confidence 478999999999999999999999999999999987643 34445678899999999999999999999987 568999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+.++.+..+......+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999998866655555556799999999999999999999985 7999999999999999999999999999765322
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh--cCCCChhhhhhcCCCCc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL--CGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~ 333 (457)
......||..|+|||++.+.. ++.++|||||||++|+|++|+.||......+... ++.. .+.+..........+..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL-MFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH-HhcCcccCCccccccCcccCCcc
Confidence 123456899999999997765 7899999999999999999999998765543322 2111 11111000000000000
Q ss_pred c---cCCCC-CCcc---c----chhcc-----cCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 T---LFKPQ-QPYK---R----CIAET-----FKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~---~~~~~-~~~~---~----~~~~~-----~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. ...+. .+.. . ..... ...++.++.+||.+||++||++|||+.|+|.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0 00000 0000 0 00000 01246678999999999999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.96 Aligned_cols=248 Identities=25% Similarity=0.437 Sum_probs=208.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
...+..++.||+|-||.||.|... ....||+|.++...... +.|.+|+++|++|+|+|||+++++|.. +..+||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~--~~piyI 278 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTK--QEPIYI 278 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEec--CCceEE
Confidence 456788999999999999999853 33379999998765443 346799999999999999999999988 447999
Q ss_pred EEecccCC-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHD-LAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|||||..+ |++.+.. .+..+...+...++.|||+|++||+++++|||||.+.||||+++..+||+|||||+...++..
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 99999875 5555554 466799999999999999999999999999999999999999999999999999996654433
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
......-....|.|||.+.... ++.+||||||||+||||+| |+.||.+.++.+.++.+.+...-|
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp------------- 424 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP------------- 424 (468)
T ss_pred eecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-------------
Confidence 3333333467899999998777 8999999999999999999 899999999999999886543221
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
....+|+++.+||..|+..+|++|||.+.+.
T Consensus 425 ---------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ---------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2245899999999999999999999998665
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=351.93 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=208.5
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|+||+.+++.+.. ...+|+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEE
Confidence 377889999999999999999999999999998755332 2334556789999999999999999988876 5679999
Q ss_pred EecccCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHDLAGLAAC--QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||+.++.+..... ....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99998765544332 22358999999999999999999999999999999999999999999999999997654321
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......|+..|+|||++.+.. ++.++|||||||++|+|++|.+||....................
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 223457899999999998766 78999999999999999999999987543221111111100000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
......+++++.+||.+||+.||++||| ++|+++||||++..+
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 222 -----------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred -----------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 0112346778899999999999999999 999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=358.76 Aligned_cols=253 Identities=24% Similarity=0.359 Sum_probs=204.6
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHH-HHHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREI-LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|++..+|+.||+|++..... .......+..|. .+++.++||||+++++++.. ...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 469999999999999999999999999975432 122233444555 46788999999999988876 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
+++.+.........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ........
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC 157 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence 98766555555667999999999999999999999999999999999999999999999999998753221 12234457
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+.......+....
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------ 212 (321)
T cd05603 158 GTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP------------------------ 212 (321)
T ss_pred CCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC------------------------
Confidence 899999999997765 7899999999999999999999999887766655553210
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCH----HHHhcCCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA----TAALNSEFFNTEPY 389 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~hp~f~~~~~ 389 (457)
.......+..+.+||.+||+.||.+|+++ .++++|+||....+
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 -----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 00112356678999999999999999875 59999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.24 Aligned_cols=289 Identities=37% Similarity=0.577 Sum_probs=231.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---Cce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~ 173 (457)
.++|.+.+.||+|+||+||++++..+|+.||||.+............+.+|+.+++.++|+||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999999999999999998754333344456778999999999999999999876532 135
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||+.+++...+. ....+++..+..++.||+.||.|||+++++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMDTDLHQIIR-SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCCCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 89999999987766554 44579999999999999999999999999999999999999999999999999998664321
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.+........
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 2234456789999999987654588999999999999999999999999988888888888888777665532211111
Q ss_pred ccC---CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 334 TLF---KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 334 ~~~---~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
..+ .+..+ ........+.+++++.+||.+||+.||++|||+.++|+||||....
T Consensus 242 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 242 RRYIRSLPYTP-RQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hHHHHhcCccc-ccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000 00000 0112233456888999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=344.00 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=211.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE---PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
++|.+.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 4689999999999999999999999999999998755332 2234568899999999999999999999887 4589
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
++||||++++.+.........+++..+..++.||+.||.|||+.||+|+||+|+||++++++.++|+|||+++.......
T Consensus 80 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 80 SIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999998866655555556799999999999999999999999999999999999999999999999999976543211
Q ss_pred CCc--ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 QPM--TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 ~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
... ....++..|+|||++.+.. ++.++|||||||++|+|++|++||...+..+...++.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------------- 224 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT-------------- 224 (263)
T ss_pred ccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--------------
Confidence 111 3346788999999998766 78999999999999999999999987665544433321100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......++..+.+||++||..||.+|||+.++|+||||
T Consensus 225 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 -------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 001123467788999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=348.10 Aligned_cols=260 Identities=31% Similarity=0.459 Sum_probs=209.8
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
|++.+.||+|+||+||++++..+++.||+|++..............+|+.++++++||||+++++++.. ...+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 778999999999999999999999999999998775444444445669999999999999999999987 677899999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccc
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 259 (457)
|+.++.+..+......+++.++..++.||+.||.+||++||+|+||||+|||++.++.++|+|||++.... ........
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~ 157 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNP 157 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99994444444445579999999999999999999999999999999999999999999999999997642 12233455
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (457)
..++..|+|||++.....++.++||||||+++|+|++|..||...........+.+.........+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 224 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ------------- 224 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-------------
Confidence 6789999999998834448999999999999999999999999875444444443322111111000
Q ss_pred CCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.....+..+.+||..||+.||++|||+.++++||||
T Consensus 225 ---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 001122678999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=360.72 Aligned_cols=290 Identities=33% Similarity=0.555 Sum_probs=233.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec--CCceEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR--MSCSLY 175 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~ 175 (457)
++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|++++||||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 689999999999999999999999999999999976544444556678899999999999999999887542 235689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK- 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~- 254 (457)
+||||+.+++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 lv~e~~~~~l~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMESDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhhhHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 999999887666554 345699999999999999999999999999999999999999999999999999976543221
Q ss_pred --CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 --QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+....+..+....|.++...+....-..
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 112345789999999998765557899999999999999999999999999888888888888888776654321110
Q ss_pred cccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 333 ATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 333 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.... .........+....+.+++++.++|++||+.||++|||++++|.||||.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0000 0000011112334566789999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=353.00 Aligned_cols=286 Identities=39% Similarity=0.649 Sum_probs=222.9
Q ss_pred CccccceeeccCceEEEEEEEcC--CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLL--TGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~--~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
+|++.++||+|+||.||+|.+.. ++..||+|.+..... .......+.+|+.+++.++||||+++++++.......+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48889999999999999999887 899999999986431 122235567899999999999999999999886557899
Q ss_pred EEEecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC----CCcEEEeeccCcc
Q 036122 176 LVFEYMEHDLAGLAACQ----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN----DGILKIADFGLAT 247 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~----~~~vkl~DFGla~ 247 (457)
+||||+++++...+... ...+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99999998877655322 236899999999999999999999999999999999999999 9999999999998
Q ss_pred ccCCCCC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH---------HHHHHHHHh
Q 036122 248 FYDPGLK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV---------EQLHKIFKL 316 (457)
Q Consensus 248 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~---------~~~~~i~~~ 316 (457)
....... .......++..|+|||++.+...++.++|||||||++|+|++|++||.+.+.. ..+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6643322 11233467899999999887666789999999999999999999999866532 356777777
Q ss_pred cCCCChhhhhhcC-CCCcccC---CCCCCcc----cchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 317 CGSPSEEYWKKSK-LPNATLF---KPQQPYK----RCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 317 ~~~~~~~~~~~~~-~~~~~~~---~~~~~~~----~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
++.+....|.... ++..... .....+. ....+.....+.++.++|.+||+.||++|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 7777766654321 1111110 0000111 11112223577889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=355.04 Aligned_cols=268 Identities=28% Similarity=0.443 Sum_probs=222.5
Q ss_pred CcCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 94 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
+-..+.|...++||+||||.||-|+.+.||+.||+|.+.+..... .......+|..||.+++.+.||.+-..|.. .+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--kd 258 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--KD 258 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--CC
Confidence 445788999999999999999999999999999999987654432 222345689999999999999999666665 56
Q ss_pred eEEEEEecccCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGV--KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
.+++||..|.|+-+.+.+.+.+ -|++..++.|+.+|+.||.+||+.+||+|||||+|||||+.|+++|+|+|+|..+.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 7999999999876665554433 69999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
.+ .+....+||.+|||||++.+.. |+...|+|||||++|||+.|+.||.........+.+-+..-..+.
T Consensus 339 ~g--~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~-------- 407 (591)
T KOG0986|consen 339 EG--KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPE-------- 407 (591)
T ss_pred CC--CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchh--------
Confidence 54 5567779999999999999888 899999999999999999999999865544333333222111111
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYAC 391 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~~ 391 (457)
+....|++++++|.+.+|+.||++|.. ++++-+||||+...|..
T Consensus 408 -----------------ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 408 -----------------EYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred -----------------hcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 223568999999999999999999864 78999999999987763
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=355.61 Aligned_cols=255 Identities=24% Similarity=0.406 Sum_probs=205.1
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||+||+|++..+++.||+|++..... .......+.+|+.++.++ +||||+.+++++.. ...+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 469999999999999999999999999986533 234456688899999888 69999999998877 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
+++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceeccc
Confidence 88766555555567999999999999999999999999999999999999999999999999998753221 12234567
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.... ..+.+.++... .+
T Consensus 158 gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~--------------- 219 (327)
T cd05617 158 GTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP--------------- 219 (327)
T ss_pred CCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC---------------
Confidence 899999999998766 7899999999999999999999996432 11122111110 00
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC------HHHHhcCCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT------ATAALNSEFFNTEPYA 390 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt------a~elL~hp~f~~~~~~ 390 (457)
......++..+.+||.+||+.||.+|++ .++++.||||+...|.
T Consensus 220 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 220 -----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred -----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 0111236778899999999999999998 5799999999986543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=337.07 Aligned_cols=256 Identities=24% Similarity=0.308 Sum_probs=210.0
Q ss_pred cCCcccc-ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC--Cc
Q 036122 97 ANTFEKL-DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM--SC 172 (457)
Q Consensus 97 ~~~y~~~-~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~--~~ 172 (457)
+++|.+. .+||-|-.|.|..|.++.+|+.+|+|++... ...++|+++.-.. .|||||.++++|.... ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 5778775 4599999999999999999999999998532 2345788776555 5999999999987532 34
Q ss_pred eEEEEEecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCcc
Q 036122 173 SLYLVFEYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLAT 247 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~ 247 (457)
.+.+|||.|+|+.+....+.. ..|+|.++..|++||+.|+.|||+.+|.||||||+|+|... |..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 688999999987665544443 45999999999999999999999999999999999999974 4589999999998
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE----VEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~----~~~~~~i~~~~~~~~~~ 323 (457)
.... .....+.+.|+.|.|||++.... |+..+|+||+||++|.|++|.|||..... .....+|......++.+
T Consensus 213 ~t~~--~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQE--PGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCC--CccccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 6653 24456778899999999987666 89999999999999999999999987653 23445555444444444
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.| ..++++++|||+.+|..+|.+|.|+++++.|||+.+.
T Consensus 290 EW-------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 290 EW-------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hH-------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 44 4478899999999999999999999999999999885
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=385.61 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=213.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+++.||+|+||+||+|++..++..||+|++............+..|+.+|++|+|||||+++++|.......+||
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 57899999999999999999999999999999999876666666677889999999999999999999987765677999
Q ss_pred EEecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeccCCCCCEEecC-----------
Q 036122 177 VFEYMEHDLAGLAACQ----GVKFSEPQVKCYMKQLLSGLEHCHNN-------GVLHRDIKGSNLLIDN----------- 234 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-------~ivHrDlkp~NILl~~----------- 234 (457)
||||+.++.+..++.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999987544433322 35699999999999999999999985 4999999999999964
Q ss_pred ------CCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChH
Q 036122 235 ------DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEV 307 (457)
Q Consensus 235 ------~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~ 307 (457)
.+.+||+|||++...... .......||+.|+|||++.+. ..++.++||||||||||+|+||.+||...+..
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 235999999999866432 223445789999999998643 34788999999999999999999999876655
Q ss_pred HHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 308 EQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 308 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..+....... + ...+..++.++.+||..||+.+|.+|||+.|+|.||||+..
T Consensus 250 ~qli~~lk~~--p--------------------------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 250 SQLISELKRG--P--------------------------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHhcC--C--------------------------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 4433322210 0 00123457789999999999999999999999999999864
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.80 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=201.6
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD 184 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~ 184 (457)
||+|+||.||++++..+|+.||+|++....... .....+..|++++++++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 799999999999999999999999997543322 223345679999999999999999988876 56799999999876
Q ss_pred HHHHHH-h-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc
Q 036122 185 LAGLAA-C-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262 (457)
Q Consensus 185 l~~~~~-~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 262 (457)
.+.... . ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .......|
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCC
Confidence 544333 2 2235889999999999999999999999999999999999999999999999999866432 22234568
Q ss_pred cCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCc
Q 036122 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342 (457)
Q Consensus 263 t~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (457)
+..|+|||++.+.. ++.++|||||||++|+|++|..||...........+....-..
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 213 (277)
T cd05607 157 TNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED---------------------- 213 (277)
T ss_pred CCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc----------------------
Confidence 99999999998776 8999999999999999999999997654322222221110000
Q ss_pred ccchhcccCCCCCCcHHHHHHhccCCCCCCcCH----HHHhcCCCCCCCCCC
Q 036122 343 KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA----TAALNSEFFNTEPYA 390 (457)
Q Consensus 343 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~hp~f~~~~~~ 390 (457)
........+++++.+||..||+.||++|||+ ++++.||||+...++
T Consensus 214 --~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 214 --EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred --ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 0001123478889999999999999999999 778899999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=354.08 Aligned_cols=286 Identities=36% Similarity=0.584 Sum_probs=228.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|.+.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999999899999999998764433334456788999999999999999999886532 13
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+...+.... +..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 57999999987654432 33689999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
......++..|+|||++.+...++.++|||||||++|||++|+.||.+.+....+..+....+.+...++.......
T Consensus 170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (342)
T cd07879 170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246 (342)
T ss_pred ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence 22345678899999998765557889999999999999999999999998888888888888877766654432211
Q ss_pred cccCC--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 333 ATLFK--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
...+. ........+...++.+++.+.+||++||+.||++|||++++|.||||+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 11100 0001112223344567888999999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=336.45 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=212.3
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEEEEecc
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
.+.||+|+|+.|.-|....+|..||||++.+. ......++.+|++++.+++ |+||++|+++|++ +..+|||||-|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm 158 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKM 158 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEecc
Confidence 35699999999999999999999999999765 3445577889999999996 9999999999988 67899999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC---cEEEeeccCccccC------CC
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIADFGLATFYD------PG 252 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~~------~~ 252 (457)
.|+.+-..+.+.+.|+|.++..+.++|+.||.|||.+||.||||||+|||..+.. -||||||.+..-.. +.
T Consensus 159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9876655566667899999999999999999999999999999999999997655 48999999875432 11
Q ss_pred CCCCcccccccCccCchHhhh----CCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------------HHHHHHH
Q 036122 253 LKQPMTSRVVTLWYRPPELLL----GATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---------------VEQLHKI 313 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---------------~~~~~~i 313 (457)
......+.+|+..|||||+.. ...+|+.++|.||||||||.||+|.+||.|... ....+.|
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 222345678999999999873 345689999999999999999999999987532 1223334
Q ss_pred HHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 314 FKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.+....+++. .|.+++.+++|||+.+|..|+.+|.++.++|+|||++...
T Consensus 319 QEGkYeFPdk-------------------------dWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 319 QEGKYEFPDK-------------------------DWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred hccCCcCChh-------------------------hhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 4433444444 3456899999999999999999999999999999999754
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=346.66 Aligned_cols=261 Identities=25% Similarity=0.417 Sum_probs=212.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.|+..+.||+|+||+||++.+..+++.||+|++...... ......+.+|+.+|+.++|+||+.+++.+.. ...+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv 78 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEE
Confidence 377889999999999999999999999999999765433 2233456789999999999999999988876 5679999
Q ss_pred EecccCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHDLAGLAA-CQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~-~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||+.++.+.... .. ...+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++...... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~ 156 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E 156 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence 9999976554333 22 346999999999999999999999999999999999999999999999999999765322 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......|+..|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-------------- 221 (285)
T ss_pred cccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--------------
Confidence 224457899999999997765 78999999999999999999999988776555444433211110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
......+++++.+|+..||+.||++||| +.+++.|+||+..++
T Consensus 222 -----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 222 -----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred -----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence 0112346778899999999999999999 899999999988543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=355.61 Aligned_cols=289 Identities=38% Similarity=0.623 Sum_probs=231.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++++ +||||+++++++.......+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4789999999999999999999988999999999865433334445677899999999 999999999988765455789
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK- 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~- 254 (457)
+||||+.+++...+.. . .+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++........
T Consensus 86 lv~e~~~~~L~~~~~~-~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMETDLHAVIRA-N-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEecccccCHHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 9999999877665543 2 689999999999999999999999999999999999999999999999999986643321
Q ss_pred ---CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 255 ---QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 255 ---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.......||..|+|||++.+...++.++|||||||++|+|++|++||.+....+...++....+.+..+.+.....+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhh
Confidence 12234568999999999876665788999999999999999999999998888888888888777665554432110
Q ss_pred Ccc-cC-CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 332 NAT-LF-KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 332 ~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
... .. ..............+.++.++.+||..||+.||++|||+.++|+||||++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000 00 000011112234455678899999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.58 Aligned_cols=255 Identities=29% Similarity=0.474 Sum_probs=219.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..|.-++.||.|+||.||.+++..+.+.||||++..... ..+....+.+|+.+|++|+|||+|.+-|+|.. +...||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~TaWL 103 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHTAWL 103 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec--cchHHH
Confidence 458889999999999999999999999999999987654 35567789999999999999999999999887 455799
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||||-|+-.+.+.-..+++.+.++..|..+.+.||.|||+.+.||||||..||||++.|.|||+|||.|.... +
T Consensus 104 VMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----P 178 (948)
T KOG0577|consen 104 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----P 178 (948)
T ss_pred HHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-----c
Confidence 99999998777776667789999999999999999999999999999999999999999999999999998764 3
Q ss_pred cccccccCccCchHhhh--CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 257 MTSRVVTLWYRPPELLL--GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~--~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
..+++|||.|||||+++ ....|+-++||||||+...||...+||+...+....+..|...- +|
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-sP-------------- 243 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP-------------- 243 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-CC--------------
Confidence 47789999999999996 44558999999999999999999999988777766665553310 00
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.. .-...+..++.||..||++-|..|||.+++|.|+|...
T Consensus 244 ----tL--------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 244 ----TL--------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ----CC--------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 00 01234556788999999999999999999999999976
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=352.17 Aligned_cols=285 Identities=36% Similarity=0.580 Sum_probs=227.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC----c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----C 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 172 (457)
.++|++++.||+|+||.||++.+..+|..||||++............+.+|+.+|++++||||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 578999999999999999999999999999999986543334444567899999999999999999998865322 2
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+++||||+++++..... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 468999999766655443 346999999999999999999999999999999999999999999999999999865422
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+......++....+.++.+++.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07880 172 ----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247 (343)
T ss_pred ----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence 2344678999999999765557889999999999999999999999988888888888877776666544322111
Q ss_pred cccCCC--CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFKP--QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...+.. .......+....+.+++.+.+||.+||+.||.+|||+.++|.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 100000 0000111223345678889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=343.89 Aligned_cols=282 Identities=43% Similarity=0.746 Sum_probs=232.7
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
|+..+.||+|+||.||+|++..+++.||+|++............+..|+.++++++|+||+++++++.. ...+++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 567889999999999999999899999999998764334444567789999999999999999999877 467999999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccc
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 259 (457)
|+++++...+......+++..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++........ ....
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTH 157 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccCc
Confidence 999887776665545799999999999999999999999999999999999999999999999999986643321 2333
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (457)
..++..|+|||.+.+...++.++|||||||++|||++|.+||.+.+..+.+.++...++.+....|..............
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP 237 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence 45678899999998764588999999999999999999999999999999999999999988888765422211111111
Q ss_pred CCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
..........++.++..+.++|++||..||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 111222334455668899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=345.18 Aligned_cols=282 Identities=45% Similarity=0.768 Sum_probs=232.4
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
|++.+.||+|++|.||+|.+..+|+.+++|.+............+.+|+.++++++|+||+++++++.. ...+++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEe
Confidence 667889999999999999998899999999997665544455678889999999999999999999877 567999999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccc
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 259 (457)
|+++++...+......+++.++..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+....... .....
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~ 157 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTH 157 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccC
Confidence 99998887777666689999999999999999999999999999999999999999999999999998765432 22334
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC-CcccCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP-NATLFKP 338 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~ 338 (457)
..++..|+|||.+.+...++.++||||||+++|+|+||++||...+..+.+.++....+.+....|...... .......
T Consensus 158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05118 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237 (283)
T ss_pred ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence 567889999999987645889999999999999999999999999998888888888888777666543210 0000000
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
............+.++.++.+||.+||+.||.+||++.++|.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0000111223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=370.48 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=212.2
Q ss_pred CCccccceeeccCceEEEEEEEcCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLT-GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~-g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||++++++.. ...+||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEE
Confidence 4599999999999999999998777 788999987543 23444567889999999999999999999987 568999
Q ss_pred EEecccCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAA----CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
||||+.++.+.... ....++++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999875543322 23456899999999999999999999999999999999999999999999999999876433
Q ss_pred CC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 253 LK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 253 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~------------ 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD------------ 289 (478)
T ss_pred cccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 21 1234557899999999998765 799999999999999999999999988877766665431100
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....++.++.+||.+||..||++|||++++|.|+|++.
T Consensus 290 ----------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 ----------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ----------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 011236778899999999999999999999999999974
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=356.57 Aligned_cols=289 Identities=37% Similarity=0.571 Sum_probs=236.1
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---CceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~ 175 (457)
+|.+.+.||.|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588999999999999999999888999999998765433455567889999999999999999999887632 23689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK- 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~- 254 (457)
+||||+++++...+. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~~l~~~l~-~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMETDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhhhHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 999999987665554 444799999999999999999999999999999999999999999999999999987654321
Q ss_pred -CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 -QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+........
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1234456799999999998774588999999999999999999999999999999999999999888776653222211
Q ss_pred ccCC--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 334 TLFK--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 334 ~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
..+. ........+....+.+++++.+||.+||+.||++|||++++|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 1110 011111223344566888999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=349.38 Aligned_cols=267 Identities=29% Similarity=0.357 Sum_probs=218.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+..|+.+++.++|+||+++++.+.. ....|+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 78 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCL 78 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEE
Confidence 36899999999999999999999999999999998765432 355678899999999999999999998876 567999
Q ss_pred EEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+.++.+..+... +..+++..+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999987544444433 35699999999999999999999999999999999999999999999999999875532211
Q ss_pred C----------------------------CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh
Q 036122 255 Q----------------------------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE 306 (457)
Q Consensus 255 ~----------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~ 306 (457)
. ......||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0 111346788999999998765 78899999999999999999999988877
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC----HHHHhcCC
Q 036122 307 VEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT----ATAALNSE 382 (457)
Q Consensus 307 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt----a~elL~hp 382 (457)
...+.++...... ......+++.+.++|.+||..||++||| ++|+|+||
T Consensus 238 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~ 290 (316)
T cd05574 238 DETFSNILKKEVT---------------------------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290 (316)
T ss_pred HHHHHHHhcCCcc---------------------------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence 6665554321000 0001126788999999999999999999 99999999
Q ss_pred CCCCCCCCCCCC
Q 036122 383 FFNTEPYACEPS 394 (457)
Q Consensus 383 ~f~~~~~~~~~~ 394 (457)
||++..|+....
T Consensus 291 ~~~~~~~~~~~~ 302 (316)
T cd05574 291 FFRGVNWALIRH 302 (316)
T ss_pred hhhcCChhhccc
Confidence 999987765544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=352.34 Aligned_cols=284 Identities=24% Similarity=0.325 Sum_probs=207.3
Q ss_pred ccceeecc--CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 102 KLDKIGQG--TYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 102 ~~~~LG~G--~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
++++||+| +|++||++.++.+|+.||+|++............+.+|+.+++.++||||+++++++.. ....|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEe
Confidence 56889999 78999999999999999999998765555666778899999999999999999999987 567999999
Q ss_pred cccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC---
Q 036122 180 YMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK--- 254 (457)
Q Consensus 180 ~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~--- 254 (457)
|++++.+..+... ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9997655544432 34589999999999999999999999999999999999999999999999987543321100
Q ss_pred ---CCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC--------CCh
Q 036122 255 ---QPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGS--------PSE 322 (457)
Q Consensus 255 ---~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~--------~~~ 322 (457)
.......++..|+|||++.+. ..++.++|||||||++|||++|..||................-. +.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 011223567889999999753 34789999999999999999999999876554433332211000 000
Q ss_pred hhhhhc-------CCCCcccCC-CCCC-cccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 323 EYWKKS-------KLPNATLFK-PQQP-YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 323 ~~~~~~-------~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+..... ......... .... ...........+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 000000 000000000 0000 0001111223456789999999999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=365.07 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=218.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+.|+++..||.|+||.||+|.++.++-..|.|+|... +.+....+.-||.||..++||+||+|++.|.. .+.+||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~--enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--ENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--cCceEEE
Confidence 5688999999999999999999999999999998644 45667778889999999999999999988776 5679999
Q ss_pred EecccCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
.|||+|+-.+ .+..-+..|++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+...... ...
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 9999987554 44455778999999999999999999999999999999999999999999999999998654322 233
Q ss_pred cccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 257 MTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
..+++|||.|||||++.. ...|++++||||||+.|.||..+.||....+..-.+-+|.+. .++
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePP---------- 253 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPP---------- 253 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCC----------
Confidence 467899999999999863 334899999999999999999999999888877777666431 110
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
+.. .....+..+.|++..||.+||..||+++++|+||||++.+
T Consensus 254 -TLl------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 254 -TLL------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred -ccc------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 011 1123567788999999999999999999999999999753
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=335.88 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=210.5
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||.|+||.||++.+..+++.||+|.+..........+.+.+|+.++++++|+|++++++.+... ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEe
Confidence 48899999999999999999999999999999987655555566788999999999999999998876542 45689999
Q ss_pred ecccCCHH-HHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 179 EYMEHDLA-GLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 179 E~~~~~l~-~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||++++.+ ..+.. ....+++.++..++.||+.||.+||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 158 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DM 158 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cc
Confidence 99987544 43333 24468999999999999999999999999999999999999999999999999998664322 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~------------------ 219 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL------------------ 219 (257)
T ss_pred cccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC------------------
Confidence 33456789999999988765 78899999999999999999999987776555444422110
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
......+++.+.+||.+||+.||++|||+.++|+||||
T Consensus 220 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 ----------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ----------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01113467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=353.33 Aligned_cols=286 Identities=37% Similarity=0.610 Sum_probs=231.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC----c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----C 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 172 (457)
.++|++.+.||+|+||.||+|++..+++.||+|++............+.+|+.+++.++|+||+++++++..... .
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 578999999999999999999999999999999987544344445667789999999999999999887755321 3
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+|+||+++++...+.. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 4899999998777665543 46999999999999999999999999999999999999999999999999999865422
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+++..+.......
T Consensus 172 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07851 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247 (343)
T ss_pred ----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence 3445678999999998765557899999999999999999999999999888889998888888777665432211
Q ss_pred cccCC--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 333 ATLFK--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 333 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
...+. ............+..+++.+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 11010 000001112233455788999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=337.61 Aligned_cols=259 Identities=27% Similarity=0.458 Sum_probs=207.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL---EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.+|++.+.||+|+||.||++.+..++..||+|++..... .......+.+|+.++++++||||+++++++.......+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999999875432 23345678899999999999999999998876545678
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL- 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~- 253 (457)
+++|||++++.+.........+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999876555555555579999999999999999999999999999999999999999999999999997653211
Q ss_pred -CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 -KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
........++..|+|||++.+.. ++.++|||||||++|+|++|++||...+..+...++... +.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~----------- 226 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT----------- 226 (266)
T ss_pred cCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC-----------
Confidence 11122345788999999998765 789999999999999999999999876554444332111 00
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
.+ .....+++.+.+|| +||..||++|||++|+++||||+
T Consensus 227 ----~~---------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----NP---------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----CC---------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00 01123566778888 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=335.04 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=212.7
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4788899999999999999999999999999998766666667788899999999999999999998876 56799999
Q ss_pred ecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 179 EYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 179 E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||+.++.+..+... ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 99987544444333 4578999999999999999999999999999999999999999999999999998665332 12
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 219 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP----------------- 219 (256)
T ss_pred hhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 23456789999999998766 788999999999999999999999888766655554321100
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.....++.++.++|.+||+.+|++||++.++++|||+
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 220 -----------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -----------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 0111367788999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=349.60 Aligned_cols=285 Identities=36% Similarity=0.571 Sum_probs=225.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++.... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 47899999999999999999999999999999999764433344566778999999999999999999876421 23
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|++++++++++...... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~- 172 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 172 (345)
T ss_pred cEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence 4789999987776554432 3599999999999999999999999999999999999999999999999999985432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
......++..|+|||.+.+...++.++|||||||++|+|++|++||...+....+..+....+.+....+.......
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T cd07877 173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249 (345)
T ss_pred ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence 22345678999999998775557889999999999999999999999888888888888877777666554321110
Q ss_pred cccCC--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFK--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...+. ............+...++++.+||.+||+.||.+|||+.++|.||||++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 00000 00000111122233467889999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.11 Aligned_cols=280 Identities=24% Similarity=0.324 Sum_probs=211.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|++++++++||||+++++++.. ...+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 36899999999999999999999999999999987542 34455668899999999999999999999887 5689999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++++.+..+......+++..+..++.||+.||.|||+ ++++|+||||+|||++.++.+||+|||++...... .
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 9999986666666556679999999999999999999997 59999999999999999999999999998755322 1
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....++..|+|||++.+.. ++.++|||||||++|+|++|..||...+..... .++....... .+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~ 230 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEG--EAKESHRPVSGHP 230 (308)
T ss_pred cccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccc--cccCCcccccCCC
Confidence 23457899999999987655 788999999999999999999999876643332 2221110000 0000000000000
Q ss_pred CCCCCc-------ccchhc-----ccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPY-------KRCIAE-----TFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~-------~~~~~~-----~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...... .....+ ....++.++.+||.+||..||++|||+.++|+||||...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000000 000000 011256678999999999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=353.19 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=197.6
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|.+. .++..||+|+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 468999999999999999999752 345789999987442 334456788999999999 899999999988653
Q ss_pred CceEEEEEecccCCHHHHHHhc----------------------------------------------------------
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQ---------------------------------------------------------- 192 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~---------------------------------------------------------- 192 (457)
...+++||||++++.+..+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 3468999999987654433322
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-CCcccccccCccC
Q 036122 193 ----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYR 267 (457)
Q Consensus 193 ----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~ 267 (457)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .......+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 12478889999999999999999999999999999999999999999999999986532211 1112334578899
Q ss_pred chHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccch
Q 036122 268 PPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCI 346 (457)
Q Consensus 268 aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (457)
|||++.+.. ++.++|||||||++|||++ |.+||.+....+........ +..
T Consensus 244 aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~-------------------------- 295 (338)
T cd05102 244 APESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR-------------------------- 295 (338)
T ss_pred CcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC--------------------------
Confidence 999998766 7999999999999999997 99999876544333222110 000
Q ss_pred hcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 347 AETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 347 ~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......++++.+||.+||+.||++|||+.|+++
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 296 MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0011245678899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=342.21 Aligned_cols=257 Identities=29% Similarity=0.442 Sum_probs=214.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|++++++++||||+++++++.. ...+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEE
Confidence 468999999999999999999999999999999875432 23345678899999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.++.+.........+++..+..++.||+.||.|||++||+|+||+|.|||++.++.+||+|||++......
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 9999976555545545567999999999999999999999999999999999999999999999999999866433
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+...++... .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------------- 215 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KV---------------- 215 (290)
T ss_pred CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc----------------
Confidence 23446889999999987665 788999999999999999999999887765555554321 00
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
.....+++.+.++|++||+.||.+|+ +++|+++||||+...|.
T Consensus 216 -----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 216 -----------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred -----------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 01123577889999999999999999 99999999999886543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=350.12 Aligned_cols=286 Identities=36% Similarity=0.587 Sum_probs=219.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC------
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS------ 171 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 171 (457)
.+|.+.+.||.|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 689999999999999999999999999999999876543 344667889999999999999999887654321
Q ss_pred ------ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-CCCcEEEeecc
Q 036122 172 ------CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFG 244 (457)
Q Consensus 172 ------~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFG 244 (457)
..+|+||||+++++...+. ...+++..++.++.||+.||.|||+.||+||||||+|||++ +++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 3579999999987665543 23689999999999999999999999999999999999997 45689999999
Q ss_pred CccccCCCCCC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 245 LATFYDPGLKQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 245 la~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
++......... ......++..|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99865432111 1123467889999998876555888999999999999999999999988887777766654433322
Q ss_pred hhhhhc--CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 323 EYWKKS--KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 323 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
..+... .++.. ................+.++.++.+||.+||+.||.+|||+.++|.||||+...
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 241 EDRNELLNVIPSF-VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred HHhhhhhhhhhhh-hhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 221110 00000 000011111122334456788899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=349.91 Aligned_cols=261 Identities=30% Similarity=0.463 Sum_probs=211.3
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 174 (457)
....|+++++||.||.+.||++.. .+...||+|.+.....+...+.-+.+|+.+|.+|+ |.+||+|++|-.. +..+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence 457899999999999999999984 55567888888777778888899999999999996 9999999998766 6789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||-+.+|...+......++.-.++.|..||+.++.++|+.||||.||||.|+|+-. |.+||+|||+|.....+..
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 999999999998888777655554589999999999999999999999999999999965 7999999999997765543
Q ss_pred CC-cccccccCccCchHhhhCCc----------CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 255 QP-MTSRVVTLWYRPPELLLGAT----------YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 255 ~~-~~~~~gt~~y~aPE~l~~~~----------~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
.. ..+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..-.+ .+.++..+. .|
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI~-~P--- 588 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAIT-DP--- 588 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhhc-CC---
Confidence 22 34579999999999996432 146789999999999999999999964321 222222211 11
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCC--CcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPS--SSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+.. -.++.+++ ++.++++.||..||.+|||+.++|+|||++..
T Consensus 589 --------~~~-------------Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 589 --------NHE-------------IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred --------Ccc-------------ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 111 12333332 38999999999999999999999999999863
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=334.92 Aligned_cols=261 Identities=28% Similarity=0.426 Sum_probs=212.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 47899999999999999999988899999999997654443 55778899999999999999999998877 5679999
Q ss_pred EecccCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 178 FEYMEHDLAGLAACQ---GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|||+.++.+...... ...+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999988655544433 24589999999999999999999999999999999999999999999999999986654322
Q ss_pred C---CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 255 Q---PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 255 ~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
. ......++..|+|||++.....++.++|+|||||++|+|++|..||...+......++... .+..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~-------- 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS-------- 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC--------
Confidence 2 1233468899999999987645789999999999999999999999876665444443221 0000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.. .......+++.+.+||.+||..||++|||+.++|+||||
T Consensus 227 ----~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 ----LE--------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----cC--------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00 001134577889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=356.50 Aligned_cols=260 Identities=29% Similarity=0.517 Sum_probs=230.0
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.....|.+.++||+|.|++|.++++..+|..||||.+.+...+......+.+|+++|..|+|||||+++.+... ...+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--ccee
Confidence 34678999999999999999999999999999999999888887777779999999999999999999999987 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+..+..+++...+..++.++.|+..|++|||+++|||||||++||||+.+.++||+|||++..+..+
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--
Confidence 999999999877777777778889999999999999999999999999999999999999999999999999988744
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
....+.+|++.|.|||++.+..+.++.+|+||+|+++|.|+.|..||.+.+-.+........ ...
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g----------k~r----- 273 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG----------KYR----- 273 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee----------eec-----
Confidence 55678899999999999999998899999999999999999999999987765544333211 000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..--++.+..+||++||..+|.+|++++++..|.|....
T Consensus 274 --------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 274 --------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred --------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 011257788999999999999999999999999999763
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=339.29 Aligned_cols=255 Identities=25% Similarity=0.371 Sum_probs=206.0
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||+|++..+++.||+|++..+. .......+.+|+.++++++||||+++++++.. ....++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICT 78 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEE
Confidence 6888999999999999999999999999999997653 34445678899999999999999999999987 56789999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||++++.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAK 151 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---ccc
Confidence 99998776544 24789999999999999999999999999999999999999999999999999865432 223
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ---LHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
...+|..|+|||++.+.. ++.++|||||||++|+|++|..||......+. ............
T Consensus 152 ~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------- 216 (279)
T cd06619 152 TYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------------- 216 (279)
T ss_pred CCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------------
Confidence 457899999999998766 78999999999999999999999965321110 001111100000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+ ......+++++.+||.+||+.||++||+++++++||||+..
T Consensus 217 ----~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 217 ----PP-----VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ----CC-----CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00 00112356778999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=336.94 Aligned_cols=280 Identities=40% Similarity=0.681 Sum_probs=222.0
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeeeEEecCC---ce
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL---DHPNVIKLEGLVTSRMS---CS 173 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~---~~ 173 (457)
|++.+.||+|+||.||+|++..+++.||+|.++...........+.+|+.+++++ +|+||+++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999988899999999976543333334566788877766 59999999999876322 24
Q ss_pred EEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
++++|||+.+++...+.... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 89999999987766554432 35899999999999999999999999999999999999999999999999999876433
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......++..|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+....|.......
T Consensus 161 --~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 161 --MALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred --cccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 2223345788999999998766 7889999999999999999999999999999999888877766555544321100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
...+. ...........+.+++.+.+||.+||+.||.+||++.++|+||||
T Consensus 238 ~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFP--SYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcc--cccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11110 111112234445677888999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=343.14 Aligned_cols=280 Identities=28% Similarity=0.444 Sum_probs=221.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--C----CceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH--P----NVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--p----niv~l~~~~~~~~ 170 (457)
.++|.++..||+|.||.|..|.+..++..||||+++.-. ...+.-.-|+++|+++.+ | -+|.+.++|..
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-- 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-- 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--
Confidence 579999999999999999999999999999999997432 223344569999999942 2 26777777776
Q ss_pred CceEEEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---------------
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN--------------- 234 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--------------- 234 (457)
.++.|||+|.++.++.+++..+ ..+++..+++.++.||+.++.|||+.+++|.||||+|||+.+
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 5679999999998888777664 357999999999999999999999999999999999999943
Q ss_pred -----CCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH
Q 036122 235 -----DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 309 (457)
Q Consensus 235 -----~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~ 309 (457)
+..|+|+|||.|+.... ..+..+.|..|+|||++++-+ ++..+||||+||||+|+.||..+|++.++.|.
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 23689999999986542 236678899999999999887 89999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChhhhhhc---------CCCCcc---------cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC
Q 036122 310 LHKIFKLCGSPSEEYWKKS---------KLPNAT---------LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN 371 (457)
Q Consensus 310 ~~~i~~~~~~~~~~~~~~~---------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 371 (457)
++.+..++|+.+....... .+.... ...+..+........ ..-..+++|||++||.+||.+
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~-d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD-DLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC-cHHHhHHHHHHHHHHccCccc
Confidence 9999999997776554432 111110 011111111111000 001235889999999999999
Q ss_pred CcCHHHHhcCCCCCCC
Q 036122 372 RGTATAALNSEFFNTE 387 (457)
Q Consensus 372 Rpta~elL~hp~f~~~ 387 (457)
|+|+.|+|.||||+.-
T Consensus 397 RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 397 RITLREALSHPFFARL 412 (415)
T ss_pred cccHHHHhcCHHhhcC
Confidence 9999999999999863
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=334.69 Aligned_cols=255 Identities=29% Similarity=0.529 Sum_probs=208.5
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-------hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-------PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
+|.+...||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 367789999999999999999889999999998754322 1233568899999999999999999998877 5
Q ss_pred ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
...++||||++++.+..+......+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||+++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 67899999998866655555556799999999999999999999999999999999999999999999999999986642
Q ss_pred CCC-----CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 252 GLK-----QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 252 ~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
... .......|+..|+|||.+.+.. ++.++|||||||++|+|++|+.||...+....+.++....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 228 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--------- 228 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC---------
Confidence 211 1112345788999999987665 7889999999999999999999998766554443332210
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......++..+.+||++||+.||.+|||+.++++||||
T Consensus 229 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 -------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 001123467788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=337.81 Aligned_cols=258 Identities=27% Similarity=0.393 Sum_probs=211.1
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
-|++.+.||+|+||.||++.+..++..+++|.+... .......+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEE
Confidence 478899999999999999999999999999998643 34445678889999999999999999999877 56789999
Q ss_pred ecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 179 EYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 179 E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
||++++.+.... .....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 999987665543 335579999999999999999999999999999999999999999999999999987553221 222
Q ss_pred ccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 258 TSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
....++..|+|||++.. ...++.++|||||||++|+|++|.+||...+..+...++.......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------------- 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-------------
Confidence 34568999999999842 2336789999999999999999999998877666555543211000
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++.++.+||.+||+.||.+|||++++++||||+..
T Consensus 228 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 -------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 00112367789999999999999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=369.19 Aligned_cols=284 Identities=24% Similarity=0.317 Sum_probs=206.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC-cEEEEEEee---------------cCCCChHHHHHHHHHHHHHHhcCCCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG-KIVALKKVR---------------FDNLEPESVKFMAREILVLRKLDHPNVI 160 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g-~~vAiK~~~---------------~~~~~~~~~~~~~~E~~~l~~l~hpniv 160 (457)
.++|+++++||+|+||+||+|..+... ..+++|.+. ...........+.+|+.+|++++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998764332 222322111 0011223345678999999999999999
Q ss_pred eEeeeEEecCCceEEEEEecccCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 161 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 161 ~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
++++++.. ....|+|+|++.+++...+.... ......+++.++.||+.||.|||++|||||||||+||||+.++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999987 56789999999988776654322 2244677889999999999999999999999999999999999
Q ss_pred cEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCC-CCCC--CChHHHHHHH
Q 036122 237 ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP-IMPG--RTEVEQLHKI 313 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~-pf~~--~~~~~~~~~i 313 (457)
.+||+|||+++.+...........+||..|+|||++.+.. ++.++|||||||++|||++|.. ||.. ......+.++
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 9999999999877544333334567999999999998766 7999999999999999999874 4432 2344556666
Q ss_pred HHhcCCCChhhh-------hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 314 FKLCGSPSEEYW-------KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 314 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
+..++....++. ..... .............+. ...++.++.++|.+||++||.+|||+.|+|.||||+.
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~--~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~ 459 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDS--AEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSA 459 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhh--hhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhc
Confidence 665544333221 11000 000000000000111 1236778899999999999999999999999999987
Q ss_pred C
Q 036122 387 E 387 (457)
Q Consensus 387 ~ 387 (457)
.
T Consensus 460 ~ 460 (501)
T PHA03210 460 E 460 (501)
T ss_pred C
Confidence 4
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=344.20 Aligned_cols=289 Identities=35% Similarity=0.532 Sum_probs=228.3
Q ss_pred CccccceeeccCceEEEEEEEcCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEec--CCce
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLT--GKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSR--MSCS 173 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~--g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~~ 173 (457)
+|++.+.||+|+||.||++++..+ +..||+|++..........+.+.+|+.+++++ +||||+++++..... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478899999999999999999877 89999999875433333455677899999999 599999998865432 2345
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|++|||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~e~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 88999999987776654 44579999999999999999999999999999999999999999999999999998654322
Q ss_pred C---CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 254 K---QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 254 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
. .......||..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+...++.+..+.+.....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 1123357899999999987655578999999999999999999999999999999999999999887766554322
Q ss_pred CCcccCC--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 331 PNATLFK--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 331 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
+...... ........+....+..+..+.+||.+||+.||.+|||+.++|.||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 2110000 000001112223345678899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=338.71 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=212.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||.|+||.||++.+..++..||+|++... .......+.+|+.++++++|+||+++++++.. ...+|+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEE
Confidence 46799999999999999999999889999999998754 34455678899999999999999999999887 567999
Q ss_pred EEecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++.+..+. .....+++.+++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999986555444 335579999999999999999999999999999999999999999999999999987653321 1
Q ss_pred CcccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 256 PMTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
......+++.|+|||++.. ...++.++|||||||++|+|++|++||...+....+.++.... ++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~---------- 226 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PP---------- 226 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CC----------
Confidence 2234568999999999853 2336778999999999999999999998876655554442210 00
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......++.++.+||.+||..||.+|||+.++|+||||...
T Consensus 227 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 --------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred --------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 000112467788999999999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=345.14 Aligned_cols=284 Identities=37% Similarity=0.594 Sum_probs=229.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
+++|++.+.||.|+||.||++.+..+|+.||+|++............+.+|+.+++.++||||+++++++... ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEE
Confidence 6789999999999999999999999999999999875444444456678899999999999999999988653 346889
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+++++...+. ...+++..+..++.||+.||.|||+++|+|+||+|+|||+++++.+||+|||++..... .
T Consensus 88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~ 161 (328)
T cd07856 88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----Q 161 (328)
T ss_pred EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----C
Confidence 99999877655443 33588999999999999999999999999999999999999999999999999975432 2
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+.......+.+.++.++++.+..........+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 23456788999999887645588999999999999999999999999888888888888888887776543211111000
Q ss_pred C--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 K--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. .............+.++..+.++|.+||+.||++|||++++|.||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0 00001112234456678899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=341.67 Aligned_cols=265 Identities=28% Similarity=0.346 Sum_probs=215.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||++.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+.. ...+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEE
Confidence 468999999999999999999999999999999876533 23344667889999999999999999988876 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC-
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ- 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~- 255 (457)
||||++++.+..+......+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||+++........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 9999998666655555567999999999999999999999999999999999999999999999999998742111000
Q ss_pred -------------CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 256 -------------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 256 -------------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
......++..|+|||.+.+.. ++.++|||||||++|||++|..||.+.+..+....+.......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 236 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 236 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC-
Confidence 011235688999999987665 78999999999999999999999998877666655433210000
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC---HHHHhcCCCCCCCCCCC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT---ATAALNSEFFNTEPYAC 391 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~hp~f~~~~~~~ 391 (457)
.....++.++.+||.+||+.||++||| +.++|+||||...++..
T Consensus 237 -------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 237 -------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred -------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 001236778899999999999999998 89999999998865543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=337.58 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=203.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHH-HHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILV-LRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||++++..+|+.||||+++........ ..+..|+.+ ++.++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 4789999999999999999999999999999999765433333 334456554 666789999999999876 567999
Q ss_pred EEecccCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAAC---QGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
||||+++++...+.. ....+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 78 CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred EhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999876555433 345699999999999999999999997 9999999999999999999999999999865432
Q ss_pred CCCCcccccccCccCchHhhhCC---cCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhc
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGA---TYYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DvwslG~vl~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
...+...++..|+|||++.+. ..++.++|+|||||++|+|++|..||... +..+.+..+.... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-------- 225 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S-------- 225 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C--------
Confidence 112335678999999988642 23688999999999999999999999643 2223333322110 0
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+. .....++.++.+||.+||..||.+|||+.+++.||||+..
T Consensus 226 ---------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 226 ---------PQ--------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ---------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 00 0012367789999999999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=335.65 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=212.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||.|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++|+||+++++++.. ...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEE
Confidence 46899999999999999999999999999999997654 23344567899999999999999999998877 5689999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
+||+.++.+....... .+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||+++...... ...
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKR 155 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-ccc
Confidence 9999986555554443 79999999999999999999999999999999999999999999999999998765432 222
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||++.+.. ++.++|||||||++|+|+||.+||...+.......+.... .
T Consensus 156 ~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------------~ 215 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------------P 215 (274)
T ss_pred ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC-------------------C
Confidence 3456788999999998766 8999999999999999999999998766544443332110 0
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+.. ....+++++.++|.+||..||++|||++++++||||+..
T Consensus 216 ~~~--------~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 216 PSL--------EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred CCC--------cccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 000 001267789999999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=334.81 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=206.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEE
Confidence 58999999999999999999999999999999987653 2233457789999999999999999998877 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++.+..+......+++.++..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 9999986665555555679999999999999999999999999999999999999999999999999987654321 222
Q ss_pred ccccccCccCchHhhh--CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 258 TSRVVTLWYRPPELLL--GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~--~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
....|+..|+|||++. ....++.++|||||||++|+|++|.+||........+..+.... .
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~--~--------------- 226 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN--F--------------- 226 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC--C---------------
Confidence 3457899999999974 22337889999999999999999999987655433332221100 0
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~ 383 (457)
.+. .......++..+.+||.+||+.||++|||++++|+|||
T Consensus 227 -~~~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 227 -QPP------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -CCC------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000 00011235677899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=351.11 Aligned_cols=253 Identities=23% Similarity=0.399 Sum_probs=217.7
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEeccc
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
.++||.|-||+||-|+++.+|+.||||+|.+-.........+++|+.||++++||.||.+.-.|+. ...+|+|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhc
Confidence 478999999999999999999999999998877776667889999999999999999999877776 567999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC---CcEEEeeccCccccCCCCCCCcc
Q 036122 183 HDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND---GILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 183 ~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
|+.+..++.. .++|++...+.++.||+.||.|||.+||+|.||||+|||+... -.+||||||+|++.... ....
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--sFRr 724 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--SFRR 724 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh--hhhh
Confidence 9988877654 5689999999999999999999999999999999999999754 37999999999988643 4456
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
+.+||+.|+|||++.... |+...|+||.|||+|.-++|..||....+ +-.+|.+ +..+-|
T Consensus 725 sVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQN-----------------AaFMyP 784 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQN-----------------AAFMYP 784 (888)
T ss_pred hhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccc--hhHHhhc-----------------cccccC
Confidence 789999999999999877 89999999999999999999999975433 2223321 222222
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.. .|..+++++.|||..+|+..-.+|.|.+..|.|||+++.
T Consensus 785 p~--------PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 785 PN--------PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred CC--------chhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 22 245689999999999999999999999999999999974
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=335.07 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=205.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC----C
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM----S 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~----~ 171 (457)
.+.|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +|+||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4679999999999999999999999999999999875432 234577899999998 6999999999987532 2
Q ss_pred ceEEEEEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
..+|+||||+.++.+..+... ...+++..+..++.||+.||.|||+++|+|+||||+||++++++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 468999999987555444333 346899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCcccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
.... .......|+..|+|||++.+ ...++.++|||||||++|||++|..||...........+... +
T Consensus 162 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~----- 232 (272)
T cd06637 162 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P----- 232 (272)
T ss_pred cccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence 4322 22344578999999999863 223788999999999999999999999765543333222110 0
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
. .......++.++.+||.+||..||.+|||+.+++.||||
T Consensus 233 ------~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 ------A-------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------C-------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 000112466788999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=338.12 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=210.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+.|+++++||.|+||.||+|++..++..||+|.+... .......+.+|+.+++.++|+||+++++.+.. ...+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEE
Confidence 6799999999999999999999999999999998754 34456678889999999999999999998876 5679999
Q ss_pred EecccCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLA-ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++++.+... ......+++..+..++.||+.+|.|||+++|+||||||+||+++.++.+||+|||++....... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cc
Confidence 999998766544 3335568999999999999999999999999999999999999999999999999987543221 12
Q ss_pred cccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 257 MTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....+++.|+|||++.+ ...++.++|||||||++|+|++|.+||...+......++.... ++
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~----------- 233 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--PP----------- 233 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC--Cc-----------
Confidence 234567889999999853 2336788999999999999999999998776555444432210 00
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......++.++.+||.+||..||++||+++++|+||||...
T Consensus 234 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 234 -------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred -------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000112356678999999999999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=335.75 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=205.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Confidence 3679999999999999999999999999999999975432 233567889999999999999999999877 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++.+.........+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+||+|||++....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cc
Confidence 99999987666555555679999999999999999999999999999999999999999999999999998664321 12
Q ss_pred cccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 257 MTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.....++..|+|||.+.+ ...++.++|||||||++|||++|.+||...+..+....+...
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------------ 224 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------------ 224 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC------------------
Confidence 234567899999998852 233678999999999999999999998654433222111100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~ 383 (457)
...+.. ......++..+.+||++||+.||++|||++++|+|+|
T Consensus 225 ~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 NFQPPK------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCCCC------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000000 0011246778899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=331.77 Aligned_cols=256 Identities=30% Similarity=0.502 Sum_probs=213.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||.|+||.||++.+..+|..||+|++..........+.+..|+.+++.++|+||+++++++.......+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48889999999999999999999999999999987666666677888999999999999999999988765567789999
Q ss_pred ecccCCHHH-HHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 179 EYMEHDLAG-LAAC---QGVKFSEPQVKCYMKQLLSGLEHCH-----NNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 179 E~~~~~l~~-~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
||++++.+. .+.. ....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999875443 3322 2457999999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
..... ......++..|+|||++.+.. ++.++|+||||+++|+|++|..||...+..+....+....
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 226 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK------------ 226 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC------------
Confidence 54321 123457899999999997766 7889999999999999999999998877555444432110
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......++..+.+|+.+||+.||++|||+.++|+|||+
T Consensus 227 ----------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ----------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ----------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 001112467788999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=332.35 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=208.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL---EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.+|++.+.||+|+||.||++.+..+|..||||.+..... .......+.+|+.++++++||||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478999999999999999999999999999999865432 23345678899999999999999999998876545678
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
++||||++++.+.........+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999998865655555556789999999999999999999999999999999999999999999999999986532111
Q ss_pred --CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 --QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......++..|+|||++.+.. ++.++|||||||++|+|++|++||...+......++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPTN---------- 227 (265)
T ss_pred cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCCC----------
Confidence 1123346889999999997755 78999999999999999999999987655544433321 1100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
+ .....++..+.++|++||. +|++|||++++++|||+.
T Consensus 228 -----~---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 228 -----P---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred -----C---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0 0112355677889999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=338.91 Aligned_cols=259 Identities=22% Similarity=0.386 Sum_probs=210.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++++.||+|+||.||++.+..+|..||+|.+.... .......+.+|+.++++++|+||+++++.+.. ...+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 36899999999999999999998899999999987542 34445678899999999999999999998877 5679999
Q ss_pred EecccCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 178 FEYMEHDLAGLAACQG---VKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
|||++++.+..+.... ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999986665554442 368999999999999999999997 59999999999999999999999999999765322
Q ss_pred CCCcccccccCccCchHhhhCCc-----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGAT-----YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
......+++.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+........
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 123346788999999986432 257899999999999999999999976554443333322111100
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+++++.+||.+||+.||++||++++++.||||...
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 228 ------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred ------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 01123477888999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.48 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=208.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE----PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
+|.+.+.||.|+||.||+|.+ .+|+.+|+|.+...... ......+.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 477889999999999999986 58899999998754322 2334568899999999999999999999887 5789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL- 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~- 253 (457)
++||||+.++.+.........+++..+..++.||+.||.|||+.+|+|+||+|+||++++++.++|+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999987666666665679999999999999999999999999999999999999999999999999987653211
Q ss_pred ----CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 254 ----KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 254 ----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
........++..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 226 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL---------- 226 (265)
T ss_pred cccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----------
Confidence 11123456889999999987665 788999999999999999999999876554443332211000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......++.++.+||++||..||++|||+.++|.||||
T Consensus 227 ----------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 ----------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011123467788999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=338.04 Aligned_cols=258 Identities=28% Similarity=0.496 Sum_probs=211.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..+|++.+.||+|+||.||+|++..++..||+|.+...... ....+.+|+.+++.++|+||+++++.+.. ....|+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEE
Confidence 36899999999999999999999999999999999765433 23567889999999999999999998877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (296)
T ss_pred eecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-cc
Confidence 9999988655555443 358999999999999999999999999999999999999999999999999988654322 12
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||...+.......+... +.+.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--------------- 235 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE--------------- 235 (296)
T ss_pred cCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC---------------
Confidence 23457889999999987655 689999999999999999999999877654433322110 0000
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++..+.+||.+||..||++|||+.++|+||||...
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 ----------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ----------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00112466778999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.27 Aligned_cols=254 Identities=27% Similarity=0.461 Sum_probs=214.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|+.++.||.|+||.||.+++..+++.+++|.+............+.+|+.++++++|+||+++++++.. ...++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 5889999999999999999999999999999998766666666778899999999999999999999987 56799999
Q ss_pred ecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 179 EYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 179 E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||+.++.+...... ...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 99987544444333 35689999999999999999999999999999999999999999999999999986643321 2
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+... ..
T Consensus 158 ~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~---------------- 218 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NY---------------- 218 (256)
T ss_pred ccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC----------------
Confidence 34457899999999987665 788999999999999999999999888777766665321 10
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
......++.++.++|.+||..||.+|||+.++|+|||+
T Consensus 219 ----------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 219 ----------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ----------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 00113467788999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.60 Aligned_cols=244 Identities=20% Similarity=0.183 Sum_probs=201.8
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEe--cCCceEEEEEec
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTS--RMSCSLYLVFEY 180 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~~~lv~E~ 180 (457)
..||+|++|.||+|.. +|+.||||+++..... ....+.+.+|+.+|++++||||+++++++.+ .....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999985 7899999999765433 2334678899999999999999999999876 434578999999
Q ss_pred ccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccc
Q 036122 181 MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259 (457)
Q Consensus 181 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 259 (457)
+.++.+.........+++.....++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFK 179 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----ccc
Confidence 99876666666666799999999999999999999984 9999999999999999999999999999865422 234
Q ss_pred ccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 260 RVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
..++..|+|||++.+. ..++.++|||||||++|||++|..||.+.+..+....+......+.
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----------------- 242 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLK----------------- 242 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC-----------------
Confidence 5688999999999752 3489999999999999999999999998887766665543211100
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....+++.+.+||.+||+.||++|||+.++|+
T Consensus 243 ----------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 243 ----------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 01246778999999999999999999999984
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=331.98 Aligned_cols=261 Identities=31% Similarity=0.515 Sum_probs=208.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC--------hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE--------PESVKFMAREILVLRKLDHPNVIKLEGLVTSRM 170 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 170 (457)
+|.+.+.||+|+||.||+|.+..+|+.||+|.++..... ....+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 477889999999999999999889999999998643211 1123567889999999999999999998876
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...+++||||+.++.+.........+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 56789999999887665555555679999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCC-CcccccccCccCchHhhhCCc-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 251 PGLKQ-PMTSRVVTLWYRPPELLLGAT-YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 251 ~~~~~-~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
..... ......++..|+|||++.+.. .++.++|+||||+++|+|++|..||...+..+.+.++......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 230 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA--------- 230 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC---------
Confidence 32111 123346789999999987543 4688999999999999999999999765554433332110000
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
..........++.++.+||.+||..||.+|||++++|+||||
T Consensus 231 --------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 231 --------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 000112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.72 Aligned_cols=280 Identities=38% Similarity=0.667 Sum_probs=225.1
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEEEE
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
|.+.+.||+|+||+||+|+...+++.||||.+....... ......+|+..+++++ |+||+++++++.. ....|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEE
Confidence 677899999999999999998899999999987543322 2233457999999999 9999999999877 56799999
Q ss_pred ecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 179 EYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 179 E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
||+.+++...+.... ..+++.++..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 78 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~ 155 (283)
T cd07830 78 EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPY 155 (283)
T ss_pred ecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCc
Confidence 999777777665543 46899999999999999999999999999999999999999999999999999866432 223
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc-C
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL-F 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~ 336 (457)
....++..|+|||++.+...++.++|+||||+++|+|++|.+||...+..+...++....+.+..+.|.......... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 445678999999998765557899999999999999999999999999999999998888888777665432111100 0
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.............+...+..+.+||++||+.||++|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 000000111223333446789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=320.29 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=218.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
.++.+.+..||.|..|+|++++.+.+|...|||.+.... +.+..+++...+.++...+ +|+||+.+|+|.. +..++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~--n~dV~ 167 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT--NTDVF 167 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--CchHH
Confidence 466778889999999999999999999999999998654 4556677888888887765 9999999999988 45689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|.||.|..-...++..-.++++|..+-++...++.||.||.++ +|+|||+||+|||+|+.|++||||||++..+-+.
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS-- 245 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS-- 245 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc--
Confidence 9999998766666666667899999999999999999999865 8999999999999999999999999999876543
Q ss_pred CCcccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
...+...|.+.|||||.+.- ...|+..+||||||+.++||.||+.||.+. ++-+.+.++.+. .|+
T Consensus 246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~--ePP---------- 313 (391)
T KOG0983|consen 246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE--EPP---------- 313 (391)
T ss_pred cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc--CCC----------
Confidence 23355688999999999853 345889999999999999999999999875 566777777551 110
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. + ..-.+|++.+++|+..||++|+.+||...++|+|||+...
T Consensus 314 -------~------L-~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 314 -------L------L-PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred -------C------C-CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 0 1 1123489999999999999999999999999999999864
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=332.96 Aligned_cols=260 Identities=30% Similarity=0.518 Sum_probs=208.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE----PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
+|+..+.||+|+||.||++.+..+++.||+|++...... ....+.+.+|+.++++++|+||+++++++.. ...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeE
Confidence 477889999999999999999999999999999754321 2245678899999999999999999999876 5678
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~ 253 (457)
++||||+.++.+..+......+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++.......
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999876665555566799999999999999999999999999999999999998776 69999999997664321
Q ss_pred C---CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 254 K---QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 254 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
. .......++..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 227 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT---------- 227 (268)
T ss_pred ccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC----------
Confidence 1 1112346788999999987655 7899999999999999999999997654433333332211000
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
........+++++.++|.+||..||++|||+.++|+||||+
T Consensus 228 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 --------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00011234678889999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=329.44 Aligned_cols=254 Identities=26% Similarity=0.493 Sum_probs=211.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||++.+..+|+.||+|.+............+.+|+.++++++||||+++++++.. ....|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEE
Confidence 5889999999999999999999999999999998655555555678899999999999999999998876 56899999
Q ss_pred ecccCC-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 179 EYMEHD-LAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 179 E~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||+.++ +...+... ...+++.++..++.||+.||.|||+++++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 157 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-EL 157 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hh
Confidence 999874 44444332 3358999999999999999999999999999999999999999999999999998654321 11
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+...++.... .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~---------------- 218 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--Y---------------- 218 (256)
T ss_pred hhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--C----------------
Confidence 22346788999999987765 7889999999999999999999998777766665553211 0
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
......++.++.++|.+||+.+|.+||++.++|+||||
T Consensus 219 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 ----------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ----------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 01123467788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=328.29 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=210.0
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+.++++++||||+++++.+.. ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEE
Confidence 4889999999999999999999999999999998766555666788999999999999999999998876 56799999
Q ss_pred ecccCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-CcEEEeeccCccccCCCCCC
Q 036122 179 EYMEHDLAGLAA-CQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 179 E~~~~~l~~~~~-~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~~~~~~~ 255 (457)
||++++.+..+. .. ...+++..+..++.|++.+|.|||++||+|+||||+||+++.+ +.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 999875444433 32 3458999999999999999999999999999999999999854 468999999998664331
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~----------------- 218 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF----------------- 218 (256)
T ss_pred cccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-----------------
Confidence 223356789999999997655 78899999999999999999999988776655544432110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
......+++++.+||.+||..||++|||+.|+|+||||
T Consensus 219 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 -----------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -----------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00112367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.56 Aligned_cols=257 Identities=28% Similarity=0.498 Sum_probs=213.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEE
Confidence 579999999999999999999999999999999975433 234567889999999999999999999876 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||+.++.+..+.... .+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KR 172 (296)
T ss_pred EEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cC
Confidence 9999987666655443 589999999999999999999999999999999999999999999999999886543321 22
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||.+.+.. ++.++|||||||++|+|++|.+||...+....+..+... ..+.
T Consensus 173 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------------- 234 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE---------------- 234 (296)
T ss_pred CCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc----------------
Confidence 3356789999999987665 788999999999999999999999887765554443221 0000
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+++.+.+||++||..||.+|||+.+++.||||+..
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 ---------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred ---------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 01123467788999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=338.47 Aligned_cols=258 Identities=28% Similarity=0.494 Sum_probs=210.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..+|++++.||+|+||.||++.+..+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 36899999999999999999999899999999999754432 33567889999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++.+..+... ..+++.++..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 171 (297)
T ss_pred eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cC
Confidence 9999998766655543 358999999999999999999999999999999999999999999999999997654332 12
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+....+..+.. .+.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~--------------- 234 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE--------------- 234 (297)
T ss_pred cCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC---------------
Confidence 23456789999999998755 78999999999999999999999977654332221110 00000
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++..+.+||.+||..||++|||+.++|+||||+..
T Consensus 235 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 235 ----------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 00112356778999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=337.63 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=212.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..|.+.+.||+|+||.||+|.+..+|+.||+|++..... ..+....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~l 92 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWL 92 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEE
Confidence 569999999999999999999988999999999875432 34445678899999999999999999999987 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.+++..........+++..+..++.||+.||.|||++||+|+||+|+||++++++.+||+|||++......
T Consensus 93 v~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 93 VMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred EHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 9999999888777665667999999999999999999999999999999999999999999999999999765322
Q ss_pred cccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 257 MTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
....++..|+|||++.+ ...++.++||||||+++|||+||.+||...+.......+... .+ +
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~----------~--- 232 (307)
T cd06607 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS----------P--- 232 (307)
T ss_pred -CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC----------C---
Confidence 33567889999998852 334788999999999999999999999877665544333210 00 0
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. .....++..+.+||.+||+.||++|||+.+++.||||...
T Consensus 233 ----~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 233 ----T--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred ----C--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0 0011256678999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=326.74 Aligned_cols=255 Identities=30% Similarity=0.490 Sum_probs=209.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL---EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
+|+..+.||+|+||.||+|.+..++..|++|.+..... ..+..+.+.+|+.+++.++|+||+++++++.. ...+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEE
Confidence 47778999999999999999888999999999876432 24455678899999999999999999998876 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+++..+..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 999999986665555555679999999999999999999999999999999999999999999999999988654332
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......++..|+|||.+.....++.++|+|||||++|+|++|.+||......+...++.....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE----------------- 219 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----------------
Confidence 224456889999999986544478899999999999999999999987664444333221000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......+++.+.+||++||+.||.+|||+.++|.||||
T Consensus 220 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 ----------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ----------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 001123467788999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=349.30 Aligned_cols=255 Identities=23% Similarity=0.343 Sum_probs=206.6
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
..+++.+...||+|.||+||+|++ -| .||||+++.+....+..+.|++|+.++++-+|.||+-++|+|... .+.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~w--hG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~A 463 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRW--HG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLA 463 (678)
T ss_pred CHHHhhccceeccccccceeeccc--cc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---cee
Confidence 356778889999999999999985 34 499999999999999999999999999999999999999999873 348
Q ss_pred EEEecccCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC-CC
Q 036122 176 LVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP-GL 253 (457)
Q Consensus 176 lv~E~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~-~~ 253 (457)
||+.+|+|..+. .+.....+|.....+.|++||++|+.|||.++|||||||..||||.++++|||+|||++..-.. ..
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999996544 4444456799999999999999999999999999999999999999999999999999974321 11
Q ss_pred CCCcccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
........|...|||||++.. ...|++.+||||||||+|||+||..||...+...++-++-+..+.+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p----------- 612 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP----------- 612 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc-----------
Confidence 222334467888999999963 2348999999999999999999999999555444433332211111
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......+.+.++++|+..|+.+++++||+..+||.
T Consensus 613 -------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 -------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 122233557789999999999999999999999885
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=328.48 Aligned_cols=257 Identities=30% Similarity=0.460 Sum_probs=209.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.++++++||||+++++++.. ...+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEE
Confidence 679999999999999999999988999999999986532 245678899999999999999999998877 5679999
Q ss_pred EecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++++.+..+.... ..+++.++..++.||+.||.|||+++|+|+||||+||++++++.+||+|||++....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence 9999986665554443 679999999999999999999999999999999999999999999999999998654321 12
Q ss_pred cccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 257 MTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||...+.......+......+.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------------- 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-------------
Confidence 2345678899999998765 1378899999999999999999999988776554443322100000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~ 383 (457)
. ......++.++.+||++||..||..|||+.++|.|+|
T Consensus 225 -----~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 -----K------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -----c------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 0011234567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=331.53 Aligned_cols=251 Identities=17% Similarity=0.240 Sum_probs=202.7
Q ss_pred CCccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCc
Confidence 57999999999999999999765 345689999987643 33444668899999999999999999999876 5679
Q ss_pred EEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
++||||++++.+..+... ...+++.+++.++.||+.||.|||++|++||||||+|||++.++.+||+|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999998766655443 4579999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
........++..|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+.+..+.+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------------- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-------------
Confidence 11111223467899999988765 7899999999999999775 99999988777766655321100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++..+.+++.+||+.+|.+|||++++++
T Consensus 228 ---------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ---------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 012346778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=330.13 Aligned_cols=259 Identities=28% Similarity=0.423 Sum_probs=208.0
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC----
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM---- 170 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---- 170 (457)
..++|++.+.||+|+||.||+|.+..+++.|++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 36899999999999999999999988999999999875432 335688999999999 6999999999987633
Q ss_pred CceEEEEEecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQ----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
...+|+||||++++.+..+... +..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 3468999999998654443322 457999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCcccccccCccCchHhhhCC----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 247 TFYDPGLKQPMTSRVVTLWYRPPELLLGA----TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
....... .......++..|+|||++... ..++.++|||||||++|+|++|.+||........+.++.... ..
T Consensus 161 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~ 236 (275)
T cd06608 161 AQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP---PP 236 (275)
T ss_pred eecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC---CC
Confidence 7654322 222345688999999998542 336788999999999999999999998665554444432210 00
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
. ......+++++.+||.+||..||++|||+.++++|||+
T Consensus 237 ----------------~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 237 ----------------T-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ----------------C-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 00012356788999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=326.72 Aligned_cols=259 Identities=30% Similarity=0.504 Sum_probs=211.0
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|.+.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.++++++|+||+++++++.. ...+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEE
Confidence 5888999999999999999998899999999998766555567889999999999999999999998766 56799999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc-
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM- 257 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~- 257 (457)
||+.++.+..+......+++..+..++.||+.||.|||+.||+|+||+|+||++++++.+||+|||++...........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999877766666666789999999999999999999999999999999999999999999999999987643322111
Q ss_pred --ccccccCccCchHhhhCCc--CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 258 --TSRVVTLWYRPPELLLGAT--YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 258 --~~~~gt~~y~aPE~l~~~~--~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
....++..|+|||++.+.. .++.++||||||+++|+|++|..||...+........... +..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~------------- 224 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK------------- 224 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC-------------
Confidence 1346788999999987543 2678999999999999999999999765433222211110 000
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
+.. .....+++.+.+||.+||+.||.+|||+.+++.|||+
T Consensus 225 ----~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 ----PPI-------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----CCC-------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 0112357788999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=332.73 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=204.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEec----CC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSR----MS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~~ 171 (457)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +|+||+++++++... ..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 468999999999999999999999999999999986542 3335678899999998 699999999988542 24
Q ss_pred ceEEEEEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
..+|++|||++++.+..+... ...+++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 578999999987544443332 345889999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCcccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
.... .......|++.|+|||.+.. ...++.++|||||||++|+|++|.+||...........+... ..
T Consensus 172 ~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~---- 243 (282)
T cd06636 172 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP---- 243 (282)
T ss_pred hccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence 3221 12234578999999999863 233778999999999999999999999766544333322110 00
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......++.++.+||++||+.||.+|||+.|+|+||||
T Consensus 244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000123467789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.04 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=206.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 176 (457)
++|...+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. |+||+++++++.. ....++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~ 80 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWI 80 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEE
Confidence 4678889999999999999999999999999998765433 44566888999999996 9999999998876 456899
Q ss_pred EEecccCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 177 VFEYMEHDLAGLAA----CQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 177 v~E~~~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
+|||+..++..... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 81 CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 99999876544321 2245799999999999999999999975 999999999999999999999999999976543
Q ss_pred CCCCCcccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.. ......|+..|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+.+........
T Consensus 161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~------ 230 (288)
T cd06616 161 SI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI------ 230 (288)
T ss_pred CC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc------
Confidence 21 12334678999999999765 3578999999999999999999999976542 222222211100000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
........++.++.+||.+||+.||++|||+++++.||||+.
T Consensus 231 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 231 ---------------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ---------------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 000111346778999999999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=332.58 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=206.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC---Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM---SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---~~ 172 (457)
.++|.+.+.||+|+||.||++.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++.... ..
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 678999999999999999999999999999999986432 2234567899999999 7999999999987532 24
Q ss_pred eEEEEEecccCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 173 SLYLVFEYMEHDLAGLAA----CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
.+|+||||++++.+.... .....+++..++.++.||+.||.|||+.+|+|+||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 689999999886554433 2345789999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCc----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGAT----YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
...... ......++..|+|||++.... .++.++|||||||++|+|++|++||...+....+..+.+. +..
T Consensus 178 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~-- 251 (291)
T cd06639 178 LTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPP-- 251 (291)
T ss_pred cccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCC--
Confidence 543221 123346789999999986432 2578999999999999999999999877665544443211 000
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
. . .....++..+.+||.+||+.||++|||+.++|+||||+
T Consensus 252 -------~--~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 252 -------T--L------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------C--C------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 0 00123455789999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=327.89 Aligned_cols=253 Identities=28% Similarity=0.483 Sum_probs=207.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||.||+|.+..++..|++|.+.... ....+.+|+.++++++|+||+++++++.. ...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEE
Confidence 68999999999999999999998889999999986542 15678899999999999999999999887 4679999
Q ss_pred EecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
+||++++.+..+. .....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999986555444 3456789999999999999999999999999999999999999999999999999986643321 2
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....++..|+|||++.+.. ++.++|||||||++|+|++|++||...+.......+... ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~--------------- 216 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP--------------- 216 (256)
T ss_pred cccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC---------------
Confidence 23345788999999987765 789999999999999999999999876554333222110 00
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
+ .......++..+.++|.+||+.||++|||+.|+|+||||
T Consensus 217 -~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 217 -P-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -C-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 000112356788999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=330.11 Aligned_cols=253 Identities=31% Similarity=0.427 Sum_probs=209.9
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ....+.+.+|+.++++++||||+++++.+.. ...+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEE
Confidence 488999999999999999999889999999999765432 3456778899999999999999999988866 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||+.++.+.........+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++....... ..
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 9999987666555555679999999999999999999999999999999999999999999999999998664332 22
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
....++..|+|||++.+.. ++.++|+||||+++|+|++|..||...+.. +.+.+.... .
T Consensus 157 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~--------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A--------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c---------------
Confidence 3456788999999987666 789999999999999999999999877642 222111110 0
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH--HHHhcCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA--TAALNSEFF 384 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta--~elL~hp~f 384 (457)
.......++..+.++|.+||..||.+||++ .|+++||||
T Consensus 218 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 ----------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001112366888999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=331.93 Aligned_cols=252 Identities=27% Similarity=0.392 Sum_probs=197.4
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH-HHHHHHHHHHH---HHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE-SVKFMAREILV---LRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~-~~~~~~~E~~~---l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
.||+|+||.||++.+..+++.||+|.+........ ......+|..+ +...+||||+.+++++.. .+.+|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 48999999999999999999999999976543222 12223344433 334579999999988876 4578999999
Q ss_pred ccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccc
Q 036122 181 MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR 260 (457)
Q Consensus 181 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 260 (457)
+.++.+.........+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++....... ....
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 155 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCc
Confidence 9987666666566679999999999999999999999999999999999999999999999999997554321 2334
Q ss_pred cccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 261 ~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
.||..|+|||.+.+...++.++|||||||++|+|++|..||...... ........ ..
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~------------------ 214 (279)
T cd05633 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TV------------------ 214 (279)
T ss_pred CCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---cC------------------
Confidence 68999999999875455789999999999999999999999754322 11111100 00
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
.......++.++.+||++||..||.+|+ |+.++++||||+...+
T Consensus 215 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 215 -------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred -------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 0011234678899999999999999999 6999999999998554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=335.83 Aligned_cols=258 Identities=26% Similarity=0.440 Sum_probs=211.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+.. ....|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEE
Confidence 45666788999999999999998899999999986532 3344668899999999999999999998876 5678999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++.+..+... ..+++.++..++.||+.||.|||+++|+||||||+||++++++.++|+|||++....... ...
T Consensus 98 ~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 98 MEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred EeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 999998766665543 368999999999999999999999999999999999999999999999999987653322 222
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||++.+.. ++.++|||||||++|||++|..||...+....+..+.......
T Consensus 176 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 237 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR----------------- 237 (292)
T ss_pred ceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-----------------
Confidence 3456899999999987655 7889999999999999999999998877665554432211000
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
......++..+.+||..||..||.+|||++++|+||||....
T Consensus 238 ---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 238 ---------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ---------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 001123566788999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=341.79 Aligned_cols=202 Identities=28% Similarity=0.406 Sum_probs=169.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
|++|...+.||+|+||.||+|.. .+|..||||++....... ..+|.+|+.++.+++|||+|+|+|||.+... ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEE
Confidence 78999999999999999999985 566999999887654332 3459999999999999999999999998432 5899
Q ss_pred EEecccCCHHHHHHhc-CC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 177 VFEYMEHDLAGLAACQ-GV-KFSEPQVKCYMKQLLSGLEHCHNNG---VLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~-~~-~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
|||||.++.+...+.. .. .++|..+.+|+.++|+||+|||+.. |||||||++|||||+++++||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999998655554443 33 8999999999999999999999863 99999999999999999999999999975543
Q ss_pred CCCCCcccc-cccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 036122 252 GLKQPMTSR-VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR 304 (457)
Q Consensus 252 ~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~ 304 (457)
. ....... .||.+|+|||++..+. .+.++|||||||+|+||+||+.+....
T Consensus 230 ~-~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 230 G-DTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred c-ccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCC
Confidence 1 1222222 8999999999998755 789999999999999999999877643
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.06 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=207.2
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|+..+.||.|+||.||++.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++.. ...+++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEE
Confidence 368889999999999999999999999999999876543 3455678899999999999999999998877 4789999
Q ss_pred EecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||+++..+..+... ...+++..+..++.||+.||.|||+ .|++|+||||+||++++++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 999996544444433 3679999999999999999999999 9999999999999999999999999999876532211
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT-----EVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
....++..|+|||++.+.. ++.++|||||||++|+|++|..||...+ ..+.++.+... ..
T Consensus 157 --~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~--------- 221 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE---PP--------- 221 (265)
T ss_pred --hcccCChhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcC---CC---------
Confidence 1256788999999997765 7899999999999999999999996542 22222222110 00
Q ss_pred CCcccCCCCCCcccchhcccCC-CCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKD-FPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
+ ..... +++++.+||.+||..||++|||+.+++.||||+.
T Consensus 222 -------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 222 -------P---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred -------C---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0 00111 6778999999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=326.49 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=206.6
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD 184 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~ 184 (457)
||.|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...+|+||||++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 7999999999999988899999999976543 23445678899999999999999999998876 56799999999876
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccC
Q 036122 185 LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264 (457)
Q Consensus 185 l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~ 264 (457)
.+.........+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 666565555679999999999999999999999999999999999999999999999999998664332 223346789
Q ss_pred ccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCc
Q 036122 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT--EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342 (457)
Q Consensus 265 ~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (457)
.|++||.+.+.. ++.++|+||||+++|+|++|..||...+ ..+...++......+
T Consensus 157 ~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------------------- 213 (262)
T cd05572 157 EYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL---------------------- 213 (262)
T ss_pred CccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCC----------------------
Confidence 999999987655 7889999999999999999999998776 444444432110000
Q ss_pred ccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCC
Q 036122 343 KRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEP 388 (457)
Q Consensus 343 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 388 (457)
......++++.++|.+||+.||++||| +.|+++||||++..
T Consensus 214 -----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 214 -----EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred -----CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 011224678899999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.69 Aligned_cols=259 Identities=25% Similarity=0.446 Sum_probs=211.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
..|.....||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv 96 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVL 96 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEE
Confidence 456667789999999999999988999999999875432 233567889999999999999999998877 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++.+..+... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ...
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 999998666555443 468999999999999999999999999999999999999999999999999997654332 122
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||++.+.. ++.++|||||||++|||++|.+||...+..+.+..+... +. .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-~-------------- 235 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-P-------------- 235 (297)
T ss_pred cceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-C--------------
Confidence 3456899999999997765 789999999999999999999999877766655443211 00 0
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
.......++..+.++|.+||+.||.+|||+.++++||||.+...
T Consensus 236 --------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 236 --------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred --------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 00112346778899999999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=326.23 Aligned_cols=254 Identities=28% Similarity=0.506 Sum_probs=208.7
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|.+.+.||+|+||.||++.+..+|..||+|.+..........+.+.+|+.+++.++|+||+++++.+.. ...+|+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEE
Confidence 4888999999999999999999999999999997765444455678899999999999999999998876 56799999
Q ss_pred ecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCccccCCCCCC
Q 036122 179 EYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 179 E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~~ 255 (457)
||+.+..+...... ...+++..+..++.||+.||.|||+++++|+||||+||++++++ .+||+|||.+....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~ 157 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-E 157 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-c
Confidence 99987554444332 23589999999999999999999999999999999999999876 56999999998765332 1
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......|++.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 218 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------------ 218 (257)
T ss_pred cccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------------
Confidence 223346889999999987665 7899999999999999999999998776655544432210
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.....+.++.++.++|.+||..+|++|||+.++++||||
T Consensus 219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ----------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 011123467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=330.03 Aligned_cols=257 Identities=27% Similarity=0.507 Sum_probs=209.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeeeEEecCCceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD---HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~ 175 (457)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.++++++ |||++++++++.. ...+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEE
Confidence 5888999999999999999999999999999987543 3344566888999999996 9999999998876 56789
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.++.+..+...+ .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 79 lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-S 156 (277)
T ss_pred EEEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-c
Confidence 999999886665555443 79999999999999999999999999999999999999999999999999998765432 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......|+..|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------------- 217 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------------- 217 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------------
Confidence 2334568899999999876655788999999999999999999999876543322211000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..+. + ....++.++.++|.+||+.||++|||+.+++.|+||+..
T Consensus 218 ~~~~------~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 218 KPPR------L--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred CCCC------C--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 0000 0 011267789999999999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=334.19 Aligned_cols=258 Identities=21% Similarity=0.254 Sum_probs=199.2
Q ss_pred cCCccccceeeccCceEEEEEEEcC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL----------------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~----------------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 160 (457)
.++|.+.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3689999999999999999997532 34579999987543 344556788999999999999999
Q ss_pred eEeeeEEecCCceEEEEEecccCCHHHHHHhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 036122 161 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG-------------------VKFSEPQVKCYMKQLLSGLEHCHNNGVL 221 (457)
Q Consensus 161 ~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~-------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iv 221 (457)
++++++.. ...+++||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999887 45689999999875444333221 2467888999999999999999999999
Q ss_pred eccCCCCCEEecCCCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh--CC
Q 036122 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA--GK 298 (457)
Q Consensus 222 HrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt--G~ 298 (457)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+.. ++.++|||||||++|||++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999865432211 112334578899999987666 7999999999999999987 56
Q ss_pred CCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHH
Q 036122 299 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAA 378 (457)
Q Consensus 299 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el 378 (457)
.||...+..+.+..+........... .......+++.+.+||.+||+.||++|||+.++
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQV---------------------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccc---------------------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 78887776666555433211000000 000113467789999999999999999999999
Q ss_pred h
Q 036122 379 L 379 (457)
Q Consensus 379 L 379 (457)
.
T Consensus 299 ~ 299 (304)
T cd05096 299 H 299 (304)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=330.93 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=210.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEE
Confidence 367999999999999999999999999999999987543 33445678899999999999999999999887 468999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++.+..+....+.+++..+..++.|++.+|.|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999987666666566679999999999999999999997 599999999999999999999999999987543221
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH----HHHHHHhcCCCChhhhhhcCCC
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ----LHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.....|+..|+|||++.+.. ++.++|||||||++|+|++|..||......+. ...+..... .....
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~---- 228 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ----QIVQE---- 228 (284)
T ss_pred -cCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH----HHhhc----
Confidence 12356899999999987665 78899999999999999999999986554211 011110000 00000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. .+. .....++..+.+||.+||+.||++|||++|+++|+||.+.
T Consensus 229 ~----~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 229 P----PPR--------LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred c----CCC--------CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 000 0001266788999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=331.53 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=203.6
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD 184 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~ 184 (457)
||+|+||+||+|.+..+|+.||+|++...... ......+..|+.++++++||||+++++++.. ...+|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 69999999999999999999999998754322 2233456789999999999999999998876 56789999999976
Q ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc
Q 036122 185 LAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262 (457)
Q Consensus 185 l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 262 (457)
.+....... ..+++.++..++.||+.||.|||+.|++|+||+|+|||+++++.+||+|||++...... .......+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC--CccccccC
Confidence 554444332 26999999999999999999999999999999999999999999999999999865432 22234567
Q ss_pred cCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCc
Q 036122 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342 (457)
Q Consensus 263 t~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (457)
+..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+......
T Consensus 157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------- 212 (277)
T cd05577 157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----------------------- 212 (277)
T ss_pred CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------------------
Confidence 88999999998766 789999999999999999999999776542222222111000
Q ss_pred ccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 343 KRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 343 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
........+++.+.+||++||+.||.+|| ++.+++.||||....|.
T Consensus 213 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 213 --MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred --ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 00012234688899999999999999999 99999999999876553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=330.40 Aligned_cols=262 Identities=28% Similarity=0.451 Sum_probs=205.6
Q ss_pred CCcCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe---
Q 036122 93 TPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS--- 168 (457)
Q Consensus 93 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--- 168 (457)
.+...++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 4445789999999999999999999999999999999886432 1224577899999999 69999999998753
Q ss_pred cCCceEEEEEecccCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 169 RMSCSLYLVFEYMEHDLAGLAA----CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
..+..+|+||||++++.+.... .....+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 2245789999999876554332 234568999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCccCchHhhhCC----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 036122 245 LATFYDPGLKQPMTSRVVTLWYRPPELLLGA----TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP 320 (457)
Q Consensus 245 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~ 320 (457)
++....... .......|++.|+|||++... ..++.++|||||||++|+|++|..||...+....+.++... .+
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~ 246 (286)
T cd06638 170 VSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--PP 246 (286)
T ss_pred ceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--CC
Confidence 998664321 122345689999999998532 23688999999999999999999999776544333222110 00
Q ss_pred ChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 321 SEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
+. ......++..+.+||.+||+.||++|||+.|+|+|+||
T Consensus 247 -----------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 247 -----------------PT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------------Cc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 00011245678999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=350.43 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=214.8
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
...+||+|+|-+||+|.|..+|..||.-.++.+.. .....++|..|+.+|+.|+|||||++|.++.+.....+.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 35679999999999999999999999877765543 4555688999999999999999999999998876677899999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCEEec-CCCcEEEeeccCccccCCCCCCC
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN--GVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
++..|.+..+..+.+.++...++.|++||++||.|||++ .|||||||.+||||+ ..|.|||+|+|||+..... .
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---H 200 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---c
Confidence 999999998988888999999999999999999999998 599999999999998 5689999999999987543 3
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
..+.+|||.|||||++. ..|+..+||||||++|+||+|+..||....+ .++++++.... .+.-+
T Consensus 201 aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGi--KP~sl----------- 265 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGI--KPAAL----------- 265 (632)
T ss_pred cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCC--CHHHh-----------
Confidence 45689999999999986 3489999999999999999999999976554 45555554321 11111
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+--.+++++||.+||.. ...|+|+.|||.||||+..
T Consensus 266 --------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 266 --------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred --------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 111257899999999999 9999999999999999985
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=328.95 Aligned_cols=252 Identities=27% Similarity=0.387 Sum_probs=199.0
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh-HHHHHHHHH---HHHHHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMARE---ILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-~~~~~~~~E---~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
.||+|+||.||++.+..+++.||+|.+....... .....+..| +.+++..+||||+.+++++.. ...+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 4899999999999999999999999987654321 111222333 344555689999999988876 5679999999
Q ss_pred ccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccc
Q 036122 181 MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR 260 (457)
Q Consensus 181 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 260 (457)
+.++.+.........+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...... .....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCc
Confidence 998766666666668999999999999999999999999999999999999999999999999998755422 12345
Q ss_pred cccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV---EQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 261 ~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
.|+..|+|||++.+...++.++|||||||++|+|++|+.||...... .....+.. .
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----~----------------- 214 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----M----------------- 214 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----c-----------------
Confidence 78999999999976555789999999999999999999999866322 11111100 0
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
.......++.++.+||.+||..||.+|| ++.++++||||+...+.
T Consensus 215 --------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 215 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred --------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 0011223578899999999999999999 99999999999886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=331.10 Aligned_cols=252 Identities=22% Similarity=0.334 Sum_probs=204.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTG-----KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g-----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CC
Confidence 57999999999999999999876555 679999987443 34445678899999999999999999999876 45
Q ss_pred eEEEEEecccCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQG----------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
..|++|||++++.+..+.... ..+++.++..++.||+.||.|||++|++|+||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 789999999875444433322 4588899999999999999999999999999999999999999
Q ss_pred cEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036122 237 ILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIF 314 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~ 314 (457)
.+||+|||++........ .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999986532211 1223345688999999987766 7899999999999999998 999999887766655543
Q ss_pred HhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.... ......++.++.+|+.+||+.||.+|||+.|++++
T Consensus 241 ~~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2110 01123578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.03 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=212.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
+.|...++||+|+||.||+|++..+|..||+|++..... .......+.+|+.+++.++|||++++++++.+ ....|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 347778899999999999999999999999999976533 33444668889999999999999999999887 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.++++..+......+++.++..++.||+.+|.|||++||+|+||+|+||+++.++.+||+|||++.... .
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~ 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P 173 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence 99999998888777666679999999999999999999999999999999999999999999999999986432 2
Q ss_pred cccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 257 MTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.....|+..|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+.... .+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~-~~-------------- 238 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND-SP-------------- 238 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CC--------------
Confidence 234568899999999852 2347889999999999999999999998877666555443210 00
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++..+.+||.+||+.+|.+|||+.++|.||||+..
T Consensus 239 ------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 239 ------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00112355678999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.57 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=209.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN---LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.++++++|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999999999999999986432 123445678899999999999999999998877555678
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
++||||++++.+.........+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999998765555544445689999999999999999999999999999999999999999999999999986532111
Q ss_pred --CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 --QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 --~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......++..|+|||++.+.. ++.++|||||||++|+|++|++||...+......++.. .+..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~---------- 227 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPTK---------- 227 (264)
T ss_pred cCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCCC----------
Confidence 1123356889999999998765 78899999999999999999999987665544443321 1100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
......+++.+.++|++||. +|.+|||+.++|.|||.
T Consensus 228 --------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 --------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred --------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 01123467789999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=327.68 Aligned_cols=256 Identities=29% Similarity=0.443 Sum_probs=211.2
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
..|+..+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.++++++|+||+++++.+.. ...+|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEE
Confidence 468889999999999999999988999999999875432 3445678899999999999999999999887 5689999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++.+...... .++++.++..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-ccc
Confidence 999998665555443 468999999999999999999999999999999999999999999999999997664322 122
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||++.+.. ++.++|+|||||++|||++|.+||...+.......+... .
T Consensus 159 ~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------------ 217 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--N------------------ 217 (277)
T ss_pred ccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--C------------------
Confidence 3346788999999987665 789999999999999999999999876654443322110 0
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......++..+.+||.+||..||++|||+.++++||||...
T Consensus 218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 218 --------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred --------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 001122356778899999999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=327.21 Aligned_cols=257 Identities=26% Similarity=0.474 Sum_probs=210.7
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
.|...+.||+|++|.||++.+..+++.|++|++.... ....+.+.+|+.+++.++||||+++++++.. ....++|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEE
Confidence 5666789999999999999998899999999986443 2334567899999999999999999998876 56789999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||+.++.+...... ..+++.++..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK 173 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence 99988666555544 4699999999999999999999999999999999999999999999999999875543221 123
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
...|++.|+|||.+.+.. ++.++|||||||++|+|++|..||...+..+.+..+.... .+
T Consensus 174 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~------------------ 233 (285)
T cd06648 174 SLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PP------------------ 233 (285)
T ss_pred cccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CC------------------
Confidence 356899999999987766 7899999999999999999999998877666655443210 00
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.......++..+.+||.+||+.||++|||+.++|+||||+...
T Consensus 234 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 234 -------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred -------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0001123667899999999999999999999999999998853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=323.88 Aligned_cols=257 Identities=33% Similarity=0.467 Sum_probs=212.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|++|.||+|++..+++.|++|++...... .....+.+|+.++.+++|+||+++++++.. ...+++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEE
Confidence 4688999999999999999999999999999998765432 445678899999999999999999999877 5789999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++++.+.........+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-Q 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-c
Confidence 9999976666565555679999999999999999999999 9999999999999999999999999999987643322 2
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT---EVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.....++..|+|||.+.+.. ++.++||||||+++|+|+||.+||.... ..+....+... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---~------------- 219 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG---P------------- 219 (264)
T ss_pred ccceeecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC---C-------------
Confidence 23456789999999987664 7899999999999999999999997764 23333332210 0
Q ss_pred ccCCCCCCcccchhcccCC-CCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKD-FPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~-~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....... ++..+.++|.+||..+|++|||+.++|+||||+..
T Consensus 220 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 220 ------------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ------------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 0011122 67789999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=324.46 Aligned_cols=252 Identities=29% Similarity=0.383 Sum_probs=202.3
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHH-HhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVL-RKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|.+..+|+.||+|++...... ......+..|..++ ..++|+||+++++++.. ...+|+||||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 5699999999999999899999999998754322 22223344555544 45589999999999876 56799999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~ 261 (457)
.++.+..+......+++..+..++.||+.||.|||+.+++|+||+|+|||++.++.+||+|||++..... .....
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~ 154 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFV 154 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCC
Confidence 9876666665556799999999999999999999999999999999999999999999999999875432 23346
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
++..|+|||.+.+.. ++.++||||||+++|+|++|.+||...+..+....+.......
T Consensus 155 ~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 212 (260)
T cd05611 155 GTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW--------------------- 212 (260)
T ss_pred CCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC---------------------
Confidence 788999999998766 7899999999999999999999998877766555443211000
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcC---HHHHhcCCCCCCCC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT---ATAALNSEFFNTEP 388 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~hp~f~~~~ 388 (457)
.......+++.+.++|.+||+.||++||| ++|+|.||||+...
T Consensus 213 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 213 ----PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred ----CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 00112357889999999999999999994 58999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=328.17 Aligned_cols=262 Identities=27% Similarity=0.395 Sum_probs=206.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|++++++++||||+++++++.......+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 468899999999999999999999999999999875432 3445678899999999999999999999876556679999
Q ss_pred EecccCCHHHHH----HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 178 FEYMEHDLAGLA----ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 178 ~E~~~~~l~~~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
|||++++.+..+ ......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999987544332 2234568999999999999999999999999999999999999999999999999987553221
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHhcCCCChhhhhhc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE-----VEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.....++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... .+....+... .. ...
T Consensus 160 ---~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~-~~~--- 228 (287)
T cd06621 160 ---AGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PN-PEL--- 228 (287)
T ss_pred ---cccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cc-hhh---
Confidence 12345688999999987665 78999999999999999999999976521 2222221110 00 000
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
+.. ...-..+++.+.+||.+||..||.+|||+.|+++||||+.
T Consensus 229 ---------~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 229 ---------KDE------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred ---------ccC------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000 0000124567889999999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=331.18 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=212.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..|...+.||+|+||.||++++..++..||+|++..... ..+....+.+|+.++++++|+|++++++++.. ....|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEE
Confidence 358899999999999999999989999999999875533 33445678889999999999999999999887 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.++++.........+++.++..++.||+.||.|||+++|+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 999999988777766666799999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 257 MTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.....+++.|+|||++.. ...++.++|||||||++|+|++|.+||...+.......+......+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 243 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT-------------- 243 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC--------------
Confidence 234567889999999852 2337889999999999999999999998776665555543311000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.....+++.+.+||.+||+.+|.+|||+.++++|+|+...
T Consensus 244 -------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 -------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred -------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0012356678999999999999999999999999999663
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=344.16 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=197.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC-----cEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG-----KIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g-----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|++...| ..||+|+++... .......+.+|+.+++.+ +|+|||++++++..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTH-- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--
Confidence 468999999999999999999864433 579999997543 334456788999999999 89999999999877
Q ss_pred CceEEEEEecccCCHHHHHHhc----------------------------------------------------------
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQ---------------------------------------------------------- 192 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~---------------------------------------------------------- 192 (457)
...+|+||||+.++.+..+...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 5678999999987544333211
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC-ccc
Q 036122 193 ------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP-MTS 259 (457)
Q Consensus 193 ------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-~~~ 259 (457)
...+++.+++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++......... ...
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1247889999999999999999999999999999999999999999999999998654322111 112
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
..++..|+|||++.+.. ++.++|||||||++|+|++ |.+||..........++......+
T Consensus 274 ~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~------------------ 334 (374)
T cd05106 274 ARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM------------------ 334 (374)
T ss_pred CCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc------------------
Confidence 23467899999997665 7999999999999999997 999998765444333332210000
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++++.+||.+||+.||++|||+.++++
T Consensus 335 ---------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 ---------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ---------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001225778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=328.18 Aligned_cols=255 Identities=35% Similarity=0.508 Sum_probs=210.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
++|.+.+.||+|+||.||++.+..+|+.||+|++..... .......+.+|+.++++++ |+||+++++++.. ...++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 478999999999999999999999999999999876433 2334467888999999998 9999999998876 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK- 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~- 254 (457)
+||||+.++.+.........+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999997654444444555799999999999999999999999999999999999999999999999999986643221
Q ss_pred ------------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 036122 255 ------------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL 316 (457)
Q Consensus 255 ------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~ 316 (457)
.......++..|+|||++.+.. ++.++||||||+++++|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 1122345789999999987665 788999999999999999999999988765555444321
Q ss_pred cCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH----HHHhcCCCC
Q 036122 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA----TAALNSEFF 384 (457)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~hp~f 384 (457)
.. .....+++.+.+||.+||+.||.+|||+ +++|+||||
T Consensus 238 ~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 238 EY-----------------------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CC-----------------------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 10 1112357788999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=342.76 Aligned_cols=254 Identities=21% Similarity=0.299 Sum_probs=196.9
Q ss_pred cCCccccceeeccCceEEEEEEE-----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARD-----LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|++ ..++..||+|+++.... ....+.+.+|+.+|..+ +||||+++++++..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 35799999999999999999964 34567899999875432 33446688999999999 89999999999877
Q ss_pred CceEEEEEecccCCHH-HHHHhc---------------------------------------------------------
Q 036122 171 SCSLYLVFEYMEHDLA-GLAACQ--------------------------------------------------------- 192 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~-~~~~~~--------------------------------------------------------- 192 (457)
....|+||||++++.+ ..+...
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 5678999999987543 333221
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 193 -----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 193 -----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788899999999999999999999999999999999999999999999999866432211
Q ss_pred C-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 256 P-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 256 ~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
. .....++..|+|||++.+.. ++.++|||||||++|||++ |.+||..........++.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------------- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY--------------- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc---------------
Confidence 1 11233467799999998766 7999999999999999998 8899987654433333222100
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.+ ......+.++.+||..||+.||++|||+.|+++.
T Consensus 335 ---~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 335 ---RM---------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ---cC---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00 0011246678999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=347.70 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=202.3
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC
Q 036122 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD 184 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~ 184 (457)
+||+|.||+||.|+|..+...+|||.+.... .+..+-+..||.+.++|+|.|||+++|.+.. ++.+-|.||-++|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 4999999999999999999999999986443 3344567889999999999999999999876 56788999999986
Q ss_pred HH-HHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-CCCcEEEeeccCccccCCCCCCCcccc
Q 036122 185 LA-GLAACQGVKF--SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSR 260 (457)
Q Consensus 185 l~-~~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~ 260 (457)
.+ .++...=+++ .|..+-.+.+||++||.|||++.|||||||-+||||+ -.|.+||+|||.++.+.. .+....+.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 55 4444555667 7889999999999999999999999999999999998 579999999999987642 22233457
Q ss_pred cccCccCchHhhhC-CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCC
Q 036122 261 VVTLWYRPPELLLG-ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339 (457)
Q Consensus 261 ~gt~~y~aPE~l~~-~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (457)
.||..|||||++-. ...|+.++|||||||.+.||.||+|||-...... ..++++ . .++..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-----------G------myKvH 797 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-----------G------MYKVH 797 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh-----------c------ceecC
Confidence 89999999999964 4459999999999999999999999996432221 112221 0 11111
Q ss_pred CCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+ ....++.+++.+|.+|+.+||.+||+|.++|+.||++..
T Consensus 798 P~-------iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 798 PP-------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CC-------CcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 11 122356678899999999999999999999999999875
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.80 Aligned_cols=254 Identities=30% Similarity=0.497 Sum_probs=212.8
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|.+.+.||.|+||.||++.+..++..||+|++............+.+|+++++.++|+|++++++.+.. ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEE
Confidence 5888999999999999999998899999999998766555666778899999999999999999998877 47899999
Q ss_pred ecccCCHH-HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 179 EYMEHDLA-GLAACQ---GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 179 E~~~~~l~-~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||++++.+ ..+... +..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 99987544 444332 3679999999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------------- 219 (258)
T ss_pred ceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----------------
Confidence 1223456789999999987666 7889999999999999999999998777555544432210
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......++..+.++|.+||..||++|||+.++|+||||
T Consensus 220 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 -----------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 001112467788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=330.58 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=208.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
..|+..+.||+|+||.||+|.+..++..||+|.+..... ......+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEE
Confidence 458889999999999999999989999999999875532 3345678899999999999999999998876 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++.+...... ..+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 999998666555443 468999999999999999999999999999999999999999999999999998654321 112
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||++.+.. ++.++|||||||++|||++|.+||...........+... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------------ 217 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--S------------------ 217 (277)
T ss_pred hcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--C------------------
Confidence 2346788999999987665 788999999999999999999999765544333221100 0
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.......++.++.+||.+||+.+|++|||+.++|+||||..
T Consensus 218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 218 --------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred --------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 00011235677899999999999999999999999999976
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=322.51 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=200.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++.+.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.. ...+++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 82 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKI 82 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEE
Confidence 345555678999999999999998899999999886543 3345678899999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHh-cCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-CCcEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAAC-QGVKF--SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~~-~~~~l--~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~ 252 (457)
||||+.++.+..... ....+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 999998755544433 33445 88899999999999999999999999999999999976 679999999998765322
Q ss_pred CCCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
. .......++..|+|||++.+. ..++.++||||||+++|+|++|.+||................
T Consensus 163 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 227 (268)
T cd06624 163 N-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF-------------- 227 (268)
T ss_pred C-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh--------------
Confidence 1 122334678999999998653 236889999999999999999999997543321111000000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.........+++++.+||.+||+.+|.+|||+.|++.||||
T Consensus 228 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 ------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00001123466788999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=327.80 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=211.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
...|...+.||+|+||.||+|++..++..||+|.+..... .......+.+|+.+++.++|+|++++++++.. ....|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 91 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 91 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeE
Confidence 3568889999999999999999999999999999875432 33445567789999999999999999999887 56789
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.+++..........+++.++..++.||+.||.|||+.+++|+||||+|||++.++.+||+|||++......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 99999998877766665667999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 256 PMTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
....++..|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+..... +
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------~-- 232 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------P-- 232 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC------------C--
Confidence 33467889999999853 23368899999999999999999999977655444433322100 0
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++..+.+||++||+.+|++|||+++++.||||...
T Consensus 233 -------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 -------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00112466778999999999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.89 Aligned_cols=261 Identities=19% Similarity=0.255 Sum_probs=204.5
Q ss_pred cCCccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--G 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 5789999999999999999997542 34589999886543 22333457789999999999999999998876 4
Q ss_pred ceEEEEEecccCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEe
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ----------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 241 (457)
...|+||||+.++.+..+... ...++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 568999999987544444332 1235677889999999999999999999999999999999999999999
Q ss_pred eccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 036122 242 DFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 242 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY- 239 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 9999985532211 1112234567899999987665 7899999999999999999 7899988777665554432100
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc------CCCCCCCCC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN------SEFFNTEPY 389 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~------hp~f~~~~~ 389 (457)
......+++.+.++|.+||+.||++|||+.++++ ||||....|
T Consensus 240 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 240 ---------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 0011235678999999999999999999999987 999988654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.33 Aligned_cols=263 Identities=33% Similarity=0.495 Sum_probs=205.8
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---- 170 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---- 170 (457)
|-.++|+.+..||+||||.||+++++-+|+.||||+|.... +......+.+|+.+|.+|+|||||+++..+....
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 34688999999999999999999999999999999998765 5566677889999999999999999865320000
Q ss_pred --------------------------------------------------------------------------------
Q 036122 171 -------------------------------------------------------------------------------- 170 (457)
Q Consensus 171 -------------------------------------------------------------------------------- 170 (457)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------ceEEEEEecccCCHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHH
Q 036122 171 -------------------------S--------CSLYLVFEYMEHDLAGLAACQGVKF-SEPQVKCYMKQLLSGLEHCH 216 (457)
Q Consensus 171 -------------------------~--------~~~~lv~E~~~~~l~~~~~~~~~~l-~~~~~~~i~~qi~~~L~~LH 216 (457)
. ..+||=||||+..++..+...+... ....++++++||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 0 2378999999999998888776544 57889999999999999999
Q ss_pred hCCceeccCCCCCEEecCCCcEEEeeccCccccC----------------CC-CCCCcccccccCccCchHhhhCCc--C
Q 036122 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD----------------PG-LKQPMTSRVVTLWYRPPELLLGAT--Y 277 (457)
Q Consensus 217 ~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~----------------~~-~~~~~~~~~gt~~y~aPE~l~~~~--~ 277 (457)
++|||||||||.||||++++.|||+|||+|.... .+ .....++.+||.-|+|||++.+.. .
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999998721 01 112356789999999999997665 5
Q ss_pred CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCc
Q 036122 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSS 357 (457)
Q Consensus 278 ~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 357 (457)
|+.|+|+||||+|||||+. ||... .|....+..+- ...+|.. ...+..--+.-
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR---------~g~iP~~-------------~~f~~~~~~~e 847 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR---------KGSIPEP-------------ADFFDPEHPEE 847 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc---------cCCCCCC-------------cccccccchHH
Confidence 8999999999999999984 46543 33332222211 1111111 00011122345
Q ss_pred HHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 358 LPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 358 ~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
..+|+.||+.||.+||||.|+|++.||-
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 6799999999999999999999999996
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.36 Aligned_cols=249 Identities=21% Similarity=0.331 Sum_probs=202.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|++.+.||+|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.++|+||+++++++.. ...+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 46889999999999999999998999999999986432 234567889999999999999999998876 5678999
Q ss_pred EecccCCHHHHHHh-c-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHDLAGLAAC-Q-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~~-~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||++++.+..... . ...+++..+..++.||+.||.|||++|++||||||+|||+++++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99998754444333 2 345899999999999999999999999999999999999999999999999999876533222
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+....+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~----------------- 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY----------------- 222 (263)
T ss_pred ccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----------------
Confidence 112223466899999987666 7889999999999999998 899998877665544442210
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.+ .....+++++.+||.+||+.||++|||+.++++
T Consensus 223 --~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 --RM---------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=320.08 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=205.4
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||++.+..++..||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 48889999999999999999999999999999875432 3345677889999999999999999999877 57899999
Q ss_pred ecccCC-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 179 EYMEHD-LAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 179 E~~~~~-l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||++++ +...+.. .+..+++..+..++.||+.||.|||++||+|+||||+||++++++.++|+|||++....... ..
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 999875 4444433 34468999999999999999999999999999999999999999999999999998664321 12
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||++.+.. ++.++|+||||+++|+|++|.+||...+.......+......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------- 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK----------------- 218 (255)
T ss_pred cccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-----------------
Confidence 23456889999999987665 789999999999999999999999887766555444221100
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....++..+.+||.+||+.||++|||+.++|.-
T Consensus 219 -----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0112356678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=321.36 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=199.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||.||++... .+..+|+|.+...... ...+.+|+.++++++||||+++++++.. ...+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 56889999999999999999864 5568999988644332 2457789999999999999999998876 4678999
Q ss_pred EecccCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++++.+. .+......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999875444 443344568999999999999999999999999999999999999999999999999998654322222
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....++..|+|||++.+.. ++.++||||||+++|+|++ |++||...+..+....+.+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------------- 220 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------------- 220 (256)
T ss_pred cCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------------
Confidence 22234566899999987655 7899999999999999999 89999888877766665331100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+..+.+||.+||+.||.+|||++++++
T Consensus 221 ------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001124567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=317.04 Aligned_cols=254 Identities=32% Similarity=0.514 Sum_probs=213.5
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|++|.||++++..+++.||+|.+............+.+|++++++++|+|++++++++.. ...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 4788999999999999999998899999999998776555666789999999999999999999998876 56799999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||+++..+.........+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........ ...
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 157 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDA 157 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-ccc
Confidence 9999866665555556799999999999999999999999999999999999999999999999999987654322 123
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
...++..|+|||.+.+.. ++.++||||||+++|+|++|.+||...+......++....
T Consensus 158 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 215 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD--------------------- 215 (254)
T ss_pred ccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC---------------------
Confidence 456789999999987665 7889999999999999999999998766544443332100
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.......+++.+.++|.+||..+|++|||+.++|.||||
T Consensus 216 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 -------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 001113467788999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=322.49 Aligned_cols=253 Identities=32% Similarity=0.449 Sum_probs=206.6
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD 184 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~ 184 (457)
||.|+||.||++.+..+|+.||+|++..... .......+.+|+.++++++||||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999988899999999975533 23445678899999999999999999988876 56799999999875
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-------CCc
Q 036122 185 LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-------QPM 257 (457)
Q Consensus 185 l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-------~~~ 257 (457)
.+..+......+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 5555554445799999999999999999999999999999999999999999999999999875532211 122
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+......+
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 220 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW----------------- 220 (265)
T ss_pred cCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC-----------------
Confidence 3346788999999998766 7889999999999999999999998877666655543210000
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH---HHHhcCCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA---TAALNSEFFNTEP 388 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta---~elL~hp~f~~~~ 388 (457)
+ ....++..+.+||.+||+.+|.+|||+ .++|.||||+...
T Consensus 221 ---~-------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 221 ---P-------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred ---C-------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 0 001147888999999999999999999 9999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=335.65 Aligned_cols=280 Identities=24% Similarity=0.338 Sum_probs=204.3
Q ss_pred cceeecc--CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 103 LDKIGQG--TYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 103 ~~~LG~G--~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
...||.| +||+||++++..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~ 80 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPF 80 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEec
Confidence 3456766 99999999999999999999998766555666788999999999999999999999987 5678999999
Q ss_pred ccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC--
Q 036122 181 MEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP-- 256 (457)
Q Consensus 181 ~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~-- 256 (457)
+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 997544444333 2358999999999999999999999999999999999999999999999998654332111000
Q ss_pred ----cccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 257 ----MTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 257 ----~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||......+.+..+.......+ +.....+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 237 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP---LDITTFP 237 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC---ccccccc
Confidence 0112346679999999764 3368899999999999999999999988766555444433211100 0000000
Q ss_pred Cc-----------------ccCCC----CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 332 NA-----------------TLFKP----QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 332 ~~-----------------~~~~~----~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.. ..... ..............+++.+.+||++||+.||++|||++|+|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 00 00000 0000000011123356778999999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=324.19 Aligned_cols=256 Identities=28% Similarity=0.429 Sum_probs=210.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+-|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEE
Confidence 347889999999999999999988999999999865432 3345678899999999999999999999877 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++.+..+... ..+++..+..++.||+.+|.|||+.|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence 999998766555543 468999999999999999999999999999999999999999999999999987654321 122
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... .
T Consensus 159 ~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~------------------ 217 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--N------------------ 217 (277)
T ss_pred ccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--C------------------
Confidence 3346788999999987655 688999999999999999999999876654444333110 0
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......++.++.++|.+||..||.+||++.++++||||...
T Consensus 218 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 218 --------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred --------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 001113467788999999999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.65 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=195.0
Q ss_pred CCcccccee--eccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKI--GQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~L--G~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
+.|++.+.+ |+|+||.||++.+..++..+|+|.+........ |+.+...+ +||||+++++.+.. ...+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~--~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTT--LKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEec--CCee
Confidence 466777776 999999999999999999999999875432211 22222222 79999999999887 4579
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~ 253 (457)
|+||||++++.+..+......+++.++..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~- 163 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP- 163 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence 99999998755544444445899999999999999999999999999999999999999988 9999999998765422
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....++..|+|||++.+.. ++.++|||||||++|+|++|..||......+. ...+.... ..
T Consensus 164 ----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~------------ 225 (267)
T PHA03390 164 ----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK------------ 225 (267)
T ss_pred ----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc------------
Confidence 2346789999999998766 78899999999999999999999986544332 11111110 00
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-HHHHhcCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-ATAALNSEFFNT 386 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-a~elL~hp~f~~ 386 (457)
.....+.+++.+.+||.+||+.||.+||+ ++|+|+||||+.
T Consensus 226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 -------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred -------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00122357888999999999999999996 599999999963
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.25 Aligned_cols=280 Identities=30% Similarity=0.568 Sum_probs=229.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++++|+|.|+.||.|.+..+.+.++||+++.. ..+.+.+|+.||+.|. ||||++|+++..++.+....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 57899999999999999999999899999999998643 3467899999999997 99999999999988888889
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-CCcEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~ 254 (457)
||+||+.+.-...+- ..|+..+++.++.|++.||.|+|++||+|||+||.|++|+. .-.++|+|+|+|.++.++.
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~- 187 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK- 187 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc-
Confidence 999999875433332 25888999999999999999999999999999999999995 4579999999999987763
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCh-hhhhhcCCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSPSE-EYWKKSKLPN 332 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~-~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~ 332 (457)
...-.+.+..|--||++.....|+.+.|+|||||+|..|+..+ |.|.|.++.+++-+|.+.+|+..- .+..+..+.-
T Consensus 188 -eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 188 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred -eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 3445677888999999998888999999999999999999986 455789999999999999987542 2222222211
Q ss_pred cc---c---CCCCCCcccchhcccCCC-CCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 333 AT---L---FKPQQPYKRCIAETFKDF-PSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 333 ~~---~---~~~~~~~~~~~~~~~~~~-~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.. . .....++...+...-..+ ++++.|||.++|.+|-.+|+||.|++.||||..
T Consensus 267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 11 1 122333333444333343 689999999999999999999999999999975
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=335.97 Aligned_cols=254 Identities=21% Similarity=0.322 Sum_probs=198.3
Q ss_pred CCccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCC
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 171 (457)
++|++.+.||+|+||.||+|.+.. +++.||+|+++... .....+.+.+|+.++.++ +|+||+++++++... +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 589999999999999999997533 45789999987543 334446678899999999 799999999988653 4
Q ss_pred ceEEEEEecccCCHHHHHHhc-----------------------------------------------------------
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ----------------------------------------------------------- 192 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~----------------------------------------------------------- 192 (457)
..++++|||++++.+......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 568999999997544433321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC-CcccccccCccCch
Q 036122 193 --GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPP 269 (457)
Q Consensus 193 --~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aP 269 (457)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...... ......++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 125889999999999999999999999999999999999999999999999999876432211 12234457789999
Q ss_pred HhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhc
Q 036122 270 ELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAE 348 (457)
Q Consensus 270 E~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (457)
|++.+.. ++.++|||||||++|||++ |.+||.+....+.+.......- .. .
T Consensus 245 E~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------------~~---------~ 296 (337)
T cd05054 245 ESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT------------------RM---------R 296 (337)
T ss_pred HHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC------------------CC---------C
Confidence 9998766 7999999999999999998 9999987554443333221100 00 0
Q ss_pred ccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 349 TFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 349 ~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....++++.+++.+||+.+|++|||+.|+++|
T Consensus 297 ~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012356778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=341.13 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=204.5
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
.+..|.+...+|.|+|+.|-.+.+..+++.+++|++.....+ ..+|+.++... +||||+++++++.+ ....
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYED--GKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecC--Ccee
Confidence 468899999999999999999999999999999999765221 23567666555 69999999999988 6789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe-cCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI-DNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl-~~~~~vkl~DFGla~~~~~~~ 253 (457)
|+|||++.|+.+...+.....+. .++..|+++|+.|+.|||++|||||||||+|||+ ++.|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999876655554443344 7888899999999999999999999999999999 69999999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
..+.+-|..|.|||++.... |+.++||||||++||+||+|+.||...... +++.+| +.+.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~----------- 530 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPK----------- 530 (612)
T ss_pred ---hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCc-----------
Confidence 34456789999999998655 899999999999999999999999876655 333333 1111
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.-..++.++++||++||+.||.+|+++.+++.||||.+
T Consensus 531 ----------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~ 568 (612)
T KOG0603|consen 531 ----------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLS 568 (612)
T ss_pred ----------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcchhc
Confidence 01347889999999999999999999999999999943
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=341.43 Aligned_cols=239 Identities=27% Similarity=0.392 Sum_probs=200.3
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
...++-||.|+.|.||+|+ -.++.||||+++.- -+.+|+-|++|+||||+.+.|+|+. ...+|||||
T Consensus 126 IsELeWlGSGaQGAVF~Gr--l~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiME 192 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGR--LHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIME 192 (904)
T ss_pred hhhhhhhccCcccceeeee--ccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC--CceeEEeee
Confidence 3446779999999999997 57889999987521 2358889999999999999999987 567999999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccc
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~ 259 (457)
||..+-+..++..+..++......|..+|+.|++|||.+.|||||||.-||||..+..|||+|||.++..... ....+
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 9999888888888888999999999999999999999999999999999999999999999999999876533 33456
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (457)
++||..|||||++...+ .+.|+|||||||||||||||..||..-+...++-- .|+.. ..+
T Consensus 271 FaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG----VGsNs------L~L--------- 330 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG----VGSNS------LHL--------- 330 (904)
T ss_pred hhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEe----ccCCc------ccc---------
Confidence 89999999999999877 89999999999999999999999987655433211 11100 000
Q ss_pred CCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+|..++-||++||+-.|..||+..++|.|
T Consensus 331 --------pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 331 --------PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred --------cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 1123467788889999999999999999999999
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=321.27 Aligned_cols=249 Identities=22% Similarity=0.387 Sum_probs=201.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|+++++||+|+||.||+|.+ .++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ....|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence 46899999999999999999986 466789999886433 234568899999999999999999988876 566899
Q ss_pred EEecccCC-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHD-LAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+.++ +...+.. ....+++..+..++.||+.||.|||+.+++|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999865 4444332 245689999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||++.+.. ++.++|||||||++|+|+| |..||...+..+....+.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 222 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR--------------- 222 (261)
T ss_pred eccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 2223334577899999987665 7889999999999999998 9999988877666655532110
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......++.++.+||.+||..||++|||++++++
T Consensus 223 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 -------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0112346778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.72 Aligned_cols=288 Identities=35% Similarity=0.530 Sum_probs=234.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC---ceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS---CSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~~~ 175 (457)
+.+..+-||.|+||+||.+.|..+|+.||+|++..-...-...+.+.+|+++|.-.+|.|++..+++.....- ..+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4455678999999999999999999999999886543344455778899999999999999999887655332 2368
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+++|+|..++...+. ....++...++-++.||++||+|||+.+|.||||||.|.|++.+..+||||||+++..+.+...
T Consensus 134 V~TELmQSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHHHhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 899999888776554 3457999999999999999999999999999999999999999999999999999998877777
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~ 334 (457)
.++..+.|..|.|||+++|...|+.++||||.|||+.||+..+-+|...+..++++.|.+++|+|..+..+..= -....
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 78888889999999999999999999999999999999999999999999999999999999999987765310 00000
Q ss_pred cC--CCCCCcccchhccc--CCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LF--KPQQPYKRCIAETF--KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~--~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.. .+..+....+.... .+-..+..+++..||..||++|++.++++.|++....
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 00 01111111111111 1223467889999999999999999999999998764
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=317.96 Aligned_cols=252 Identities=26% Similarity=0.434 Sum_probs=210.1
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|+||.||++.+..+++.+|+|.+............+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 4888999999999999999999999999999998765555556677889999999999999999988877 47799999
Q ss_pred ecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 179 EYMEHDLAGLAACQ----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 179 E~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||+++..+...... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99987544433322 356899999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......++..|++||.+.+.. ++.++|+||||+++|+|++|+.||...+..+....+.....
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 218 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY---------------- 218 (256)
T ss_pred -CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 223356789999999997665 78899999999999999999999988876655444322100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
......++.++.++|.+||+.+|++|||+.++|+||++
T Consensus 219 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 ------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 01112467788999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.98 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=199.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKI----VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~----vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
..+|++.+.||+|+||.||+|++..+|.. ||+|+++... .......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~ 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---S 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---C
Confidence 36799999999999999999987666654 8999986432 34445678899999999999999999999875 2
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..++|+||+.++ +.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 467999999875 4455544455689999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQP-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
..... .....++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+... +......+
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~--------- 230 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERL--------- 230 (316)
T ss_pred CCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCC---------
Confidence 32211 11223467899999998765 7899999999999999998 999998776554432 22210000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....++.++.++|..||..||++|||+.+++.+
T Consensus 231 ------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012356678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=315.65 Aligned_cols=259 Identities=31% Similarity=0.520 Sum_probs=211.8
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|.+.+.||+|++|.||+|.+..+++.|++|++..........+.+.+|+.++++++|+||+++++.+.......+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788999999999999999988999999999987655556677889999999999999999999988774336799999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC-Cc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ-PM 257 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~-~~ 257 (457)
||+.++.+..+......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 99977666555555558999999999999999999999999999999999999999999999999999876543211 12
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...... ...+......
T Consensus 161 ~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~------------------ 219 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGSS------------------ 219 (260)
T ss_pred cCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhcccc------------------
Confidence 3456789999999987666 789999999999999999999999876621 1111111100
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.........++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 220 ------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 220 ------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00011123357889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=329.82 Aligned_cols=279 Identities=23% Similarity=0.284 Sum_probs=200.8
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.+.+|.|+ .||.+++..+++.||||++............+.+|+.+++.++|+||+++++++.. ....|++|||+
T Consensus 6 i~~~~~~~~--~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~ 81 (314)
T cd08216 6 IGKCFEDLM--IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLM 81 (314)
T ss_pred hhHhhcCCc--eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEecc
Confidence 344444444 45555556799999999998765566677889999999999999999999998877 56789999999
Q ss_pred cCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-----
Q 036122 182 EHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK----- 254 (457)
Q Consensus 182 ~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~----- 254 (457)
+++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 97655544432 34689999999999999999999999999999999999999999999999999875532111
Q ss_pred -CCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 -QPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 -~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......++..|+|||++.+. ..++.++|||||||++|||++|..||........+..... +.... .+.....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~ 238 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPC-LLDKSTYPL 238 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcc-ccccCchhh
Confidence 112234567889999998753 3378899999999999999999999987665543322211 11110 000000000
Q ss_pred ccc--------CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATL--------FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
... .................++.++.+||.+||..||++|||++++|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 000 0000000000011122345678899999999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=328.88 Aligned_cols=258 Identities=28% Similarity=0.500 Sum_probs=209.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEE
Confidence 368999999999999999999988899999999986443 2234567889999999999999999999877 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|+||++++.+..+.... .+++.++..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~ 171 (293)
T cd06647 94 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 171 (293)
T ss_pred EEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence 99999886665555433 588999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||...+..+.+..+... +.+
T Consensus 172 ~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~~~---------------- 233 (293)
T cd06647 172 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP---------------- 233 (293)
T ss_pred cccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-CCC----------------
Confidence 23346888999999987655 788999999999999999999999876554433222110 000
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. ......++..+.+||++||..||++||++.+++.|+||+..
T Consensus 234 --~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 234 --E-------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred --C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 0 00112356678999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=324.15 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=203.1
Q ss_pred cCCccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
..+|.+.+.||+|+||.||+|.+.. ++..||+|++.... ..+....+.+|+++++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec--C
Confidence 3579999999999999999998743 35789999987543 33345678899999999999999999999887 4
Q ss_pred ceEEEEEecccCCHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ--------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 237 (457)
...++||||++++.+..+... ...+++.++..++.||+.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 679999999987655444332 134789999999999999999999999999999999999999999
Q ss_pred EEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 036122 238 LKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFK 315 (457)
Q Consensus 238 vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~ 315 (457)
+||+|||++........ .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||...+..+....+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999975432211 1122334578899999998766 7899999999999999999 9999988777666555432
Q ss_pred hcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
... ......++..+.+||.+||+.||++|||+.|+++
T Consensus 240 ~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRL----------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 100 0111246778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=318.18 Aligned_cols=245 Identities=22% Similarity=0.372 Sum_probs=195.2
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccC
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH 183 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~ 183 (457)
+.||+|+||.||+|++..+++.||+|.+... ...+....+.+|+.+++.++||||+++++++.. ...+|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 4699999999999999899999999987643 244555678899999999999999999999877 5678999999987
Q ss_pred CHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc-cccc
Q 036122 184 DLAGLA-ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM-TSRV 261 (457)
Q Consensus 184 ~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~-~~~~ 261 (457)
+.+..+ ......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........... ....
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 554444 34455689999999999999999999999999999999999999999999999999976543211111 1112
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQ 340 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (457)
.+..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+.......+......
T Consensus 158 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 215 (252)
T cd05084 158 IPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL--------------------- 215 (252)
T ss_pred CceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---------------------
Confidence 245799999987666 7889999999999999998 88999776665544433221000
Q ss_pred CcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 341 PYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 216 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 -------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011235778899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=328.39 Aligned_cols=262 Identities=27% Similarity=0.386 Sum_probs=221.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 174 (457)
..+|..+.+||+|+||.|.++..+.+.+.||||+++++.. +.+.++-...|-.+|.... -|.+++++..|.. -+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence 5689999999999999999999899999999999988753 3444444556777777664 6788899887766 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.|+-+...+++-+.|.|..+..++.+|+.||-+||++|||+||||.+||||+.+|++||+|||+++.---+ .
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-~ 504 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-G 504 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC-C
Confidence 999999998877777777778999999999999999999999999999999999999999999999999999743211 1
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
....+.+||+.|+|||++.-.+ |+.++|+||+||+||||+.|++||.+.+..+..+.|.+.--
T Consensus 505 ~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv---------------- 567 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV---------------- 567 (683)
T ss_pred cceeeecCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC----------------
Confidence 2345679999999999988666 89999999999999999999999999999999998876321
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYAC 391 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~~ 391 (457)
...+.++.++.++.+.+|.+.|.+|.. -.++-.||||+...|..
T Consensus 568 -------------syPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek 616 (683)
T KOG0696|consen 568 -------------SYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK 616 (683)
T ss_pred -------------cCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence 123568889999999999999999965 35788999999887753
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=326.33 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=206.9
Q ss_pred CccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCc
Q 036122 99 TFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNL--EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 172 (457)
+|++.+.||.|+||.||++.+. .+|..||+|++..... .....+.+.+|+.+++++ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4788999999999999999874 4789999999875432 122345678899999999 59999999988876 56
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||++++.+.........+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 78999999998655555555567999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.........|+..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------- 227 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----------- 227 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-----------
Confidence 22233345689999999998753 236788999999999999999999997543322222222111000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEP 388 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 388 (457)
. ......+++.+.+||++||+.||++|| ++++++.||||+...
T Consensus 228 -------~-------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 228 -------E-------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred -------C-------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 0 001123667789999999999999997 899999999998864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=319.25 Aligned_cols=244 Identities=22% Similarity=0.283 Sum_probs=198.0
Q ss_pred eeeccCceEEEEEEE--cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEeccc
Q 036122 105 KIGQGTYSNVYKARD--LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~--~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
+||+|+||.||+|.. ..++..||+|+++.........+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 689999999999964 4567899999997665555666788999999999999999999998754 45789999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC--cccc
Q 036122 183 HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP--MTSR 260 (457)
Q Consensus 183 ~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~--~~~~ 260 (457)
++.+..+......+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||++.......... ....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence 87555555555679999999999999999999999999999999999999999999999999998664332111 1222
Q ss_pred cccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCC
Q 036122 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339 (457)
Q Consensus 261 ~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (457)
.++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...+..+....+..... +
T Consensus 159 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-------------------~- 217 (257)
T cd05116 159 KWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-------------------M- 217 (257)
T ss_pred CCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-------------------C-
Confidence 3457899999887555 7889999999999999998 9999988777666555532100 0
Q ss_pred CCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++++.+||.+||+.||++|||++++..
T Consensus 218 --------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 --------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 011347788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=323.60 Aligned_cols=252 Identities=20% Similarity=0.338 Sum_probs=201.5
Q ss_pred CCccccceeeccCceEEEEEEEc----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
++|++.+.||+|+||+||+|... .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCc
Confidence 57899999999999999999853 456789999987533 34445678899999999999999999998876 457
Q ss_pred EEEEEecccCCHHHHHHh-c----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 174 LYLVFEYMEHDLAGLAAC-Q----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~-~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
.|+||||+.++.+..+.. . ...+++.++..++.||+.||.|||++||+|+||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 899999998754443332 1 12478899999999999999999999999999999999999999
Q ss_pred cEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036122 237 ILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIF 314 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~ 314 (457)
.+||+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999986543211 1123344577899999997665 7899999999999999998 999998877666555543
Q ss_pred HhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
... .......+++.+.++|.+||+.||++||++.+++++
T Consensus 241 ~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQ----------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCC----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 210 001123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=320.84 Aligned_cols=253 Identities=19% Similarity=0.268 Sum_probs=199.2
Q ss_pred ccccceeeccCceEEEEEEEcCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cce
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGK--IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SCS 173 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~--~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~ 173 (457)
|.+.+.||+|+||.||+|++..++. .||+|.++...........+.+|+.+++.++|+||+++++++.... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999877765 6999998876555666778889999999999999999999875321 235
Q ss_pred EEEEEecccCCHHHHHH-h-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 174 LYLVFEYMEHDLAGLAA-C-----QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~-~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.+++|||+.++.+.... . ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999875443322 1 22358999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCCC-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 248 FYDPGLKQP-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 248 ~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
......... .....+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 232 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------- 232 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 764322111 12234577899999987665 7899999999999999999 7999988776655544422100
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......++..+.++|.+||+.||++|||+.+++++
T Consensus 233 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 ---------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00112466778999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=322.50 Aligned_cols=253 Identities=18% Similarity=0.242 Sum_probs=199.3
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||+||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 81 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 81 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--C
Confidence 578999999999999999999864 235679999986433 22344568899999999999999999998866 5
Q ss_pred ceEEEEEecccCCHHHHHHhc-C---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEe
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ-G---------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~-~---------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 241 (457)
...++||||++++.+..+... . ..+++..+..++.||+.||.|||+.|++|+||||+|||+++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 678999999987655444332 1 235778899999999999999999999999999999999999999999
Q ss_pred eccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 036122 242 DFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 242 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL- 239 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 9999875532211 1112234578899999998665 7899999999999999999 6899988777665554432100
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......+++.+.+||.+||+.||++|||+.|++++
T Consensus 240 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 ---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112356778999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=319.19 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=199.2
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|.+.+.||+|+||+||++... .+..||+|.+...... ...+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEE
Confidence 56899999999999999999764 4456999998754332 3457889999999999999999999876 4568999
Q ss_pred EecccCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLA-ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||+.++.+... ......+++.+++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999987644444 3334478999999999999999999999999999999999999999999999999988654322111
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------------- 220 (256)
T ss_pred cCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------------
Confidence 12234567899999997665 7889999999999999999 99999887766655555331100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......++.+.+++.+||..||.+|||+.+++.+
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0011256788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=320.01 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=200.5
Q ss_pred ccccceeeccCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC----c
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----C 172 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 172 (457)
|.+.+.||+|+||.||+|.+..+ +..||+|.++.+.........+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999987643 4789999998765555666778999999999999999999998765322 2
Q ss_pred eEEEEEecccCCHHHHHH-h-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 173 SLYLVFEYMEHDLAGLAA-C-----QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~-~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
..++||||+.++.+.... . ....+++..+..++.||+.||.|||+++|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999875444333 1 1235899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 247 TFYDPGLKQP-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 247 ~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
+......... .....++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 233 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR------ 233 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 8664332111 11223467899999987655 7899999999999999999 8999988777665554422100
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......++..+.++|.+||+.||.+|||+.|++++
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 234 ----------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ----------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.50 Aligned_cols=281 Identities=33% Similarity=0.552 Sum_probs=234.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC----c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----C 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 172 (457)
..+|.-+..+|.|.- .|..+.|...++.||+|++..........++..+|..++..++|+||++++.+++.... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888899999998 88899999999999999987665555666778899999999999999999999876432 3
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+|||||..++...... .++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+..+..
T Consensus 95 e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc
Confidence 4799999999988776653 4778899999999999999999999999999999999999999999999999976654
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
...+..+.|..|.|||++.+.. |...+||||+||++.||++|+-.|+|.+..++..++.+.+|+|.+.+..+..-..
T Consensus 172 --~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~ 248 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV 248 (369)
T ss_pred --cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence 4568889999999999999888 8999999999999999999999999999999999999999999998876532111
Q ss_pred --cccCCCCCCcccchhcccCC------------CCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 333 --ATLFKPQQPYKRCIAETFKD------------FPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 333 --~~~~~~~~~~~~~~~~~~~~------------~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
.....++... ....+.+++ -...+++|+.+||..||++|.+++++|+||||+
T Consensus 249 r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 249 RNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1111121111 222222322 123578999999999999999999999999998
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=324.05 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=209.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
.|....+||+|+||.||++.+..+|+.||||++.... ......+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 96 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVM 96 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEE
Confidence 3445678999999999999998999999999986432 3344668899999999999999999999887 56799999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||++++.+..+... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~ 174 (292)
T cd06657 97 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK 174 (292)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccc
Confidence 99998766665543 368999999999999999999999999999999999999999999999999987554322 1223
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
...+++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||.+.+..+....+......
T Consensus 175 ~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~------------------- 234 (292)
T cd06657 175 SLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------------- 234 (292)
T ss_pred ccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-------------------
Confidence 356789999999887655 688999999999999999999999887766555444221100
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.......+++.+.++|.+||+.||.+||++.++|.||||....
T Consensus 235 -------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 -------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 0001233567789999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=318.88 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=203.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||+||+|.+..+ ...||+|.+.... .......+.+|+.++++++||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCc
Confidence 36799999999999999999987644 4579999987543 34445668889999999999999999998876 567
Q ss_pred EEEEEecccCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+++||||+.++.+. .+......+++..+..++.|++.||.|||+++|+|+||||+|||+++++.++|+|||++......
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 89999999875444 44444557999999999999999999999999999999999999999999999999999876421
Q ss_pred CCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+......
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL----------- 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 111 111223467899999987665 7899999999999999998 99999877766655554321100
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......++.+.+|+.+||+.||++||++.+++++
T Consensus 228 -----------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 -----------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0112467788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=318.17 Aligned_cols=253 Identities=32% Similarity=0.468 Sum_probs=202.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||+|++..+++.||||.+.... ........+.+|+.+++.++||||+++++++.. ....++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 57999999999999999999999999999999886533 344555678899999999999999999999887 467899
Q ss_pred EEecccCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAA----CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
||||++++.+..+. .....+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 99999975443332 23345899999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ......+ ...+.++
T Consensus 160 ~-~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--------- 227 (267)
T cd08228 160 T-TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPP--------- 227 (267)
T ss_pred h-HHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCC---------
Confidence 1 1123346788999999998665 78899999999999999999999865432 2222222 1111110
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....++..+.+||.+||..||++|||+.++|+.
T Consensus 228 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 -----------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -----------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0112356778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=357.26 Aligned_cols=149 Identities=28% Similarity=0.421 Sum_probs=131.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|.++++||+|+||.||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++++.. ...+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999975433 34445678899999999999999999988776 56899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
+||||+.++.+..+......+++..++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999876555555555679999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=324.59 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=206.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|.+..+++.||||.++..... .....+..|+.++.++. |+||+++++++.. ...+|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 90 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVF 90 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEE
Confidence 47899999999999999999999888999999999765432 23345566777776665 9999999999877 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
+||||+++.+..........+++..+..++.||+.||.|||+ .||+||||+|+||++++++.+||+|||++.......
T Consensus 91 ~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred EEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 999999887776666555679999999999999999999997 599999999999999999999999999997654321
Q ss_pred CCcccccccCccCchHhhhCC---cCCCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhcCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGA---TYYGVGVDLWSAGCILAELLAGKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~---~~~~~~~DvwslG~vl~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
......++..|+|||++.+. ..++.++||||||+++|+|++|+.||..... .+.+..+.....
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------ 236 (296)
T cd06618 170 -AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP------------ 236 (296)
T ss_pred -cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC------------
Confidence 12334578899999998654 2367899999999999999999999975332 233333322100
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+ .. .....++.++.+||.+||..||.+|||++++++||||+..
T Consensus 237 ~-------~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 237 P-------SL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred C-------CC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 0 00 0011367788999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.80 Aligned_cols=258 Identities=31% Similarity=0.515 Sum_probs=212.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.+.|+..+.||+|+||.||++.+..++..|++|++..... ....+.+|+.+++.++|+||+++++.+.. ....|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEE
Confidence 5679999999999999999999988899999999976532 44567889999999999999999999887 467999
Q ss_pred EEecccCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGV-KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|+||+++..+..+..... .+++.++..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-S 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-h
Confidence 999999655554444443 79999999999999999999999999999999999999999999999999987654321 1
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......++..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.... .+.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-------------- 235 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG-IPP-------------- 235 (286)
T ss_pred hhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-CCC--------------
Confidence 223345788999999987665 7899999999999999999999998776655544432210 000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++..+.+||++||+.+|.+|||+.++|.|+||+..
T Consensus 236 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 236 -----------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -----------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 00112367788999999999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=317.68 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=199.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|++.+.||+|+||.||++.+. ++..+|+|++...... ...+.+|+.++++++|+||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEE
Confidence 46889999999999999999875 5668999998654332 2346789999999999999999998876 4578999
Q ss_pred EecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++++ +.+.+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999875 444444444578999999999999999999999999999999999999999999999999998654322111
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---------------- 220 (256)
T ss_pred cCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC----------------
Confidence 12223356799999988665 7889999999999999999 79999887776665554321100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......++++.+|+.+||..+|++|||+.++++.
T Consensus 221 ------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0112367789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=352.24 Aligned_cols=254 Identities=24% Similarity=0.396 Sum_probs=201.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEee-eEEec---C-
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEG-LVTSR---M- 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~~~---~- 170 (457)
..++++.+.|.+|||+.||+|++...|..||+|++-.. +....+.+.+||.+|++|. |+|||.+++ ..... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 45788999999999999999999888899999998654 6777888999999999997 999999998 33222 1
Q ss_pred CceEEEEEeccc-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 171 SCSLYLVFEYME-HDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 171 ~~~~~lv~E~~~-~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
...++|.||||. |++.+++..+ ...|+|.++++|+.|+++|+.+||.+. |||||||-|||||+.+|+.||||||.|
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 246899999999 5788776643 334999999999999999999999997 999999999999999999999999999
Q ss_pred cccCCCCCCCc--------ccccccCccCchHhhh--CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 036122 247 TFYDPGLKQPM--------TSRVVTLWYRPPELLL--GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL 316 (457)
Q Consensus 247 ~~~~~~~~~~~--------~~~~gt~~y~aPE~l~--~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~ 316 (457)
.-.-....... -...-|+.|+|||++. .+...+.|+|||+|||+||-|+....||.......++.--+.
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~- 272 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS- 272 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc-
Confidence 74321110000 0123489999999984 333378999999999999999999999986543322221111
Q ss_pred cCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCC
Q 036122 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383 (457)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~ 383 (457)
-..++.++..+.+||+.||+.||.+||++.|++.+-+
T Consensus 273 ------------------------------~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 273 ------------------------------FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ------------------------------CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 0112346778899999999999999999999987644
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.80 Aligned_cols=252 Identities=33% Similarity=0.518 Sum_probs=207.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+|++.+.||+|++|.||++.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++.. ....++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence 47888999999999999999988999999999976543 345678899999999999999999998877 46789999
Q ss_pred ecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 179 EYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 179 E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
||+++..+...... ...+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||.+........ .
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 99996555444433 35799999999999999999999999999999999999999999999999999987654321 2
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....++..|+|||.+.+.. ++.++||||||+++|+|++|.+||...+....+..+.... .+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~---------------- 216 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG-PPG---------------- 216 (253)
T ss_pred cceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC-CCC----------------
Confidence 3456789999999987665 7889999999999999999999998776554444332200 000
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~ 383 (457)
. .....++..+.++|.+||+.||++|||+.++|+|||
T Consensus 217 --~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 --L-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred --c-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 0 000113677899999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=322.75 Aligned_cols=250 Identities=21% Similarity=0.307 Sum_probs=200.4
Q ss_pred CCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
++|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 57999999999999999999852 34567999988643 34445678899999999999999999999876 56
Q ss_pred eEEEEEecccCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEE
Q 036122 173 SLYLVFEYMEHDLAGLAACQG-------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILK 239 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vk 239 (457)
.+++||||+.++.+..+.... ..+++.++..++.||+.||.|||++|++||||||+|||+++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 799999999875554443321 2489999999999999999999999999999999999999999999
Q ss_pred EeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 036122 240 IADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLC 317 (457)
Q Consensus 240 l~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~ 317 (457)
|+|||++........ .......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+....+....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999986543211 1122334577899999987655 7899999999999999999 899998887766665553311
Q ss_pred CCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
. ......++.++.+|+.+||+.||.+|||+.+++.
T Consensus 240 ~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 V----------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred c----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 0011236678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=323.49 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=202.5
Q ss_pred CCccccceeeccCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLT-----GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.+|.+.+.||+|+||.||+|.+..+ +..||+|+++... .......+.+|+.++..++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CC
Confidence 5688999999999999999987543 5789999997543 33445668899999999999999999999877 45
Q ss_pred eEEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
..++++||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 68999999987544443321 23478899999999999999999999999999999999999999
Q ss_pred cEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036122 237 ILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIF 314 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~ 314 (457)
.+||+|||+++....... .......+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999886533211 1122334578899999997666 7899999999999999998 889998887776666654
Q ss_pred HhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..... ....+++..+.+|+.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVL----------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcC----------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 32100 1123577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.82 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=199.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+. +++.||+|.++..... .+.+.+|+.++++++|+||+++++++.. ...+|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec--CCCeee
Confidence 357999999999999999999864 5578999998754322 3457889999999999999999998876 567899
Q ss_pred EEecccCC-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHD-LAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+.++ +...+... +..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999664 44444332 24689999999999999999999999999999999999999999999999999987653221
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
........+..|+|||++.+.. ++.++||||||+++|+|++ |+.||.+.+....+..+......
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------------- 223 (261)
T ss_pred cccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1111222345799999887655 7899999999999999999 99999988776666555321100
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+..+.+||.+||+.||.+|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 --------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011235678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=320.99 Aligned_cols=253 Identities=21% Similarity=0.326 Sum_probs=200.1
Q ss_pred cCCccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 4679999999999999999999876 67889999886543 23334567889999999999999999998876 4
Q ss_pred ceEEEEEecccCCHHHHHH-hcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC---cEEEe
Q 036122 172 CSLYLVFEYMEHDLAGLAA-CQG------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~-~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~ 241 (457)
...++||||+.++.+..+. ... ..+++.++..++.||+.||.|||+++++|+||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 5679999999875444433 322 2589999999999999999999999999999999999998655 69999
Q ss_pred eccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 036122 242 DFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 242 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
|||+++....... ........+..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGG-R 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c
Confidence 9999986532211 1111223356799999998766 7999999999999999997 999999877766554432210 0
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
+ .....++..+.++|.+||+.||++|||+.++|+|
T Consensus 240 ~---------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 L---------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0113467788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.08 Aligned_cols=261 Identities=31% Similarity=0.501 Sum_probs=219.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
+-++....+||.|.||.||-|.+..+|...|+|.++...........+.+|..++..|+|||+|+++|+-.++ ..++|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--ekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--EKVYI 1311 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH--HHHHH
Confidence 3456778899999999999999999999999999988766666667788999999999999999999987773 56899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC--
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-- 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 254 (457)
.||||.++.+..+...+.-.+|...+.+..|++.|+.|||++|||||||||+||||+.+|.+|++|||.|..+.+...
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 999999998888888887788889999999999999999999999999999999999999999999999998765432
Q ss_pred -CCcccccccCccCchHhhhCCc--CCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhcCC
Q 036122 255 -QPMTSRVVTLWYRPPELLLGAT--YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 255 -~~~~~~~gt~~y~aPE~l~~~~--~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 330 (457)
.......||+-|||||++.+.. ...-+.||||||||++||+||+.||...++.-+ +.++-.
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--------------- 1456 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--------------- 1456 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc---------------
Confidence 2234678999999999997633 256689999999999999999999987655433 332211
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...|+.| ..++++..|||.+||..||.+|.++.|+|.|.|=+..
T Consensus 1457 ----gh~Pq~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1457 ----GHKPQIP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ----cCCCCCc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 1112211 2388899999999999999999999999999997753
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.75 Aligned_cols=259 Identities=20% Similarity=0.266 Sum_probs=203.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC----------------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG----------------KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g----------------~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 160 (457)
..+|++.++||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 368999999999999999999876543 468999987553 335567788999999999999999
Q ss_pred eEeeeEEecCCceEEEEEecccCCHHHHHHhcCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 036122 161 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGV-----------KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSN 229 (457)
Q Consensus 161 ~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 229 (457)
++++++.. ...+++||||+.++.+..+..... .+++..++.++.||+.||.|||++||+|+||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999876 467899999998765544443333 68999999999999999999999999999999999
Q ss_pred EEecCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh--CCCCCCCCCh
Q 036122 230 LLIDNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA--GKPIMPGRTE 306 (457)
Q Consensus 230 ILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt--G~~pf~~~~~ 306 (457)
||++.++.++|+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999999976532211 1223345678899999987655 7899999999999999998 6788887776
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 307 VEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 307 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.+.+..+.......... ........++.++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQ---------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhcccccccc---------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 66655543321110000 000112345678999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=322.76 Aligned_cols=284 Identities=26% Similarity=0.402 Sum_probs=223.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----C---CCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-----H---PNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~~ 168 (457)
.++|.+.++||.|.|++||+|.|..+.+.||+|+.+... ...+....||.+|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 479999999999999999999999999999999987432 23345667999999983 3 369999999865
Q ss_pred --cCCceEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecC----------
Q 036122 169 --RMSCSLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDN---------- 234 (457)
Q Consensus 169 --~~~~~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~---------- 234 (457)
..+.++++|+|+++.+|+.++...+ .-++...++.|++||+.||.|||.. ||||.||||+|||+..
T Consensus 154 sGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred cCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 3456899999999999999887653 4599999999999999999999965 9999999999999900
Q ss_pred --------------------------------------------------------------------------------
Q 036122 235 -------------------------------------------------------------------------------- 234 (457)
Q Consensus 235 -------------------------------------------------------------------------------- 234 (457)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred ------------------------C----------------------------------------------------CcE
Q 036122 235 ------------------------D----------------------------------------------------GIL 238 (457)
Q Consensus 235 ------------------------~----------------------------------------------------~~v 238 (457)
+ -+|
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 0 037
Q ss_pred EEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC------ChHHHHHH
Q 036122 239 KIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR------TEVEQLHK 312 (457)
Q Consensus 239 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~------~~~~~~~~ 312 (457)
||+|||-|.++. ...+..+.|..|+|||++.|.. |++.+||||++|++|||+||..+|... .+++.++.
T Consensus 394 KIaDlGNACW~~----khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 394 KIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEeeccchhhhh----hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 888888888765 3456667899999999999988 899999999999999999999999643 47789999
Q ss_pred HHHhcCCCChhhhhhcC-----------CCCcccCCCCCCcccchhcccCCCC----CCcHHHHHHhccCCCCCCcCHHH
Q 036122 313 IFKLCGSPSEEYWKKSK-----------LPNATLFKPQQPYKRCIAETFKDFP----SSSLPLIETLLSIDPDNRGTATA 377 (457)
Q Consensus 313 i~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~Li~~~L~~dP~~Rpta~e 377 (457)
|++++|..+..+....+ +.+....++..- ...+. ...+++ .++.+||.-||+.+|++||||.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL-~~VL~-eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPL-YEVLI-EKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcH-HHHHH-HHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 99999987765543322 222222222111 11111 112233 35678999999999999999999
Q ss_pred HhcCCCCCCCCCC
Q 036122 378 ALNSEFFNTEPYA 390 (457)
Q Consensus 378 lL~hp~f~~~~~~ 390 (457)
+|+|||++..+.+
T Consensus 547 cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 547 CLKHPWLNPVAGP 559 (590)
T ss_pred HhcCccccCCCCC
Confidence 9999999986554
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=317.89 Aligned_cols=250 Identities=21% Similarity=0.321 Sum_probs=204.0
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
...+|++.+.||.|+||.||+|.+.. +..+|+|++.... ......+.+|+.+++.++|+||+++++++.. ...++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeE
Confidence 35689999999999999999999876 8899999987543 2234568889999999999999999998876 56789
Q ss_pred EEEecccCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 176 LVFEYMEHDLAGLAAC--QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+||||++++.+..+.. .+..+++.++..++.||+.||.|||++||+|+||||+|||+++++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999998754444433 24468999999999999999999999999999999999999999999999999998664322
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
. ......++..|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+......
T Consensus 159 ~-~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------- 223 (261)
T cd05148 159 Y-LSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM------------- 223 (261)
T ss_pred c-cccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-------------
Confidence 1 122334577899999987655 7889999999999999998 89999888776666655321100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++++.++|.+||+.||.+|||+.++++
T Consensus 224 ---------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 ---------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011346778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.38 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=198.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.++||+|+||.||+|.+. ++..||+|.+...... ...+.+|+.++++++|+||+++++++.. ...|++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEE
Confidence 57999999999999999999864 6677999998765433 2457889999999999999999987743 457999
Q ss_pred EecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||+.++.+...... ...+++.++..++.||+.||.|||+++|+|+||||+||++++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999987544444332 345899999999999999999999999999999999999999999999999999866433222
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......++..|+|||++.+.. ++.++||||||+++|+|++ |.+||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM--------------- 222 (260)
T ss_pred cccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 222234567899999987665 7899999999999999999 89999887776666555321000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
....+.+..+.+||.+||..||.+|||+.+++
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 223 -------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred -------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 11234677899999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=316.69 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=198.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.++||+|+||.||+|++..+ ..||+|++...... ...+.+|+.++++++|+||+++++++.. ...|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEECC---CCcEE
Confidence 35799999999999999999987655 46999998754332 2457889999999999999999987643 45799
Q ss_pred EEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||++++.+..+... ...+++..+..++.||+.||.|||+.+|+|+||||+||++++++.+||+|||+++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999987544444332 34589999999999999999999999999999999999999999999999999986653322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||++.+.. ++.++|||||||++|+|+| |.+||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 222 (262)
T ss_pred ccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC--------------
Confidence 2222344577899999887666 7899999999999999999 88999887776665554221000
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 223 --------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 011346778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.46 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=199.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.++||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.++++++||||+++++++.. ....|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEE
Confidence 579999999999999999999999999999999975433 23345678899999999999999999999877 567899
Q ss_pred EEecccCCHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccC
Q 036122 177 VFEYMEHDLAGLAACQ-----------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGL 245 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~-----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGl 245 (457)
||||++|+.+..+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 9999998655443321 12356778899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-----------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHH
Q 036122 246 ATFYDPGLK-----------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE 308 (457)
Q Consensus 246 a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~ 308 (457)
++....... ......+||+.|+|||++.+.. ++.++|||||||++|||+||.+||...+...
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 986521100 0112346899999999998776 7999999999999999999999998754433
Q ss_pred HHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 309 QLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 309 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..... ....+. . ......+|+.+.+++.+||+.||++|++..+.|.+
T Consensus 239 i~~~~--~i~~P~-~-----------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 239 ISYRD--VILSPI-E-----------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhh--hccChh-h-----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22110 000000 0 01123577888999999999999999887665543
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=324.45 Aligned_cols=251 Identities=26% Similarity=0.325 Sum_probs=197.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKI--VALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~--vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~ 82 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 82 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence 46899999999999999999998877764 577766532 2344556788899999999 89999999999876 567
Q ss_pred EEEEEecccCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc
Q 036122 174 LYLVFEYMEHDLAGLAACQG----------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 237 (457)
+|+||||++++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 99999999875444333221 25789999999999999999999999999999999999999999
Q ss_pred EEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 036122 238 LKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKL 316 (457)
Q Consensus 238 vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~ 316 (457)
+||+|||++....... ......++..|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+...
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999986432111 111123366799999887655 7899999999999999998 99999877665554433110
Q ss_pred cCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. .. .....+++++.+||.+||+.||++|||++++|++
T Consensus 240 ~-------------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 Y-------------------RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C-------------------cC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 0112357788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.64 Aligned_cols=250 Identities=24% Similarity=0.276 Sum_probs=197.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGK--IVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~--~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
++|++.+.||+|+||.||+|++..++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 579999999999999999999877765 4788887632 2334456688899999999 79999999998876 4578
Q ss_pred EEEEecccCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcE
Q 036122 175 YLVFEYMEHDLAGLAACQG----------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGIL 238 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~v 238 (457)
|+||||++++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 9999999875444333221 248899999999999999999999999999999999999999999
Q ss_pred EEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 036122 239 KIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLC 317 (457)
Q Consensus 239 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~ 317 (457)
||+|||++........ ......+..|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+...++....
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999864321111 11122356799999987665 7899999999999999998 999998877766555442210
Q ss_pred CCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. ......++.++.+||.+||+.||.+|||++++++.
T Consensus 236 ~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 R----------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00113467789999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=312.48 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=202.1
Q ss_pred ceeeccCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 104 DKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+.+++.++|+||+++++++.. ...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEe
Confidence 4699999999999998765 8899999997654333 46778899999999999999999999887 5679999999
Q ss_pred ccCC-HHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 181 MEHD-LAGLAACQ--------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 181 ~~~~-l~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
+.++ +...+... ...+++.+++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||.+.....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9665 44444433 36799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~------------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY------------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC------------
Confidence 321 1123345688999999988765 7899999999999999999 599999887766665553210
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.......+++++.++|.+||..||.+|||+.|++++
T Consensus 225 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ----------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 001123457899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=314.79 Aligned_cols=248 Identities=23% Similarity=0.407 Sum_probs=200.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|+++++||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.++++++|+||+++++++.. ..+++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVTQ---EPIYI 77 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEcc---CCcEE
Confidence 36799999999999999999985 56788999998754433 3457889999999999999999988643 45899
Q ss_pred EEecccCC-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHD-LAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
+|||+.++ +...+.. .+..+++.++..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 99999865 4444333 244689999999999999999999999999999999999999999999999999987653222
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||++.+.. ++.++||||||+++|+|++ |++||.+.+..+....+......
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 222 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM-------------- 222 (260)
T ss_pred ccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------------
Confidence 2222334577899999987665 7889999999999999999 99999988776665554321110
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++.++.+||.+||+.||++|||+++++.
T Consensus 223 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 --------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=321.53 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=201.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-----GKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||++.+... ...+|+|.+.... .......+.+|+.+++++ +|+||+++++++..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 87 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-- 87 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--
Confidence 46799999999999999999987643 3689999987543 333446688999999999 79999999998876
Q ss_pred CceEEEEEecccCCHHHHHHh----------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC
Q 036122 171 SCSLYLVFEYMEHDLAGLAAC----------------QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN 234 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 234 (457)
...++++|||+.++.+..+.. ....+++..+..++.||+.||.|||+.+|+||||||+|||+++
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 567999999998755444432 2346899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 036122 235 DGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHK 312 (457)
Q Consensus 235 ~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 312 (457)
++.+||+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999986643221 1112223467899999987655 7899999999999999998 8999988776665544
Q ss_pred HHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 313 IFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 313 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
+..... + ......+..+.+||.+||..||++|||+.++|++
T Consensus 247 ~~~~~~-------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 247 LKEGYR-------------------M---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHcCCc-------------------C---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 422100 0 0112356788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=313.39 Aligned_cols=244 Identities=21% Similarity=0.291 Sum_probs=195.3
Q ss_pred ceeeccCceEEEEEEEcCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 104 DKIGQGTYSNVYKARDLLTG---KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++|+||+++++++.. ..+++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEe
Confidence 47999999999999876554 78999998765443 445678899999999999999999998753 457999999
Q ss_pred ccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccc-
Q 036122 181 MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS- 259 (457)
Q Consensus 181 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~- 259 (457)
+.++.+.........+++..+..++.||+.||.|||+.+++|+||||+|||++.++.+||+|||+++............
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9876555555555579999999999999999999999999999999999999999999999999998764332211111
Q ss_pred -ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 260 -RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 260 -~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
..++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+.....
T Consensus 157 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~------------------- 216 (257)
T cd05060 157 AGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER------------------- 216 (257)
T ss_pred CccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-------------------
Confidence 12346799999997665 7899999999999999998 9999988776655544422100
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......++..+.+||.+||..||++|||+.++++
T Consensus 217 ---------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 ---------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112346778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=317.41 Aligned_cols=251 Identities=22% Similarity=0.302 Sum_probs=199.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
..+|++.+.||+|+||+||+|.+..+|. .||+|+++... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---C
Confidence 4689999999999999999999877776 48999987543 34445678899999999999999999998865 3
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..+++|||++++ +...+......+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 468999999864 5444444455799999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.... ......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||...........+.. ...+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~--------- 230 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK-GERL--------- 230 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCcC---------
Confidence 2211 112223467899999997665 7899999999999999998 8999987665444333211 1000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++.++.++|.+||..||++|||+.+++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 ------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011235677899999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=333.82 Aligned_cols=253 Identities=19% Similarity=0.268 Sum_probs=196.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-----GKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+++. |||||++++++..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 46899999999999999999986433 3479999997543 3344567889999999996 9999999999876
Q ss_pred CceEEEEEecccCCHHHHHHhc----------------------------------------------------------
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQ---------------------------------------------------------- 192 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~---------------------------------------------------------- 192 (457)
...+||||||+.++.+..+...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 5679999999987544332211
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC
Q 036122 193 --------------------------------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN 234 (457)
Q Consensus 193 --------------------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 234 (457)
...+++.++..++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124788889999999999999999999999999999999999
Q ss_pred CCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 036122 235 DGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHK 312 (457)
Q Consensus 235 ~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 312 (457)
++.+||+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||...........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 99999999999986543211 1122345678899999998765 7899999999999999997 8899987544333222
Q ss_pred HHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 313 IFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 313 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
...... .. .....++.++.+||.+||+.||++|||+.++.+
T Consensus 352 ~~~~~~------------------~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGY------------------RM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCC------------------CC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 211100 00 011246778899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.61 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=209.2
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
..+....++||+|+||+||+|+.. .....||||.++... +.+...+|++|+++|..|+|||||+|+|+|.. +
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~ 561 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE--G 561 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--C
Confidence 456677899999999999999753 223579999998553 45567889999999999999999999999988 6
Q ss_pred ceEEEEEecccCC-HHHHHHhcC---------C----CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc
Q 036122 172 CSLYLVFEYMEHD-LAGLAACQG---------V----KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 172 ~~~~lv~E~~~~~-l~~~~~~~~---------~----~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 237 (457)
..+|+|+|||.++ |..+++... . +|+..+...|+.||+.|+.||-++.+|||||-..|+||.++..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 7899999999865 444444321 2 2889999999999999999999999999999999999999999
Q ss_pred EEEeeccCcccc-CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 036122 238 LKIADFGLATFY-DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFK 315 (457)
Q Consensus 238 vkl~DFGla~~~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~ 315 (457)
|||+|||+++.. ..+.........-...||+||.|+-+. |+.+||||||||+|||+++ |..||.+..+.+.++.|.+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~ 720 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA 720 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence 999999999854 333222222334478899999999777 8999999999999999998 7999999999999988854
Q ss_pred hcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
. .+.+...++|.++.+||..|++.+|.+||+..||=
T Consensus 721 g----------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 721 G----------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred C----------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 2 12344567899999999999999999999998864
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=314.69 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=203.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+..|+.++++++|+||+++.+++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCC
Confidence 4578899999999999999999876654 79999986543 33345678899999999999999999999876 467
Q ss_pred EEEEEecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.|+||||++++.+.... .....+++.++..++.|++.||.|||+.|++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 89999999986555444 34567999999999999999999999999999999999999999999999999999866433
Q ss_pred CCCCccc--ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 253 LKQPMTS--RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 253 ~~~~~~~--~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
....... ...+..|+|||++.+.. ++.++|||||||++|||++ |..||...+..+....+......+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--------- 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--------- 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---------
Confidence 2221111 12345799999987655 7899999999999999998 999998877766666553211000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
...++++++.+|+.+||+.||++||++.++++
T Consensus 231 -------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11246778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=318.20 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=194.9
Q ss_pred cccceeeccCceEEEEEEEc----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 101 EKLDKIGQGTYSNVYKARDL----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 101 ~~~~~LG~G~fg~Vy~~~~~----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.+.+.||.|.||.||+|... ..+..|+||.++. ....+..+.+.+|+.++++++||||++++|++.. ...+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccc--cccccc
Confidence 35688999999999999987 3467899999954 3345557788999999999999999999999985 455899
Q ss_pred EEecccCC-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHD-LAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+.++ +...+... ...+++.++..|+.||+.||.|||+++++|+||+++|||++.++.+||+|||++........
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999865 55444444 46799999999999999999999999999999999999999999999999999987622111
Q ss_pred -CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 -QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
...........|+|||.+.+.. ++.++||||||+++|||++ |..||...+..+...++.+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------------
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------------
Confidence 1122334678899999998776 7999999999999999999 6899998888777776633210
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......++..+.+||..||..||++|||+.++++
T Consensus 224 --------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 --------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0112346778999999999999999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=316.33 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=200.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-----GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--G 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--C
Confidence 46899999999999999999987643 3789999986443 33334567889999999999999999999877 4
Q ss_pred ceEEEEEecccCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEe
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ----------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 241 (457)
...|+||||+.++.+..+... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 678999999986544433321 1247888999999999999999999999999999999999999999999
Q ss_pred eccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 036122 242 DFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 242 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
|||+++....... .......++..|+|||.+.+.. ++.++|||||||++|||+| |.+||.+.+..+....+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC
Confidence 9999986543221 1223345678899999987665 7899999999999999998 89999887776665544210 00
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+ .....++.++.+||.+||+.+|++|||+.++++
T Consensus 240 ~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 L---------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred C---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 011235778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=319.51 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=204.6
Q ss_pred CccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCc
Q 036122 99 TFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNL--EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~ 172 (457)
+|++.+.||+|+||.||++++. .+++.||||+++.... .......+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4788999999999999999864 4678999999875322 123345678899999999 59999999988866 56
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+.++.+.........+++..++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 78999999988655555555567999999999999999999999999999999999999999999999999998865433
Q ss_pred CCCCcccccccCccCchHhhhCCc-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGAT-YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.........|+..|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+.+... ..
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-------~~---- 227 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-------KS---- 227 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-------cc----
Confidence 222223346789999999986543 357899999999999999999999965432211112111100 00
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC---HHHHhcCCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT---ATAALNSEFFNTEPY 389 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt---a~elL~hp~f~~~~~ 389 (457)
.......++..+.+||.+||+.||++||| +.++|+||||+...|
T Consensus 228 --------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 228 --------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred --------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 00111336778899999999999999998 577899999988654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=314.89 Aligned_cols=252 Identities=32% Similarity=0.462 Sum_probs=200.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||++++..+|..||||.+.... ........+.+|+.+++.++|+||+++++++.. ...+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 57899999999999999999998999999999886533 234445678899999999999999999999877 567899
Q ss_pred EEecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+|||+.++.+..+.. ....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999998754443322 2456899999999999999999999999999999999999999999999999998866432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
. .......++..|+|||++.+.. ++.++||||||+++|+|++|..||.+.... +....+... ..
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~----------- 225 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DY----------- 225 (267)
T ss_pred C-cccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CC-----------
Confidence 2 1223456889999999997665 788999999999999999999999765432 111211110 00
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+ ......+++.+.+||.+||..||++|||+.++++
T Consensus 226 -------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 226 -------P--------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -------C--------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 0011236778999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=319.02 Aligned_cols=250 Identities=22% Similarity=0.300 Sum_probs=199.5
Q ss_pred CCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+... .....+.+.+|+.++++++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGD--GD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CC
Confidence 56889999999999999999753 34567999988643 23344668899999999999999999999876 56
Q ss_pred eEEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
.+++||||++++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 78999999987655444332 13489999999999999999999999999999999999999999
Q ss_pred cEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036122 237 ILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIF 314 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~ 314 (457)
.++|+|||++........ .......++..|+|||++.+.. ++.++|||||||++|||+| |.+||...+..+.+..+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999976543211 1123345678899999988765 7889999999999999999 999998877766555432
Q ss_pred HhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
... .......++..+.+||.+||+.||++|||+.++++
T Consensus 240 ~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGR----------------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCC----------------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 210 00011235678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=312.10 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=201.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||++.+. ++..||||.+...... ...+.+|+.++++++|+||+++++++.. ...+++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEE
Confidence 478999999999999999999864 5578999998754432 3457889999999999999999998876 467899
Q ss_pred EEecccCCHHH-HHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAG-LAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~-~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||++++.+. .+... +..+++..+..++.||+.||.|||++|++|+||||+||++++++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 99999875444 44332 24689999999999999999999999999999999999999999999999999986643211
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||.+.+.. ++.++|||||||++|+|++ |+.||.+.+....+..+......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------------- 223 (261)
T ss_pred hhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1112223467899999998665 7899999999999999999 99999988877776665332110
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+.++.+++.+||+.||++|||++++++
T Consensus 224 --------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 --------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 011235778899999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=300.01 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=199.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec---CCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR---MSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---~~~~ 173 (457)
.++|.+.+.||+|||+-||++++..++..||+|++.... .+..+...+|++..++++|||+++++++.... ....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 578999999999999999999999999999999998664 45567788999999999999999998775432 2345
Q ss_pred EEEEEecccCC-HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 174 LYLVFEYMEHD-LAGLAAC---QGVKFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.||++.|...+ +++.+.. .+..++|.++..|+.+|++||.+||+.. +.||||||.|||+.+++.++|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 89999999765 5554432 3457999999999999999999999998 9999999999999999999999999997
Q ss_pred ccCCCCCC--------CcccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 036122 248 FYDPGLKQ--------PMTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC 317 (457)
Q Consensus 248 ~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~ 317 (457)
...-.... .......|..|+|||.+.-. ...+.++|||||||+||+|+.|..||. .+++.-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe---------~~~~~G 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFE---------RIYQQG 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcch---------HHhhcC
Confidence 65322111 12234568999999988532 226789999999999999999999994 222211
Q ss_pred CCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
|+-. ......+.. +... .-+++.+.+||+.||+.||.+||++.++|.+
T Consensus 249 gSla-----------LAv~n~q~s----~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLA-----------LAVQNAQIS----IPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEE-----------Eeeeccccc----cCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1110 000000000 0011 1278899999999999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=316.13 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=197.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
..+|++.+.||+|+||+||+|....++. .|++|.+... ........+..|+.++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---C
Confidence 3679999999999999999999877776 4777776532 223344667789999999999999999998753 3
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..++++||+.++ +...+......+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 578899999864 5455544456799999999999999999999999999999999999999999999999999986643
Q ss_pred CCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.........+... ..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~--------- 230 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERL--------- 230 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcC---------
Confidence 3221 122345677899999998766 7899999999999999998 99999887655443322110 000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+.++.+++.+||..||++|||+.|+++
T Consensus 231 ------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 ------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 001124557788999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=319.73 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=198.9
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|.+.+.||+|+||.||++.+. .++..||+|.++... .......+.+|+.+++++ +|+||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 467999999999999999999752 345689999987543 234456788999999999 79999999998876
Q ss_pred CceEEEEEecccCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 171 SCSLYLVFEYMEHDLAGLAA-CQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~-~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
...+|+||||+.++.+..+. .. ...+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 45789999999875444443 32 23489999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 249 YDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 249 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
....... ......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||...+..+...+......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~-------- 261 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY-------- 261 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC--------
Confidence 5432111 112234578899999997766 7899999999999999998 9999987765544433322100
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.+ ......++.+.+||.+||..||++|||+.|+++
T Consensus 262 ----------~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 ----------RM---------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ----------cC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 011235678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=319.36 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=200.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCC--------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT--------------GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~--------------g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l 162 (457)
.++|++.+.||+|+||.||+|++..+ ...||+|.++... .......+.+|++++++++|+||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 36899999999999999999986543 2359999987543 34455678899999999999999999
Q ss_pred eeeEEecCCceEEEEEecccCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q 036122 163 EGLVTSRMSCSLYLVFEYMEHDLAGLAACQG------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNL 230 (457)
Q Consensus 163 ~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 230 (457)
++++.. ...+++||||+.++.+..+.... ..+++..+..++.||+.||.|||++|++|+||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999876 56789999999975554443221 1368889999999999999999999999999999999
Q ss_pred EecCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh--CCCCCCCCChH
Q 036122 231 LIDNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA--GKPIMPGRTEV 307 (457)
Q Consensus 231 Ll~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt--G~~pf~~~~~~ 307 (457)
|+++++.+||+|||++........ .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999976533211 1112234577899999988766 7999999999999999998 66888887776
Q ss_pred HHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 308 EQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 308 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+.+..+.+........ ......+.+++.+.+||.+||+.||++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 240 QVIENTGEFFRNQGRQ---------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHhhhhcccc---------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6655543321100000 000112236778999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=313.70 Aligned_cols=251 Identities=24% Similarity=0.385 Sum_probs=201.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.+|++.+.||+|+||.||+|.+..++. .+|+|.++... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcc
Confidence 578999999999999999998765443 79999987543 33445678899999999999999999999876 5678
Q ss_pred EEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
|+||||++++ +...+......+++.++..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999875 444444445578999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcc--cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 254 KQPMT--SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 254 ~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
..... ...++..|+|||++.+.. ++.++|||||||++|++++ |..||...+..+....+.+....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----------- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-----------
Confidence 21111 122356899999998665 7899999999999999886 99999887766655554321100
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++.+.+++.+||+.+|.+|||+.++++
T Consensus 229 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 -----------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011246778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=316.65 Aligned_cols=250 Identities=21% Similarity=0.301 Sum_probs=199.4
Q ss_pred CCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.+|.+.++||+|+||.||++... .++..+|+|.+... .......+.+|+.+++.++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--GR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CC
Confidence 57888999999999999999642 35678999987643 34455678899999999999999999998876 56
Q ss_pred eEEEEEecccCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc
Q 036122 173 SLYLVFEYMEHDLAGLAACQG---------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 237 (457)
..++||||+.++.+..+.... ..+++..+..++.||+.||.|||++||+|+||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 789999999875554443322 24889999999999999999999999999999999999999999
Q ss_pred EEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 036122 238 LKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFK 315 (457)
Q Consensus 238 vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~ 315 (457)
+||+|||++........ .......+++.|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+....+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999975532211 1112234567899999998766 7899999999999999998 8999987776665554432
Q ss_pred hcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
... ......+++.+.+||.+||+.||.+||++.++++
T Consensus 240 ~~~----------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRE----------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred Ccc----------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 110 0111246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.83 Aligned_cols=252 Identities=32% Similarity=0.484 Sum_probs=201.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.+.||+|+||.||+|.+..+|+.||+|.++... ........+.+|+.++++++|+||+++++++.. ....++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 57999999999999999999998899999999987533 234446678899999999999999999999877 567899
Q ss_pred EEecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
||||++++.+..... ....+++.++..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999998754443332 2345899999999999999999999999999999999999999999999999998865432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
. .......++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... .+....+....
T Consensus 160 ~-~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------- 224 (267)
T cd08224 160 T-TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD------------- 224 (267)
T ss_pred C-cccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC-------------
Confidence 2 1223456788999999997665 78899999999999999999999965432 11222211100
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
. +. .....++..+.++|.+||..+|++|||+.++++
T Consensus 225 -----~-~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 -----Y-PP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----C-CC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0 00 001246678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=311.99 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=197.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|.+...||+|+||.||+|.+..+ ..+|+|.+..... ....+.+|+.++++++|+||+++++++.. ...|+|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVSE---EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEcC---CCcEEE
Confidence 5699999999999999999987544 4699998865432 23457789999999999999999987743 457899
Q ss_pred EecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEH-DLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||+.+ ++...+... ...+++..+..++.||+.||.|||+.||+|+||||+||++++++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999987 455544432 345899999999999999999999999999999999999999999999999999866433222
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......++..|+|||.+.+.. ++.++|||||||++|+|+| |.+||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM--------------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 222334577899999887666 7899999999999999999 89999988776666554321000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....+++..+.+||++||..||++|||++++++
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 012346778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=309.58 Aligned_cols=246 Identities=31% Similarity=0.465 Sum_probs=203.4
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD 184 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~ 184 (457)
||.|+||.||++.+..+++.||+|++...... ......+..|+.++++++|+||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 69999999999999888999999998765432 3355678899999999999999999988876 56799999999665
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccC
Q 036122 185 LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264 (457)
Q Consensus 185 l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~ 264 (457)
.+.........+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 554444455579999999999999999999999999999999999999999999999999998664321 1234456788
Q ss_pred ccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCccc
Q 036122 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKR 344 (457)
Q Consensus 265 ~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (457)
.|++||.+.+.. .+.++|+||||+++|+|++|..||...+..+....+... ..
T Consensus 158 ~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------------------ 210 (250)
T cd05123 158 EYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--PL------------------------ 210 (250)
T ss_pred cccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--CC------------------------
Confidence 999999987665 688999999999999999999999877765544444220 00
Q ss_pred chhcccCCCCCCcHHHHHHhccCCCCCCcCH---HHHhcCCCC
Q 036122 345 CIAETFKDFPSSSLPLIETLLSIDPDNRGTA---TAALNSEFF 384 (457)
Q Consensus 345 ~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta---~elL~hp~f 384 (457)
.....++..+.++|++||..||++|||+ ++++.||||
T Consensus 211 ---~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 0112347788999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=332.57 Aligned_cols=253 Identities=25% Similarity=0.365 Sum_probs=207.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc---E-EEEEEeecC-CCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK---I-VALKKVRFD-NLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~-vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++-.+.++||+|+||.||+|..+..+. . ||+|..+.. ....+....+.+|+++|++++|||||+++|++.. .
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~ 233 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--E 233 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--C
Confidence 5666677999999999999998765432 3 899999863 3677888899999999999999999999999988 5
Q ss_pred ceEEEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
..+|||||+|.|+.+..++.. ...++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||+++...
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 679999999998655555544 4469999999999999999999999999999999999999999999999999988543
Q ss_pred CCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.. ............|+|||.+.... |+.++|||||||++||+++ |..||.+....+...+|.......
T Consensus 314 ~~-~~~~~~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~--------- 382 (474)
T KOG0194|consen 314 QY-VMKKFLKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM--------- 382 (474)
T ss_pred ce-eeccccccCcceecChhhhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC---------
Confidence 11 11111123467899999998774 8999999999999999999 788999999999988884421110
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......|.++..++.+|+..||++|||+.++.+
T Consensus 383 ------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 ------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 011245677888999999999999999988874
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=307.81 Aligned_cols=244 Identities=23% Similarity=0.365 Sum_probs=195.1
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccC
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH 183 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~ 183 (457)
+.||+|+||.||+|.. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ....++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 3699999999999985 478899999987543 33444568899999999999999999999876 4578999999987
Q ss_pred CHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc
Q 036122 184 DLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262 (457)
Q Consensus 184 ~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 262 (457)
+.+. .+......+++..+..++.||+.+|.|||++|++|+||||+||+++.++.+||+|||++...............+
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 5444 444444568999999999999999999999999999999999999999999999999997554332211122234
Q ss_pred cCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 263 t~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
+..|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+.......+.....
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 212 (250)
T cd05085 157 PIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR----------------------- 212 (250)
T ss_pred cccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 67799999987655 7889999999999999998 9999988776655544422100
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......++..+.+|+.+||+.||++|||+.++++
T Consensus 213 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 213 -----MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0011246778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=316.58 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=196.5
Q ss_pred CccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
+|++.+.||+|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCC
Confidence 47889999999999999998643 23578999886543 33445678899999999999999999998876 456
Q ss_pred EEEEEecccCCHHHHHHhc------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQ------------------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSN 229 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 229 (457)
.++||||+.++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 8999999997655444321 1347899999999999999999999999999999999
Q ss_pred EEecCCCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 036122 230 LLIDNDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 307 (457)
Q Consensus 230 ILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~ 307 (457)
||+++++.+||+|||+++........ ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999865322111 112234567899999987665 7899999999999999999 99999887765
Q ss_pred HHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 308 EQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 308 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+....+.... .. .....++.++.+||..||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~-------------------~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGY-------------------RM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCC-------------------CC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5444332110 00 011246678899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.06 Aligned_cols=243 Identities=21% Similarity=0.252 Sum_probs=193.1
Q ss_pred eeeccCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEeccc
Q 036122 105 KIGQGTYSNVYKARDL--LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ..+++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 4899999999999765 445679999987543 34445678899999999999999999998753 46899999998
Q ss_pred CCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC--ccc
Q 036122 183 HDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP--MTS 259 (457)
Q Consensus 183 ~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~--~~~ 259 (457)
++.+.... .....+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++.......... ...
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 75554443 345579999999999999999999999999999999999999999999999999998654332211 111
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
..++..|+|||++.+.. ++.++|||||||++|+|++ |.+||......+....+.... .
T Consensus 158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~------------------ 216 (257)
T cd05115 158 GKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--R------------------ 216 (257)
T ss_pred CCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--C------------------
Confidence 22357899999987655 7889999999999999996 999998877766555442210 0
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......++++.+||.+||..||++||++.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 --------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011245788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=325.25 Aligned_cols=255 Identities=21% Similarity=0.325 Sum_probs=195.7
Q ss_pred cCCccccceeeccCceEEEEEEE-----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARD-----LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 36899999999999999999984 3567899999997543 233456688899999999 689999999988654
Q ss_pred CceEEEEEecccCCHHHHHHhc----------------------------------------------------------
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQ---------------------------------------------------------- 192 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~---------------------------------------------------------- 192 (457)
...+++||||++++.+..+...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 3468999999997654433321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-CCcccccc
Q 036122 193 ---------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-QPMTSRVV 262 (457)
Q Consensus 193 ---------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~g 262 (457)
...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12367888899999999999999999999999999999999999999999999986532211 11122345
Q ss_pred cCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCC
Q 036122 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQP 341 (457)
Q Consensus 263 t~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (457)
+..|+|||++.+.. ++.++|||||||++|+|++ |..||................ . ..
T Consensus 244 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~-----------------~~--- 301 (343)
T cd05103 244 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-T-----------------RM--- 301 (343)
T ss_pred CcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhcc-C-----------------CC---
Confidence 67899999987665 7899999999999999997 899997754333222221100 0 00
Q ss_pred cccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......++++.+++..||+.||++|||+.++++|
T Consensus 302 ------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 302 ------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0011245678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=315.41 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=199.9
Q ss_pred cCCccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--G 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--C
Confidence 4689999999999999999998743 67899999987543 34445678899999999999999999998876 4
Q ss_pred ceEEEEEecccCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQG----------------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSN 229 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 229 (457)
..+++||||++++.+....... ..+++.++..++.||+.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 5789999999875444333221 247888999999999999999999999999999999
Q ss_pred EEecCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChH
Q 036122 230 LLIDNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEV 307 (457)
Q Consensus 230 ILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~ 307 (457)
||++.++.++|+|||++........ ........+..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999875532211 1112233467799999987665 7899999999999999998 88899877766
Q ss_pred HHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 308 EQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 308 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+....+.... .......++.++.+||.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGN----------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6555442210 00011246778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=319.24 Aligned_cols=253 Identities=22% Similarity=0.314 Sum_probs=198.0
Q ss_pred cCCccccceeeccCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-------TGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 168 (457)
.++|.+.+.||+|+||.||++++.. ++..||+|.+.... .......+.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3679999999999999999998643 23579999987543 233445688899999999 79999999999877
Q ss_pred cCCceEEEEEecccCCHH-HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 169 RMSCSLYLVFEYMEHDLA-GLAACQG---------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~-~~~~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
...+|+||||+.++.+ ..+.... ..+++.++..++.||+.||.|||++|++||||||+|||+
T Consensus 96 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 96 --DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 4578999999987544 4443221 248899999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||++......... ......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 99999999999999765322111 111223456899999997765 7899999999999999998 88999877665544
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+.... .......++.++.+||.+||..+|.+|||+.+++++
T Consensus 253 ~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 253 KLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHcCC----------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4432110 001123467788999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=307.93 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=200.5
Q ss_pred ccccceeeccCceEEEEEEEcCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTG----KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
|++.+.||.|+||.||++++...+ ..||+|++..... ......+..|+.+++.++|+||+++++++.. ....|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeE
Confidence 456789999999999999988766 8999999965532 2255678899999999999999999998877 46799
Q ss_pred EEEecccCCHHHHHH-hcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 176 LVFEYMEHDLAGLAA-CQGVK-FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 176 lv~E~~~~~l~~~~~-~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
++|||++++.+.... ..... +++.++..++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999875444443 33323 9999999999999999999999999999999999999999999999999998665432
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
........+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+.......+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 222 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------------- 222 (258)
T ss_pred ccccccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------------
Confidence 11111233678999999986544 7899999999999999998 7899988777666655432110
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......++.++.+++.+||..||++|||+.|+++
T Consensus 223 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 --------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0011236778999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.54 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=199.8
Q ss_pred CCccccceeeccCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.+|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCc
Confidence 5688999999999999999987544 3469999886443 34455678899999999999999999998865 347
Q ss_pred EEEEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
|+||||++++.+ ..+......+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999987544 4443334468999999999999999999999999999999999999999999999999998664332
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....+...++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------------- 226 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-------------- 226 (270)
T ss_pred ceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc--------------
Confidence 21122233456899999887655 7899999999999999996 9999988877666554422100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+++.+.+||.+||..+|.+|||+.+++.
T Consensus 227 --------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 227 --------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred --------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112346788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=307.55 Aligned_cols=244 Identities=24% Similarity=0.375 Sum_probs=195.3
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccC
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH 183 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~ 183 (457)
+.||+|+||.||++.+.. ++.||+|.+...... .....+.+|+.++++++|+||+++++++.. ....|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 469999999999999876 999999998765433 455678899999999999999999998876 5678999999987
Q ss_pred CHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc-cccc
Q 036122 184 DLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM-TSRV 261 (457)
Q Consensus 184 ~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~-~~~~ 261 (457)
+.+ ..+......+++..+..++.|++.+|.|||+++++||||||+|||++.++.+||+|||++........... ....
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 544 44444455689999999999999999999999999999999999999999999999999986542211111 1123
Q ss_pred ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCC
Q 036122 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQ 340 (457)
Q Consensus 262 gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (457)
++..|+|||.+.+.. ++.++|||||||++|+|+| |..||...........+......
T Consensus 157 ~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~--------------------- 214 (251)
T cd05041 157 IPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM--------------------- 214 (251)
T ss_pred ceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC---------------------
Confidence 356799999987665 7899999999999999999 78999877665544443211000
Q ss_pred CcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 341 PYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++..+.+||.+||..+|.+|||+.|+|+
T Consensus 215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011246778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=313.56 Aligned_cols=266 Identities=22% Similarity=0.291 Sum_probs=197.5
Q ss_pred CCc-cccceeeccCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 98 NTF-EKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 98 ~~y-~~~~~LG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
++| .+.+.||+|+||+||++. ...++..||+|.+.... .......+.+|+.++++++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 889999999999998864 33578899999987543 233446678899999999999999999988765556
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+.++.+....... .+++.+++.++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 789999999986665554443 5999999999999999999999999999999999999999999999999999866432
Q ss_pred CCCC--cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-cCCCChhhhhhcC
Q 036122 253 LKQP--MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL-CGSPSEEYWKKSK 329 (457)
Q Consensus 253 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 329 (457)
.... .....++..|+|||.+.+.. ++.++|||||||++|+|+||..||....... ..+... .+......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~- 236 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMIGPKQGQMTVVRLIEL- 236 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhhcccccccchhhhhhh-
Confidence 2111 12234567799999987665 7899999999999999999999986543211 111100 000000000000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.. ... .......++.++.+|+.+||+.||++|||++++++
T Consensus 237 -~~---~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 -LE---RGM-------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred -hh---cCC-------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 000 00112346788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.24 Aligned_cols=269 Identities=20% Similarity=0.326 Sum_probs=198.9
Q ss_pred CCccccceeeccCceEEEEEEE----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARD----LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~----~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
..|.+++.||+|+||.||++.. ..++..||+|.++... .......+.+|+.+++.++||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3578999999999999999974 4568899999986543 3444567889999999999999999999887754567
Q ss_pred EEEEEecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+++||||++++.+..+. .....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999876555444 33446899999999999999999999999999999999999999999999999999866432
Q ss_pred CCC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
... ......++..|+|||++.+.. ++.++|||||||++|+|+|+..|+...... .....+....+.......
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMTL-----FLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccch-----hhhhcccccccccHHHHH
Confidence 211 112345677899999987665 788999999999999999987665332110 011111111000000000
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..... .........++..+.+||.+||+.||++|||+.+++++
T Consensus 237 ---~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 ---RVLEE-----GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ---HHHHc-----CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00000 00011224577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=313.08 Aligned_cols=253 Identities=20% Similarity=0.329 Sum_probs=200.7
Q ss_pred CCccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.+|++...||+|+||.||+|+.+. +.+.|++|.+.... .......+.+|+.++++++|+||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CC
Confidence 578999999999999999998653 34679999886432 23345678899999999999999999998876 45
Q ss_pred eEEEEEecccCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeec
Q 036122 173 SLYLVFEYMEHDLAGLAACQGV---------KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
..|+||||++++.+..+..... .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 7899999999755554443333 6899999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 244 GLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
|++...............++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...........+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~---- 236 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL---- 236 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc----
Confidence 998754322222233445678899999987665 6889999999999999999 7889987666555444321000
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. ......++..+.++|.+||+.||++|||+.|++.+
T Consensus 237 --------~---------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 --------E---------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred --------C---------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 00112467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.57 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=198.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEE
Confidence 46799999999999999999985 588999999975432 45678899999999999999999999876 567899
Q ss_pred EEecccCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGV--KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||++++.+........ .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999744444433322 68999999999999999999999999999999999999999999999999998663221
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.....+..|+|||++.+.. ++.++||||||+++|+|++ |..||...+..+....+....
T Consensus 157 ---~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY---------------- 216 (256)
T ss_pred ---ccCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 1233466799999987655 7889999999999999997 999998776655544332110
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
. ......+++.+.+||.+||..+|++|||+.+++.
T Consensus 217 ---~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 217 ---R---------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---C---------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 0111346788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=311.58 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=201.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
++|.+.+.||+|+||.||+|.+..+++ .||||.+.... .......+..|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCce
Confidence 468899999999999999999877665 69999986542 34455778999999999999999999998866 5678
Q ss_pred EEEEecccCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
++||||++++.+. .+......+++.+++.++.|++.||.|||++|++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999876554 444445678999999999999999999999999999999999999999999999999987654322
Q ss_pred CCC-ccccc---ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 254 KQP-MTSRV---VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 254 ~~~-~~~~~---gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
... ..... .+..|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+....+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~--------- 230 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL--------- 230 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC---------
Confidence 111 11111 245799999997666 7899999999999999886 99999887776665555321100
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....+++..+.+++.+||..+|.+|||+.+++.
T Consensus 231 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 -------------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011346778899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.65 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=200.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|++.+.||+|+||.||++.+. ++..+|+|.+...... ...+.+|+.++++++||||+++++++.. ...+++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence 57889999999999999999874 5778999998754433 2457789999999999999999998876 4578999
Q ss_pred EecccCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||+.++.+..+.. ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++..........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999865554443 34568999999999999999999999999999999999999999999999999998654322111
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....++..|+|||++.+.. ++.++||||||+++|||++ |.+||......+....+.+....
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 220 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---------------- 220 (256)
T ss_pred cCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCC----------------
Confidence 22234467899999987655 7889999999999999998 99999887776666554221000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......+..+.+|+.+||+.+|++|||+.+++++
T Consensus 221 ------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 221 ------------YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0012256788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=317.98 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=198.4
Q ss_pred cCCccccceeeccCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-------TGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 168 (457)
.++|.+.+.||+|+||.||++++.. ....||+|.++... .......+.+|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3689999999999999999997632 34579999987543 344456788899999999 59999999998876
Q ss_pred cCCceEEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 169 RMSCSLYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
...+|+||||+.++.+..+... ...+++.++..++.||+.||.|||++||+|+||||+|||+
T Consensus 90 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 90 --EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 4578999999987654444322 1348899999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~ 246 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999986542211 1111223356799999997655 7899999999999999999 89999887766655
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
..+.... .......++.++.+||.+||..||++|||+.++++
T Consensus 247 ~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 247 KLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5442210 00111245678899999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.92 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=197.4
Q ss_pred ceeeccCceEEEEEEEcC-CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 104 DKIGQGTYSNVYKARDLL-TGK--IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~-~g~--~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
+.||+|+||.||+|.+.. +++ .||||.+...... ...+.+.+|+.++++++||||+++++++.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEe
Confidence 468999999999998755 333 6999999876544 556788899999999999999999998876 578999999
Q ss_pred ccCC-HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC--C
Q 036122 181 MEHD-LAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ--P 256 (457)
Q Consensus 181 ~~~~-l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~--~ 256 (457)
++++ +...+.... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++......... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9865 444444433 46899999999999999999999999999999999999999999999999999876442211 1
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL--------------- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcC---------------
Confidence 11235678899999987665 7889999999999999999 999998877777666553310000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+|..+.+|+.+||+.+|++|||+.++++
T Consensus 221 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 221 ------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 011235778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=332.25 Aligned_cols=265 Identities=30% Similarity=0.430 Sum_probs=213.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
..-|..++.||-|+||.|.+++...|...||+|.+++.. +.+..+..+..|..||..-+++-||+||..|.+ .+.+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLY 705 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLY 705 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceE
Confidence 355888999999999999999988999999999997643 456667778899999999999999999766666 67899
Q ss_pred EEEecccCCH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc-----
Q 036122 176 LVFEYMEHDL-AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY----- 249 (457)
Q Consensus 176 lv~E~~~~~l-~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~----- 249 (457)
+||+|++|+. ..+++. -+-|.|..+++|+.++..|+++.|..|+|||||||+|||||.+|++||+||||+.-+
T Consensus 706 FVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccc
Confidence 9999999854 444444 446999999999999999999999999999999999999999999999999998533
Q ss_pred ----CCCCC--------------------------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHH
Q 036122 250 ----DPGLK--------------------------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAE 293 (457)
Q Consensus 250 ----~~~~~--------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~e 293 (457)
..+.. -...+.+||+.|+|||+|.... |+..+|+||.||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYE 863 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHH
Confidence 10000 0012468999999999998766 7999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc
Q 036122 294 LLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG 373 (457)
Q Consensus 294 lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp 373 (457)
|+.|++||-..+..+...++.. |... .- -.....++.++.+||.++. .+++.|.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~n---------w~~~-----l~-----------~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVIN---------WRNF-----LH-----------IPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeee---------hhhc-----cc-----------cccccccCHHHHHHHHHHh-cChhhhh
Confidence 9999999988877666555432 2110 00 0112457889999999865 5788886
Q ss_pred C---HHHHhcCCCCCCCCCCC
Q 036122 374 T---ATAALNSEFFNTEPYAC 391 (457)
Q Consensus 374 t---a~elL~hp~f~~~~~~~ 391 (457)
. ++|+-.||||+...|..
T Consensus 918 Gkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 918 GKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred cccchhhhhcCccccccchHh
Confidence 5 78899999999987754
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.07 Aligned_cols=268 Identities=22% Similarity=0.328 Sum_probs=197.3
Q ss_pred cCCccccceeeccCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
..+|++++.||+|+||.||++. +..++..||+|.+... .....+.+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 3579999999999999999997 3457889999998644 344456788999999999999999999987665556
Q ss_pred eEEEEEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
.+++||||++++.+ ..+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 78999999987544 44444445689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCc--ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCChhhhhhc
Q 036122 252 GLKQPM--TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCG-SPSEEYWKKS 328 (457)
Q Consensus 252 ~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 328 (457)
...... ....++..|+|||++.+.. ++.++|||||||++|||++|..++..... .....+..... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHHH
Confidence 321111 1122345699999997665 78999999999999999999776643321 11111100000 0000000000
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+.. . ........++.++.+||.+||..||++|||+.++++
T Consensus 239 -~~~------~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 -LKN------N-----GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred -Hhc------C-----CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 0 000112456778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.92 Aligned_cols=243 Identities=22% Similarity=0.380 Sum_probs=195.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|.+.+.||+|+||.||++.. .|..||+|.++.+. ..+.+.+|+.++++++|+||+++++++... ...+|+|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEE
Confidence 5799999999999999999974 58889999986432 235678899999999999999999876543 4568999
Q ss_pred EecccCC-HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEHD-LAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~~-l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||++++ +...+.... ..+++..+..++.||+.||.|||++||+||||||+||++++++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--- 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc---
Confidence 9999874 444444333 24889999999999999999999999999999999999999999999999998754322
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.....++..|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+.....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------------- 217 (256)
T cd05082 156 -QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---------------- 217 (256)
T ss_pred -CCCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC----------------
Confidence 12234467899999987655 7889999999999999998 9999987766555544422100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+++.+.++|.+||+.||++|||+.++++
T Consensus 218 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 ------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112346788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.60 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=229.9
Q ss_pred CcCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 94 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.-...+++++..||-||||.|-++........+|+|++++... +....+.+..|-.||..++.|.||++|..|.+ +.
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--ch
Confidence 3446788899999999999999998655555699999976543 44555678899999999999999999888876 77
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|++||-|-|+.+..+....+.|.+..++.++..+++|++|||.+|||+|||||+|++|+.+|-+||.|||+|+.+..+
T Consensus 494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 89999999988777777777778999999999999999999999999999999999999999999999999999988765
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....+.+||+.|.|||++++.. .+.++|.||||+++|||++|.|||.+.+....+..|.+.+.. |
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----i------- 638 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----I------- 638 (732)
T ss_pred --CceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----h-------
Confidence 3456789999999999999877 689999999999999999999999999999999998775321 0
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYA 390 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~ 390 (457)
+....++..+.+||+++...+|.+|.. +.++-.|-||.+..|.
T Consensus 639 ---------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 639 ---------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred ---------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 112347788999999999999999977 8999999999987765
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=310.32 Aligned_cols=253 Identities=26% Similarity=0.421 Sum_probs=201.1
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN---LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
+|.+.+.||+|+||.||++.+..++..+++|+++... ........+..|+.++++++||||+++++++.. ....+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 5888999999999999999988777777777765422 223333456679999999999999999998876 45689
Q ss_pred EEEecccCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 176 LVFEYMEHDLAGLAA----CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 176 lv~E~~~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
+||||+.++.+.... .....+++.+++.++.||+.||.|||+.|++|+||||+||++++ +.+||+|||++.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 999999875544332 23456999999999999999999999999999999999999975 5799999999976643
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+... ..
T Consensus 158 ~~-~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~----------- 222 (260)
T cd08222 158 SC-DLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT----------- 222 (260)
T ss_pred Cc-ccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-----------
Confidence 22 1223346788999999987655 688999999999999999999999876665555443221 00
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
......++.++.++|.+||..||++||++.++|+||||
T Consensus 223 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 ---------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00112467788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=312.41 Aligned_cols=253 Identities=20% Similarity=0.264 Sum_probs=200.7
Q ss_pred cCCccccceeeccCceEEEEEEEcC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|.+.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+.++++++|+||+++++++... ..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 4689999999999999999999865 3578999988643 3455567788999999999999999999987654 35
Q ss_pred eEEEEEecccCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 173 SLYLVFEYMEHDLAGLAACQG--------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
..++++||+.++.+..+.... ..+++..+..++.||+.||.|||+++++|+||||+|||+++++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 689999999865444443221 458999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 245 LATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 245 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
+++.+...... ......++..|+|||++.+.. ++.++|||||||++||+++ |.+||...+..+....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----- 236 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY----- 236 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-----
Confidence 99865332211 112234577899999997665 7899999999999999999 999998776655443332110
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.. .....+++++.++|.+||..||++|||+.++++
T Consensus 237 --------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 237 --------------RL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred --------------CC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 011235678899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=325.00 Aligned_cols=281 Identities=32% Similarity=0.528 Sum_probs=226.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC------CCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD------HPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l~~~~~~~~ 170 (457)
..+|.+....|+|-||+|.+|.+...|..||||+|+.+.. -.+.=.+|++||++|+ --|+++|+..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--
Confidence 5789999999999999999999999999999999986532 2233457999999995 3478898877766
Q ss_pred CceEEEEEecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-CcEEEeeccCcc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLAT 247 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~ 247 (457)
.+++|||+|-+.-+|...+..-+ .-|....++.|+.|++.||..|-.+||+|.||||+||||++. ..+||||||.|.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 57899999999888777666543 347889999999999999999999999999999999999965 478999999998
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
....+ ..+.+..+..|.|||+++|.+ |++..|+||+||+||||.||+-+|+|.++..++...+.+-|.++......
T Consensus 586 ~~~en---eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 586 FASEN---EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred ccccc---cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 76543 346677788999999999988 89999999999999999999999999999999999999999988877665
Q ss_pred cCCCCcc----------------------cCCCCCCcccchhcccC--CCC-------CCcHHHHHHhccCCCCCCcCHH
Q 036122 328 SKLPNAT----------------------LFKPQQPYKRCIAETFK--DFP-------SSSLPLIETLLSIDPDNRGTAT 376 (457)
Q Consensus 328 ~~~~~~~----------------------~~~~~~~~~~~~~~~~~--~~~-------~~~~~Li~~~L~~dP~~Rpta~ 376 (457)
..+.... .+....|.+...+++.. .+| ..+.+||..||..||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 4322211 01111111111111111 122 3578899999999999999999
Q ss_pred HHhcCCCCCC
Q 036122 377 AALNSEFFNT 386 (457)
Q Consensus 377 elL~hp~f~~ 386 (457)
|+|.||||+.
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999975
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=310.08 Aligned_cols=239 Identities=19% Similarity=0.257 Sum_probs=186.0
Q ss_pred ceeeccCceEEEEEEEcC------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 104 DKIGQGTYSNVYKARDLL------------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~------------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
+.||+|+||.||+|+... ....|++|++... .......+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVR--D 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 469999999999997432 2235888987543 23344567889999999999999999999876 4
Q ss_pred ceEEEEEecccCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc-------EEEeec
Q 036122 172 CSLYLVFEYMEHDLAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI-------LKIADF 243 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-------vkl~DF 243 (457)
...++||||++++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++. ++++||
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 56799999999876655554 3456999999999999999999999999999999999999987664 899999
Q ss_pred cCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 244 GLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ell-tG~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
|++...... ....++..|+|||++.+...++.++|||||||++|||+ +|..||......+... +....
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~----- 225 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQ----- 225 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcC-----
Confidence 998754321 23467888999999875555889999999999999998 5788887655433321 11100
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. ......+.++.+||.+||+.||.+|||+.++|++
T Consensus 226 -------------~-----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 -------------C-----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -------------c-----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0011234567899999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.37 Aligned_cols=253 Identities=21% Similarity=0.311 Sum_probs=200.5
Q ss_pred cCCccccceeeccCceEEEEEEEc-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-------LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-------~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 168 (457)
.++|.+.+.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 468999999999999999999753 234579999886442 334456788999999999 79999999999877
Q ss_pred cCCceEEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 169 RMSCSLYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
...+|+||||+.++.+..+... ...+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 4678999999987544444332 1347888999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||+++........ ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999866432211 122234567899999997765 7899999999999999998 78999887776665
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+..... ......++.++.+||.+||..+|.+|||+.++|+.
T Consensus 250 ~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 250 KLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 54422100 00112467789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=347.61 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=208.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-C----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-G----KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-g----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
-..-+..+.||+|+||.||.|..... | ..||||.++.. .+.+....|.+|..+|+.++|||||+++|++.+ .
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--S 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--C
Confidence 34567788899999999999986533 2 24999998754 356667889999999999999999999999998 5
Q ss_pred ceEEEEEecccC-CHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 172 CSLYLVFEYMEH-DLAGLAACQ------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 172 ~~~~lv~E~~~~-~l~~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
...+|++|||.+ +|+.++... ...++..+...++.||++|+.||+++++|||||...|+||+....|||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 678999999987 566666665 5569999999999999999999999999999999999999999999999999
Q ss_pred Ccccc-CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 245 LATFY-DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 245 la~~~-~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
+|+.. ..+.........-...|||||.+.... ++.++|||||||+|||++| |..||+..++.+.+....+.-.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR---- 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR---- 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc----
Confidence 99944 322211111112356899999999765 8999999999999999999 7899999999988876544210
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.+....+|..+.+||.+|++.+|++||+...++.
T Consensus 923 ------------------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 923 ------------------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ------------------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1122458889999999999999999999999986
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=313.48 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=196.9
Q ss_pred CCccccceeeccCceEEEEEEEcC----------------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCcee
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL----------------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~----------------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 161 (457)
++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 34579999987542 3444567889999999999999999
Q ss_pred EeeeEEecCCceEEEEEecccCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCE
Q 036122 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG-----------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNL 230 (457)
Q Consensus 162 l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 230 (457)
+++++.. ...+++||||+.++.+..+.... ..+++.++..++.||+.||.|||++||+|+||||+||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999877 45689999999875444333221 2377889999999999999999999999999999999
Q ss_pred EecCCCcEEEeeccCccccCCCCCCC-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh--CCCCCCCCChH
Q 036122 231 LIDNDGILKIADFGLATFYDPGLKQP-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA--GKPIMPGRTEV 307 (457)
Q Consensus 231 Ll~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt--G~~pf~~~~~~ 307 (457)
|++.++.++|+|||+++.+....... .....++..|+|||+..+.. ++.++|||||||++|||++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999998654322111 12233467899999887766 7999999999999999998 67899877666
Q ss_pred HHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 308 EQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 308 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+.+....... ..... ... ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~--------~~~~~---~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFF--------RDQGR---QVY----------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHH--------hhccc---ccc----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5554332211 00000 000 0111235678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=326.60 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=198.0
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 170 (457)
.++|.+.++||+|+||.||+|++. .++..||+|+++.... ......+.+|+.+|.++. |||||++++++..
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 357888999999999999999854 3456899999975432 333456889999999997 9999999999877
Q ss_pred CceEEEEEecccCCHHHHHHhcC---------------------------------------------------------
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQG--------------------------------------------------------- 193 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~--------------------------------------------------------- 193 (457)
...+++||||+.++.+..+....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 45789999999875443333211
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 194 -----------------------------------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 194 -----------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
..+++..+..++.||+.||.|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 136778889999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
++++.+||+|||+++....... .......++..|+|||++.+.. ++.++|||||||++|||++ |..||......+..
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 9999999999999986532211 1122345678899999998665 7899999999999999998 88999876655544
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
....... . .+ .....++.++.+||.+||..||.+||++.++++.
T Consensus 352 ~~~~~~~-~-----------------~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRG-Y-----------------RM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcC-C-----------------CC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3332210 0 00 0112457788999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=306.38 Aligned_cols=248 Identities=23% Similarity=0.387 Sum_probs=198.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||.||++.+ ..+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 36899999999999999999985 456679999886432 234568889999999999999999988765 45799
Q ss_pred EEecccC-CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEH-DLAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~-~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
+|||+++ ++...+.. .+..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999986 45444433 244688899999999999999999999999999999999999999999999999986643322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||++.+.. ++.++|+|||||++|+|+| |.+||.+.+.......+.....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR--------------- 221 (260)
T ss_pred ccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC---------------
Confidence 2222334567899999997655 7889999999999999999 8999988776665554422100
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......++.++.+++.+||+.||++||++.+++.
T Consensus 222 -------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 -------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112346778999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=309.18 Aligned_cols=243 Identities=26% Similarity=0.335 Sum_probs=189.2
Q ss_pred ceeeccCceEEEEEEEcCCCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEEEEec
Q 036122 104 DKIGQGTYSNVYKARDLLTGK--IVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~--~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
+.||+|+||.||+|++..++. .+|+|.+... ........+.+|+.++.++ +||||+++++++.. ...+|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEe
Confidence 368999999999999887776 4688887632 2344456788999999999 79999999999877 4568999999
Q ss_pred ccCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 181 MEHDLAGLAACQG----------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 181 ~~~~l~~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
++++.+..+.... ..+++.++..++.||+.||.|||+.|++|+||||+|||+++++.+||+|||
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCC
Confidence 9875444333221 247899999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 245 LATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 245 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
++....... .......+..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------ 228 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------ 228 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC------
Confidence 986332111 111122356799999987655 7899999999999999997 999998776655544431100
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.. .....++.++.+|+.+||..||.+|||++++++
T Consensus 229 -------------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 -------------RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -------------CC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00 011235677899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=310.84 Aligned_cols=238 Identities=20% Similarity=0.270 Sum_probs=185.8
Q ss_pred eeeccCceEEEEEEEcCC------------------------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce
Q 036122 105 KIGQGTYSNVYKARDLLT------------------------GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~~~------------------------g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 160 (457)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 699999999999975322 2358899886432 23345677899999999999999
Q ss_pred eEeeeEEecCCceEEEEEecccCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC---
Q 036122 161 KLEGLVTSRMSCSLYLVFEYMEHDLAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG--- 236 (457)
Q Consensus 161 ~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~--- 236 (457)
++++++.. ....++||||++++.+..+.. ....+++..+..++.||+.||.|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999987 567899999999876665554 356789999999999999999999999999999999999997644
Q ss_pred ----cEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHH-hCCCCCCCCChHHHHH
Q 036122 237 ----ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLH 311 (457)
Q Consensus 237 ----~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ell-tG~~pf~~~~~~~~~~ 311 (457)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|.+||......+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999998643221 23456788999999876555889999999999999995 6899998766544322
Q ss_pred HHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 312 KIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 312 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. +... .. .....++.+.+||.+||+.+|++|||+.++|++
T Consensus 233 ~-~~~~----------~~-------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 F-YEKK----------HR-------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred H-HHhc----------cC-------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 1 1100 00 001234568999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=318.60 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=199.2
Q ss_pred CCccccceeeccCceEEEEEEEcCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEec
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLT-------GKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSR 169 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~-------g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 169 (457)
.+|.+.+.||+|+||.||+|++... +..||+|.++.. ........+.+|+.+++++ +||||+++++++..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 5799999999999999999986432 237999988743 2344556788999999999 79999999999876
Q ss_pred CCceEEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID 233 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 233 (457)
...+|++|||++++.+..+... ...+++.++..++.||+.||.|||++||+||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 4578999999987554444332 12478889999999999999999999999999999999999
Q ss_pred CCCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 036122 234 NDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 311 (457)
Q Consensus 234 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~ 311 (457)
.++.+||+|||+++........ ......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999999865432111 112223456799999997765 7889999999999999998 889998887766655
Q ss_pred HHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 312 KIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 312 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.+..... ......++.++.+||.+||+.+|++|||+.++|.+
T Consensus 248 ~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 248 LLKEGHR----------------------------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4422100 00112456788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=308.41 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=200.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 4679999999999999999999876665 58999886553 34455678899999999999999999998875 4
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..++||||+.++ +...+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 689999999865 4444444455699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQP-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
..... .....++..|+|||.+.... ++.++|||||||++|||++ |.+||.+....+....+..... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--------- 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-L--------- 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-C---------
Confidence 32111 11122356799999987655 7889999999999999998 9999988776665544422100 0
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+..+.+++.+||..||.+|||+.++++
T Consensus 231 ------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 231 ------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011224567889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.95 Aligned_cols=279 Identities=22% Similarity=0.281 Sum_probs=184.7
Q ss_pred CcCCccccceeeccCceEEEEEEEcCC----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeE----E
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLT----GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLV----T 167 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~----g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~----~ 167 (457)
..++|++.+.||+|+||.||+|++..+ +..||+|++...... +....| .++...+.+++.+...+ .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 468999999999999999999999888 899999987643211 111111 12222233333222111 1
Q ss_pred ecCCceEEEEEecccCCHHHHHHhcCC--------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 036122 168 SRMSCSLYLVFEYMEHDLAGLAACQGV--------------------KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKG 227 (457)
Q Consensus 168 ~~~~~~~~lv~E~~~~~l~~~~~~~~~--------------------~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 227 (457)
......+++||||++++.+..+..... ...+..+..++.||+.||.|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 123457899999999865544333211 112345678999999999999999999999999
Q ss_pred CCEEecC-CCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCc---------------------CCCccchhh
Q 036122 228 SNLLIDN-DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT---------------------YYGVGVDLW 285 (457)
Q Consensus 228 ~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---------------------~~~~~~Dvw 285 (457)
+||||+. ++.+||+|||+|+.+............+|+.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999985 689999999999866544334445678899999999764322 133456999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhc
Q 036122 286 SAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLL 365 (457)
Q Consensus 286 slG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L 365 (457)
||||+||||+++.. ...+....+..++...+.... .|.....+. ..+ .. ....+.+.......++||.+||
T Consensus 364 SlGviL~el~~~~~--~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~---~~~--~~-~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 364 SAGLIFLQMAFPNL--RSDSNLIQFNRQLKRNDYDLV-AWRKLVEPR---ASP--DL-RRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHhCcC--CCchHHHHHHHHHHhcCCcHH-HHHHhhccc---cch--hh-hhhhhhccccchHHHHHHHHHc
Confidence 99999999998654 444444455555544443322 222211100 000 00 0001112223445679999999
Q ss_pred cCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 366 SIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 366 ~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
++||++|||+.|+|+||||+....
T Consensus 435 ~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 435 RFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCcccCCCHHHHhCCcCcCCCCc
Confidence 999999999999999999988543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=305.67 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=189.3
Q ss_pred ceeeccCceEEEEEEEcC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 104 DKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++... +...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEec
Confidence 468999999999998653 3457999987532 2334456788899999999999999999977643 3457899999
Q ss_pred ccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC---CC
Q 036122 181 MEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK---QP 256 (457)
Q Consensus 181 ~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~---~~ 256 (457)
+.++.+ ..+......+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 987544 44433344578888899999999999999999999999999999999999999999999975532211 11
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....++..|+|||++.+.. ++.++|||||||++|||++ |.+||...+..+....+.... +
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--~--------------- 220 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--R--------------- 220 (262)
T ss_pred cccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--C---------------
Confidence 12234577899999987665 7899999999999999999 467887766555444332210 0
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+ .....+++.+.+++.+||..||++|||+.+++.
T Consensus 221 --~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 221 --L---------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred --C---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 001235678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=309.33 Aligned_cols=239 Identities=18% Similarity=0.231 Sum_probs=186.7
Q ss_pred ceeeccCceEEEEEEEcCCCc-------EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 104 DKIGQGTYSNVYKARDLLTGK-------IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~-------~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
+.||.|+||.||+|.+...+. .||+|.+... .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEE
Confidence 469999999999998765543 4888887533 23344567889999999999999999999887 456899
Q ss_pred EEecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc--------EEEeeccCcc
Q 036122 177 VFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI--------LKIADFGLAT 247 (457)
Q Consensus 177 v~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--------vkl~DFGla~ 247 (457)
||||+.++.+..+. .....+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++.
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999886555444 34446899999999999999999999999999999999999987764 6999999987
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
.... .....++..|+|||++.+...++.++|||||||++|+|++| .+||...+........ ...
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~--------- 221 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDR--------- 221 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hcc---------
Confidence 5432 12346788999999998755578999999999999999999 4676655544332211 100
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. ......+.++.+||.+||+.||++|||++++++.
T Consensus 222 -~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 -H-------------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -c-------------------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0 0011234568899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=301.99 Aligned_cols=317 Identities=23% Similarity=0.387 Sum_probs=239.6
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCce
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 173 (457)
..++|.++.+||+|+|++|.+++++.+.+.||+|++++.-. +.+.++-.+.|-.+..+- +||.+|-|+..|.. +..
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esr 325 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESR 325 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cce
Confidence 36889999999999999999999999999999999987643 344556677788887765 69999999988876 678
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+++|.||+.|+-+.+..++..+|+++.++.+..+|+.||.|||++|||+||||.+|||++..|++||+|+|+++.--..
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~- 404 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP- 404 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC-
Confidence 9999999999877666677778999999999999999999999999999999999999999999999999999743221
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHhcCCCChhhhh
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPG-------RTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
....++.+||+.|+|||++.|.. |++.+|+|+|||+|+||+.|+.||.- .+.++.+-+++-. +
T Consensus 405 gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile---------k 474 (593)
T KOG0695|consen 405 GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE---------K 474 (593)
T ss_pred CcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh---------h
Confidence 23456789999999999999887 89999999999999999999999952 1222223222110 0
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC------HHHHhcCCCCCCCCCCC--CCCCCCC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT------ATAALNSEFFNTEPYAC--EPSSLPK 398 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt------a~elL~hp~f~~~~~~~--~~~~~~~ 398 (457)
+. .....++-.+..+++..|++||.+|.. ..++-.|+||+...|.. .....|+
T Consensus 475 qi-------------------riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 475 QI-------------------RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred cc-------------------cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 00 112335566777899999999999964 78999999999887764 2345666
Q ss_pred CCCChhhhhhhhHHHHH---HhhhccCCCCccccccccccccccCCCcCCc
Q 036122 399 YPPSKEMDVKLREEEAR---RQRGLSGKANAVDGAKRVRHRDRAGRAIPAP 446 (457)
Q Consensus 399 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (457)
+.|..+-+..+...... ...+++. +..|-.+|..+..++++.+--|
T Consensus 536 f~p~i~~d~~l~~fd~qft~e~~qltp--dd~d~i~ridqsefegfeyinp 584 (593)
T KOG0695|consen 536 FQPQITDDYGLDNFDTQFTSEPVQLTP--DDEDAIKRIDQSEFEGFEYINP 584 (593)
T ss_pred CCCccccccCccccccccccCCcccCC--CCHHHHHhcchhhcCcceecch
Confidence 66654333222211110 0111221 3344455666677777776544
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.04 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=187.3
Q ss_pred ceeeccCceEEEEEEEcC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLL--TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~--~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
++||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.. ...+|+||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeC
Confidence 369999999999996432 34578888776432 33444567889999999999999999998876 56789999999
Q ss_pred cCCHHHHHHhc-C----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-C
Q 036122 182 EHDLAGLAACQ-G----VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-Q 255 (457)
Q Consensus 182 ~~~l~~~~~~~-~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~ 255 (457)
.++.+..+... . ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 87555444332 1 2346788899999999999999999999999999999999999999999999875432211 1
Q ss_pred CcccccccCccCchHhhhC------CcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 256 PMTSRVVTLWYRPPELLLG------ATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~------~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
......++..|+|||++.. ...++.++|||||||++|||++ |.+||....+.+.+..+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~-------- 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK-------- 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc--------
Confidence 1123345778999999753 2236789999999999999999 788998877766655543321100
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
++. ......+++.+.+++..|+ .||++|||++++++
T Consensus 230 -~~~--------------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 -LPK--------------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -CCC--------------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 000 0112346677788898888 59999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=305.07 Aligned_cols=251 Identities=25% Similarity=0.432 Sum_probs=201.1
Q ss_pred CccccceeeccCceEEEEEEEcC-CCcEEEEEEeecCC--------CChHHHHHHHHHHHHHHh-cCCCCceeEeeeEEe
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLL-TGKIVALKKVRFDN--------LEPESVKFMAREILVLRK-LDHPNVIKLEGLVTS 168 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~ 168 (457)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999877 67899999986432 123344567788888875 799999999999877
Q ss_pred cCCceEEEEEecccCCHHH-HH---HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeec
Q 036122 169 RMSCSLYLVFEYMEHDLAG-LA---ACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~-~~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
....++||||++++.+. .+ ......+++..++.++.||+.||.|||+ .+++|+||+|+|||++.++.+||+||
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 56899999999875433 32 2334569999999999999999999996 68999999999999999999999999
Q ss_pred cCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 244 GLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
|++....... ......++..|+|||++.+.. ++.++||||||+++|+|++|.+||...+.......+......+
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--- 232 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP--- 232 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc---
Confidence 9998654332 334557889999999998765 7899999999999999999999998776665555443211110
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+++.+.+||.+||+.||++|||+.|+..+
T Consensus 233 ------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 ------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0012356788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=332.31 Aligned_cols=280 Identities=22% Similarity=0.367 Sum_probs=231.9
Q ss_pred CCCCCCCCCCCCCCCchhhHhhhcccccccCCcC-cCCccccceeeccCceEEEEEEEcCCCc---EEEEEEeecCCCCh
Q 036122 63 PPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRR-ANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEP 138 (457)
Q Consensus 63 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~~~~ 138 (457)
.|..+....+.+..+|. ++++.|+.+. .+...+.++||.|.||.||+|+.+..|+ .||||.++... ..
T Consensus 600 ~pG~k~YiDP~TYEDPn-------qAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-te 671 (996)
T KOG0196|consen 600 LPGTKTYIDPHTYEDPN-------QAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TE 671 (996)
T ss_pred CCCceeecCCccccCcc-------HHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cH
Confidence 34444455555555555 3344443332 3445677889999999999999887774 69999998765 44
Q ss_pred HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 036122 139 ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217 (457)
Q Consensus 139 ~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (457)
.....|..|+.||.+++||||++|.|+.+. ...+.||.|||+++ |..++..++++|+..++..+++.|+.|++||-+
T Consensus 672 kqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd 749 (996)
T KOG0196|consen 672 KQRRDFLSEASIMGQFDHPNIIRLEGVVTK--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD 749 (996)
T ss_pred HHHhhhhhhhhhcccCCCCcEEEEEEEEec--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence 555678899999999999999999999988 56799999999975 556677778899999999999999999999999
Q ss_pred CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc--cCccCchHhhhCCcCCCccchhhhHHHHHHHHH
Q 036122 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~~DvwslG~vl~ell 295 (457)
+|+|||||...||||+.+..+||+|||+++.++++.....++..| ...|.|||.+.-.+ ++.++||||||++|||.+
T Consensus 750 m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVm 828 (996)
T KOG0196|consen 750 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVM 828 (996)
T ss_pred cCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEec
Confidence 999999999999999999999999999999887665455555555 67899999998766 899999999999999988
Q ss_pred h-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC
Q 036122 296 A-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT 374 (457)
Q Consensus 296 t-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt 374 (457)
+ |..||-..++.+.++.|.+...-|+ ..++|..+..|+..|+++|-.+||+
T Consensus 829 SyGERPYWdmSNQdVIkaIe~gyRLPp----------------------------PmDCP~aL~qLMldCWqkdR~~RP~ 880 (996)
T KOG0196|consen 829 SYGERPYWDMSNQDVIKAIEQGYRLPP----------------------------PMDCPAALYQLMLDCWQKDRNRRPK 880 (996)
T ss_pred ccCCCcccccchHHHHHHHHhccCCCC----------------------------CCCCcHHHHHHHHHHHHHHhhcCCC
Confidence 6 8899999999999999977544332 2468999999999999999999999
Q ss_pred HHHHhcC
Q 036122 375 ATAALNS 381 (457)
Q Consensus 375 a~elL~h 381 (457)
.+|++.+
T Consensus 881 F~qiV~~ 887 (996)
T KOG0196|consen 881 FAQIVST 887 (996)
T ss_pred HHHHHHH
Confidence 9998863
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=305.70 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=197.6
Q ss_pred ccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC----c
Q 036122 100 FEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----C 172 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 172 (457)
|.+.+.||+|+||.||+|.+. .++..||||++..........+.+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999864 357899999997765555566778899999999999999999998765321 1
Q ss_pred eEEEEEecccCCHHHHHH-hc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 173 SLYLVFEYMEHDLAGLAA-CQ-----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~-~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
..++++||+.++.+.... .. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347889999865443332 11 124789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 247 TFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 247 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
+....... .......+++.|++||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~----- 233 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-R----- 233 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-c-----
Confidence 86543211 1112234567899999987665 7889999999999999999 899998777655544442210 0
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......+++.+.+|+.+||+.+|++|||+.+++++
T Consensus 234 ----------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 ----------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00112466788999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=311.00 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=197.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
..+|+..+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~ 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS---P 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---C
Confidence 4678999999999999999999877776 47888876443 23334567889999999999999999998865 2
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..++++||++++ +...+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 467999999865 5554444455689999999999999999999999999999999999999999999999999987643
Q ss_pred CCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.... ......++..|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+ .....+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~--------- 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-EKGERL--------- 230 (303)
T ss_pred cccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCC---------
Confidence 3221 112234577899999987665 7899999999999999997 88999876544433222 110000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......+..+.++|..||..||++||++.++++.
T Consensus 231 ------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012345678899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=302.47 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=209.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHH-hcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLR-KLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++.+-+..||.|+||+|++..++.+|+..|||.|+..+... ..+++..|..... .-+.||||++||.+.. ++..|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k-eq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcW 139 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK-EQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCW 139 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH-HHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCcee
Confidence 356677889999999999999999999999999999876533 3456777777654 4579999999999887 45579
Q ss_pred EEEecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 176 LVFEYMEHDLAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
|.||+|.-++..++.. +...++|.-+-.|....+.||.||-+. .|||||+||+||||+..|.+||||||++..+.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9999999876655432 345699999999999999999999864 89999999999999999999999999998765
Q ss_pred CCCCCCcccccccCccCchHhhhCCcC-CCccchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhc
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLLGATY-YGVGVDLWSAGCILAELLAGKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~DvwslG~vl~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
... ..+...|...|||||.+..... |+.++||||||+.|||+.||..||.+-+. .+++.++.. |.|+.-.
T Consensus 220 ~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~--gdpp~l~---- 291 (361)
T KOG1006|consen 220 DSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI--GDPPILL---- 291 (361)
T ss_pred HHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--CCCCeec----
Confidence 432 2345678999999999975433 89999999999999999999999976443 345554432 3332110
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.....-.++..+..+|..||.+|-..||...+++.+||+...
T Consensus 292 -----------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 292 -----------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred -----------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 011123467788999999999999999999999999999863
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=302.55 Aligned_cols=250 Identities=20% Similarity=0.219 Sum_probs=186.6
Q ss_pred ceeeccCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDL--LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.++++++||||+++++++.. ...+++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 36999999999999754 3456799999876542 2334567889999999999999999998876 45689999999
Q ss_pred cCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-C
Q 036122 182 EHDLAGLAACQ-----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-Q 255 (457)
Q Consensus 182 ~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~ 255 (457)
+++.+..+... ...+++..+..++.||+.||.|||+.+++|+||||+||+++.++.+||+|||++........ .
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 97554443321 22467778889999999999999999999999999999999999999999999975432211 1
Q ss_pred CcccccccCccCchHhhhCCc------CCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 256 PMTSRVVTLWYRPPELLLGAT------YYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~------~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
......++..|+|||++.+.. .++.++|||||||++|||++ |.+||...+..+.......... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ---------L 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc---------C
Confidence 112345678899999986421 25789999999999999996 9999987666554332211100 0
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
..+ . ......+++.+.++|+.|+ .+|++|||++++++
T Consensus 229 ~~~--------~------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 KLP--------K------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCC--------C------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 0 0011235667888999998 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=304.88 Aligned_cols=229 Identities=24% Similarity=0.319 Sum_probs=182.9
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCCHHHH
Q 036122 109 GTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 188 (457)
Q Consensus 109 G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~ 188 (457)
|.||.||++++..+++.||+|.+.... ...+|...+....||||+++++++.. ...+|+||||++++.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997542 12345555566679999999998876 567999999999865554
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCc
Q 036122 189 AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP 268 (457)
Q Consensus 189 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~a 268 (457)
.......+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 4444456999999999999999999999999999999999999999999999999988755432 233455778999
Q ss_pred hHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhc
Q 036122 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAE 348 (457)
Q Consensus 269 PE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (457)
||.+.+.. ++.++||||+||++|||++|..||...... + .. .. ...
T Consensus 151 PE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~-----~~-----------~~~ 196 (237)
T cd05576 151 PEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT-----HT-----------TLN 196 (237)
T ss_pred CcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc-----cc-----------ccC
Confidence 99887655 688999999999999999999877432110 0 00 00 001
Q ss_pred ccCCCCCCcHHHHHHhccCCCCCCcCH-----HHHhcCCCC
Q 036122 349 TFKDFPSSSLPLIETLLSIDPDNRGTA-----TAALNSEFF 384 (457)
Q Consensus 349 ~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~hp~f 384 (457)
....+++.+.+||.+||+.||++|+|+ ++++.||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 112367788999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=305.17 Aligned_cols=245 Identities=22% Similarity=0.315 Sum_probs=192.3
Q ss_pred ceeeccCceEEEEEEEcCCC------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 104 DKIGQGTYSNVYKARDLLTG------KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g------~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+.||+|+||.||+|++.... ..||||.+.... .......+.+|+.+++.++||||+++++++.. ....++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEE
Confidence 36999999999999876443 689999886432 23345668889999999999999999999876 4568999
Q ss_pred EecccCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-----cEEEeeccC
Q 036122 178 FEYMEHDLAGLAAC-------QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-----ILKIADFGL 245 (457)
Q Consensus 178 ~E~~~~~l~~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-----~vkl~DFGl 245 (457)
|||++++.+..... ....+++.++..++.||+.||.|||+.+++|+||||+|||++.++ .++|+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99998754433332 123478899999999999999999999999999999999999887 899999999
Q ss_pred ccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 246 ATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 246 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
+........ .......++..|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG------ 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC------
Confidence 975532211 1112334578899999998766 7999999999999999998 999998877766554442110
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......+|+.+.+||.+||..+|.+|||++++++
T Consensus 231 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ----------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ----------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00111346778899999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=313.51 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=214.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh-----HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-----ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|-+++.||+|||+.||++.+....++||+|+-..+.... ...+..-+|..|.+.|+||.||++|+++.-. .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence 467999999999999999999999999999999876554322 2334566899999999999999999999764 4
Q ss_pred ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCEEecC---CCcEEEeeccCc
Q 036122 172 CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN--GVLHRDIKGSNLLIDN---DGILKIADFGLA 246 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NILl~~---~~~vkl~DFGla 246 (457)
..+|-|+|||+|+.+++++..++.+++.+++.|+.||+.||.||.+. .|||-||||.||||.+ .|.+||+|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 57899999999988888888888999999999999999999999987 5999999999999964 578999999999
Q ss_pred cccCCCCCC------CcccccccCccCchHhhhC---CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 036122 247 TFYDPGLKQ------PMTSRVVTLWYRPPELLLG---ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC 317 (457)
Q Consensus 247 ~~~~~~~~~------~~~~~~gt~~y~aPE~l~~---~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~ 317 (457)
++++.+... ..+...||.||++||.+.- .+..+.++||||+|||+|.++.|+.||..+.....+-+...++
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 988654332 1234578999999999853 2346889999999999999999999998664433222211111
Q ss_pred CCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.. ..+..|. -+.+++++.+||++||++--+.|....++-.||||..
T Consensus 701 kA-------------tEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 701 KA-------------TEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred cc-------------eeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 00 0011111 1347889999999999999999999999999999975
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.10 Aligned_cols=241 Identities=25% Similarity=0.438 Sum_probs=194.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|++.+.||+|+||.||++. .+++.||+|+++... ....+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEE
Confidence 568999999999999999996 578899999986432 23567889999999999999999998765 347999
Q ss_pred EecccC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 178 FEYMEH-DLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 178 ~E~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
|||+.+ ++...+.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999986 4544444332 35899999999999999999999999999999999999999999999999999754322
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+..|+|||++.+.. ++.++|||||||++|+|++ |++||...+..+....+....
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------- 214 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----------------- 214 (254)
T ss_pred -CCCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-----------------
Confidence 12233457799999987665 7889999999999999998 999998877665544442210
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.+ .....++..+.+||.+||+.+|++|||+++++.
T Consensus 215 --~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 --RM---------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred --CC---------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 011346778899999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=305.19 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=198.2
Q ss_pred CCccccceeeccCceEEEEEEEc----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
..|.+.+.||+|+||.||++... .++..||+|++...... .....+.+|+.+++.++|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46888999999999999999854 34789999999765433 34567899999999999999999999887755667
Q ss_pred EEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.++||||++++ +...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 89999999874 44444444446999999999999999999999999999999999999999999999999999876532
Q ss_pred CCCC--cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-----------HHHHHHhcCC
Q 036122 253 LKQP--MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-----------LHKIFKLCGS 319 (457)
Q Consensus 253 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~-----------~~~i~~~~~~ 319 (457)
.... .....++..|+|||.+.+.. ++.++|||||||++|||+||..||........ ...+...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence 2111 11234466799999987665 78899999999999999999988865432110 1111110000
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
. . .......++.++.+|+.+||..||.+|||+.|+++
T Consensus 242 ~-----------------~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 242 G-----------------E-------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred C-----------------C-------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0 00011235678899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.63 Aligned_cols=236 Identities=22% Similarity=0.288 Sum_probs=185.8
Q ss_pred ceeeccCceEEEEEEEcCCC----------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 104 DKIGQGTYSNVYKARDLLTG----------KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g----------~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
+.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR---DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec---CC
Confidence 46999999999999987766 35888877544321 4668889999999999999999998876 34
Q ss_pred EEEEEecccCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-------cEEEeeccC
Q 036122 174 LYLVFEYMEHDLAGLAACQGV-KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-------ILKIADFGL 245 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-------~vkl~DFGl 245 (457)
.++||||+.++.+..+..... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 689999999876665554433 789999999999999999999999999999999999999888 899999999
Q ss_pred ccccCCCCCCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 246 ATFYDPGLKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 246 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
+..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||...+..+.......
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-------- 221 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-------- 221 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc--------
Confidence 986532 1234567789999998765 347899999999999999999 5778866553332221110
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.... .......+.+||.+||..||.+|||+.++++
T Consensus 222 ---~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 ---QHRL-------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ---CCCC-------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 0001267889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=305.43 Aligned_cols=261 Identities=19% Similarity=0.166 Sum_probs=189.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCC---CcEEEEEEeecCCCChHHH---------HHHHHHHHHHHhcCCCCceeEee
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESV---------KFMAREILVLRKLDHPNVIKLEG 164 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~l~~ 164 (457)
.++|.+.+.||+|+||+||+|.+..+ +..+|+|+........... .....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998777 6678888755433211100 11223344556678999999998
Q ss_pred eEEecCCc--eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEee
Q 036122 165 LVTSRMSC--SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIAD 242 (457)
Q Consensus 165 ~~~~~~~~--~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~D 242 (457)
.+...... ..++++|++...+...... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 76543221 3478888887766554433 33468889999999999999999999999999999999999999999999
Q ss_pred ccCccccCCCCC------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 036122 243 FGLATFYDPGLK------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL 316 (457)
Q Consensus 243 FGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~ 316 (457)
||+|+.+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+......+......
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 999986642211 1112346899999999988766 799999999999999999999999877432222111110
Q ss_pred cCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+++...... ....+..+..+.++++.|+..+|++||+.+++++
T Consensus 249 ------~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ------DFIKRLHEG---------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ------HHHHHhhhh---------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 010000000 0012345778999999999999999999999874
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.09 Aligned_cols=202 Identities=33% Similarity=0.500 Sum_probs=173.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----CceE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SCSL 174 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~~ 174 (457)
.+...+.||+|+||.||+++++.+|+.||||.++... .....+.+-+|+++|++|+|+|||++.++-.... ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 4556788999999999999999999999999998654 3445577889999999999999999988765544 4567
Q ss_pred EEEEecccCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec--CCC--cEEEeeccCcc
Q 036122 175 YLVFEYMEHDLAGLAACQ---GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID--NDG--ILKIADFGLAT 247 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~--~vkl~DFGla~ 247 (457)
.+|||||.|+.+...... ..-|++.+...++.++..||.|||++|||||||||+||++. .+| .-||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 899999998766555443 23499999999999999999999999999999999999985 334 57999999999
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCC
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPG 303 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~ 303 (457)
-++.+ ...++.+||..|.+||++....+|+..+|.|||||++|+++||..||..
T Consensus 173 el~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 173 ELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 88765 4788999999999999998656689999999999999999999999853
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.87 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=185.9
Q ss_pred eeeccCceEEEEEEEcCC--CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEeccc
Q 036122 105 KIGQGTYSNVYKARDLLT--GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~~~--g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
.||+|+||.||++....+ ...+++|.+.... .......+.+|+.+++.++||||+++++.+.. ...+|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 699999999999975333 2356777765543 23345678899999999999999999999876 457899999999
Q ss_pred CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC-CCCCc
Q 036122 183 HDLAGLAACQ----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG-LKQPM 257 (457)
Q Consensus 183 ~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-~~~~~ 257 (457)
++.+..+... ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 7544433332 234677788899999999999999999999999999999999999999999998643211 11122
Q ss_pred ccccccCccCchHhhhCC------cCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 258 TSRVVTLWYRPPELLLGA------TYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~------~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
....++..|+|||++.+. ..++.++|||||||++|||++ |.+||...+..+.+..+......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~----------- 227 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV----------- 227 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-----------
Confidence 345678899999988531 125678999999999999997 47889877776666655331100
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....+ .....+++.+.++|..|+ .+|++|||++++++
T Consensus 228 ---~~~~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 ---KLFKP---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ---ccCCC---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 00000 111236677888999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.44 Aligned_cols=263 Identities=28% Similarity=0.455 Sum_probs=214.2
Q ss_pred CcCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe---c
Q 036122 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS---R 169 (457)
Q Consensus 94 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~---~ 169 (457)
+..++.|++.++||.|.+|.||+++++.+|+.+|+|+...+.. ..+.++.|.++|+.+ +|||++.++|+|.. .
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3446889999999999999999999999999999999876542 334567789999887 59999999999864 3
Q ss_pred CCceEEEEEecccCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 170 MSCSLYLVFEYMEHDLAGLAAC--QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.++.+|||||||.++...++.. .+..+.|..+..|++.++.||.+||.+.++|||||-.|||++.++.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 4578999999999865444332 26679999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCc----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGAT----YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
.++.... ...+.+||+.|||||++.... .|+..+|+||||++..||.-|.||+......-. +|.....|+..
T Consensus 172 QldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---LF~IpRNPPPk 247 (953)
T KOG0587|consen 172 QLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNPPPK 247 (953)
T ss_pred eeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---hccCCCCCCcc
Confidence 8765433 345678999999999996432 367789999999999999999999976655333 33333333322
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.. ..+..+.++.++|..||.+|-++||+..++|+|||++.
T Consensus 248 Lk-----------------------rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 LK-----------------------RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred cc-----------------------chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 11 12234567788999999999999999999999999984
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=311.49 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=201.1
Q ss_pred ccceeeccCceEEEEEEEcC--CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 102 KLDKIGQGTYSNVYKARDLL--TGK--IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~--~g~--~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
..+.||+|-||.||+|.... .|+ .||||+.+.+. ..+..+.|..|+.+|+.++|||||+|+|+|.. ...|||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~Wiv 468 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWIV 468 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeEE
Confidence 34679999999999997542 333 58999887654 45557789999999999999999999999987 468999
Q ss_pred EecccCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||+++.+.+.. +..+...|+......++.||+.||.|||+.++|||||...||||...-.|||+|||+++.++++....
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 99999765544 44455679999999999999999999999999999999999999999999999999999987664443
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.+...-..-|||||.+.-.. ++.++|||.|||++||+++ |..||.+-.+.+.+-.|.+.-.
T Consensus 549 aS~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR----------------- 610 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER----------------- 610 (974)
T ss_pred ccccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC-----------------
Confidence 33333467899999986555 8999999999999999986 8999999877776655533211
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
....+.+|+.+..|+.+|+++||.+||+..++.
T Consensus 611 -----------lP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 611 -----------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred -----------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 123456899999999999999999999977764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=305.08 Aligned_cols=258 Identities=20% Similarity=0.259 Sum_probs=207.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.....+.++||+|-||.|.+|.. ..+..||+|+++.+. .......|.+|+++|.+|+|||||+|+|+|.. +..+++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicm 612 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCM 612 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHH
Confidence 35678899999999999999983 456899999998664 34445789999999999999999999999988 567999
Q ss_pred EEecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+|||+++.+..+...+ ..+.......|+.||+.||+||.+.++|||||.+.|||++.++++||+|||+++-+-.+..
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999986665555444 2235566778999999999999999999999999999999999999999999995432222
Q ss_pred C-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 255 Q-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA--GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 255 ~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt--G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
. .....+-...|||+|.+.-++ ++.++|||+||+.+||+++ ...||...++.+..++....+......
T Consensus 693 y~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~-------- 763 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ-------- 763 (807)
T ss_pred eeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc--------
Confidence 2 222345578999999998777 8999999999999999865 578999888887777665543322211
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+-+|..+.+||.+|+..|-++|||.+++-.
T Consensus 764 -------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 -------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 112233457889999999999999999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=311.21 Aligned_cols=275 Identities=25% Similarity=0.325 Sum_probs=186.9
Q ss_pred CcCCccccceeeccCceEEEEEEEc----------------CCCcEEEEEEeecCCCCh--H----------HHHHHHHH
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDL----------------LTGKIVALKKVRFDNLEP--E----------SVKFMARE 147 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~----------------~~g~~vAiK~~~~~~~~~--~----------~~~~~~~E 147 (457)
..++|++.++||+|+||+||+|.+. ..++.||||.+....... + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3679999999999999999999752 345679999986543110 0 11123347
Q ss_pred HHHHHhcCCCCc-----eeEeeeEEec------CCceEEEEEecccCCHHHHHHhc------------------------
Q 036122 148 ILVLRKLDHPNV-----IKLEGLVTSR------MSCSLYLVFEYMEHDLAGLAACQ------------------------ 192 (457)
Q Consensus 148 ~~~l~~l~hpni-----v~l~~~~~~~------~~~~~~lv~E~~~~~l~~~~~~~------------------------ 192 (457)
+.++.+++|.++ ++++++|... .....|+||||++++.+..+...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 6677776532 12457999999998655443321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhh
Q 036122 193 GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELL 272 (457)
Q Consensus 193 ~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l 272 (457)
...+++..++.++.||+.+|.|||+++|+||||||+|||++.++.+||+|||++...............+|+.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 11246778899999999999999999999999999999999999999999999976543322111223448899999998
Q ss_pred hCCcC-------------------CC--ccchhhhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 273 LGATY-------------------YG--VGVDLWSAGCILAELLAGKP-IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 273 ~~~~~-------------------~~--~~~DvwslG~vl~elltG~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
..... |+ .+.||||+||++|+|++|.. ||......... .+.. ......|.....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~-~~~~~~~r~~~~ 458 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQY-DNDLNRWRMYKG 458 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhc-cchHHHHHhhcc
Confidence 64221 11 24799999999999999874 76543211110 0000 000111221100
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCC---CCCcCHHHHhcCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDP---DNRGTATAALNSEFFNT 386 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP---~~Rpta~elL~hp~f~~ 386 (457)
.. ..-..+...++..+|||.+||..+| .+|+|++|+|+||||..
T Consensus 459 ~~------------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QK------------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred cC------------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0011244568899999999999876 68999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=280.79 Aligned_cols=244 Identities=41% Similarity=0.630 Sum_probs=196.0
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCCHHHHH
Q 036122 110 TYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA 189 (457)
Q Consensus 110 ~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~ 189 (457)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+.++++++|+||+++++++.. ....+++|||++++.+...
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999988899999999976543322 5678899999999999999999999877 4678999999998444444
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCch
Q 036122 190 ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPP 269 (457)
Q Consensus 190 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aP 269 (457)
......+++..+..++.+++.+|.|||+.+++|+||+|.||+++.++.++|+|||.+....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 4344348999999999999999999999999999999999999999999999999998765431 23455678899999
Q ss_pred HhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcc
Q 036122 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAET 349 (457)
Q Consensus 270 E~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (457)
|.+.+.. ++.++||||||+++|+|++|..||......+.+.+........ ....
T Consensus 156 E~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~ 209 (244)
T smart00220 156 EVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP-------------------------FPPP 209 (244)
T ss_pred HHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC-------------------------Cccc
Confidence 9987655 6889999999999999999999998743333332222110000 0001
Q ss_pred cCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 350 FKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 350 ~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
...++.++.+++.+||..||++||++.++++||||
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 11167788999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=301.40 Aligned_cols=247 Identities=22% Similarity=0.356 Sum_probs=203.5
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
+...-++||.|.||.||.|.++.-...||||.++.+.. .+.+|..|+.+|+.++|||+|+|+|+|+. +..+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEE
Confidence 45567899999999999999988888999999976543 34678899999999999999999999988 56799999
Q ss_pred ecccC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 179 EYMEH-DLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 179 E~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||.. +|++.+...+ ..++.-....++.||..|+.||..+++|||||...|+||.++..|||+|||+++++..+....
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 99985 5666655443 346777788999999999999999999999999999999999999999999999886543322
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
........-|.|||.|.-.. ++.++|||+|||+|||+.| |-.||++-+....+..+.+..
T Consensus 423 HAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------------------ 483 (1157)
T KOG4278|consen 423 HAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------------------ 483 (1157)
T ss_pred ccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc------------------
Confidence 22233367899999987555 7899999999999999998 678999988766655443221
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
.-+...++|+.+.+||++|++++|.+||+..|+-
T Consensus 484 ----------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 484 ----------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ----------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 0112346899999999999999999999988764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.45 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=206.9
Q ss_pred CCccccceeeccCceEEEEEEEcC-CCc--EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL-TGK--IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~-~g~--~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.+..+.++||+|.||+|++|.+.. +|+ .||||.++.+.... ....|.+|+.+|.+|+|+|+++|||++.+ ..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp~ 185 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QPA 185 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---chh
Confidence 456678999999999999997653 343 69999998776554 66789999999999999999999999886 357
Q ss_pred EEEEecccCC-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 175 YLVFEYMEHD-LAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 175 ~lv~E~~~~~-l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|||+++.+ |++.+.. ....|.......|+.||+.||.||..+++|||||-..|+||-....|||+||||.+.+..+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 8999999864 5555544 3456888999999999999999999999999999999999999999999999999987644
Q ss_pred CCCC-cc-cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 253 LKQP-MT-SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 253 ~~~~-~~-~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.... +. .......|+|||.|.... ++.++|||+|||.+|||+| |.-||.|.....++++|-+.-
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e------------ 332 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE------------ 332 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc------------
Confidence 3322 11 123367899999998777 8999999999999999999 579999999999988874210
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+.+++++.+++..|+..+|++|||...|...
T Consensus 333 ----------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 333 ----------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ----------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 112235688999999999999999999999888643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=312.45 Aligned_cols=250 Identities=29% Similarity=0.405 Sum_probs=192.6
Q ss_pred CccccceeeccCceE-EEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEE
Q 036122 99 TFEKLDKIGQGTYSN-VYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~-Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 176 (457)
-|.-.+.+|.|+.|+ ||+|. -.|+.||||.+-. +......+|+..|+.-+ |||||++ ||.+.+...+||
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRy--yc~E~d~qF~YI 580 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRY--YCSEQDRQFLYI 580 (903)
T ss_pred eeccHHHcccCCCCcEEEEEe--eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEE--EeeccCCceEEE
Confidence 355567899999985 89997 6788999998743 34456779999999885 9999999 455555788999
Q ss_pred EEecccCCHHHHHHhc--CCCC-CHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---C--CcEEEeeccCccc
Q 036122 177 VFEYMEHDLAGLAACQ--GVKF-SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---D--GILKIADFGLATF 248 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~--~~~l-~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~--~~vkl~DFGla~~ 248 (457)
..|+|..+|.+.+... .... .....+..+.|++.||++||+.+||||||||.||||+. + .+++|+|||+++.
T Consensus 581 alELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 581 ALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred EehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999999988877663 1111 11456788999999999999999999999999999985 3 4799999999998
Q ss_pred cCCCCCC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 249 YDPGLKQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 249 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
+..+... ...+..||-+|+|||++.... -+.++||||||||+|+.++| .+||...-. .-.+|... ..
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~--~~----- 730 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTG--NY----- 730 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcC--cc-----
Confidence 8654332 244567899999999998766 46799999999999999997 899975432 22233221 00
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
++...-+.-..++.|||.+||.+||..||||.++|.||||-.
T Consensus 731 -------------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 731 -------------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred -------------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 000111111127899999999999999999999999999965
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=289.90 Aligned_cols=282 Identities=32% Similarity=0.519 Sum_probs=211.9
Q ss_pred CcCCccccceeeccCceEEEEEEEcC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCC
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMS 171 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 171 (457)
..+.|..+++||+|.|++||++.+.. ..+.||+|.+..... ...+.+|+++|..+. +.||+++.+.+.. .
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn--n 107 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN--N 107 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc--C
Confidence 35779999999999999999999876 778999999865432 245789999999995 9999999888766 6
Q ss_pred ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-CCCcEEEeeccCccccC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYD 250 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~ 250 (457)
+.+.+||||+++.-...+.. .++..+++.+++.++.||.++|.+|||||||||+|+|.+ ..++-.|+|||+|...+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 77999999999865444433 377899999999999999999999999999999999998 56788999999997221
Q ss_pred CCC-------------------------------------------CCCcccccccCccCchHhhhCCcCCCccchhhhH
Q 036122 251 PGL-------------------------------------------KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSA 287 (457)
Q Consensus 251 ~~~-------------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Dvwsl 287 (457)
... ........||++|.|||++...+.-++++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0001245789999999999988778899999999
Q ss_pred HHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCh--------h--hhhhcCCCCccc----CCCC--CCcc-----cc
Q 036122 288 GCILAELLAGKPIM-PGRTEVEQLHKIFKLCGSPSE--------E--YWKKSKLPNATL----FKPQ--QPYK-----RC 345 (457)
Q Consensus 288 G~vl~elltG~~pf-~~~~~~~~~~~i~~~~~~~~~--------~--~~~~~~~~~~~~----~~~~--~~~~-----~~ 345 (457)
|||++-+++++.|| ...++.+.+.+|..+.|...- . +|.....+.... +... .... ..
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999998776 456666777777666653211 1 222111111000 0000 0000 11
Q ss_pred hhcccCC-CCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 346 IAETFKD-FPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 346 ~~~~~~~-~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
..+.+.+ ++..+.||+.+||..||.+|+||+++|.||||..
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 2223333 3558899999999999999999999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=259.62 Aligned_cols=214 Identities=25% Similarity=0.416 Sum_probs=181.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++...+..||+|++|.|-+.++..+|...|+|.+...- ..+..+++.+|+.+..+. .+|.+|.++|.+.. ...+|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvw 121 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVW 121 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEE
Confidence 466777889999999999999999999999999997654 344556778899887665 69999999998776 56799
Q ss_pred EEEecccCCHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 176 LVFEYMEHDLAGLA---ACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 176 lv~E~~~~~l~~~~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
|.||.|..++..++ ...+..++|..+-+|+..|+.||.|||++ .++|||+||+|||++.+|+||+||||++..+.+
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99999998766554 44577899999999999999999999987 899999999999999999999999999987754
Q ss_pred CCCCCcccccccCccCchHhhhC---CcCCCccchhhhHHHHHHHHHhCCCCCC-CCChHHHHHHHHH
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLG---ATYYGVGVDLWSAGCILAELLAGKPIMP-GRTEVEQLHKIFK 315 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~~DvwslG~vl~elltG~~pf~-~~~~~~~~~~i~~ 315 (457)
... .+-..|...|||||.+.. ...|+.++||||||+.++||.+++.||. +.+.-+++.++.+
T Consensus 202 SiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 202 SIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred hhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 321 233568889999999853 3358999999999999999999999986 5678888888865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.43 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=184.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
..|...+.||+|+||.||+|++..+|..||+|.+...... ...|+.++++++|||||++++++.. ....|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEE
Confidence 3466778999999999999999899999999998643211 1246889999999999999999987 4568999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH---NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|||++++.+..+.. .+++.++..++.||+.||.||| +.+|+||||||+||+++.++..++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999876665553 3899999999999999999999 6699999999999999998888876 666543321
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcC-CCChhhhhhcCCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCG-SPSEEYWKKSKLPN 332 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~-~~~~~i~~~~~-~~~~~~~~~~~~~~ 332 (457)
.....+|+.|+|||++.+.. ++.++|||||||++|||+||+.||...... ..+.+..+... ......|.+..+
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 909 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI-- 909 (968)
T ss_pred --CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc--
Confidence 12346789999999988766 799999999999999999999998532110 11111111100 000000000000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..... .......++.+++.+||+.||++|||+.|+++.
T Consensus 910 ----~~~~~-------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 910 ----RGDVS-------VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ----cCCCC-------ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000 000011246789999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=295.93 Aligned_cols=261 Identities=27% Similarity=0.406 Sum_probs=215.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|+.+.++|.|.||.||+++++.+++..|+|+++.... +...-+++|+-+++..+|||||.++|.|.. ...+||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr--~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR--RDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhh--hcCcEE
Confidence 4689999999999999999999999999999999987642 334557789999999999999999999877 456899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
.||||+++.+..+-.-.+++++.++....+..+.||+|||++|=+|||||-.|||+++.|.+|++|||.+..+.... ..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~K 168 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AK 168 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh-hh
Confidence 99999998887777777899999999999999999999999999999999999999999999999999998665432 33
Q ss_pred cccccccCccCchHhhh--CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 257 MTSRVVTLWYRPPELLL--GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~--~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
..++.||+.|||||+.. ....|...+|||++|+...|+---++|.........+..+.+-...|+
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp------------- 235 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP------------- 235 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC-------------
Confidence 46789999999999863 233488999999999999999888887766555554444433221111
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.. +.-...++.+-+|++.+|.++|.+|||++.+|+|||..+
T Consensus 236 ----~l-------kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 236 ----TL-------KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ----cc-------cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 00 111224556677899999999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=276.09 Aligned_cols=264 Identities=26% Similarity=0.321 Sum_probs=187.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCceeEeeeEEecC--Cce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK--LDHPNVIKLEGLVTSRM--SCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~--~~~ 173 (457)
...++++.||+|.||.||+|+ .+++.||||++.. +..+.+.+|-+|.+. ++|+||+++++.-.... ...
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 456778999999999999997 5679999999853 445667888888776 47999999987654321 236
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCEEecCCCcEEEeecc
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN---------GVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
++||+||.+.+.+..++..+ .++|....+++..|++||+|||+. .|+|||||..||||.+|+++.|+|||
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 89999999987666666554 599999999999999999999973 49999999999999999999999999
Q ss_pred CccccCCCCCC-CcccccccCccCchHhhhCCcCCC-----ccchhhhHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhc
Q 036122 245 LATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYG-----VGVDLWSAGCILAELLAGKPIMP-GRTEVEQLHKIFKLC 317 (457)
Q Consensus 245 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~-----~~~DvwslG~vl~elltG~~pf~-~~~~~~~~~~i~~~~ 317 (457)
+|..+.++... .....+||..|||||+|.|...+. .+.||||+|.|||||++...-+. +....-++.--.++-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99988755332 233478999999999998765444 35899999999999998754332 221111111001111
Q ss_pred CCCChhhhhhcCCCCcccCCCCCCcccchhcccCC--CCCCcHHHHHHhccCCCCCCcCHHH
Q 036122 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKD--FPSSSLPLIETLLSIDPDNRGTATA 377 (457)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~Li~~~L~~dP~~Rpta~e 377 (457)
..|.-+....... .+...| .+...+.. -..-+++.+..|++.||+-|.|+.=
T Consensus 442 ~hPt~e~mq~~VV-----~kK~RP---~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 442 NHPTLEEMQELVV-----RKKQRP---KIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred CCCCHHHHHHHHH-----hhccCC---CChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 1222222111100 000000 01111111 1245688999999999999999753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=293.91 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=197.3
Q ss_pred CCccccceeeccCceEEEEEEEc---C----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEec
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL---L----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSR 169 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~---~----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 169 (457)
++..+.+.||+|.||.|++|... . ....||||.++..... ...+.+..|+++|+.+. |+||+.++|.|..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 44466779999999999999643 1 1357999999866544 66678999999999995 9999999999988
Q ss_pred CCceEEEEEecccC-CHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec
Q 036122 170 MSCSLYLVFEYMEH-DLAGLAACQG---------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID 233 (457)
Q Consensus 170 ~~~~~~lv~E~~~~-~l~~~~~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~ 233 (457)
.+.+++|+||+.. +++..+.... ..++..+...++.||+.|++||++.++|||||-..|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 6779999999986 4555554444 2489999999999999999999999999999999999999
Q ss_pred CCCcEEEeeccCccccCCCCCCCccccc--ccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCC-hHHH
Q 036122 234 NDGILKIADFGLATFYDPGLKQPMTSRV--VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRT-EVEQ 309 (457)
Q Consensus 234 ~~~~vkl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~-~~~~ 309 (457)
.+..+||+|||+|+.............. -...|||||.+.... |+.++||||||++||||+| |..||++-. ..+.
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 9999999999999965433222212222 244599999998755 8999999999999999999 689998854 4444
Q ss_pred HHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 310 LHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 310 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
++.+.+.. +. +....+++++.++++.|++.+|++||+..++.
T Consensus 532 ~~~l~~G~-------------------r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 532 LEFLKEGN-------------------RM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHHHhcCC-------------------CC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 44332210 00 11234678889999999999999999998887
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=286.94 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=202.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
......++||+|+||+||+|.....|+ +||||++.... .......+..|+.+|.+|+|||+++|++++... .
T Consensus 696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~ 771 (1177)
T KOG1025|consen 696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLS---T 771 (1177)
T ss_pred hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---h
Confidence 345668899999999999998866665 68999887543 344456788999999999999999999999863 3
Q ss_pred EEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+.||++|++++ |++.+......+-......|..||++||.|||++++|||||-..||||..-.++||+|||+++.+.++
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 78999999975 66666666778999999999999999999999999999999999999999999999999999988766
Q ss_pred CCCCcccc-cccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQPMTSR-VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
........ .-.+-|||-|.+.... |+.++|||||||.+||++| |..|+.+....++-..+.... +
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-----------R- 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-----------R- 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-----------c-
Confidence 54333221 2257799999988766 8999999999999999998 788998877766544332110 0
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....+..+-++.-++.+||..|+..||++.++..
T Consensus 919 ----------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 ----------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred ----------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1122346778889999999999999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=279.85 Aligned_cols=201 Identities=27% Similarity=0.453 Sum_probs=174.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhcC---CCCceeEeeeEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP------ESVKFMAREILVLRKLD---HPNVIKLEGLVT 167 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~------~~~~~~~~E~~~l~~l~---hpniv~l~~~~~ 167 (457)
..+|..+..||+|+||.|++|.++.+...|+||.|.+...-. ...-.+-.||.||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 567999999999999999999999999999999997764311 11223456999999998 999999999999
Q ss_pred ecCCceEEEEEecccCCH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 168 SRMSCSLYLVFEYMEHDL-AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 168 ~~~~~~~~lv~E~~~~~l-~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
+ +..+||+||-.+.++ +..++.....++|.++..|++||+.|+++||++||||||||-+||.|+.+|-+||+|||.|
T Consensus 640 d--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 D--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred c--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 8 678999999887542 2334455667999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCC
Q 036122 247 TFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP 302 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~ 302 (457)
..... .+....+||..|.|||++.|..+.+..-|||+||++||-++....||.
T Consensus 718 a~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 87654 355678999999999999999988999999999999999998888875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=256.23 Aligned_cols=191 Identities=27% Similarity=0.373 Sum_probs=154.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCceeEeeeEEec--CCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK--LDHPNVIKLEGLVTSR--MSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~--~~~~ 173 (457)
.+..+.+.||+|.||.||+|. ..|+.||||++.... ...+.+|.+|.+. |+|+||+.+++.-... .-.+
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeecc--ccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 457789999999999999997 689999999996331 2346677777765 5999999997653321 1246
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEEecCCCcEEEeeccC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN--------GVLHRDIKGSNLLIDNDGILKIADFGL 245 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DFGl 245 (457)
+|||.+|.+.+.+.+++.+ ..++.+...+++..++.||.|||.. .|.|||||+.||||..+|.+-|+|+||
T Consensus 284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 9999999998877777766 4699999999999999999999953 399999999999999999999999999
Q ss_pred ccccCCCC---CCCcccccccCccCchHhhhCCcC---C-C-ccchhhhHHHHHHHHHh
Q 036122 246 ATFYDPGL---KQPMTSRVVTLWYRPPELLLGATY---Y-G-VGVDLWSAGCILAELLA 296 (457)
Q Consensus 246 a~~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~---~-~-~~~DvwslG~vl~ellt 296 (457)
|...+... .......+||-.|||||+|...-. + + ..+||||||.|+||++.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 98775432 234566899999999999853211 1 1 24899999999999975
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-31 Score=238.34 Aligned_cols=213 Identities=40% Similarity=0.645 Sum_probs=178.5
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCC-
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD- 184 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~- 184 (457)
||+|.+|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++.. ....+++|||+++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999988789999999997654322 34668899999999999999999998876 46789999999954
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-CCcEEEeeccCccccCCCCCCCccccccc
Q 036122 185 LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLATFYDPGLKQPMTSRVVT 263 (457)
Q Consensus 185 l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~~~~~~~~~gt 263 (457)
+...+......+++..+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 44444333246899999999999999999999999999999999999999 89999999999986653321 12345678
Q ss_pred CccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcc
Q 036122 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYK 343 (457)
Q Consensus 264 ~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (457)
..|++||.+.....++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999987653478899999999999999
Q ss_pred cchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCC
Q 036122 344 RCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382 (457)
Q Consensus 344 ~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp 382 (457)
..+.+++..||+.||++||++.++++|+
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1235579999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=239.22 Aligned_cols=211 Identities=38% Similarity=0.588 Sum_probs=173.5
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEe
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E 179 (457)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..+++++|+|++++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEe
Confidence 56778999999999999999888999999999765433 245678899999999999999999998876 467899999
Q ss_pred cccCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 180 YMEHDLAGLAACQGVK-FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
|+++..+......... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.++|+|||++............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9998444444444334 899999999999999999999999999999999999999999999999999876543211224
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCC-CChH-HHHHHH
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPG-RTEV-EQLHKI 313 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~-~~~~-~~~~~i 313 (457)
...++..|++||.+.+...++.++|||+||+++++|++|++||.. .++. +..+.+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 456788999999984333477899999999999999999999977 4444 444444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=294.99 Aligned_cols=202 Identities=17% Similarity=0.194 Sum_probs=144.0
Q ss_pred cCC-CCceeEeeeEEec-----CCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 036122 154 LDH-PNVIKLEGLVTSR-----MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKG 227 (457)
Q Consensus 154 l~h-pniv~l~~~~~~~-----~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 227 (457)
++| +||+++++++... ....++++|||++++|...+......+++.+++.++.||+.||.|||++||+||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 344 5777777766211 1235788999998888777655455699999999999999999999999999999999
Q ss_pred CCEEecCCC-------------------cEEEeeccCccccCCCCC---------------CCcccccccCccCchHhhh
Q 036122 228 SNLLIDNDG-------------------ILKIADFGLATFYDPGLK---------------QPMTSRVVTLWYRPPELLL 273 (457)
Q Consensus 228 ~NILl~~~~-------------------~vkl~DFGla~~~~~~~~---------------~~~~~~~gt~~y~aPE~l~ 273 (457)
+||||+..| .+||+|||+++....... ......+||++|||||++.
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 188 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN 188 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence 999996544 455666666653211000 0011246799999999998
Q ss_pred CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCC
Q 036122 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDF 353 (457)
Q Consensus 274 ~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (457)
+.. |+.++|||||||+||||++|.+||.... ..+..+.... .++ . ...-
T Consensus 189 ~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~--------------------------~~~~ 237 (793)
T PLN00181 189 GSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q--------------------------ILLN 237 (793)
T ss_pred cCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h--------------------------hhhc
Confidence 776 7999999999999999999988875321 1122221110 000 0 0001
Q ss_pred CCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 354 PSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 354 ~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.+...+++..||+.||.+|||+.|+|+||||..
T Consensus 238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 238 WPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred CHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 234567899999999999999999999999976
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=237.73 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=191.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
.+.|.+.+.||+|.||.+-+|.|+.+.+.+++|.+... ......|.+|...--.|. |.||+.-|++.... .+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEE
Confidence 47899999999999999999999999999999988654 344567888888766664 89999988765443 45788
Q ss_pred EEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec--CCCcEEEeeccCccccCCC
Q 036122 176 LVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID--NDGILKIADFGLATFYDPG 252 (457)
Q Consensus 176 lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~vkl~DFGla~~~~~~ 252 (457)
++|||++.+ |...+... -+-|...+.++.|++.|+.|||+.++||||||.+||||- +.-+|||||||+.+..+..
T Consensus 99 F~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred EeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 999999865 44444333 388999999999999999999999999999999999996 3448999999999855422
Q ss_pred CCCCcccccccCccCchHhhhCCc----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhh
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGAT----YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~ 327 (457)
. ...--+..|.+||++.... ...+.+|||.||+|+|.++||.+||......+. +.+..+ |..
T Consensus 177 V----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~---------w~~ 243 (378)
T KOG1345|consen 177 V----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ---------WLK 243 (378)
T ss_pred e----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH---------Hhc
Confidence 1 1112256799999875322 246779999999999999999999974322111 111111 222
Q ss_pred cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCC---cCHHHHhcCCCCC
Q 036122 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR---GTATAALNSEFFN 385 (457)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R---pta~elL~hp~f~ 385 (457)
.+.+ -....|.-|++.+..+.++.|..+|++| -++......-|..
T Consensus 244 rk~~-------------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 244 RKNP-------------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ccCc-------------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 2221 1234566788999999999999999999 5666555555643
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=237.10 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=198.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-----GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
..+++....+-+|.||.||.|..+.. .+.|-+|.++.. .++-+...+..|.-++..+.|||+..+.+++... .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-Y 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-c
Confidence 35678888899999999999976533 245667776543 3455667788999999999999999999998764 3
Q ss_pred ceEEEEEecccCCHHHHHHh--c------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeec
Q 036122 172 CSLYLVFEYMEHDLAGLAAC--Q------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~--~------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
...+.++.+++-+.+..+.. + ...++..+...++.|++.|+.|||++||||.||...|++|++.-+|||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 45778888887544433332 1 124778889999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCCCCccc-ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 036122 244 GLATFYDPGLKQPMTS-RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPS 321 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~-~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~ 321 (457)
.+++.+-+........ .-....||+||.+.... |+.++|||||||+||||+| |+.|+..-++.|....+.+..
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy---- 515 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY---- 515 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc----
Confidence 9999764443222221 22356799999998766 8999999999999999998 789999888888766654321
Q ss_pred hhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 322 EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+-.+| -++|.++..++.-|+..+|++||+.+|+..
T Consensus 516 ---------------RlaQP---------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 ---------------RLAQP---------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ---------------eecCC---------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11222 248899999999999999999999999863
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=267.20 Aligned_cols=266 Identities=27% Similarity=0.373 Sum_probs=202.8
Q ss_pred cccceeeccCceEEEEEEEcCCCcEEEEEEeec----CCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRF----DNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 101 ~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~----~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.....+|.|++|.|+.+......+.++.|..+. ..........+..|..+-..|.|+|++..+..+... ...+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchh
Confidence 456789999999999998877777777776552 222222223366788888889999998877666553 22344
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC--
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-- 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 254 (457)
+||||++++...+ .....++..++..++.|++.||+|||+.||.|||||++|+++..+|.+||+|||.+..+.....
T Consensus 399 ~mE~~~~Dlf~~~-~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPYDLFSLV-MSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccHHHHHHH-hcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 5999999544444 4445799999999999999999999999999999999999999999999999999987754433
Q ss_pred -CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhcCCCChhhhhhcCCCC
Q 036122 255 -QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLH-KIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~ 332 (457)
......+|+..|+|||++.+..+.....||||.|+++..|++|+.||......+... .+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------------------- 538 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------------------- 538 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------------------
Confidence 334567899999999999988877778999999999999999999997543322211 00
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
....+..........+..+|.+.+.+|.+||+.||.+|.|+++|++.+||+....+
T Consensus 539 --~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 539 --NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred --ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 00000111122234456688899999999999999999999999999999986543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=220.43 Aligned_cols=165 Identities=24% Similarity=0.324 Sum_probs=126.1
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCccccccc
Q 036122 184 DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVT 263 (457)
Q Consensus 184 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt 263 (457)
+|.+.+...+..+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||++...... ...||
T Consensus 2 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~ 67 (176)
T smart00750 2 SLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVD 67 (176)
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCc
Confidence 455555554667999999999999999999999999 999999999999999 9999866432 22688
Q ss_pred CccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCc
Q 036122 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342 (457)
Q Consensus 264 ~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (457)
+.|||||++.+.. ++.++|||||||++|||+||.+||...... ..+..+........ +.
T Consensus 68 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~--- 127 (176)
T smart00750 68 PYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------PR--- 127 (176)
T ss_pred ccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------cc---
Confidence 9999999998766 789999999999999999999999765432 22333322111000 00
Q ss_pred ccchhcccCCCCC--CcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 343 KRCIAETFKDFPS--SSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 343 ~~~~~~~~~~~~~--~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
.. .....++. ++.+||.+||..||.+|||+.|+++|+|+.
T Consensus 128 ~~---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 DR---SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cc---ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00 00111223 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=230.63 Aligned_cols=166 Identities=20% Similarity=0.207 Sum_probs=129.0
Q ss_pred cCCccccceeeccCceEEEEEEEcC-CCcEEEEEEeecCCC---ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-TGKIVALKKVRFDNL---EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|.+.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+.+|++++|+||+..+.. . .
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--~---~ 91 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--T---G 91 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--c---C
Confidence 5789999999999999999998876 678889998753311 23345668999999999999999853321 1 2
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDI-KGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl-kp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..|+||||++|+.+.... ... ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CcEEEEEccCCCCHHHhC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 479999999987665321 111 1467899999999999999999999 99999999999999999999997643
Q ss_pred CCCC-------CcccccccCccCchHhhhC
Q 036122 252 GLKQ-------PMTSRVVTLWYRPPELLLG 274 (457)
Q Consensus 252 ~~~~-------~~~~~~gt~~y~aPE~l~~ 274 (457)
.... ..+...+++.|+|||++..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 3211 1245567888999998853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=246.48 Aligned_cols=243 Identities=26% Similarity=0.412 Sum_probs=199.6
Q ss_pred eeeccCceEEEEEEE---cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEEEEec
Q 036122 105 KIGQGTYSNVYKARD---LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~---~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
.+|+|+||.|++++. ...|..||+|++++.............|..++..++ ||.+|+++..+.. ...++++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhh
Confidence 479999999998853 245678999998765443222225567889999987 9999999877766 5679999999
Q ss_pred ccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccc
Q 036122 181 MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR 260 (457)
Q Consensus 181 ~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~ 260 (457)
..++.+.........+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.... .
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~ 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----A 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----c
Confidence 99977776666777799999999999999999999999999999999999999999999999999987644322 2
Q ss_pred cccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCC
Q 036122 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQ 340 (457)
Q Consensus 261 ~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (457)
+||..|||||++.+ +..++|+||||+++|||+||..||.+ +.+..|.+..-..
T Consensus 154 cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~-------------------- 206 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM-------------------- 206 (612)
T ss_pred ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC--------------------
Confidence 89999999999983 56789999999999999999999988 6666665422111
Q ss_pred CcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCCC
Q 036122 341 PYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPYA 390 (457)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~~ 390 (457)
...++..+.+++..|+..+|.+|.- +.|+++|+||+...|.
T Consensus 207 ---------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 207 ---------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ---------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 1235677889999999999999976 5899999999987765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-25 Score=216.20 Aligned_cols=264 Identities=35% Similarity=0.533 Sum_probs=203.9
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH-HHHHHHHHHHHHHhcCCC-CceeEeeeEEecCCceEEEE
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE-SVKFMAREILVLRKLDHP-NVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~~~lv 177 (457)
|.+...||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++++.. ....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEE
Confidence 677889999999999999976 8899999987654433 567788999999999988 79999998855 4458999
Q ss_pred EecccCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCccccCCCC
Q 036122 178 FEYMEHDLAGLAACQGV---KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGL 253 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~ 253 (457)
++|+.+..+........ .+++.....++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++.......
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999866654444443 699999999999999999999999999999999999999988 79999999998654332
Q ss_pred CC-----CcccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChh
Q 036122 254 KQ-----PMTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 254 ~~-----~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~ 323 (457)
.. ......||..|+|||.+.+. ..++...|+||+|++++++++|..||..... .............+.
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS-- 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc--
Confidence 21 24567899999999999874 4578899999999999999999999887764 233333322221110
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......... ......+.+++..++..+|..|.+..+...++|....
T Consensus 235 -----------~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 235 -----------LASPLSPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred -----------cccccCcccc------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1122467889999999999999999999999777653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-25 Score=214.26 Aligned_cols=209 Identities=28% Similarity=0.285 Sum_probs=167.4
Q ss_pred CccccceeeccCceEEEEEEEcCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC----CCceeEeeeEEecCCce
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTG-KIVALKKVRFDNLEPESVKFMAREILVLRKLDH----PNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g-~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~~~~~~~~ 173 (457)
+|.+.+.||+|+||.||+|.+..++ ..+|+|........... .+..|+.++..+.. +++..+++... .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCce
Confidence 8999999999999999999987664 67999987754322211 46678888888863 57888877663 22557
Q ss_pred EEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-----CcEEEeeccCcc
Q 036122 174 LYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-----GILKIADFGLAT 247 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-----~~vkl~DFGla~ 247 (457)
-|+||+.++.+|.++..... ..|+...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 96 ~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 96 NFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred eEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 89999999999988775554 789999999999999999999999999999999999999865 469999999998
Q ss_pred --ccCCCCC----CC---cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 036122 248 --FYDPGLK----QP---MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLH 311 (457)
Q Consensus 248 --~~~~~~~----~~---~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~ 311 (457)
.+..... .. .....||..|+++....+.. .+.+.|+||++.++.+++.|..||.+........
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~ 247 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS 247 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHH
Confidence 3311111 11 12345999999999988777 6999999999999999999999997766443333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=191.15 Aligned_cols=247 Identities=23% Similarity=0.252 Sum_probs=189.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH-PNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~ 175 (457)
.+.|.++++||.|+||.+|.|....+|..||||+-+.....+ ++..|..+.+.|++ ..|..+..+... ...-.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTE--KDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccc--cccce
Confidence 478999999999999999999999999999999876543332 36678899888874 556666555554 45568
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCccccCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPG 252 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~ 252 (457)
+||++++.++.+++......|+...+..++-|++.-++|+|.+++|||||||+|+|..- ...+.|+|||+|+.+-+.
T Consensus 88 lVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred eeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 99999999999888877888999999999999999999999999999999999999863 357999999999877432
Q ss_pred CC------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH---HHHHhcCCCChh
Q 036122 253 LK------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLH---KIFKLCGSPSEE 323 (457)
Q Consensus 253 ~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~---~i~~~~~~~~~~ 323 (457)
.. .......||..|.+--...+.. -+...|+-|+|.+|....-|..||.+.......+ +|.+.--+
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s---- 242 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS---- 242 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC----
Confidence 21 1124567899999888777655 4778999999999999999999999876554433 33321111
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT 374 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt 374 (457)
..+...++++|.++.-.+.-|=..-=++-|.
T Consensus 243 --------------------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 243 --------------------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred --------------------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 1133456777777777777775444444444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=194.89 Aligned_cols=141 Identities=23% Similarity=0.256 Sum_probs=109.4
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHH------------------------HHHHHHHHHHHHhcCCCC
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES------------------------VKFMAREILVLRKLDHPN 158 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~hpn 158 (457)
.+.||+|+||.||+|.+. +|+.||||+++........ .....+|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321111 122345999999998877
Q ss_pred ceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEEecCCCc
Q 036122 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC-HNNGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 159 iv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~NILl~~~~~ 237 (457)
+.....+... ..+|||||++++.+.........+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 6443222211 2389999999865433323345799999999999999999999 799999999999999998 478
Q ss_pred EEEeeccCcccc
Q 036122 238 LKIADFGLATFY 249 (457)
Q Consensus 238 vkl~DFGla~~~ 249 (457)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-25 Score=228.44 Aligned_cols=226 Identities=31% Similarity=0.401 Sum_probs=171.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|+.++.|-.|+||.||.++|+.+.+.+|+| ++++++ +.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------
Confidence 578999999999999999999999999999994 443321 1110 22222233322
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC--
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-- 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-- 254 (457)
|+....+. .-++++.. ++.+++|||+.||+|||+||+|.||+.-|++|++|||+++.......
T Consensus 136 ------gDc~tllk-~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLLK-NIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhcc-cCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33222222 22234433 27889999999999999999999999999999999999865321100
Q ss_pred ------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 255 ------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 255 ------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
......+||+.|+|||++.... |+..+|+|++|+|+||.+-|..||.+.+.++...+++......++
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 0113458999999999998776 899999999999999999999999999999998887664333222
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCC---cCHHHHhcCCCCCCCCCC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR---GTATAALNSEFFNTEPYA 390 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R---pta~elL~hp~f~~~~~~ 390 (457)
.-..+++++++||.++|+.+|..| ..+.++-+|+||+.-.|.
T Consensus 280 --------------------------~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 --------------------------EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred --------------------------cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 233478999999999999999999 457788899999987665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=230.71 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=179.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN--LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
+|...+.||.+.|=+|.+|++ ..|. |+||++-+.. .+-....+...|++ ...++|||++.+.-+... ....|+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHH
Confidence 688899999999999999986 4555 9999986543 23333333444556 666789999998665443 455689
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc--CCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY--DPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~--~~~~~ 254 (457)
|-+|+.++|.+.+..+. .+...+.+.|+.||+.||..+|..||+|+|||.+||||+.-+-+.|+||..-+.. ..+..
T Consensus 99 vRqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 99999999888765543 5788889999999999999999999999999999999999999999999977532 11111
Q ss_pred CC----cccccccCccCchHhhhCC----------cCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 036122 255 QP----MTSRVVTLWYRPPELLLGA----------TYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 255 ~~----~~~~~gt~~y~aPE~l~~~----------~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
.. ..+...-.+|+|||.+... ...+++.||||+||+++||++ |+|||.- .+++..-..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-------SQL~aYr~~ 250 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-------SQLLAYRSG 250 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-------HHHHhHhcc
Confidence 11 1112224679999998641 114678999999999999987 6999952 222221000
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. .-......+... +..+++||..|++.||++|.+|++.|+-
T Consensus 251 ~-------------------~~~~e~~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 N-------------------ADDPEQLLEKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred C-------------------ccCHHHHHHhCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0 000011111122 3478999999999999999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=193.59 Aligned_cols=209 Identities=24% Similarity=0.303 Sum_probs=172.2
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 176 (457)
-.|.+.++||+|.||+.+.|.+..+++.||||.-...... -++..|....+.|. .+.|...|.+ .+.+-+-.|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYF--GqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYF--GQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeee--ccccchhhh
Confidence 4799999999999999999999999999999976443322 34666777777775 7888888533 333455679
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-----CcEEEeeccCccccCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-----GILKIADFGLATFYDP 251 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-----~~vkl~DFGla~~~~~ 251 (457)
|||+++.+|.+++.-.+..|+...+..++.|++.-++|+|++.+|+|||||+|+||..- ..+.|+|||+|+.+-+
T Consensus 102 VidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 99999999999998889999999999999999999999999999999999999999743 4699999999997743
Q ss_pred CCC-C-----CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC---ChHHHHHHH
Q 036122 252 GLK-Q-----PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR---TEVEQLHKI 313 (457)
Q Consensus 252 ~~~-~-----~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~---~~~~~~~~i 313 (457)
... . ...+..||..||+=-..+|.. -+...|+=|||-|++..|-|..||.|. +..+..++|
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 221 1 124567999999999888877 588999999999999999999999875 455555554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=198.45 Aligned_cols=238 Identities=22% Similarity=0.302 Sum_probs=152.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCC----------CCceeEeeeE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDH----------PNVIKLEGLV 166 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h----------pniv~l~~~~ 166 (457)
..+.....||.|+++.||.+++..+|+.+|+|++...... ....+.+.+|.-....+.+ -.++--++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 3567788899999999999999999999999998766532 3345667776655554322 1122111221
Q ss_pred E---------ec-CCc-----eEEEEEecccCCHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccC
Q 036122 167 T---------SR-MSC-----SLYLVFEYMEHDLAGLAAC---QGVK---FSEPQVKCYMKQLLSGLEHCHNNGVLHRDI 225 (457)
Q Consensus 167 ~---------~~-~~~-----~~~lv~E~~~~~l~~~~~~---~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl 225 (457)
. .. ... ..+++|+-+.+++...... .... +.......+..|+++.+++||..|+||+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 11 011 2477888888877655332 1111 222333455589999999999999999999
Q ss_pred CCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCC-------cCCCccchhhhHHHHHHHHHhCC
Q 036122 226 KGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA-------TYYGVGVDLWSAGCILAELLAGK 298 (457)
Q Consensus 226 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DvwslG~vl~elltG~ 298 (457)
||+|+|++.+|.++|+||+.....+.. ......+..|.+||..... ..++.+.|.|+||+++|.|++|.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 999999999999999999988755421 1113446779999977432 23688899999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCC
Q 036122 299 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR 372 (457)
Q Consensus 299 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R 372 (457)
.||........... .+..+ .++|+.++.||..||+.||++|
T Consensus 248 lPf~~~~~~~~~~~--------------------------------~f~~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW--------------------------------DFSRC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG--------------------------------GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc--------------------------------cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence 99976533111000 11222 3789999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=187.59 Aligned_cols=142 Identities=24% Similarity=0.305 Sum_probs=111.6
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH------------------------HHHHHHHHHHHHHhcCCCC
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE------------------------SVKFMAREILVLRKLDHPN 158 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~------------------------~~~~~~~E~~~l~~l~hpn 158 (457)
.+.||+|+||.||+|.+. +|+.||||+++....... ....+.+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999976 899999999986532100 0123467999999999998
Q ss_pred ceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCc
Q 036122 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 159 iv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~ 237 (457)
|.....+... ..|+||||++++.+.........+++.++..++.|++.+|.+||+ +||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 7544433322 248999999986322222233468889999999999999999999 9999999999999999 889
Q ss_pred EEEeeccCccccC
Q 036122 238 LKIADFGLATFYD 250 (457)
Q Consensus 238 vkl~DFGla~~~~ 250 (457)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=190.71 Aligned_cols=174 Identities=15% Similarity=0.164 Sum_probs=131.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH-HHHH------HHHHHHHHHhcCCCCceeEeeeEEec
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE-SVKF------MAREILVLRKLDHPNVIKLEGLVTSR 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~-~~~~------~~~E~~~l~~l~hpniv~l~~~~~~~ 169 (457)
.++|.+++.||.|+||.||+..+ ++..+|||+++......+ .... +.+|+..+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999754 566899999975543222 2222 67899999999999999998876543
Q ss_pred C------CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeec
Q 036122 170 M------SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 170 ~------~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
. ....+|||||++|..+.... .+++. ...+|+.+|..||+.|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 23578999999996554442 23332 456999999999999999999999999999988 999999
Q ss_pred cCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHH
Q 036122 244 GLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ell 295 (457)
|.......... . ..+++... |+.++|+||||+.+....
T Consensus 179 g~~~~~~e~~a---~----------d~~vler~-y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKA---K----------DRIDLERH-YGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhh---H----------HHHHHHhH-hcccccccceeEeehHHH
Confidence 98875421100 0 11333334 668999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=180.60 Aligned_cols=189 Identities=17% Similarity=0.140 Sum_probs=139.6
Q ss_pred cccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEEE
Q 036122 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE--PESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 101 ~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+...|++|+||+||.+. ..+..++.+.+.....- .-....+.+|+++|++|. |++|++++++ ...|++
T Consensus 5 ~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEE
Confidence 356789999999999876 47788888877654331 112235789999999995 5889999875 235899
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccC-CCCCEEecCCCcEEEeeccCccccCCCCCC-
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDI-KGSNLLIDNDGILKIADFGLATFYDPGLKQ- 255 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDl-kp~NILl~~~~~vkl~DFGla~~~~~~~~~- 255 (457)
|||+.|..+..... . ....++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 77 meyI~G~~L~~~~~------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 77 RSYLAGAAMYQRPP------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred EeeecCccHHhhhh------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99999876543221 1 12357889999999999999999999 799999999999999999999865433210
Q ss_pred ---C--------cccccccCccCchHhhhCCcCCC-ccchhhhHHHHHHHHHhCCCCCCCC
Q 036122 256 ---P--------MTSRVVTLWYRPPELLLGATYYG-VGVDLWSAGCILAELLAGKPIMPGR 304 (457)
Q Consensus 256 ---~--------~~~~~gt~~y~aPE~l~~~~~~~-~~~DvwslG~vl~elltG~~pf~~~ 304 (457)
. ..-...++.|++|+.-.--...+ ...++++.|+.+|.++|+..++-+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 00112478899998654322122 4679999999999999998776543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-23 Score=204.70 Aligned_cols=177 Identities=31% Similarity=0.447 Sum_probs=128.2
Q ss_pred EEEEEecccCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 174 LYLVFEYMEHDLAGLAACQ---GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
+||.|++|....+.+++.. ....+......++.|++.|+.| ++.+|+|+||.||++..+..+||.|||+.....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 5667777776555555432 2235667788899999999999 999999999999999999999999999998765
Q ss_pred CCC-----CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 251 PGL-----KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 251 ~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
... ....+..+||.+||+||.+.+.. |+.++||||||+||+|++.- ...| +.......+
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~-------- 472 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQF------ERIATLTDI-------- 472 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhhh--------
Confidence 443 22346678999999999999877 89999999999999999972 2221 111111110
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
.... +.+.+..=.+.-.+|+.+||...|.+||++.+.-.|+|.+
T Consensus 473 -r~g~----------------ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 473 -RDGI----------------IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred -hcCC----------------CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 0000 1111111124456799999999999999888877777753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=191.50 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=174.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc-----------------------------------EEEEEEeec---CCCCh
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK-----------------------------------IVALKKVRF---DNLEP 138 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~-----------------------------------~vAiK~~~~---~~~~~ 138 (457)
.++|++...||+|+...||.+....+|. +.|||.+-. +..+.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 5679999999999999999997543211 345554421 11112
Q ss_pred HHHHHHHHHHH------HH--------Hh--------cCCCCceeEeeeEEecC-------------------------C
Q 036122 139 ESVKFMAREIL------VL--------RK--------LDHPNVIKLEGLVTSRM-------------------------S 171 (457)
Q Consensus 139 ~~~~~~~~E~~------~l--------~~--------l~hpniv~l~~~~~~~~-------------------------~ 171 (457)
...+.+.+|.. .+ +. -+|||||++.+.|.+.. .
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 22233333331 11 11 15999999988774421 2
Q ss_pred ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec--CCC--cEEEeeccCcc
Q 036122 172 CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID--NDG--ILKIADFGLAT 247 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~--~vkl~DFGla~ 247 (457)
..+|+||.-...++...+-.++ .+.....-++.|+++|+.|||++||.|||+|.+||||. +|+ .+.|+|||.+-
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 4589999998888777665543 67778888999999999999999999999999999985 343 68999999875
Q ss_pred ccCCC-----CCCCcccccccCccCchHhhhCCcC-----CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 036122 248 FYDPG-----LKQPMTSRVVTLWYRPPELLLGATY-----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC 317 (457)
Q Consensus 248 ~~~~~-----~~~~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~ 317 (457)
-.+.. .........|.-.-||||+....+. .-.++|.|+.|.+.||+++...||.+......-..
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r----- 468 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR----- 468 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-----
Confidence 33221 1111233456788999998864321 11368999999999999999999987322111000
Q ss_pred CCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH---HHHhcCCCCC
Q 036122 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA---TAALNSEFFN 385 (457)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta---~elL~hp~f~ 385 (457)
.+.... +......+|+.+++||..+|+.||.+|+++ +.+|+--.|.
T Consensus 469 ------~Yqe~q----------------LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~ 517 (598)
T KOG4158|consen 469 ------TYQESQ----------------LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWR 517 (598)
T ss_pred ------hhhhhh----------------CCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhc
Confidence 011111 222334578899999999999999999984 4555544333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=176.41 Aligned_cols=251 Identities=17% Similarity=0.214 Sum_probs=190.2
Q ss_pred cccCCcCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec
Q 036122 90 RDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR 169 (457)
Q Consensus 90 ~~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 169 (457)
..++.....+..++.+|.+...|..|+|+ ..|..+++|++............|..|.-.|+-+.||||+.++|.|..+
T Consensus 182 sr~~gid~~~lnl~tkl~e~hsgelwrgr--wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 182 SRYTGIDVSSLNLITKLAESHSGELWRGR--WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred ccccCcchhhhhhhhhhccCCCccccccc--ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 33444445667788899999999999997 6777788899987776666667788899999999999999999999874
Q ss_pred CCceEEEEEecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEecCCCcEEEe--ec
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLIDNDGILKIA--DF 243 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~--DF 243 (457)
..+.++..||+.+.+...+... ...+..++.+++.+|++|+.|||+.. |----|....++|+++.+.+|. |-
T Consensus 260 --pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 260 --PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred --CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccc
Confidence 5688999999976665555443 33677899999999999999999974 3344688999999998877664 22
Q ss_pred cCccccCCCCCCCcccccccCccCchHhhhCCcC--CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 036122 244 GLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS 321 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~ 321 (457)
-++- ......-.+.||+||.+...+. .-.++|+|||++++|||.|...||..-.+.+.--+|.-
T Consensus 338 kfsf--------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial------ 403 (448)
T KOG0195|consen 338 KFSF--------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL------ 403 (448)
T ss_pred eeee--------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh------
Confidence 1111 1122233788999999986543 23578999999999999999999988777665443311
Q ss_pred hhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 322 EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
...-....++++..+..|++-|+..||.+||..+.++
T Consensus 404 ---------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 ---------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ---------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 0011123456788899999999999999999987654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=171.26 Aligned_cols=138 Identities=18% Similarity=0.179 Sum_probs=104.9
Q ss_pred cccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-----CCCCceeEeeeEEecCC-ce-
Q 036122 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-----DHPNVIKLEGLVTSRMS-CS- 173 (457)
Q Consensus 101 ~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~~-~~- 173 (457)
.-...||+|+||.||. ++.++.. +||++...... ..+.+.+|+.+++.+ +||||++++|++.+..+ ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 4467899999999995 6777665 69998764322 345688999999999 67999999999987532 23
Q ss_pred EEEEEeccc--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeccCCCCCEEecC----CCcEEEeeccCc
Q 036122 174 LYLVFEYME--HDLAGLAACQGVKFSEPQVKCYMKQLLSGL-EHCHNNGVLHRDIKGSNLLIDN----DGILKIADFGLA 246 (457)
Q Consensus 174 ~~lv~E~~~--~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~ivHrDlkp~NILl~~----~~~vkl~DFGla 246 (457)
+.+||||.+ ++.+..+..+. .+++. ..++.|++.++ .|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 337899954 54555454443 46666 35678888888 8999999999999999999974 348999995544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=178.20 Aligned_cols=145 Identities=24% Similarity=0.210 Sum_probs=113.2
Q ss_pred CccccceeeccCceEEEEEE-EcCCCcEEEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhcC
Q 036122 99 TFEKLDKIGQGTYSNVYKAR-DLLTGKIVALKKVRFDNLEP----------------------ESVKFMAREILVLRKLD 155 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~-~~~~g~~vAiK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l~ 155 (457)
.|.+.+.||+|+||.||+|. +..+|+.||||+++...... .....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 67899999999997543210 01134678999999997
Q ss_pred CCC--ceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeccCCCCCEEe
Q 036122 156 HPN--VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG-VLHRDIKGSNLLI 232 (457)
Q Consensus 156 hpn--iv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-ivHrDlkp~NILl 232 (457)
+.. +.+++++ ...++||||+++..+.........+...++..++.||+.+|.+||++| |+|+||||+||++
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 533 3344332 124899999999655433333445677778899999999999999999 9999999999999
Q ss_pred cCCCcEEEeeccCccccC
Q 036122 233 DNDGILKIADFGLATFYD 250 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~ 250 (457)
+ ++.++|+|||.+...+
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999987543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7e-20 Score=195.50 Aligned_cols=193 Identities=24% Similarity=0.259 Sum_probs=148.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD---HPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~ 173 (457)
...|.|.+.||+|+||+||+|.+.. |+.||+|+-+......-. --.+++.+|+ -+.|..+...+.. .+.
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~~~--~~~ 768 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAHVF--QNA 768 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHHcc--CCc
Confidence 4568889999999999999999755 999999987655432111 1233444444 1233444333333 234
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-------CCcEEEeeccCc
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-------DGILKIADFGLA 246 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-------~~~vkl~DFGla 246 (457)
-+||+||.+.+.+..+....+.++|..+..+..|++..+++||..+|||+||||+|+||.. +.-++|+|||-+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 5899999997666556667778999999999999999999999999999999999999952 346999999998
Q ss_pred cccCCCC-CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCC
Q 036122 247 TFYDPGL-KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGK 298 (457)
Q Consensus 247 ~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~ 298 (457)
..+..-. .......++|-.+-++|+..|.+ +++.+|.|.|+.+++.||.|+
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence 7542111 13455667899999999999888 899999999999999999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-21 Score=202.03 Aligned_cols=263 Identities=29% Similarity=0.410 Sum_probs=204.7
Q ss_pred CCccccceeeccCceEEEEEEEcC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL-TGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
..|.+...||+|+|+.|-...... +...+|.|.+............+..|..+-..+. |.|++.+++.... ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 567888889999999999987643 3446777777655444455566667888888887 9999999988766 55688
Q ss_pred EEEecccCCHHHHHH-hcCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCEEecCCC-cEEEeeccCccccCC
Q 036122 176 LVFEYMEHDLAGLAA-CQGV-KFSEPQVKCYMKQLLSGLEHCH-NNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDP 251 (457)
Q Consensus 176 lv~E~~~~~l~~~~~-~~~~-~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~ 251 (457)
++++|..++.+.... ..+. ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999998876555444 3343 5778888999999999999999 99999999999999999999 999999999987754
Q ss_pred --CCCCCcccccc-cCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 252 --GLKQPMTSRVV-TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 252 --~~~~~~~~~~g-t~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
+........+| ++.|+|||...+..+.....|+||.|+++.-+++|..|+.......... ..|...
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~~ 246 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKSN 246 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-----------eeeccc
Confidence 33344455678 9999999999887767889999999999999999998886543322100 001100
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
+ ...-...+..++....+++.++|..+|..|.+.+++-.+||+..
T Consensus 247 ~-------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 K-------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred c-------------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0 00011235567888899999999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.9e-19 Score=161.52 Aligned_cols=139 Identities=24% Similarity=0.241 Sum_probs=107.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh--------------------HHHHHHHHHHHHHHhcCCCC
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP--------------------ESVKFMAREILVLRKLDHPN 158 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~--------------------~~~~~~~~E~~~l~~l~hpn 158 (457)
.|.+.+.||+|+||.||++.+ .+|+.||||++....... ........|..++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 478889999999999999986 489999999987543110 01123567899999998874
Q ss_pred --ceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 159 --VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 159 --iv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
++..++ .+..++||||+++..+..... ......++.+|+.++.++|+.||+|+||||+||++++++
T Consensus 95 i~v~~~~~------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444432 134589999999865543321 145567889999999999999999999999999999999
Q ss_pred cEEEeeccCccccC
Q 036122 237 ILKIADFGLATFYD 250 (457)
Q Consensus 237 ~vkl~DFGla~~~~ 250 (457)
.++|+|||++....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-18 Score=160.71 Aligned_cols=136 Identities=18% Similarity=0.237 Sum_probs=108.5
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE------SVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+.||+|++|.||+|.+ +|..|++|+......... ....+.+|+.++..+.|++|+....++.. ....++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 5799999999999985 778899998754332211 12457789999999999988766555554 3457899
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
|||++|..+........ . ....++.+|+.+|.+||+.+++|+|++|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999865555544322 2 7888999999999999999999999999999999 78999999999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-18 Score=155.55 Aligned_cols=133 Identities=19% Similarity=0.248 Sum_probs=102.2
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh------HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP------ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
.||+|+||.||+|. .+|..|++|+........ .....+.+|+.++..+.|+++.....++.. ....++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 48999999999998 577889999865432211 123567789999999998765444333333 33468999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
||++|..+......... .++.+|+.+|.+||+.|++|+|++|+||+++ ++.++|+|||++...
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99998665544432211 7889999999999999999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=173.34 Aligned_cols=205 Identities=26% Similarity=0.410 Sum_probs=151.6
Q ss_pred HHhcCCCCceeEeeeEEecCCceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeccCCCC
Q 036122 151 LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV-LHRDIKGS 228 (457)
Q Consensus 151 l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-vHrDlkp~ 228 (457)
|+.+.|.|+.+++|.+.+. ...++|.+||..+ +.+.+......+++-....++++|+.||.|||.-.| .|+.|++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578999999999999984 6789999999865 455555556778999999999999999999998866 99999999
Q ss_pred CEEecCCCcEEEeeccCccccCCCC-CCCcccccccCccCchHhhhCCcC------CCccchhhhHHHHHHHHHhCCCCC
Q 036122 229 NLLIDNDGILKIADFGLATFYDPGL-KQPMTSRVVTLWYRPPELLLGATY------YGVGVDLWSAGCILAELLAGKPIM 301 (457)
Q Consensus 229 NILl~~~~~vkl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~------~~~~~DvwslG~vl~elltG~~pf 301 (457)
|++++....+||+|||+........ ........-..-|.|||.+.+... .+.+.||||||++++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999988664210 011111123566999999976421 356799999999999999999999
Q ss_pred CCCC----hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHH
Q 036122 302 PGRT----EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATA 377 (457)
Q Consensus 302 ~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e 377 (457)
.... ..+.+.++.+ .+. ..++|. +.. ...+++++..++++|+..+|++||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~--------------~~~rP~------i~~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGS--------------NPFRPS------IEL-LNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCC--------------CCcCcc------hhh-hhhcchHHHHHHHHhcccChhhCccHHH
Confidence 7532 2233333322 000 001111 111 1145668899999999999999999988
Q ss_pred Hh
Q 036122 378 AL 379 (457)
Q Consensus 378 lL 379 (457)
+-
T Consensus 217 i~ 218 (484)
T KOG1023|consen 217 IR 218 (484)
T ss_pred HH
Confidence 75
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.1e-18 Score=153.17 Aligned_cols=138 Identities=27% Similarity=0.270 Sum_probs=98.8
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHH----------------------HHHHHHHHHhcCCCC--
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF----------------------MAREILVLRKLDHPN-- 158 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~----------------------~~~E~~~l~~l~hpn-- 158 (457)
.+.||+|+||+||+|.+. +|+.||||+++........... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 567999999999999975 8999999998764322111111 135666666665433
Q ss_pred ceeEeeeEEecCCceEEEEEecccCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCC
Q 036122 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 159 iv~l~~~~~~~~~~~~~lv~E~~~~~l~~-~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~ 236 (457)
+.+.++. ...++||||++++... ...... ... .++..++.+++.++.++|. .+|+|+||||+||+++ ++
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 3444332 2358999999983211 111110 111 6788999999999999999 9999999999999999 89
Q ss_pred cEEEeeccCccccC
Q 036122 237 ILKIADFGLATFYD 250 (457)
Q Consensus 237 ~vkl~DFGla~~~~ 250 (457)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=175.17 Aligned_cols=140 Identities=18% Similarity=0.187 Sum_probs=107.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-C-----hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-E-----PESVKFMAREILVLRKLDHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 170 (457)
...|...+.||+|+||+||++... +..+++|+...... . ......+.+|+.+++.++|++|+....++..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--
Confidence 344567899999999999999854 33445544322111 1 1123567899999999999999887666555
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
....++||||+++..+..... ....++.||+.+|.+||+.||+||||||+|||+ +++.++|+|||+++..
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 345689999999866554432 456789999999999999999999999999999 6789999999999753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=148.41 Aligned_cols=138 Identities=19% Similarity=0.207 Sum_probs=103.1
Q ss_pred ceee-ccCceEEEEEEEcCCCcEEEEEEeecCCC-----------ChHHHHHHHHHHHHHHhcCCCCc--eeEeeeEEec
Q 036122 104 DKIG-QGTYSNVYKARDLLTGKIVALKKVRFDNL-----------EPESVKFMAREILVLRKLDHPNV--IKLEGLVTSR 169 (457)
Q Consensus 104 ~~LG-~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~ 169 (457)
..|| .||.|+||.+.. .+..++||.+..... +......+.+|+.++.+|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4687 899999999974 478899998864321 11233567889999999998875 6666654432
Q ss_pred CCc--eEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 170 MSC--SLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 170 ~~~--~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
... ..++||||++| ..+..+... ..+++.. +.||+.+|.+||++||+|+||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 221 23599999997 344444333 3466543 578999999999999999999999999999999999999998
Q ss_pred cc
Q 036122 247 TF 248 (457)
Q Consensus 247 ~~ 248 (457)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-17 Score=164.78 Aligned_cols=256 Identities=24% Similarity=0.278 Sum_probs=194.9
Q ss_pred cCCccccceeec--cCceEEEEEEE--cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQ--GTYSNVYKARD--LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~--G~fg~Vy~~~~--~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~ 171 (457)
...|.+...+|. |.+|.||.+.. ..++..+|+|.-+...........=.+|+.....++ |+|.++.+..+.. .
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~ 190 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--S 190 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--C
Confidence 356778899999 99999999988 888999999985443322222222235666666665 9999997777666 5
Q ss_pred ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeccCCCCCEEecCC-CcEEEeeccCc
Q 036122 172 CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLS----GLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLA 246 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla 246 (457)
..+|+-+|+++..+..........++...++.++.+... ||.++|..+|+|-|+||.||+...+ ...+++|||+.
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 678999999998888777666666899999999999999 9999999999999999999999999 89999999999
Q ss_pred cccCCCCCCCc----ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCC
Q 036122 247 TFYDPGLKQPM----TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR--TEVEQLHKIFKLCGSP 320 (457)
Q Consensus 247 ~~~~~~~~~~~----~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~--~~~~~~~~i~~~~~~~ 320 (457)
..+.++..... ....|...|++||.+.+- ++...|||+||.++.+..++..++... +.-.++.++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~------- 341 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG------- 341 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-------
Confidence 87765432111 112466779999988654 688999999999999999986544322 111111111
Q ss_pred ChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 321 SEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
+ .-.+.+...+.++...+.+|++.||..|+++..++.|+++..
T Consensus 342 ---------------------~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 342 ---------------------Y--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ---------------------c--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 0 112233445666677999999999999999999999999975
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.9e-16 Score=134.76 Aligned_cols=132 Identities=24% Similarity=0.249 Sum_probs=108.2
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeeeEEecCCceEEEEEe
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH--PNVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~lv~E 179 (457)
+++.||+|.++.||++.. ++..+++|....... ...+.+|+.+++.+.| .++++++++... ....+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~--~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEe--cCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEE
Confidence 467899999999999985 347899999865432 3567889999999976 588888877655 356899999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN---GVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
|+.+..+... +......++.+++.+|.+||.. +++|+||+|+||++++.+.++++|||.+..
T Consensus 74 ~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9987544322 5567778899999999999985 699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.5e-17 Score=170.07 Aligned_cols=268 Identities=22% Similarity=0.242 Sum_probs=197.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.+.+.+.+-+-.|.++.++.+.-..+|...++|+..... +.....+....+-.++-..++|-+++..--+ ......+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~ 880 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLP 880 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcc
Confidence 467888889999999999999877888777887665432 1222223334444454445566666553222 2245689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC-----
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD----- 250 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~----- 250 (457)
||++|..++-+.-.+...+..+++-++.+...+..+++|||...+.|+|++|.|+|...+|+.+++|||+.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 999999875444444455567888888899999999999999999999999999999999999999998543221
Q ss_pred --C--------------CCC---------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 036122 251 --P--------------GLK---------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT 305 (457)
Q Consensus 251 --~--------------~~~---------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~ 305 (457)
. ... ......++|+.|.+||.+.+.. .+..+|+|++|++++|.++|.+||...+
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 000 0012346799999999999877 5788999999999999999999999888
Q ss_pred hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHH---HHhcCC
Q 036122 306 EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT---AALNSE 382 (457)
Q Consensus 306 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~---elL~hp 382 (457)
.....+.|....- .+.......+.++.+++..+|..+|.+|..+. ++-.|+
T Consensus 1040 pq~~f~ni~~~~~--------------------------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~ 1093 (1205)
T KOG0606|consen 1040 PQQIFENILNRDI--------------------------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHP 1093 (1205)
T ss_pred hhhhhhccccCCC--------------------------CCCCCccccChhhhhhhhhhhccCchhccCcccccccccCC
Confidence 7766655532110 01122234678899999999999999999988 899999
Q ss_pred CCCCCCCCCCC
Q 036122 383 FFNTEPYACEP 393 (457)
Q Consensus 383 ~f~~~~~~~~~ 393 (457)
||+..+|....
T Consensus 1094 ~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1094 FFQDVDWENLA 1104 (1205)
T ss_pred ccCCCCccccc
Confidence 99998776443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=6e-14 Score=126.04 Aligned_cols=141 Identities=18% Similarity=0.195 Sum_probs=101.1
Q ss_pred cceeeccCceEEEEEEEcC------CCcEEEEEEeecCCC-----------C---------hHHHHHHH----HHHHHHH
Q 036122 103 LDKIGQGTYSNVYKARDLL------TGKIVALKKVRFDNL-----------E---------PESVKFMA----REILVLR 152 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~------~g~~vAiK~~~~~~~-----------~---------~~~~~~~~----~E~~~l~ 152 (457)
...||.|--+.||.|.... .+..+|||+.+.... + ......+. +|...|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998543 357999999864211 0 11122233 7999999
Q ss_pred hcCC--CCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCC
Q 036122 153 KLDH--PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC-HNNGVLHRDIKGSN 229 (457)
Q Consensus 153 ~l~h--pniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~N 229 (457)
++.. -++...+.+ . .-+|||||++++.+.........+++.+...+..+++.+|..| |+.||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~--~----~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL--K----KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe--c----CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9853 455666543 1 2489999998742211111223466677788889999999998 89999999999999
Q ss_pred EEecCCCcEEEeeccCccccC
Q 036122 230 LLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 230 ILl~~~~~vkl~DFGla~~~~ 250 (457)
||+. ++.+.|+|||.+...+
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9997 4789999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.7e-13 Score=139.30 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=95.1
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----------------------------HH----H------HHHH
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----------------------------ES----V------KFMA 145 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----------------------------~~----~------~~~~ 145 (457)
+.||.|++|.||+|+. .+|+.||||+.+...... .. . -.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999985 589999999986432100 00 0 0134
Q ss_pred HHHHHHHhc----CCCCceeEeeeEEecCCceEEEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 036122 146 REILVLRKL----DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLS-GLEHCHNNG 219 (457)
Q Consensus 146 ~E~~~l~~l----~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~-~L~~LH~~~ 219 (457)
+|+..+.++ .|.+-+.+-.++... ....+|||||++|..+...... ...+ ....++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 455555554 233334443344332 2346899999998654433221 1112 23445666665 478899999
Q ss_pred ceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 220 ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
++|+|+||.||+++.++.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.6e-14 Score=146.02 Aligned_cols=145 Identities=21% Similarity=0.273 Sum_probs=95.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC---------------------------C-h----HHHHH--
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL---------------------------E-P----ESVKF-- 143 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---------------------------~-~----~~~~~-- 143 (457)
..|+. +.||.|++|+||+|+.+.+|+.||||+++.... + . +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999887799999999975420 0 0 11122
Q ss_pred ----HHHHHHHHHhcC----CCCceeEeeeEEecCCceEEEEEecccCCHHHHH---HhcCC---CCCHHHHHHHHHHHH
Q 036122 144 ----MAREILVLRKLD----HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA---ACQGV---KFSEPQVKCYMKQLL 209 (457)
Q Consensus 144 ----~~~E~~~l~~l~----hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~---~~~~~---~l~~~~~~~i~~qi~ 209 (457)
+.+|+..+.++. +.+.+.+-.++.+- .+..+|||||+.|.-+... ...+. .+.+..+..++.||
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 333444444442 33444444444332 3346899999998654432 11221 24444444444554
Q ss_pred HHHHHHHhCCceeccCCCCCEEecCCC----cEEEeeccCccccCC
Q 036122 210 SGLEHCHNNGVLHRDIKGSNLLIDNDG----ILKIADFGLATFYDP 251 (457)
Q Consensus 210 ~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~~~ 251 (457)
...|++|+|+||.||+++.+| .++++|||++..++.
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 468999999999999999888 999999999987653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3e-14 Score=143.24 Aligned_cols=256 Identities=21% Similarity=0.202 Sum_probs=179.9
Q ss_pred CCcCcCCccccceeeccCceEEEEEEEc-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecC
Q 036122 93 TPRRANTFEKLDKIGQGTYSNVYKARDL-LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRM 170 (457)
Q Consensus 93 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~ 170 (457)
......+|..+..||.|.|+.|+.+.-. .++..|++|.+............-..|+-+...+. |.+++.++..+..
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-- 337 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-- 337 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--
Confidence 4445778999999999999999998755 67889999988765443333223334666666654 7778876554444
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-CcEEEeeccCcccc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLATFY 249 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~~ 249 (457)
....|+=.|||.+....+.......+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||....+
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 34467999999886555544434458889999999999999999999999999999999999886 78899999998642
Q ss_pred CCCCCCCcccccccCccC-chHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 250 DPGLKQPMTSRVVTLWYR-PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~-aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
. .........-+++ ..|++.....+..+.|++|||.-+.+.++|.+.-...+.. ..|
T Consensus 418 ~----~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~~i--------------- 475 (524)
T KOG0601|consen 418 A----FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---LTI--------------- 475 (524)
T ss_pred c----eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---eee---------------
Confidence 1 1111222344455 3565655555788999999999999999987532211110 000
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
........+.....+..+.+.|...|+..|+.+.++..|.=|..
T Consensus 476 --------------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 476 --------------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --------------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 00111122333356677899999999999999999998876644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.8e-13 Score=134.40 Aligned_cols=169 Identities=20% Similarity=0.312 Sum_probs=127.5
Q ss_pred EEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCC
Q 036122 116 KARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK 195 (457)
Q Consensus 116 ~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~ 195 (457)
.|..+.++.+|.|...+.... .......+-++-|+.|+||||++++..+.. ...+|||+|-+..-. ..+. .
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~Pl~-~~lk----~ 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRPLE-TVLK----E 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccccHH-HHHH----H
Confidence 455678899999998876543 444556778889999999999999988776 557999999986421 1111 1
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-hCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhC
Q 036122 196 FSEPQVKCYMKQLLSGLEHCH-NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274 (457)
Q Consensus 196 l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 274 (457)
+....+...+.||+.||.||| +.+++|++|.-+.|+|+..|..||++|.++........ +......--.|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 346778888999999999998 56899999999999999999999999999875532211 1122222344777775542
Q ss_pred CcCCCccchhhhHHHHHHHHHhC
Q 036122 275 ATYYGVGVDLWSAGCILAELLAG 297 (457)
Q Consensus 275 ~~~~~~~~DvwslG~vl~elltG 297 (457)
.. ...|.|.|||+++|++.|
T Consensus 180 s~---~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE---WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc---cchhhhhHHHHHHHHhCc
Confidence 22 357999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=4.7e-13 Score=118.57 Aligned_cols=127 Identities=17% Similarity=0.140 Sum_probs=93.4
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce-eEeeeEEecCCceEEEEEecc
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI-KLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~~lv~E~~ 181 (457)
++.|+.|.++.||++.. .+..|++|+...... ....+.+|+.+++.+.+.+++ +++.+.. ..-++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEEEEec
Confidence 46789999999999984 478899998754321 112356799999988655544 4443322 2247999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV-----LHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i-----vHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
+|..+... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 74 ~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 74 EGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 98644321 01123456899999999999985 9999999999999 6789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4e-14 Score=131.95 Aligned_cols=239 Identities=18% Similarity=0.203 Sum_probs=150.6
Q ss_pred EEEEEEEcCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---CceEEEEEecccCCHHH
Q 036122 113 NVYKARDLLTGKIVALKKVRFDNLE--PESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCSLYLVFEYMEHDLAG 187 (457)
Q Consensus 113 ~Vy~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~~~lv~E~~~~~l~~ 187 (457)
.||++.+...|.+|..-.++..... .........-..-|-++.|-|||+++.|+.+.. .....++.|||..+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 4677776677766655433321111 111111222234455667999999999887632 23478899999875443
Q ss_pred HH----HhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeccCCCCCEEecCCCcEEEeeccCccccCCCC----CCCc
Q 036122 188 LA----ACQGVKFSEPQVKCYMKQLLSGLEHCHNN--GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL----KQPM 257 (457)
Q Consensus 188 ~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~----~~~~ 257 (457)
.+ ......+......+|+.||+.||.|||+. -|+|+++..+-|++..+|-+|+.----.. ..+.. ....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhh
Confidence 33 33355688999999999999999999998 59999999999999999988876311111 00000 0001
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP-IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
....+.++|.|||.=.... .+-++|||+||+..+||..+.- +-.+....+.-..+....
T Consensus 240 ~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------- 299 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------- 299 (458)
T ss_pred hccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence 1223567899999644333 4668999999999999988752 222221111111111100
Q ss_pred CCCCCcccchhcccCCC-CCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDF-PSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~-~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
-.+ ..--+++|..||+..|..||++.++|.||.+=.
T Consensus 300 --------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 300 --------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred --------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 000 111234699999999999999999999998644
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.3e-11 Score=102.32 Aligned_cols=143 Identities=20% Similarity=0.271 Sum_probs=100.3
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-h-----HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-P-----ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.+..|-+|+-+.|+++. ..|+...||.--..... + -...+..+|+.+|.++.--.|.--.=++.+. ..-.
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQ 86 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCe
Confidence 57889999999999997 68888888854322221 1 1235677899999988633332211133332 2237
Q ss_pred EEEecccC--CHHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC---cEEEeeccCccc
Q 036122 176 LVFEYMEH--DLAGLAACQGVKFSEPQV-KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIADFGLATF 248 (457)
Q Consensus 176 lv~E~~~~--~l~~~~~~~~~~l~~~~~-~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~ 248 (457)
|+|||++| .+...+......-.+++. ..++++|-..+.-||.++|||+||..+||+|..++ .+.++|||++..
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99999998 444444443333333333 78899999999999999999999999999998655 458999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.8e-11 Score=102.61 Aligned_cols=131 Identities=24% Similarity=0.310 Sum_probs=92.6
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChH-----HHHHHHHHHHHHHhcCCCCc--eeEeeeEEecCCceEE
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPE-----SVKFMAREILVLRKLDHPNV--IKLEGLVTSRMSCSLY 175 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~-----~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~~~~~~ 175 (457)
..+++|+-+.+|.+.. -|..+.+|.-.... ..++ ...+..+|+.++.++.--.| ..++.+ + .....
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D--~~~~~ 75 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--D--PDNGL 75 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--c--CCCCE
Confidence 4578999999999953 45556666432222 1222 12456689999998864333 333332 3 23457
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
|+|||++|.++....... ...+++.|-.-+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998887665443 245677777888889999999999999999998764 99999999974
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.2e-12 Score=128.97 Aligned_cols=155 Identities=23% Similarity=0.327 Sum_probs=115.5
Q ss_pred HHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc--------cccccCccCchHhhhCCcC
Q 036122 207 QLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT--------SRVVTLWYRPPELLLGATY 277 (457)
Q Consensus 207 qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~--------~~~gt~~y~aPE~l~~~~~ 277 (457)
+++.||.|+|.. ++||++|.|++|.++.+|..||+.|+++.........+.. ...-...|.|||++.+..
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~- 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT- 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence 344999999976 8999999999999999999999999998765442221111 112256799999998744
Q ss_pred CCccchhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCC
Q 036122 278 YGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSS 356 (457)
Q Consensus 278 ~~~~~DvwslG~vl~ell-tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (457)
.+.++|+|||||++|.+. .|++.|.+.........-....+.. ....-..+|++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcHH
Confidence 789999999999999999 6677776654433322221111000 00111568999
Q ss_pred cHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 357 SLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 357 ~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+++=|.++|..|+..||++.+++..|||+..
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 9999999999999999999999999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.4e-11 Score=108.30 Aligned_cols=143 Identities=22% Similarity=0.269 Sum_probs=102.3
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeeeEEecC-CceEEEEEe
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH--PNVIKLEGLVTSRM-SCSLYLVFE 179 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~-~~~~~lv~E 179 (457)
.+.|+.|.++.||++.. .+|..+++|+....... .....+.+|+.+++.+.+ .++.+++.+..... ....++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEe-cCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 35689999999999985 34688999987654321 123457889999999975 34566665544321 124689999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN------------------------------------------ 217 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~------------------------------------------ 217 (457)
|++|..+...... ..+++.+...++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9998644332211 246677777777777777777773
Q ss_pred --------------CCceeccCCCCCEEecC--CCcEEEeeccCccc
Q 036122 218 --------------NGVLHRDIKGSNLLIDN--DGILKIADFGLATF 248 (457)
Q Consensus 218 --------------~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~ 248 (457)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 67789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.5e-10 Score=103.76 Aligned_cols=127 Identities=25% Similarity=0.280 Sum_probs=83.2
Q ss_pred EEEEEEEcCCCcEEEEEEeecCCC-----------------------C-hHHHHHHHHHHHHHHhcCCC--CceeEeeeE
Q 036122 113 NVYKARDLLTGKIVALKKVRFDNL-----------------------E-PESVKFMAREILVLRKLDHP--NVIKLEGLV 166 (457)
Q Consensus 113 ~Vy~~~~~~~g~~vAiK~~~~~~~-----------------------~-~~~~~~~~~E~~~l~~l~hp--niv~l~~~~ 166 (457)
.||.|.. .+|..+|+|+.+.... . ........+|...|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899985 6788999999864210 0 01123567899999999865 456665432
Q ss_pred EecCCceEEEEEeccc--CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCCEEecCCCcEEEeec
Q 036122 167 TSRMSCSLYLVFEYME--HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH-CHNNGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 167 ~~~~~~~~~lv~E~~~--~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
.-+|||||++ |..+..+.... ++..+...++.+++..+.. +|..||+|+||.+.|||++++ .+.|+||
T Consensus 80 ------~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ------RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ------TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ------CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 1279999999 64443333221 2245667788888886555 679999999999999999987 9999999
Q ss_pred cCcccc
Q 036122 244 GLATFY 249 (457)
Q Consensus 244 Gla~~~ 249 (457)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 998744
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.3e-10 Score=110.22 Aligned_cols=213 Identities=21% Similarity=0.261 Sum_probs=153.0
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEe--cCCceEEEEEecccC--CHH
Q 036122 111 YSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTS--RMSCSLYLVFEYMEH--DLA 186 (457)
Q Consensus 111 fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~~~lv~E~~~~--~l~ 186 (457)
-.+.|++....+|..|++|.+..+..... .....-+++++++.|+|||++.+++.. -.+..+++||+|.++ +|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~--nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST--NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc--ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 45789999999999999999954432211 112345788999999999999988762 124568999999987 343
Q ss_pred HHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 187 GLAAC--------------QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 187 ~~~~~--------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+.+.. .+...+|..+|.|+.||..||.++|+.|+.-+-|.|.+||++.+.+++|+..|....+..+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 33221 1234788999999999999999999999999999999999999889999988888766543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQ-LHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 330 (457)
.. |-+.+. .+-|.=.||.+++.|.||..- +......+. +..|
T Consensus 447 ~~---------------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I----------------- 490 (655)
T KOG3741|consen 447 PT---------------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI----------------- 490 (655)
T ss_pred CC---------------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------------
Confidence 21 112221 246888999999999999531 111111111 2222
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
-..++.+++++|.-+...+++. -++.++|.|
T Consensus 491 -------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 -------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1235667778888888888886 677787765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.8e-09 Score=100.27 Aligned_cols=140 Identities=18% Similarity=0.133 Sum_probs=93.2
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecCCCCh---------HHHHHHHHHHHHHHhcCCCCc--eeEeeeEEecC---C
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP---------ESVKFMAREILVLRKLDHPNV--IKLEGLVTSRM---S 171 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~---------~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~---~ 171 (457)
+-......|+++. ..|+.|.||......... .......+|...+.+|..-+| +..+++..... .
T Consensus 30 v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3333334466664 467789999764322110 001136688888888743333 33344443321 2
Q ss_pred ceEEEEEecccCC--HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-------CCcEEEe
Q 036122 172 CSLYLVFEYMEHD--LAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-------DGILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~~--l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-------~~~vkl~ 241 (457)
..-+||||++++. +...... .....+......++.+|+..+.-||+.||+|+||++.|||++. ++.+.|+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 2468999999984 3333321 1234667788899999999999999999999999999999975 4689999
Q ss_pred eccCcc
Q 036122 242 DFGLAT 247 (457)
Q Consensus 242 DFGla~ 247 (457)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999886
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.1e-09 Score=95.76 Aligned_cols=138 Identities=25% Similarity=0.254 Sum_probs=102.8
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC------------------C--hHHHHHHHHHHHHHHhcCCC--
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL------------------E--PESVKFMAREILVLRKLDHP-- 157 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------------------~--~~~~~~~~~E~~~l~~l~hp-- 157 (457)
+.+.+.||.|--|.||.|.+ ..|..+|||.=+.... + .-.....++|..+|++|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45678899999999999985 5899999997543211 0 11233456899999999755
Q ss_pred CceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc
Q 036122 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 158 niv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 237 (457)
.+.+.+++ +.-.+||||++|-.+.... ++......++..|+.-+.-+-..||||+|+.+-|||++++|.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 66666553 3457999999985544322 245556666777777777666999999999999999999999
Q ss_pred EEEeeccCcccc
Q 036122 238 LKIADFGLATFY 249 (457)
Q Consensus 238 vkl~DFGla~~~ 249 (457)
+.++||-.+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999877643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-08 Score=98.57 Aligned_cols=251 Identities=15% Similarity=0.134 Sum_probs=152.5
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeee-----EEecCCceEEE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGL-----VTSRMSCSLYL 176 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-----~~~~~~~~~~l 176 (457)
...||+|+-+.+|-.- .-+. .+.|+.....-... . +-+..|... .||-+-.-+.+ +-.+.+..+-+
T Consensus 16 gr~LgqGgea~ly~l~--e~~d-~VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRD-QVAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CccccCCccceeeecc--hhhc-hhheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 5679999999999763 2222 34477654432111 1 122333333 45543220111 11111223667
Q ss_pred EEecccCC--HHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 177 VFEYMEHD--LAGLAA-----CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 177 v~E~~~~~--l~~~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
.|..+.+- ....+. +....+.|..+.+.++.|+.+...||+.|.+-+|+.++|+||++++.|.|.|=..-...
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeec
Confidence 88888762 222221 12234789999999999999999999999999999999999999999999986554443
Q ss_pred CCCCCCCcccccccCccCchHhhh-----CCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChH----HHHH-HHHHhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLL-----GATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEV----EQLH-KIFKLCG 318 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~----~~~~-~i~~~~~ 318 (457)
..+ ......+|...|.+||.-. +.. -+...|.|.||+++|+++.| ++||.|-... .-++ .|.....
T Consensus 168 ~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 168 ANG--TLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred cCC--ceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 332 3345568899999999754 222 35678999999999999997 8999763210 0000 1111111
Q ss_pred CCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccC--CCCCCcCHHH
Q 036122 319 SPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSI--DPDNRGTATA 377 (457)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~--dP~~Rpta~e 377 (457)
....+ ...+..+ ...+--+.-+++++..|..+|+.. ++.-|||++.
T Consensus 245 ~ya~~-----------~~~g~~p--~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 245 AYASD-----------QRRGLKP--PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred eechh-----------ccCCCCC--CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 10000 0000000 111223455788999999999875 3568999654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.1e-08 Score=90.77 Aligned_cols=107 Identities=21% Similarity=0.230 Sum_probs=79.2
Q ss_pred HHHHHHHHHHHhcCCCC--ceeEeeeEEecCC--ceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 036122 142 KFMAREILVLRKLDHPN--VIKLEGLVTSRMS--CSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216 (457)
Q Consensus 142 ~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~--~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH 216 (457)
....+|...+..|..-. .++.+++...... ...+||+|++++. .+..+......++......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 34667888877775332 3444555444222 2358999999983 34444433223677788899999999999999
Q ss_pred hCCceeccCCCCCEEecCCC---cEEEeeccCccc
Q 036122 217 NNGVLHRDIKGSNLLIDNDG---ILKIADFGLATF 248 (457)
Q Consensus 217 ~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~ 248 (457)
++||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-09 Score=110.84 Aligned_cols=250 Identities=18% Similarity=0.132 Sum_probs=167.8
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN-VIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~ 174 (457)
++.-|...+.+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+. .+...
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~ 309 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYL 309 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCC--ccccc
Confidence 3566788899999999999999866555544 6665432 22345899999999999 444444333 36678
Q ss_pred EEEEecccCC--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 175 YLVFEYMEHD--LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 175 ~lv~E~~~~~--l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+++|+++.++ ...........+.+-+...+.+.-+++|++||+.-=+|+| ||+..+ +..|..||+....+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999875 1111111112244455566667777899999998778998 887765 68999999998876544
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
. ...+..+|+.++|||+..... +....|+|++|+-..+|.-|.+|-.. |+........-++
T Consensus 385 ~--~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~----------------P~~~~~~~g~~p~ 445 (829)
T KOG0576|consen 385 M--KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS----------------PPAVLPMIGNGPN 445 (829)
T ss_pred c--ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC----------------CccccCCCCCCCC
Confidence 2 345667899999999988777 67789999999887788777776533 1111100000000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
. +....+..+...+. .++...|+..-|..|++...++-|.+|+..+.
T Consensus 446 s----~~L~~~~aw~~~~~------~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 446 S----PMLTDKSAWSPVFH------RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred c----cccchhhhcCcccc------cCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 0 00000011111111 14678899999999999999999999998543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.8e-07 Score=84.45 Aligned_cols=140 Identities=17% Similarity=0.193 Sum_probs=97.8
Q ss_pred eeccCceEEEEEEEcCCCcEEEEEEeecC---CCC-hHHHHHHHHHHHHHHhcCCCC--ceeEeeeEE---ecCCceEEE
Q 036122 106 IGQGTYSNVYKARDLLTGKIVALKKVRFD---NLE-PESVKFMAREILVLRKLDHPN--VIKLEGLVT---SRMSCSLYL 176 (457)
Q Consensus 106 LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~---~~~-~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~---~~~~~~~~l 176 (457)
-|+||-+.|++.. -.|+.+=+|.-... ... +.-...|.+|...|.+|..-+ +.+.. ++. ....-.-+|
T Consensus 26 ~~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 3568899999976 34456888876411 111 223456889999999885322 33433 222 122234689
Q ss_pred EEecccC--CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc--EEEeeccCccc
Q 036122 177 VFEYMEH--DLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI--LKIADFGLATF 248 (457)
Q Consensus 177 v~E~~~~--~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~ 248 (457)
|+|-+++ +|...+... -.+.+..+...++.+|+..+.-||+.|+.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998885 444443222 124577888899999999999999999999999999999987677 99999997763
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=7.9e-08 Score=88.06 Aligned_cols=140 Identities=22% Similarity=0.260 Sum_probs=96.3
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHH----------------------HHHHHHHHHHHHhcC--CCC
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES----------------------VKFMAREILVLRKLD--HPN 158 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~----------------------~~~~~~E~~~l~~l~--hpn 158 (457)
...|..|--+.||+|. ..++..+|+|+++........ ..-..+|..-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 3467788888999997 367899999998754221110 112335777777764 334
Q ss_pred ceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCc
Q 036122 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 159 iv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~ 237 (457)
+.+-+++.. -.|||||++....---...+..+...++..+..++++.+.-|-. .++||+||..-|||+. ++.
T Consensus 132 vP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 132 VPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 444444332 27999999865211111122234444788888999999988776 8999999999999999 789
Q ss_pred EEEeeccCccccC
Q 036122 238 LKIADFGLATFYD 250 (457)
Q Consensus 238 vkl~DFGla~~~~ 250 (457)
+.|+|||.|...+
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.3e-07 Score=83.15 Aligned_cols=140 Identities=21% Similarity=0.243 Sum_probs=90.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHH-HH------HHHHHHHHHHhcC---CCCceeEeeeE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES-VK------FMAREILVLRKLD---HPNVIKLEGLV 166 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~-~~------~~~~E~~~l~~l~---hpniv~l~~~~ 166 (457)
.++|.+.+.+-......|.+.. .+|..+.+|..+......+. .. ...+++..+.++. .-.+..++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4678888899888888888775 67888999988654322111 11 1234444444443 22222322222
Q ss_pred Ee---cCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeec
Q 036122 167 TS---RMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 167 ~~---~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
.. ......+++|||++|-.+..... +++ .+...|..++.-||+.|++|+|..|.|++++++ .++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 21 11234678999999854332221 333 244567788999999999999999999999865 4999999
Q ss_pred cCcc
Q 036122 244 GLAT 247 (457)
Q Consensus 244 Gla~ 247 (457)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.8e-07 Score=93.05 Aligned_cols=143 Identities=22% Similarity=0.293 Sum_probs=88.4
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC---------------------------Ch-HHH----H------HHH
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL---------------------------EP-ESV----K------FMA 145 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---------------------------~~-~~~----~------~~~ 145 (457)
+-|+.++-|.||+|+. .+|+.||||+.+.+-. .. ... + .+.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5699999999999995 5699999999864311 00 001 1 133
Q ss_pred HHHHHHHhcC-----CCCceeEeeeEEecCCceEEEEEecccCCHHHHH-HhcCCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 036122 146 REILVLRKLD-----HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA-ACQGVKFSEPQVKCYMKQLLSG-LEHCHNN 218 (457)
Q Consensus 146 ~E~~~l~~l~-----hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~-L~~LH~~ 218 (457)
+|+.-+.++. .++ +.+=.+|.+- .+.-.|+|||++|--.... ......++... ++..++.+ +..+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc
Confidence 4555555542 233 2332333321 2345899999998322222 11112244333 33333322 3344458
Q ss_pred CceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 219 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
|++|.|.+|.||+++.+|++.+.|||+...+++.
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 9999999999999999999999999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.2e-06 Score=79.59 Aligned_cols=134 Identities=18% Similarity=0.142 Sum_probs=79.7
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc--eeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV--IKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~~~~~~~lv~E~~ 181 (457)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-.+ .+.+++... .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeec
Confidence 57999999999984 24467888875422 22346789999988864333 555555544 44578899999
Q ss_pred cCCH-HH---------------HHHh-----cCC---CCCHHHH-HHHHH----------HHHH-HHHHHHh----CCce
Q 036122 182 EHDL-AG---------------LAAC-----QGV---KFSEPQV-KCYMK----------QLLS-GLEHCHN----NGVL 221 (457)
Q Consensus 182 ~~~l-~~---------------~~~~-----~~~---~l~~~~~-~~i~~----------qi~~-~L~~LH~----~~iv 221 (457)
+|.. .. .+.. ... ....... ..+.. .+.. ...+|.. ..++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 9841 10 0000 000 0111110 11100 1111 1222221 2478
Q ss_pred eccCCCCCEEecCCCcEEEeeccCccc
Q 036122 222 HRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 222 HrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.3e-06 Score=79.32 Aligned_cols=139 Identities=24% Similarity=0.280 Sum_probs=79.7
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeeeEEec-CCceEEEEEe
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN--VIKLEGLVTSR-MSCSLYLVFE 179 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~-~~~~~~lv~E 179 (457)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|.... +.+++.+.... .....+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 4679999999999998533 58999986432 44566788999998886333 45666544332 1334789999
Q ss_pred cccCCHHHH--------------------HHhc---CCCCCHHH------HHHH---------------HHHHHH-HHHH
Q 036122 180 YMEHDLAGL--------------------AACQ---GVKFSEPQ------VKCY---------------MKQLLS-GLEH 214 (457)
Q Consensus 180 ~~~~~l~~~--------------------~~~~---~~~l~~~~------~~~i---------------~~qi~~-~L~~ 214 (457)
+++|..+.. +... ...+.... .... ...+.. .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 998743222 0011 01111000 0000 011222 2333
Q ss_pred HH-------hCCceeccCCCCCEEec-CCCcEEEeeccCcc
Q 036122 215 CH-------NNGVLHRDIKGSNLLID-NDGILKIADFGLAT 247 (457)
Q Consensus 215 LH-------~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~ 247 (457)
++ ...++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33 23599999999999999 66777899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.41 E-value=7.8e-07 Score=96.39 Aligned_cols=206 Identities=19% Similarity=0.165 Sum_probs=140.7
Q ss_pred HHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce--EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 036122 140 SVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS--LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217 (457)
Q Consensus 140 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~--~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (457)
.+...+.|+..+..+.|+|++.++.|-..+.... ..+..+++....+......-...+....+.+..+++.||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3444556788888899999999987765432222 23345677665555555555678999999999999999999999
Q ss_pred CCceeccCCCC---CEEecCCCcEEEe--eccCccccCCCCCCCcccccccCccCchHhhhCCcC-CCccchhhhHHHHH
Q 036122 218 NGVLHRDIKGS---NLLIDNDGILKIA--DFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY-YGVGVDLWSAGCIL 291 (457)
Q Consensus 218 ~~ivHrDlkp~---NILl~~~~~vkl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~~DvwslG~vl 291 (457)
....|.-|..+ +--.+.++.+.++ ||+....+... ........+..+.++|....... .....|+|++|.++
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~--~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN--EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCc--ccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 97666666555 4444566677777 89888766433 22233344667888887764431 22347999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccC-CCCCCcHHHHHHhccCCCC
Q 036122 292 AELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFK-DFPSSSLPLIETLLSIDPD 370 (457)
Q Consensus 292 ~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~Li~~~L~~dP~ 370 (457)
..+..|..+-... ..+.. .+. .+.....+++.+|+.-|++
T Consensus 383 ~~~~~~~~i~~~~------~~~~~---------------------------------~l~~~~~~~~~d~~~~~~~~~~~ 423 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS------AVPVS---------------------------------LLDVLSTSELLDALPKCLDEDSE 423 (1351)
T ss_pred hhhhhcCcccccc------cchhh---------------------------------hhccccchhhhhhhhhhcchhhh
Confidence 9999886432110 00000 001 1122567889999999999
Q ss_pred CCcCHHHHhcCCCCCC
Q 036122 371 NRGTATAALNSEFFNT 386 (457)
Q Consensus 371 ~Rpta~elL~hp~f~~ 386 (457)
+|+++.++|.|+|.+.
T Consensus 424 ~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 424 ERLSALELLTHPFLRF 439 (1351)
T ss_pred hccchhhhhhchhccc
Confidence 9999999999999875
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.7e-06 Score=73.11 Aligned_cols=132 Identities=23% Similarity=0.227 Sum_probs=90.9
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCcee-EeeeEEecCCceEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK-LEGLVTSRMSCSLYLV 177 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~~~lv 177 (457)
.....+.|++|.+|.||+|. ..|..+|+|+-+.+.. ...++.|+++|..+.--++.. ++.|- ..++.
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~yg------~~~i~ 90 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFYG------EDFIR 90 (201)
T ss_pred hhhhhhhhhcccccEEEEee--ccCceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEec------hhhhh
Confidence 34567889999999999997 6777999998775542 345788999999988666544 43332 13567
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCC-CCCEEecCCCcEEEeeccCcccc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIK-GSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk-p~NILl~~~~~vkl~DFGla~~~ 249 (457)
|||+.|--+...... .+ +.-+..++..---|-..||-|..|. |..++|..++.+.|+||..|+.-
T Consensus 91 me~i~G~~L~~~~~~---~~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 91 MEYIDGRPLGKLEIG---GD----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhcCcchhhhhhc---cc----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 999998433322211 11 2233456666556778899999986 45555555569999999999743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.36 E-value=9.3e-06 Score=72.92 Aligned_cols=130 Identities=24% Similarity=0.341 Sum_probs=92.9
Q ss_pred cCCccccceeeccCc-eEEEEEEEcCCCcEEEEEEeec---CCC-------Ch---------HHHHHHHHHHHHHHhcC-
Q 036122 97 ANTFEKLDKIGQGTY-SNVYKARDLLTGKIVALKKVRF---DNL-------EP---------ESVKFMAREILVLRKLD- 155 (457)
Q Consensus 97 ~~~y~~~~~LG~G~f-g~Vy~~~~~~~g~~vAiK~~~~---~~~-------~~---------~~~~~~~~E~~~l~~l~- 155 (457)
+.+++.++.||.|.- |.||++. .+|+.||+|+++. ... .. ....-|..|.....+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 478999999999999 9999997 6888999999432 110 00 12234677888877774
Q ss_pred --CCCc--eeEeeeEEecC----------------CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 036122 156 --HPNV--IKLEGLVTSRM----------------SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215 (457)
Q Consensus 156 --hpni--v~l~~~~~~~~----------------~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L 215 (457)
+.++ |+++||..-.. ....-||.||+.... .++... +.+|.+-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHH
Confidence 4556 99999874321 122467888886543 233333 45777888899
Q ss_pred HhCCceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 216 H~~~ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
|..||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999985 3478999965
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.2e-06 Score=76.71 Aligned_cols=134 Identities=16% Similarity=0.098 Sum_probs=78.3
Q ss_pred eeeccCc-eEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEEEEeccc
Q 036122 105 KIGQGTY-SNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYLVFEYME 182 (457)
Q Consensus 105 ~LG~G~f-g~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~E~~~ 182 (457)
.|-.|.. ..||+... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++... ....++|||+++
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~ 75 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVP 75 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeC
Confidence 4555655 78999963 34678888775332 234667888888874 3345566665544 245689999998
Q ss_pred CCHHHHHHh------------------cCC-----CCCHH--HHHHHHH--------------------HHHHHHHHHH-
Q 036122 183 HDLAGLAAC------------------QGV-----KFSEP--QVKCYMK--------------------QLLSGLEHCH- 216 (457)
Q Consensus 183 ~~l~~~~~~------------------~~~-----~l~~~--~~~~i~~--------------------qi~~~L~~LH- 216 (457)
|..+..... ... .+... ....... .+...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 853321100 000 11100 0000000 0111122221
Q ss_pred ------hCCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 217 ------NNGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 217 ------~~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2248999999999999998888999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.6e-05 Score=87.72 Aligned_cols=147 Identities=25% Similarity=0.387 Sum_probs=90.0
Q ss_pred cceeeccCceEEEEEEEcCCC--cEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCc--eeEeeeEEecC-CceEEE
Q 036122 103 LDKIGQGTYSNVYKARDLLTG--KIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNV--IKLEGLVTSRM-SCSLYL 176 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g--~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~~-~~~~~l 176 (457)
+..|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.+. |.+| .+++.++.+.. ....|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 677999999999998754332 46777875433211 12345779999999995 6665 77777765521 135789
Q ss_pred EEecccCCHHH---------------------H---HHhcCC----------C--CCHHHHHHHHHH-------------
Q 036122 177 VFEYMEHDLAG---------------------L---AACQGV----------K--FSEPQVKCYMKQ------------- 207 (457)
Q Consensus 177 v~E~~~~~l~~---------------------~---~~~~~~----------~--l~~~~~~~i~~q------------- 207 (457)
||||++|.... . +..... + ....++..|..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 99999874210 0 000000 0 111233322221
Q ss_pred --HHHHHHHHHh-----------CCceeccCCCCCEEecC-CC-cEEEeeccCccccC
Q 036122 208 --LLSGLEHCHN-----------NGVLHRDIKGSNLLIDN-DG-ILKIADFGLATFYD 250 (457)
Q Consensus 208 --i~~~L~~LH~-----------~~ivHrDlkp~NILl~~-~~-~vkl~DFGla~~~~ 250 (457)
+...+.+|.. ..+||+|+++.|||++. ++ .+-|.||+++..-+
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2234556632 24999999999999985 33 45799999987543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.6e-05 Score=79.20 Aligned_cols=138 Identities=22% Similarity=0.237 Sum_probs=85.1
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-----------------------------hHHHHH------HHHHH
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-----------------------------PESVKF------MAREI 148 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-----------------------------~~~~~~------~~~E~ 148 (457)
+.||.-+.|.||+|+. .+|+.||||+-+.+-.. .+..+. |.+|+
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5699999999999996 45999999987543110 001111 22333
Q ss_pred HHHHh----cCCCC------ceeEeeeEEecCCceEEEEEecccCC---HHHHHHhcCCCCCHHHHHHHHHHHHHHH-HH
Q 036122 149 LVLRK----LDHPN------VIKLEGLVTSRMSCSLYLVFEYMEHD---LAGLAACQGVKFSEPQVKCYMKQLLSGL-EH 214 (457)
Q Consensus 149 ~~l~~----l~hpn------iv~l~~~~~~~~~~~~~lv~E~~~~~---l~~~~~~~~~~l~~~~~~~i~~qi~~~L-~~ 214 (457)
+-..+ +.|-+ |.++ +.+- .....|+||||+|. -++.+...+ ++...+.. .+.++. ..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~V---y~~~-st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~---~l~~~~~~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKV---YWDL-STKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILN---KLVEAYLEQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCee---hhhc-CcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHH---HHHHHHHHH
Confidence 33222 23444 3333 3221 33568999999982 223333332 55554433 333322 23
Q ss_pred HHhCCceeccCCCCCEEecC----CCcEEEeeccCccccCC
Q 036122 215 CHNNGVLHRDIKGSNLLIDN----DGILKIADFGLATFYDP 251 (457)
Q Consensus 215 LH~~~ivHrDlkp~NILl~~----~~~vkl~DFGla~~~~~ 251 (457)
|-..|++|.|=+|.||++.. ++.+.+-|||+......
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 44568999999999999994 67899999999876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.5e-05 Score=73.00 Aligned_cols=30 Identities=27% Similarity=0.460 Sum_probs=26.0
Q ss_pred CceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 219 GVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 219 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
+++|+|+.+.|||+++++..-|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 589999999999998776667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00016 Score=65.40 Aligned_cols=134 Identities=19% Similarity=0.253 Sum_probs=90.4
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCC--------------CChHHHHHHHHHHHHHHhcC------CCCceeE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN--------------LEPESVKFMAREILVLRKLD------HPNVIKL 162 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--------------~~~~~~~~~~~E~~~l~~l~------hpniv~l 162 (457)
...||+|+.=.||.- .......||+..... ......+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 467999999999965 344567889987655 11112345566776666665 8889999
Q ss_pred eeeEEecCCceEEEEEecccC------CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 163 EGLVTSRMSCSLYLVFEYMEH------DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 163 ~~~~~~~~~~~~~lv~E~~~~------~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
+|+... +..+-+|+|.+.+ -.+..+...+ .+++ .. ...+-.-..||-+++|+.+||+|.||++....
T Consensus 83 ~G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 83 YGFVET--NLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred eEEEec--CCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 999987 4557788888753 1333344333 3555 33 33344556688999999999999999997432
Q ss_pred ----cEEEee-ccCc
Q 036122 237 ----ILKIAD-FGLA 246 (457)
Q Consensus 237 ----~vkl~D-FGla 246 (457)
.+.|+| ||..
T Consensus 156 ~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 156 SGEFRLVLIDGLGEK 170 (199)
T ss_pred CCceEEEEEeCCCCc
Confidence 578887 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.5e-05 Score=70.28 Aligned_cols=99 Identities=27% Similarity=0.250 Sum_probs=78.0
Q ss_pred HHHHHHHhcCC-CCceeEeeeEEecCCceEEEEEecccCC-HHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 036122 146 REILVLRKLDH-PNVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLA--ACQGVKFSEPQVKCYMKQLLSGLEHCHN---N 218 (457)
Q Consensus 146 ~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~lv~E~~~~~-l~~~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~ 218 (457)
.|..+|+.+++ +++++++|+|- .++|.||.+.+ +.... ...-...+|..+..|+.+++..+.+|+. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 58888999976 69999999873 37899999853 32110 0111246899999999999999999997 3
Q ss_pred CceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 219 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
.+.-.|++++|+-++++|++|++|...+...+
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 57778999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00019 Score=69.49 Aligned_cols=143 Identities=23% Similarity=0.289 Sum_probs=99.6
Q ss_pred cccceeeccCceEEEEEEEcCCCcEEEEEEeecCC--------------------C--ChHH-HH-HHHHHHHHHHhcCC
Q 036122 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN--------------------L--EPES-VK-FMAREILVLRKLDH 156 (457)
Q Consensus 101 ~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--------------------~--~~~~-~~-~~~~E~~~l~~l~h 156 (457)
++-..|..|--+.||.+. ..+|..+|||+++..- . .+.. ++ ..+.|+.-|.+|+.
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 345678889999999998 5788999999885321 0 1111 11 23468888888865
Q ss_pred CCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEEecCC
Q 036122 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC-HNNGVLHRDIKGSNLLIDND 235 (457)
Q Consensus 157 pniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~NILl~~~ 235 (457)
..|.--.-+... .-.|||+|++.+-...-...+..++...+..+..|++.-+.-| |.+++||.||.=-|+|+. +
T Consensus 226 aGIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-d 300 (520)
T KOG2270|consen 226 AGIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-D 300 (520)
T ss_pred cCCCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-C
Confidence 554322111111 2379999998643332333455688888999999999988876 567999999999999996 4
Q ss_pred CcEEEeeccCcccc
Q 036122 236 GILKIADFGLATFY 249 (457)
Q Consensus 236 ~~vkl~DFGla~~~ 249 (457)
|.+.|+|.+-+.-.
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 79999999887643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.72 E-value=2.8e-05 Score=73.93 Aligned_cols=138 Identities=19% Similarity=0.201 Sum_probs=94.9
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH--------------------HHHHHHHHHHHHHhcC-CC
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE--------------------SVKFMAREILVLRKLD-HP 157 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~--------------------~~~~~~~E~~~l~~l~-hp 157 (457)
-+.+.+.||-|--+.||.+-+ ..|++.++|.-+....+-. +.-...+|...|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 477889999999999999985 6789999996543221100 1112346888888885 32
Q ss_pred C-ceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 158 N-VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 158 n-iv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
. +.+.++ .+..++|||++.+-.+...... .....+...+..-+--|-.+|+||+|..-=||+|.+++
T Consensus 172 fpVPkpiD------~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPID------HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCccc------ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 2 333333 2446899999987544333211 12334445555666678899999999999999999999
Q ss_pred cEEEeeccCcccc
Q 036122 237 ILKIADFGLATFY 249 (457)
Q Consensus 237 ~vkl~DFGla~~~ 249 (457)
.++++||--....
T Consensus 240 ~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 240 KIVVIDFPQMVST 252 (465)
T ss_pred CEEEeechHhhcc
Confidence 9999999876543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00025 Score=67.22 Aligned_cols=134 Identities=21% Similarity=0.246 Sum_probs=75.7
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeeeEEecCCceEEEEEecccC
Q 036122 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV-IKLEGLVTSRMSCSLYLVFEYMEH 183 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~lv~E~~~~ 183 (457)
.+..|-...+|+.. .++..+++|......... .. ...+|..+++.+....+ .+++... . -++||||++|
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~-~r~~E~~~l~~l~~~g~~P~~i~~~----~--~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GV-DRQREYQILQALSALGLAPKPILVN----E--HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cC-cHHHHHHHHHHHHhcCCCCceEEEe----C--CEEEEEeccC
Confidence 35567778899886 456778888754322111 01 24578888888864333 3343322 1 2689999987
Q ss_pred CHHHH------------------HHhc---CCCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceecc
Q 036122 184 DLAGL------------------AACQ---GVKFSEP-QVKCYMKQL---------LSGLEHCHN--------NGVLHRD 224 (457)
Q Consensus 184 ~l~~~------------------~~~~---~~~l~~~-~~~~i~~qi---------~~~L~~LH~--------~~ivHrD 224 (457)
..... +... ..+++.. .+..+..++ ...+..+-. ..++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 42210 0000 1112211 122222111 111222221 2489999
Q ss_pred CCCCCEEecCCCcEEEeeccCcccc
Q 036122 225 IKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 225 lkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
+.|.||++++++ +.|+||..+..-
T Consensus 153 l~~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 153 VHAYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred CCcCcEEEeCCC-CEEEeccccCcC
Confidence 999999999877 789999998643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=1.5e-05 Score=88.64 Aligned_cols=219 Identities=15% Similarity=0.023 Sum_probs=140.4
Q ss_pred hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHH
Q 036122 138 PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----VKFSEPQVKCYMKQLLSGLE 213 (457)
Q Consensus 138 ~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~----~~l~~~~~~~i~~qi~~~L~ 213 (457)
+...+....|...++...|++++....-..+......|.+++|+.++-+...+.++ ..+.+.-+.....+...+..
T Consensus 1270 ePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1270 EPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred hHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence 33344455566667777899988876666555566679999999876655554443 22444444444444466666
Q ss_pred HHHhC-----CceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHH
Q 036122 214 HCHNN-----GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAG 288 (457)
Q Consensus 214 ~LH~~-----~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG 288 (457)
-+|.. -.+|++||+-|.+|..+..+|++++|+.+...+. .......++++.|+.|++...-. ++.++|+|..|
T Consensus 1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRS 1427 (2724)
T ss_pred hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHH
Confidence 66654 1789999999999999999999999999843322 22334456788899999776544 67779999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCC
Q 036122 289 CILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSID 368 (457)
Q Consensus 289 ~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d 368 (457)
+.+|+..-|.++|. ..++.+.+.. +.+...+ +...-.|.++-.+...+|-+.
T Consensus 1428 ~~ly~rs~~n~~fi-----~flq~~Lkgi------------idn~tf~-----------sIe~l~pgdaNve~~~~Ll~K 1479 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFI-----FFLQPALKGI------------IDNHTFF-----------SIEKLKPGDANVEALHRLLWK 1479 (2724)
T ss_pred HHHHHHhcccHHHH-----HHHHHHHcCc------------ccccccc-----------cccccCCCcccHHHHHHHHHH
Confidence 99999998887763 2222222110 0000000 000112344444555566666
Q ss_pred CCCCcCHHHHhcCCCCCC
Q 036122 369 PDNRGTATAALNSEFFNT 386 (457)
Q Consensus 369 P~~Rpta~elL~hp~f~~ 386 (457)
-..||.-...+.-+.|..
T Consensus 1480 ~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1480 YMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred hhhcchhhhhcccccccc
Confidence 677888888887777643
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0013 Score=66.07 Aligned_cols=77 Identities=21% Similarity=0.145 Sum_probs=51.5
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCC----CC-hHHHHHHHHHHHHHHhcC---CCCceeEeeeEEecCCceE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN----LE-PESVKFMAREILVLRKLD---HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~----~~-~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~ 174 (457)
.+.||.|.+..||++.+...++.|.||.-.... .. +-...+...|.+.|+.+. -.++++++.+ + ....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D--EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CCCC
Confidence 467999999999999975433589999853110 00 123455667888888763 2456777655 2 2346
Q ss_pred EEEEecccC
Q 036122 175 YLVFEYMEH 183 (457)
Q Consensus 175 ~lv~E~~~~ 183 (457)
++||||+++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 899999975
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.001 Score=64.49 Aligned_cols=76 Identities=16% Similarity=0.131 Sum_probs=52.4
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC---CCceeEeeeEEec-CCceEEEEE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH---PNVIKLEGLVTSR-MSCSLYLVF 178 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~~-~~~~~~lv~ 178 (457)
.+.||.|..+.||+... .++ .+.+|..+. .. ....+..|...|+.|.- -.+.++++++... ..+..+|||
T Consensus 19 ~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 19 VECISEQPYAALWALYD-SQG-NPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eeecCCccceeEEEEEc-CCC-CEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 56799999999999963 334 467777432 11 12457789999988853 3577788776542 134579999
Q ss_pred ecccCC
Q 036122 179 EYMEHD 184 (457)
Q Consensus 179 E~~~~~ 184 (457)
|++++.
T Consensus 93 E~i~G~ 98 (297)
T PRK10593 93 ERLRGV 98 (297)
T ss_pred eccCCE
Confidence 999873
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.0012 Score=61.50 Aligned_cols=73 Identities=14% Similarity=0.164 Sum_probs=45.4
Q ss_pred cceeeccCceEEEEEEEcC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeeeEEecCCceEEEEEec
Q 036122 103 LDKIGQGTYSNVYKARDLL-TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN-VIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~~~lv~E~ 180 (457)
++.|..|-...+|++.... .+..|++|+...... ......+|+.+++.+.... .+++++... . .++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEe
Confidence 4567888888999997432 357889997653321 1112346888888885433 344443221 1 379999
Q ss_pred ccCC
Q 036122 181 MEHD 184 (457)
Q Consensus 181 ~~~~ 184 (457)
++|.
T Consensus 74 i~G~ 77 (235)
T cd05157 74 IPGR 77 (235)
T ss_pred eCCC
Confidence 9873
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00044 Score=66.94 Aligned_cols=139 Identities=18% Similarity=0.164 Sum_probs=80.8
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeeeE----EecCCceEE
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN--VIKLEGLV----TSRMSCSLY 175 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~----~~~~~~~~~ 175 (457)
-++.|..|....+|+... ++..+++|+... . ....+..|+.++..|.+.. +.+++... .....+..+
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEK--V---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCC--C---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 356788888889999863 344688898753 1 1234667888888875332 34443210 001134568
Q ss_pred EEEecccCCHHH---------------HHHhcCCCC----------CHHHH--H--------HHHHHHHHHHHHHHh---
Q 036122 176 LVFEYMEHDLAG---------------LAACQGVKF----------SEPQV--K--------CYMKQLLSGLEHCHN--- 217 (457)
Q Consensus 176 lv~E~~~~~l~~---------------~~~~~~~~l----------~~~~~--~--------~i~~qi~~~L~~LH~--- 217 (457)
+|++|++|.... .+......+ .+... . .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 999999873210 011000000 11000 0 011112334444443
Q ss_pred ----CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 218 ----NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 218 ----~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999998778999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0027 Score=62.19 Aligned_cols=30 Identities=33% Similarity=0.567 Sum_probs=26.3
Q ss_pred CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999976666899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0012 Score=64.46 Aligned_cols=142 Identities=19% Similarity=0.179 Sum_probs=80.1
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeeeE----EecCCce
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN--VIKLEGLV----TSRMSCS 173 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~----~~~~~~~ 173 (457)
...+..++.|-...+|++.. .+| .+.+|+..... . ...+..|+.++..|.... +.+++... .....+.
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 33456678887789999863 344 57788765421 1 233456777777774222 33433211 1111345
Q ss_pred EEEEEecccCCHH---------------HHHHhcCCCC--------CHH---HH--H----------HHHHHHHHHHHHH
Q 036122 174 LYLVFEYMEHDLA---------------GLAACQGVKF--------SEP---QV--K----------CYMKQLLSGLEHC 215 (457)
Q Consensus 174 ~~lv~E~~~~~l~---------------~~~~~~~~~l--------~~~---~~--~----------~i~~qi~~~L~~L 215 (457)
.+++|+|++|... ..+......+ ... .. . .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 7899999987310 0011100001 000 00 0 0011233345555
Q ss_pred Hh-------CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 216 HN-------NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 216 H~-------~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 32 589999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00044 Score=69.74 Aligned_cols=172 Identities=24% Similarity=0.303 Sum_probs=109.9
Q ss_pred HHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q 036122 144 MAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223 (457)
Q Consensus 144 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHr 223 (457)
+.--..+++.+.|+|+..++.+..... ....+|||++.-++.+...... +-.... . .+++.|
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~-~r~IVV~e~~~~Sled~~~~~~--l~~~s~-------~-------~~~~~~- 90 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKH-ERVIVVMEHYTMSLEDILKTGN--LKDESL-------L-------AHGVLH- 90 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCcc-ceEEEEehhhccchHHHHHhcc--cchhhh-------c-------ccccce-
Confidence 445678899999999999887765543 3488999999887776554432 111111 0 112211
Q ss_pred cCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCC
Q 036122 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPG 303 (457)
Q Consensus 224 Dlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~ 303 (457)
-| .++.+| -++. . | |- ..++++||||+|.++.++.-|...+..
T Consensus 91 ----~~-------~~~~td-~~~t-------~----------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 91 ----LN-------IIYITD-HFLT-------K----------Y--PS------PIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred ----eh-------hhhccc-cccc-------c----------C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 12 223333 0000 0 0 00 012489999999999999999999988
Q ss_pred CChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCC
Q 036122 304 RTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383 (457)
Q Consensus 304 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~ 383 (457)
.+..+++..+.+....+....-- .+.......++...+++...|+...|..||...++..++-
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~-----------------a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i 196 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLST-----------------AMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCS 196 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHH-----------------HHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCcc
Confidence 88888888776654333221100 0001112235667788999999999999999999999999
Q ss_pred CCCC
Q 036122 384 FNTE 387 (457)
Q Consensus 384 f~~~ 387 (457)
|...
T Consensus 197 ~~ev 200 (725)
T KOG1093|consen 197 FTEV 200 (725)
T ss_pred HHHH
Confidence 9764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0011 Score=64.25 Aligned_cols=73 Identities=25% Similarity=0.263 Sum_probs=44.3
Q ss_pred cceeeccCceEEEEEEEcC------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeeeEEecCCceEE
Q 036122 103 LDKIGQGTYSNVYKARDLL------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV-IKLEGLVTSRMSCSLY 175 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~ 175 (457)
++.|..|-...||++.... .++.|++|+..... .......+|..++..+....+ .++++++.. .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN------G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC------C
Confidence 3456667777899987432 25789999865432 111234578888888753333 345444321 3
Q ss_pred EEEecccCC
Q 036122 176 LVFEYMEHD 184 (457)
Q Consensus 176 lv~E~~~~~ 184 (457)
+|+||++|.
T Consensus 74 ~v~e~i~G~ 82 (302)
T cd05156 74 RIEEFIPSR 82 (302)
T ss_pred chhheeCCC
Confidence 588998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0033 Score=61.89 Aligned_cols=75 Identities=17% Similarity=0.174 Sum_probs=47.0
Q ss_pred eeeccCceEEEEEEEcCCCcEEEEEEeec-----CCCChHHHHHHHHHHHHHHhcC--CC-CceeEeeeEEecCCceEEE
Q 036122 105 KIGQGTYSNVYKARDLLTGKIVALKKVRF-----DNLEPESVKFMAREILVLRKLD--HP-NVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 105 ~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~-----~~~~~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~~~l 176 (457)
.||.|....||++.+...++.|+||.-.. ....+-...+..-|...|+... -| .+++++.+ + .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D--~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--D--TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--c--ccccee
Confidence 57999999999999754346899997531 1111223344556777777663 34 45556433 2 234569
Q ss_pred EEecccC
Q 036122 177 VFEYMEH 183 (457)
Q Consensus 177 v~E~~~~ 183 (457)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.003 Score=60.56 Aligned_cols=31 Identities=26% Similarity=0.380 Sum_probs=26.1
Q ss_pred CceeccCCCCCEEecCCCc-EEEeeccCcccc
Q 036122 219 GVLHRDIKGSNLLIDNDGI-LKIADFGLATFY 249 (457)
Q Consensus 219 ~ivHrDlkp~NILl~~~~~-vkl~DFGla~~~ 249 (457)
.++|+|+++.|||+++++. .-|+||+.+..-
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 569999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0066 Score=58.88 Aligned_cols=149 Identities=23% Similarity=0.259 Sum_probs=84.4
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeeeEEecCCceEEEE
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH--PNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~lv 177 (457)
..+++.+-.|---.+|... .+++.++++ ...............+|..+|+.+.- --+...+++|....-...|.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~--~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLG--DTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEe--cCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 3445555334333455554 337888888 32222233344556778888888753 223445566655322356999
Q ss_pred EecccCC----------HH-HHHH--------h---c---CC-------CCCHHHHHHHHHHH--------------HHH
Q 036122 178 FEYMEHD----------LA-GLAA--------C---Q---GV-------KFSEPQVKCYMKQL--------------LSG 211 (457)
Q Consensus 178 ~E~~~~~----------l~-~~~~--------~---~---~~-------~l~~~~~~~i~~qi--------------~~~ 211 (457)
|+|++|. .. .... . - +. .....++..+..+. ..-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 9999872 11 0111 0 0 00 01112222222222 223
Q ss_pred HHHHHhC--------CceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 212 LEHCHNN--------GVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 212 L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..||+.+ .++|+|+.+.||+|+.++-+=|.||+++..-++
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 4555543 489999999999999998899999999986544
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.017 Score=56.24 Aligned_cols=29 Identities=28% Similarity=0.495 Sum_probs=25.7
Q ss_pred CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.014 Score=57.72 Aligned_cols=138 Identities=14% Similarity=0.176 Sum_probs=78.0
Q ss_pred ccceeeccCceEEEEEEEcC----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce-eEeeeEEecCCceEEE
Q 036122 102 KLDKIGQGTYSNVYKARDLL----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI-KLEGLVTSRMSCSLYL 176 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~~~l 176 (457)
-+..|-.|-.-.+|++.... +++.|.+|+..... ....+ -.+|..+++.+..-++. ++++.+.. . .
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~--g----~ 110 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN--G----R 110 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC--c----e
Confidence 34566668888999986432 24679999875432 12222 25688888888644443 45444422 1 5
Q ss_pred EEecccCCHHHH------------------HHhcCC-----CCCHHHHHHHHHHH-----------------HHHHHHH-
Q 036122 177 VFEYMEHDLAGL------------------AACQGV-----KFSEPQVKCYMKQL-----------------LSGLEHC- 215 (457)
Q Consensus 177 v~E~~~~~l~~~------------------~~~~~~-----~l~~~~~~~i~~qi-----------------~~~L~~L- 215 (457)
|++|+++..+.. +..... ......+..+..++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 788887632110 000010 11123333333222 1111122
Q ss_pred ---H----hCCceeccCCCCCEEecC-CCcEEEeeccCccc
Q 036122 216 ---H----NNGVLHRDIKGSNLLIDN-DGILKIADFGLATF 248 (457)
Q Consensus 216 ---H----~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~ 248 (457)
. ...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 47899999998864
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.013 Score=58.37 Aligned_cols=77 Identities=22% Similarity=0.154 Sum_probs=49.6
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeec----CCCChHHHHHHHHHHHHHHhcC--CC-CceeEeeeEEecCCceEE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRF----DNLEPESVKFMAREILVLRKLD--HP-NVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~----~~~~~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~~~ 175 (457)
.+.||.|.-.-||++.+...++.|+||.-.. ...-+-..++..-|..+|+.+. .| .+++++.+ + .....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D--~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D--SVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C--cHHhh
Confidence 6789999999999998743356799997531 1111223455566788887764 34 45556433 2 23457
Q ss_pred EEEecccC
Q 036122 176 LVFEYMEH 183 (457)
Q Consensus 176 lv~E~~~~ 183 (457)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 89999864
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.016 Score=56.46 Aligned_cols=30 Identities=23% Similarity=0.268 Sum_probs=27.9
Q ss_pred CceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 219 GVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 219 ~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
++||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998863
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.027 Score=56.49 Aligned_cols=75 Identities=16% Similarity=0.173 Sum_probs=48.9
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCC--C---hHHHHHHHHHHHHHHhcC---CCCceeEeeeEEecCCceE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL--E---PESVKFMAREILVLRKLD---HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~--~---~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~ 174 (457)
.+.||.|....||+..+ .+..|+||.-..... . +-...+...|...|+.+. -.++.+++.++.+ .-
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CC
Confidence 67799999999999985 345688997642111 0 012333445677776654 2477788776653 34
Q ss_pred EEEEecccC
Q 036122 175 YLVFEYMEH 183 (457)
Q Consensus 175 ~lv~E~~~~ 183 (457)
+++|||+++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 789999975
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.026 Score=55.55 Aligned_cols=137 Identities=13% Similarity=0.168 Sum_probs=75.6
Q ss_pred cceeeccCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeeeEEecCCceEEEEE
Q 036122 103 LDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV-IKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~lv~ 178 (457)
++.|..|=.-.+|++..... +..|.+|+...... ..+ .-.+|..+++.+..-++ .++++++. .. +|.
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~I-dR~~E~~il~~l~~~gl~P~~l~~~~---~G---~i~ 89 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD--YVI-DRERELQAIKYLSAAGFGAKLLGVFG---NG---MIQ 89 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC--eEe-chHHHHHHHHHHHhcCCCCceeEEeC---Cc---Eee
Confidence 45565577778999864332 23788998754321 111 12468888888865444 34554442 11 488
Q ss_pred ecccCCHHH-----------H-------HHhcCCC----C-CHHHHHHHHHHH----------------------HHHHH
Q 036122 179 EYMEHDLAG-----------L-------AACQGVK----F-SEPQVKCYMKQL----------------------LSGLE 213 (457)
Q Consensus 179 E~~~~~l~~-----------~-------~~~~~~~----l-~~~~~~~i~~qi----------------------~~~L~ 213 (457)
+|+++..+. . +.....+ . .+..+..+..++ ..-+.
T Consensus 90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 169 (330)
T PLN02421 90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV 169 (330)
T ss_pred hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence 888763211 0 1110100 1 122333333222 11111
Q ss_pred H----HHhC----CceeccCCCCCEEecC-CCcEEEeeccCccc
Q 036122 214 H----CHNN----GVLHRDIKGSNLLIDN-DGILKIADFGLATF 248 (457)
Q Consensus 214 ~----LH~~----~ivHrDlkp~NILl~~-~~~vkl~DFGla~~ 248 (457)
. +... -++|.|+.+.|||+++ ++.++++||..|..
T Consensus 170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1111 2799999999999975 57899999999864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.022 Score=55.56 Aligned_cols=103 Identities=18% Similarity=0.273 Sum_probs=70.5
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
+.+.|++|++.++.+...- .-...++..++.+.+..++-+... ..-|||+...||||+ +|+|-|+||-+++.-
T Consensus 298 ~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 4567889998876553321 235678888888888888777765 789999999999999 899999999999843
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhH
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSA 287 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Dvwsl 287 (457)
-++ ..+.-...--|-.+.|.. +..-+||-+
T Consensus 372 ~~q------~~isy~rldhp~lF~G~d--d~QFeIYrl 401 (488)
T COG5072 372 YSQ------GIISYNRLDHPDLFNGVD--DYQFEIYRL 401 (488)
T ss_pred cCC------ceeeccccCchhhhcCcc--ceeeeHHHH
Confidence 221 111122233455555443 455667654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.087 Score=51.64 Aligned_cols=137 Identities=20% Similarity=0.264 Sum_probs=78.1
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC------ceeEeeeEEecCCc--eEE
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN------VIKLEGLVTSRMSC--SLY 175 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~~--~~~ 175 (457)
..|.+ .-..||+... .+|.. ++|+.... ... ..+..|+..|..|.-.. |..+-|-....-.. ..+
T Consensus 32 ~~l~s-~eN~~f~~~~-~~g~~-iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQT-EDGRY-ILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEEe-cCCCe-EEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 34555 5567899974 45554 88988765 222 34566888888874221 22222222111123 678
Q ss_pred EEEecccCCHHHH----------------HHh--cCC---------CCCHH----H---------HHHHHHHHHHHHHHH
Q 036122 176 LVFEYMEHDLAGL----------------AAC--QGV---------KFSEP----Q---------VKCYMKQLLSGLEHC 215 (457)
Q Consensus 176 lv~E~~~~~l~~~----------------~~~--~~~---------~l~~~----~---------~~~i~~qi~~~L~~L 215 (457)
-+++|++|..... +.. ++. ...|. . -.....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999998743320 100 010 01121 0 001223344444444
Q ss_pred Hh--------CC--ceeccCCCCCEEecCCCc-EEEeeccCcc
Q 036122 216 HN--------NG--VLHRDIKGSNLLIDNDGI-LKIADFGLAT 247 (457)
Q Consensus 216 H~--------~~--ivHrDlkp~NILl~~~~~-vkl~DFGla~ 247 (457)
.+ .+ +||+|+.|.|||++.+.. +.++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 43 24 999999999999998874 8999999875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.05 Score=52.30 Aligned_cols=74 Identities=16% Similarity=0.206 Sum_probs=45.2
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeeeEEecCCceEEEEE
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD---HPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
..+.|+.|....+|+.. .+++.+.+|+-... ....+..|..-|+.|. --.+++.+++.... ..-||||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLll 91 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLL 91 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEE
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEE
Confidence 35679999999999987 78888999987622 2244677888888773 34466777766553 3348999
Q ss_pred ecccCC
Q 036122 179 EYMEHD 184 (457)
Q Consensus 179 E~~~~~ 184 (457)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 998753
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.22 Score=56.56 Aligned_cols=30 Identities=37% Similarity=0.625 Sum_probs=25.9
Q ss_pred CCceeccCCCCCEEecCCC--cEE-EeeccCcc
Q 036122 218 NGVLHRDIKGSNLLIDNDG--ILK-IADFGLAT 247 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~~--~vk-l~DFGla~ 247 (457)
.++||+|+.+.|||++.++ ++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999775 555 99999875
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.063 Score=53.89 Aligned_cols=29 Identities=28% Similarity=0.179 Sum_probs=24.5
Q ss_pred CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
...+|.|+-+.|||.++ +.+.++||..|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 35799999999999765 469999999875
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.037 Score=53.32 Aligned_cols=75 Identities=21% Similarity=0.208 Sum_probs=46.2
Q ss_pred EEEEecccCCHH----HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh----CCceeccCCCCCEEecCCC----------
Q 036122 175 YLVFEYMEHDLA----GLAACQGVKFSEPQVKCYMKQLLSGLEHCHN----NGVLHRDIKGSNLLIDNDG---------- 236 (457)
Q Consensus 175 ~lv~E~~~~~l~----~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----~~ivHrDlkp~NILl~~~~---------- 236 (457)
.||+.+..++.. ......+-.--.+-++.++.||+.-.-.+-+ .+.+|-||||+||||-+..
T Consensus 251 IIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 330 (444)
T PHA03111 251 IIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDA 330 (444)
T ss_pred EEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCe
Confidence 577777654321 1122222222345577788898876544432 3699999999999996543
Q ss_pred --------cEEEeeccCcccc
Q 036122 237 --------ILKIADFGLATFY 249 (457)
Q Consensus 237 --------~vkl~DFGla~~~ 249 (457)
.++|.||.+++..
T Consensus 331 ~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 331 TYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred EEEeccchhhhhcccCHHHHc
Confidence 3567777777654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.57 Score=46.00 Aligned_cols=72 Identities=17% Similarity=0.140 Sum_probs=41.0
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--cee---EeeeEEecCCceEEEEEecccC
Q 036122 109 GTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN--VIK---LEGLVTSRMSCSLYLVFEYMEH 183 (457)
Q Consensus 109 G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~---l~~~~~~~~~~~~~lv~E~~~~ 183 (457)
+.-..||+... .+|..+++|+.+..... ...+..|+.++..|.... ++. .-|-.....++..+.|+++++|
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~---~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWS---DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCC---HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 34467899873 56778999988643322 344566777777763211 222 1121101113457889999886
Q ss_pred C
Q 036122 184 D 184 (457)
Q Consensus 184 ~ 184 (457)
.
T Consensus 112 ~ 112 (325)
T PRK11768 112 R 112 (325)
T ss_pred C
Confidence 3
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.15 E-value=0.067 Score=53.06 Aligned_cols=58 Identities=24% Similarity=0.243 Sum_probs=38.4
Q ss_pred EEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceeccCCCCCEEec
Q 036122 174 LYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEH-CHNNGVLHRDIKGSNLLID 233 (457)
Q Consensus 174 ~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~ivHrDlkp~NILl~ 233 (457)
..++-+|..| +....+... ..++.....++.-...||.- |--.+++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3456666666 333433332 35566667777666666654 4456899999999999995
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.043 Score=52.75 Aligned_cols=136 Identities=18% Similarity=0.204 Sum_probs=90.8
Q ss_pred ccceeeccCceEEEEEEE-------cC---CCcEEEEEEeecC----------------------CCChHHHHH--HHHH
Q 036122 102 KLDKIGQGTYSNVYKARD-------LL---TGKIVALKKVRFD----------------------NLEPESVKF--MARE 147 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~-------~~---~g~~vAiK~~~~~----------------------~~~~~~~~~--~~~E 147 (457)
+...|..|.-+.|+.+.- .. .-..+|||+++.. ...+..+-. .++|
T Consensus 256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE 335 (531)
T KOG2269|consen 256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE 335 (531)
T ss_pred hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence 345688888899988842 01 2246899987421 001111111 2234
Q ss_pred HHHHHhc-----CCCCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCce
Q 036122 148 ILVLRKL-----DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC-HNNGVL 221 (457)
Q Consensus 148 ~~~l~~l-----~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~iv 221 (457)
..-|.++ .+|-+|.+. .-.|||.|++..-+.--..+...|+..+......|+..++.-| |++-+|
T Consensus 336 mhNL~RMq~~GlpcP~vV~lk---------khvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LV 406 (531)
T KOG2269|consen 336 MHNLSRMQKHGLPCPQVVKLK---------KHVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLV 406 (531)
T ss_pred HHHHHHHHhcCCCCCceeeee---------cceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhhee
Confidence 4445554 467777663 2479999998643332233345688899999999999998876 678899
Q ss_pred eccCCCCCEEecCCCcEEEeeccCcc
Q 036122 222 HRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 222 HrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
|-||.--|+|...+ .+-++|..-+.
T Consensus 407 HADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 407 HADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred ecchhhhhheecCC-ceEEEechhcc
Confidence 99999999999875 89999977654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.22 Score=51.00 Aligned_cols=77 Identities=13% Similarity=0.107 Sum_probs=45.4
Q ss_pred CCccccceeeccCceEEEEEEEcC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCce-eEeeeEEe
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL--------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI-KLEGLVTS 168 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~--------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~ 168 (457)
++. .++.|..|=.-.+|++.... .++.|.+++.-.... ... .-..|..+++.+...+|- ++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te--~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~- 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD--ELY-NPISEFEVYKTMSKYRIAPQLLNTFS- 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc--cee-CHHHHHHHHHHHHHCCCCCceEEEeC-
Confidence 344 56777778788899987432 156788888743321 111 123577777777544443 4444432
Q ss_pred cCCceEEEEEecccCC
Q 036122 169 RMSCSLYLVFEYMEHD 184 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~ 184 (457)
+ +.|.||++|.
T Consensus 181 --g---g~I~efi~g~ 191 (442)
T PTZ00296 181 --G---GRIEEWLYGD 191 (442)
T ss_pred --C---CEEEEeeCCc
Confidence 1 4578888864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 457 | ||||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-60 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-60 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-60 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-60 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-60 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-59 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-59 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-59 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-59 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-59 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-59 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-59 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-59 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-59 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-59 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-59 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-59 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-59 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-59 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-59 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-58 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-58 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-58 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-58 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-58 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-58 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-58 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-58 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-58 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-58 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-58 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-58 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-58 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-58 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-58 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-58 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-58 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-58 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-58 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-58 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-57 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-57 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-53 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-53 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-52 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-52 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-52 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-51 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-49 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-46 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-46 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-45 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-45 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-45 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-45 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-45 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-45 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-44 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-43 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-43 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-43 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-42 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-42 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-42 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-42 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-42 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-42 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-42 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-42 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-42 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-42 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-42 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-42 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-42 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-42 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-42 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-42 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-42 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-42 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-42 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-42 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-42 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-42 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-42 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-42 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-42 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-42 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-42 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-42 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-42 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-42 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-42 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-42 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-42 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-42 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-42 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-42 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-42 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-42 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-42 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-42 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-42 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-42 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-42 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-41 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-41 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-41 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-41 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-41 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-41 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-41 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-41 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-41 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-41 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-41 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-41 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-41 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-41 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-41 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-41 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-41 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-41 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-41 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-41 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-41 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-41 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-41 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-41 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-41 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-41 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-41 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-41 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-41 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-41 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-41 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-41 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-41 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-41 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-40 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-40 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-40 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-40 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-40 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-40 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-39 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-39 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-39 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-39 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-39 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-38 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-38 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-38 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-38 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-38 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-38 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-38 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-38 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-38 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-38 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-38 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-38 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-38 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-38 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-37 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-37 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-37 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-37 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-36 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-36 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-36 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-36 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-35 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-35 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-35 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-35 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-35 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-35 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-35 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-35 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-35 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-35 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-35 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-35 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-35 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-35 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-35 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-35 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-35 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-35 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-35 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-35 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-35 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-35 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-35 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-35 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-34 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-34 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-34 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-34 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-34 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-34 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-33 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-33 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-32 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-30 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-30 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-29 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-29 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-28 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-28 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-28 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-27 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-27 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-27 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-27 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-27 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-27 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-27 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-27 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-27 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-27 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-26 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-26 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-26 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-26 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-26 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 9e-26 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-26 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-26 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-25 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-25 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-25 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-25 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-25 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-25 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-25 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-25 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-25 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-25 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-25 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-25 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-25 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-25 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-25 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-25 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-25 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-25 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-25 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-25 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-25 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-25 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-25 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-25 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-25 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-25 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-25 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-25 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-25 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-24 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-24 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-24 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-23 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-23 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-23 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-23 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-23 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-23 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-23 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-22 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-22 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-22 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-22 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-22 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-22 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-22 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-22 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-22 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-21 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-21 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-21 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-21 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-21 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-20 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-20 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-20 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-20 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-20 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-20 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-19 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-19 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-19 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-19 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-19 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-19 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-19 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-18 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-18 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-18 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-18 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-18 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-18 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-18 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-18 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-18 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-18 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-18 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-18 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-18 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-18 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-18 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-18 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-18 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-18 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-18 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-18 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-18 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-18 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-18 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-18 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-17 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-17 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-17 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-17 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-17 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-17 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-17 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-17 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-17 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-17 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-17 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-17 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-17 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-17 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-16 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-16 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-15 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-15 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-14 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-14 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-14 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-14 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-12 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-12 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-12 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-12 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-12 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-12 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 5e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 9e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-08 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-07 |
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 540 bits (1394), Expect = 0.0
Identities = 136/345 (39%), Positives = 188/345 (54%), Gaps = 14/345 (4%)
Query: 87 DAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA- 145
D++ + +EKL KIGQGT+ V+KAR TG+ VALKKV +N E E A
Sbjct: 6 DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITAL 64
Query: 146 REILVLRKLDHPNVIKLEGLVTSRMS------CSLYLVFEYMEHDLAGLAACQGVKFSEP 199
REI +L+ L H NV+ L + ++ S S+YLVF++ EHDLAGL + VKF+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 200 QVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK---QP 256
++K M+ LL+GL + H N +LHRD+K +N+LI DG+LK+ADFGLA +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL 316
T+RVVTLWYRPPELLLG YG +DLW AGCI+AE+ PIM G TE QL I +L
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244
Query: 317 CGSPSEEYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSS--LPLIETLLSIDPDNRG 373
CGS + E W + + KR + + K + L LI+ LL +DP R
Sbjct: 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 304
Query: 374 TATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQR 418
+ ALN +FF ++P + + + +
Sbjct: 305 DSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHHHH 349
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 487 bits (1256), Expect = e-173
Identities = 129/345 (37%), Positives = 189/345 (54%), Gaps = 11/345 (3%)
Query: 93 TPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE--PESVKFMA-REIL 149
RA +EKLD +G+G ++ VYKARD T +IVA+KK++ + + + A REI
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLL 209
+L++L HPN+I L + + + LVF++ME DL + + + +K YM L
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRP 268
GLE+ H + +LHRD+K +NLL+D +G+LK+ADFGLA +F P + T +VVT WYR
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRA 180
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 327
PELL GA YGVGVD+W+ GCILAELL P +PG ++++QL +IF+ G+P+EE W
Sbjct: 181 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387
LP+ FK + F L LI+ L +P R TAT AL ++F+
Sbjct: 241 CSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298
Query: 388 PYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKR 432
P LP+ E + +R + K+
Sbjct: 299 PGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKK 343
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-144
Identities = 117/325 (36%), Positives = 173/325 (53%), Gaps = 10/325 (3%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
T+ KLDK+G+GTY+ VYK + LT +VALK++R ++ E + RE+ +L+ L H
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHA 60
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
N++ L ++ + S L LVFEY++ DL G + VK ++ QLL GL +CH
Sbjct: 61 NIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
VLHRD+K NLLI+ G LK+ADFGLA P + + VVTLWYRPP++LLG+T
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGST 176
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATL 335
Y +D+W GCI E+ G+P+ PG T EQLH IF++ G+P+EE W
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSS 395
+ + + S L+ LL + NR +A A+ FF +
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK-- 294
Query: 396 LPKYPPSKEMD-VKLREEEARRQRG 419
LP + ++L++E + R
Sbjct: 295 LPDTTSIFALKEIQLQKEASLRSAH 319
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 416 bits (1070), Expect = e-144
Identities = 118/393 (30%), Positives = 188/393 (47%), Gaps = 43/393 (10%)
Query: 91 DWTPRRANTFEKLD-KIGQGTYSNVYKAR--DLLTGKIVALKKVRFDNLEPESVKFMARE 147
R + FE K+G+GTY +VYKA+ D K ALK++ + + RE
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----RE 68
Query: 148 ILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL--------AACQGVKFSEP 199
I +LR+L HPNVI L+ + S ++L+F+Y EHDL + A + V+
Sbjct: 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 200 QVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFYDPGLKQ 255
VK + Q+L G+ + H N VLHRD+K +N+L+ G +KIAD G A ++ LK
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 256 --PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV------ 307
+ VVT WYR PELLLGA +Y +D+W+ GCI AELL +PI R E
Sbjct: 189 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248
Query: 308 ---EQLHKIFKLCGSPSEEYWKK-SKLPNATLFKP---QQPYKRC-----IAETFKDFPS 355
+QL +IF + G P+++ W+ K+P + + Y C + + S
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308
Query: 356 SSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLP---KYPPSKEMDVKLREE 412
+ L++ LL++DP R T+ A+ +F +P YP + + + ++
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDD 368
Query: 413 EARRQRG-LSGKANAVDGAKRVRHRDRAGRAIP 444
+ ++ N +G ++D + P
Sbjct: 369 KGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGP 401
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 408 bits (1050), Expect = e-142
Identities = 107/305 (35%), Positives = 158/305 (51%), Gaps = 17/305 (5%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF---MAREILVL 151
+ +E + +IG G Y VYKARD +G VALK VR N RE+ +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 152 RKL---DHPNVIKLEGLVTSR---MSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCY 204
R+L +HPNV++L + + + LVFE+++ DL L +K
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
M+Q L GL+ H N ++HRD+K N+L+ + G +K+ADFGLA Y + +T VVTL
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPVVVTL 183
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
WYR PE+LL +T Y VD+WS GCI AE+ KP+ G +E +QL KIF L G P E+
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 325 WKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
W + LP P + + + + S L+ +L+ +P R +A AL +
Sbjct: 243 WPRDVSLPRGAF--PPRGPRP-VQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
Query: 384 FNTEP 388
+ +
Sbjct: 300 LHKDE 304
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-142
Identities = 115/322 (35%), Positives = 172/322 (53%), Gaps = 20/322 (6%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKL 154
++ F++L+K+G GTY+ VYK + TG VALK+V+ D+ E E A REI ++++L
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPSTAIREISLMKEL 60
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL-----AACQGVKFSEPQVKCYMKQLL 209
H N+++L ++ + L LVFE+M++DL VK + QLL
Sbjct: 61 KHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRP 268
GL CH N +LHRD+K NLLI+ G LK+ DFGLA F P +S VVTLWYR
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRA 176
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 327
P++L+G+ Y +D+WS GCILAE++ GKP+ PG + EQL IF + G+P+E W
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLP-----LIETLLSIDPDNRGTATAALNSE 382
+KLP Q+P + + + + L + LL ++PD R +A AL+
Sbjct: 237 TKLPKYNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHP 295
Query: 383 FFNTEPYACEPSSLPKYPPSKE 404
+F + +
Sbjct: 296 WFAEYYHHASMGGSRSHHHHHH 317
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-140
Identities = 122/301 (40%), Positives = 177/301 (58%), Gaps = 9/301 (2%)
Query: 91 DWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REIL 149
+ ++KL+K+G+GTY VYKA+D G+IVALK++R D E E + A REI
Sbjct: 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREIS 71
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLL 209
+L++L HPN++ L ++ S L LVFE+ME DL + + Q+K Y+ QLL
Sbjct: 72 LLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRP 268
G+ HCH + +LHRD+K NLLI++DG LK+ADFGLA F P + T VVTLWYR
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRA 187
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK- 327
P++L+G+ Y VD+WS GCI AE++ GKP+ PG T+ +QL KIF + G+P+ W +
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387
+LP Q K+ + F + L+ +L DP+ R +A A+N +F
Sbjct: 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
Query: 388 P 388
Sbjct: 308 D 308
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-140
Identities = 119/329 (36%), Positives = 172/329 (52%), Gaps = 19/329 (5%)
Query: 90 RDWTPRRANTFEKLDKIGQGTYSNVYKARDL-LTGKIVALKKVRFDNLEPESVKFMA-RE 147
+D R +E + +IG+G Y V+KARDL G+ VALK+VR E + RE
Sbjct: 3 KDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIRE 61
Query: 148 ILVLRKL---DHPNVIKLEGLVTSRMS---CSLYLVFEYMEHDLAG-LAACQGVKFSEPQ 200
+ VLR L +HPNV++L + T + L LVFE+++ DL L
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 121
Query: 201 VKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR 260
+K M QLL GL+ H++ V+HRD+K N+L+ + G +K+ADFGLA Y + +TS
Sbjct: 122 IKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSV 179
Query: 261 VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP 320
VVTLWYR PE+LL ++ Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P
Sbjct: 180 VVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 321 SEEYWKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379
EE W + LP + I + D L+ L+ +P R +A +AL
Sbjct: 239 GEEDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295
Query: 380 NSEFFNTEPYACE--PSSLPKYPPSKEMD 406
+ +F E S LP + E++
Sbjct: 296 SHPYFQDLERCKENLDSHLPPSQNTSELN 324
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-139
Identities = 96/321 (29%), Positives = 166/321 (51%), Gaps = 9/321 (2%)
Query: 88 AIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-R 146
+ + +E L +G+G+Y V K R+ TG+IVA+KK + + + VK +A R
Sbjct: 15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMR 73
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMK 206
EI +L++L H N++ L + + YLVFE+++H + V+ Y+
Sbjct: 74 EIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLW 265
Q+++G+ CH++ ++HRDIK N+L+ G++K+ DFG A T PG + V T W
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRW 189
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
YR PELL+G YG VD+W+ GC++ E+ G+P+ PG ++++QL+ I G+ +
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 326 KK-SKLPNATLFK-PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
+ +K P + P+ + + + + L + L IDPD R L+ +F
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
Query: 384 FNTEPYACEPSSLPKYPPSKE 404
F + +A S + K+
Sbjct: 310 FQMDGFAERFSQELQLKVQKD 330
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-139
Identities = 121/293 (41%), Positives = 175/293 (59%), Gaps = 10/293 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + E V A REI +L++L H N
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKN 62
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+++L ++ S L LVFE+ + DL VK ++ QLL GL CH+
Sbjct: 63 IVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
VLHRD+K NLLI+ +G LK+A+FGLA F P + ++ VVTLWYRPP++L GA
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKL 178
Query: 278 YGVGVDLWSAGCILAELL-AGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATL 335
Y +D+WSAGCI AEL AG+P+ PG +QL +IF+L G+P+EE W +KLP+
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388
+ P P + ++ L++ LL +P R +A AL +F+
Sbjct: 239 Y-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 396 bits (1019), Expect = e-137
Identities = 102/311 (32%), Positives = 154/311 (49%), Gaps = 9/311 (2%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDH 156
+EK+ KIG+G+Y V+K R+ TG+IVA+KK + +K +A REI +L++L H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKH 61
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
PN++ L + R L+LVFEY +H + E VK Q L + CH
Sbjct: 62 PNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
+ +HRD+K N+LI ++K+ DFG A P V T WYR PELL+G
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGD 177
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNAT 334
T YG VD+W+ GC+ AELL+G P+ PG+++V+QL+ I K G + + S +
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 335 LFK-PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
K P + F + +L L++ L +DP R T L+ +F +
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 394 SSLPKYPPSKE 404
+ P
Sbjct: 298 AKEHDKPAENL 308
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-137
Identities = 110/289 (38%), Positives = 167/289 (57%), Gaps = 10/289 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
+ L+KIG+GTY VYKA++ G+ ALKK+R + E E + REI +L++L H N
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSN 61
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
++KL ++ ++ L LVFE+++ DL L K ++ QLL+G+ +CH+
Sbjct: 62 IVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
VLHRD+K NLLI+ +G LKIADFGLA F P + T +VTLWYR P++L+G+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKK 177
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNATLF 336
Y +D+WS GCI AE++ G P+ PG +E +QL +IF++ G+P+ + W ++LP
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
K S + L+ +L +DP+ R TA AL +F
Sbjct: 238 FTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-137
Identities = 108/306 (35%), Positives = 170/306 (55%), Gaps = 14/306 (4%)
Query: 92 WTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILV 150
+ + + ++ K+G+GTY VYKA D +T + VA+K++R ++ E E V A RE+ +
Sbjct: 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSL 86
Query: 151 LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLS 210
L++L H N+I+L+ ++ L+L+FEY E+DL + S +K ++ QL++
Sbjct: 87 LKELQHRNIIELKSVIHHNHR--LHLIFEYAENDLKKYMD-KNPDVSMRVIKSFLYQLIN 143
Query: 211 GLEHCHNNGVLHRDIKGSNLLID-----NDGILKIADFGLA-TFYDPGLKQPMTSRVVTL 264
G+ CH+ LHRD+K NLL+ +LKI DFGLA F P + T ++TL
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITL 201
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
WYRPPE+LLG+ +Y VD+WS CI AE+L P+ PG +E++QL KIF++ G P +
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 325 WKK-SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
W + LP+ P+ K L L+ +L +DP R +A AL +
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 384 FNTEPY 389
F+ +
Sbjct: 322 FSHNDF 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-115
Identities = 126/428 (29%), Positives = 190/428 (44%), Gaps = 32/428 (7%)
Query: 48 RAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIG 107
R T P S+ S + V + + ++ IG
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63
Query: 108 QGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVT 167
G++ VY+A+ +G++VA+KKV D +F RE+ ++RKLDH N+++L
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 168 S----RMSCSLYLVFEYMEHDLAGLA---ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
S + L LV +Y+ + +A + VK YM QL L + H+ G+
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 177
Query: 221 LHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
HRDIK NLL+D + +LK+ DFG A G +P S + + +YR PEL+ GAT Y
Sbjct: 178 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYT 235
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339
+D+WSAGC+LAELL G+PI PG + V+QL +I K+ G+P+ E ++ PN T FK
Sbjct: 236 SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFKFP 294
Query: 340 QPYKRCIAETF-KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT--EPYACEPSSL 396
Q + F P ++ L LL P R T A FF+ +P P+
Sbjct: 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGR 354
Query: 397 P----------KYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAP 446
+ + + L AR Q S NA + + G+ A
Sbjct: 355 DTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASD--ANTGDRGQTNNAA 412
Query: 447 EANAEIQT 454
A+A T
Sbjct: 413 SASASNST 420
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-103
Identities = 110/349 (31%), Positives = 168/349 (48%), Gaps = 31/349 (8%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL 154
+R + IG G++ V++A+ + + + VA+KKV D +F RE+ ++R +
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIV 89
Query: 155 DHPNVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLA---ACQGVKFSEPQVKCYMKQ 207
HPNV+ L+ S L LV EY+ + + A +K YM Q
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
LL L + H+ G+ HRDIK NLL+D G+LK+ DFG A G +P S + + +Y
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYY 207
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
R PEL+ GAT Y +D+WS GC++AEL+ G+P+ PG + ++QL +I K+ G+PS E
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI- 266
Query: 327 KSKLPNATLFKPQQPYKRCIAETF-KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
K+ PN K Q ++ F P ++ LI LL P R TA AL FF+
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326
Query: 386 T--EPYACEPSSLPKYPP----------SKEMDVKLREEEARRQRGLSG 422
A P+ P ++ +L + A + G
Sbjct: 327 ELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRG 375
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 3e-95
Identities = 92/333 (27%), Positives = 151/333 (45%), Gaps = 27/333 (8%)
Query: 84 VAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF 143
A A + + + + F+ GQGT+ V ++ TG VA+KKV D +F
Sbjct: 9 NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD------PRF 62
Query: 144 MAREILVLRKL---DHPNVIKLEGLVTSRMSCS-----LYLVFEYMEHDLAGLA---ACQ 192
RE+ +++ L HPN+++L+ + L +V EY+ L +
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 193 GVKFSEPQVKCYMKQLLSGLEHCHNN--GVLHRDIKGSNLLID-NDGILKIADFGLATFY 249
V +K ++ QL+ + H V HRDIK N+L++ DG LK+ DFG A
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 309
P +P + + + +YR PEL+ G +Y VD+WS GCI AE++ G+PI G Q
Sbjct: 183 SPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240
Query: 310 LHKIFKLCGSPSEEYWKKSKLPNATLFKPQ---QPYKRCIAETFKDFPSSSLPLIETLLS 366
LH+I ++ G PS E +K + + P+ ++ + L+ LL
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQ 300
Query: 367 IDPDNRGTATAALNSEFFNT--EPYACEPSSLP 397
P+ R AL +F+ +P P++
Sbjct: 301 YLPEERMKPYEALCHPYFDELHDPATKLPNNKD 333
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 284 bits (729), Expect = 2e-93
Identities = 88/299 (29%), Positives = 149/299 (49%), Gaps = 23/299 (7%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPN 158
++ + K+G+G YS V++A ++ + V +K ++ P K + REI +L L PN
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPN 92
Query: 159 VIKLEGLVTSRMSCSLYLVFEY-MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+I L +V +S + LVFE+ D L ++ ++ YM ++L L++CH+
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHS 148
Query: 218 NGVLHRDIKGSNLLIDND-GILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
G++HRD+K N++ID++ L++ D+GLA FY PG Q RV + +++ PELL+
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQ 206
Query: 277 YYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSPSEE-YWKKSKLPNAT 334
Y +D+WS GC+LA ++ K P G +QL +I K+ G+ Y K +
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 335 LFKPQQPYKRCI-------AETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386
F +E +L ++ LL D +R TA A+ +F T
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 325
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 5e-93
Identities = 94/351 (26%), Positives = 154/351 (43%), Gaps = 57/351 (16%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
+ + +G G++ V + D+ +GK ALKKV D ++ RE+ +++
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKV 56
Query: 154 LDHPNVIKLEGLVTSRMSCS------------------------------------LYLV 177
LDH N+IKL + L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 178 FEYMEHDLAGLA---ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID- 233
EY+ L + G + Y+ QL + H+ G+ HRDIK NLL++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 234 NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAE 293
D LK+ DFG A P +P + + + +YR PEL+LGAT Y +DLWS GC+ E
Sbjct: 177 KDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234
Query: 294 LLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK-PQQPYKRCIAETFKD 352
L+ GKP+ G T ++QL +I ++ G+P++E + P+ T + P + + +
Sbjct: 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN-PHYTEVRFPTLK-AKDWRKILPE 292
Query: 353 F-PSSSLPLIETLLSIDPDNRGTATAALNSEFFN-----TEPYACEPSSLP 397
PS ++ L+E +L +PD R A+ FF+ E S+ P
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFP 343
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 7e-90
Identities = 106/328 (32%), Positives = 164/328 (50%), Gaps = 18/328 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPN 158
+ L IG+G Y V A D L VA+KK+ F++ + REI +L + H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 86
Query: 159 VIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
+I + ++ + +Y+V + ME DL L Q S + ++ Q+L GL++
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYI 144
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLA--TFYDPGLKQPMTSRVVTLWYRPPELLL 273
H+ VLHRD+K SNLL++ LKI DFGLA D +T V T WYR PE++L
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
+ Y +D+WS GCILAE+L+ +PI PG+ ++QL+ I + GSPS+E A
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 334 TLFKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391
+ P+ K F + S +L L++ +L+ +P R AL + E Y
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL--EQYYD 322
Query: 392 ---EPSSLPKYPPSKEMDVKLREEEARR 416
EP + + E+D L +E+ +
Sbjct: 323 PSDEPIAEAPFKFDMELD-DLPKEKLKE 349
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-89
Identities = 114/328 (34%), Positives = 170/328 (51%), Gaps = 23/328 (7%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHP 157
+ +G G Y +V A D +G+ VA+KK+ F + K RE+L+L+ + H
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHE 83
Query: 158 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
NVI L + T S YLV +M+ DL G+KFSE +++ + Q+L GL+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQ---KIMGLKFSEEKIQYLVYQMLKGLK 140
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ H+ GV+HRD+K NL ++ D LKI DFGLA D MT VVT WYR PE++L
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVIL 196
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
+Y VD+WS GCI+AE+L GK + G+ ++QL +I K+ G P E+ +K A
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256
Query: 334 TLFKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391
+ P ++ + F + L+E +L +D D R TA AL FF EP+
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF--EPFRD 314
Query: 392 ---EPSSLPKYPPSKEMDVKLREEEARR 416
E + + S E KL +E ++
Sbjct: 315 PEEETEAQQPFDDSLE-HEKLTVDEWKQ 341
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 3e-89
Identities = 116/442 (26%), Positives = 187/442 (42%), Gaps = 79/442 (17%)
Query: 43 GKERARAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWT-PRRANTFE 101
E A A+ + G + + + P+ M DW P R +E
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPH---SDWQIPDR---YE 56
Query: 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHPNV 159
IG G+Y +V +A D L ++VA+KK+ F++ K + REI +L +L+H +V
Sbjct: 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED--LIDCKRILREIAILNRLNHDHV 114
Query: 160 IKLEGLVTSRMSCS---LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
+K+ +V + LY+V E + D L V +E +K + LL G+++ H
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVH 173
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLA--------------------------TFYD 250
+ G+LHRD+K +N L++ D +K+ DFGLA +
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233
Query: 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL-----------AGKP 299
LK+ +T VVT WYR PEL+L Y +D+WS GCI AELL P
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 300 IMPG--------------------RTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339
+ PG R +QL+ IF + G+PSEE + + +A +
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353
Query: 340 QPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY---ACEPS 394
P +AE F + ++ L++ +L +P+ R T L FF + E +
Sbjct: 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF--KEVRIAEVETN 411
Query: 395 SLPKYPPSKEMDVKLREEEARR 416
+ K + + E + R
Sbjct: 412 ATEKVRLPFNDWMNMDEPQLRY 433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 5e-89
Identities = 110/328 (33%), Positives = 163/328 (49%), Gaps = 23/328 (7%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHP 157
+ L +G G Y V A D TG VA+KK+ F + K RE+ +L+ + H
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHE 84
Query: 158 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
NVI L + T + YLV +M DL L + K E +++ + Q+L GL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 142
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ H G++HRD+K NL ++ D LKI DFGLA D MT VVT WYR PE++L
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVIL 198
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y VD+WS GCI+AE++ GK + G ++QL +I K+ G+P E+ ++ + A
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 334 TLFKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY-- 389
+ P K+ A + ++ L+E +L +D + R TA AL +F E
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF--ESLHD 316
Query: 390 -ACEPSSLPKYPPSKEMDVKLREEEARR 416
EP KY S + DV +E +R
Sbjct: 317 TEDEPQV-QKYDDSFD-DVDRTLDEWKR 342
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 1e-87
Identities = 113/330 (34%), Positives = 162/330 (49%), Gaps = 23/330 (6%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLD 155
++ L +G G Y +V A D TG VA+KK+ F + K RE+ +L+ +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMK 86
Query: 156 HPNVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSG 211
H NVI L + T S +YLV M DL + CQ K ++ V+ + Q+L G
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRG 144
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
L++ H+ ++HRD+K SNL ++ D LKI DFGLA MT V T WYR PE+
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----EMTGYVATRWYRAPEI 200
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
+L +Y VD+WS GCI+AELL G+ + PG ++QL I +L G+P E KK
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 332 NATLFKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389
+A + K A F ++ L+E +L +D D R TA AL +F Y
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF--AQY 318
Query: 390 AC---EPSSLPKYPPSKEMDVKLREEEARR 416
EP + Y S E L +E +
Sbjct: 319 HDPDDEPVA-DPYDQSLE-SRDLLIDEWKS 346
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 3e-87
Identities = 103/314 (32%), Positives = 157/314 (50%), Gaps = 27/314 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ L +G G V+ A D K VA+KK+ + P+SVK REI ++R+LDH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNI 70
Query: 160 IKLEGLVTSRMSCS------------LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQ 207
+K+ ++ S +Y+V EYME DLA + E + +M Q
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG--PLLEEHARLFMYQ 128
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLA--TFYDPGLKQPMTSRVVTL 264
LL GL++ H+ VLHRD+K +NL I+ D +LKI DFGLA K ++ +VT
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
WYR P LLL Y +D+W+AGCI AE+L GK + G E+EQ+ I + EE
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 325 WKK--SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382
++ S +P +P + + + ++ +E +L+ P +R TA AL+
Sbjct: 249 RQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307
Query: 383 FFNTEPYAC---EP 393
+ Y+ EP
Sbjct: 308 YM--SIYSFPMDEP 319
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 5e-86
Identities = 102/339 (30%), Positives = 158/339 (46%), Gaps = 28/339 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPN 158
F+ +G+G Y V A TG+IVA+KK+ FD P REI +L+ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHEN 70
Query: 159 VIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
+I + + + +Y++ E M+ DL + + Q S+ ++ ++ Q L ++
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVL 128
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP---------MTSRVVTLWY 266
H + V+HRD+K SNLLI+++ LK+ DFGLA D M V T WY
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP-SEEYW 325
R PE++L + Y +D+WS GCILAEL +PI PGR QL IF + G+P S+
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 326 KKSKLPNATLFKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
+ + P A + P + + F + L++ +L DP R TA AL +
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPY 308
Query: 384 FNT------EPYACEPSSLPKYPPSKEMDVKLREEEARR 416
T EP EP + L ++ ++
Sbjct: 309 LQTYHDPNDEP-EGEPIPPSFFEFDHY-KEALTTKDLKK 345
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 264 bits (677), Expect = 4e-85
Identities = 89/319 (27%), Positives = 132/319 (41%), Gaps = 29/319 (9%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-----------FDNLEPESVKFMAREI 148
+ I G+Y V D G VA+K+V + K + REI
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSD--SFLCKRVLREI 80
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYM 205
+L HPN++ L + + LYLV E M DLA + Q + S ++ +M
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW 265
+L GL H GV+HRD+ N+L+ ++ + I DF LA T V W
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTA--DANKTHYVTHRW 198
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
YR PEL++ + VD+WSAGC++AE+ K + G T QL+KI ++ G+P E
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDV 258
Query: 326 KKSKLPNATLF----KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381
P+A + P R +L LI +L +P R + AL
Sbjct: 259 VMFSSPSARDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317
Query: 382 EFFNTEPYAC---EPSSLP 397
+F E L
Sbjct: 318 PYF--ESLFDPLDLTEGLS 334
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 1e-83
Identities = 104/361 (28%), Positives = 171/361 (47%), Gaps = 50/361 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKL-DH 156
+E + K+G+G Y V+K+ D TG++VA+KK+ F N + REI++L +L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGH 68
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
N++ L ++ + +YLVF+YME DL + + + QL+ +++ H
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH 126
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLA--------------------TFYDPGLKQP 256
+ G+LHRD+K SN+L++ + +K+ADFGL+ T +
Sbjct: 127 SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKL 316
+T V T WYR PE+LLG+T Y G+D+WS GCIL E+L GKPI PG + + QL +I +
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 317 CGSPSEEYW----------------KKSKLPNATLFKPQQPYKRCIAETFKDFPSSS--L 358
PS E +K ++ + +K + + + L
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 359 PLIETLLSIDPDNRGTATAALNSEFFNTEPYAC---EPSSLPKYPPSKEMDVKLREEEAR 415
L++ LL +P+ R +A AL F + EP+ +VK ++ R
Sbjct: 307 DLLDKLLQFNPNKRISANDALKHPFV--SIFHNPNEEPNCDHIITIPINDNVKHSIDDYR 364
Query: 416 R 416
Sbjct: 365 N 365
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 3e-81
Identities = 94/346 (27%), Positives = 160/346 (46%), Gaps = 46/346 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHP 157
++ L IG G V A D + + VA+KK+ F N K RE+++++ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 84
Query: 158 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVK--FSEPQVKCYMKQLLSG 211
N+I L + T + S +Y+V E M+ +L CQ ++ ++ + Q+L G
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANL-----CQVIQMELDHERMSYLLYQMLCG 139
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
++H H+ G++HRD+K SN+++ +D LKI DFGLA MT VVT +YR PE+
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEV 197
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK---- 327
+LG Y VD+WS GCI+ E++ G + PG ++Q +K+ + G+P E+ KK
Sbjct: 198 ILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256
Query: 328 -----SKLPNATLFKPQQPYKR--------CIAETFKDFPSSSLPLIETLLSIDPDNRGT 374
P +++ +E K S + L+ +L ID R +
Sbjct: 257 VRTYVENRP----KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312
Query: 375 ATAALNSEFFNTEPYAC---EPSSLP-KYPPSKEMDVKLREEEARR 416
AL + + + P + + + EE +
Sbjct: 313 VDEALQHPYI--NVWYDPSEAEAPPPKIPDKQLD-EREHTIEEWKE 355
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-80
Identities = 105/376 (27%), Positives = 166/376 (44%), Gaps = 64/376 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHP 157
+ IG+G+Y VY A D T K VA+KKV F++ K + REI +L +L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDCKRILREITILNRLKSD 85
Query: 158 NVIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
+I+L L+ LY+V E + DL L + +E +K + LL G
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENF 144
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLA---------------------TFYDPGL 253
H +G++HRD+K +N L++ D +K+ DFGLA ++ L
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-----------KPIMP 302
K+ +TS VVT WYR PEL+L Y +D+WS GCI AELL P+ P
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 303 G-----------------RTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRC 345
G ++ +QL+ IF + G+P+E+ K P + P+++
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 346 I--AETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC---EPSSLPKYP 400
I + + + L+E++L +P+ R T AL+ + + E S K
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL--KDVRKKKLENFSTKKII 382
Query: 401 PSKEMDVKLREEEARR 416
+ + L E + R
Sbjct: 383 LPFDDWMVLSETQLRY 398
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 3e-80
Identities = 99/344 (28%), Positives = 163/344 (47%), Gaps = 42/344 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLDHP 157
++ L IG G V A D + + VA+KK+ F N K RE+++++ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHK 121
Query: 158 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVK--FSEPQVKCYMKQLLSG 211
N+I L + T + + +YLV E M+ +L CQ ++ ++ + Q+L G
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANL-----CQVIQMELDHERMSYLLYQMLCG 176
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
++H H+ G++HRD+K SN+++ +D LKI DFGLA MT VVT +YR PE+
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEV 234
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK---- 327
+LG Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+ KK
Sbjct: 235 ILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293
Query: 328 -----SKLPNATLFKPQQPYKR--------CIAETFKDFPSSSLPLIETLLSIDPDNRGT 374
P + + +E K S + L+ +L IDP R +
Sbjct: 294 VRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349
Query: 375 ATAALNSEFFNT--EPYACEPSSLPKYPPSKEMDVKLREEEARR 416
AL + N +P E Y + + + EE +
Sbjct: 350 VDDALQHPYINVWYDPAEVEAPPPQIYDKQLD-EREHTIEEWKE 392
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-73
Identities = 75/316 (23%), Positives = 129/316 (40%), Gaps = 55/316 (17%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL 154
R A+ FE++ +GQG + V KAR+ L + A+KK+R + ++ E+++L L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL---SEVMLLASL 59
Query: 155 DHPNVIKL-----------EGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKFSEPQVK 202
+H V++ + + + +L++ EY E L L + + +
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP------ 256
+Q+L L + H+ G++HRD+K N+ ID +KI DFGLA L
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 257 -------MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 309
+TS + T Y E+L G +Y +D++S G I E++ P G V
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237
Query: 310 LHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDP 369
L K+ + ++ + K +I L+ DP
Sbjct: 238 LKKLRSVSIEFPPDFDDN------------------KMKVEKK-------IIRLLIDHDP 272
Query: 370 DNRGTATAALNSEFFN 385
+ R A LNS +
Sbjct: 273 NKRPGARTLLNSGWLP 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-70
Identities = 76/330 (23%), Positives = 128/330 (38%), Gaps = 59/330 (17%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ L +IG G S V++ + +I A+K V + + +++ EI L KL
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 158 N--VIKLEG-LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
+ +I+L +T + +Y+V E DL + + K Y K +L +
Sbjct: 87 SDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHT 142
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM-TSRVVTLWYRPPELLL 273
H +G++H D+K +N LI + G+LK+ DFG+A P + S+V T+ Y PPE +
Sbjct: 143 IHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 274 GATY----------YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323
+ D+WS GCIL + GK P + + Q+ K+ +
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII------ 253
Query: 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLP-LIETLLSIDPDNRGTATAALNSE 382
P + F D P L +++ L DP R + L
Sbjct: 254 -------------DPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294
Query: 383 FFNTEPYACEPSSLPKYPPSKEMDVKLREE 412
+ + P +M EE
Sbjct: 295 YVQ-----------IQTHPVNQMAKGTTEE 313
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 3e-68
Identities = 77/341 (22%), Positives = 131/341 (38%), Gaps = 49/341 (14%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ L +IG G S V++ + +I A+K V + + +++ EI L KL
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 158 N--VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
+ +I+L + +Y+V E DL + + K Y K +L +
Sbjct: 68 SDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 124
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM-TSRVVTLWYRPPELLLG 274
H +G++H D+K +N LI + G+LK+ DFG+A P + S+V T+ Y PPE +
Sbjct: 125 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 275 ATY----------YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
+ D+WS GCIL + GK P + + Q+ K+ +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII------- 234
Query: 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLP-LIETLLSIDPDNRGTATAALNSEF 383
P + F D P L +++ L DP R + L +
Sbjct: 235 ------------DPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276
Query: 384 FNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKA 424
+ P + ++EM L + KA
Sbjct: 277 VQIQT---HPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKA 314
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-66
Identities = 72/334 (21%), Positives = 127/334 (38%), Gaps = 46/334 (13%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ L +IG G S V++ + +I A+K V + + +++ EI L KL
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 158 N--VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
+ +I+L + +Y+V E DL + + K Y K +L +
Sbjct: 115 SDKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTI 171
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM-TSRVVTLWYRPPELLLG 274
H +G++H D+K +N LI + G+LK+ DFG+A P + S+V + Y PPE +
Sbjct: 172 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 275 ATY----------YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
+ D+WS GCIL + GK P + + Q+ K+ +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHAII------- 281
Query: 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLP-LIETLLSIDPDNRGTATAALNSEF 383
P + F D P L +++ L DP R + L +
Sbjct: 282 ------------DPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 323
Query: 384 FNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQ 417
+ + + K + +L +
Sbjct: 324 VQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS 357
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 6e-66
Identities = 68/300 (22%), Positives = 113/300 (37%), Gaps = 27/300 (9%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ D +GQG +NV++ R TG + A+K + V RE VL+KL+H N+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNI 69
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCH 216
+KL + + L+ E+ L + E + ++ ++ G+ H
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 217 NNGVLHRDIKGSNLLI----DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELL 272
NG++HR+IK N++ D + K+ DFG A + + S T Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMY 187
Query: 273 LGAT-------YYGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIFKLCGSPS 321
A YG VDLWS G G R E ++KI G PS
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS 245
Query: 322 EEYWKKSKLPNATL-FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
K N + + P ++ + P++ +L D +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQV---LLTPVLANILEADQEKCWGFDQFFA 302
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-64
Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 58/307 (18%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
R F++++ IG G + V+KA+ + GK +K+V+++N + RE+ L K
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK------AEREVKALAK 60
Query: 154 LDHPNVIKL--------------EGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFS 197
LDH N++ + + L++ E+ + L + +G K
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 198 EPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257
+ +Q+ G+++ H+ +++RD+K SN+ + + +KI DFGL T K
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--R 178
Query: 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC 317
T TL Y PE + YG VDL++ G ILAELL + +
Sbjct: 179 TRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCD--TAFETSKFFTDL---- 231
Query: 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATA 377
+ + + + K L++ LLS P++R +
Sbjct: 232 --------RDGIISD------------IFDKKEKT-------LLQKLLSKKPEDRPNTSE 264
Query: 378 ALNSEFF 384
L +
Sbjct: 265 ILRTLTV 271
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-64
Identities = 70/305 (22%), Positives = 117/305 (38%), Gaps = 32/305 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ D +GQG +NV++ R TG + A+K + V RE VL+KL+H N+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNI 69
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCH 216
+KL + + L+ E+ L + E + ++ ++ G+ H
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 217 NNGVLHRDIKGSNLLI----DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELL 272
NG++HR+IK N++ D + K+ DFG A + + S T Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMY 187
Query: 273 LGAT-------YYGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIFKLCGSPS 321
A YG VDLWS G G R E ++KI G PS
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GKPS 245
Query: 322 EEYWKKSKLPNATL-FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
K N + + P ++ + + P++ +L D +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLANILEADQEKCWGF----- 297
Query: 381 SEFFN 385
+FF
Sbjct: 298 DQFFA 302
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-64
Identities = 73/325 (22%), Positives = 119/325 (36%), Gaps = 37/325 (11%)
Query: 61 FGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDL 120
F + +P S +G S + G +F++L ++G G+Y V+K R
Sbjct: 20 FQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSK 79
Query: 121 LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFE 179
G++ A+K+ P+ E+ K+ HP ++LE LYL E
Sbjct: 80 EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTE 137
Query: 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILK 239
L G E QV Y++ L L H H+ G++H D+K +N+ + G K
Sbjct: 138 LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCK 197
Query: 240 IADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP 299
+ DFGL + Y PELL G+ YG D++S G + E+
Sbjct: 198 LGDFGLLVELGTA--GAGEVQEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNME 253
Query: 300 IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLP 359
+P E ++ + G E+ ++ +
Sbjct: 254 -LP--HGGEGWQQLRQ--GYLPPEFTAG------------------LSSELRSV------ 284
Query: 360 LIETLLSIDPDNRGTATAALNSEFF 384
+ +L DP R TA A L
Sbjct: 285 -LVMMLEPDPKLRATAEALLALPVL 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 4e-64
Identities = 77/351 (21%), Positives = 138/351 (39%), Gaps = 36/351 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ +L KIG+G++ + G+ +K++ + + + RE+ VL + HPN+
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 160 IK-LEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
++ E + SLY+V +Y E DL + A +GV F E Q+ + Q+ L+H H
Sbjct: 86 VQYRESFEENG---SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ +LHRDIK N+ + DG +++ DFG+A + ++ + + T +Y PE+
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGTPYYLSPEICENKP 201
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
Y D+W+ GC+L EL K + + KI P
Sbjct: 202 -YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI------------ISGSFP----- 243
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSL 396
P + + L+ L +P +R + + L F L
Sbjct: 244 ----PVSLHYSYDLRS-------LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292
Query: 397 PKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDRAGRAIPAPE 447
+ K + +R SG+ + + + A IP
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAY 343
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 1e-63
Identities = 78/300 (26%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
P RA +E L IG G+Y K R GKI+ K++ + ++ + + E+ +LR+
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL---AACQGVKFSEPQVKCYMKQLL 209
L HPN+++ + R + +LY+V EY E DLA + + E V M QL
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 210 SGLEHCH-----NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
L+ CH + VLHRD+K +N+ +D +K+ DFGLA + + V T
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKTFVGTP 180
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
+Y PE + + Y D+WS GC+L EL A P ++ E KI
Sbjct: 181 YYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----------- 228
Query: 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
++ K ++ + +I +L++ +R + L +
Sbjct: 229 -REGKFR---------RIPYRYSDELNE-------IITRMLNLKDYHRPSVEEILENPLI 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 9e-62
Identities = 88/333 (26%), Positives = 152/333 (45%), Gaps = 60/333 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ + +G+G++ V K +D +T + A+K + + + + + RE+ +L+KLDHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQLL 209
+KL ++ S Y+V E G +FSE +KQ+
Sbjct: 84 MKLFEILEDSS--SFYIVGEL----------YTGGELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
SG+ + H + ++HRD+K N+L+++ D +KI DFGL+T + M R+ T +Y
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYY 189
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--EEY 324
PE+L G Y D+WSAG IL LL+G P G+ E + L ++ G +
Sbjct: 190 IAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQ 245
Query: 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
W+ I++ KD LI +L+ P R TAT L +
Sbjct: 246 WRT------------------ISDDAKD-------LIRKMLTFHPSLRITATQCLEHPWI 280
Query: 385 NTEPYACEPSSLPKYPPSKEMDVKLREEEARRQ 417
Y+ E ++ P + +R+ +A ++
Sbjct: 281 QK--YSSETPTISDLPSLESAMTNIRQFQAEKK 311
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 3e-61
Identities = 92/329 (27%), Positives = 144/329 (43%), Gaps = 64/329 (19%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
++++ K+G G Y V RD +T A+K +R ++ S + E+ VL+ LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQ 207
N++KL + + YLV E +G +KF+E +KQ
Sbjct: 97 NIMKLYDFFEDKR--NYYLVMEC----------YKGGELFDEIIHRMKFNEVDAAVIIKQ 144
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGLKQPMTSRVVTL 264
+LSG+ + H + ++HRD+K NLL+++ D ++KI DFGL+ ++ + M R+ T
Sbjct: 145 VLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTA 202
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--E 322
+Y PE+L Y D+WS G IL LLAG P G+T+ E L K+ K G +
Sbjct: 203 YYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK--GKYTFDS 258
Query: 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382
WK ++E KD I+ +L D R +A AL
Sbjct: 259 PEWKN------------------VSEGAKDL-------IKQMLQFDSQRRISAQQALEH- 292
Query: 383 FFNTEPYACEPSSLPKYPPSKEMDVKLRE 411
P+ E S + E
Sbjct: 293 -----PWIKEMCSKKESGIELPSLANAIE 316
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-60
Identities = 74/311 (23%), Positives = 116/311 (37%), Gaps = 19/311 (6%)
Query: 86 GDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA 145
G + +E +++G G + V + TG+ VA+K+ R + L P++ +
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC 60
Query: 146 REILVLRKLDHPNVIKL----EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQG--VKFSE 198
EI +++KL+HPNV+ +GL + L EY E DL E
Sbjct: 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 199 PQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID---NDGILKIADFGLATFYDPGLKQ 255
++ + + S L + H N ++HRD+K N+++ I KI D G A D G +
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--E 178
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
T V TL Y PELL Y V VD WS G + E + G + Q H +
Sbjct: 179 LCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
+ + P ++ +L RGT
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPNHLS-----GILAGKLERWLQCMLMWHQRQRGTD 292
Query: 376 TAALNSEFFNT 386
N F
Sbjct: 293 PQNPNVGCFQA 303
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 3e-60
Identities = 83/292 (28%), Positives = 134/292 (45%), Gaps = 58/292 (19%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
+G+G++ V K +D +T + A+K + + + + + RE+ +L+KLDHPN++KL
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQLLSGLE 213
++ S Y+V E G +FSE +KQ+ SG+
Sbjct: 88 EILEDSS--SFYIVGEL----------YTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 214 HCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
+ H + ++HRD+K N+L+ + D +KI DFGL+T + M R+ T +Y PE
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE 193
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKKS 328
+L G Y D+WSAG IL LL+G P G+ E + L ++ G + W+
Sbjct: 194 VLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRT- 248
Query: 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
I++ KD LI +L+ P R TAT L
Sbjct: 249 -----------------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 9e-60
Identities = 87/334 (26%), Positives = 151/334 (45%), Gaps = 62/334 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPN 158
++ +G+G++ V +D +TG+ A+K + ++ + + RE+ +L++LDHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQL 208
++KL + YLV E G +FSE ++Q+
Sbjct: 88 IMKLYEFFEDKGY--FYLVGEV----------YTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGLKQPMTSRVVTLW 265
LSG+ + H N ++HRD+K NLL+++ D ++I DFGL+T ++ + M ++ T +
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAY 193
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--EE 323
Y PE+L G Y D+WS G IL LL+G P G E + L K+ K G +
Sbjct: 194 YIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELP 249
Query: 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
WKK ++E+ KD I +L+ P R +A AL+ E+
Sbjct: 250 QWKK------------------VSESAKDL-------IRKMLTYVPSMRISARDALDHEW 284
Query: 384 FNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQ 417
T + P + +R+ + ++
Sbjct: 285 IQT---YTKEQISVDVPSLDNAILNIRQFQGTQK 315
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-59
Identities = 73/314 (23%), Positives = 122/314 (38%), Gaps = 56/314 (17%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL 154
R FE + +G+G + V++A++ + A+K++R N E K M RE+ L KL
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKL 60
Query: 155 DHPNVIK----------LEGLVTSRMSCSLYLVFEYMEH-DLAGL--AACQGVKFSEPQV 201
+HP +++ E L S LY+ + +L C +
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-----------TFYD 250
Q+ +E H+ G++HRD+K SN+ D ++K+ DFGL
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 310
T +V T Y PE + G + Y VD++S G IL ELL P T++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL-----YPFSTQMERV 234
Query: 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPD 370
+ + + K P F +++ +LS P
Sbjct: 235 RTLTDV---------RNLKFP----------------PLFTQKYPCEYVMVQDMLSPSPM 269
Query: 371 NRGTATAALNSEFF 384
R A + + F
Sbjct: 270 ERPEAINIIENAVF 283
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 7e-59
Identities = 90/361 (24%), Positives = 143/361 (39%), Gaps = 43/361 (11%)
Query: 63 PPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLT 122
P + + G P+ PR + + +G+G ++ ++ D T
Sbjct: 6 DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADT 65
Query: 123 GKIVALKKVRFDNLEPESVKF-MAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181
++ A K V L + M+ EI + R L H +V+ G +++V E
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELC 123
Query: 182 EH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKI 240
L L + +EP+ + Y++Q++ G ++ H N V+HRD+K NL ++ D +KI
Sbjct: 124 RRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKI 182
Query: 241 ADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPI 300
DFGLAT + ++ T Y PE+L + VD+WS GCI+ LL GKP
Sbjct: 183 GDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPP 240
Query: 301 MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPL 360
E +I K EY +P K + L
Sbjct: 241 FETSCLKETYLRIKKN------EY----SIP-------------------KHINPVAASL 271
Query: 361 IETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKY----PPSKEMDVKLREEEARR 416
I+ +L DP R T LN EFF + P+ LP PP + + R+
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTSG---YIPARLPITCLTIPPRFSIAPSSLDPSNRK 328
Query: 417 Q 417
Sbjct: 329 P 329
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-58
Identities = 85/313 (27%), Positives = 134/313 (42%), Gaps = 41/313 (13%)
Query: 87 DAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF-MA 145
+ + D PR + + +G+G ++ ++ D T ++ A K V L + M+
Sbjct: 6 EVLVD--PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 63
Query: 146 REILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCY 204
EI + R L H +V+ G +++V E L L + +EP+ + Y
Sbjct: 64 MEISIHRSLAHQHVVGFHGFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYY 120
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
++Q++ G ++ H N V+HRD+K NL ++ D +KI DFGLAT + ++ T
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTP 179
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
Y PE+L + VD+WS GCI+ LL GKP E +I K EY
Sbjct: 180 NYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY 232
Query: 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+P K + LI+ +L DP R T LN EFF
Sbjct: 233 ----SIP-------------------KHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269
Query: 385 NTEPYACEPSSLP 397
+ P+ LP
Sbjct: 270 TSG---YIPARLP 279
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-58
Identities = 88/379 (23%), Positives = 141/379 (37%), Gaps = 72/379 (18%)
Query: 64 PERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTG 123
P Q G S M A D ++ +++G+G +S V + TG
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSD-------NYDVKEELGKGAFSVVRRCVHKTTG 54
Query: 124 KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH 183
A K + L + + RE + RKL HPN+++L + YLVF+
Sbjct: 55 LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES--FHYLVFDL--- 109
Query: 184 DLAGLAACQG----------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI- 232
G +SE ++Q+L + +CH+NG++HR++K NLL+
Sbjct: 110 -------VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162
Query: 233 --DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCI 290
+K+ADFGLA + + T Y PE+L Y VD+W+ G I
Sbjct: 163 SKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVI 219
Query: 291 LAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKKSKLPNATLFKPQQPYKRCIAE 348
L LL G P + +I G+ W +
Sbjct: 220 LYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDT------------------VTP 259
Query: 349 TFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVK 408
K LI+++L+++P R TA AL P+ C + ++
Sbjct: 260 EAKS-------LIDSMLTVNPKKRITADQALKV------PWICNRERVASAIHRQDTVDC 306
Query: 409 LREEEARRQRGLSGKANAV 427
L++ ARR+ L G
Sbjct: 307 LKKFNARRK--LKGAILTT 323
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 4e-58
Identities = 74/294 (25%), Positives = 118/294 (40%), Gaps = 61/294 (20%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
+++G+G +S V + TG A K + L + + RE + RKL HPN+++L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQLLSGLE 213
+ YLVF+ G +SE ++Q+L +
Sbjct: 72 DSIQEES--FHYLVFDL----------VTGGELFEDIVAREFYSEADASHCIQQILESIA 119
Query: 214 HCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
+CH+NG++HR++K NLL+ +K+ADFGLA + + T Y PE
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE 177
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGSPS--EEYWK 326
+L Y VD+W+ G IL LL G P P + +I G+ W
Sbjct: 178 VLKK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDYPSPEWD 232
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+ K LI+++L+++P R TA AL
Sbjct: 233 T------------------VTPEAKS-------LIDSMLTVNPKKRITADQALK 261
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 7e-58
Identities = 60/299 (20%), Positives = 116/299 (38%), Gaps = 46/299 (15%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
+ + K+G+G +S V L G ALK++ + + RE + R +HPN
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPN 87
Query: 159 VIKLEG--LVTSRMSCSLYLVFEYMEH-DLAGL---AACQGVKFSEPQVKCYMKQLLSGL 212
+++L L +L+ + + L +G +E Q+ + + GL
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--------TL 264
E H G HRD+K +N+L+ ++G + D G ++ + + T+
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 265 WYRPPELLLGATYYGVG--VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322
YR PEL ++ + D+WS GC+L ++ G+ P + + +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------YDMVFQKGD 254
Query: 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSL-PLIETLLSIDPDNRGTATAALN 380
+ N + SS+L L+ +++++DP R L+
Sbjct: 255 SV--ALAVQNQLSIPQSPRH------------SSALWQLLNSMMTVDPHQRPHIPLLLS 299
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 9e-58
Identities = 84/326 (25%), Positives = 136/326 (41%), Gaps = 69/326 (21%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-----------FDNLEPESVKFMAR 146
++ K+ K+G G Y V ++ A+K ++ + + + +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKF 196
EI +L+ LDHPN+IKL + + YLV E+ +G KF
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKY--FYLVTEF----------YEGGELFEQIINRHKF 143
Query: 197 SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGL 253
E MKQ+LSG+ + H + ++HRDIK N+L++N +KI DFGL++F+
Sbjct: 144 DECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD- 202
Query: 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
+ R+ T +Y PE+L Y D+WS G I+ LL G P G+ + + + K+
Sbjct: 203 -YKLRDRLGTAYYIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 314 FKLCGSPS--EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN 371
K G WK I++ K+ I+ +L+ D +
Sbjct: 260 EK--GKYYFDFNDWKN------------------ISDEAKEL-------IKLMLTYDYNK 292
Query: 372 RGTATAALNSEFFNTEPYACEPSSLP 397
R TA ALNS + S
Sbjct: 293 RCTAEEALNSRWIKKYANNINKSDQK 318
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-57
Identities = 83/315 (26%), Positives = 125/315 (39%), Gaps = 60/315 (19%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKV------RFDNLEPESVKFMAREILVLRKLDHPN 158
+G G V A + T K VA+K + E + + EI +L+KL+HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
+IK++ + Y+V E ME D + E K Y Q+L +++
Sbjct: 77 IIKIKNFFDAE---DYYIVLELMEGGELFD----KVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 215 CHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
H NG++HRD+K N+L+ + D ++KI DFG + M + T Y PE+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEV 187
Query: 272 LLGATY--YGVGVDLWSAGCILAELLAGKPIMP---GRTEVEQLHKIFKLCGS---PSEE 323
L+ Y VD WS G IL L+G P P RT+V +I G E
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGKYNFIP-E 242
Query: 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
W + ++E D L++ LL +DP R T AL +
Sbjct: 243 VWAE------------------VSEKALD-------LVKKLLVVDPKARFTTEEALRHPW 277
Query: 384 FNTEPYACEPSSLPK 398
E + L
Sbjct: 278 LQDEDMKRKFQDLLS 292
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-57
Identities = 85/286 (29%), Positives = 126/286 (44%), Gaps = 34/286 (11%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
F KIG+G +S VY+A LL G VALKKV+ +L + +EI +L++L+HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL---AACQGVKFSEPQVKCYMKQLLSGLEH 214
VIK L +V E + DL+ + Q E V Y QL S LEH
Sbjct: 94 VIKYYASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
H+ V+HRDIK +N+ I G++K+ D GL F+ S V T +Y PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLVGTPYYMSPERIHE 210
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
Y D+WS GC+L E+ A + P + L+ + K ++ P
Sbjct: 211 NG-YNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCKKI--------EQCDYPPL- 258
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
P Y +E + + ++ DP+ R T +
Sbjct: 259 ---PSDHY----SEELRQL-------VNMCINPDPEKRPDVTYVYD 290
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-56
Identities = 79/308 (25%), Positives = 124/308 (40%), Gaps = 66/308 (21%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVK----FMAREILVLRKLD-H 156
+G+G S V + T K A+K + E V+ +E+ +LRK+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMK 206
PN+I+L+ + +LVF+ + V SE + + M+
Sbjct: 84 PNIIQLKDTYETNTF--FFLVFDL----------MKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
LL + H ++HRD+K N+L+D+D +K+ DFG + DPG + + T Y
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSY 189
Query: 267 RPPELLLGATY-----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS 321
PE++ + YG VD+WS G I+ LLAG P R ++ L I + G+
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGNYQ 247
Query: 322 --EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379
W ++T KD L+ L + P R TA AL
Sbjct: 248 FGSPEWDD------------------YSDTVKD-------LVSRFLVVQPQKRYTAEEAL 282
Query: 380 NSEFFNTE 387
FF
Sbjct: 283 AHPFFQQY 290
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-56
Identities = 89/347 (25%), Positives = 140/347 (40%), Gaps = 58/347 (16%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
+++G+G +S V + +L G+ A + L + + RE + R L HPN+++L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 164 GLVTSRMSCSLYLVFEYME-----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
++ YL+F+ + D+ +SE ++Q+L + HCH
Sbjct: 77 DSISEEG--HHYLIFDLVTGGELFEDI-----VAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 219 GVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
GV+HR++K NLL+ +K+ADFGLA + +Q T Y PE+L
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPEVLRK- 187
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGSPS--EEYWKKSKLP 331
YG VDLW+ G IL LL G P P + +I G+ W
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAYDFPSPEWDT---- 239
Query: 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391
+ KD LI +L+I+P R TA AL P+
Sbjct: 240 --------------VTPEAKD-------LINKMLTINPSKRITAAEALKH------PWIS 272
Query: 392 EPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRHRDR 438
S++ +E L++ ARR+ L G V A R +
Sbjct: 273 HRSTVASCMHRQETVDCLKKFNARRK--LKGAILTVMLATRNFSVRK 317
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-56
Identities = 67/297 (22%), Positives = 109/297 (36%), Gaps = 45/297 (15%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HP 157
+F D +G G + R + + VA+K++ PE F RE+ +LR+ D HP
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRI-----LPECFSFADREVQLLRESDEHP 78
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
NVI+ R Y+ E L + + ++Q SGL H H+
Sbjct: 79 NVIRYFCTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 218 NGVLHRDIKGSNLLIDNDG-----ILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPE 270
++HRD+K N+LI I+DFGL G + T + PE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 271 LLLGATY--YGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
+L VD++SAGC+ +++ G + + + C K
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-GACSLDCLHPEKH 255
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
++ LIE ++++DP R +A L FF
Sbjct: 256 ------------------EDVIARE-------LIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 85/293 (29%), Positives = 123/293 (41%), Gaps = 62/293 (21%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKL 162
+ IG+G++ V A T A KK+ +E + K +EI +++ LDHPN+I+L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRL 71
Query: 163 EGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQLLSGL 212
+YLV E C G F E MK +LS +
Sbjct: 72 YETFEDNTD--IYLVMEL----------CTGGELFERVVHKRVFRESDAARIMKDVLSAV 119
Query: 213 EHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPP 269
+CH V HRD+K N L D LK+ DFGLA + PG + M ++V T +Y P
Sbjct: 120 AYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSP 177
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKK 327
++L G YG D WSAG ++ LL G P T+ E + KI G+ + E+ W
Sbjct: 178 QVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLN 233
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
++ + LI LL+ P R T+ AL
Sbjct: 234 ------------------VSPQAES-------LIRRLLTKSPKQRITSLQALE 261
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-56
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 44/286 (15%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
K+G G + +V+ + +G +K + D + ++ + EI VL+ LDHPN+IK+
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 164 GLVTSRMSCSLYLVFEYME-----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+ + +Y+V E E + A SE V MKQ+++ L + H+
Sbjct: 87 EVFEDYHN--MYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHSQ 143
Query: 219 GVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
V+H+D+K N+L + +KI DFGLA + + T+ T Y PE+
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVFKRD 201
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSKLPNAT 334
D+WSAG ++ LL G G + E K P+ +
Sbjct: 202 --VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRP------- 250
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+ D ++ +L+ DP+ R +A L+
Sbjct: 251 -----------LTPQAVDL-------LKQMLTKDPERRPSAAQVLH 278
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-56
Identities = 73/294 (24%), Positives = 138/294 (46%), Gaps = 35/294 (11%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF-MAREILVLR 152
+ F+ + +G+G+++ VY+A + TG VA+K + + + + E+ +
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSG 211
+L HP++++L +YLV E + ++ + FSE + + +M Q+++G
Sbjct: 67 QLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
+ + H++G+LHRD+ SNLL+ + +KIADFGLAT ++ T T Y PE+
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYISPEI 183
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
+ +G+ D+WS GC+ LL G+P T L+K+ +Y ++P
Sbjct: 184 ATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY----EMP 232
Query: 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
+ + LI LL +P +R + ++ L+ F +
Sbjct: 233 S-------------------FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 6e-56
Identities = 81/301 (26%), Positives = 125/301 (41%), Gaps = 52/301 (17%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKV------RFDNLEPESVKFMAREILVLRKLDHPN 158
+G G V A + T K VA++ + E + + EI +L+KL+HP
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+IK++ + Y+V E ME +L + E K Y Q+L +++ H
Sbjct: 202 IIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHE 257
Query: 218 NGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
NG++HRD+K N+L+ + D ++KI DFG + M + T Y PE+L+
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVS 315
Query: 275 ATY--YGVGVDLWSAGCILAELLAGKPIMP---GRTEVEQLHKIFKLCGSPS--EEYWKK 327
Y VD WS G IL L+G P P RT+V +I G + E W +
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI--TSGKYNFIPEVWAE 371
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387
++E D L++ LL +DP R T AL + E
Sbjct: 372 ------------------VSEKALD-------LVKKLLVVDPKARFTTEEALRHPWLQDE 406
Query: 388 P 388
Sbjct: 407 D 407
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 7e-56
Identities = 85/366 (23%), Positives = 148/366 (40%), Gaps = 41/366 (11%)
Query: 24 SVTVTVSSGAVVSGNVVRLGKERARAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMA 83
S V + + + ++ G + +R+ + + + ER S+ + A
Sbjct: 9 SSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPA 68
Query: 84 VAG-DAIRDWTPRRAN-----TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE 137
R T ++ T K + +G G + V+K + TG +A K ++ ++
Sbjct: 69 PPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK 128
Query: 138 PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKF 196
+ + EI V+ +LDH N+I+L S+ + LV EY++ +L +
Sbjct: 129 --DKEEVKNEISVMNQLDHANLIQLYDAFESKND--IVLVMEYVDGGELFDRIIDESYNL 184
Query: 197 SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN--DGILKIADFGLATFYDPGLK 254
+E +MKQ+ G+ H H +LH D+K N+L N +KI DFGLA Y P
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-- 242
Query: 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIF 314
+ + T + PE++ + D+WS G I LL+G G + E L+ I
Sbjct: 243 EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301
Query: 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT 374
+E ++ I+E K+F I LL + R +
Sbjct: 302 ACRWDLEDEEFQD------------------ISEEAKEF-------ISKLLIKEKSWRIS 336
Query: 375 ATAALN 380
A+ AL
Sbjct: 337 ASEALK 342
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-55
Identities = 79/366 (21%), Positives = 132/366 (36%), Gaps = 72/366 (19%)
Query: 93 TPRRANTFEKL----DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFM 144
P + E +++G G ++ V K R+ TG A K ++ S + +
Sbjct: 3 EPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI 62
Query: 145 AREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------V 194
RE+ +LR++ H NVI L + +R + L+ E G
Sbjct: 63 EREVSILRQVLHHNVITLHDVYENRTD--VVLILEL----------VSGGELFDFLAQKE 110
Query: 195 KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFYD 250
SE + ++KQ+L G+ + H + H D+K N+++ +K+ DFGLA +
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVE 308
G + T + PE++ G+ D+WS G I LL+G P G T+ E
Sbjct: 171 DG--VEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQE 225
Query: 309 QLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSID 368
L I + EE++ +E KDF I LL +
Sbjct: 226 TLANITSVSYDFDEEFFSH------------------TSELAKDF-------IRKLLVKE 260
Query: 369 PDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVD 428
R T AL + + S R++ RR+ + V
Sbjct: 261 TRKRLTIQEALRHPWITPV----DNQQAMVRRESVVNLENFRKQYVRRR--WKLSFSIVS 314
Query: 429 GAKRVR 434
+
Sbjct: 315 LCNHLT 320
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-55
Identities = 77/356 (21%), Positives = 130/356 (36%), Gaps = 53/356 (14%)
Query: 36 SGNVVRLGKERARAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPR 95
SG+V G+ + A K +R P +E +G +
Sbjct: 2 SGSV-SSGQAHSLASLAKTWSSGS--AKLQRLGPETEDNEGVLL-TEKLKPVDYEYREEV 57
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
++G+G++ V++ +D TG A+KKVR + E E++ L
Sbjct: 58 H--WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLS 108
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAAC--QGVKFSEPQVKCYMKQLLSGL 212
P ++ L G R + + E +E G L Q E + Y+ Q L GL
Sbjct: 109 SPRIVPLYG--AVREGPWVNIFMELLE---GGSLGQLIKQMGCLPEDRALYYLGQALEGL 163
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGIL-KIADFGLAT-FYDPGLKQPMTSR---VVTLWYR 267
E+ H +LH D+K N+L+ +DG + DFG A GL + + + T +
Sbjct: 164 EYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
PE+++G VD+WS+ C++ +L G P T+ + K+ P
Sbjct: 224 APEVVMG-KPCDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEP------- 272
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
P + A I+ L +P +R +A
Sbjct: 273 ---------PPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRRKVG 312
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 6e-55
Identities = 91/367 (24%), Positives = 143/367 (38%), Gaps = 73/367 (19%)
Query: 44 KERARAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKL 103
+ RA + ++ E ++ + +G + G A F +
Sbjct: 36 QRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQK 95
Query: 104 ----DKIGQGTYSNVYKARDLLTGKIVALK-----KVRFDNLEPESVKFM-AREILVLRK 153
D IG+G S V + TG A+K R + E V+ RE +LR+
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 154 L-DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVK 202
+ HP++I L S ++LVF+ + V SE + +
Sbjct: 156 VAGHPHIITLIDSYESSSF--MFLVFDL----------MRKGELFDYLTEKVALSEKETR 203
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262
M+ LL + H N ++HRD+K N+L+D++ ++++DFG + +PG + +
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCG 261
Query: 263 TLWYRPPELLLGATY-----YGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFK 315
T Y PE+L + YG VDLW+ G IL LLAG P P R ++ L I
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP--PFWHRRQILMLRMI-- 317
Query: 316 LCGSPS--EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG 373
+ G W + T KD LI LL +DP+ R
Sbjct: 318 MEGQYQFSSPEWDD------------------RSSTVKD-------LISRLLQVDPEARL 352
Query: 374 TATAALN 380
TA AL
Sbjct: 353 TAEQALQ 359
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 8e-55
Identities = 69/329 (20%), Positives = 121/329 (36%), Gaps = 62/329 (18%)
Query: 89 IRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREI 148
I ++ N +G G+ V G+ VA+K+ + + EI
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR-----MLIDFCDIALMEI 59
Query: 149 LVLRKLD-HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLA------GLAACQGVKFSEPQV 201
+L + D HPNVI+ T+ LY+ E +L ++ E
Sbjct: 60 KLLTESDDHPNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-------------DGILKIADFGLATF 248
++Q+ SG+ H H+ ++HRD+K N+L+ + + I+DFGL
Sbjct: 118 ISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 249 YDPG---LKQPMTSRVVTLWYRPPELLLGAT------YYGVGVDLWSAGCILAELL-AGK 298
D G + + + T +R PELL + +D++S GC+ +L GK
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 299 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSL 358
P + + I + + +L + + + R + D
Sbjct: 238 H--PFGDKYSRESNIIR------GIF---------SLDEMKCLHDRSLIAEATD------ 274
Query: 359 PLIETLLSIDPDNRGTATAALNSEFFNTE 387
LI ++ DP R TA L F +
Sbjct: 275 -LISQMIDHDPLKRPTAMKVLRHPLFWPK 302
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-54
Identities = 61/304 (20%), Positives = 115/304 (37%), Gaps = 40/304 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ + +G+G + V++ + + K K V+ + VK +EI +L H N+
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNI 63
Query: 160 IKLEGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+ L S L ++FE++ D+ + +E ++ Y+ Q+ L+ H++
Sbjct: 64 LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 219 GVLHRDIKGSNLLIDN--DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ H DI+ N++ +KI +FG A PG Y PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH-D 178
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
D+WS G ++ LL+G P T + + I + EE +K+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAFKE------- 229
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPS 394
I+ DF ++ LL + +R TA+ AL + +
Sbjct: 230 -----------ISIEAMDF-------VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 395 SLPK 398
+
Sbjct: 272 VIRT 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-54
Identities = 61/314 (19%), Positives = 116/314 (36%), Gaps = 43/314 (13%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMA--------- 145
N + + + QG ++ + K ALK K + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 146 ---REILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME--------HDLAGLAACQGV 194
E+ ++ + + + EG++T+ +Y+++EYME L
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 195 KFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253
+KC +K +L+ + HN + HRD+K SN+L+D +G +K++DFG + +
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 254 KQPMTSRVVTLWYRPPELLLG-ATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLH 311
+ T + PPE ++Y G VD+WS G L + P + VE +
Sbjct: 207 ---IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263
Query: 312 KIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN 371
I + + P + + + + ++ L +P
Sbjct: 264 NIRT------KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
Query: 372 RGTATAALNSEFFN 385
R T+ AL E+
Sbjct: 314 RITSEDALKHEWLA 327
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 74/339 (21%), Positives = 123/339 (36%), Gaps = 80/339 (23%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMAREILVLRKL 154
+ IGQG+Y V A + T I A+K K + + P+ V+ + E+ +++KL
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYME-------------------------------- 182
HPN+ +L + + LV E
Sbjct: 86 HHPNIARLYEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 183 --------HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI-- 232
+ G E + M+Q+ S L + HN G+ HRDIK N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 233 DNDGILKIADFGLATFY---DPGLKQPMTSRVVTLWYRPPELLLGATY-YGVGVDLWSAG 288
+ +K+ DFGL+ + + G MT++ T ++ PE+L YG D WSAG
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 289 CILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKKSKLPNATLFKPQQPYKRCI 346
+L LL G PG + + + ++ + +
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNYNV------------------L 303
Query: 347 AETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
+ +D L+ LL+ + D R A AL + +
Sbjct: 304 SPLARD-------LLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 2e-54
Identities = 78/348 (22%), Positives = 137/348 (39%), Gaps = 70/348 (20%)
Query: 93 TPRRANTFEKL----DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFM 144
T R + +++G G ++ V K R+ TG A K ++ S + +
Sbjct: 2 TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI 61
Query: 145 AREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------V 194
RE+ +L+++ HPNVI L + ++ + L+ E G
Sbjct: 62 EREVSILKEIQHPNVITLHEVYENKTD--VILILEL----------VAGGELFDFLAEKE 109
Query: 195 KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFYD 250
+E + ++KQ+L+G+ + H+ + H D+K N+++ +KI DFGLA D
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 251 PGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVE 308
G + T + PE++ G+ D+WS G I LL+G P G T+ E
Sbjct: 170 FG--NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQE 224
Query: 309 QLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSID 368
L + + +EY+ + KDF I LL D
Sbjct: 225 TLANVSAVNYEFEDEYFSN------------------TSALAKDF-------IRRLLVKD 259
Query: 369 PDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARR 416
P R T +L + + +L + + M+ K ++ AR+
Sbjct: 260 PKKRMTIQDSLQHPWIKPKD---TQQALSRKASAVNME-KFKKFAARK 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-54
Identities = 59/308 (19%), Positives = 108/308 (35%), Gaps = 62/308 (20%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPN 158
F +L+KIG G + +V+K L G I A+K+ + + RE+ L H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL---AACQGVKFSEPQVKCYMKQLLSGLEH 214
V++ + + EY LA F E ++K + Q+ GL +
Sbjct: 73 VVRYFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 215 CHNNGVLHRDIKGSNLLIDNDGIL-------------------KIADFGLATFYDPGLKQ 255
H+ ++H DIK SN+ I I KI D G T +
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT----RISS 186
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
P + E+L + D+++ + +P +P +Q H+I +
Sbjct: 187 PQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP-LP--RNGDQWHEIRQ 242
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
G +P +++ F + ++ ++ DP+ R +A
Sbjct: 243 --GRLPR-------IPQ------------VLSQEFTEL-------LKVMIHPDPERRPSA 274
Query: 376 TAALNSEF 383
A +
Sbjct: 275 MALVKHSV 282
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-54
Identities = 92/342 (26%), Positives = 147/342 (42%), Gaps = 64/342 (18%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+ IG+G +S V + + TG+ A+K +F + S + + RE + L HP+++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 161 KLEGLVTSRMSCSLYLVFEYME-----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
+L +S LY+VFE+M+ ++ A G +SE YM+Q+L L +C
Sbjct: 90 ELLETYSSDGM--LYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYC 146
Query: 216 HNNGVLHRDIKGSNLLI---DNDGILKIADFGLAT-FYDPGLKQPMTSRVVTLWYRPPEL 271
H+N ++HRD+K +L+ +N +K+ FG+A + G RV T + PE+
Sbjct: 147 HDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEV 204
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFK--LCGSPS--EEYW 325
+ YG VD+W G IL LL+G P G E ++F+ + G W
Sbjct: 205 VKR-EPYGKPVDVWGCGVILFILLSGCL--PFYGTKE-----RLFEGIIKGKYKMNPRQW 256
Query: 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
I+E+ KD L+ +L +DP R T ALN +
Sbjct: 257 SH------------------ISESAKD-------LVRRMLMLDPAERITVYEALNHPWL- 290
Query: 386 TEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAV 427
E E +LR+ ARR+ L G A
Sbjct: 291 -----KERDRYAYKIHLPETVEQLRKFNARRK--LKGAVLAA 325
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-54
Identities = 82/291 (28%), Positives = 122/291 (41%), Gaps = 60/291 (20%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
+G G +S V+ + LTGK+ ALK ++ + + EI VL+K+ H N++ LE
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIVTLED 73
Query: 165 LVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQLLSGLEH 214
+ S YLV + G ++E ++Q+LS +++
Sbjct: 74 IYESTTH--YYLVMQL----------VSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 215 CHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
H NG++HRD+K NLL + + + I DFGL+ G M++ T Y PE+
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEV 178
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKKSK 329
L Y VD WS G I LL G P TE + KI + G +W
Sbjct: 179 LAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEFESPFWDD-- 233
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
I+E+ KDF I LL DP+ R T AL+
Sbjct: 234 ----------------ISESAKDF-------ICHLLEKDPNERYTCEKALS 261
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-54
Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 62/301 (20%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLD 155
+E +++G G ++ V K R TGK A K ++ L S + + RE+ +LR++
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYM 205
HPN+I L + ++ + L+ E G +E + ++
Sbjct: 67 HPNIITLHDIFENKTD--VVLILEL----------VSGGELFDFLAEKESLTEDEATQFL 114
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDN----DGILKIADFGLATFYDPGLKQPMTSRV 261
KQ+L G+ + H+ + H D+K N+++ + + +K+ DFG+A + G +
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIF 172
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGS 319
T + PE++ G+ D+WS G I LL+G P G T+ E L I +
Sbjct: 173 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNISAVNYD 229
Query: 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379
EEY+ +E KDF I LL DP R T +L
Sbjct: 230 FDEEYFSN------------------TSELAKDF-------IRRLLVKDPKRRMTIAQSL 264
Query: 380 N 380
Sbjct: 265 E 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-54
Identities = 70/285 (24%), Positives = 124/285 (43%), Gaps = 37/285 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPN 158
++ L+++G G + V++ + TG++ K + +VK EI ++ +L HP
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPK 109
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+I L + + L+ E++ +L A + K SE +V YM+Q GL+H H
Sbjct: 110 LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 218 NGVLHRDIKGSNLLIDN--DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
+ ++H DIK N++ + +KI DFGLAT +P + + T + PE++
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR- 224
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
G D+W+ G + LL+G G ++E L + + E+ +
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS-------- 276
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
++ KDF I+ LL +P R T AL
Sbjct: 277 ----------VSPEAKDF-------IKNLLQKEPRKRLTVHDALE 304
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 184 bits (467), Expect = 5e-54
Identities = 50/363 (13%), Positives = 91/363 (25%), Gaps = 64/363 (17%)
Query: 63 PPERRRPHSESQQGWPSWLMAVAGDAIRDWTP--------RRANTFEKLDKIGQGTYSNV 114
E+ + + + AV + + ++ + G S V
Sbjct: 19 EELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVV 78
Query: 115 YKARDLLTGKIVALKKVRFDNLEPES-VKFMAREILVLRKLDHPN--------------- 158
+ RD+ + ALK S ++ + +L +
Sbjct: 79 FLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138
Query: 159 ---------VIKLEGLVTSRMSCSLYLVFEYMEHDLAGL------AACQGVKFSEPQVKC 203
+L + L+ DL L +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198
Query: 204 YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVT 263
QL+ + + G++H NL I DG L + D + V
Sbjct: 199 LTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG----TRGPASSVP 254
Query: 264 LWYRPPELLLG-ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322
+ Y P E L + ++ W G + + P F L +
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P-----------FGLVTPGIK 301
Query: 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382
WK+ L + + K LI L+ D R A+ +
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-------LIGRFLNFDRRRRLLPLEAMETP 354
Query: 383 FFN 385
F
Sbjct: 355 EFL 357
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 9e-54
Identities = 74/355 (20%), Positives = 135/355 (38%), Gaps = 68/355 (19%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLD 155
++ +++G G ++ V K R+ TG A K ++ + + RE+ +LR++
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYM 205
HPN+I L + +R + L+ E G SE + ++
Sbjct: 74 HPNIITLHDVYENRTD--VVLILEL----------VSGGELFDFLAQKESLSEEEATSFI 121
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFYDPGLKQPMTSRV 261
KQ+L G+ + H + H D+K N+++ +K+ DFGLA + G +
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIF 179
Query: 262 VTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGS 319
T + PE++ G+ D+WS G I LL+G P G T+ E L I +
Sbjct: 180 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITAVSYD 236
Query: 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379
EE++ + +E KDF I LL + R T AL
Sbjct: 237 FDEEFFSQ------------------TSELAKDF-------IRKLLVKETRKRLTIQEAL 271
Query: 380 NSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVR 434
+ ++ + ++ +++ RR+ + V +
Sbjct: 272 RHPWITPVD---TQQAMVRRESVVNLE-NFKKQYVRRR--WKLSFSIVSLCNHLT 320
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-53
Identities = 82/287 (28%), Positives = 122/287 (42%), Gaps = 38/287 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES-VKFMAREILVLRKLDHPN 158
FE +G+G + NVY AR+ + I+ALK + LE + RE+ + L HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+++L G +YL+ EY + KF E + Y+ +L + L +CH+
Sbjct: 71 ILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS 127
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
V+HRDIK NLL+ + G LKIADFG + + + TL Y PPE++ G
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEGRM- 183
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
+ VDLWS G + E L GKP T E +I ++ E+ P+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF----TFPD----- 228
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ LI LL +P R L +
Sbjct: 229 --------------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 1e-52
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 44/286 (15%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH-PNVIKLE 163
++G+G ++ V + TG+ A K ++ + + EI VL P VI L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 164 GLVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
+ + + L+ EY L SE V +KQ+L G+ + H N
Sbjct: 96 EVYENTSE--IILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 220 VLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
++H D+K N+L+ + G +KI DFG++ + + T Y PE+L
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPEILNY-D 208
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
D+W+ G I LL P G E I ++ SEE +
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNISQVNVDYSEETFSS------- 259
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+++ DF I++LL +P+ R TA L+
Sbjct: 260 -----------VSQLATDF-------IQSLLVKNPEKRPTAEICLS 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-52
Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 40/288 (13%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE 163
+IG+G++ VYK D T VA +++ L + E +L+ L HPN+++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 164 G--LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLE--HCHNN 218
T + + LV E M L ++ + +Q+L GL+ H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 219 GVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGAT 276
++HRD+K N+ I G +KI D GLAT + V+ T + PE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPE--MYEE 204
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
Y VD+++ G + E+ + P +E + +I++ S
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSGV--------------- 246
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
KP K I E K+ IE + + D R + LN FF
Sbjct: 247 KPASFDKVAIPE-VKEI-------IEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-52
Identities = 78/373 (20%), Positives = 135/373 (36%), Gaps = 46/373 (12%)
Query: 11 RSSPVNRRGSERASVTVTVSSGAVVSGNVVRLGKERARAETEKNRRHTGDFGPPERRRPH 70
R N+ G + + V+ R + + +
Sbjct: 81 RIIAENKHGQSKPCE----PTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYV 136
Query: 71 SESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKK 130
+ + + + + D + D ++ +++G G + V++ + TG A K
Sbjct: 137 FDIWKQYYPQPVEIKHDHVLD-------HYDIHEELGTGAFGVVHRVTERATGNNFAAKF 189
Query: 131 VRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLA 189
V + + + +EI + L HP ++ L + +++E+M +L
Sbjct: 190 VMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE--MVMIYEFMSGGELFEKV 245
Query: 190 ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN--DGILKIADFGLAT 247
A + K SE + YM+Q+ GL H H N +H D+K N++ LK+ DFGL
Sbjct: 246 ADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305
Query: 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV 307
DP Q + T + PE+ G G D+WS G + LL+G G +
Sbjct: 306 HLDPK--QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362
Query: 308 EQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSI 367
E L + + + + I+E KDF I LL
Sbjct: 363 ETLRNVKSCDWNMDDSAFSG------------------ISEDGKDF-------IRKLLLA 397
Query: 368 DPDNRGTATAALN 380
DP+ R T AL
Sbjct: 398 DPNTRMTIHQALE 410
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-52
Identities = 75/370 (20%), Positives = 133/370 (35%), Gaps = 51/370 (13%)
Query: 97 ANTFEKLDKIGQG--TYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL 154
+E L IG+G V AR TG+ V ++++ + E V F+ E+ V +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLS 210
+HPN++ + L++V +M DL + +E + ++ +L
Sbjct: 84 NHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLK 139
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG-LATFYDPGLKQ-----PMTSRVVTL 264
L++ H+ G +HR +K S++LI DG + ++ + G +Q V L
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 265 WYRPPELLL-GATYYGVGVDLWSAGCILAELLAGKP------------------------ 299
+ PE+L Y D++S G EL G
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 300 IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLP 359
E + + S + S + P PY R + F F
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF------ 313
Query: 360 LIETLLSIDPDNRGTATAALNSEFF-NTEPYACEPSSLPKYPPSKEMDVKLREEEARRQR 418
+E L +PD R +A+ LN FF + A +LP+ +++
Sbjct: 314 -VEQCLQRNPDARPSASTLLNHSFFKQIKRRA--SEALPELLRPVTPITNFEGSQSQDHS 370
Query: 419 GLSGKANAVD 428
G+ G ++
Sbjct: 371 GIFGLVTNLE 380
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-52
Identities = 98/358 (27%), Positives = 153/358 (42%), Gaps = 80/358 (22%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAR----EILVLR 152
A +E L IG+G++ V KA D + VALK VR + K R EI +L
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILE 148
Query: 153 KL------DHPNVIKLEG---------LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFS 197
L + NVI + + +S +LY E ++ + + FS
Sbjct: 149 HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLY---ELIKKN-------KFQGFS 198
Query: 198 EPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG--ILKIADFGLATFYDPGLKQ 255
P V+ + +L L+ H N ++H D+K N+L+ G +K+ DFG + + Q
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH----Q 254
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
+ + + + +YR PE++LGA Y G+ +D+WS GCILAELL G P++PG E +QL + +
Sbjct: 255 RVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAET------------------FKDFPSSS 357
L G PS++ SK A F + Y R T + P S
Sbjct: 314 LLGMPSQKLLDASK--RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESR 371
Query: 358 LP--------------LIETLLSIDPDNRGTATAALNSEFFN---TEPYACEPSSLPK 398
++ L DP R T AL + +P E +S+ +
Sbjct: 372 EWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 8e-52
Identities = 51/347 (14%), Positives = 99/347 (28%), Gaps = 81/347 (23%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRK 153
R T + +GQ +A D TG+ + F P ++K M E+L LR
Sbjct: 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 129
Query: 154 L-------------------------DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 188
L +I++ S + ++ M+ +L
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189
Query: 189 ------AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIAD 242
+ Q++ L H+ G++H ++ ++++D G + +
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249
Query: 243 FGLATFYDPGLKQPMTSRVVTLWYRPPELL----------LGATYYGVGVDLWSAGCILA 292
F V+ + PPEL T D W+ G ++
Sbjct: 250 FEHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 293 ELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKD 352
+ + + IF+ C K+
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSC---------------------------------KN 331
Query: 353 FPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKY 399
P L+E L ++R A+ + + ++LP Y
Sbjct: 332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR-TELSAALPLY 377
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 3e-51
Identities = 86/307 (28%), Positives = 125/307 (40%), Gaps = 42/307 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESV-KFMAREILVLRKLDHPN 158
F+ +G+G + NVY AR+ I+ALK + LE E V + REI + L HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
++++ R +YL+ E+ +L G +F E + +M++L L +CH
Sbjct: 76 ILRMYNYFHDRKR--IYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE 132
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
V+HRDIK NLL+ G LKIADFG + ++ M TL Y PPE++ G T
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYLPPEMIEGKT- 188
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
+ VDLW AG + E L G P + E +I + + K P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL----KFPP----- 233
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLP 397
S LI LL P R + + LP
Sbjct: 234 --------------FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN----SRRVLP 275
Query: 398 KYPPSKE 404
S +
Sbjct: 276 PVYQSTQ 282
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 7e-51
Identities = 88/359 (24%), Positives = 128/359 (35%), Gaps = 79/359 (22%)
Query: 43 GKERARAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEK 102
+ + + + W+ DA+ D FE
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD-------FFEV 57
Query: 103 LDKIGQGTYSNVYKARDLLTGKIVAL----KKVRFDNLEPESVKFMAREILVLRKLDHPN 158
++G+G S VY+ + T K AL K V + EI VL +L HPN
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR--------TEIGVLLRLSHPN 109
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQL 208
+IKL+ + + + LV E G +SE +KQ+
Sbjct: 110 IIKLKEIFETPTE--ISLVLEL----------VTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLW 265
L + + H NG++HRD+K NLL D LKIADFGL+ + M + T
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPG 215
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK--LCGSPS-- 321
Y PE+L G YG VD+WS G I LL G P E +F+ L
Sbjct: 216 YCAPEILRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRRILNCEYYFI 271
Query: 322 EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+W + ++ KD + L+ +DP R T AL
Sbjct: 272 SPWWDE------------------VSLNAKDL-------VRKLIVLDPKKRLTTFQALQ 305
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 8e-51
Identities = 81/312 (25%), Positives = 141/312 (45%), Gaps = 38/312 (12%)
Query: 102 KLDK-IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+L K IG+G ++ V AR +LTG+ VA+K + L P S++ + RE+ +++ L+HPN++
Sbjct: 18 RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIV 77
Query: 161 KL-EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
KL E + T + LYL+ EY ++ G + E + + +Q++S +++CH
Sbjct: 78 KLFEVIETEKT---LYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQK 133
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
++HRD+K NLL+D D +KIADFG + + G + + Y PEL G Y
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYD 191
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
G VD+WS G IL L++G G+ E ++ + G ++
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR--GKYRIPFY------------- 236
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPK 398
+ L++ L ++P RGT + + N E +
Sbjct: 237 --------------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE 282
Query: 399 YPPSKEMDVKLR 410
++
Sbjct: 283 PELDISDQKRID 294
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 64/293 (21%), Positives = 105/293 (35%), Gaps = 56/293 (19%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKL 162
+G G V + TG+ ALK + +E+ + P+++ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSPKARQEVDHHWQASGGPHIVCI 87
Query: 163 EGLV--TSRMSCSLYLVFEYMEHDLAG------LAACQGVKFSEPQVKCYMKQLLSGLEH 214
+ L ++ E ME G + F+E + M+ + + ++
Sbjct: 88 LDVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143
Query: 215 CHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
H++ + HRD+K NLL + D +LK+ DFG A + + T +Y PE
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPE- 199
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK--LCGSPS--EEYWKK 327
+LG Y D+WS G I+ LL G P T + + G W +
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
++E K LI LL DP R T T +N
Sbjct: 260 ------------------VSEDAKQ-------LIRLLLKTDPTERLTITQFMN 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-50
Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 50/294 (17%)
Query: 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
+G+GTY VY RDL +A+K++ + + + EI + + L H N+++
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 162 LEGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKF--SEPQVKCYMKQLLSGLEHCHNN 218
G + + + + E + L+ L + +E + Y KQ+L GL++ H+N
Sbjct: 84 YLG--SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 219 GVLHRDIKGSNLLIDN-DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
++HRDIKG N+LI+ G+LKI+DFG + G+ + TL Y PE++
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 278 -YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
YG D+WS GC + E+ GKP P + + P A +F
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKP--P----------------------FYELGEPQAAMF 236
Query: 337 K-------PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
K P+ P ++ K F I DPD R A L EF
Sbjct: 237 KVGMFKVHPEIP--ESMSAEAKAF-------ILKCFEPDPDKRACANDLLVDEF 281
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-50
Identities = 86/367 (23%), Positives = 144/367 (39%), Gaps = 70/367 (19%)
Query: 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAR----EILVLRKL---- 154
+ K+G G +S V+ A+D++ VA+K VR K EI +L+++
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-------GDKVYTEAAEDEIKLLQRVNDAD 76
Query: 155 -------DHPNVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLAAC-QGVKFSEPQVKCY 204
+++KL + +VFE + +L L + VK
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 205 MKQLLSGLEHCH-NNGVLHRDIKGSNLLID------NDGILKIADFGLATFYDPGLKQPM 257
KQLL GL++ H G++H DIK N+L++ N +KIAD G A +YD +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD----EHY 192
Query: 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQLH 311
T+ + T YR PE+LLGA +G G D+WS C++ EL+ G + + + +
Sbjct: 193 TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251
Query: 312 KIFKLCGSPSEEYWKKSKL--------------------PNATLFKPQQPYKRCIAETFK 351
+I +L G + K P + + + + A+
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311
Query: 352 DFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLRE 411
DF + +L +DP R A +N + E + D+
Sbjct: 312 DF-------LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364
Query: 412 EEARRQR 418
EE R +
Sbjct: 365 EEVRDHK 371
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 8e-50
Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 46/289 (15%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
+G+G Y V A + +T + VA+K R + PE++K +EI + + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 163 -EGLVTSRMSCSLYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+ YL EY D + EP + + QL++G+ + H
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGAT 276
G+ HRDIK NLL+D LKI+DFGLAT + ++ + +++ TL Y PELL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
++ VD+WS G +L +LAG+ +P + +EY + +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE---KKTY 227
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
+K S+ L L+ +L +P R T ++N
Sbjct: 228 LNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-50
Identities = 74/319 (23%), Positives = 124/319 (38%), Gaps = 45/319 (14%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
+ +E + IG G + V A + VA+K++ + + + + +EI + +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMSQ 69
Query: 154 LDHPNVIKLEG--LVTSRMSCSLYLVFEYME----HDL----AGLAACQGVKFSEPQVKC 203
HPN++ +V L+LV + + D+ + E +
Sbjct: 70 CHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 204 YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF-YDPGLKQPMTSR-- 260
++++L GLE+ H NG +HRD+K N+L+ DG ++IADFG++ F G R
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 261 -VVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGS 319
V T + PE++ Y D+WS G EL G P HK
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--P-------YHKY-----P 231
Query: 320 PSEEYWKKSKLPNATLFKPQQPYKRCIA--ETFKDFPSSSLPLIETLLSIDPDNRGTATA 377
P + + +L Q + ++F+ I L DP+ R TA
Sbjct: 232 PMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKM-------ISLCLQKDPEKRPTAAE 284
Query: 378 ALNSEFFNTEPYACEPSSL 396
L +FF A L
Sbjct: 285 LLRHKFFQK---AKNKEFL 300
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-49
Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 71/301 (23%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMAREILVLRKLD-HPNV 159
+G+G++S K + + A+K K N + +EI L+ + HPN+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNI 68
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQLL 209
+KL + ++ +LV E G FSE + M++L+
Sbjct: 69 VKLHEVFHDQLH--TFLVMEL----------LNGGELFERIKKKKHFSETEASYIMRKLV 116
Query: 210 SGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
S + H H+ GV+HRD+K NLL +++ +KI DFG A P QP+ + TL Y
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHY 175
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIFK--LCGSPS 321
PE LL Y DLWS G IL +L+G+ +I K G S
Sbjct: 176 AAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234
Query: 322 --EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379
E WK +++ KD LI+ LL++DP+ R +
Sbjct: 235 FEGEAWKN------------------VSQEAKD-------LIQGLLTVDPNKRLKMSGLR 269
Query: 380 N 380
Sbjct: 270 Y 270
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-49
Identities = 80/319 (25%), Positives = 132/319 (41%), Gaps = 48/319 (15%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
+G+G Y V A + +T + VA+K R + PE++K +EI + + L+H NV+K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVKF 70
Query: 163 -EGLVTSRMSCSLYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+ YL EY D + EP + + QL++G+ + H
Sbjct: 71 YGHRREGNI---QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGAT 276
G+ HRDIK NLL+D LKI+DFGLAT + ++ + +++ TL Y PELL
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
++ VD+WS G +L +LAG+ +P + +EY + +
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE---KKTY 227
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT--EPYACEPS 394
+K S+ L L+ +L +P R T ++N + A P
Sbjct: 228 LNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPR 277
Query: 395 SLPKYPPSKEMDVKLREEE 413
+
Sbjct: 278 VTSGGVSESPSGFSKHIQS 296
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 75/323 (23%), Positives = 124/323 (38%), Gaps = 65/323 (20%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALK------------------------ 129
+ N + D+IG+G+Y V A + A+K
Sbjct: 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRP 68
Query: 130 KVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH----DL 185
++ + +EI +L+KLDHPNV+KL ++ LY+VFE + ++
Sbjct: 69 APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128
Query: 186 AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGL 245
SE Q + Y + L+ G+E+ H ++HRDIK SNLL+ DG +KIADFG+
Sbjct: 129 P----TLK-PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 246 ATFYDPGLKQPMTSRVVTLWYRPPELLLGAT--YYGVGVDLWSAGCILAELLAGK-PIMP 302
+ + + V T + PE L + G +D+W+ G L + G+ P M
Sbjct: 184 SNEFKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM- 241
Query: 303 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIE 362
+ KI + + P+ KD LI
Sbjct: 242 DERIMCLHSKIKS------QAL----EFPDQPDIAED----------LKD-------LIT 274
Query: 363 TLLSIDPDNRGTATAALNSEFFN 385
+L +P++R +
Sbjct: 275 RMLDKNPESRIVVPEIKLHPWVT 297
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-49
Identities = 78/349 (22%), Positives = 127/349 (36%), Gaps = 84/349 (24%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAR----EILVLR 152
N F + K+G GT+ V + + K A+K VR ++K R E +L+
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILK 86
Query: 153 KL-----DHPNVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLAACQGVKFS 197
K+ ++ N++K G L+ + SLY E + ++ G F
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIITRNNYNG--------FH 135
Query: 198 EPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSN-LLIDNDGI------------------- 237
+K Y ++L L + + H D+K N LL D
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 238 -----LKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILA 292
+K+ DFG ATF S + T YR PE++L + V D+WS GC+LA
Sbjct: 196 TKSTGIKLIDFGCATFKS----DYHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLA 250
Query: 293 ELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKD 352
EL G + +E L + + + ++ N + + + K E
Sbjct: 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASS 310
Query: 353 FPS-----SSLP------------LIETLLSIDPDNRGTATAALNSEFF 384
S LP + ++L IDP R + L +F
Sbjct: 311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-48
Identities = 77/363 (21%), Positives = 124/363 (34%), Gaps = 81/363 (22%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK-IVALKKVRFDNLEPESVKFMAR----EILVL 151
+E + +G+GT+ V + D GK VALK +R +V EI VL
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVL 70
Query: 152 RKL------DHPNVIKLEG---------LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKF 196
+K+ + + + + + + + + L +
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTF--------EF--LKENNFQPY 120
Query: 197 SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSN-LLIDNDGI------------------ 237
P V+ QL L H N + H D+K N L ++++
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 238 LKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG 297
+++ADFG ATF + T+ V T YRPPE++L + D+WS GCIL E G
Sbjct: 181 IRVADFGSATFDH----EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRG 235
Query: 298 KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSS 357
+ E L + K+ G +++ F + + +
Sbjct: 236 FTLFQTHENREHLVMMEKILGPIPSHMIHRTR--KQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 358 LPL-----------------IETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYP 400
PL + +L DP R T AL FF E S
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF-AGLTPEERSFHTSRN 352
Query: 401 PSK 403
PS+
Sbjct: 353 PSR 355
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 82/317 (25%), Positives = 132/317 (41%), Gaps = 50/317 (15%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALK-----KVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+G+G+Y V + D T A+K K+R +VK +EI +LR+L H NVI
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVI 69
Query: 161 KLEGLVTSRMSCSLYLVFEYMEHDLAGL--AACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+L ++ + +Y+V EY + + + + +F Q Y QL+ GLE+ H+
Sbjct: 70 QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM--TSRVVTLWYRPPELLLGA- 275
G++H+DIK NLL+ G LKI+ G+A P TS+ + ++PPE+ G
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-GSPAFQPPEIANGLD 187
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
T+ G VD+WSAG L + G P G + I K Y +P
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGK------GSY----AIP-- 233
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
D L++ +L +P R + +F +
Sbjct: 234 -----------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH--PPA 274
Query: 394 SSLPKYPPSKEMDVKLR 410
+ PPS + + R
Sbjct: 275 EAPVPIPPSPDTKDRWR 291
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-48
Identities = 76/386 (19%), Positives = 134/386 (34%), Gaps = 67/386 (17%)
Query: 62 GPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLD----KIGQGTYSNVYKA 117
PP PH +Q P ++ + +G G V +
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 118 RDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLV--TSRMSCSL 174
+ T + ALK + + RE+ + + P+++++ + L
Sbjct: 82 FNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 175 YLVFEYMEHDLAG------LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGS 228
+V E ++ G + F+E + MK + +++ H+ + HRD+K
Sbjct: 135 LIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190
Query: 229 NLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLW 285
NLL + ILK+ DFG A +T+ T +Y PE +LG Y D+W
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPE-VLGPEKYDKSCDMW 247
Query: 286 SAGCILAELLAGKPIMPGRTEVEQLHKIFK--LCGSPS--EEYWKKSKLPNATLFKPQQP 341
S G I+ LL G P + + G W +
Sbjct: 248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE-------------- 293
Query: 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYPP 401
++E K LI LL +P R T T +N P+ + + +P+ P
Sbjct: 294 ----VSEEVKM-------LIRNLLKTEPTQRMTITEFMNH------PWIMQSTKVPQTPL 336
Query: 402 SKEMDVKLREEEARRQRGLSGKANAV 427
L+E++ R + +A+
Sbjct: 337 HTS--RVLKEDKERWEDVKEEMTSAL 360
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 76/320 (23%), Positives = 118/320 (36%), Gaps = 73/320 (22%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLE 163
IG G+YS + T A+K + +P EI +L + HPN+I L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQHPNIITLK 82
Query: 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQLLSGLE 213
+ +Y+V E +G FSE + + + +E
Sbjct: 83 DVYDDGKY--VYVVTEL----------MKGGELLDKILRQKFFSEREASAVLFTITKTVE 130
Query: 214 HCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPP 269
+ H GV+HRD+K SN+L N ++I DFG A + + T + P
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTANFVAP 189
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKP---IMPGRTEVEQLHKIFKLCGSPS--EEY 324
E+L Y D+WS G +L +L G P T E L +I G S Y
Sbjct: 190 EVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI--GSGKFSLSGGY 246
Query: 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
W +++T KD L+ +L +DP R TA L +
Sbjct: 247 WNS------------------VSDTAKD-------LVSKMLHVDPHQRLTAALVLRHPWI 281
Query: 385 NTEPYACEPSSLPKYPPSKE 404
LP+Y +++
Sbjct: 282 ------VHWDQLPQYQLNRQ 295
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-48
Identities = 72/347 (20%), Positives = 123/347 (35%), Gaps = 78/347 (22%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTG-KIVALKKVRFDNLEPESVKFMAR----EILVL 151
+ +E +D +G+G + V + D G + VA+K V+ +V EI VL
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVL 65
Query: 152 RKL------DHPNVIKLEG---------LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKF 196
L +++ +V + S Y D + + F
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY--------DF--IKENGFLPF 115
Query: 197 SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSN-LLIDNDGI------------------ 237
++ Q+ + H+N + H D+K N L + +D
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 238 LKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG 297
+K+ DFG AT+ D + ++ V T YR PE++L + D+WS GCIL E G
Sbjct: 176 IKVVDFGSATYDD----EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLG 230
Query: 298 KPIMPGRTEVEQLHKIFKLCGSPSEEY----------------WKKSKLPNATLFKPQQP 341
+ P E L + ++ G + W + + + +P
Sbjct: 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP 290
Query: 342 YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388
K + + LI+ +L DP R T AL FF+
Sbjct: 291 LKEFMLSQDVEHE-RLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-48
Identities = 79/353 (22%), Positives = 133/353 (37%), Gaps = 94/353 (26%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAR----EILVLR 152
+ +E IG+G++ V KA D + + VA+K ++ + K E+ +L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLE 105
Query: 153 KL------DHPNVIKLEG---------LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFS 197
+ ++ L+ LV +S +LY + + S
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY---DLLR-------NTNFRGVS 155
Query: 198 EPQVKCYMKQLLSGLEHCHNN--GVLHRDIKGSNLLIDNDG--ILKIADFGLATFYDPGL 253
+ + +Q+ + L ++H D+K N+L+ N +KI DFG +
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--- 212
Query: 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
Q + + + +YR PE+LLG Y + +D+WS GCIL E+ G+P+ G EV+Q++KI
Sbjct: 213 -QRIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
Query: 314 FKLCGSPSEEYWKKS---------------------------------KLPNATLFKPQQ 340
++ G P ++ KL N +
Sbjct: 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330
Query: 341 PYKRCIAET---------FKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
P R E+ FKD I +L DP R AL FF
Sbjct: 331 PGGRRAGESGHTVADYLKFKDL-------ILRMLDYDPKTRIQPYYALQHSFF 376
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 8e-48
Identities = 71/316 (22%), Positives = 113/316 (35%), Gaps = 78/316 (24%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKL 162
D +G+G ++ V +L+T + A+K + S + RE+ +L + H NV++L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLEL 76
Query: 163 EGLVTSRMSCSLYLVFEYMEHDLAGLAACQG----------VKFSEPQVKCYMKQLLSGL 212
YLVFE +G F+E + ++ + S L
Sbjct: 77 IEFFEEEDR--FYLVFEK----------MRGGSILSHIHKRRHFNELEASVVVQDVASAL 124
Query: 213 EHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPG------LKQPMTSRVVT 263
+ HN G+ HRD+K N+L + +KI DF L + + + +
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 264 LWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKP-----------IMPGRTEVE 308
Y PE++ A+ Y DLWS G IL LL+G P G
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 309 QLHKIFK--LCGSPS--EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETL 364
+ +F+ G ++ W I+ KD LI L
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAH------------------ISCAAKD-------LISKL 279
Query: 365 LSIDPDNRGTATAALN 380
L D R +A L
Sbjct: 280 LVRDAKQRLSAAQVLQ 295
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-47
Identities = 71/348 (20%), Positives = 122/348 (35%), Gaps = 53/348 (15%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALK-----KVRFDNL-EPESVKFMAREILVLRK 153
+ + +G G + V+ A D K V +K KV D E + + EI +L +
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 154 LDHPNVIKL-EGLVTSRMSCSLYLVFEYMEH--DLAGLAACQGVKFSEPQVKCYMKQLLS 210
++H N+IK+ + LV E DL + EP +QL+S
Sbjct: 86 VEHANIIKVLDIFENQGF---FQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVS 141
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
+ + ++HRDIK N++I D +K+ DFG A + + G + + T+ Y PE
Sbjct: 142 AVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPE 199
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330
+L+G Y G +++WS G L L+ + P +L + + + Y
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEE--NP----FCELEETVE--AAIHPPYL----- 246
Query: 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE--- 387
+ L+ LL P+ R T + +
Sbjct: 247 ----------------------VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284
Query: 388 PYACEPSSLPKYPPSKEMDVKLREEEARRQRGLSGKANAVDGAKRVRH 435
P + E R +A + G + H
Sbjct: 285 ADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGHHH 332
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 81/326 (24%), Positives = 142/326 (43%), Gaps = 47/326 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-ESVKFMAREILVLRKLDHPN 158
F L +IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L+KL HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 159 VIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
I+ G L +LV EY + L E ++ L GL + H
Sbjct: 116 TIQYRGCYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
++ ++HRD+K N+L+ G++K+ DFG A + P S V T ++ PE++L
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAMD 226
Query: 277 --YYGVGVDLWSAGCILA-ELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y VD+WS G I EL KP P + + ++ + +++ P
Sbjct: 227 EGQYDGKVDVWSLG-ITCIELAERKP--P-LFNMNAMSALYHI---------AQNESP-- 271
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
L +E F++F +++ L P +R T+ L F P
Sbjct: 272 ALQSGH------WSEYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR---ERPP 315
Query: 394 SSL-PKYPPSKEMDVKLREEEARRQR 418
+ + +K+ +L + R+ +
Sbjct: 316 TVIMDLIQRTKDAVRELDNLQYRKMK 341
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 74/315 (23%), Positives = 113/315 (35%), Gaps = 54/315 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA----REILVLRKLD 155
++ +G G + +VY + VA+K V D + E+++L+K+
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 156 H--PNVIKL-EGLVTSRMSCSLYLVFEYMEH--DLAGLAACQGVKFSEPQVKCYMKQLLS 210
VI+L + L+ E E DL +G E + + Q+L
Sbjct: 105 SGFSGVIRLLDWFERPDS---FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLE 160
Query: 211 GLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPP 269
+ HCHN GVLHRDIK N+LID N G LK+ DFG + T T Y PP
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPP 217
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329
E + Y+G +WS G +L +++ G +P + +I + G
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHD----EEIIR--GQVFFRQR---- 265
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE-- 387
S LI L++ P +R T N +
Sbjct: 266 -----------------------VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
Query: 388 PYACEPSSLPKYPPS 402
P L P
Sbjct: 303 PQETAEIHLHSLSPG 317
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-46
Identities = 51/372 (13%), Positives = 101/372 (27%), Gaps = 72/372 (19%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES-VKFMAREILVLRK 153
R T + +GQ +A D TG+ + F P + +K M E+L LR
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 154 L-------------------------DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 188
L +I++ S + ++ M+ +L
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 189 ------AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIAD 242
+ Q++ L H+ G++H ++ ++++D G + +
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 243 FGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA----TYYGVGVDLWSAGCILAELLAGK 298
F P+ +L T D W+ G + +
Sbjct: 255 FEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 299 PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSL 358
+ IF+ C + +
Sbjct: 315 LPNTDDAALGGSEWIFRSCKNIPQPVR--------------------------------- 341
Query: 359 PLIETLLSIDPDNRGTATAALNSEFFN---TEPYACEPSSLPKYPPSKEMDVKLREEEAR 415
L+E L ++R A+ + + TE A P P++E
Sbjct: 342 ALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQP 401
Query: 416 RQRGLSGKANAV 427
+ G + A+
Sbjct: 402 DEAGAAEAVTAI 413
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-46
Identities = 72/315 (22%), Positives = 116/315 (36%), Gaps = 55/315 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----ESVKFMAREILVLRKLD 155
+ +G+G + V+ L VA+K + + + E+ +L K+
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 156 ----HPNVIKL-EGLVTSRMSCSLYLVFEYMEH--DLAGLAACQGVKFSEPQVKCYMKQL 208
HP VI+L + T LV E DL +G E +C+ Q+
Sbjct: 93 AGGGHPGVIRLLDWFETQEG---FMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQV 148
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLATFYDPGLKQPMTSRVVTLWYR 267
++ ++HCH+ GV+HRDIK N+LID G K+ DFG P T T Y
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGTRVYS 205
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
PPE + Y+ + +WS G +L +++ G +P E+ +I + E
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGD--IP----FERDQEILE------AELH-- 251
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387
P LI L+ P +R + L +
Sbjct: 252 --FP-------------------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ-T 289
Query: 388 PYACEPSSLPKYPPS 402
P P + K P+
Sbjct: 290 PAEDVPLNPSKGGPA 304
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-45
Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 13/196 (6%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL-EG 164
IG G + RD LT ++VA+K + E+V+ REI+ R L HPN+++ E
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEV 84
Query: 165 LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
++T L ++ EY +L G +FSE + + + +QLLSG+ +CH+ + HR
Sbjct: 85 ILTPTH---LAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHR 140
Query: 224 DIKGSNLLIDNDGI--LKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVG 281
D+K N L+D LKI DFG + QP ++ V T Y PE+LL Y G
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST-VGTPAYIAPEVLLRQEYDGKI 198
Query: 282 VDLWSAGCILAELLAG 297
D+WS G L +L G
Sbjct: 199 ADVWSCGVTLYVMLVG 214
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 5e-45
Identities = 77/314 (24%), Positives = 129/314 (41%), Gaps = 52/314 (16%)
Query: 102 KLDK-IGQGTYSNVYKARDLLTGKIVALK---KVRFDNLE-PESVKFMAREILVLRKLDH 156
+ + +G+G++ V A T + VALK + + V+ REI L+ L H
Sbjct: 12 IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRH 68
Query: 157 PNVIKL-EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
P++IKL + + T + +V EY +L + + +E + + + +Q++ +E+C
Sbjct: 69 PHIIKLYDVITTPTD---IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYC 124
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPELLL 273
H + ++HRD+K NLL+D++ +KIADFGL+ G LK TS + Y PE++
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK---TS-CGSPNYAAPEVIN 180
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
G Y G VD+WS G +L +L G+ K+ Y +P
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY----VMP-- 228
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
+ LI ++ DP R T +FN P
Sbjct: 229 -----------------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN----LP 267
Query: 394 SSLPKYPPSKEMDV 407
L +
Sbjct: 268 DYLRPMEEVQGSYA 281
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-45
Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 26/225 (11%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHP 157
+ +G ++ VY+A+D+ +G+ ALK++ + E + + +E+ ++KL HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHP 86
Query: 158 NVIKLEG---LVTSRMSCSLYLVFEYMEHDLAGL-----AACQGVKFSEPQVKCYMKQLL 209
N+++ + E L S V Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 210 SGLEHCHNNG--VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS-------- 259
++H H ++HRD+K NLL+ N G +K+ DFG AT ++
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 260 ---RVVTLWYRPPEL--LLGATYYGVGVDLWSAGCILAELLAGKP 299
R T YR PE+ L G D+W+ GCIL L +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 7e-45
Identities = 80/287 (27%), Positives = 122/287 (42%), Gaps = 46/287 (16%)
Query: 106 IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF-MAREILVLRKLDHPNVIKL-E 163
+G GT+ V LTG VA+K + + V + REI L+ HP++IKL +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 164 GLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLH 222
+ T ++V EY+ +L G + E + + +Q+LS +++CH + V+H
Sbjct: 79 VISTPTD---FFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVH 134
Query: 223 RDIKGSNLLIDNDGILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPELLLGATYYGV 280
RD+K N+L+D KIADFGL+ G L+ TS + Y PE++ G Y G
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TS-CGSPNYAAPEVISGRLYAGP 190
Query: 281 GVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
VD+WS G IL LL G +P KI + +P
Sbjct: 191 EVDIWSCGVILYALLCGT--LPFDDEHVPTLFKKIRG------GVF----YIP------- 231
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
+ S L+ +L +DP R T E+F
Sbjct: 232 ------------EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-45
Identities = 86/311 (27%), Positives = 140/311 (45%), Gaps = 64/311 (20%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F KL+KIG+G++ V+K D T K+VA+K + + E E ++ + +EI VL + D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 82
Query: 160 IKLEG--LVTSRMSCSLYLVFEYMEHDLAGLAACQGV----KFSEPQVKCYMKQLLSGLE 213
K G L ++ L+++ EY+ G + + E Q+ ++++L GL+
Sbjct: 83 TKYYGSYLKDTK----LWIIMEYLG---GG--SALDLLEPGPLDETQIATILREILKGLD 133
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPE 270
+ H+ +HRDIK +N+L+ G +K+ADFG+A L R V T ++ PE
Sbjct: 134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAG----QLTDTQIKRNTFVGTPFWMAPE 189
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKP----IMPGRTEVEQLHKIFKLCGSPS-EEYW 325
++ + Y D+WS G EL G+P + P + L I K P+ E +
Sbjct: 190 VIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKV----LFLIPK-NNPPTLEGNY 243
Query: 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
K K+F +E L+ +P R TA L +F
Sbjct: 244 SKP---------------------LKEF-------VEACLNKEPSFRPTAKELLKHKFIL 275
Query: 386 TEPYACEPSSL 396
A + S L
Sbjct: 276 R--NAKKTSYL 284
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 69/307 (22%), Positives = 135/307 (43%), Gaps = 49/307 (15%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+E + ++G G + VYKA++ TG + A K + + E ++ EI +L DHP +
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDHPYI 78
Query: 160 IKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
+KL G + L+++ E+ + + +EPQ++ +Q+L L H
Sbjct: 79 VKLLGAYYHDGK----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPELLL 273
+ ++HRD+K N+L+ +G +++ADFG++ + + R + T ++ PE+++
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK----NLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 274 GATY----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329
T Y D+WS G L E+ +P P E+ + + K+ S
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP--P-HHELNPMRVLLKIAKSDP------PT 241
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389
L + + + F+DF ++ L +P+ R +A L F ++
Sbjct: 242 LLTPSKWSVE----------FRDF-------LKIALDKNPETRPSAAQLLEHPFVSS--- 281
Query: 390 ACEPSSL 396
+L
Sbjct: 282 ITSNKAL 288
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-44
Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 52/308 (16%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-D 155
A FE ++ +G GTY VYK R + TG++ A+K + ++ + + + +EI +L+K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSH 79
Query: 156 HPNVIKLEG----LVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQ 207
H N+ G M L+LV E+ DL + +G E + ++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICRE 137
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTL 264
+L GL H H + V+HRDIKG N+L+ + +K+ DFG++ L + + R + T
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA----QLDRTVGRRNTFIGTP 193
Query: 265 WYRPPELLLGATY----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP 320
++ PE++ Y DLWS G E+ G P + + L I
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------- 246
Query: 321 SEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+ P L + K + F+ F IE+ L + R +
Sbjct: 247 -------PRNPAPRL----KSKKWS--KKFQSF-------IESCLVKNHSQRPATEQLMK 286
Query: 381 SEFFNTEP 388
F +P
Sbjct: 287 HPFIRDQP 294
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 83/306 (27%), Positives = 133/306 (43%), Gaps = 54/306 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ + +KIGQG VY A D+ TG+ VA++++ + + EILV+R+ +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII--NEILVMRENKNPNI 79
Query: 160 IKLEG--LVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
+ LV L++V EY+ D+ E Q+ ++ L LE
Sbjct: 80 VNYLDSYLVGDE----LWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALE 130
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPE 270
H+N V+HRDIK N+L+ DG +K+ DFG + + R V T ++ PE
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA----QITPEQSKRSTMVGTPYWMAPE 186
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330
++ Y G VD+WS G + E++ G+P + L+ I G+P +L
Sbjct: 187 VVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP--------EL 236
Query: 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390
N F+DF + L +D + RG+A L +F A
Sbjct: 237 QNPEKLSAI----------FRDF-------LNRCLEMDVEKRGSAKELLQHQFLKI---A 276
Query: 391 CEPSSL 396
SSL
Sbjct: 277 KPLSSL 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-44
Identities = 77/306 (25%), Positives = 138/306 (45%), Gaps = 54/306 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ KIG+G+ V AR+ +G+ VA+K + D + + + + E++++R H NV
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNV 104
Query: 160 IKLEG--LVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
+++ LV L+++ E+++ D+ V+ +E Q+ + +L L
Sbjct: 105 VEMYKSYLVGEE----LWVLMEFLQGGALTDIV-----SQVRLNEEQIATVCEAVLQALA 155
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPE 270
+ H GV+HRDIK ++L+ DG +K++DFG + + + R V T ++ PE
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCA----QISKDVPKRKSLVGTPYWMAPE 211
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330
++ + Y VD+WS G ++ E++ G+P P + + +L SP KL
Sbjct: 212 VISRSLY-ATEVDIWSLGIMVIEMVDGEP--P-YFSDSPVQAMKRLRDSP------PPKL 261
Query: 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390
N+ P +DF +E +L DP R TA L+ F
Sbjct: 262 KNSHKVSPV----------LRDF-------LERMLVRDPQERATAQELLDHPFLLQ---T 301
Query: 391 CEPSSL 396
P L
Sbjct: 302 GLPECL 307
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-44
Identities = 84/325 (25%), Positives = 145/325 (44%), Gaps = 49/325 (15%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F+ L+K+G+G+Y +VYKA TG+IVA+K+V +E ++ + +EI ++++ D P+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVE-SDLQEIIKEISIMQQCDSPHV 86
Query: 160 IKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
+K G + L++V EY ++ + + +E ++ ++ L GLE+ H
Sbjct: 87 VKYYGSYFKNTD----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPELLL 273
+HRDIK N+L++ +G K+ADFG+A L M R + T ++ PE++
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAG----QLTDTMAKRNTVIGTPFWMAPEVIQ 198
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y D+WS G E+ GKP + + I P
Sbjct: 199 EIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPP--------TFRKP 248
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
L+ F DF ++ L P+ R TAT L F + A
Sbjct: 249 ELWSDN----------FTDF-------VKQCLVKSPEQRATATQLLQHPFVRS---AKGV 288
Query: 394 SSL-PKYPPSKEMDVKLREEEARRQ 417
S L + ++ +K +E + R +
Sbjct: 289 SILRDLINEAMDVKLKRQESQQREE 313
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-43
Identities = 63/330 (19%), Positives = 111/330 (33%), Gaps = 84/330 (25%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLE 163
+G G V + + T + ALK + + RE+ + + P+++++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 164 GLV--TSRMSCSLYLVFEYMEHDLAG------LAACQGVKFSEPQVKCYMKQLLSGLEHC 215
+ L +V E ++ G + F+E + MK + +++
Sbjct: 78 DVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 216 HNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELL 272
H+ + HRD+K NLL + ILK+ DFG A E
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KETT 171
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK--LCGSPS--EEYWKKS 328
Y D+WS G I+ LL G P + + G W +
Sbjct: 172 GEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE- 228
Query: 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388
++E K LI LL +P R T T +N P
Sbjct: 229 -----------------VSEEVKM-------LIRNLLKTEPTQRMTITEFMNH------P 258
Query: 389 YACEPSSLPKYPPSKEMDVKLREEEARRQR 418
+ + + +P+ P L+E++ R +
Sbjct: 259 WIMQSTKVPQTP--LHTSRVLKEDKERWED 286
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 87/318 (27%), Positives = 136/318 (42%), Gaps = 47/318 (14%)
Query: 102 KLDK-IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF-MAREILVLRKLDHPNV 159
L +G GT+ V + LTG VA+K + + V + REI L+ HP++
Sbjct: 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 160 IKL-EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
IKL + + T +++V EY+ +L G + E + + +Q+LSG+++CH
Sbjct: 79 IKLYQVISTPSD---IFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHR 134
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPELLLGA 275
+ V+HRD+K N+L+D KIADFGL+ G L+ TS + Y PE++ G
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR---TS-CGSPNYAAPEVISGR 190
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMP--GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y G VD+WS+G IL LL G +P KI + P
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD------GIF----YTP-- 236
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
+ S + L++ +L +DP R T E+F +
Sbjct: 237 -----------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLF 279
Query: 394 SSLPKYPPSKEMDVKLRE 411
P Y + D L+E
Sbjct: 280 PEDPSYSSTMIDDEALKE 297
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 1e-41
Identities = 65/358 (18%), Positives = 113/358 (31%), Gaps = 99/358 (27%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVA----------------------LKKVR 132
R FE + +G+G + V++A++ + A L K+
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 133 FDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS------------------- 173
+ ++ ++ +K E S S
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 174 -------------LYLVFEYMEH-DLAG-LAACQGVKFSEPQ-VKCYMKQLLSGLEHCHN 217
LY+ + +L + ++ E Q+ +E H+
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT-----------FYDPGLKQPMTSRVVTLWY 266
G++HRD+K SN+ D ++K+ DFGL T T +V T Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
PE + G Y VD++S G IL ELL T++E++ I + +
Sbjct: 243 MSPEQIHGNN-YSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDV---------R 287
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
K P F +++ +LS P R AT + + F
Sbjct: 288 NLKFP----------------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-40
Identities = 42/286 (14%), Positives = 88/286 (30%), Gaps = 33/286 (11%)
Query: 98 NTFEKLDKIGQGTYSNVYKAR-----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLR 152
+G+G ++ VY+A D + LK + N P + + L+
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLK 122
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHD-----LAGLAACQGVKFSEPQVKCYMKQ 207
+K + LV E + + + V + +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLI-----------DNDGILKIADFGLATFYDPGLK-Q 255
+L +E H+ ++H DIK N ++ D L + D G + K
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQLHKIF 314
T++ T ++ E+L + +D + + +L G + + + +F
Sbjct: 241 IFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299
Query: 315 KLCGSPSEEYWKK--SKLPNATLFKPQQPYKRCIAETFKDFPSSSL 358
+ P + W + + N P + + K
Sbjct: 300 R--RLPHLDMWNEFFHVMLNIPDCH-HLPSLDLLRQKLKKVFQQHY 342
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 79/276 (28%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
F+ +G+G++S V AR+L T + A+K + + ++ V ++ RE V+ +LDHP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+KL T + LY Y ++ +L G F E + Y +++S LE+ H
Sbjct: 92 FVKLYF--TFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG 148
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGAT 276
G++HRD+K N+L++ D ++I DFG A P KQ + V T Y PELL
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-K 207
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
DLW+ GCI+ +L+AG P E KI K + P
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK----------LEYDFP----- 252
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR 372
+ F + L+E LL +D R
Sbjct: 253 --------------EKFFPKARDLVEKLLVLDATKR 274
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-40
Identities = 50/213 (23%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEG 164
+G+G + K TG+++ +K+ + E+ + +E+ V+R L+HPNV+K G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 165 LVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHR 223
++ L + EY++ L G+ ++ Q + K + SG+ + H+ ++HR
Sbjct: 75 VLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 224 DIKGSNLLIDNDGILKIADFGLATFYD-------------PGLKQPMTSRVVTLWYRPPE 270
D+ N L+ + + +ADFGLA ++ + V ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPG 303
++ G + Y VD++S G +L E++ P
Sbjct: 193 MINGRS-YDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 36/210 (17%), Positives = 76/210 (36%), Gaps = 21/210 (10%)
Query: 100 FEKLD---KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
F++L+ K+ + ++K R G + +K ++ + + E LR H
Sbjct: 9 FKQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
PNV+ + G S + L+ +M +++ L + Q + + G+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGM 124
Query: 213 E--HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
H + + +++ID D +I+ + + R+ + PE
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE 178
Query: 271 LLLGATY--YGVGVDLWSAGCILAELLAGK 298
L D+WS +L EL+ +
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 71/310 (22%), Positives = 122/310 (39%), Gaps = 41/310 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
FEK+ ++G G V+K +G ++A K + + +P + RE+ VL + + P +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYI 93
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+ G S + + E+M+ L + G + E + ++ GL +
Sbjct: 94 VGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK 150
Query: 219 G-VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT-SRVVTLWYRPPELLLGAT 276
++HRD+K SN+L+++ G +K+ DFG++ L M S V T Y PE L G T
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQG-T 205
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
+Y V D+WS G L E+ G+ +P E + E + + P L
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 337 KPQQPYKRCIA----------------------ETFKDFPSSSLPLIETLLSIDPDNRGT 374
K + +A F+DF + L +P R
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF-------VNKCLIKNPAERAD 318
Query: 375 ATAALNSEFF 384
+ F
Sbjct: 319 LKQLMVHAFI 328
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 68/298 (22%), Positives = 113/298 (37%), Gaps = 38/298 (12%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
N E L ++G GT V+K R TG ++A+K++R E K + ++ V+ K
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLK 79
Query: 154 L-DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
D P +++ G + + +++ E M L E + ++ L
Sbjct: 80 SHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKAL 137
Query: 213 EHCH-NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE- 270
+ +GV+HRD+K SN+L+D G +K+ DFG++ + Y PE
Sbjct: 138 YYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPER 195
Query: 271 ---LLLGATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
Y + D+WS G L EL G+ P +T+ E L K+ +
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEPP---- 248
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
LP F F+ F ++ L+ D R L F
Sbjct: 249 --LLPGHMGFSGD----------FQSF-------VKDCLTKDHRKRPKYNKLLEHSFI 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 24/212 (11%)
Query: 100 FEKLD---KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
+ L+ KIG G++ V++A G VA+K + + E V RE+ ++++L H
Sbjct: 36 WCDLNIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYME--------HDLAGLAACQGVKFSEPQVKCYMKQL 208
PN++ G VT + L +V EY+ H + E + +
Sbjct: 94 PNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGA-----REQLDERRRLSMAYDV 146
Query: 209 LSGLE--HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
G+ H N ++HR++K NLL+D +K+ DFGL+ S T +
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEW 205
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGK 298
PE+L D++S G IL EL +
Sbjct: 206 MAPEVLRDEP-SNEKSDVYSFGVILWELATLQ 236
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-38
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 13/217 (5%)
Query: 87 DAIRDWT-PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA 145
DA DW P +IG G++ VYK + G VA+K + P+ ++
Sbjct: 14 DAADDWEIPD--GQITVGQRIGSGSFGTVYKGK--WHGD-VAVKMLNVTAPTPQQLQAFK 68
Query: 146 REILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCY 204
E+ VLRK H N++ G T+ L +V ++ E L KF ++
Sbjct: 69 NEVGVLRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDI 125
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF-YDPGLKQPMTSRVVT 263
+Q G+++ H ++HRD+K +N+ + D +KI DFGLAT +
Sbjct: 126 ARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 264 LWYRPPELLLGATY--YGVGVDLWSAGCILAELLAGK 298
+ + PE++ Y D+++ G +L EL+ G+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 22/213 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES-----VKFMAREILVLRKL 154
E +IG+G + V+K R + +VA+K + + E E+ + RE+ ++ L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
+HPN++KL GL+ + +V E++ DL + M + G+E
Sbjct: 81 NHPNIVKLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 214 --HCHNNGVLHRDIKGSNLLIDNDG-----ILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
N ++HRD++ N+ + + K+ADFGL+ ++ + +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192
Query: 267 RPPELLLGA-TYYGVGVDLWSAGCILAELLAGK 298
PE + Y D +S IL +L G+
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 67/299 (22%), Positives = 123/299 (41%), Gaps = 39/299 (13%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL- 154
A + L +IG+G Y +V K +G+I+A+K++R ++ + K + ++ V+ +
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSS 78
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYM----EHDLAGLAACQGVKFSEPQVKCYMKQLLS 210
D P +++ G + ++ E M + + + E + +
Sbjct: 79 DCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 211 GLEHCHNNG-VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPP 269
L H N ++HRDIK SN+L+D G +K+ DFG++ + + T Y P
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAP 194
Query: 270 ELLLGATY---YGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYW 325
E + + Y V D+WS G L EL G+ P + +QL ++ K G P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDP----- 247
Query: 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+L N ++ + + +F +F + L+ D R L F
Sbjct: 248 --PQLSN----SEEREF----SPSFINF-------VNLCLTKDESKRPKYKELLKHPFI 289
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
E + +G+G + V KA+ K VA+K++ ++ F+ E+ L +++HPN+
Sbjct: 10 IEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKA---FI-VELRQLSRVNHPNI 63
Query: 160 IKLEGLVTSRMSCSLYLVFEYME----HDLAGLAAC-QGVKFSEPQVKCYMKQLLSGLEH 214
+KL G + + LV EY E +++ L ++ + Q G+ +
Sbjct: 64 VKLYGACLN----PVCLVMEYAEGGSLYNV--LHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 215 CHN---NGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
H+ ++HRD+K NLL+ G +LKI DFG A ++ MT+ + + PE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPE 173
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGK 298
+ G+ Y D++S G IL E++ +
Sbjct: 174 VFEGSN-YSEKCDVFSWGIILWEVITRR 200
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 63/301 (20%), Positives = 117/301 (38%), Gaps = 47/301 (15%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILV-LRKL 154
+A+ E + ++G+G Y V K R + +G+I+A+K++R + + K + ++ + +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTV 63
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYME---HDLAGLAACQGVKFSEPQVKCYMKQLLSG 211
D P + G + +++ E M+ +G E + ++
Sbjct: 64 DCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 212 LEHCHNNG-VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
LEH H+ V+HRD+K SN+LI+ G +K+ DFG++ + + Y PE
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPE 179
Query: 271 LLLGATY---YGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSP---SEE 323
+ Y V D+WS G + EL + P T +QL ++ + +
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPAD 237
Query: 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
+ F DF L + R T + F
Sbjct: 238 KFSAE---------------------FVDF-------TSQCLKKNSKERPTYPELMQHPF 269
Query: 384 F 384
F
Sbjct: 270 F 270
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 61/228 (26%), Positives = 93/228 (40%), Gaps = 22/228 (9%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
FE L IG+G +S V + TG++ A+K + + L+ V E VL D
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 159 VIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSG 211
+ +L + LYLV EY DL L + G + + Y+ +++
Sbjct: 123 ITQLH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
++ H G +HRDIK N+L+D G +++ADFG V T Y PE+
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 272 LLG------ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
L YG D W+ G E+ G+ + E KI
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-36
Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 100 FEKLD---KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
FE+L+ IG+G + VY R G+ VA++ + + + +K RE++ R+ H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGR--WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
NV+ G S L ++ + L + + + + ++++ G+ +
Sbjct: 89 ENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATF----YDPGLKQPMTSRVVTLWYRPPEL 271
H G+LH+D+K N+ DN G + I DFGL + + + + L + PE+
Sbjct: 147 HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 272 LLGATY--------YGVGVDLWSAGCILAELLAGK 298
+ + + D+++ G I EL A +
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 67/288 (23%), Positives = 114/288 (39%), Gaps = 28/288 (9%)
Query: 45 ERARAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRA-----NT 99
+ + G F P R Q + +L ++ W A +
Sbjct: 127 DAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDW 186
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
F +G+G + V+ + TGK+ A KK+ + + + E +L K+
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 159 VIKLEGLVTSRMSC-----SLYLVFEYME------HDLAGLAACQGVKFSEPQVKCYMKQ 207
++ L L LV M H + + F EP+ Y Q
Sbjct: 247 IVSLA-------YAFETKTDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTAQ 297
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYR 267
++SGLEH H +++RD+K N+L+D+DG ++I+D GLA + T +
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFM 356
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
PELLLG Y VD ++ G L E++A + R E + ++ +
Sbjct: 357 APELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ 403
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 9/219 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPN 158
+E + IG+G + V R T K+ A+K + F+ ++ F E ++ + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 159 VIKLEGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
V++L + LY+V EYM DL + E + Y +++ L+ H+
Sbjct: 131 VVQLFY--AFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFYTAEVVLALDAIHS 186
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL---G 274
G +HRD+K N+L+D G LK+ADFG + + V T Y PE+L G
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
YYG D WS G L E+L G + V KI
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 100 FEKLD---KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP--ESVKFMAREILVLRKL 154
F +L IG G + VY+A G VA+K R D E ++++ + +E + L
Sbjct: 6 FAELTLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
HPN+I L G+ +L LV E+ L G + + + Q+ G+
Sbjct: 64 KHPNIIALRGVCLKEP--NLCLVMEFARGGPL--NRVLSGKRIPPDILVNWAVQIARGMN 119
Query: 214 HCHNNG---VLHRDIKGSNLLIDNDG--------ILKIADFGLATFYDPGLKQPMTSRVV 262
+ H+ ++HRD+K SN+LI ILKI DFGLA + + S
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH---RTTKMSAAG 176
Query: 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGK 298
+ PE++ + + G D+WS G +L ELL G+
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-34
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 26/230 (11%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDH 156
NTF + +G+G + V + TGK+ A KK+ + + + E +L K++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 157 PNVIKLEGLVTSRMSC-----SLYLVFEYME------HDLAGLAACQGVKFSEPQVKCYM 205
V+ L +L LV M H + F E + Y
Sbjct: 244 RFVVSLA-------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYA 292
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW 265
++ GLE H +++RD+K N+L+D+ G ++I+D GLA G Q + RV T+
Sbjct: 293 AEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVG 350
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
Y PE++ Y D W+ GC+L E++AG+ R + + ++ +
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 60/226 (26%), Positives = 94/226 (41%), Gaps = 20/226 (8%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVR-FDNLEPESVKFMAREILVLRKLDHPN 158
FE L IG+G + V + K+ A+K + ++ L+ E VL D
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 159 VIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSG 211
+ L + LYLV +Y DL L + + E + Y+ +++
Sbjct: 136 ITTLH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
++ H +HRDIK N+L+D +G +++ADFG + V T Y PE+
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 272 LL----GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
L G YG D WS G + E+L G+ + VE KI
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 69/304 (22%), Positives = 119/304 (39%), Gaps = 64/304 (21%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
FE L IG+G++ V + T K+ A+K + +E V+ + +E+ +++ L+HP
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 159 VIKLEGLVTSRMSCS------LYLVFEYME------HDLAGLAACQGVKFSEPQVKCYMK 206
++ L S +++V + + H Q V F E VK ++
Sbjct: 77 LVNLW--------YSFQDEEDMFMVVDLLLGGDLRYH------LQQNVHFKEETVKLFIC 122
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
+L+ L++ N ++HRD+K N+L+D G + I DF +A +T+ T Y
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPY 180
Query: 267 RPPELLL--GATYYGVGVDLWSAGCILAELLAGKP---IMPGRTEVEQLHKIFKLCGSPS 321
PE+ Y VD WS G ELL G+ I + E +H
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------ 234
Query: 322 EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR-GTATAALN 380
P+A + + L++ LL +PD R + N
Sbjct: 235 ----TVVTYPSA-------------------WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271
Query: 381 SEFF 384
+
Sbjct: 272 FPYM 275
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 80/381 (20%), Positives = 137/381 (35%), Gaps = 110/381 (28%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-- 154
+ + K+G G +S V+ + D+ K VA+K V+ E+ EI +L+ +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRN 92
Query: 155 ---DHPN---VIKL------EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVK-FSEPQV 201
+ PN V++L G+ + + C +VFE + H L + P V
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHI-C---MVFEVLGHHLLKWIIKSNYQGLPLPCV 148
Query: 202 KCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLI---------------------------- 232
K ++Q+L GL++ H ++H DIK N+L+
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 233 ---------------------DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271
+KIAD G A + + T + T YR E+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH----KHFTEDIQTRQYRSLEV 264
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQLHKIFKLCGSPSEEYW 325
L+G+ Y D+WS C+ EL G + + + + + I +L G +
Sbjct: 265 LIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 326 KKSK-----------LPNATLFKPQQPYKRCI---------AETFKDFPSSSLPLIETLL 365
K L + T KP ++ + A F DF + +L
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDF-------LLPML 376
Query: 366 SIDPDNRGTATAALNSEFFNT 386
+ P+ R TA L + N+
Sbjct: 377 ELIPEKRATAAECLRHPWLNS 397
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFD-NLEPESVKFMAREILVLRKLDHPN 158
++ +DK+G G S VY A D + VA+K + + E++K RE+ +L H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 159 VIKL------EGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKFSEPQVKCYMKQLLSG 211
++ + + YLV EY+E L+ G S + Q+L G
Sbjct: 73 IVSMIDVDEEDDCY--------YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDG 123
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVV-TLWYRPP 269
++H H+ ++HRDIK N+LID++ LKI DFG+A + L Q T+ V+ T+ Y P
Sbjct: 124 IKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ--TNHVLGTVQYFSP 181
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKP 299
E G D++S G +L E+L G+P
Sbjct: 182 EQAKGEA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 64/248 (25%), Positives = 100/248 (40%), Gaps = 26/248 (10%)
Query: 62 GPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLL 121
G HS S + A + +G+G +VY+A D +
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMDGTAESREGTQFGP----YRLRRLVGRGGMGDVYEAEDTV 57
Query: 122 TGKIVALKKVRFD-NLEPESVKFMAREILVLRKLDHPNVIKL------EGLVTSRMSCSL 174
+IVALK + + +P M RE +L P+V+ + +G L
Sbjct: 58 RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ--------L 109
Query: 175 YLVFEYME-HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID 233
Y+ + DLA + QG + P+ ++Q+ S L+ H G HRD+K N+L+
Sbjct: 110 YVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168
Query: 234 NDGILKIADFGLA-TFYDPGLKQPMTSRVV-TLWYRPPELLLGATYYGVGVDLWSAGCIL 291
D + DFG+A D L Q V TL+Y PE + D+++ C+L
Sbjct: 169 ADDFAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMAPERFSESH-ATYRADIYALTCVL 225
Query: 292 AELLAGKP 299
E L G P
Sbjct: 226 YECLTGSP 233
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 10/207 (4%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFD-NLEPESVKFMAREILVLRKLDHPN 158
+E + +G G S V+ ARDL + VA+K +R D +P RE L+HP
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 159 VIKL--EGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
++ + G + Y+V EY++ L + +G + + + L
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFS 132
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT--SRVV-TLWYRPPELL 272
H NG++HRD+K +N++I +K+ DFG+A +T + V+ T Y PE
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS-GNSVTQTAAVIGTAQYLSPEQA 191
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKP 299
G + D++S GC+L E+L G+P
Sbjct: 192 RGDS-VDARSDVYSLGCVLYEVLTGEP 217
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 56/223 (25%), Positives = 84/223 (37%), Gaps = 32/223 (14%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
A L+ +G+G Y V++ G+ VA+K + E F E+ L H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRD---EKSWFRETELYNTVMLRH 61
Query: 157 PNVIKLEGLVTSRMSCS--LYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLS 210
N++ + S L+L+ Y E +D L Q + + S
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY--L---QLTTLDTVSCLRIVLSIAS 116
Query: 211 GLEHCH--------NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG---LKQPMTS 259
GL H H + HRD+K N+L+ +G IAD GLA + L
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 260 RVVTLWYRPPELLLGATYYGVG-----VDLWSAGCILAELLAG 297
RV T Y PE+L VD+W+ G +L E+
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-32
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 32/234 (13%)
Query: 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+ + +IG+G Y V+ + G+ VA+K E+ F EI + H N++
Sbjct: 40 QMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENIL 94
Query: 161 KLEGLVT--SRMSCSLYLVFEYME----HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
+ LYL+ +Y E +D L + + +SGL H
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDY--L---KSTTLDAKSMLKLAYSSVSGLCH 149
Query: 215 CH--------NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ---PMTSRVVT 263
H + HRD+K N+L+ +G IAD GLA + + P +RV T
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGT 209
Query: 264 LWYRPPELLLGATYYGVG-----VDLWSAGCILAELLAGKPIMPGRTEVEQLHK 312
Y PPE+L + D++S G IL E+ E + +
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-32
Identities = 60/253 (23%), Positives = 109/253 (43%), Gaps = 31/253 (12%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
++ + L+ +G + V+KA+ L + VA+K F + +S + E+ L +
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKI--FPIQDKQSWQN-EYEVYSLPGMK 76
Query: 156 HPNVIKLEGLVT--SRMSCSLYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQLL 209
H N+++ G + + L+L+ + E D L + S ++ + +
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF--L---KANVVSWNELCHIAETMA 131
Query: 210 SGLEHCHNN----------GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS 259
GL + H + + HRDIK N+L+ N+ IADFGLA ++ G T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 260 RVV-TLWYRPPELLLGATYYGVG----VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIF 314
V T Y PE+L GA + +D+++ G +L EL + G + L
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251
Query: 315 KLCGSPSEEYWKK 327
++ PS E ++
Sbjct: 252 EIGQHPSLEDMQE 264
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-31
Identities = 73/280 (26%), Positives = 119/280 (42%), Gaps = 37/280 (13%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA---REILVL-RK 153
N F IG+G + VY R TGK+ A+K + ++ + + +A R +L L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
D P ++ + + L + + M DL + G FSE ++ Y +++ GL
Sbjct: 249 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGL 305
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELL 272
EH HN V++RD+K +N+L+D G ++I+D GLA + + V T Y PE+L
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVL 362
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332
Y D +S GC+L +LL G P R + K ++
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHS--PFRQHKTK----------------DKHEIDR 404
Query: 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR 372
TL + + + L+E LL D + R
Sbjct: 405 MTLTMAVE-LPDSFSPELRS-------LLEGLLQRDVNRR 436
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 53/228 (23%), Positives = 81/228 (35%), Gaps = 32/228 (14%)
Query: 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+ IG+G + V++ + G+ VA+K E F EI L H N++
Sbjct: 45 VLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENIL 99
Query: 161 KLEGLVTSRMSCS--LYLVFEYMEH----DLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
L+LV +Y EH D L + + SGL H
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDY--L---NRYTVTVEGMIKLALSTASGLAH 154
Query: 215 CH--------NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL---KQPMTSRVVT 263
H + HRD+K N+L+ +G IAD GLA +D RV T
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 264 LWYRPPELLLGATYYGVG-----VDLWSAGCILAELLAGKPIMPGRTE 306
Y PE+L + D+++ G + E+ I +
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 37/227 (16%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA-REILVLRKLDHPN 158
+ L+ IG+G Y VYK L + VA+K F ++ F+ + I + ++H N
Sbjct: 15 LKLLELIGRGRYGAVYKGS--LDERPVAVKV--FSFANRQN--FINEKNIYRVPLMEHDN 68
Query: 159 VIKLEG---LVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYM-KQLLSGLE 213
+ + VT+ LV EY + G L + S+ C + + GL
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPN---GSLXKYLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 214 HCH---------NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ-------PM 257
+ H + HRD+ N+L+ NDG I+DFGL+
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 258 TSRVVTLWYRPPELLLGA------TYYGVGVDLWSAGCILAELLAGK 298
S V T+ Y PE+L GA VD+++ G I E+
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
F+ L +G+GT+ V R+ TG+ A+K +R + + + V E VL+ HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 159 VIKLEGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCYMKQ 207
+ L+ L V EY H + F+E + + Y +
Sbjct: 67 LTALK-------YAFQTHDRLCFVMEYANGGELFFH------LSRERVFTEERARFYGAE 113
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV----- 262
++S LE+ H+ V++RDIK NL++D DG +KI DFGL K+ ++
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC-------KEGISDGATMKTFC 166
Query: 263 -TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
T Y PE+L YG VD W G ++ E++ G+ + I
Sbjct: 167 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 28/211 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
F+ L +G G++ V+ R G+ A+K ++ + + + V+ E L+L + HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 159 VIKLEGLVTSRMSCSLYLVFEYME------HDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
+I++ G T + + ++++ +Y+E L Q +F P K Y ++ L
Sbjct: 68 IIRMWG--TFQDAQQIFMIMDYIEGGELFSL----LRKSQ--RFPNPVAKFYAAEVCLAL 119
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLW----YRP 268
E+ H+ +++RD+K N+L+D +G +KI DFG A K + TL Y
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA-------KY-VPDVTYTLCGTPDYIA 171
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKP 299
PE++ Y +D WS G ++ E+LAG
Sbjct: 172 PEVVSTKP-YNKSIDWWSFGILIYEMLAGYT 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 28/211 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
F+++ +G G++ V + +G A+K + ++ + ++ E +L+ ++ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 159 VIKLEGLVTSRMSCSLYLVFEYME------HDLAGLAACQGVKFSEPQVKCYMKQLLSGL 212
++KLE + + + +LY+V EY+ H L +FSEP + Y Q++
Sbjct: 103 LVKLEF--SFKDNSNLYMVMEYVAGGEMFSH----LRRIG--RFSEPHARFYAAQIVLTF 154
Query: 213 EHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL----WYRP 268
E+ H+ +++RD+K NLLID G +++ DFG A K+ + R TL
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-------KR-VKGRTWTLCGTPEALA 206
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKP 299
PE++L Y VD W+ G ++ E+ AG P
Sbjct: 207 PEIILSKG-YNKAVDWWALGVLIYEMAAGYP 236
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 21/216 (9%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDL-LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
A +E I G +Y A D + G+ V LK + + E+ E L ++
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVV 137
Query: 156 HPNVIKLEGLV---TSRMSCSLYLVFEYMEHDLAG--LAACQGVKFSEPQVKCYMKQLLS 210
HP+++++ V Y+V EY+ G L +G K + Y+ ++L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVG----GQSLKRSKGQKLPVAEAIAYLLEILP 193
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPP 269
L + H+ G+++ D+K N+++ + + K+ D G + + + T ++ P
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRIN------SFGYLYGTPGFQAP 246
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT 305
E++ V D+++ G LA L P GR
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 7e-29
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 43/238 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNL--EPESVKFMAREILVLRKL 154
FE L +G+G Y V++ R + TGKI A+K ++ + + E +L ++
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 155 DHPNVIKLEGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKC 203
HP ++ L + LYL+ EY L F E
Sbjct: 79 KHPFIVDL-------IYAFQTGGKLYLILEYLSGGELFMQ----LEREG--IFMEDTACF 125
Query: 204 YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV- 262
Y+ ++ L H H G+++RD+K N+++++ G +K+ DFGL K+ + V
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC-------KESIHDGTVT 178
Query: 263 -----TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
T+ Y PE+L+ + + VD WS G ++ ++L G P G + + KI K
Sbjct: 179 HTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 59/238 (24%), Positives = 109/238 (45%), Gaps = 45/238 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNL-EPESVKFMAREILVLRKLD 155
FE L +GQG++ V+ + + ++ A+K ++ L + V+ E +L +++
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 156 HPNVIKLEGLVTSRMSCS------LYLVFEY------MEHDLAGLAACQGVKFSEPQVKC 203
HP ++KL + LYL+ ++ + V F+E VK
Sbjct: 85 HPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR------LSKEVMFTEEDVKF 130
Query: 204 YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV- 262
Y+ +L L+H H+ G+++RD+K N+L+D +G +K+ DFGL+ K+ +
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-------KESIDHEKKA 183
Query: 263 -----TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
T+ Y PE++ + D WS G ++ E+L G G+ E + I K
Sbjct: 184 YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPN 158
FE L +G+GT+ V ++ TG+ A+K ++ + + + V E VL+ HP
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 159 VIKLEGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCYMKQ 207
+ L+ L V EY H L+ + FSE + + Y +
Sbjct: 210 LTALK-------YSFQTHDRLCFVMEYANGGELFFH----LSRER--VFSEDRARFYGAE 256
Query: 208 LLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV---- 262
++S L++ H+ V++RD+K NL++D DG +KI DFGL K+ +
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC-------KEGIKDGATMKTF 309
Query: 263 --TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
T Y PE+L YG VD W G ++ E++ G+ + + I
Sbjct: 310 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 363
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 47/242 (19%)
Query: 100 FEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNL--EPESVKFMAREILVLRKL 154
FE L +G G Y V+ R + TGK+ A+K ++ + + ++ + E VL +
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 155 DH-PNVIKLEGLVTSRMSCS------LYLVFEY------MEHDLAGLAACQGVKFSEPQV 201
P ++ L + L+L+ +Y H Q +F+E +V
Sbjct: 116 RQSPFLVTLH--------YAFQTETKLHLILDYINGGELFTH------LSQRERFTEHEV 161
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261
+ Y+ +++ LEH H G+++RDIK N+L+D++G + + DFGL+ K+ +
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS-------KEFVADET 214
Query: 262 VTLW-------YRPPELLLGATY-YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
+ Y P+++ G + VD WS G ++ ELL G E +I
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274
Query: 314 FK 315
+
Sbjct: 275 SR 276
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 46/340 (13%), Positives = 97/340 (28%), Gaps = 78/340 (22%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE------PESVKFMAREILVL 151
++ +KIG+G + V++ VA+K + + + ++ + + EI++
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 152 RKL---------DHPNVIKLEGLVTSRMSCS----------------------------L 174
++L I L + + S L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLID 233
++V E E L + S K + QL + L + HRD+ N+L+
Sbjct: 138 FIVLE-FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 234 NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAE 293
+ K+ P V++ Y + + +
Sbjct: 197 KTSLKKLHYTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFCD 241
Query: 294 LLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK-SKLPNA--------TLFKPQQPYKR 344
+ + + G + + I++L + W + N + K +
Sbjct: 242 VSMDEDLFTG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK 299
Query: 345 CIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
C K T+L+ +AT L
Sbjct: 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 68/294 (23%), Positives = 109/294 (37%), Gaps = 73/294 (24%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLD 155
F L IG+G++ V AR A+K ++ + E + + R +L L+ +
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM-SERNVL-LKNVK 97
Query: 156 HPNVIKLEGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCY 204
HP ++ L LY V +Y H + F EP+ + Y
Sbjct: 98 HPFLVGLH-------FSFQTADKLYFVLDYINGGELFYH------LQRERCFLEPRARFY 144
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-- 262
++ S L + H+ +++RD+K N+L+D+ G + + DFGL K+ +
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-------KENIEHNSTTS 197
Query: 263 ----TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCG 318
T Y PE+L Y VD W G +L E+L G P R E I
Sbjct: 198 TFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--- 253
Query: 319 SPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR 372
K +L + +S+ L+E LL D R
Sbjct: 254 -------KPLQLK-------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 44/237 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLD 155
FE + +G+G++ V AR TG + A+K ++ D + + E + IL L +
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRILSL-ARN 82
Query: 156 HPNVIKLEGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCY 204
HP + +L C L+ V E+ M H + +F E + + Y
Sbjct: 83 HPFLTQLF-------CCFQTPDRLFFVMEFVNGGDLMFH------IQKSRRFDEARARFY 129
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
+++S L H+ G+++RD+K N+L+D++G K+ADFG+ K+ + + V T
Sbjct: 130 AAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-------KEGICNGVTTA 182
Query: 265 W------YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
Y PE+L YG VD W+ G +L E+L G E + I
Sbjct: 183 TFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 65/235 (27%), Positives = 104/235 (44%), Gaps = 44/235 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLD 155
F +G+G++ V+ A T + A+K ++ D + + E + + +L L +
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM-VEKRVLSL-AWE 76
Query: 156 HPNVIKLEGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCY 204
HP + + +L+ V EY M H KF + Y
Sbjct: 77 HPFLTHMF-------CTFQTKENLFFVMEYLNGGDLMYH------IQSCHKFDLSRATFY 123
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
+++ GL+ H+ G+++RD+K N+L+D DG +KIADFG+ K+ M T
Sbjct: 124 AAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-------KENMLGDAKTN 176
Query: 265 W------YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
Y PE+LLG Y VD WS G +L E+L G+ G+ E E H I
Sbjct: 177 TFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 44/237 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLD 155
F L +G+G++ V + T ++ A+K ++ D + + E + + +L L
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLAL-PGK 79
Query: 156 HPNVIKLEGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCY 204
P + +L SC LY V EY M H Q +F EP Y
Sbjct: 80 PPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYH------IQQVGRFKEPHAVFY 126
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-- 262
++ GL + G+++RD+K N+++D++G +KIADFG+ K+ + V
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTK 179
Query: 263 ----TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
T Y PE++ YG VD W+ G +L E+LAG+ G E E I +
Sbjct: 180 TFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 40/219 (18%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRK-LDHP 157
F+ L IG+G+Y+ V R T +I A+K V+ + + E + ++ E V + +HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 158 NVIKLEGLVTSRMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCYMK 206
++ L SC L+ V EY M H + K E + Y
Sbjct: 71 FLVGLH-------SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEHARFYSA 117
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV---- 262
++ L + H G+++RD+K N+L+D++G +K+ D+G+ K+ +
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTSTF 170
Query: 263 --TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP 299
T Y PE+L G YG VD W+ G ++ E++AG+
Sbjct: 171 CGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 34/230 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLD 155
F L +G+G++ V + T ++ A+K ++ D + + E + + +L L
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM-VEKRVLAL-PGK 400
Query: 156 HPNVIKLEGLVTSRMSC-----SLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLL 209
P + +L SC LY V EY+ DL G +F EP Y ++
Sbjct: 401 PPFLTQLH-------SCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIA 452
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV------T 263
GL + G+++RD+K N+++D++G +KIADFG+ K+ + V T
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-------KENIWDGVTTKTFCGT 505
Query: 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313
Y PE++ YG VD W+ G +L E+LAG+ G E E I
Sbjct: 506 PDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 63/268 (23%), Positives = 110/268 (41%), Gaps = 41/268 (15%)
Query: 52 EKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPR-RANTFEKLDKIGQGT 110
+ H D E G A+ + F+ L IG+G+
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGS 64
Query: 111 YSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRK-LDHPNVIKLEGLVTS 168
Y+ V R T +I A++ V+ + + E + ++ E V + +HP ++ L
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH----- 119
Query: 169 RMSC-----SLYLVFEY------MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
SC L+ V EY M H + K E + Y ++ L + H
Sbjct: 120 --SCFQTESRLFFVIEYVNGGDLMFH------MQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV------TLWYRPPEL 271
G+++RD+K N+L+D++G +K+ D+G+ K+ + T Y PE+
Sbjct: 172 RGIIYRDLKLDNVLLDSEGHIKLTDYGMC-------KEGLRPGDTTSTFCGTPNYIAPEI 224
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKP 299
L G YG VD W+ G ++ E++AG+
Sbjct: 225 LRG-EDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 42/180 (23%), Positives = 81/180 (45%), Gaps = 7/180 (3%)
Query: 70 HSESQQGWPSWLMAVAGDAIR--DWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVA 127
+QQ V A+ W + ++IG+G + V+ R +VA
Sbjct: 85 LLSTQQPLTKKSGVVLHRAVPKDKWVLNHED-LVLGEQIGRGNFGEVFSGRLRADNTLVA 143
Query: 128 LKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLA 186
+K R KF+ +E +L++ HPN+++L G+ T + +Y+V E ++ D
Sbjct: 144 VKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRLIGVCTQKQP--IYIVMELVQGGDFL 200
Query: 187 GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+G + + + +G+E+ + +HRD+ N L+ +LKI+DFG++
Sbjct: 201 TFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREIL 149
+R + +G+G + V R G VA+K ++ ++ +EI
Sbjct: 19 EKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIE 75
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQ 207
+LR L H N++K +G+ T + L+ E++ L L + K + Q Y Q
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQ 134
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ G+++ + +HRD+ N+L++++ +KI DFGL
Sbjct: 135 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 32/255 (12%)
Query: 55 RRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNV 114
H D+ P + + G RD T + L ++G+G + +V
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSAF--------EDRDPTQFEERHLKFLQQLGKGNFGSV 57
Query: 115 YKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM 170
R TG++VA+KK++ + E F REI +L+ L H N++K +G+ S
Sbjct: 58 EMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHDNIVKYKGVCYSAG 115
Query: 171 SCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSN 229
+L L+ EY+ + L + ++ Y Q+ G+E+ +HRD+ N
Sbjct: 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 175
Query: 230 LLIDNDGILKIADFGLA-------TFYDP--GLKQPMTSRVVTLWYRPPELLLGATYYGV 280
+L++N+ +KI DFGL +Y + P+ WY PE L + + V
Sbjct: 176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------WY-APESLTESKFS-V 227
Query: 281 GVDLWSAGCILAELL 295
D+WS G +L EL
Sbjct: 228 ASDVWSFGVVLYELF 242
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-25
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 10/158 (6%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREIL 149
+R + +G+G + V T +VA+K ++ D + +EI
Sbjct: 29 HKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEID 85
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQL 208
+LR L H ++IK +G + SL LV EY+ L Q+ + +Q+
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL--RDYLPRHSIGLAQLLLFAQQI 143
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
G+ + H +HRD+ N+L+DND ++KI DFGLA
Sbjct: 144 CEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 33/237 (13%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILV 150
+ +K +G G + V R L K VA+K ++ E + F+ E +
Sbjct: 43 DATNISIDK--VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASI 99
Query: 151 LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLL 209
+ + DHPN+I+LEG+VT S + +V EYME+ L +F+ Q+ ++ +
Sbjct: 100 MGQFDHPNIIRLEGVVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIA 157
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA---------TFYDPGLKQPMTSR 260
SG+++ + G +HRD+ N+LI+++ + K++DFGL + G K P+
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPI--- 214
Query: 261 VVTLWYRPPELLLGATYYGV---GVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
W PE A Y D+WS G +L E+++ G+ + + + +
Sbjct: 215 ---RWT-SPE----AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREIL 149
R F + ++G+G + +V R TG++VA+KK++ + E F REI
Sbjct: 8 EERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIE 63
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQL 208
+L+ L H N++K +G+ S +L L+ EY+ + L + ++ Y Q+
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-------TFYDP--GLKQPMTS 259
G+E+ +HRD+ N+L++N+ +KI DFGL F+ + P+
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF- 182
Query: 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELL 295
WY PE L + + V D+WS G +L EL
Sbjct: 183 -----WY-APESLTESKFS-VASDVWSFGVVLYELF 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 9/157 (5%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILV 150
EK IG G V R + G+ VA+K ++ E + F+ E +
Sbjct: 47 EASRIHIEK--IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASI 103
Query: 151 LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLL 209
+ + DHPN+I+LEG+VT +V EYME+ L +F+ Q+ ++ +
Sbjct: 104 MGQFDHPNIIRLEGVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+G+ + + G +HRD+ N+L+D++ + K++DFGL+
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
R T + K+G G Y VY+ VA+K ++ D +E E +F+ +E V+++
Sbjct: 11 ERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFL-KEAAVMKE 65
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSG 211
+ HPN+++L G+ T Y++ E+M + +L L C + S + Q+ S
Sbjct: 66 IKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250
+E+ +HRD+ N L+ + ++K+ADFGL+
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 38/215 (17%), Positives = 65/215 (30%), Gaps = 36/215 (16%)
Query: 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF-MAREILVLRKLDHPNVIK 161
L G ++A D + VAL V + P+ V L L ++D P V +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 162 LEGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
+ +V +R +V E++ L +A S M+ L + + H GV
Sbjct: 96 VLDVVHTRAGG--LVVAEWIRGGSLQEVADTSP---SPVGAIRAMQSLAAAADAAHRAGV 150
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGV 280
S + + DG + +A +
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPATM--------PDANPQD------------------- 183
Query: 281 GVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
D+ G L LL + +P L +
Sbjct: 184 --DIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 7/164 (4%)
Query: 88 AIRDWT-PRRANTFEKLDKIGQGTYSNVYKARDLLTGKI---VALKKVRFDNLEPESVKF 143
A++ + + IG+G + VY L A+K + E +F
Sbjct: 14 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 73
Query: 144 MAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVK 202
+ E ++++ HPNV+ L G+ R S +V YM+H DL + + +
Sbjct: 74 L-TEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 131
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ Q+ G+++ + +HRD+ N ++D +K+ADFGLA
Sbjct: 132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 54/224 (24%), Positives = 100/224 (44%), Gaps = 13/224 (5%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
R T + K+G G Y VY+ VA+K ++ D +E E +F+ E V+++
Sbjct: 218 ERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFLK-EAAVMKE 272
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSG 211
+ HPN+++L G+ T Y++ E+M + +L L C + S + Q+ S
Sbjct: 273 IKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY-DPGLKQPMTSRVVTLWYRPPE 270
+E+ +HR++ N L+ + ++K+ADFGL+ ++ W P
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 390
Query: 271 LLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
L + + D+W+ G +L E+ G PG + +
Sbjct: 391 LAYNK--FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 40/169 (23%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 83 AVAGDAIRDW-TPRRANTFEKLDKIGQGTYSNVYKARDLLTGKI---VALKKVRFDNLEP 138
G + RD+ R + IG+G + +V++ + VA+K + +
Sbjct: 1 GAMGSSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS 58
Query: 139 ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFS 197
KF+ +E L +R+ DHP+++KL G++T ++++ E +L +
Sbjct: 59 VREKFL-QEALTMRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKYSLD 114
Query: 198 EPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ Y QL + L + + +HRDI N+L+ ++ +K+ DFGL+
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 9e-24
Identities = 37/155 (23%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
+ + IG+G + +V G VA+K ++ ++ + F+ E V+ +
Sbjct: 19 NMKELKLLQ--TIGKGEFGDVMLGD--YRGNKVAVKCIK-NDATAQ--AFL-AEASVMTQ 70
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSG 211
L H N+++L G++ LY+V EYM L L + + + +
Sbjct: 71 LRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+E+ N +HRD+ N+L+ D + K++DFGL
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 15/224 (6%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR + E K+GQG + V+ T + VA+K ++ + PE F+ +E V++K
Sbjct: 182 PRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKK 235
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSG 211
L H +++L +V+ +Y+V EYM L L G PQ+ Q+ SG
Sbjct: 236 LRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPE 270
+ + +HRD++ +N+L+ + + K+ADFGLA D ++ W P
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 352
Query: 271 LLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
L G + + D+WS G +L EL G+ PG E L ++
Sbjct: 353 ALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 40/206 (19%), Positives = 85/206 (41%), Gaps = 7/206 (3%)
Query: 44 KERARAETEKNRRHTGDFGPPERRRPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKL 103
+ ++ P++ RP + S + +R N
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIAD 341
Query: 104 DKIGQGTYSNVYKARDLLTGKI--VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK 161
++G G + +V + + K VA+K ++ + ++ + M RE ++ +LD+P +++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVR 400
Query: 162 LEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
L G+ + +L LV E L + + V + Q+ G+++
Sbjct: 401 LIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLA 246
+HR++ N+L+ N KI+DFGL+
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-23
Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLR 152
PR + ++G G + V+ G VA+K ++ ++ P+ F+A E +++
Sbjct: 11 PRETLKLVE--RLGAGQFGEVWMG--YYNGHTKVAVKSLKQGSMSPD--AFLA-EANLMK 63
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLS 210
+L H +++L +VT +Y++ EYME+ L L G+K + ++ Q+
Sbjct: 64 QLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
G+ +HRD++ +N+L+ + KIADFGLA
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 36/239 (15%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKI----VALKKVRFDNLEPESVKFMAREIL 149
T +K IG G + VYK + VA+K ++ E + V F+ E
Sbjct: 42 HPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAG 98
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQL 208
++ + H N+I+LEG+++ + ++ EYME+ L + +FS Q+ ++ +
Sbjct: 99 IMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA---------TFYDPGLKQPMTS 259
+G+++ N +HRD+ N+L++++ + K++DFGL+ T+ G K P+
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI-- 214
Query: 260 RVVTLWYRPPELLLGATYYGV---GVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKI 313
W PE A Y D+WS G ++ E+ +P + E + I
Sbjct: 215 ----RWT-APE----AISYRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 37/155 (23%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLR 152
R T K ++G G + V + G+ VA+K ++ ++ + +F +E +
Sbjct: 6 KREEITLLK--ELGSGQFGVVKLGK--WKGQYDVAVKMIKEGSMSED--EFF-QEAQTMM 58
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSG 211
KL HP ++K G+ + +Y+V EY+ + L G Q+ + G
Sbjct: 59 KLSHPKLVKFYGVCSKEYP--IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ ++ +HRD+ N L+D D +K++DFG+
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 15/224 (6%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR + E K+GQG + V+ T + VA+K ++ + PE F+ +E V++K
Sbjct: 265 PRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKK 318
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSG 211
L H +++L +V+ +Y+V EYM L L G PQ+ Q+ SG
Sbjct: 319 LRHEKLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRPPE 270
+ + +HRD++ +N+L+ + + K+ADFGLA D ++ W P
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 271 LLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313
L G + + D+WS G +L EL G+ PG E L ++
Sbjct: 436 ALYGR--FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 50/244 (20%), Positives = 91/244 (37%), Gaps = 17/244 (6%)
Query: 8 GDRRSSPVNRRGSERASVTVTVSSGAVVSGNVVRLGKERARAETEKNRRHTGDFGPPERR 67
G RR S A + V S + + + + +
Sbjct: 8 GHHHHHHGRRRASVAAGILVPRGSPG--LDGICSIEELSTSLYKKAGSENLY---FQGAN 62
Query: 68 RPHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDK-IGQGTYSNVYKARDLLTGKI- 125
H + P + AV + ++ ++ IG+G + VY L
Sbjct: 63 TVHIDLSALNPELVQAV-----QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKK 117
Query: 126 --VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH 183
A+K + E +F+ E ++++ HPNV+ L G+ R S +V YM+H
Sbjct: 118 IHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVLSLLGICL-RSEGSPLVVLPYMKH 175
Query: 184 -DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIAD 242
DL + + + + Q+ G++ + +HRD+ N ++D +K+AD
Sbjct: 176 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 243 FGLA 246
FGLA
Sbjct: 236 FGLA 239
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 36/161 (22%), Positives = 74/161 (45%), Gaps = 9/161 (5%)
Query: 90 RDW-TPRRANTFEKLDKIGQGTYSNVYKARDLLTGKI--VALKKVRFDNLEPESVKFMAR 146
+ R + ++G G + +V + + K VA+K ++ + ++ + M R
Sbjct: 2 KKLFLKRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-R 59
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYM 205
E ++ +LD+P +++L G+ + +L LV E L + + V +
Sbjct: 60 EAQIMHQLDNPYIVRLIGVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
Q+ G+++ +HRD+ N+L+ N KI+DFGL+
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-23
Identities = 65/239 (27%), Positives = 97/239 (40%), Gaps = 53/239 (22%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK----FMAREILV 150
+K+G+G + VYK + VA+KK+ ++ + + F EI V
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLA-AMVDITTEELKQQFDQ-EIKV 83
Query: 151 LRKLDHPNVIKLEGLVTSRMSCS----LYLVFEYME--------HDLAGLAA-------- 190
+ K H N+++L G S L LV+ YM L G
Sbjct: 84 MAKCQHENLVELLGF------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 191 -CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249
QG +G+ H N +HRDIK +N+L+D KI+DFGLA
Sbjct: 138 IAQGAA--------------NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 250 DPGLKQPMTSRVV-TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTE 306
+ + MTSR+V T Y PE L G D++S G +L E++ G + R
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREIL 149
R + ++G+G + +V R TG +VA+K+++ P+ + REI
Sbjct: 21 EERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQ 76
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQL 208
+L+ L ++K G+ SL LV EY+ L + ++ Y Q+
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
G+E+ + +HRD+ N+L++++ +KIADFGLA
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 9e-23
Identities = 38/155 (24%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLR 152
+ TF K ++G G + V + G+ VA+K ++ ++ + +F+ E V+
Sbjct: 22 DPKDLTFLK--ELGTGQFGVVKYGK--WRGQYDVAIKMIKEGSMSED--EFI-EEAKVMM 74
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSG 211
L H +++L G+ T + ++++ EYM + L +F Q+ K +
Sbjct: 75 NLSHEKLVQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+E+ + LHRD+ N L+++ G++K++DFGL+
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLR 152
TF + +IG G + V+ K VA+K +R + E F+ E V+
Sbjct: 6 DPSELTFVQ--EIGSGQFGLVHLGY--WLNKDKVAIKTIREGAMSEE--DFI-EEAEVMM 58
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSG 211
KL HP +++L G+ + + LV E+MEH L+ Q F+ + + G
Sbjct: 59 KLSHPKLVQLYGVCLEQAP--ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ + V+HRD+ N L+ + ++K++DFG+
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 37/165 (22%), Positives = 70/165 (42%), Gaps = 11/165 (6%)
Query: 87 DAIRDWTPRRANTFEKLDKIGQGTYSNVYKAR---DLLTGKI-VALKKVRFDNLEPESVK 142
A+ K +G G + VYK + KI VA+K++R + +
Sbjct: 6 QALLRILKETEFKKIK--VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 143 FMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQV 201
+ E V+ +D+P+V +L G+ + ++ L+ + M L +
Sbjct: 64 IL-DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ Q+ G+ + + ++HRD+ N+L+ +KI DFGLA
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 7/163 (4%)
Query: 89 IRDWT-PRRANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFM 144
++D P IG+G + VY + + A+K + + F+
Sbjct: 11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL 70
Query: 145 AREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKC 203
RE L++R L+HPNV+ L G++ +++ YM H DL + +
Sbjct: 71 -REGLLMRGLNHPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLIS 128
Query: 204 YMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ Q+ G+E+ +HRD+ N ++D +K+ADFGLA
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 49/225 (21%), Positives = 84/225 (37%), Gaps = 42/225 (18%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE- 163
KIG G + +Y A + A V+ +E + + E+ +++ + IK
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK---VEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 164 ----------------GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQ 207
GL + ++V E + DL ++ G F + V +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLID--NDGILKIADFGLATFY-DPGLKQPMTSRVVTL 264
+L LE+ H N +H DIK +NLL+ N + +AD+GL+ Y G +
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ------ 213
Query: 265 WYRPPELLLGATYY-------GVGV----DLWSAGCILAELLAGK 298
P + G + GV + D+ G + L GK
Sbjct: 214 -ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 36/148 (24%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 103 LDKIGQGTYSNVYKA--RDLLTGKI-VALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+G+G + VY+ + KI VA+K + D KFM E ++++ LDHP++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNLDHPHI 75
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+KL G++ +++ E + +L + Y Q+ + + +
Sbjct: 76 VKLIGIIEEE---PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLA 246
+HRDI N+L+ + +K+ DFGL+
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-22
Identities = 48/227 (21%), Positives = 96/227 (42%), Gaps = 16/227 (7%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKI---VALKKVRFDNLEPESVKFMAREILV 150
R + IG+G + +V++ + VA+K + + KF+ +E L
Sbjct: 388 QRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALT 444
Query: 151 LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLL 209
+R+ DHP+++KL G++T ++++ E +L + + Y QL
Sbjct: 445 MRQFDHPHIVKLIGVITEN---PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA-TFYDPGLKQPMTSRVVTLWYRP 268
+ L + + +HRDI N+L+ ++ +K+ DFGL+ D + ++ W P
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 561
Query: 269 PELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKI 313
+ + D+W G + E+ KP G + + +I
Sbjct: 562 ESINFRR--FTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 40/190 (21%), Positives = 76/190 (40%), Gaps = 15/190 (7%)
Query: 70 HSESQQGWPSWLMAVAGDAIRDWT-PRRANTFEKLDKIGQGTYSNVYKA--RDLLTGKI- 125
H G + + D R K +G+G + +V + + +
Sbjct: 7 HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLK 64
Query: 126 VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVT---SRMSCSLYLVFEYME 182
VA+K ++ DN ++ E ++ HPNVI+L G+ S+ ++ +M+
Sbjct: 65 VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 183 H-DL-----AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236
+ DL + +M + G+E+ N LHRD+ N ++ +D
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184
Query: 237 ILKIADFGLA 246
+ +ADFGL+
Sbjct: 185 TVCVADFGLS 194
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 38/146 (26%), Positives = 69/146 (47%), Gaps = 9/146 (6%)
Query: 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
L IG+G + +V G VA+K ++ ++ + F+ E V+ +L H N+++L
Sbjct: 198 LQTIGKGEFGDVMLGD--YRGNKVAVKCIK-NDATAQ--AFL-AEASVMTQLRHSNLVQL 251
Query: 163 EGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
G++ LY+V EYM L L + + + + +E+ N
Sbjct: 252 LGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLA 246
+HRD+ N+L+ D + K++DFGL
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 38/174 (21%), Positives = 77/174 (44%), Gaps = 16/174 (9%)
Query: 87 DAIRDW-TPRRANTFEKLDKIGQGTYSNVYKA--RDLLTGKI-VALKKVRFDNLEPESVK 142
+ + D P + T + +G+G + +V +A + + VA+K ++ D + ++
Sbjct: 13 EKLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 143 FMAREILVLRKLDHPNVIKLEGLVT----SRMSCSLYLVFEYMEH-DL-----AGLAACQ 192
RE +++ DHP+V KL G+ ++ +M+H DL A
Sbjct: 71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 193 GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ +M + G+E+ + +HRD+ N ++ D + +ADFGL+
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 37/165 (22%), Positives = 73/165 (44%), Gaps = 11/165 (6%)
Query: 87 DAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVK 142
A+ F+K+ +G G + VYK + G+ VA+K++R + +
Sbjct: 6 QALLRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 143 FMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQV 201
+ E V+ +D+P+V +L G+ + ++ L+ + M L +
Sbjct: 64 IL-DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ Q+ G+ + + ++HRD+ N+L+ +KI DFGLA
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 34/146 (23%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 105 KIGQGTYSNVYKARDLLTGKI--VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
++G G + V K + + VA+K ++ + +P + E V+++LD+P ++++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 163 EGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGV 220
G+ + S LV E E L L + + + + Q+ G+++ +
Sbjct: 84 IGICEAE---SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 221 LHRDIKGSNLLIDNDGILKIADFGLA 246
+HRD+ N+L+ KI+DFGL+
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 46/155 (29%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR + EK K+G G + V+ A K VA+K ++ ++ E F+ E V++
Sbjct: 186 PRESLKLEK--KLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE--AFL-AEANVMKT 239
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSG 211
L H ++KL +VT +Y++ E+M L L + +G K P++ + Q+ G
Sbjct: 240 LQHDKLVKLHAVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ +HRD++ +N+L+ + KIADFGLA
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 63/245 (25%), Positives = 97/245 (39%), Gaps = 66/245 (26%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVK----FMAREILVLRK 153
N F+ IG G + VYK L G VALK+ PES + F EI L
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSF 91
Query: 154 LDHPNVIKLEGLVTSRMSCS----LYLVFEYMEHD-----LAGLAACQGVKFSEPQVKCY 204
HP+++ L G C + L+++YME+ L G
Sbjct: 92 CRHPHLVSLIGF------CDERNEMILIYKYMENGNLKRHLYGSDLPTMS---------- 135
Query: 205 MKQLLS-------------GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251
+S GL + H ++HRD+K N+L+D + + KI DFG++
Sbjct: 136 ----MSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 252 GLKQPMTSRVV-TLWYRPPELLLGATYYGVG-----VDLWSAGCILAELLAGK-PIMPGR 304
+ +++ V TL Y PE Y+ G D++S G +L E+L + I+
Sbjct: 192 LDQTHLSTVVKGTLGYIDPE------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL 245
Query: 305 TEVEQ 309
Sbjct: 246 PREMV 250
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 38/168 (22%), Positives = 76/168 (45%), Gaps = 20/168 (11%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYK--ARDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
R T + ++GQG++ VY+ A+ ++ + VA+K V E ++F+ E
Sbjct: 23 AREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEA 79
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------AGLAACQGVKFSE 198
V+++ + +V++L G+V+ ++ E M DL A S
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 199 PQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
++ ++ G+ + + N +HRD+ N ++ D +KI DFG+
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 26/174 (14%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYK--ARDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
A F + ++G+ + VYK G+ VA+K ++ P +F E
Sbjct: 7 SLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEA 63
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLAACQ 192
++ +L HPNV+ L G+VT L ++F Y H DL
Sbjct: 64 MLRARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 193 GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
P + Q+ +G+E+ ++ V+H+D+ N+L+ + +KI+D GL
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 10/153 (6%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKI---VALKKVRFDNLEPESV--KFMAREILVLRKL 154
L+K+G G++ V + VA+K ++ D L F+ RE+ + L
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSL 78
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
DH N+I+L G+V + + +V E L F + Y Q+ G+
Sbjct: 79 DHRNLIRLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ + +HRD+ NLL+ ++KI DFGL
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 58/232 (25%), Positives = 106/232 (45%), Gaps = 37/232 (15%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ F + +G+G + VYK R L G +VA+K+++ + + ++F E+ ++ H
Sbjct: 30 DNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-EVEMISMAVHR 87
Query: 158 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAAC-QGVKFSEPQVKCY--MKQLL- 209
N+++L G C LV+ YM + +A+C + S+P + + L
Sbjct: 88 NLLRLRGF------CMTPTERLLVYPYMANG--SVASCLRERPESQPPLDWPKRQRIALG 139
Query: 210 --SGLEHCH---NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-T 263
GL + H + ++HRD+K +N+L+D + + DFGLA D +T+ V T
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK-DTHVTTAVRGT 198
Query: 264 LWYRPPELLLGATYYGVG-----VDLWSAGCILAELLAG-KPIMPGRTEVEQ 309
+ + PE Y G D++ G +L EL+ G + R +
Sbjct: 199 IGHIAPE------YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 34/152 (22%), Positives = 67/152 (44%), Gaps = 9/152 (5%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREILVLRKLD 155
KL +G G + V+K + G+ V +K + + +L + LD
Sbjct: 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGSLD 73
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
H ++++L GL SL LV +Y+ L + + Q+ G+ +
Sbjct: 74 HAHIVRLLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+G++HR++ N+L+ + +++ADFG+A
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-20
Identities = 64/267 (23%), Positives = 102/267 (38%), Gaps = 56/267 (20%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF--MAREILVLRKL 154
N + KIG G++ ++Y D+ G+ VA+K E K + E + + +
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMM 61
Query: 155 DH----PNVIKL--EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQL 208
P + EG +V E + L L KFS V Q+
Sbjct: 62 QGGVGIPTIRWCGAEGDYN-------VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLW 265
+S +E+ H+ +HRD+K N L+ ++ I DFGLA Y + T + +
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY----RDARTHQHIP-- 168
Query: 266 YRPPELLLGATYYG-----VGV------DLWSAGCILAELLAGK---PIMPGRTEVEQLH 311
YR + L G Y +G+ DL S G +L G + T+ ++
Sbjct: 169 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228
Query: 312 KIFK---------LC-GSPSE--EYWK 326
+I + LC G PSE Y
Sbjct: 229 RISEKKMSTPIEVLCKGYPSEFATYLN 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 66/271 (24%), Positives = 96/271 (35%), Gaps = 62/271 (22%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKF--MAREILVLRKL 154
F KIG G + + ++L T + VA+K LEP + + E ++L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQL 61
Query: 155 DH----PNVIKL--EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQL 208
P V G +V E + L L FS V QL
Sbjct: 62 GSGDGIPQVYYFGPCGKYN-------AMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQL 114
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDG-----ILKIADFGLATFY-DPGLKQ--PMTSR 260
+S +E+ H+ +++RD+K N LI G ++ I DF LA Y DP K+ P
Sbjct: 115 ISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP---- 170
Query: 261 VVTLWYRPPELLLGATYYG-----VGV------DLWSAGCILAELLAGK-P--IMPGRTE 306
YR + L G Y +G DL + G + L G P + T
Sbjct: 171 -----YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL 225
Query: 307 VEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
E+ KI K P L +
Sbjct: 226 KERYQKIGD----------TKRATPIEVLCE 246
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 26/173 (15%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYK--ARDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
RR + ++G+G + V+ +LL + +VA+K ++ + E F RE
Sbjct: 39 KRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REA 94
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL--------------AGLAACQG 193
+L L H ++++ G+ T L +VFEYM H DL AG
Sbjct: 95 ELLTMLQHQHIVRFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 194 VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
Q+ Q+ +G+ + +HRD+ N L+ ++KI DFG++
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 24/172 (13%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGK--IVALKKVRFDNLEPESVKFMAREILVL 151
F+ IG+G + V KAR G A+K+++ + + F E+ VL
Sbjct: 23 DWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVL 79
Query: 152 RKL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLAACQGV 194
KL HPN+I L G R LYL EY H +L +A
Sbjct: 80 CKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137
Query: 195 KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
S Q+ + + G+++ +HRD+ N+L+ + + KIADFGL+
Sbjct: 138 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-20
Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 20/168 (11%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYK--ARDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR+ T + +G G + VY+ + VA+K + E + + F+ E
Sbjct: 28 PRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEA 84
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLAACQGVKFSEPQV 201
L++ K +H N+++ G+ + +++ E M DL Q + +
Sbjct: 85 LIISKFNHQNIVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIADFGLA 246
+ + G ++ N +HRDI N L+ G + KI DFG+A
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 66/268 (24%), Positives = 106/268 (39%), Gaps = 56/268 (20%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
++ +IG+G++ +++ +LL + VA+K + P+ + E + L
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 64
Query: 157 ----PNVIKL--EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLS 210
PNV EGL LV + + L L G KFS V KQ+L+
Sbjct: 65 CTGIPNVYYFGQEGLHN-------VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLA 117
Query: 211 GLEHCHNNGVLHRDIKGSNLLI-----DNDGILKIADFGLATFY-DPGLKQPMTSRVVTL 264
++ H +++RDIK N LI N ++ + DFG+ FY DP KQ +
Sbjct: 118 RVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP------ 171
Query: 265 WYRPPELLLGATYYG-----VGV------DLWSAGCILAELLAGK---PIMPGRTEVEQL 310
YR + L G Y +G DL + G + L G + T ++
Sbjct: 172 -YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 230
Query: 311 HKIFK---------LC-GSPSE--EYWK 326
+I + LC G P E +Y
Sbjct: 231 ERIGEKKQSTPLRELCAGFPEEFYKYMH 258
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 42/174 (24%), Positives = 78/174 (44%), Gaps = 27/174 (15%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYK--ARDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
RR ++ ++G+G + V+ +L K +VA+K ++ D F RE
Sbjct: 13 KRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REA 68
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL--------AGLAACQGVKFSEP 199
+L L H +++K G+ L +VFEYM+H DL + +
Sbjct: 69 ELLTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 200 QVKCYMKQLL-------SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ + + Q+L SG+ + + +HRD+ N L+ + ++KI DFG++
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 44/240 (18%), Positives = 84/240 (35%), Gaps = 34/240 (14%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKI-------VALKKVRFDNLEPESVKFMAR 146
F + +GQGT++ ++K G V LK + + F
Sbjct: 6 RNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF-E 61
Query: 147 EILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYM 205
++ KL H +++ G+ LV E+++ L +
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 206 KQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG--------ILKIADFGLA-TFYD-PGLKQ 255
KQL + + N ++H ++ N+L+ + +K++D G++ T L++
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE 179
Query: 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAEL--LAGKPIMPGRTEVEQLHKI 313
+ W PPE + + D WS G L E+ KP + +L
Sbjct: 180 RIP------WV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 34/182 (18%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYK--ARDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR + + IG+G + V++ A LL + +VA+K ++ + F RE
Sbjct: 45 PRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 101
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL----------------AGLAAC 191
++ + D+PN++KL G+ + + L+FEYM + DL +
Sbjct: 102 ALMAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159
Query: 192 QGVKFSEPQVKCYMKQLL-------SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244
+ S + L +G+ + +HRD+ N L+ + ++KIADFG
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 245 LA 246
L+
Sbjct: 220 LS 221
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 20/168 (11%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYK--ARDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR+ T + +G G + VY+ + VA+K + E + + F+ E
Sbjct: 69 PRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEA 125
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLAACQGVKFSEPQV 201
L++ K +H N+++ G+ + +++ E M DL Q + +
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIADFGLA 246
+ + G ++ N +HRDI N L+ G + KI DFG+A
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 40/175 (22%), Positives = 69/175 (39%), Gaps = 26/175 (14%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKA--RDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR K +G+G + V +A + VA+K ++ E M E+
Sbjct: 25 PRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SEL 81
Query: 149 LVLRKLD-HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLAAC 191
+L + H NV+ L G T + L ++ E+ + +L
Sbjct: 82 KILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 192 QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ + CY Q+ G+E + +HRD+ N+L+ ++KI DFGLA
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKAR--DLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR+ K +G+G + V KA L VA+K ++ + E + E
Sbjct: 21 PRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEF 77
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL----------------AGLAAC 191
VL++++HP+VIKL G + L L+ EY ++ L +G +
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 192 QGVKFSEPQVKCYMKQLLS-------GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244
+ M L+S G+++ ++HRD+ N+L+ +KI+DFG
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 245 LA 246
L+
Sbjct: 196 LS 197
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 47/225 (20%), Positives = 78/225 (34%), Gaps = 39/225 (17%)
Query: 105 KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLE- 163
IGQG + +Y A + + V +EP + E+ ++ P I+
Sbjct: 42 PIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 164 ----------------GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQ 207
GL +++ + DL + +FS V +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLID--NDGILKIADFGLATFY-DPGLKQPMTSRVVTL 264
+L LE+ H + +H DIK SNLL++ N + + D+GLA Y G+ +
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA------ 214
Query: 265 WYRPPELLLGATYY-------GVGV----DLWSAGCILAELLAGK 298
P G + GV DL G + + L G
Sbjct: 215 -ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 44/177 (24%), Positives = 72/177 (40%), Gaps = 29/177 (16%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKA--RDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR +F K +G G + V +A L+ VA+K ++ E M E+
Sbjct: 21 PRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SEL 77
Query: 149 LVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL----------AGLAACQGVKF 196
VL L +H N++ L G T ++ EY + DL +
Sbjct: 78 KVLSYLGNHMNIVNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 197 SEPQVKCYMKQLLS-------GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ ++ ++ LLS G+ + +HRD+ N+L+ + I KI DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 29/177 (16%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKA--RDLLTGK-----IVALKKVRFDNLEPESVKFMAR 146
PR T K +G+G + V A + K VA+K ++ D E + +
Sbjct: 33 PRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-S 89
Query: 147 EILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL--------AGLAACQGVKF 196
E+ +++ + H N+I L G T LY++ EY +L
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 197 SEPQVKCYMKQLLS-------GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
P+ + K L+S G+E+ + +HRD+ N+L+ + ++KIADFGLA
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKAR--DLLTGK-----IVALKKVRFDNLEPESVKFMAR 146
PR T K +G+G + V A + K VA+K ++ D E + +
Sbjct: 79 PRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-S 135
Query: 147 EILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLA 189
E+ +++ + H N+I L G T LY++ EY +L +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 190 ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
+ + + QL G+E+ + +HRD+ N+L+ + ++KIADFGLA
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYK--ARDLLTGK-----IVALKKVRFDNLEPESVKFMAR 146
PR K +G+G + V A L K VA+K ++ D E + +
Sbjct: 67 PRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-S 123
Query: 147 EILVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL--------AGLAACQGVKF 196
E+ +++ + H N+I L G T LY++ EY +L
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 197 SEPQVKCYMKQLLS-------GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
P+ + K L+S G+E+ + +HRD+ N+L+ D ++KIADFGLA
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 70/263 (26%), Positives = 100/263 (38%), Gaps = 52/263 (19%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK 153
PR N F KIG G++ +Y ++ T + VA+K P+ + E + R
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRI 58
Query: 154 LDH----PNVIKL--EGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQ 207
L PNV EG LV + + L L K S V Q
Sbjct: 59 LQGGTGIPNVRWFGVEGDYN-------VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
Query: 208 LLSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFY-DPGLKQPMTSRVVT 263
+++ +E H+ LHRDIK N L+ + I DFGLA Y D Q +
Sbjct: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP----- 166
Query: 264 LWYRPPELLLGATYYG-----VGV------DLWSAGCILAELLAGK---PIMPGRTEVEQ 309
YR + L G Y +G+ DL S G +L L G + T+ ++
Sbjct: 167 --YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
Query: 310 LHKIFK---------LC-GSPSE 322
KI + LC G P+E
Sbjct: 225 YEKISEKKVATSIEALCRGYPTE 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 44/182 (24%), Positives = 71/182 (39%), Gaps = 34/182 (18%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKA--RDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR F K +G G + V A + VA+K ++ E M E+
Sbjct: 43 PRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SEL 99
Query: 149 LVLRKL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLAAC 191
++ +L H N++ L G T +YL+FEY + DL
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 192 QGVKFSEPQVKCYMKQLLS-------GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244
+ ++ E + LL G+E +HRD+ N+L+ + ++KI DFG
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 245 LA 246
LA
Sbjct: 218 LA 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 42/173 (24%), Positives = 67/173 (38%), Gaps = 25/173 (14%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKA--RDLLTGK---IVALKKVRFDNLEPESVKFMAREI 148
PR F K +G G + V +A L VA+K ++ E M E+
Sbjct: 44 PRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SEL 100
Query: 149 LVLRKLD-HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DL-------------AGLAACQG 193
++ L H N++ L G T + ++ EY + DL A
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 194 VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
S + + Q+ G+ + +HRD+ N+L+ N + KI DFGLA
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 38/230 (16%), Positives = 66/230 (28%), Gaps = 49/230 (21%)
Query: 105 KIGQGTYSNVYKARDLLTGKI--------VALKKVRFDNLEPESVKFMAREILVLRKLDH 156
+ +Y+A T +LK L+ + + + R
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGRLFNEQNFFQRAAKP 102
Query: 157 PNVIKLEGLVTSRMSC--SLY-----------LVFEYMEHDLAGL-AACQGVKFSEPQVK 202
V K + L ++ + + LV + L SE V
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLI--DNDGILKIADFGLATFY-DPGLKQPMTS 259
+LL LE H N +H ++ N+ + ++ + +A +G A Y G
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV- 221
Query: 260 RVVTLWYRPPELLLGATYY-------GVGV----DLWSAGCILAELLAGK 298
G + G G DL S G + + L G
Sbjct: 222 ------EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 3e-09
Identities = 57/449 (12%), Positives = 129/449 (28%), Gaps = 119/449 (26%)
Query: 79 SWLMAVAGDAIRD------------W-TPRRANTFEKLDKIGQGTYSNV---YKARDLLT 122
+W+ A D W + N+ E + ++ Q + + +R +
Sbjct: 164 TWV---ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS 220
Query: 123 GKIVALKKVRFDNLEPESVKFMARE-----ILVLRKLDHPNVIK-LEG----LVTSRMSC 172
I K+R +++ E + + + +LVL + + L+T+R
Sbjct: 221 SNI----KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 173 ------SLYLVFEYMEHDLAG---------LAACQGVKFSE-PQVKCYMKQLLSGL---- 212
+ ++H L + + P+ +
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336
Query: 213 ---EHCHNNGVLHRDIKGSNLLIDND-GILKIADF-----GLATFYDPGLKQPMTSRVVT 263
+ H + +I++ +L+ A++ L+ F P P T +
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF-PPSAHIP-TILLSL 394
Query: 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP-------------IMPGRTEVEQL 310
+W+ + V + L+ +P + L
Sbjct: 395 IWFDVIK---------SDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQ--------PY--KRC-IAETFKDFPSSSLP 359
H+ + Y + L P + K E F L
Sbjct: 446 HRSI------VDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 360 L--IETLLSIDPDNRGTATAALN--SEFFNTEPYAC--EP------SSLPKYPPSKEMDV 407
+E + D + + LN + +PY C +P +++ + P E ++
Sbjct: 500 FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENL 559
Query: 408 KLREEEAR-RQRGLSGKANAV--DGAKRV 433
+ + + L + A+ + K+V
Sbjct: 560 -ICSKYTDLLRIALMAEDEAIFEEAHKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 2e-05
Identities = 47/330 (14%), Positives = 85/330 (25%), Gaps = 108/330 (32%)
Query: 69 PHSESQQGWPSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVAL 128
P E P +++ ++IRD + ++ ++ D LT I
Sbjct: 319 PR-EVLTTNP-RRLSIIAESIRDG-LATWDNWKHVNC-------------DKLTTII--- 359
Query: 129 KKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL--YLVFEYMEHDLA 186
+ + LEP + M + V + + + + + ++ + +
Sbjct: 360 -ESSLNVLEPAEYRKMFDRLSVFPP----SA-----HIPTILLSLIWFDVIKSDVMVVVN 409
Query: 187 -----GLAACQGVKFSEPQVKCYMKQL-LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKI 240
L Q + + + + L N LHR ++D+ I K
Sbjct: 410 KLHKYSLVEKQPKEST-----ISIPSIYLELKVKLENEYALHR------SIVDHYNIPKT 458
Query: 241 ADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPI 300
+D P L Y +G L + E
Sbjct: 459 --------FDS-------------DDLIPPYLDQYFYSHIGHHLKNIE--HPE------- 488
Query: 301 MPGRTEVEQLHKIF--------KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAE---- 348
+ +F K+ + S L K YK I +
Sbjct: 489 -----RMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK---FYKPYICDNDPK 540
Query: 349 ------TFKDFPSSSLPLIETLLSIDPDNR 372
DF LP IE L
Sbjct: 541 YERLVNAILDF----LPKIEENLICSKYTD 566
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 17/44 (38%), Positives = 26/44 (59%)
Query: 203 CYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246
CY Q+ G+E + +HRD+ N+L+ ++KI DFGLA
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 6e-06
Identities = 21/96 (21%), Positives = 40/96 (41%), Gaps = 10/96 (10%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGK-----IVALKKVRFDNLEPESVKFMAREI 148
PR K +G+G + V +A K VA+K ++ + + + E+
Sbjct: 20 PRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSEL 76
Query: 149 LVLRKLD-HPNVIKLEGLVTSRMSCSLYLVFEYMEH 183
+L + H NV+ L G T + L ++ E+ +
Sbjct: 77 KILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKF 111
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 457 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.82 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.6 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.55 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.17 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.03 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.03 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.99 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.28 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.44 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.66 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 92.18 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.26 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-65 Score=489.57 Aligned_cols=263 Identities=29% Similarity=0.425 Sum_probs=228.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++|+|||||++++++.+ ...+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~y 108 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 108 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEE
Confidence 4689999999999999999999999999999999976432 22345678899999999999999999999987 67899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-C
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL-K 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 254 (457)
||||||+|+.+..+....+.+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999986555555555679999999999999999999999999999999999999999999999999999875432 2
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
....+.+||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+..+.+.+|.+.-..
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~--------------- 252 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYD--------------- 252 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------------
T ss_pred ccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 3456679999999999998776 799999999999999999999999999999988888653111
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHH------HhcCCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATA------ALNSEFFNTEPYAC 391 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e------lL~hp~f~~~~~~~ 391 (457)
....+++++++||.+||+.||++|||++| +++||||++..|..
T Consensus 253 --------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 253 --------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp --------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred --------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 11247788999999999999999999988 58999999987754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-63 Score=497.10 Aligned_cols=292 Identities=32% Similarity=0.511 Sum_probs=244.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec----CCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR----MSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~ 172 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|++|+|||||++++++... ...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3679999999999999999999999999999999987666666677888999999999999999999987643 235
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|||||||+|++...+. ....+++.+++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~g~L~~~i~-~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLMESDLHQIIH-SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCSEEHHHHHT-SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 799999999988766654 4567999999999999999999999999999999999999999999999999999876432
Q ss_pred ---CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 253 ---LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 253 ---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
......+.+||+.|||||++.+..+|+.++||||+||++|||++|++||.+.+..+++..|....|.|+...|....
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 12344667999999999999988778999999999999999999999999999999999999999999887765432
Q ss_pred CCCcccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 330 LPNATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 330 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
....... .........+...++.++++++|||.+||++||++|||++|+|+||||++...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1111100 00111122345566788999999999999999999999999999999998644
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-64 Score=477.49 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=209.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... ......+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEE
Confidence 46899999999999999999999999999999999876543 3345678999999999999999999999987 57899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++|++...+.. .+.+++.+++.++.||+.||.|||++||+||||||+||||+.++++||+|||+|+..... .
T Consensus 90 ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~ 166 (275)
T 3hyh_A 90 MVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--N 166 (275)
T ss_dssp EEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--C
Confidence 9999998888776655 457999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
...+.+||+.|||||++.+..+++.++|||||||++|+|+||++||.+.+..+...++......
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~---------------- 230 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT---------------- 230 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC----------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 3456789999999999998886788999999999999999999999998888887777542110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
....+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 231 -------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 231 -------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 11347888999999999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-63 Score=487.90 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=223.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
..|+++++||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|++++|||||++++++.+ ...+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 57999999999999999999999999999999998654332 3457899999999999999999999988 5689999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
||||+|+.+..+..+ ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.... ...
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCB
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC-Ccc
Confidence 999998766665554 369999999999999999999999999999999999999999999999999999775432 334
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
++.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|.......
T Consensus 228 ~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----------------- 289 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR----------------- 289 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------------
T ss_pred cccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------------
Confidence 6679999999999998766 8999999999999999999999999999888888775421100
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...+..+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 290 ---------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 290 ---------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp ---------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 01223578899999999999999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-64 Score=491.92 Aligned_cols=258 Identities=25% Similarity=0.470 Sum_probs=220.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|+++++||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yi 100 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYI 100 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEE
Confidence 478999999999999999999999999999999999887777777889999999999999999999999987 578999
Q ss_pred EEecccCC-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHD-LAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|||||+|+ |...+... +..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999875 44444433 4468999999999999999999999999999999999999999999999999998764321
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
...++.+||+.|||||++.+.. |+.++|||||||+||||+||++||.+.+..+.+.+|......
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------------- 243 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP--------------- 243 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC---------------
T ss_pred ccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence 1234568999999999998776 899999999999999999999999999999988888653111
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 244 -------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 244 -------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 112357888999999999999999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-62 Score=489.47 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=224.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
...|+++++||+|+||+||+|+++.+|+.||||++....... .+.+.+|+.+|++|+|||||+++++|.+ ...+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEE
Confidence 357999999999999999999999999999999998654332 3457899999999999999999999988 568999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||||+|+.+..+...+ .+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.... ..
T Consensus 226 VmEy~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~~ 303 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR 303 (423)
T ss_dssp EEECCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-CC
T ss_pred EEeCCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC-cc
Confidence 99999987666655543 69999999999999999999999999999999999999999999999999999775432 33
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
..+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..|......
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~----------------- 365 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP----------------- 365 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----------------
T ss_pred ccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-----------------
Confidence 46779999999999998766 899999999999999999999999999998888877542110
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+..+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 366 ---------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 366 ---------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp ---------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ---------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 001234578899999999999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-62 Score=467.82 Aligned_cols=258 Identities=23% Similarity=0.291 Sum_probs=216.2
Q ss_pred CCc-cccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec--CCceE
Q 036122 98 NTF-EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR--MSCSL 174 (457)
Q Consensus 98 ~~y-~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~ 174 (457)
++| .+.++||+|+||+||+|++..++..||+|++..........+.+.+|+.+|++|+|||||++++++... ....+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 455 667789999999999999999999999999987777777778899999999999999999999998652 23568
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEec-CCCcEEEeeccCccccCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLID-NDGILKIADFGLATFYDP 251 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~ 251 (457)
|||||||+++.+..+..+...+++..++.|+.||+.||.|||++| ||||||||+||||+ .+|.+||+|||+|+....
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999998766666666678999999999999999999999998 99999999999998 479999999999986543
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
....+.+||+.|||||++.+ . |+.++|||||||++|||+||++||.+.+....+.+..... ..+.
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~~--------- 249 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPA--------- 249 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCG---------
T ss_pred ---CccCCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCCC---------
Confidence 23456789999999998865 4 8999999999999999999999998766555443332210 0000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 250 ----------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 ----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 112346678999999999999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-63 Score=479.50 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=216.3
Q ss_pred CCccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
++|++++.||+|+||+||+|++. .+++.||||+++...........+.+|+.+|++++|||||++++++.+ ...+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 67999999999999999999874 467899999997654333333457789999999999999999999988 5789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|||||||+|+.+..+..+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 180 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 180 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC-
Confidence 9999999986665555556689999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
....+.+||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+..+.+.+|.+....
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------------- 244 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG--------------- 244 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred ccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence 3345678999999999998776 899999999999999999999999999999988888652110
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
....+++++.+||.+||+.||++||| ++|+|+||||++..|
T Consensus 245 --------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 245 --------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 11347888999999999999999998 589999999998655
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-61 Score=469.32 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=215.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.+... .+|+.+|++|+|||||++++++.+ ...+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~i 127 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNI 127 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 46789999999999999999999999999999999865432 369999999999999999999987 568999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~~ 255 (457)
|||||+|+.+..+....+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999866655555556799999999999999999999999999999999999999988 6999999999977543211
Q ss_pred ----CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 256 ----PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 256 ----~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.....+||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+..+.+.+|.... +
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~----------- 273 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP--P----------- 273 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC--C-----------
T ss_pred cceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC--C-----------
Confidence 123457999999999998876 8999999999999999999999999887777776665421 0
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHH-------------hcCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAA-------------LNSEFFNTE 387 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el-------------L~hp~f~~~ 387 (457)
...+..+.+++++.+||.+||+.||.+|||+.|+ |+|||++..
T Consensus 274 -------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 274 -------------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp -------------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred -------------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 0112335688899999999999999999999997 679999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-59 Score=462.94 Aligned_cols=285 Identities=28% Similarity=0.402 Sum_probs=221.6
Q ss_pred CcCcCCccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEec
Q 036122 94 PRRANTFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSR 169 (457)
Q Consensus 94 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 169 (457)
|.-.++|++.++||+|+||+||+|+++ .+++.||||++.... ....+.+|+.+|+.+ +|||||++++++.+
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~- 91 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRK- 91 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-
Confidence 334578999999999999999999875 467899999986543 234577899999998 69999999999987
Q ss_pred CCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-CcEEEeeccCccc
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLATF 248 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~ 248 (457)
...+|+||||++++.+..+. ..+++.+++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.
T Consensus 92 -~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 92 -NDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp -TTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred -CCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 57899999999875444444 259999999999999999999999999999999999999876 8999999999986
Q ss_pred cCCCC---------------------------CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCC
Q 036122 249 YDPGL---------------------------KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIM 301 (457)
Q Consensus 249 ~~~~~---------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf 301 (457)
..... ....++.+||++|||||++.+...|+.++||||+||++|||+||++||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 54321 112345689999999999988777899999999999999999999888
Q ss_pred -CCCChHHHHHHHHHhcCCCChhhhhhcC---------CCCcc------------cCCC----CCCcccchhcccCCCCC
Q 036122 302 -PGRTEVEQLHKIFKLCGSPSEEYWKKSK---------LPNAT------------LFKP----QQPYKRCIAETFKDFPS 355 (457)
Q Consensus 302 -~~~~~~~~~~~i~~~~~~~~~~~~~~~~---------~~~~~------------~~~~----~~~~~~~~~~~~~~~~~ 355 (457)
.+.++.+++.+|...+|++....+.... .+... ...+ .........+.+..+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 5677889999999998875543332210 00000 0000 00000111234566788
Q ss_pred CcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 356 SSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 356 ~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+++|||++||++||++|+|++|+|+||||++.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-59 Score=449.84 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=197.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC------
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS------ 171 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~------ 171 (457)
++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+|||||++++++.....
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 57999999999999999999999999999999998654 34455678899999999999999999999875432
Q ss_pred ----ceEEEEEecccCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 172 ----CSLYLVFEYMEHDLAGLAACQGVK---FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 172 ----~~~~lv~E~~~~~l~~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
..+|+|||||.++.+..+...... ..+..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 247999999998666555544433 4556789999999999999999999999999999999999999999999
Q ss_pred CccccCCCCC-----------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 036122 245 LATFYDPGLK-----------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKI 313 (457)
Q Consensus 245 la~~~~~~~~-----------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i 313 (457)
+|+....... ...++.+||+.|||||++.+.. |+.++|||||||++|||++ ||.+. .+....+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 9987653321 1224568999999999998776 8999999999999999996 67543 2333333
Q ss_pred HHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 314 FKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
........+ ..+...++.+.+||.+||+.||++|||+.|+|+||||++..+
T Consensus 238 ~~~~~~~~p-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 238 TDVRNLKFP-------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHTTCCC-------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHhcCCCC-------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 222111100 111223456788999999999999999999999999998644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=439.10 Aligned_cols=255 Identities=24% Similarity=0.328 Sum_probs=205.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.++||+|+||+||+|++. ..||||+++......+..+.|.+|+.+|++++|||||+++|++.. ..+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~i 108 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAI 108 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEE
Confidence 468899999999999999999743 359999998776677778889999999999999999999998864 35799
Q ss_pred EEecccCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-C
Q 036122 177 VFEYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL-K 254 (457)
Q Consensus 177 v~E~~~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 254 (457)
|||||+++.+.. +......+++.++..|+.||+.||.|||+++||||||||+||||++++++||+|||+|+...... .
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 999999765544 44455679999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCcccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
......+||+.|||||++.+. ..|+.++|||||||+||||+||++||.+.+....+..+......++
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p----------- 257 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP----------- 257 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC-----------
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----------
Confidence 334567899999999999753 2489999999999999999999999998877666555443211100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.+.....++|+++.+||.+||+.||++|||+.|+++
T Consensus 258 ------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 258 ------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp ------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 011223467888999999999999999999998753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=476.06 Aligned_cols=265 Identities=25% Similarity=0.402 Sum_probs=230.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||++++++.+ ...+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999997643 3445678899999999999999999999987 678999
Q ss_pred EEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC--CcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND--GILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~--~~vkl~DFGla~~~~~~~ 253 (457)
|||||.|+ |...+......|++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 99999875 545554555679999999999999999999999999999999999999854 89999999999987644
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
......+||+.|||||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+.+|......++.
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 377 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 377 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-----------
T ss_pred -CceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-----------
Confidence 3345678999999999998876 799999999999999999999999999999998888664332222
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~ 393 (457)
..+..+++++++||++||+.||.+|||++|+|+||||+...++...
T Consensus 378 --------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 378 --------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp --------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTT
T ss_pred --------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCch
Confidence 2335688899999999999999999999999999999987655443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-57 Score=440.29 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=204.6
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
..+|.+.++||+|+||+||+|++. .+++.||||+++.. .....+.|.+|+.+|++|+|||||+++|+|.+ .
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 115 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--G 115 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 357889999999999999999864 36889999999743 45566789999999999999999999999987 5
Q ss_pred ceEEEEEecccCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ---------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
..+|||||||+++.+..+... ..++++.++..|+.||+.||.|||+++||||||||+||||++++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 679999999998665554432 24599999999999999999999999999999999999999999
Q ss_pred cEEEeeccCccccCCCC-CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036122 237 ILKIADFGLATFYDPGL-KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIF 314 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~ 314 (457)
++||+|||+|+...... ....+..+||+.|||||++.+.. |+.++|||||||+||||+| |++||.+.+..+.+..+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999998764332 22234567999999999998776 8999999999999999999 899999999888887775
Q ss_pred HhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
+.... +....+|+++.+||.+||+.||++|||++|++++
T Consensus 275 ~g~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 275 QGREL----------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HTCCC----------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cCCCC----------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 42100 1123478889999999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-57 Score=472.69 Aligned_cols=262 Identities=26% Similarity=0.362 Sum_probs=217.1
Q ss_pred CcCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec
Q 036122 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLDHPNVIKLEGLVTSR 169 (457)
Q Consensus 94 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 169 (457)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+... ..........++.+++.++|||||+++++|.+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~- 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-
Confidence 3447899999999999999999999999999999999975422 22223333445677788899999999999987
Q ss_pred CCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
...+|||||||.|+.+..++...+.|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 264 -~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 264 -PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred -CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 6789999999998766655556668999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhhh
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 326 (457)
... ...+.+||+.|||||++.+...|+.++|||||||++|||++|.+||.+.+. .+....+....
T Consensus 343 ~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--------- 410 (689)
T 3v5w_A 343 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--------- 410 (689)
T ss_dssp SSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC---------
T ss_pred CCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC---------
Confidence 543 235679999999999997655589999999999999999999999976432 23333332210
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
......+++++++||.+||+.||.+|++ ++|+++||||++..|
T Consensus 411 --------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 411 --------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred --------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 0112357889999999999999999998 799999999998655
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=435.79 Aligned_cols=255 Identities=20% Similarity=0.305 Sum_probs=210.7
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|.+.++||+|+||+||+|++. .++..||||+++.. .....+.|.+|+.+|++|+|||||+++|+|.+ .
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~ 87 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--G 87 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--C
Confidence 368999999999999999999865 35789999999743 45566789999999999999999999999987 5
Q ss_pred ceEEEEEecccCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcE
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ-------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGIL 238 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~v 238 (457)
..+|||||||+++.+..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||++++++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 679999999997655544432 2469999999999999999999999999999999999999999999
Q ss_pred EEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 036122 239 KIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKL 316 (457)
Q Consensus 239 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~ 316 (457)
||+|||+|+........ ......||+.|||||++.+.. |+.++|||||||++|||+| |++||.+.+..+.+..+...
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876433221 123346899999999998776 8999999999999999999 89999999988888877552
Q ss_pred cCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
... .....+|+++.+||.+||+.||++|||++|++ +|++.
T Consensus 247 ~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 247 RVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp CCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred CCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence 110 11235788899999999999999999999994 56543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=433.73 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=209.7
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
..++++.++||+|+||+||+|+.. .+++.||||+++... .....+.|.+|+.+|++|+|||||+++|+|.. .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--D 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--C
Confidence 356888999999999999999853 467899999997543 33445679999999999999999999999987 5
Q ss_pred ceEEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND 235 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 235 (457)
..+|||||||+++.+..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||+++
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 568999999998655544432 2358999999999999999999999999999999999999999
Q ss_pred CcEEEeeccCccccCCCC-CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 036122 236 GILKIADFGLATFYDPGL-KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKI 313 (457)
Q Consensus 236 ~~vkl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i 313 (457)
+++||+|||+|+...... ....+..+||+.|||||++.+.. |+.++|||||||+||||+| |.+||.+.+..+.+..+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999998664322 22345568999999999998776 8999999999999999999 89999999988887776
Q ss_pred HHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 314 FKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
...... ....++|+++.+||.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~----------------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVL----------------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCC----------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 432110 1123578889999999999999999999999865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-55 Score=420.71 Aligned_cols=287 Identities=39% Similarity=0.681 Sum_probs=244.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 57999999999999999999999999999999998776666666778899999999999999999999987 5689999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 158 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SCC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-ccc
Confidence 9999999988888777789999999999999999999999999999999999999999999999999998765332 233
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
....||+.|+|||++.+...++.++|||||||++|+|++|. ++|.+.+..+.+..+.+..+.+....|...........
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence 45678999999999988776899999999999999999875 55788888899999999999988877764321111111
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+..+.........+.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 111222223344556788899999999999999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=421.78 Aligned_cols=287 Identities=40% Similarity=0.722 Sum_probs=238.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|++. +|+.||+|++............+.+|+.++++++||||+++++++.. ...+|+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEE
Confidence 578999999999999999999984 69999999998665555555778899999999999999999999876 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 97 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 97 VFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp EEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 99999999888887777779999999999999999999999999999999999999999999999999998765332 23
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC-ccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN-ATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~ 335 (457)
.....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....|....... ...
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 3456789999999999876668999999999999999999999999999999999999999988877665432110 000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..........+....+.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0111111223445566788899999999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-54 Score=413.60 Aligned_cols=284 Identities=37% Similarity=0.681 Sum_probs=233.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++++.||+|+||+||+|++ .+|+.||+|++............+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 5799999999999999999998 689999999997654433344667899999999999999999999987 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 157 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-ccc
Confidence 9999998888777666789999999999999999999999999999999999999999999999999998765322 223
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcccC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNATLF 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~ 336 (457)
....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++.+..+.+....|.... .+.....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence 455789999999999876668999999999999999999999999999999999999998888776665321 1111000
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
........+......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 238 -~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 -FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp -CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000111233445678889999999999999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=416.56 Aligned_cols=259 Identities=29% Similarity=0.498 Sum_probs=226.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999998776677777889999999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~ 169 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GK 169 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CG
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Cc
Confidence 9999987655554444557999999999999999999999999999999999999999999999999999876543 33
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
....+||+.|+|||++.+..+++.++|||||||++|+|++|++||.+.+..+...++......
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------------- 232 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR----------------- 232 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------------
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------------
Confidence 456789999999999998876678999999999999999999999999988887777542110
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
....+++++.+||++||+.||.+|||++|+|+||||+...
T Consensus 233 ------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 233 ------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp ------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred ------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 0123677889999999999999999999999999998743
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=428.52 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=206.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-----CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-----GKIVALKKVRFDNLEPESVKFMAREILVLRKLDH-PNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||+||+|.+..+ ++.||||++.... .....+.+.+|+.+|.+++| ||||+++|+|...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 46899999999999999999987654 3689999997543 34456778999999999965 8999999998763
Q ss_pred CceEEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN 234 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 234 (457)
...+|||||||+++.+..++.. ...+++.++..|+.||+.||.|||+++||||||||+||||++
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 3468999999998655444432 234899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 036122 235 DGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHK 312 (457)
Q Consensus 235 ~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 312 (457)
++.+||+|||+|+........ ..+..+||+.|||||++.+.. |+.++|||||||+||||+| |.+||.+.+..+.+.+
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876543222 233457899999999998776 8999999999999999998 8999998764444433
Q ss_pred HHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 313 IFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 313 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
+......+ .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 300 ~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 32211000 0113467889999999999999999999999987
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=437.49 Aligned_cols=294 Identities=34% Similarity=0.545 Sum_probs=228.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---Cce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~ 173 (457)
.++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|++++|||||++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999999999999999999766556666778999999999999999999999985432 256
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 89999999988777665 44579999999999999999999999999999999999999999999999999998764221
Q ss_pred C--------------------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-----------
Q 036122 254 K--------------------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA----------- 296 (457)
Q Consensus 254 ~--------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt----------- 296 (457)
. ...+..+||++|+|||++.....|+.++|||||||++|||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~ 290 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGG
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccccc
Confidence 1 123556889999999988666668999999999999999999
Q ss_pred CCCCCCCCC--------------------hHHHHHHHHHhcCCCChhhhhhcCCCCcccC--CCCCCcccchhcccCCCC
Q 036122 297 GKPIMPGRT--------------------EVEQLHKIFKLCGSPSEEYWKKSKLPNATLF--KPQQPYKRCIAETFKDFP 354 (457)
Q Consensus 297 G~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 354 (457)
|+++|.+.+ ..+++..|++.+|.+..+.+..........+ .........+...++..+
T Consensus 291 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 370 (458)
T 3rp9_A 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASS 370 (458)
T ss_dssp CCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSC
T ss_pred ccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCC
Confidence 788888765 3678899999999999887765322111100 001111223455667789
Q ss_pred CCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCC
Q 036122 355 SSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391 (457)
Q Consensus 355 ~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 391 (457)
+++.+||++||.+||++|||++|+|+||||+...++.
T Consensus 371 ~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 371 ADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 9999999999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=423.95 Aligned_cols=289 Identities=34% Similarity=0.569 Sum_probs=229.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++++. ||||+++++++.......+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999999999999999999766556666777889999999997 99999999999875556799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC---
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG--- 252 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~--- 252 (457)
+||||+++++...+.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 9999999887776654 36999999999999999999999999999999999999999999999999999865321
Q ss_pred -----------------CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 036122 253 -----------------LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315 (457)
Q Consensus 253 -----------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~ 315 (457)
.....+..+||++|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.+|..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 112234568999999999998766689999999999999999999999999999999999999
Q ss_pred hcCCCChhhhhhcCCCCcccCC---------CCCCcccch---------hcccCCCCCCcHHHHHHhccCCCCCCcCHHH
Q 036122 316 LCGSPSEEYWKKSKLPNATLFK---------PQQPYKRCI---------AETFKDFPSSSLPLIETLLSIDPDNRGTATA 377 (457)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~---------~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e 377 (457)
.++.|..+.+.....+....+. ......... ......+++++.+||++||+.||++|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 9999988776543322111000 000000000 0011267888999999999999999999999
Q ss_pred HhcCCCCCCC
Q 036122 378 ALNSEFFNTE 387 (457)
Q Consensus 378 lL~hp~f~~~ 387 (457)
+|+||||+..
T Consensus 326 ~l~Hp~~~~~ 335 (388)
T 3oz6_A 326 ALKHPFVSIF 335 (388)
T ss_dssp HTTSTTTTTT
T ss_pred HhCCHHHHHh
Confidence 9999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=438.73 Aligned_cols=285 Identities=32% Similarity=0.540 Sum_probs=229.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999999999999999999876555666778899999999999999999999986532 24
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+++++...+.. .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 141 ~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 217 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred eEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence 6899999999987776642 4999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
...+..+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+++.+|.+.+|.|..+.+.......
T Consensus 218 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 218 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred --cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 3345678999999999998876 8999999999999999999999999999999999999999999988775432000
Q ss_pred cccCCCCCCc-ccchhcccCC------------CCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFKPQQPY-KRCIAETFKD------------FPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~~~~~~-~~~~~~~~~~------------~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.........+ ...+...++. .++++.+||.+||++||++|||++|+|+||||+..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0000000000 0001111111 14568999999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=414.84 Aligned_cols=288 Identities=38% Similarity=0.703 Sum_probs=223.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|.+..+|+.||+|+++.... ......+.+|+.++++++||||+++++++.. ...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEE
Confidence 4689999999999999999999999999999999986542 2233557789999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 177 VFEYMEHDLAGLAACQG-----VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99999998777665432 3589999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-C
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-L 330 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~ 330 (457)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.+....|.... +
T Consensus 161 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 161 PV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred Cc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence 32 223456789999999999876568999999999999999999999999999999999999999998887776432 1
Q ss_pred CCcccCC---CCCCcccch-hcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 331 PNATLFK---PQQPYKRCI-AETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 331 ~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
+...... +.......+ ......+++++.+||.+||+.||++|||++|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 1111000 011111111 122245788899999999999999999999999999998743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=417.37 Aligned_cols=261 Identities=25% Similarity=0.370 Sum_probs=226.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.+.|++.+.||+|+||+||+|++..+|+.||+|++....... ...+.+.+|+.+|++++||||+++++++.. ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CC
Confidence 467999999999999999999999999999999998754321 134678899999999999999999999987 56
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC----cEEEeeccCccc
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG----ILKIADFGLATF 248 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~ 248 (457)
.+|+||||+.++.+..+......+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 8999999998766666666667899999999999999999999999999999999999998877 799999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.......+...
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~---- 241 (361)
T 2yab_A 169 IEDG--VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF---- 241 (361)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH----
T ss_pred cCCC--CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh----
Confidence 7543 2345568999999999998766 79999999999999999999999999999888888866544443333
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+..+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 242 ---------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 242 ---------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp ---------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred ---------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 24578889999999999999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=427.63 Aligned_cols=293 Identities=32% Similarity=0.534 Sum_probs=238.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC---ce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS---CS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~~ 173 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|++++||||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999999999999999998665566667789999999999999999999999876321 56
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCcCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 89999999987776654 45579999999999999999999999999999999999999999999999999998764332
Q ss_pred C---------------------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-----------CCCCC
Q 036122 254 K---------------------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-----------GKPIM 301 (457)
Q Consensus 254 ~---------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-----------G~~pf 301 (457)
. ...+..+||++|+|||++.....|+.++|||||||++|||++ |.++|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f 263 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSC
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccC
Confidence 1 124667899999999998766668999999999999999998 56777
Q ss_pred CCCC-----------------hHHHHHHHHHhcCCCChhhhhhcCCCCcccC--CCCCCcccchhcccCCCCCCcHHHHH
Q 036122 302 PGRT-----------------EVEQLHKIFKLCGSPSEEYWKKSKLPNATLF--KPQQPYKRCIAETFKDFPSSSLPLIE 362 (457)
Q Consensus 302 ~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~ 362 (457)
.+.+ ..+++..|++.+|.|+.+.+..........+ .........+...++.+++++.+||+
T Consensus 264 ~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 343 (432)
T 3n9x_A 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLE 343 (432)
T ss_dssp CCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred CCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 7654 4688999999999999887765432211100 00111122344556778999999999
Q ss_pred HhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 363 TLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 363 ~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
+||+.||++|||++|+|+||||++..+.
T Consensus 344 ~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 344 SMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 9999999999999999999999986554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=407.14 Aligned_cols=286 Identities=37% Similarity=0.640 Sum_probs=232.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC---hHHHHHHHHHHHHHHhc---CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE---PESVKFMAREILVLRKL---DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~---~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 57899999999999999999999999999999999754321 11123455677777766 4999999999987643
Q ss_pred Cc---eEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCc
Q 036122 171 SC---SLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLA 246 (457)
Q Consensus 171 ~~---~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla 246 (457)
.. .+++||||+++++...+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 22 589999999988777665543 23999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 247 TFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
+..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+.++....+.++...|.
T Consensus 168 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (308)
T 3g33_A 168 RIYSYQ--MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244 (308)
T ss_dssp TTSTTC--CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred cccCCC--cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence 876533 3345678899999999998776 7999999999999999999999999999999999999999998887776
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.........+.+ ..........+.+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 245 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 245 RDVSLPRGAFPP--RGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCSSCGGGSCC--CCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred chhhccccccCC--CCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 432211111111 11223445567788999999999999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=417.12 Aligned_cols=287 Identities=34% Similarity=0.550 Sum_probs=234.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC----c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----C 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 172 (457)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|++++||||+++++++..... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 478999999999999999999999999999999997665556666788999999999999999999999876422 3
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~- 180 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 180 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-
Confidence 5799999997666665544 4699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
..+..++|++|+|||++.+...++.++|||||||++|||++|++||.+.+..+++.+|.+..|.++.+.+.......
T Consensus 181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 257 (367)
T 1cm8_A 181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257 (367)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence 23556889999999999885558999999999999999999999999999999999999999999988776432111
Q ss_pred cccCC--CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 333 ATLFK--PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
...+. ........+...+..+++.+.+||.+||+.||.+|||++|+|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 10000 0000112234456678899999999999999999999999999999998543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=413.64 Aligned_cols=289 Identities=36% Similarity=0.664 Sum_probs=227.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.++++++||||+++++++.. ...+|+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 110 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLHL 110 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEEE
Confidence 578999999999999999999999999999999998765555555667899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-----CCCcEEEeeccCccccCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-----NDGILKIADFGLATFYDP 251 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-----~~~~vkl~DFGla~~~~~ 251 (457)
||||+++++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++.....
T Consensus 111 v~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999999977776654 44699999999999999999999999999999999999994 555699999999987653
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-C
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-L 330 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~ 330 (457)
.. .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....|.... .
T Consensus 190 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 190 PI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 32 233456789999999999876668999999999999999999999999999999999999999888877665321 1
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
+......+..............+++++.+||.+||+.||++|||++|+|+||||++..|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 11111111111111111112236788999999999999999999999999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=415.28 Aligned_cols=288 Identities=39% Similarity=0.659 Sum_probs=232.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|.+++.||+|+||+||+|++..+++.||+|++...... .....+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 5799999999999999999999999999999999754321 111234579999999999999999999987 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 9999998888887777789999999999999999999999999999999999999999999999999998654321 223
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC-cccC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN-ATLF 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~ 336 (457)
....||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+....|+...... ....
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY 237 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence 455789999999999876668999999999999999999999999999999999999999998887775421110 0000
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
..............+.+++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 11111112233445678889999999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=401.58 Aligned_cols=288 Identities=34% Similarity=0.550 Sum_probs=235.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++++.||+|+||+||+|++..+|+.||||++..........+.+.+|+.++++++||||+++++++.. ...+++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEE
Confidence 68999999999999999999999999999999998766666667778899999999999999999999987 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++++..+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYY 159 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-ccc
Confidence 9999998888777777789999999999999999999999999999999999999999999999999998765322 223
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc--c
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT--L 335 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~ 335 (457)
....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+......+......... .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 45678999999999987666899999999999999999999999999999999888888877665443321111000 0
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
..+...........++.+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 00111111223344567888999999999999999999999999999999854
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=413.74 Aligned_cols=295 Identities=44% Similarity=0.702 Sum_probs=239.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM------ 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 170 (457)
.++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 57899999999999999999999999999999999766554444456778999999999999999999987643
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...+|+||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 34689999999998888887776789999999999999999999999999999999999999999999999999998764
Q ss_pred CC---CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 251 PG---LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 251 ~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
.. .........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+...++.++...|..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 22 122334567899999999998766689999999999999999999999999999999999999999888776654
Q ss_pred cCCCCc-ccCCCCCCcccchhcccC--CCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCC
Q 036122 328 SKLPNA-TLFKPQQPYKRCIAETFK--DFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391 (457)
Q Consensus 328 ~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 391 (457)
...... ................+. ..++.+.+||.+||+.||++|||++|+|+||||+..+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 256 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp GGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred cccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 321110 000000000000111110 1356789999999999999999999999999998865443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=411.19 Aligned_cols=292 Identities=41% Similarity=0.701 Sum_probs=237.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP---ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.++++++||||+++++++.. ...
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 86 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSN 86 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CCc
Confidence 578999999999999999999999999999999997543221 122457789999999999999999999876 567
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+++||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 89999999998887777666679999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~ 332 (457)
.......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.+..+.|.... ++.
T Consensus 167 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 167 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 234556789999999999876668999999999999999999999999999999999999999988877776431 221
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~ 393 (457)
...+.... ...+...+..+++++.+||.+||+.||++|||++|+|+||||+..+.+...
T Consensus 246 ~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~ 304 (346)
T 1ua2_A 246 YVTFKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 304 (346)
T ss_dssp CCCCCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred cccccccC--CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCc
Confidence 11111100 112334456778899999999999999999999999999999987655443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=412.31 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=225.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+ ...+|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 467999999999999999999999999999999998877677777889999999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC---CcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND---GILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~ 253 (457)
||||+.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~- 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 184 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-
Confidence 99999986665555556679999999999999999999999999999999999999865 45999999999876533
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+.......+..
T Consensus 185 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---------- 252 (362)
T 2bdw_A 185 -EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---------- 252 (362)
T ss_dssp -CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----------
T ss_pred -cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc----------
Confidence 2345568999999999998766 7999999999999999999999999998888877776543222211
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.+..+++++.+||.+||+.||++|||+.|+|+||||+.
T Consensus 253 ---------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 253 ---------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ---------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ---------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 23347888999999999999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=420.41 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=224.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.+ ...+|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999998776666667789999999999999999999999987 678999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec---CCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID---NDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~~~~ 253 (457)
||||+.++.+.........+++.++..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 88 v~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~ 167 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167 (444)
T ss_dssp EECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence 999999865555555556799999999999999999999999999999999999998 56889999999998765432
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+....+.......+.
T Consensus 168 -~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 234 (444)
T 3soa_A 168 -QAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPS----------- 234 (444)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT-----------
T ss_pred -ceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCc-----------
Confidence 2335578999999999998766 799999999999999999999999999988888887654322221
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
..+..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 235 --------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 235 --------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred --------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 123457888999999999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=414.96 Aligned_cols=288 Identities=36% Similarity=0.558 Sum_probs=224.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++.... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999999999999999999766555666678889999999999999999999986531 24
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 108 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~- 184 (367)
T 2fst_X 108 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD- 184 (367)
T ss_dssp CCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence 5899999998766655543 4699999999999999999999999999999999999999999999999999986542
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
..+..+||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+.+.+|.|..+.+.......
T Consensus 185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 261 (367)
T 2fst_X 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred ---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 23556889999999999875668999999999999999999999999999999999999999999888776532111
Q ss_pred cccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 333 ATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 333 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
...+ .........+...+...++.+.+||++||+.||.+|||++|+|+||||+....+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 1000 000001122445566788899999999999999999999999999999985443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=418.67 Aligned_cols=283 Identities=37% Similarity=0.587 Sum_probs=231.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
..+|++.+.||+|+||+||+|++..+|+.||||++..+.. ...+|+.+|++++|||||++++++.... ..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4579999999999999999999999999999999975432 1346999999999999999999885421 23
Q ss_pred eEEEEEecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-CcEEEeeccCccc
Q 036122 173 SLYLVFEYMEHDLAGLAA---CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-GILKIADFGLATF 248 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-~~vkl~DFGla~~ 248 (457)
.+++||||+++++..... .....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 127 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 127 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 477999999987665543 345679999999999999999999999999999999999999954 6789999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... ......+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.+..+++.++++.+|.+..+.+...
T Consensus 207 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6543 23355688999999999987656899999999999999999999999999999999999999999998877653
Q ss_pred CCCCcccCCCCCCcccchhcc-cCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAET-FKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
. +....+.........+... ...+++++.+||.+||++||.+|||+.|+|+||||+...
T Consensus 285 ~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 285 N-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp C-SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred C-hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 2 1211111111111122222 245788999999999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=412.39 Aligned_cols=281 Identities=32% Similarity=0.532 Sum_probs=230.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec-------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR------- 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 169 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++..+... ..+|+.+|+.++||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 47899999999999999999999999999999999755322 23699999999999999999988542
Q ss_pred -----------------------------CCceEEEEEecccCCHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 036122 170 -----------------------------MSCSLYLVFEYMEHDLAGLA---ACQGVKFSEPQVKCYMKQLLSGLEHCHN 217 (457)
Q Consensus 170 -----------------------------~~~~~~lv~E~~~~~l~~~~---~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 217 (457)
....+++||||+++++...+ ...+..+++..++.++.||+.||.|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 23358999999998755443 3456679999999999999999999999
Q ss_pred CCceeccCCCCCEEec-CCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh
Q 036122 218 NGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA 296 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt 296 (457)
+||+||||||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999998 6899999999999876543 234556789999999999877668999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhc-ccCCCCCCcHHHHHHhccCCCCCCcCH
Q 036122 297 GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAE-TFKDFPSSSLPLIETLLSIDPDNRGTA 375 (457)
Q Consensus 297 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~Li~~~L~~dP~~Rpta 375 (457)
|++||.+.+..+++.++.+.+|.+..+.+..... ..............+.. ....+++++.+||.+||+.||.+|||+
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP-HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT-TC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCc-ccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9999999999999999999999999887765321 11111111111112222 234578889999999999999999999
Q ss_pred HHHhcCCCCCC
Q 036122 376 TAALNSEFFNT 386 (457)
Q Consensus 376 ~elL~hp~f~~ 386 (457)
.|+|+||||+.
T Consensus 317 ~e~l~hp~f~~ 327 (383)
T 3eb0_A 317 YEAMAHPFFDH 327 (383)
T ss_dssp HHHHTSGGGHH
T ss_pred HHHhcCHHHHH
Confidence 99999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=408.05 Aligned_cols=261 Identities=27% Similarity=0.398 Sum_probs=222.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|++..+|+.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~ 81 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEE
Confidence 4689999999999999999999999999999999975421 12234567889999999999999999999887 56899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CC
Confidence 99999998666555555567999999999999999999999999999999999999999999999999999864322 12
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+....+.....
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------- 222 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred cccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------
Confidence 345678999999999998766 79999999999999999999999999888777777654210
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
.....+++++.+||.+||+.||++|| +++|+++||||+...|.
T Consensus 223 ------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 01124678899999999999999999 99999999999986543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=402.57 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=224.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.+.|.+.+.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+|++++||||+++++++.. ..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CC
Confidence 367999999999999999999999999999999998654321 135678899999999999999999999987 56
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC----cEEEeeccCccc
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG----ILKIADFGLATF 248 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~ 248 (457)
.+|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 7999999998866666666666799999999999999999999999999999999999999887 899999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+..........
T Consensus 168 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 239 (326)
T 2y0a_A 168 IDFG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE----- 239 (326)
T ss_dssp CCTT--SCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH-----
T ss_pred CCCC--CccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc-----
Confidence 7543 2334567999999999997666 7999999999999999999999999998888887776543333222
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+..+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 240 --------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 240 --------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp --------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred --------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 234577889999999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=413.63 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=218.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+++.+ +||||+++++++.. ...+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 5789999999999999999999999999999999975422 223445678899999988 69999999999887 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~ 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-G 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-C
Confidence 999999998666555555567999999999999999999999999999999999999999999999999999854322 1
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+...+|......
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 242 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV--------------- 242 (353)
T ss_dssp -------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred ccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC---------------
Confidence 2345568999999999998766 799999999999999999999999999998888888652111
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH------HHHhcCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA------TAALNSEFFNTEPYA 390 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta------~elL~hp~f~~~~~~ 390 (457)
....+++++.+||++||+.||.+||++ +|+++||||+...|.
T Consensus 243 --------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 243 --------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred --------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 112367789999999999999999999 999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=403.93 Aligned_cols=259 Identities=21% Similarity=0.357 Sum_probs=223.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|.+..+|+.||+|++... ......+.+|+.+++.++||||+++++++.+ ...+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEE
Confidence 47899999999999999999999999999999998743 3344568899999999999999999999987 567999
Q ss_pred EEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC--CCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN--DGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~ 253 (457)
||||++++ +...+......+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999875 44444444457999999999999999999999999999999999999997 789999999999877543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+......+...
T Consensus 158 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 225 (321)
T 1tki_A 158 -DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE---------- 225 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH----------
T ss_pred -CccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh----------
Confidence 2334567899999999998765 7899999999999999999999999999988888887654433332
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.+..+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 226 ---------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 226 ---------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ---------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ---------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 2345788899999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=424.45 Aligned_cols=278 Identities=23% Similarity=0.299 Sum_probs=227.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|+++++||+|+||+||+|++..+++.||+|++..... .......+.+|+.++..++||||+++++++.+ ...+|
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 150 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLY 150 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEE
Confidence 5789999999999999999999999999999999975321 11112337789999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.......
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999987555444443 56799999999999999999999999999999999999999999999999999987654433
Q ss_pred CCcccccccCccCchHhhh----CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 255 QPMTSRVVTLWYRPPELLL----GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~----~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
......+||+.|+|||++. +...|+.++|||||||++|||++|++||.+.+..+...+|...... ..
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------~~- 301 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--------FQ- 301 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--------CC-
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc--------cc-
Confidence 3344568999999999997 2344899999999999999999999999999998888887642110 00
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC--CcCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN--RGTATAALNSEFFNTEPYACEPSSLPKYP 400 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~~~~~~~~~~~ 400 (457)
+......+++++.+||++||..+|++ |++++|+++||||++..|.......|++.
T Consensus 302 ---------------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~ 358 (437)
T 4aw2_A 302 ---------------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYI 358 (437)
T ss_dssp ---------------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCC
T ss_pred ---------------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCC
Confidence 01122457889999999999999988 99999999999999887764433333333
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=395.02 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=219.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++....... .+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEE
Confidence 478999999999999999999999999999999997654332 3567899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+.++.+..+.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 172 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SK 172 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CC
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cc
Confidence 99999876655555443 59999999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 235 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE---------------- 235 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC----------------
T ss_pred cCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------------
Confidence 44568999999999998776 7999999999999999999999999988877766654321100
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 236 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 ----------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ----------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 00113467788999999999999999999999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=410.33 Aligned_cols=283 Identities=36% Similarity=0.582 Sum_probs=230.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
..+|.+.+.||+|+||+||+|++..++. ||+|++...... ..+|+.+|+.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4679999999999999999999876665 888888654321 236999999999999999999986532 22
Q ss_pred eEEEEEecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-CCCcEEEeeccCccc
Q 036122 173 SLYLVFEYMEHDLAGLAA---CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATF 248 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~~ 248 (457)
.+|+||||++++++.... .....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 478999999998765543 2356799999999999999999999999999999999999999 799999999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... .......||+.|+|||++.+...++.++|||||||++|||++|++||.+.+..+++..+.+.++.+..+.+...
T Consensus 192 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 192 LIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6543 23355688999999999987766899999999999999999999999999999999999999999998876543
Q ss_pred CCCCcccCCCCCCcccchhccc-CCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETF-KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
. ++.............+...+ ..+++++.+||.+||++||.+|||+.|+|+||||+...+
T Consensus 270 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 270 N-PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp C-GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred C-hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 2 11111111111111222222 347889999999999999999999999999999997544
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=401.78 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=222.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|++..+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+ ...+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~ 82 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 82 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEE
Confidence 4789999999999999999999999999999999975421 11234567889999999999999999999887 56899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 9999999866655655666799999999999999999999999999999999999999999999999999986543
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+...++......
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~---------------- 221 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---------------- 221 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------------
Confidence 234568999999999998766 799999999999999999999999999888888777552100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
....+++++.+||.+||+.||++|| +++++++||||+...|.
T Consensus 222 -------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 222 -------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred -------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 1124678899999999999999999 99999999999986553
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=410.97 Aligned_cols=285 Identities=31% Similarity=0.522 Sum_probs=223.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47899999999999999999999999999999999876556666778889999999999999999999987642 13
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 689999999998777664 35999999999999999999999999999999999999999999999999999866432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+.++.+.++.+..+.+.......
T Consensus 181 --~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 181 --FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp -----------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred --cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 2234568899999999998766 7999999999999999999999999999999999999999988887765421000
Q ss_pred cc--cCCCCCCcccchhcccC------------CCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 333 AT--LFKPQQPYKRCIAETFK------------DFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 333 ~~--~~~~~~~~~~~~~~~~~------------~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.. ...+... ...+...++ ..++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 258 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 258 RTYVENRPKYA-GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHSSCCCC-CCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHHHhhCcccc-ccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 0000000 000011111 1145688999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-51 Score=404.57 Aligned_cols=288 Identities=33% Similarity=0.538 Sum_probs=239.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---Cce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~ 173 (457)
.++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.++++++||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999999999999999997533 4455577889999999999999999999986532 246
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||+++++...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999999987776654 359999999999999999999999999999999999999999999999999998765332
Q ss_pred C--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 254 K--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 254 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
. ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+...++.+..+.+......
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 12345689999999999887666899999999999999999999999999999999999999999988776542111
Q ss_pred CcccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 332 NATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 332 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+ .........+...++.+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 00000 001111222445567788999999999999999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=402.61 Aligned_cols=256 Identities=23% Similarity=0.256 Sum_probs=188.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC--ceEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS--CSLY 175 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~~ 175 (457)
.+|.+.++||+|+||+||+|++ +|+.||||+++... ......+.|+..+.+++|||||++++++..... ..+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4688899999999999999985 68999999996432 222234456777788999999999999986432 3689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN--------GVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
||||||+++.+..+.... .+++..+..++.||+.||.|||++ +||||||||+||||+.++++||+|||+|+
T Consensus 78 lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999986665555443 599999999999999999999987 99999999999999999999999999998
Q ss_pred ccCCCCC---CCcccccccCccCchHhhhCCc-----CCCccchhhhHHHHHHHHHhCCCCCCCCCh-------------
Q 036122 248 FYDPGLK---QPMTSRVVTLWYRPPELLLGAT-----YYGVGVDLWSAGCILAELLAGKPIMPGRTE------------- 306 (457)
Q Consensus 248 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DvwslG~vl~elltG~~pf~~~~~------------- 306 (457)
....... ......+||+.|||||++.+.. .|+.++|||||||+||||+||.+||.....
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7654322 1223468999999999997642 267799999999999999999887754321
Q ss_pred -HHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 307 -VEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 307 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.+.+.+.... ...+|..+.. ......+..+.+||.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~-----------------~~~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 237 SVEEMRKVVCE-----------------QKLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CHHHHHHHHTT-----------------SCCCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhc-----------------ccCCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1111111000 0001110000 000112235678999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=401.59 Aligned_cols=287 Identities=30% Similarity=0.569 Sum_probs=236.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 101 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWYL 101 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEEE
Confidence 578999999999999999999999999999999998776666666778899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++++..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 180 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 180 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cc
Confidence 99999999888887777789999999999999999999999999999999999999999999999999998664322 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCcc-
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK-LPNAT- 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~- 334 (457)
.....||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+......+.... .+...
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 3456789999999999876568999999999999999999999999999999999998888877655432110 00000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
...+............+.+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0011111122234455678899999999999999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=410.35 Aligned_cols=261 Identities=23% Similarity=0.404 Sum_probs=214.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++++.||+|+||+||+|+++.+++.||+|+++..... ......+.+|..++.++ +|||||++++++.. ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 57899999999999999999999999999999999865432 33345677899999887 89999999999887 5689
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~ 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence 999999998666555555567999999999999999999999999999999999999999999999999999853322 2
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCCCChhhh
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~ 325 (457)
......+||+.|+|||++.+.. |+.++|||||||++|||++|++||..... ......+....
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-------- 278 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------- 278 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--------
T ss_pred CccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--------
Confidence 3345678999999999998766 79999999999999999999999964321 11222222110
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH------HHHhcCCCCCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA------TAALNSEFFNTEPYA 390 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta------~elL~hp~f~~~~~~ 390 (457)
......+++++.+||++||+.||.+||++ +|+++||||+...|.
T Consensus 279 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 279 ---------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred ---------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 01123477889999999999999999985 899999999987654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=415.60 Aligned_cols=279 Identities=26% Similarity=0.373 Sum_probs=227.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.++..++||||+++++++.+ ...+|
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 137 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYLY 137 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEE
Confidence 5789999999999999999999999999999999975321 12223457789999999999999999999887 56899
Q ss_pred EEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
+||||+.++ +...+...+..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999765 4444444455799999999999999999999999999999999999999999999999999987654433
Q ss_pred CCcccccccCccCchHhhhC------CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 255 QPMTSRVVTLWYRPPELLLG------ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~------~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
......+||+.|+|||++.+ ...|+.++|||||||++|||++|++||.+.+..+...+|...... .
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------~ 289 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH--------L 289 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--------C
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--------c
Confidence 22345689999999999973 234799999999999999999999999999988888887642100 0
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCC---cCHHHHhcCCCCCCCCCCCCCCCCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR---GTATAALNSEFFNTEPYACEPSSLPKYPPS 402 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R---pta~elL~hp~f~~~~~~~~~~~~~~~~~~ 402 (457)
.. ......+++++++||++||. ||.+| ++++|+++||||+...|.......|++.|.
T Consensus 290 ~~----------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~ 349 (412)
T 2vd5_A 290 SL----------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPD 349 (412)
T ss_dssp CC----------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC
T ss_pred CC----------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCc
Confidence 00 01123578899999999999 99998 599999999999998887655555555554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=417.32 Aligned_cols=268 Identities=26% Similarity=0.361 Sum_probs=222.7
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..++|++++.||+|+||+||+|++..+++.||+|++..... .......+.+|+.+++.++|||||++++++.+ ...+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~ 144 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYL 144 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEE
Confidence 36789999999999999999999999999999999975211 11112346789999999999999999999987 6789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||++++.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.......
T Consensus 145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999987555444444 3699999999999999999999999999999999999999999999999999987654432
Q ss_pred CCcccccccCccCchHhhhCCc---CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGAT---YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
......+||+.|+|||++.+.. .|+.++|||||||++|||++|++||.+.+..+...+|....... ..
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------~~- 294 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--------TF- 294 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--------CC-
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc--------cC-
Confidence 2344678999999999998644 26889999999999999999999999999888888876531000 00
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCC--CcCHHHHhcCCCCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN--RGTATAALNSEFFNTEPYAC 391 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~--Rpta~elL~hp~f~~~~~~~ 391 (457)
.....+++++.+||.+||+.+|.+ |++++|+++||||+...|..
T Consensus 295 ----------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~ 340 (410)
T 3v8s_A 295 ----------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAW 340 (410)
T ss_dssp ----------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCS
T ss_pred ----------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHH
Confidence 012357889999999999999998 99999999999999876653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=405.55 Aligned_cols=286 Identities=37% Similarity=0.591 Sum_probs=235.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc----
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC---- 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~---- 172 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4789999999999999999999999999999999987666666677889999999999999999999998764321
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 121 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~- 196 (371)
T 4exu_A 121 DFYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA- 196 (371)
T ss_dssp CCEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred eEEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence 24999999998766544 33599999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+..+.+.......
T Consensus 197 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 273 (371)
T 4exu_A 197 ---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273 (371)
T ss_dssp ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHH
T ss_pred ---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhh
Confidence 23456789999999999875558999999999999999999999999999999999999999999887765432110
Q ss_pred cccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 333 ATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
...+ .........+...+..+++.+.+||.+||+.||++|||++|+|+||||+....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 332 (371)
T 4exu_A 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 332 (371)
T ss_dssp HHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence 0000 00011112234455678899999999999999999999999999999987543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=399.85 Aligned_cols=261 Identities=24% Similarity=0.411 Sum_probs=216.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.++.++ +||||+++++++.. ...+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEE
Confidence 5789999999999999999999999999999999987543 345567788999999988 89999999999877 5689
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-T
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-C
Confidence 999999988655555555567999999999999999999999999999999999999999999999999999864322 1
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCChhhh
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT---------EVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~ 325 (457)
......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.... .......+....
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-------- 235 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-------- 235 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--------
T ss_pred CcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--------
Confidence 2345678999999999998766 7999999999999999999999997521 122222222110
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH------HHHhcCCCCCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA------TAALNSEFFNTEPYA 390 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta------~elL~hp~f~~~~~~ 390 (457)
......+++++.+||.+||+.||.+||++ +|+++||||+...|.
T Consensus 236 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 236 ---------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 00113467889999999999999999995 899999999987653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=405.10 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=221.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|.+.+.||+|+||.||+|+++.+|+.||||+++.... .......+..|..++..+ +||||+++++++.+ ...+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~ 93 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 93 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEE
Confidence 5789999999999999999999999999999999975421 122345577899999887 89999999999887 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 172 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD- 172 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence 9999999886555555555579999999999999999999999999999999999999999999999999998643221
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+...++.....
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~---------------- 235 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP---------------- 235 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------------
T ss_pred CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC----------------
Confidence 2345678999999999998766 79999999999999999999999999988888777744210
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHH-HHhcCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT-AALNSEFFNTEPYA 390 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~-elL~hp~f~~~~~~ 390 (457)
.....+++++.+||.+||+.||++||++. ++++||||+...|.
T Consensus 236 -------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 236 -------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred -------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 01123678899999999999999999998 99999999987653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=403.71 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=221.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||+++++++.+ ...+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 117 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEE
Confidence 5789999999999999999999999999999999975422 12234568889999999999999999999887 56899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999987655555555557999999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+...++......
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------- 256 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---------------- 256 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred -cccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 34568999999999998766 799999999999999999999999999888888777552100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
....+++++.+||.+||+.||.+||+ ++|+++||||+...|
T Consensus 257 -------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 257 -------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 11246788999999999999999998 999999999998665
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=408.87 Aligned_cols=290 Identities=37% Similarity=0.645 Sum_probs=218.1
Q ss_pred CCcccc-ceeeccCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKL-DKIGQGTYSNVYKARDL--LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~-~~LG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
+.|++. ++||+|+||+||+|++. .+++.||||++...... ..+.+|+.+|++++||||+++++++.......+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 457774 47999999999999966 56889999999755433 346789999999999999999999977667789
Q ss_pred EEEEecccCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----cCCCcEEEee
Q 036122 175 YLVFEYMEHDLAGLAACQ--------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIAD 242 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~D 242 (457)
|+||||+++++...+... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 999999999887765432 1249999999999999999999999999999999999999 6778999999
Q ss_pred ccCccccCCCCC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 036122 243 FGLATFYDPGLK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---------VEQLH 311 (457)
Q Consensus 243 FGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---------~~~~~ 311 (457)
||+++....... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+. .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999987653211 2234568899999999998866689999999999999999999999987654 48889
Q ss_pred HHHHhcCCCChhhhhhcC-CCCcccC--------CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCC
Q 036122 312 KIFKLCGSPSEEYWKKSK-LPNATLF--------KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382 (457)
Q Consensus 312 ~i~~~~~~~~~~~~~~~~-~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp 382 (457)
.++..+|.+....|.... ++..... .........+.......++.+.+||.+||++||.+|||++|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 999999999887776431 1110000 0000000111112233477899999999999999999999999999
Q ss_pred CCCCCCCCC
Q 036122 383 FFNTEPYAC 391 (457)
Q Consensus 383 ~f~~~~~~~ 391 (457)
||+..+.+.
T Consensus 336 ~f~~~~~~~ 344 (405)
T 3rgf_A 336 YFLEDPLPT 344 (405)
T ss_dssp GGTSSSCCC
T ss_pred hhccCCCCc
Confidence 999876654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=407.10 Aligned_cols=281 Identities=32% Similarity=0.501 Sum_probs=229.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc------CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL------DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~ 170 (457)
..+|++++.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence 56899999999999999999999999999999999643 34445677888888887 57799999999987
Q ss_pred CceEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc--EEEeeccCcc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI--LKIADFGLAT 247 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~ 247 (457)
...+++||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 171 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 171 RNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 56899999999998887776553 35999999999999999999999999999999999999999887 9999999997
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
.... .....+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+..+.+.++.++...+..
T Consensus 251 ~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 251 YEHQ----RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp ETTC----CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ecCC----cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 6542 234568899999999998876 79999999999999999999999999999999999999999999887654
Q ss_pred cCCCCcccCCC-----------------------------CCCcccchhccc-CCCCCCcHHHHHHhccCCCCCCcCHHH
Q 036122 328 SKLPNATLFKP-----------------------------QQPYKRCIAETF-KDFPSSSLPLIETLLSIDPDNRGTATA 377 (457)
Q Consensus 328 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~-~~~~~~~~~Li~~~L~~dP~~Rpta~e 377 (457)
........... ..+....+...+ ...++.+.+||++||++||++|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 32110000000 000011111112 233667899999999999999999999
Q ss_pred HhcCCCCCCC
Q 036122 378 ALNSEFFNTE 387 (457)
Q Consensus 378 lL~hp~f~~~ 387 (457)
+|+||||+..
T Consensus 406 ~L~Hpw~~~~ 415 (429)
T 3kvw_A 406 ALRHPWLRRR 415 (429)
T ss_dssp HHTSTTTC--
T ss_pred HhCChhhccC
Confidence 9999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=400.20 Aligned_cols=279 Identities=25% Similarity=0.383 Sum_probs=226.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----CCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-----HPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~~~~~~~~~ 171 (457)
.++|.++++||+|+||+||+|++..+++.||||++.. .......+..|+.+++.+. ||||+++++++.. .
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~ 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--Y 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--T
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--C
Confidence 5789999999999999999999999999999999963 2344566778999999996 9999999999987 5
Q ss_pred ceEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC----------------
Q 036122 172 CSLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---------------- 234 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---------------- 234 (457)
..+|+||||+++++...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 6799999999777777665543 35999999999999999999999999999999999999975
Q ss_pred ---------CCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 036122 235 ---------DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT 305 (457)
Q Consensus 235 ---------~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~ 305 (457)
++.+||+|||++..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 78999999999986543 234567899999999998776 8999999999999999999999999999
Q ss_pred hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCccc-----------------chhcccCCCCCCcHHHHHHhccCC
Q 036122 306 EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKR-----------------CIAETFKDFPSSSLPLIETLLSID 368 (457)
Q Consensus 306 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~Li~~~L~~d 368 (457)
..+.+..+....+.++...+................... +........++.+.+||.+||+.|
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 343 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID 343 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence 999999999998888877655432211110000000000 000001112356779999999999
Q ss_pred CCCCcCHHHHhcCCCCC
Q 036122 369 PDNRGTATAALNSEFFN 385 (457)
Q Consensus 369 P~~Rpta~elL~hp~f~ 385 (457)
|++|||++|+|+||||+
T Consensus 344 P~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 344 PTLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGGSCCHHHHTTSGGGC
T ss_pred hhhCCCHHHHhcCcccC
Confidence 99999999999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=395.00 Aligned_cols=260 Identities=28% Similarity=0.380 Sum_probs=212.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh------------------------HHHHHHHHHHHHHH
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP------------------------ESVKFMAREILVLR 152 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~------------------------~~~~~~~~E~~~l~ 152 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999997653211 12356889999999
Q ss_pred hcCCCCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 153 ~l~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
+++||||+++++++.......+|+||||++++.+..+. ....+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99999999999999876567899999999876554433 33479999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcC--CCccchhhhHHHHHHHHHhCCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||++....... .......||+.|+|||++.+... ++.++|||||||++|+|++|.+||...+.....
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 249 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHH
Confidence 999999999999998765332 22345679999999999876542 477899999999999999999999988776665
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
..+....... .....+++++.+||.+||+.||++|||+.|+|+||||+
T Consensus 250 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 250 SKIKSQALEF---------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHCCCCC---------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHhcccCCC---------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 5553311000 01235778899999999999999999999999999995
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=386.01 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=224.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++.. ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEE
Confidence 478999999999999999999999999999999998877677777889999999999999999999999876 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc---EEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI---LKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~~~~~~~ 253 (457)
||||+.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++......
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 9999988655444444457999999999999999999999999999999999999986655 999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|.+||.+.+..+....+.......+.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------- 228 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS----------- 228 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----------
T ss_pred -ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc-----------
Confidence 2334567899999999998766 799999999999999999999999998888877776553222111
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
..+..+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 229 --------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 229 --------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred --------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 12345778899999999999999999999999999998743
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-52 Score=408.72 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=214.6
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..++|.+.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 84 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDI 84 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 357899999999999999999999999999999999753211 1123468899999999999999999999987 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+++++...+... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 85 VMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp EEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred EEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence 999999988887766554 46999999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+....+...++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------------------- 220 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------------------- 220 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------------
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------------
Confidence 23455689999999999988775688999999999999999999999764322111000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..........+++++.+||++||+.||.+|||++|+|+||||+..
T Consensus 221 --------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 --------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp --------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred --------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000111223467889999999999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-51 Score=402.90 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=221.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++++.||+|+||.||+|++..+|+.||||+++.... .......+..|..++..+ +||||+++++++.. ...+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEE
Confidence 5789999999999999999999999999999999975421 122345677899999988 79999999999877 5689
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..... .
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~ 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-C
Confidence 999999988655555555557999999999999999999999999999999999999999999999999999864322 1
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+...+|......
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------- 239 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------------- 239 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred cccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 2345678999999999998766 799999999999999999999999999988888877652100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
....+++++.+||.+||+.||.+|| +++++++||||+...|.
T Consensus 240 --------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 240 --------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred --------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 1134778899999999999999999 57999999999986653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=396.99 Aligned_cols=262 Identities=28% Similarity=0.420 Sum_probs=214.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEE
Confidence 4789999999999999999999999999999999975532 2233567899999999999999999999887 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-CC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL-KQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 255 (457)
||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999886555555556679999999999999999999999999999999999999999999999999998653221 22
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|+|||++.+...++.++|||||||++|+|++|..||...+..............
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------- 226 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 226 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT----------------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc----------------
Confidence 2345689999999999988775688999999999999999999999876554222221111000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+..+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 227 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 001123477888999999999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=398.90 Aligned_cols=290 Identities=30% Similarity=0.479 Sum_probs=224.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC-----C
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM-----S 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~ 171 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++..+.... ....+|+..+..++||||+++++++.... .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 578999999999999999999999999999999986543222 23556888889999999999999986532 2
Q ss_pred ceEEEEEecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCEEecC-CCcEEEeeccC
Q 036122 172 CSLYLVFEYMEHDLAGLAA---CQGVKFSEPQVKCYMKQLLSGLEHCH--NNGVLHRDIKGSNLLIDN-DGILKIADFGL 245 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NILl~~-~~~vkl~DFGl 245 (457)
..+++||||+++++...+. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 2388999999998765443 34567999999999999999999999 999999999999999996 89999999999
Q ss_pred ccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 246 ATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 246 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
++..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++.+.+
T Consensus 179 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 179 AKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp CBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 9876543 23345678999999999987766899999999999999999999999999999999999999999998887
Q ss_pred hhcCCCCcccC---CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCC
Q 036122 326 KKSKLPNATLF---KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391 (457)
Q Consensus 326 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 391 (457)
........... ....+....+.......++++.+||.+||+.||.+|||+.|+|+||||++...+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 65432111110 0111111112222233566899999999999999999999999999999865443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=404.60 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=218.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+|+.++|||||++++++.+ ...+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 91 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDMF 91 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 5789999999999999999999999999999999975421 22334668899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... .
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~ 169 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--T 169 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--C
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--C
Confidence 99999988777666667778999999999999999999999999999999999999999999999999999876543 3
Q ss_pred CcccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhhhhcCC
Q 036122 256 PMTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
.....+||+.|+|||++.+. ..|+.++|||||||++|+|++|.+||..... .+....+....
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~------------- 236 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV------------- 236 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC-------------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc-------------
Confidence 34667899999999999642 3478999999999999999999999975432 23333322110
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-HHHHhcCCCCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-ATAALNSEFFNTEPY 389 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-a~elL~hp~f~~~~~ 389 (457)
......+++.+.+||.+||+.||.+||+ ++++++||||+...|
T Consensus 237 ----------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 237 ----------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred ----------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 0112346788999999999999999998 999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=390.85 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=223.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.++++++||||+++++++.. ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CC
Confidence 467999999999999999999999999999999998654321 135678899999999999999999999887 56
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC----cEEEeeccCccc
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG----ILKIADFGLATF 248 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~ 248 (457)
.+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 7999999998766655556666799999999999999999999999999999999999999888 899999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......+..
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~----- 240 (321)
T 2a2a_A 169 IEDG--VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE----- 240 (321)
T ss_dssp CCTT--CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH-----
T ss_pred cCcc--ccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh-----
Confidence 6543 2234567899999999998766 7999999999999999999999999998888887775543222222
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+..+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 241 --------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 241 --------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp --------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred --------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 234577889999999999999999999999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=401.02 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=220.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 468999999999999999999999999999999997543 3344578899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC--CCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN--DGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~ 253 (457)
||||+.++.+.... .....+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 99999875554444 34457999999999999999999999999999999999999974 578999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~------------ 270 (387)
T 1kob_A 205 -EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD------------ 270 (387)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred -cceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 2234557899999999998766 79999999999999999999999999988888777754321111
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
...+..+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 271 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 271 -------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 112345788999999999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=393.19 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=209.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~l 176 (457)
++|++.++||+|+||+||+|++..+|+.||||++...............|+..+.++ +||||+++++++.. ...+|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 679999999999999999999999999999999876655555555556666666655 89999999999987 578999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||+++++...+...+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~ 212 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GA 212 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CC
Confidence 9999999888888777778999999999999999999999999999999999999999999999999999876533 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....||+.|+|||++.+ . ++.++|||||||++|||++|..||.+..... .+.. +..+
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~--~~~~--------------- 270 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-S-YGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ--GYLP--------------- 270 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-C-CSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--TCCC---------------
T ss_pred CcccCCCccccCHhHhcC-C-CCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--cCCC---------------
Confidence 345578999999999876 3 7999999999999999999977665433221 1111 0000
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 271 ----------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 ----------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ----------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1123457888999999999999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=401.28 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=214.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN---LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.. ...
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 100 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGM 100 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 367999999999999999999999999999999996432 111234668899999999999999999999987 567
Q ss_pred EEEEEecccCCHH-HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc---EEEeeccCc
Q 036122 174 LYLVFEYMEHDLA-GLAAC---QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI---LKIADFGLA 246 (457)
Q Consensus 174 ~~lv~E~~~~~l~-~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla 246 (457)
+|+||||++++.+ ..+.. .+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999997544 33332 2345899999999999999999999999999999999999986654 999999999
Q ss_pred cccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 247 TFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
....... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.. .+....+.........
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~---- 253 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP---- 253 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH----
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc----
Confidence 8765432 2234568999999999998766 7999999999999999999999998753 3444555442222221
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..+..+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus 254 ---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 254 ---------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ---------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ---------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1234578889999999999999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=395.69 Aligned_cols=257 Identities=31% Similarity=0.417 Sum_probs=201.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEE
Confidence 467999999999999999999999999999999997543 23457789999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~~ 253 (457)
||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~- 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ- 204 (349)
T ss_dssp EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence 9999988666555556667999999999999999999999999999999999999975 889999999999876432
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......+ ....+.......
T Consensus 205 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~------------ 270 (349)
T 2w4o_A 205 -VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF------------ 270 (349)
T ss_dssp ---------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC------------
T ss_pred -cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc------------
Confidence 2234567899999999998766 7999999999999999999999998766554 444443321111
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+..++.++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 271 -------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 271 -------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp -------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred -------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 011234578889999999999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=394.09 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=210.1
Q ss_pred cCCccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||.||+|++. .+|+.||+|+++.... .......+.+|+.+|++++||||+++++++.. .
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 93 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--G 93 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--C
Confidence 478999999999999999999985 6899999999976532 22334567789999999999999999999877 5
Q ss_pred ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 67999999998765555555555799999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+.++......
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~------------ 239 (327)
T 3a62_A 174 DG-TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN------------ 239 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------------
T ss_pred CC-ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC------------
Confidence 21 2234567999999999998766 799999999999999999999999999888888777553110
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
....+++++.+||.+||..||.+|| +++|+|+||||+...|
T Consensus 240 -----------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 240 -----------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp -----------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred -----------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 1124678899999999999999999 8999999999997654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=402.27 Aligned_cols=291 Identities=23% Similarity=0.326 Sum_probs=217.9
Q ss_pred cCCccccceeecc--CceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQG--TYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G--~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++++.||+| +||.||+|++..+|+.||||++............+.+|+.+++.++|||||++++++.. ...+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 101 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNEL 101 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEE
Confidence 5789999999999 99999999999999999999998877677777889999999999999999999999987 5679
Q ss_pred EEEEecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 175 YLVFEYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
|+||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 9999999976555544432 56999999999999999999999999999999999999999999999999998644211
Q ss_pred ------CCCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC------
Q 036122 253 ------LKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGS------ 319 (457)
Q Consensus 253 ------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~------ 319 (457)
........+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+......
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence 11122334789999999999873 34899999999999999999999999887766555443321100
Q ss_pred --CChhhhhhc-------CCCCcccC-CCCCC-cccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 320 --PSEEYWKKS-------KLPNATLF-KPQQP-YKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 320 --~~~~~~~~~-------~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
+........ ........ .+... ...........+++++.+||++||+.||++|||++|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 000000000 00000000 00000 00001123355788899999999999999999999999999998754
Q ss_pred C
Q 036122 389 Y 389 (457)
Q Consensus 389 ~ 389 (457)
+
T Consensus 342 ~ 342 (389)
T 3gni_B 342 R 342 (389)
T ss_dssp -
T ss_pred h
Confidence 3
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=413.06 Aligned_cols=258 Identities=29% Similarity=0.478 Sum_probs=223.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~ 92 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDIF 92 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEE
Confidence 57899999999999999999999999999999999754221 1234578899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~ 170 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--E 170 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--C
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--c
Confidence 99999988666666666678999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....+||+.|+|||++.+..+++.++|||||||++|+|++|.+||.+.+......++......
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 234 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY---------------- 234 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC----------------
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC----------------
Confidence 3455689999999999988776688999999999999999999999998888777776542110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+++++.+||++||+.||.+|||++|+++||||+..
T Consensus 235 -------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 235 -------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 112367789999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=398.24 Aligned_cols=289 Identities=30% Similarity=0.451 Sum_probs=229.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC---------hHHHHHHHHHHHHHHhcCCCCceeEeeeEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE---------PESVKFMAREILVLRKLDHPNVIKLEGLVT 167 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~---------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 167 (457)
.++|.+.+.||+|+||.||+|.+. +|..||||++...... ....+.+.+|+.++++++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 578999999999999999999974 5999999998654322 223467889999999999999999999986
Q ss_pred ec---CCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 168 SR---MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 168 ~~---~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
.. ....+|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 52 234689999999999988888777789999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 245 LATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 245 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
++...... .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.+..+.
T Consensus 180 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 99855432 2234567899999999998755589999999999999999999999999999999999999999887765
Q ss_pred hhhcCCCCcccC---CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 325 WKKSKLPNATLF---KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 325 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
+.....+..... .........+....+.+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 443211110000 0001111223445566788899999999999999999999999999999853
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=395.76 Aligned_cols=286 Identities=37% Similarity=0.594 Sum_probs=232.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC----c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----C 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----~ 172 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++............+.+|+.++++++||||+++++++..... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999999999999999998765566666788899999999999999999999876432 2
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||+.+++.... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCSEEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEeccccCCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 36999999998665543 235999999999999999999999999999999999999999999999999999865422
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+..+.++.+.+.......
T Consensus 180 ----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 255 (353)
T 3coi_A 180 ----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255 (353)
T ss_dssp --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred ----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence 3456789999999999875558999999999999999999999999999999999999999998877765422110
Q ss_pred cccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 333 ATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
...+ .........+...+..+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 0000 00000011223344567889999999999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=412.82 Aligned_cols=260 Identities=27% Similarity=0.384 Sum_probs=212.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~ 224 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLC 224 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEE
Confidence 5789999999999999999999999999999999975421 23334567789999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
+||||++++.+.........+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||+++..... .
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~ 303 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 303 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-C
Confidence 999999987666555556679999999999999999999998 99999999999999999999999999999864322 2
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+||+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+....+......
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 367 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR--------------- 367 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------
T ss_pred cccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 2345678999999999998776 799999999999999999999999998888777776542110
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
....+++++.+||.+||+.||.+|| |++|+|+||||++..|
T Consensus 368 --------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~ 413 (446)
T 4ejn_A 368 --------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW 413 (446)
T ss_dssp --------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred --------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence 1134678899999999999999999 9999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=390.98 Aligned_cols=292 Identities=32% Similarity=0.509 Sum_probs=232.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---Cce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~ 173 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++.... .......+.+|+.++++++||||+++++++.... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 478999999999999999999999999999999996432 3445567889999999999999999999876521 256
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||+.+++...+.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 89 ~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999999887766654 369999999999999999999999999999999999999999999999999998764321
Q ss_pred CC---------CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 254 KQ---------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 254 ~~---------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
.. ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 246 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence 11 123357899999999988756689999999999999999999999999999999999988888765322
Q ss_pred hhhc-CCCCccc--CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCC
Q 036122 325 WKKS-KLPNATL--FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391 (457)
Q Consensus 325 ~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~ 391 (457)
.... ..+.... ..........+...++.+++++.+||.+||+.||++|||++|+|+||||+....+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 1100 0000000 00000001123344567889999999999999999999999999999999865543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=388.16 Aligned_cols=288 Identities=38% Similarity=0.620 Sum_probs=233.6
Q ss_pred cCCccccceeeccCceEEEEEEEc-CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeeeEEe---c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL---DHPNVIKLEGLVTS---R 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~---~ 169 (457)
.++|++.+.||+|+||.||+|++. .+|+.||+|++............+.+|+.+++.+ +||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 578999999999999999999985 6789999999976543322223455677777766 89999999999862 1
Q ss_pred CCceEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
....+++||||+++++...+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 90 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 246789999999988777665543 3599999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+.++....+.+....|...
T Consensus 170 ~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (326)
T 1blx_A 170 YSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246 (326)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred ccCC--CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence 5432 2234567899999999998766 799999999999999999999999999999999999999988887777543
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
.......+.. .....+......+++.+.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 247 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 247 VALPRQAFHS--KSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CSSCGGGSCC--CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccchhhhcc--cCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 2111111111 0112233455678889999999999999999999999999999988643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=415.74 Aligned_cols=259 Identities=32% Similarity=0.515 Sum_probs=216.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|++..++..||+|++............+.+|+.+++.++|||||++++++.. ...+|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 457999999999999999999999999999999998765444445678899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~~ 253 (457)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 9999988655444444457999999999999999999999999999999999999976 456999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
......+||+.|+|||++.+ . |+.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 193 -~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 258 (494)
T 3lij_A 193 -KKMKERLGTAYYIAPEVLRK-K-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS----------- 258 (494)
T ss_dssp -BCBCCCCSCTTTCCHHHHTT-C-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS-----------
T ss_pred -ccccccCCCcCeeCHHHHcc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 23455689999999998864 3 799999999999999999999999999998888887664332222
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
..+..+++.+.+||++||+.||.+|||+.|+|+||||+.
T Consensus 259 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 259 --------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp --------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred --------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 223457888999999999999999999999999999976
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=401.47 Aligned_cols=261 Identities=26% Similarity=0.360 Sum_probs=214.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHH-HHhcCCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILV-LRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++++.||+|+||.||+|+++.+++.||||+++..... ......+.+|..+ ++.++||||+++++++.. ...+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~ 114 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKL 114 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEE
Confidence 57899999999999999999999999999999999865432 2334456677776 577899999999999887 5689
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..... .
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~ 193 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-N 193 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-C
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-C
Confidence 999999998666555555567999999999999999999999999999999999999999999999999999864322 1
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+...+|....-
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~---------------- 256 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------------- 256 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCC----------------
T ss_pred CccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhccc----------------
Confidence 2345678999999999998766 79999999999999999999999999988888887755210
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH----HHHhcCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA----TAALNSEFFNTEPYA 390 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta----~elL~hp~f~~~~~~ 390 (457)
.....+++++.+||.+||+.||.+||++ .++++||||+...|.
T Consensus 257 -------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 257 -------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp -------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 0113477889999999999999999996 699999999986653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=400.32 Aligned_cols=255 Identities=28% Similarity=0.408 Sum_probs=212.8
Q ss_pred cccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEec
Q 036122 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 101 ~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~ 180 (457)
...+.||+|+||.||+|.+..+|+.||+|+++... ....+.+.+|+.+|++++||||+++++++.. ...+|+||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeC
Confidence 33678999999999999999999999999998643 3445678899999999999999999999987 5679999999
Q ss_pred ccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe--cCCCcEEEeeccCccccCCCCCCCc
Q 036122 181 MEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI--DNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 181 ~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl--~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
++++ +...+......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..... ...
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~~ 245 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKL 245 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CBC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--ccc
Confidence 9875 445555555579999999999999999999999999999999999999 56789999999999877543 233
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
...+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.+.++........
T Consensus 246 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~---------------- 308 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE---------------- 308 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC----------------
T ss_pred ccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC----------------
Confidence 4567999999999997665 79999999999999999999999999999888888866422211
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...+..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 309 ---------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 309 ---------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ---------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ---------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12335678899999999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=401.63 Aligned_cols=261 Identities=27% Similarity=0.408 Sum_probs=201.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||++++..+++.||||++....... ..+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEE
Confidence 578999999999999999999999999999999997654322 447789999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc--EEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI--LKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~~~~~~~ 254 (457)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++.....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-- 171 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 171 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc--
Confidence 9999987655555555557999999999999999999999999999999999999987765 999999999754322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+||+.|+|||++.+..+.+.++|||||||++|+|++|++||.+.+......++........ ...
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~------~~~---- 241 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK------YSI---- 241 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC------CCC----
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC------CCC----
Confidence 2234567999999999998877555669999999999999999999987554322222222110000 000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.....+++++.+||.+||+.||++|||+.|+|+||||...
T Consensus 242 -------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 242 -------------PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -------------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -------------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0112467889999999999999999999999999999653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=392.21 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=220.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
...|++++.||+|+||+||+|++..+|+.||||++...... ......+.+|+.++++++||||+++++++.. ....|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEE
Confidence 35699999999999999999999999999999999865433 3445678899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.+++...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 9999999988887766677899999999999999999999999999999999999999999999999999986543
Q ss_pred CcccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 256 PMTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.....||+.|+|||++.+ ...++.++|||||||++|||++|.+||.+.+..+.+..+.......
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~------------- 272 (348)
T 1u5q_A 207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------------- 272 (348)
T ss_dssp -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-------------
T ss_pred -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------------
Confidence 234678999999999863 3347899999999999999999999999888777766654321000
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.....+++.+.+||.+||+.||++|||++++|+||||...
T Consensus 273 --------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 --------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred --------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0112467788999999999999999999999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=379.79 Aligned_cols=257 Identities=32% Similarity=0.465 Sum_probs=220.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEE
Confidence 36799999999999999999999999999999999765332 34568899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---cCCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~ 253 (457)
||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 99999886554444445579999999999999999999999999999999999999 78899999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+. ++.++|||||||++|+|++|.+||...+..+...++.......+...
T Consensus 163 -~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 230 (277)
T 3f3z_A 163 -KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD--------- 230 (277)
T ss_dssp -SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH---------
T ss_pred -cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh---------
Confidence 233456789999999998654 78999999999999999999999999998888877766443333322
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
+..+++.+.+||.+||+.||++|||+.|+|+||||++
T Consensus 231 ----------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 231 ----------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ----------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ----------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 2347888999999999999999999999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=395.11 Aligned_cols=256 Identities=26% Similarity=0.349 Sum_probs=211.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||+||+|.++.+|+.||||++...... ..+|+.++.++ +||||+++++++.+ ...+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~ 92 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVY 92 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEE
Confidence 46799999999999999999999999999999999865432 34688888888 79999999999987 57899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC----CcEEEeeccCccccCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND----GILKIADFGLATFYDP 251 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~~~~ 251 (457)
+||||+.++.+.........+++.++..++.||+.||.|||++||+||||||+|||+.++ +.+||+|||++.....
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 999999886555555556679999999999999999999999999999999999998543 3599999999987643
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCChhhhhhc
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR---TEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.. ......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+. +..+.+..+........
T Consensus 173 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~------- 243 (342)
T 2qr7_A 173 EN-GLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS------- 243 (342)
T ss_dssp TT-CCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-------
T ss_pred CC-CceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-------
Confidence 32 2334568899999999998655 789999999999999999999999863 44455555533211111
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...+..+++++.+||++||..||++|||+.|+|+||||...
T Consensus 244 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 244 ------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp ------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 11234578899999999999999999999999999999763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=415.54 Aligned_cols=260 Identities=30% Similarity=0.491 Sum_probs=219.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEE
Confidence 468999999999999999999999999999999997543223334678899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec---CCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID---NDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~~~~ 253 (457)
||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.....
T Consensus 99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999998865544444445799999999999999999999999999999999999995 4568999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
......+||+.|+|||++.+. |+.++|||||||++|+|++|.+||.+.+..+.+..+..........
T Consensus 178 -~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------- 244 (486)
T 3mwu_A 178 -TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP---------- 244 (486)
T ss_dssp -----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG----------
T ss_pred -CccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc----------
Confidence 234556899999999998753 7999999999999999999999999999988888876543222211
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 245 ---------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 245 ---------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ---------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ---------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 234578889999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=385.85 Aligned_cols=281 Identities=29% Similarity=0.522 Sum_probs=222.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||+||+|++..+++.||||++.... .+.+.+|+.++++++ ||||+++++++........+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 578999999999999999999999999999999986432 356889999999997 99999999999876667799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 254 (457)
+||||+.++.+..+.. .+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999999876665553 489999999999999999999999999999999999999776 89999999998765432
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCChhhhh-hcCCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIM-PGRTEVEQLHKIFKLCGSPSEEYWK-KSKLPN 332 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~-~~~~~~ 332 (457)
......||..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+...++.+....+. ......
T Consensus 186 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 264 (330)
T 3nsz_A 186 -EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264 (330)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred -ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence 2345678999999999987566899999999999999999999888 4556667777777666543322111 111000
Q ss_pred cc------cCCCCCCcccc-hhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 AT------LFKPQQPYKRC-IAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~------~~~~~~~~~~~-~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.. ........... .......+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 00 00000000000 011123368889999999999999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=414.50 Aligned_cols=260 Identities=31% Similarity=0.494 Sum_probs=224.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.++++++||||+++++++.. ...+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 46799999999999999999999999999999999765433 3445678899999999999999999999987 56899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---cCCCcEEEeeccCccccCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~ 252 (457)
+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999886665555566689999999999999999999999999999999999999 56789999999999877543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
......+||+.|+|||++.+ . |+.++|||||||++|+|++|.+||.+.+..+.+.++......+..
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---------- 248 (484)
T 3nyv_A 183 --KKMKDKIGTAYYIAPEVLHG-T-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL---------- 248 (484)
T ss_dssp --CSHHHHTTGGGTCCHHHHHT-C-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS----------
T ss_pred --cccccCCCCccccCceeecC-C-CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC----------
Confidence 23455689999999999976 3 789999999999999999999999999998888887654322221
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 249 ---------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 249 ---------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp ---------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred ---------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 1234578889999999999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=411.29 Aligned_cols=260 Identities=31% Similarity=0.472 Sum_probs=219.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh-----------HHHHHHHHHHHHHHhcCCCCceeEeee
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-----------ESVKFMAREILVLRKLDHPNVIKLEGL 165 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~hpniv~l~~~ 165 (457)
.++|.++++||+|+||+||+|++..+++.||||++....... .....+.+|+.+|++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 578999999999999999999999999999999997654321 234678899999999999999999999
Q ss_pred EEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC---cEEEee
Q 036122 166 VTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIAD 242 (457)
Q Consensus 166 ~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~D 242 (457)
+.. ...+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 987 568999999998865544444445799999999999999999999999999999999999999776 699999
Q ss_pred ccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 243 FGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 243 FGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
||++...... ......+||+.|+|||++.+ . ++.++|||||||++|+|++|.+||.+.+..+.+..+......+..
T Consensus 193 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 193 FGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-K-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-C-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred CCCCEEcCCC--CccccccCCcCCCCHHHhcc-C-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 9999877543 23456689999999999874 3 789999999999999999999999999999888888664333322
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. .+..+++++.+||++||+.||.+|||++|+|+||||+..
T Consensus 269 ~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 269 N-------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp H-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred c-------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 2 234578899999999999999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=390.53 Aligned_cols=255 Identities=30% Similarity=0.458 Sum_probs=191.5
Q ss_pred Ccccc---ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceE
Q 036122 99 TFEKL---DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 99 ~y~~~---~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 174 (457)
+|++. +.||+|+||+||+|++..+|+.||||++... ....+.+|+.+++.+. ||||+++++++.+ ...+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~ 81 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHT 81 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEE
Confidence 45554 7899999999999999999999999999643 3356778999999997 9999999999987 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC---cEEEeeccCccccCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIADFGLATFYDP 251 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~~~~~ 251 (457)
|+||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 99999998866655555667899999999999999999999999999999999999998766 899999999986653
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCChhh
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE-------VEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~-------~~~~~~i~~~~~~~~~~~ 324 (457)
.. ......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+. .+.+..+.........
T Consensus 162 ~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~-- 237 (325)
T 3kn6_A 162 DN-QPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG-- 237 (325)
T ss_dssp -----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS--
T ss_pred CC-CcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc--
Confidence 32 2345567899999999998766 79999999999999999999999987543 2333333222111111
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..+..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 238 -----------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 238 -----------------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp -----------------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred -----------------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 2234578899999999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=383.35 Aligned_cols=256 Identities=25% Similarity=0.428 Sum_probs=216.7
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
.|...+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEE
Confidence 47778899999999999999988999999999976543 234567899999999999999999999987 56799999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||++++.+..+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (321)
T 2c30_A 122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRK 199 (321)
T ss_dssp CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBC
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccc
Confidence 99998766666543 469999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
...||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+.......
T Consensus 200 ~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------------------ 260 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK------------------ 260 (321)
T ss_dssp CCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC------------------
T ss_pred cccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------------------
Confidence 568999999999998765 7899999999999999999999999888877766654321000
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+++.+.+||.+||+.||++|||+.|+|+||||.+.
T Consensus 261 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 261 --------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp --------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred --------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 00112367788999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=390.87 Aligned_cols=261 Identities=32% Similarity=0.482 Sum_probs=220.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC--Ch----HHHHHHHHHHHHHHhc-CCCCceeEeeeEEec
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL--EP----ESVKFMAREILVLRKL-DHPNVIKLEGLVTSR 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~--~~----~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~ 169 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++..... .. ...+.+.+|+.+++++ +||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES- 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence 3679999999999999999999988999999999986542 11 2245678899999999 79999999999877
Q ss_pred CCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
....|+||||+.++.+..+......+++..+..++.||+.||.|||+.||+|+||||+|||++.+|.+||+|||++...
T Consensus 172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 5689999999998655555555567999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCcccccccCccCchHhhhCC-----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGA-----TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
... .......||+.|+|||++.+. ..++.++|||||||++|+|++|.+||...+....+..+......+...
T Consensus 251 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~- 327 (365)
T 2y7j_A 251 EPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP- 327 (365)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH-
T ss_pred CCC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc-
Confidence 543 234556899999999998632 237889999999999999999999999988887777765543222222
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.+..+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 328 ------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 328 ------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp ------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 22456788999999999999999999999999999973
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=389.12 Aligned_cols=264 Identities=25% Similarity=0.333 Sum_probs=219.2
Q ss_pred cCCcccc-ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKL-DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~-~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~ 174 (457)
.+.|.+. +.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.+. ||||+++++++.. ...+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence 3567777 8899999999999999999999999999876555555677889999999995 6999999999977 5679
Q ss_pred EEEEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCcccc
Q 036122 175 YLVFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFY 249 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~ 249 (457)
|+||||+.++.+..+... ...+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 999999988554444322 357999999999999999999999999999999999999997 789999999999876
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+.........
T Consensus 185 ~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 254 (327)
T 3lm5_A 185 GHA--CELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------- 254 (327)
T ss_dssp -----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-------
T ss_pred CCc--cccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc-------
Confidence 533 2234567899999999998766 789999999999999999999999999988887777654322211
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
..+..+++.+.+||.+||+.||++|||++|+|+||||++..+.
T Consensus 255 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 255 ------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp ------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 1234577889999999999999999999999999999986554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=383.82 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=204.8
Q ss_pred cCCcccc-ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKL-DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~-~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
.+.|.+. +.||+|+||+||+|++..+++.||||++.... ......+.+|+.++.++ +||||+++++++.. ...+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 5789885 78999999999999999999999999997653 23345688999999985 79999999999987 5689
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc---EEEeeccCccccCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI---LKIADFGLATFYDP 251 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~~~~~ 251 (457)
|+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999987555444444557999999999999999999999999999999999999998776 99999999976532
Q ss_pred CC------CCCcccccccCccCchHhhhCC----cCCCccchhhhHHHHHHHHHhCCCCCCCCCh---------------
Q 036122 252 GL------KQPMTSRVVTLWYRPPELLLGA----TYYGVGVDLWSAGCILAELLAGKPIMPGRTE--------------- 306 (457)
Q Consensus 252 ~~------~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwslG~vl~elltG~~pf~~~~~--------------- 306 (457)
.. .......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+...
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 21 1112345689999999998741 2378899999999999999999999987642
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 307 VEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 307 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
......+.......+ ...+..+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 247 ~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 301 (316)
T 2ac3_A 247 NMLFESIQEGKYEFP-------------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301 (316)
T ss_dssp HHHHHHHHHCCCCCC-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-
T ss_pred HHHHHHHhccCcccC-------------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcC
Confidence 122233322111111 1123457888999999999999999999999999999987
Q ss_pred C
Q 036122 387 E 387 (457)
Q Consensus 387 ~ 387 (457)
.
T Consensus 302 ~ 302 (316)
T 2ac3_A 302 C 302 (316)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=392.95 Aligned_cols=281 Identities=27% Similarity=0.441 Sum_probs=224.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CC-----CceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HP-----NVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ......+.+|+.+++.++ |+ +|+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 57899999999999999999999999999999999642 344566778999998885 55 49999999887
Q ss_pred CceEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceeccCCCCCEEec--CCCcEEEeeccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCH--NNGVLHRDIKGSNLLID--NDGILKIADFGL 245 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~~ivHrDlkp~NILl~--~~~~vkl~DFGl 245 (457)
...+|+||||+++++...+.... ..+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||+|||+
T Consensus 128 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 56899999999998887776553 46999999999999999999999 57999999999999995 478899999999
Q ss_pred ccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 246 ATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 246 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
++.... ......||+.|+|||++.+.. ++.++|||||||++|||+||++||.+.+..+.+.++....+.++...+
T Consensus 208 a~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 282 (382)
T 2vx3_A 208 SCQLGQ----RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHIL 282 (382)
T ss_dssp CEETTC----CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ceeccc----ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987643 234568899999999998776 899999999999999999999999999999999999999998887776
Q ss_pred hhcC--------CCCccc---------CCCCCCcccchhcccCC-----------C-------CCCcHHHHHHhccCCCC
Q 036122 326 KKSK--------LPNATL---------FKPQQPYKRCIAETFKD-----------F-------PSSSLPLIETLLSIDPD 370 (457)
Q Consensus 326 ~~~~--------~~~~~~---------~~~~~~~~~~~~~~~~~-----------~-------~~~~~~Li~~~L~~dP~ 370 (457)
.... ++.... .....+....+...+.. . .+++.+||.+||++||+
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 362 (382)
T 2vx3_A 283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK 362 (382)
T ss_dssp TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence 4321 110000 00000000001000000 0 02578999999999999
Q ss_pred CCcCHHHHhcCCCCCCC
Q 036122 371 NRGTATAALNSEFFNTE 387 (457)
Q Consensus 371 ~Rpta~elL~hp~f~~~ 387 (457)
+|||++|+|+||||++.
T Consensus 363 ~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 363 TRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TSCCHHHHTTSGGGCC-
T ss_pred hCCCHHHHhcCcccccC
Confidence 99999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=418.03 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=215.7
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l 259 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDAL 259 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEE
Confidence 46789999999999999999999999999999999975422 12234557889999999999999999999877 5689
Q ss_pred EEEEecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 175 YLVFEYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
|+||||+.++.+....... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999876555544443 34999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChhhhhhc
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE----VEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+. .+....+....
T Consensus 340 --~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~----------- 405 (576)
T 2acx_A 340 --QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP----------- 405 (576)
T ss_dssp --CCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC-----------
T ss_pred --ccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc-----------
Confidence 2335568999999999998766 79999999999999999999999987643 22222222110
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
......+++++.+||.+||+.||.+|| +++|+++||||+...|
T Consensus 406 ------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 406 ------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred ------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 001134788999999999999999999 8999999999998554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=379.19 Aligned_cols=257 Identities=28% Similarity=0.431 Sum_probs=209.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... ....+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEE
Confidence 4679999999999999999999999999999999986542 2334678899999999999999999999977 567999
Q ss_pred EEecccCC-HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---cCCCcEEEeeccCcccc
Q 036122 177 VFEYMEHD-LAGLAAC---QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFY 249 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~ 249 (457)
||||++++ +...+.. .+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999874 4444322 34679999999999999999999999999999999999999 45688999999999866
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......||+.|+|||++.+ . ++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------- 243 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFKR-D-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN---------- 243 (285)
T ss_dssp -----------CTTGGGCCHHHHTT-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------
T ss_pred CCc--ccCcCcccccCcCChHHhcc-C-CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc----------
Confidence 543 22345678999999998864 3 789999999999999999999999998877766554331100
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.......+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 244 ----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 244 ----------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00112336778999999999999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=392.53 Aligned_cols=266 Identities=26% Similarity=0.377 Sum_probs=215.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC---CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN---LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||+||+|++..++..||+|++.... ......+.+.+|+.++++++||||+++++++.. ...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 468999999999999999999999999999999997542 234455778999999999999999999999977 567
Q ss_pred EEEEEecccCCHHHHHHhc----------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 036122 174 LYLVFEYMEHDLAGLAACQ----------------------------------------GVKFSEPQVKCYMKQLLSGLE 213 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~----------------------------------------~~~l~~~~~~~i~~qi~~~L~ 213 (457)
+|+||||++++.+...... ...+++..++.++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999987655554421 112467889999999999999
Q ss_pred HHHhCCceeccCCCCCEEecCCC--cEEEeeccCccccCCC---CCCCcccccccCccCchHhhhCC-cCCCccchhhhH
Q 036122 214 HCHNNGVLHRDIKGSNLLIDNDG--ILKIADFGLATFYDPG---LKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSA 287 (457)
Q Consensus 214 ~LH~~~ivHrDlkp~NILl~~~~--~vkl~DFGla~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~Dvwsl 287 (457)
|||++||+||||||+||||+.++ .+||+|||++..+... .........||+.|+|||++.+. ..++.++|||||
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99999999999999999998776 8999999999865321 11123456789999999999752 447899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccC
Q 036122 288 GCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSI 367 (457)
Q Consensus 288 G~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~ 367 (457)
||++|+|++|..||.+.+..+...++......... .....+++++.+||.+||+.
T Consensus 263 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHHHcCC
Confidence 99999999999999999988888777653221111 12234678899999999999
Q ss_pred CCCCCcCHHHHhcCCCCCCCCC
Q 036122 368 DPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 368 dP~~Rpta~elL~hp~f~~~~~ 389 (457)
||.+|||+.|+|+||||++..+
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTSS
T ss_pred ChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999987543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=384.26 Aligned_cols=289 Identities=34% Similarity=0.571 Sum_probs=225.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec-------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR------- 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 169 (457)
.++|.+++.||+|+||.||+|.+..+|+.||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 47899999999999999999999999999999999754 455667788999999999999999999987432
Q ss_pred -----CCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-CCCcEEEeec
Q 036122 170 -----MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADF 243 (457)
Q Consensus 170 -----~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DF 243 (457)
....+|+||||+++++...+. ...+++..++.++.||+.||.|||++||+||||||+|||++ +++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 235789999999987766553 34699999999999999999999999999999999999997 5679999999
Q ss_pred cCccccCCCCC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 036122 244 GLATFYDPGLK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS 321 (457)
Q Consensus 244 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~ 321 (457)
|+++....... .......+|..|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+........
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99987643211 2234456799999999998755689999999999999999999999999999999988888776665
Q ss_pred hhhhhhcC--CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCC
Q 036122 322 EEYWKKSK--LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390 (457)
Q Consensus 322 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 390 (457)
.+.+.... ++..... ........+....+.+++++.+||.+||+.||++|||++|+|+||||+...++
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRN-DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHHTTSCHHHHH-HTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhhcCcccccc-cccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 55443211 0000000 00000112334456788999999999999999999999999999999986544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=396.77 Aligned_cols=282 Identities=25% Similarity=0.411 Sum_probs=226.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--------CCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD--------HPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~~ 168 (457)
.++|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.+++.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 47899999999999999999999999999999999643 445567889999999985 7889999998873
Q ss_pred c--CCceEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCC--------
Q 036122 169 R--MSCSLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDG-------- 236 (457)
Q Consensus 169 ~--~~~~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~-------- 236 (457)
. ....+|+||||++++++..+.... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 2 245789999999999888776654 5699999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------cEEEeeccCccccCCCCCCCcccccccCccCchHhhhCC
Q 036122 237 -----------------------------------------ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275 (457)
Q Consensus 237 -----------------------------------------~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 275 (457)
.+||+|||++...... ....+||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876432 3456789999999999887
Q ss_pred cCCCccchhhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC--------CCC
Q 036122 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP--------QQP 341 (457)
Q Consensus 276 ~~~~~~~DvwslG~vl~elltG~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 341 (457)
. ++.++|||||||++|+|+||++||.+.+ ....+..+....+.++...+............. ..+
T Consensus 269 ~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 G-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp C-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred C-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 6 7999999999999999999999998765 567788888999988877765433221110000 000
Q ss_pred c--ccchhcc---cCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 342 Y--KRCIAET---FKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 342 ~--~~~~~~~---~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
. ...+... ....++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 0000000 0112346789999999999999999999999999963
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=380.48 Aligned_cols=259 Identities=24% Similarity=0.387 Sum_probs=201.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|++..+|+.||+|++............+.++...++.++||||+++++++.. ...+|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEEE
Confidence 578999999999999999999999999999999997665444444555566666888999999999999987 567999
Q ss_pred EEecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAA---CQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
||||+++++...+. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 84 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 84 CMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred EEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 99999987755443 3466799999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCchHhh---hCCcCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhc
Q 036122 253 LKQPMTSRVVTLWYRPPELL---LGATYYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~~DvwslG~vl~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
. ......||+.|+|||++ .....++.++|||||||++|+|++|..||... .....+..+.......
T Consensus 164 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 233 (290)
T 3fme_A 164 V--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ-------- 233 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--------
T ss_pred c--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--------
Confidence 2 22345789999999997 33444789999999999999999999999863 4444444443311000
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 234 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 -------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp -------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred -------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011346778999999999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=379.54 Aligned_cols=256 Identities=32% Similarity=0.467 Sum_probs=214.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.++++++||||+++++++.. ...++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 85 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 85 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEEE
Confidence 57899999999999999999999999999999999653221 1224568899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 99999997655555445557999999999999999999999999999999999999999999999999998654332
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|+|||++.+.. ++.++||||||+++|+|++|.+||...+..+....+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 225 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------- 225 (279)
T ss_dssp -----CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC----------------
T ss_pred cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC----------------
Confidence 234567899999999998765 789999999999999999999999998888877776542111
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 226 -------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 226 -------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp -------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred -------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 112366788999999999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=377.11 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=216.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
++|++.+.||+|+||.||+|++..+|+.||+|++....... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 57999999999999999999999999999999998654321 135678899999999999999999999987 567
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC----cEEEeeccCcccc
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG----ILKIADFGLATFY 249 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~~ 249 (457)
+|+||||++++.+..+......+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999998765555555555799999999999999999999999999999999999999877 8999999999876
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+.+..+.........
T Consensus 163 ~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------- 232 (283)
T 3bhy_A 163 EAG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE------- 232 (283)
T ss_dssp C----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred cCC--CcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-------
Confidence 543 2234557899999999998766 789999999999999999999999998888777766543222221
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
..+..+++.+.+||.+||..||++|||+.|+|+||||+.
T Consensus 233 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 233 ------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 223457788999999999999999999999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=422.64 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=223.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++++.||+|+||.||+|++..+++.||||+++.... .......+..|..+|..+ +||||+++++++.+ ...+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~ 417 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL 417 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEE
Confidence 5789999999999999999999999999999999975421 122345677899999987 69999999988876 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||||+.++.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+++......
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 9999999986666555555679999999999999999999999999999999999999999999999999998643222
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+.+|......
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------------- 560 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------------- 560 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC---------------
T ss_pred cccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC---------------
Confidence 2345678999999999998766 799999999999999999999999999998888887542110
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH-----HHHhcCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA-----TAALNSEFFNTEPYA 390 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta-----~elL~hp~f~~~~~~ 390 (457)
....+++++.+||++||+.||++||++ +|+++||||+...|.
T Consensus 561 --------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 561 --------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp --------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred --------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 113478889999999999999999997 999999999987654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=389.79 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=211.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE------SVKFMAREILVLRKLDHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++........ ....+.+|+.++++++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 4689999999999999999999999999999999987543221 23456789999999999999999999977
Q ss_pred CceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 171 SCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 171 ~~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
...+++||||+.++ .+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 56799999999664 55555556667999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......||+.|+|||++.+..+++.++|||||||++|+|++|..||..... . ...
T Consensus 181 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~-----------~~~-- 239 (335)
T 3dls_A 181 ERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------T-----------VEA-- 239 (335)
T ss_dssp CTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------G-----------TTT--
T ss_pred CCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------H-----------Hhh--
Confidence 543 2334567999999999998877568899999999999999999999965211 0 000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......+++++.+||.+||+.||++|||++++|+||||++.
T Consensus 240 ----------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 240 ----------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ----------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ----------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000112367889999999999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=382.07 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=202.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC-----
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS----- 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----- 171 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|++++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 467999999999999999999999999999999998654 33445678899999999999999999998865321
Q ss_pred --------------------------------------------------ceEEEEEecccCCHHHHHHhcCC---CCCH
Q 036122 172 --------------------------------------------------CSLYLVFEYMEHDLAGLAACQGV---KFSE 198 (457)
Q Consensus 172 --------------------------------------------------~~~~lv~E~~~~~l~~~~~~~~~---~l~~ 198 (457)
..+|+||||++++.+..+..... ..++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 23899999999865555554432 3566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-----------CCcccccccCccC
Q 036122 199 PQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-----------QPMTSRVVTLWYR 267 (457)
Q Consensus 199 ~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-----------~~~~~~~gt~~y~ 267 (457)
..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....... .......||+.|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 67899999999999999999999999999999999999999999999987754321 1224457899999
Q ss_pred chHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchh
Q 036122 268 PPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIA 347 (457)
Q Consensus 268 aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (457)
|||++.+.. ++.++|||||||++|+|++|..|+.. .......+.. +..+
T Consensus 244 aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~--~~~~-------------------------- 292 (332)
T 3qd2_B 244 SPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN--LKFP-------------------------- 292 (332)
T ss_dssp CHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT--TCCC--------------------------
T ss_pred ChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc--cCCC--------------------------
Confidence 999998766 79999999999999999998765421 1111111111 0000
Q ss_pred cccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 348 ETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 348 ~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
..+...++++.+||.+||+.||++|||++|+|+||||++
T Consensus 293 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 293 LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 111224566789999999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=373.96 Aligned_cols=259 Identities=24% Similarity=0.296 Sum_probs=214.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec--CCceEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR--MSCSLY 175 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~~ 175 (457)
..|.+.+.||+|+||.||+|.+..++..||+|++..........+.+.+|+.++++++||||+++++++... ....+|
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 458899999999999999999999999999999987777777778899999999999999999999988653 245689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEec-CCCcEEEeeccCccccCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLID-NDGILKIADFGLATFYDPG 252 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~~ 252 (457)
+||||++++.+..+......+++..++.++.||+.||.|||+++ |+|+||||+|||++ .++.+||+|||++......
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999988655555555567999999999999999999999999 99999999999998 7899999999999765432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
......||+.|+|||++.+ . ++.++|||||||++|+|++|..||..................+
T Consensus 186 ---~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------ 248 (290)
T 1t4h_A 186 ---FAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------------ 248 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC------------
T ss_pred ---ccccccCCcCcCCHHHHhc-c-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc------------
Confidence 2345678999999998864 3 7899999999999999999999998866554443322210000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 249 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 --------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp --------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred --------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 01123356778999999999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=373.42 Aligned_cols=262 Identities=29% Similarity=0.433 Sum_probs=219.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC---C----hHHHHHHHHHHHHHHhcC-CCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL---E----PESVKFMAREILVLRKLD-HPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---~----~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~ 168 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++..... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999976542 1 123456789999999995 9999999999876
Q ss_pred cCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 169 RMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
...+|+||||++++.+..+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 577999999998755555544556799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhh-----CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLL-----GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
.... .......||+.|+|||++. ....++.++|||||||++|+|++|..||...+..+....+.........
T Consensus 174 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 250 (298)
T 1phk_A 174 LDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS- 250 (298)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-
T ss_pred cCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc-
Confidence 6543 2334567899999999986 2334788999999999999999999999998887777766543211110
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..+..+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 251 ------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 ------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp ------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 1223577889999999999999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=399.67 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=204.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL------EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 170 (457)
.++|.+.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+|++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 4789999999999999999999999999999999976432 11222347889999999999999999999754
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC---cEEEeeccCcc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIADFGLAT 247 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~DFGla~ 247 (457)
..+|+||||+.++.+.........+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 45899999998866655555566899999999999999999999999999999999999997544 59999999998
Q ss_pred ccCCCCCCCcccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCChhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQL-HKIFKLCGSPSEEY 324 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~-~~i~~~~~~~~~~~ 324 (457)
..... ......+||+.|+|||++.+ ...++.++|||||||++|+|++|.+||........+ ..+.......
T Consensus 291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~---- 364 (419)
T 3i6u_A 291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 364 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC----
T ss_pred ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC----
Confidence 76533 23345689999999999863 344788999999999999999999999875443322 2222211111
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
....+..+++.+.+||.+||+.||++|||++|+|+||||+.
T Consensus 365 ---------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 365 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ---------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 12234557889999999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=406.58 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=217.0
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
...++|.+.+.||+|+||.||+|+++.+|+.||||++...... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCE
Confidence 3468899999999999999999999999999999999754321 1234567889999999999999999998877 567
Q ss_pred EEEEEecccCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 174 LYLVFEYMEHDLAGLAACQ----GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
+|+||||+.|+.+...... ...+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+++..
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 9999999998655544433 346999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCCCChhhh
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT----EVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~----~~~~~~~i~~~~~~~~~~~~ 325 (457)
.... ......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+ ..+....+.....
T Consensus 340 ~~~~-~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~------- 410 (543)
T 3c4z_A 340 KAGQ-TKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV------- 410 (543)
T ss_dssp CTTC-CCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-------
T ss_pred cCCC-cccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-------
Confidence 5432 2234468999999999998766 8999999999999999999999998763 3344444432110
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
.....+++++.+||.+||+.||.+||+ ++++++||||+...|
T Consensus 411 ----------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 411 ----------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred ----------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 011347888999999999999999995 589999999998655
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=382.33 Aligned_cols=260 Identities=29% Similarity=0.403 Sum_probs=221.9
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..++|.+.+.||+|+||.||++++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeE
Confidence 35789999999999999999999999999999999976543 44556778899999999999999999999987 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~- 195 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 195 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-
Confidence 9999999976555555555679999999999999999999999999999999999999999999999999998765332
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------- 258 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---------------- 258 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC----------------
T ss_pred ccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC----------------
Confidence 2234567899999999998766 78999999999999999999999998887776665543210
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.....+++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus 259 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 259 -------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 01124677889999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=372.82 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=207.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||+||+|++..+++.||||++............+.+|+.++..+ +||||+++++++.. ...++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 5789999999999999999999999999999999987665556667788999999999 89999999999987 56899
Q ss_pred EEEecccCC-HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC----------------
Q 036122 176 LVFEYMEHD-LAGLAACQ---GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND---------------- 235 (457)
Q Consensus 176 lv~E~~~~~-l~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---------------- 235 (457)
+||||++++ +...+... ...+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999874 44444332 2569999999999999999999999999999999999999844
Q ss_pred ---CcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036122 236 ---GILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 312 (457)
Q Consensus 236 ---~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~ 312 (457)
..+||+|||++...... ....||+.|+|||++.+...++.++|||||||++|+|++|.+++...... ..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~ 239 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HE 239 (289)
T ss_dssp --CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HH
T ss_pred CCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HH
Confidence 48999999999876532 23468999999999987755778999999999999999999877554322 22
Q ss_pred HHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 313 IFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 313 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+... . .......+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 240 ~~~~------------~----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 240 IRQG------------R----------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HHTT------------C----------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred HHcC------------C----------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2110 0 011123577889999999999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=374.34 Aligned_cols=261 Identities=29% Similarity=0.400 Sum_probs=221.7
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
..++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEE
Confidence 35789999999999999999999999999999999976543 34556778899999999999999999999987 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+||||++++.+..+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 169 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 169 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence 9999999976555555555679999999999999999999999999999999999999999999999999998765322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..+....+.....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 232 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY---------------- 232 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC----------------
T ss_pred cccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC----------------
Confidence 2234467899999999998766 78999999999999999999999998887766655532100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
.....+++.+.+||.+||+.||++|||++|+|+||||+....
T Consensus 233 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 233 -------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred -------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 011246778899999999999999999999999999987543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=376.63 Aligned_cols=257 Identities=29% Similarity=0.436 Sum_probs=216.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|++..++..||+|++...... ......+.+|+.++++++||||+++++++.. ...+|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 90 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIY 90 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEE
Confidence 57899999999999999999999999999999999753221 1223568899999999999999999999887 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+.........+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred EEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 99999987544444444457999999999999999999999999999999999999999999999999999765432
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|+|||++.+.. ++.++||||||+++|+|++|.+||...+..+....+.....
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------------- 229 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL----------------- 229 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC-----------------
T ss_pred ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc-----------------
Confidence 224467899999999998766 78999999999999999999999998887777666543210
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.....++.++.+||.+||+.||.+|||++++|+||||+...
T Consensus 230 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 230 ------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 01134677889999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=372.67 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=214.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEE
Confidence 3679999999999999999999999999999999976543 2345678899999999999999999999887 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-CC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL-KQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 255 (457)
||||++++.+.........+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999875555455555679999999999999999999999999999999999999999999999999998653221 12
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......||+.|+|||++.+...++.++|||||||++|+|++|..||...+... ....+.....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 226 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 226 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT----------------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc----------------
Confidence 23456789999999999877656789999999999999999999998765432 2222211000
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+..+++.+.+||.+||+.||.+|||++|+|+||||++.
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 -----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 001123467889999999999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=379.59 Aligned_cols=258 Identities=30% Similarity=0.443 Sum_probs=215.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.++++++||||+++++++.. ...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEE
Confidence 3679999999999999999999999999999999985432 223567899999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---cCCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~ 253 (457)
||||++++.+.........+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 99999875444444444579999999999999999999999999999999999999 78899999999999754322
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+........
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~------------ 227 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE------------ 227 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC------------
T ss_pred --ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 234457899999999998765 79999999999999999999999999888887777755321111
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+++++.+||.+||..||++|||++|+|+||||+..
T Consensus 228 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 -------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 11234578889999999999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=383.25 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=214.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC--ce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS--CS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~ 173 (457)
.++|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4789999999999999999999999999999999987543 34556678899999999999999999998876432 24
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 69999999876555555555679999999999999999999999999999999999999999999999999998664332
Q ss_pred C--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 254 K--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 254 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+...++......++
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 239 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------- 239 (311)
T ss_dssp -----------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH----------
T ss_pred cccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc----------
Confidence 1 1223457899999999998776 79999999999999999999999999888777666544321111
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
......+++++.+||.+||+.||++||++.++|.|+|++.
T Consensus 240 ---------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 ---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1223457888999999999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-49 Score=394.94 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=198.9
Q ss_pred cCCcccc-ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh-cCCCCceeEeeeEEe--cCCc
Q 036122 97 ANTFEKL-DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK-LDHPNVIKLEGLVTS--RMSC 172 (457)
Q Consensus 97 ~~~y~~~-~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~--~~~~ 172 (457)
.++|.+. +.||+|+||+||+|++..+|+.||||++... ..+.+|+.++.+ ++||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4678877 6899999999999999999999999999632 346678888744 589999999998864 2245
Q ss_pred eEEEEEecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCcc
Q 036122 173 SLYLVFEYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLAT 247 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~ 247 (457)
.+||||||+.++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 689999999875444444332 35999999999999999999999999999999999999997 7899999999998
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCChh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE----QLHKIFKLCGSPSEE 323 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~----~~~~i~~~~~~~~~~ 323 (457)
..... ......+||+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+... ....+.......
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~--- 286 (400)
T 1nxk_A 213 ETTSH--NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF--- 286 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC---
T ss_pred ccCCC--CccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC---
Confidence 66432 2345668899999999987665 8999999999999999999999998765322 222222110000
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+..+++++.+||++||+.||++|||++|+|+||||.+.
T Consensus 287 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 287 ----------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ----------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ----------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 011234578889999999999999999999999999999763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=377.23 Aligned_cols=263 Identities=27% Similarity=0.400 Sum_probs=217.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++.......+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4689999999999999999999999999999999975421 12345678899999999999999999999865556679
Q ss_pred EEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
|+||||+.+++...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 999999999876655543 4569999999999999999999999999999999999999999999999999998764322
Q ss_pred -CCCcccccccCccCchHhhhCCc-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 254 -KQPMTSRVVTLWYRPPELLLGAT-YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 254 -~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
........||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-------------
Confidence 12234457899999999997643 347799999999999999999999999887777666543210
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.....+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 231 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 231 ----------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ----------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ----------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 01134677889999999999999999999999999998753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=384.20 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=206.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH--PNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~ 174 (457)
.++|++++.||+|+||.||++.+ .+++.||||++............+.+|+.+|++++| +||+++++++.. ...+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 84 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 84 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEE
Confidence 46799999999999999999986 578999999998877777777889999999999986 999999999887 5689
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+|||+..+++...+.. ...+++.++..++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.......
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99999877777666654 45799999999999999999999999999999999999997 67899999999987654322
Q ss_pred C-CcccccccCccCchHhhhC----------CcCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCh
Q 036122 255 Q-PMTSRVVTLWYRPPELLLG----------ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCGSPSE 322 (457)
Q Consensus 255 ~-~~~~~~gt~~y~aPE~l~~----------~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~ 322 (457)
. .....+||+.|+|||++.+ ...++.++|||||||++|+|++|++||...... ..+..+......
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--- 239 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 239 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC---
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc---
Confidence 2 2345679999999999864 234788999999999999999999999865432 233322210000
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 240 ------------------------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 240 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred ------------------------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 00112234578999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=373.58 Aligned_cols=263 Identities=29% Similarity=0.455 Sum_probs=220.3
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.++++++||||+++++++.......+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34578999999999999999999999999999999998877677777889999999999999999999998876556789
Q ss_pred EEEEecccC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCEEecCCCcEEEeeccC
Q 036122 175 YLVFEYMEH-DLAGLAAC---QGVKFSEPQVKCYMKQLLSGLEHCHNNG-----VLHRDIKGSNLLIDNDGILKIADFGL 245 (457)
Q Consensus 175 ~lv~E~~~~-~l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NILl~~~~~vkl~DFGl 245 (457)
|+||||+++ ++...+.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999987 44444432 2345999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 246 ATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 246 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
+....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+..+....+......
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~------ 234 (279)
T 2w5a_A 163 ARILNHDT-SFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR------ 234 (279)
T ss_dssp HHHC---C-HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred heeecccc-ccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc------
Confidence 98764321 1123356899999999998766 789999999999999999999999998877766666442100
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.....+++++.+||.+||+.||.+|||++|+|+|+|+...
T Consensus 235 ----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 235 ----------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp ----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ----------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 1113467889999999999999999999999999999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=389.77 Aligned_cols=260 Identities=26% Similarity=0.391 Sum_probs=208.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD--HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~ 174 (457)
..+|++.+.||+|+||+||+|.+. +++.||||++............+.+|+.+|++++ ||||+++++++.. ...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 356999999999999999999975 4899999999887767777788999999999996 5999999999887 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+|||+..+++...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.......
T Consensus 132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999766666665554 45799999999999999999999999999999999999995 58999999999987654322
Q ss_pred C-CcccccccCccCchHhhhCC----------cCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCh
Q 036122 255 Q-PMTSRVVTLWYRPPELLLGA----------TYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCGSPSE 322 (457)
Q Consensus 255 ~-~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DvwslG~vl~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~ 322 (457)
. .....+||+.|+|||++.+. ..++.++|||||||++|||++|.+||...... ..+..+......
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~--- 286 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 286 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC---
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc---
Confidence 1 23456799999999999752 24789999999999999999999999875432 333333221000
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.......+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 287 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 287 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ------------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 000112356789999999999999999999999999998643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=373.78 Aligned_cols=258 Identities=28% Similarity=0.449 Sum_probs=190.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|.+.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.++++++||||+++++++.. ...+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYVY 87 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeEE
Confidence 56899999999999999999999999999999999753211 1224668899999999999999999999887 56799
Q ss_pred EEEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
+||||++++.+ ..+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 166 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH- 166 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-
Confidence 99999987544 4444444679999999999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|++||...+..+.+..+.. ..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------~~-- 228 (278)
T 3cok_A 167 EKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------AD-- 228 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS---------------SC--
T ss_pred CcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh---------------cc--
Confidence 1223457899999999988665 78999999999999999999999987654333222100 00
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++.++.+||.+||+.||++|||++++|+||||+..
T Consensus 229 ------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 229 ------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 01112367788999999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=374.30 Aligned_cols=262 Identities=27% Similarity=0.380 Sum_probs=212.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 4689999999999999999999999999999999976543 45556788999999999999999999999876 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999988665555555567999999999999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|+|||++.+.. ++.++|||||||++|+|+||++||.+.+..+...+.......
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~---------------- 230 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP---------------- 230 (294)
T ss_dssp -------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC----------------
T ss_pred ccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC----------------
Confidence 344567899999999998766 789999999999999999999999998877665444321100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
........++|+.+.++|.+||+.||.+||+..+.|.+.|..
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 231 --------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp --------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred --------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 011223356788999999999999999999766666666654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=372.96 Aligned_cols=258 Identities=29% Similarity=0.442 Sum_probs=209.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 87 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFF 87 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEE
Confidence 4789999999999999999999999999999999975421 12234568899999999999999999999877 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.++.+..+......+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...... .
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~ 165 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--E 165 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--c
Confidence 99999987555444444557999999999999999999999999999999999999999999999999999876543 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|+|||++.+....+.++||||||+++|+|++|..||...+..+....+......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 229 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY---------------- 229 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc----------------
Confidence 2344578999999999987765578999999999999999999999988777766665432100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 230 -------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 230 -------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 112356788999999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=377.49 Aligned_cols=281 Identities=25% Similarity=0.393 Sum_probs=225.4
Q ss_pred cCCccccceeeccCceEEEEEEE-cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC------CceeEeeeEEec
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARD-LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP------NVIKLEGLVTSR 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~-~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~l~~~~~~~ 169 (457)
.++|++.+.||+|+||+||+|.+ ..+|+.||||+++.. ......+.+|+.+++.++|+ +|+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-
Confidence 46899999999999999999998 568899999999642 34456788999999998765 49999999887
Q ss_pred CCceEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC--------------
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-------------- 234 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-------------- 234 (457)
...+|+||||+++++...+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 89 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 -HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 56899999999888877766543 36899999999999999999999999999999999999987
Q ss_pred -----CCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH
Q 036122 235 -----DGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 309 (457)
Q Consensus 235 -----~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~ 309 (457)
++.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999865432 34567899999999998766 79999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChhhhhhcCCCCccc-----CCCCCCcccchh----------cccCCCCCCcHHHHHHhccCCCCCCcC
Q 036122 310 LHKIFKLCGSPSEEYWKKSKLPNATL-----FKPQQPYKRCIA----------ETFKDFPSSSLPLIETLLSIDPDNRGT 374 (457)
Q Consensus 310 ~~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~----------~~~~~~~~~~~~Li~~~L~~dP~~Rpt 374 (457)
+..+....+..+...+.......... +........... ......++++.+||.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 99999988888877765432111000 000000000000 001112456789999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 036122 375 ATAALNSEFFNTE 387 (457)
Q Consensus 375 a~elL~hp~f~~~ 387 (457)
++|+|+||||+..
T Consensus 323 ~~ell~hp~f~~~ 335 (339)
T 1z57_A 323 LREALKHPFFDLL 335 (339)
T ss_dssp HHHHTTSGGGGGG
T ss_pred HHHHhcCHHHHHH
Confidence 9999999999863
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=379.43 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=207.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL------EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 170 (457)
.++|.+.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 3679999999999999999999999999999999975432 122234578899999999999999999998652
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc---EEEeeccCcc
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI---LKIADFGLAT 247 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla~ 247 (457)
.+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp --SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred --ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 38999999987555555555667999999999999999999999999999999999999987664 9999999998
Q ss_pred ccCCCCCCCcccccccCccCchHhhh--CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLL--GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVE-QLHKIFKLCGSPSEEY 324 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 324 (457)
..... .......||+.|+|||++. +...++.++|||||||++|+|++|.+||....... ....+.......
T Consensus 166 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 239 (322)
T 2ycf_A 166 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF---- 239 (322)
T ss_dssp ECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC----
T ss_pred ecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc----
Confidence 76432 1223457899999999984 23447899999999999999999999998655432 222232211111
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
....+..+++.+.+||.+||+.||++|||++++|+||||+.
T Consensus 240 ---------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 ---------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp ---------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred ---------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 11233457888999999999999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=390.80 Aligned_cols=262 Identities=27% Similarity=0.430 Sum_probs=209.5
Q ss_pred cCCccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNL--EPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|++. .+|+.||||+++.... .......+.+|+.+|+++ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 478999999999999999999984 5899999999864321 111223466799999999 69999999999877
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 56799999999986555555555579999999999999999999999999999999999999999999999999998664
Q ss_pred CCCCCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChhhh
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTE----VEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~----~~~~~~i~~~~~~~~~~~~ 325 (457)
..........+||+.|+|||++.+. ..++.++|||||||++|||++|..||..... ......+....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 282 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------- 282 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC--------
Confidence 3333334456799999999999863 3478899999999999999999999975432 22222222110
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
......+++.+.+||.+||..||.+|| |++|+|+||||+...|
T Consensus 283 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 283 ---------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 011234677889999999999999999 9999999999997543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=389.34 Aligned_cols=266 Identities=17% Similarity=0.184 Sum_probs=195.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhc--CCCCceeEe-------eeE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKL--DHPNVIKLE-------GLV 166 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l--~hpniv~l~-------~~~ 166 (457)
..+|.+.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4569999999999999999999999999999999987654 334556677885555444 699988754 444
Q ss_pred EecCC---------------ceEEEEEecccCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceeccC
Q 036122 167 TSRMS---------------CSLYLVFEYMEHDLAGLAACQGVKFSEPQV------KCYMKQLLSGLEHCHNNGVLHRDI 225 (457)
Q Consensus 167 ~~~~~---------------~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~ivHrDl 225 (457)
..... ..+|+||||++++|...+...+..+.+..+ ..++.||+.||.|||++||+||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 33221 448999999998887777655444555555 677799999999999999999999
Q ss_pred CCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 036122 226 KGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGR 304 (457)
Q Consensus 226 kp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~ 304 (457)
||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+. ..++.++|||||||++|||+||++||.+.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999866421 2245677999999999761 34899999999999999999999999876
Q ss_pred ChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 305 TEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 305 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
+.... ..+........ ............+++.+.+||.+||+.||++|||+.|+|+||||
T Consensus 297 ~~~~~-------------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 297 TPGIK-------------GSWKRPSLRVP-------GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp CTTCT-------------TCCCBCCTTSC-------CCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred Ccccc-------------cchhhhhhhhc-------cccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 43110 00000000000 00011112234678899999999999999999999999999999
Q ss_pred CC
Q 036122 385 NT 386 (457)
Q Consensus 385 ~~ 386 (457)
++
T Consensus 357 ~~ 358 (371)
T 3q60_A 357 LQ 358 (371)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=376.85 Aligned_cols=281 Identities=26% Similarity=0.375 Sum_probs=226.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC-cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC------ceeEeeeEEec
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG-KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN------VIKLEGLVTSR 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g-~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~ 169 (457)
.++|++.+.||+|+||+||+|++..++ ..||+|+++.. ......+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 478999999999999999999998777 68999999642 344567888999999997665 8899888877
Q ss_pred CCceEEEEEecccCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----------------
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI---------------- 232 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---------------- 232 (457)
...+|+||||++++++..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred -CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 56899999999988888776654 469999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH
Q 036122 233 ---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ 309 (457)
Q Consensus 233 ---~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~ 309 (457)
+.++.+||+|||+++.... ......||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+..+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5678999999999986543 234567899999999998766 79999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChhhhhhcCCCCcccC-----CCCCCcccchhcc----------cCCCCCCcHHHHHHhccCCCCCCcC
Q 036122 310 LHKIFKLCGSPSEEYWKKSKLPNATLF-----KPQQPYKRCIAET----------FKDFPSSSLPLIETLLSIDPDNRGT 374 (457)
Q Consensus 310 ~~~i~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~----------~~~~~~~~~~Li~~~L~~dP~~Rpt 374 (457)
+..+....+..+...+........... ............. ....+.++.+||.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 999999999888877654321111000 0000000000000 0111346789999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 036122 375 ATAALNSEFFNTE 387 (457)
Q Consensus 375 a~elL~hp~f~~~ 387 (457)
+.|+|+||||++.
T Consensus 328 ~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 328 LAEALLHPFFAGL 340 (355)
T ss_dssp HHHHTTSGGGGGC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=372.04 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=217.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.++++++||||+++++++.. ...+|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 368999999999999999999999999999999998665444456778899999999999999999999877 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC---CcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND---GILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~---~~vkl~DFGla~~~~~~~ 253 (457)
||||+.++.+.........+++.+++.++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~- 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence 99999875444443344579999999999999999999999999999999999999754 47999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......+|+.|+|||++.+. ++.++||||||+++|+|++|.+||.+.+..+.+..+........
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 242 (287)
T 2wei_A 178 -TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD------------ 242 (287)
T ss_dssp -SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred -CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 223445689999999998753 78999999999999999999999999888877776654221110
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...+..+++++.+||.+||+.||++|||+.|+|+||||++.
T Consensus 243 -------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 243 -------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 11234578889999999999999999999999999999763
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=373.87 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=207.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|++ +|..||||++..........+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 111 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLSI 111 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceEE
Confidence 57899999999999999999985 68899999998777677777889999999999999999999999876 456899
Q ss_pred EEecccCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 177 VFEYMEHDLAGLAACQGV---KFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
||||+.++.+..+..... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+++....
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999998865555554433 3999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~----------- 258 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL----------- 258 (309)
T ss_dssp -----------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred cc-cccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-----------
Confidence 21 2234567899999999998776 7899999999999999999999999988877766553211100
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc--CCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN--SEFFNT 386 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~--hp~f~~ 386 (457)
.....+++++.+||.+||+.||.+|||++++++ .++++.
T Consensus 259 ----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 259 ----------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 112357788999999999999999999999997 677765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=384.38 Aligned_cols=284 Identities=22% Similarity=0.319 Sum_probs=214.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.++++++||||+++++++.. ...+|+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEE
Confidence 578999999999999999999999999999999998653 45566778999999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++.+..+......+++..+..++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999998855555555555799999999999999999999996 9999999999999999999999999999755322
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCChhhhhhcC----C
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC-GSPSEEYWKKSK----L 330 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~----~ 330 (457)
......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+.... +......+.... +
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 223457899999999998766 7999999999999999999999999877665543321111 111000000000 0
Q ss_pred CCcccC-CCCCCcccc----h-----hcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 331 PNATLF-KPQQPYKRC----I-----AETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 331 ~~~~~~-~~~~~~~~~----~-----~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
...... .+....... . ......++.++.+||.+||+.||++|||++|+|+||||+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000000 000000000 0 00112356789999999999999999999999999999863
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=381.36 Aligned_cols=277 Identities=22% Similarity=0.315 Sum_probs=209.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.++++++||||+++++++.......+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 4689999999999999999999999999999999975432 223456779999999999999999999998766668899
Q ss_pred EEecccCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----cCCCcEEEeeccCcccc
Q 036122 177 VFEYMEHDLAGLAACQG---VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFY 249 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~~~ 249 (457)
||||+.++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 99999875554444332 239999999999999999999999999999999999999 78889999999999877
Q ss_pred CCCCCCCcccccccCccCchHhhhC-------CcCCCccchhhhHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLG-------ATYYGVGVDLWSAGCILAELLAGKPIMPGRT----EVEQLHKIFKLCG 318 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DvwslG~vl~elltG~~pf~~~~----~~~~~~~i~~~~~ 318 (457)
... .......||+.|+|||++.. ...++.++|||||||++|||++|..||.... ..+.+.++....
T Consensus 167 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~- 243 (319)
T 4euu_A 167 EDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK- 243 (319)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC-
T ss_pred CCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC-
Confidence 543 23345679999999999862 2348899999999999999999999997433 334444444321
Q ss_pred CCChhhhhhcC-CCCcc-cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCC
Q 036122 319 SPSEEYWKKSK-LPNAT-LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382 (457)
Q Consensus 319 ~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp 382 (457)
+...+.... ..... .+....+. .......++..+.+||++||+.||++|||++|+|+||
T Consensus 244 --p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 244 --PSGAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp --CTTCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred --CcccchhhhcccCCccccCccCCc---ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 111111100 00000 00000000 0011122345678899999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=396.23 Aligned_cols=251 Identities=18% Similarity=0.255 Sum_probs=199.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHH---HHHHhcCCCCceeEe-------ee
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREI---LVLRKLDHPNVIKLE-------GL 165 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~---~~l~~l~hpniv~l~-------~~ 165 (457)
.++|.+.+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+ .+|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 5789999999999999999999988999999999986532 344567788999 555566899999998 55
Q ss_pred EEecCC----------c-----eEEEEEecccCCHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCceec
Q 036122 166 VTSRMS----------C-----SLYLVFEYMEHDLAGLAACQGVKFS-------EPQVKCYMKQLLSGLEHCHNNGVLHR 223 (457)
Q Consensus 166 ~~~~~~----------~-----~~~lv~E~~~~~l~~~~~~~~~~l~-------~~~~~~i~~qi~~~L~~LH~~~ivHr 223 (457)
+..... . ..|+||||+++++...+.... .++ +..+..|+.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 554211 0 378999999887776665432 244 48888899999999999999999999
Q ss_pred cCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCC----------cCCCccchhhhHHHHHHH
Q 036122 224 DIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA----------TYYGVGVDLWSAGCILAE 293 (457)
Q Consensus 224 Dlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DvwslG~vl~e 293 (457)
||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. ..++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999999999999999986432 3345677 999999999876 238999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc
Q 036122 294 LLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG 373 (457)
Q Consensus 294 lltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp 373 (457)
|++|++||.+.+....... +......+++++.+||.+||+.||++||
T Consensus 306 lltg~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 306 IWCADLPITKDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHSSCCC------CCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred HHHCCCCCcccccccchhh---------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCC
Confidence 9999999976543221111 1112246788999999999999999999
Q ss_pred CHHHHhcCCCCCC
Q 036122 374 TATAALNSEFFNT 386 (457)
Q Consensus 374 ta~elL~hp~f~~ 386 (457)
|+.|+|+||||++
T Consensus 353 t~~e~l~hp~f~~ 365 (377)
T 3byv_A 353 LPLQAMETPEYEQ 365 (377)
T ss_dssp CHHHHHTSHHHHH
T ss_pred CHHHHhhChHHHH
Confidence 9999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=374.94 Aligned_cols=269 Identities=25% Similarity=0.362 Sum_probs=192.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|++..+++.||||++..... ......+.+|+.++++++||||+++++++.. ...+|+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES--SSCEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEE
Confidence 5789999999999999999999888999999999865432 2334567889999999999999999999987 457899
Q ss_pred EEecccCCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 177 VFEYMEHDLAGLAAC--------QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 177 v~E~~~~~l~~~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
||||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 999998754433332 245699999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCC----CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 249 YDPGLK----QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 249 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||...+................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 247 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL--- 247 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT---
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc---
Confidence 643211 1123457899999999997644478999999999999999999999988776555443322110000
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
............+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 248 ----------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 248 ----------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp ----------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred ----------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00001112345678889999999999999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=370.14 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=209.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEE
Confidence 478999999999999999999999999999999987543 2345678899999999999999999999887 567999
Q ss_pred EEecccCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++.+.. +......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 999998865544 44445679999999999999999999999999999999999999999999999999976432110 1
Q ss_pred CcccccccCccCchHhhh----CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 256 PMTSRVVTLWYRPPELLL----GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~----~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
......||+.|+|||++. ....++.++|||||||++|+|++|.+||...+....+..+.......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 241 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT----------- 241 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc-----------
Confidence 123457899999999984 33447899999999999999999999999888777666554321000
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++..+.+||.+||+.||++|||+.++|+||||+..
T Consensus 242 ---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 ---------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp ---------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ---------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 00112357788999999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=379.05 Aligned_cols=283 Identities=29% Similarity=0.473 Sum_probs=221.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----------CCCceeEeee
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-----------HPNVIKLEGL 165 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~ 165 (457)
.++|.+.+.||+|+||+||+|++..+++.||||++... ......+.+|+.++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 47899999999999999999999999999999999643 344566788999999886 8999999999
Q ss_pred EEecC--CceEEEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEec------CC
Q 036122 166 VTSRM--SCSLYLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLID------ND 235 (457)
Q Consensus 166 ~~~~~--~~~~~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~------~~ 235 (457)
+.... ...+++||||+++++...+... ...+++..++.++.||+.||.|||++ ||+||||||+||||+ ..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 87632 2368999999977777766553 34599999999999999999999998 999999999999994 44
Q ss_pred CcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC------hHHH
Q 036122 236 GILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQ 309 (457)
Q Consensus 236 ~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~------~~~~ 309 (457)
+.+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||+||.+||.+.+ ..+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 58999999999876432 34457899999999998876 7999999999999999999999998654 5677
Q ss_pred HHHHHHhcCCCChhhhhhcCCCCc-----ccCCCC-----CCcccchhc---ccCCCCCCcHHHHHHhccCCCCCCcCHH
Q 036122 310 LHKIFKLCGSPSEEYWKKSKLPNA-----TLFKPQ-----QPYKRCIAE---TFKDFPSSSLPLIETLLSIDPDNRGTAT 376 (457)
Q Consensus 310 ~~~i~~~~~~~~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~~---~~~~~~~~~~~Li~~~L~~dP~~Rpta~ 376 (457)
+.++...++.++...+........ ...... .+....... ....+++++.+||.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 888888899888776554321100 000000 000000010 0112346788999999999999999999
Q ss_pred HHhcCCCCCCC
Q 036122 377 AALNSEFFNTE 387 (457)
Q Consensus 377 elL~hp~f~~~ 387 (457)
|+|+||||++.
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 99999999974
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=366.04 Aligned_cols=257 Identities=29% Similarity=0.448 Sum_probs=217.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
...|++.+.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEE
Confidence 46799999999999999999999999999999999865433 345678899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
||||++++.+..+... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 175 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 175 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CC
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cc
Confidence 9999998655555543 469999999999999999999999999999999999999999999999999998764332 22
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.......+.... +
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---------------- 236 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P---------------- 236 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C----------------
T ss_pred cCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C----------------
Confidence 34567899999999998766 7899999999999999999999999887766655543210 0
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 237 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 ----------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ----------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 01123467789999999999999999999999999999763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=370.15 Aligned_cols=261 Identities=27% Similarity=0.450 Sum_probs=207.9
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC----
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM---- 170 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~---- 170 (457)
..++|++.+.||+|+||.||+|++..+|+.||||++...... ...+.+|+.+++++ +||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 368899999999999999999999999999999999765322 35578899999999 7999999999987643
Q ss_pred CceEEEEEecccCC-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 171 SCSLYLVFEYMEHD-LAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 171 ~~~~~lv~E~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
...+|+||||++++ +...+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCcee
Confidence 45789999999874 44444332 24699999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
..... .......||+.|+|||++.+ ...++.++|||||||++|+|++|.+||...+....+..+.....
T Consensus 179 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------ 251 (326)
T 2x7f_A 179 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA------ 251 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------
T ss_pred cCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------
Confidence 64321 12344578999999999863 23478999999999999999999999988877666555432110
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
+ ......+++.+.+||.+||..||.+|||++++|+||||+..
T Consensus 252 ------~---------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 252 ------P---------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ------C---------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ------c---------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0 00123467889999999999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=366.81 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=209.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.++++++||||+++++++.. ...+|+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 101 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWI 101 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 5789999999999999999999999999999999976532 2457889999999999999999999987 567999
Q ss_pred EEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++ +...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-A 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-S
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-c
Confidence 99999884 444444456679999999999999999999999999999999999999999999999999998664332 2
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+..... +
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--------------- 243 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-P--------------- 243 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C---------------
T ss_pred ccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-c---------------
Confidence 234457899999999998766 78999999999999999999999998776655544322100 0
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. ......+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 ---~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 244 ---T-------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp ---C-------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred ---c-------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0 00112357788999999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=369.36 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=198.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||.||+|++..+|+.||||++............+..+..+++.++||||+++++++.. ...+|+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 101 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFI 101 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEE
Confidence 578999999999999999999999999999999998765444444555566677888999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+++.+..........+++..++.++.||+.||.|||++ ||+|+||||+|||++.++.+||+|||++...... .
T Consensus 102 v~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~ 179 (318)
T 2dyl_A 102 AMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--K 179 (318)
T ss_dssp EECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--c
Confidence 999996655555555566799999999999999999999995 9999999999999999999999999999766433 2
Q ss_pred CcccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 256 PMTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
......||+.|+|||++.+ ...++.++|||||||++|+|++|..||... +..+.+..+......
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 248 (318)
T 2dyl_A 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP----------- 248 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-----------
T ss_pred cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-----------
Confidence 2344578999999999852 334788999999999999999999999874 444555555432100
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.......+++++.+||.+||+.||.+|||++++|+||||+.
T Consensus 249 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 249 ---------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ---------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ---------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 00112347788999999999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=365.89 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=201.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec-------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR------- 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------- 169 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++... ......+.+|+.++++++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 36799999999999999999999999999999999642 34557788999999999999999999988652
Q ss_pred ----CCceEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 170 ----MSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 170 ----~~~~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
....+|+||||+++ ++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 13568999999987 5555555455568999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCC-------------CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHH
Q 036122 245 LATFYDPGL-------------KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQL 310 (457)
Q Consensus 245 la~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~-~~~~~~ 310 (457)
++....... ........||+.|+|||++.+...++.++|||||||++|+|++ ||... +..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 998654221 1223445789999999999876558999999999999999998 44432 222333
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
..+.......+ .......++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 239 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 KKLRSVSIEFP-------------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHSTTCCCC-------------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HhccccccccC-------------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 33321100000 0111234556899999999999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=362.42 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=205.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.. ......+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 84 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNF 84 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEE
Confidence 4789999999999999999999999999999998853 355667789999999999999999999999987 567999
Q ss_pred EEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+.++.+ ..+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 9999988544 444444678999999999999999999999999999999999999999999999999999876433221
Q ss_pred C-------------cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 256 P-------------MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 256 ~-------------~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
. .....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~----------- 232 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF----------- 232 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------
Confidence 1 12457899999999998766 7999999999999999999999886532110000
Q ss_pred hhhhhcCCCCcccCCCCCCccc-chhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 323 EYWKKSKLPNATLFKPQQPYKR-CIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
...... ........+++.+.+||.+||+.||++|||+.++++
T Consensus 233 ----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 ----------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ----------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000000 001123568899999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=378.07 Aligned_cols=274 Identities=22% Similarity=0.369 Sum_probs=213.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh---------------HHHHHHHHHHHHHHhcCCCCcee
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP---------------ESVKFMAREILVLRKLDHPNVIK 161 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hpniv~ 161 (457)
.++|.+.+.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 57899999999999999999997 99999999997542211 11267889999999999999999
Q ss_pred EeeeEEecCCceEEEEEecccCCHHHHH------Hhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEe
Q 036122 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLA------ACQ--GVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLI 232 (457)
Q Consensus 162 l~~~~~~~~~~~~~lv~E~~~~~l~~~~------~~~--~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl 232 (457)
+++++.. ...+|+||||++++.+..+ ... ...+++..++.++.||+.||.|||+ +||+|+||||+|||+
T Consensus 108 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999987 5689999999998544333 222 5679999999999999999999999 999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCc-cchhhhHHHHHHHHHhCCCCCCCCCh-HHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGV-GVDLWSAGCILAELLAGKPIMPGRTE-VEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~~DvwslG~vl~elltG~~pf~~~~~-~~~~ 310 (457)
+.++.+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|.+||...+. .+..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999876432 3345678999999999987744555 99999999999999999999998776 5555
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..+.......+.. ......+. ...........+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 263 ~~i~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 263 NNIRTKNIEYPLD--------RNHFLYPL--TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHTSCCCCCCCS--------SSSSTTTT--CC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHhccCcCCccc--------hhhhhccc--cccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 5553321111100 00000000 0001112235678899999999999999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=371.75 Aligned_cols=262 Identities=19% Similarity=0.276 Sum_probs=193.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc-
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC- 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~- 172 (457)
.++|++.+.||+|+||.||+|++..++. .||||++..........+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 5789999999999999999999876665 899999987665566678899999999999999999999998763221
Q ss_pred ---eEEEEEecccCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeec
Q 036122 173 ---SLYLVFEYMEHDLAGLAACQ------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 173 ---~~~lv~E~~~~~l~~~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
..++||||+.++.+..+... ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Df 181 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADF 181 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeec
Confidence 24899999998544433322 125999999999999999999999999999999999999999999999999
Q ss_pred cCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 036122 244 GLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPS 321 (457)
Q Consensus 244 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~ 321 (457)
|+++....... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 182 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~--- 257 (323)
T 3qup_A 182 GLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR--- 257 (323)
T ss_dssp CC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred cccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC---
Confidence 99986643321 1223345688999999998766 7999999999999999999 8999999888777666543210
Q ss_pred hhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-------HHHHhcCCCCCCC
Q 036122 322 EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-------ATAALNSEFFNTE 387 (457)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-------a~elL~hp~f~~~ 387 (457)
......+++++.+||.+||+.||++||| +++++.|||+...
T Consensus 258 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 -------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 0112346788999999999999999999 8999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=359.60 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=209.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 82 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 82 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEE
Confidence 468999999999999999999975 67789999997654333 457899999999999999999999877 566899
Q ss_pred EEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++.+ ..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 9999987544 444455567999999999999999999999999999999999999999999999999999876543222
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred cccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------------
Confidence 334456688899999998666 7999999999999999999 99999998888877766442110
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+++.+.+||.+||+.||++|||+.++++|
T Consensus 227 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 -------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0112357788999999999999999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=368.25 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=208.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||.||+|.+..++. .||||++.... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCc
Confidence 5789999999999999999999886655 59999997543 45556778999999999999999999999876 567
Q ss_pred EEEEEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+|+||||++++.+ ..+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 8999999987544 444445567999999999999999999999999999999999999999999999999999877543
Q ss_pred CCCC--cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 253 LKQP--MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 253 ~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......+
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 274 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--------- 274 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------
T ss_pred ccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---------
Confidence 2222 22234578899999998766 7899999999999999999 999999988888777764421110
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....+++.+.+||..||..||.+|||+.++++
T Consensus 275 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 -------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12347788999999999999999999999984
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=374.67 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=207.2
Q ss_pred cCCccccceeeccCceEEEEEEEc-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-------LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-------~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 168 (457)
.++|.+.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.+|+.+ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 478999999999999999999874 345679999997553 445567789999999999 89999999999876
Q ss_pred cCCceEEEEEecccCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 169 RMSCSLYLVFEYMEHDLAGLAACQG----------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
...+|+||||+.++.+..+.... ..+++.++..++.||+.||.|||++||+||||||+||||
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 55789999999885444443322 348999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999986643322 2223446688999999998766 8999999999999999999 99999988776666
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+..... ......+++++.+||.+||+.||.+|||+.|++++
T Consensus 316 ~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 55432110 01123467789999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=363.91 Aligned_cols=252 Identities=22% Similarity=0.217 Sum_probs=206.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++++ +||||+++++++.. ....|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccE
Confidence 36899999999999999999999999999999999765432 2477899999999 89999999999887 56789
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc-----EEEeeccCccccC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI-----LKIADFGLATFYD 250 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-----vkl~DFGla~~~~ 250 (457)
+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 82 lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 82 MVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred EEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99999966777766655668999999999999999999999999999999999999998887 9999999998764
Q ss_pred CCCCC------CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCC
Q 036122 251 PGLKQ------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT---EVEQLHKIFKLCGSPS 321 (457)
Q Consensus 251 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~---~~~~~~~i~~~~~~~~ 321 (457)
..... ......||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+ ..+.+..+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC
Confidence 33211 124568999999999998766 7999999999999999999999998754 3334444432211111
Q ss_pred hhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 322 EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......+| ++.+||..||+.||.+||+++++++
T Consensus 241 ------------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 ------------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ------------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111223455 8999999999999999999988876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=357.91 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=204.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|.....||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 97 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIF 97 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEE
Confidence 45666679999999999999999999999999997653 3344668899999999999999999999987 5679999
Q ss_pred EecccCCHHHH-HHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-CCcEEEeeccCccccCCCC
Q 036122 178 FEYMEHDLAGL-AACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLATFYDPGL 253 (457)
Q Consensus 178 ~E~~~~~l~~~-~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~~~~~~ 253 (457)
|||++++.+.. +.... ..+++..++.++.||+.||.|||++||+|+||||+|||++. ++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99998654444 43332 34679999999999999999999999999999999999987 8999999999998764321
Q ss_pred CCCcccccccCccCchHhhhCC-cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......||+.|+|||++.+. ..++.++|||||||++|+|++|..||..................
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------- 243 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC-------------
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc-------------
Confidence 223445789999999999754 23688999999999999999999999765433221111110000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.......+++++.+||.+||+.||++|||++++|+||||+..
T Consensus 244 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 -------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 001123467889999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=355.79 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=208.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+. ++..||+|++....... ..+.+|+.++++++||||+++++++.. ...+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEcc--CCceEE
Confidence 578999999999999999999864 67789999997654332 457899999999999999999999876 567899
Q ss_pred EEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++ +...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999875 55555544556999999999999999999999999999999999999999999999999999876544332
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+|+.|+|||++.+.. ++.++||||||+++|+|++ |.+||...+..+....+.......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 225 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY-------------- 225 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred cccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCC--------------
Confidence 333445678899999998766 7899999999999999999 999999988887776654321100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 226 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 226 --------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112356778999999999999999999999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=358.94 Aligned_cols=250 Identities=20% Similarity=0.318 Sum_probs=205.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|.+. ++..||+|++....... +.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEec--CCCeEE
Confidence 478999999999999999999864 67789999998654332 457899999999999999999999876 567899
Q ss_pred EEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+.++ +...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp EECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999875 44444443567999999999999999999999999999999999999999999999999999876443222
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+|+.|+|||++.+.. ++.++|||||||++|+|+| |+.||...+..+....+.......
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 241 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------------- 241 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC--------------
T ss_pred cccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC--------------
Confidence 233445688899999998766 7999999999999999998 999999988887777765421110
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
....+++.+.+||.+||+.||.+|||+.++|+|
T Consensus 242 --------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 242 --------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 112356788999999999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.16 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=208.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.+ +|+||+++++++.. ....|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 82 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNV 82 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeE
Confidence 46899999999999999999999999999999998754322 3367899999999 79999999998876 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc-----EEEeeccCccccC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI-----LKIADFGLATFYD 250 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~-----vkl~DFGla~~~~ 250 (457)
+||||+++++...+...+..+++.++..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 83 lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 83 LVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999966777776665667999999999999999999999999999999999999987776 9999999998765
Q ss_pred CCCC------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCC
Q 036122 251 PGLK------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR---TEVEQLHKIFKLCGSPS 321 (457)
Q Consensus 251 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~---~~~~~~~~i~~~~~~~~ 321 (457)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+. +..+.+..+......++
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 4322 1234567899999999998766 799999999999999999999999874 34444444433211111
Q ss_pred hhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 322 EEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......+++++.+||.+||+.||++|||++++++
T Consensus 242 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 ------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 12233468889999999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=377.09 Aligned_cols=258 Identities=20% Similarity=0.324 Sum_probs=210.2
Q ss_pred cCCccccceeeccCceEEEEEE-----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKAR-----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~-----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||+||+|+ +..++..||||++.... .......+.+|+.++++++||||+++++++.. .
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--S 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--C
Confidence 4789999999999999999999 44577899999997433 44555678899999999999999999999876 4
Q ss_pred ceEEEEEecccC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC---cEEEe
Q 036122 172 CSLYLVFEYMEH-DLAGLAACQG------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG---ILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~-~l~~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~---~vkl~ 241 (457)
...|+||||+.+ +|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 567999999977 5555444332 3599999999999999999999999999999999999999555 59999
Q ss_pred eccCccccCCC-CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 036122 242 DFGLATFYDPG-LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 242 DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
|||+++..... .........||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999855221 122234456799999999998766 8999999999999999998 99999999888877766442110
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....+++.+.+||.+||+.||++|||+.++++|.++-.
T Consensus 306 ----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 306 ----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 112346778999999999999999999999999987743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=373.09 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=205.8
Q ss_pred cCCccccceeeccCceEEEEEE-----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKAR-----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~-----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|+ +..+++.||||+++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 5789999999999999999998 45677899999997543 445556789999999999 799999999998764
Q ss_pred CceEEEEEecccCCHHHHHHhcCC--------------------------------------------------------
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGV-------------------------------------------------------- 194 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~-------------------------------------------------------- 194 (457)
...+++||||+.++.+..+.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 345899999999854444443322
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC-CCccccccc
Q 036122 195 ----------KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK-QPMTSRVVT 263 (457)
Q Consensus 195 ----------~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt 263 (457)
.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ .......||
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 189999999999999999999999999999999999999999999999999986643322 223345678
Q ss_pred CccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCc
Q 036122 264 LWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPY 342 (457)
Q Consensus 264 ~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (457)
+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+....+.+.........+
T Consensus 259 ~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 315 (359)
T 3vhe_A 259 LKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------- 315 (359)
T ss_dssp GGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------
T ss_pred ceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC----------------------
Confidence 9999999998766 7999999999999999998 999998876554444433321100
Q ss_pred ccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 343 KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 343 ~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+++++.+||.+||+.||.+|||+.|+++|
T Consensus 316 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 -----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1123467789999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=365.81 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=188.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHH-HHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREIL-VLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... ......+..|+. +++.++||||+++++++.. ....|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~ 97 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCW 97 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceE
Confidence 5789999999999999999999999999999999986543 333344555555 7778899999999999987 56799
Q ss_pred EEEecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 176 LVFEYMEHDLAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCHNN-GVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
+||||+.+++...+.. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9999999977665542 256799999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCCCcccccccCccCchHhhh---CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhh
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLL---GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~ 326 (457)
.. .......||+.|+|||++. ....++.++|||||||++|+|++|..||.+.+.. +.+..+..
T Consensus 178 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------- 244 (327)
T 3aln_A 178 DS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK----------- 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC-----------
T ss_pred cc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc-----------
Confidence 33 1223447899999999984 2233789999999999999999999999764321 11110000
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
...+ .........+++.+.+||.+||+.||++|||+.++|+||||..
T Consensus 245 --------~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 245 --------GDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp --------SCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred --------CCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 0000 0001122457888999999999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=357.53 Aligned_cols=252 Identities=20% Similarity=0.327 Sum_probs=196.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEcc---Cc
Confidence 47899999999999999999998654 4579999986542 44556778899999999999999999998743 45
Q ss_pred EEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+|+||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 79999999874 55555445557999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.........+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------------- 235 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------------- 235 (281)
T ss_dssp ---------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------------
T ss_pred cccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-------------
Confidence 322333445688999999998666 7899999999999999997 9999998887776666543110
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......+++.+.+||.+||+.||++|||+.|++++
T Consensus 236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 ---------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ---------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123577889999999999999999999999853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=370.40 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=207.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----ESVKFMAREILVLRKLD--HPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.++++++ |+||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 578999999999999999999999999999999997654321 12234667999999996 5999999999987
Q ss_pred CceEEEEEecccC--CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-CCCcEEEeeccCcc
Q 036122 171 SCSLYLVFEYMEH--DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLAT 247 (457)
Q Consensus 171 ~~~~~lv~E~~~~--~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla~ 247 (457)
...+++||||+.+ ++...+. ....+++..++.++.||+.||.|||++||+||||||+||||+ +++.+||+|||++.
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCcEEEEEEcCCCCccHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 5679999999974 4555444 445799999999999999999999999999999999999999 78999999999998
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
..... ......||+.|+|||++.+...++.++|||||||++|||++|..||...+. +... .
T Consensus 199 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~-------- 259 (320)
T 3a99_A 199 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q-------- 259 (320)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C--------
T ss_pred ccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c--------
Confidence 76532 234567899999999998777567899999999999999999999965321 1110 0
Q ss_pred cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus 260 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 260 -------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp -------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred -------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 00113477889999999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=374.39 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=208.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||.||+|++..+++.||||+++.. ........+.+|+.+|++++||||+++++++.. ...+|+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEE
Confidence 57899999999999999999999889999999998754 344555678899999999999999999999976 456899
Q ss_pred EEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+++ ++...+...+..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++........
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence 9999986 455555555556999999999999999999999999999999999999999999999999999865432111
Q ss_pred C-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 256 P-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 256 ~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
. .....+++.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+......
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 334 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-------------- 334 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC--------------
T ss_pred ecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1 11223577899999998766 7999999999999999998 99999998877766555321100
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+|+++.+||.+||+.||++|||++++++
T Consensus 335 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 --------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 011236778899999999999999999999984
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.55 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=199.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ...+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLY 110 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEE
Confidence 4789999999999999999999999999999999976533 34445778899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999998555545444557999999999999999999999999999999999999999999999999999876544333
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+.......+ ......
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~--------------- 253 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPR--------------- 253 (309)
T ss_dssp ------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCC---------------
T ss_pred cccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCC---------------
Confidence 344567899999999998765 789999999999999999999999887655333222 211000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-CHHHHhc
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-TATAALN 380 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-ta~elL~ 380 (457)
.......+|+++.+||.+||+.||++|| |++++++
T Consensus 254 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1122356888999999999999999999 7888774
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.57 Aligned_cols=260 Identities=26% Similarity=0.390 Sum_probs=205.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC--CCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD--HPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++.+.||+|+||.||+|.+ .+++.||||++............+.+|+.++++++ |+||+++++++.. ...+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEE
T ss_pred cceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEE
Confidence 56799999999999999999987 46899999999887767777788999999999997 5999999999877 5679
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
|+|||+..+++...+.. ...+++.+++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++........
T Consensus 104 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred EEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 99999777677666554 457999999999999999999999999999999999999964 8999999999987643322
Q ss_pred C-CcccccccCccCchHhhhCC----------cCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCh
Q 036122 255 Q-PMTSRVVTLWYRPPELLLGA----------TYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLHKIFKLCGSPSE 322 (457)
Q Consensus 255 ~-~~~~~~gt~~y~aPE~l~~~----------~~~~~~~DvwslG~vl~elltG~~pf~~~~~~-~~~~~i~~~~~~~~~ 322 (457)
. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+......
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--- 258 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--- 258 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC---
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc---
Confidence 1 22345789999999998752 34788999999999999999999999865433 233222210000
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.......++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 259 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 259 ------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp ------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ------------------------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 001122456789999999999999999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=365.24 Aligned_cols=253 Identities=23% Similarity=0.335 Sum_probs=208.2
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||.||+|++. .+++.||||+++... .......+.+|+.++++++||||+++++++.. .
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 122 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 122 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--C
Confidence 578999999999999999999986 355899999997543 45556778999999999999999999999876 5
Q ss_pred ceEEEEEecccCCHHHHHHhc------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ------------------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKG 227 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 227 (457)
..+|+||||++++.+..+... ...+++.+++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 678999999987544443332 15699999999999999999999999999999999
Q ss_pred CCEEecCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 036122 228 SNLLIDNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRT 305 (457)
Q Consensus 228 ~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~ 305 (457)
+|||++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|+| |..||.+.+
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999999986543211 2223456789999999998766 7999999999999999999 999999988
Q ss_pred hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 306 EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 306 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+....+..... ......+++++.+||.+||+.||.+|||+.+++++
T Consensus 282 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 282 HEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 8777666543110 01123467789999999999999999999999853
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=349.52 Aligned_cols=249 Identities=17% Similarity=0.212 Sum_probs=209.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|++ +|+.||+|++..........+.+.+|+.++++++||||+++++++.......+++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 47899999999999999999996 4889999999887767777788999999999999999999999998755577899
Q ss_pred EEecccCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 177 VFEYMEHDLAGLAACQGV--KFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
||||++++.+..+..... .+++.+++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-- 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-- 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS--
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec--
Confidence 999999754444444433 5899999999999999999999999 9999999999999999999999999876432
Q ss_pred CCCCcccccccCccCchHhhhCCcC--CCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATY--YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~--~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
.....||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 230 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP---------- 230 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC----------
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC----------
Confidence 234578999999999987542 2337999999999999999999999888877766554321110
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++++.+||.+||+.||++|||++++++
T Consensus 231 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 -----------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112347788999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.89 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=199.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhc----CCCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----ESVKFMAREILVLRKL----DHPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l----~hpniv~l~~~~~~ 168 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++....... .....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 478999999999999999999999999999999997654322 1223455799999998 89999999999876
Q ss_pred cCCceEEEEEec-ccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec-CCCcEEEeeccCc
Q 036122 169 RMSCSLYLVFEY-MEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLA 246 (457)
Q Consensus 169 ~~~~~~~lv~E~-~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~-~~~~vkl~DFGla 246 (457)
....++|||| +.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 110 --~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 --QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred --CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 4568999999 66544444444455799999999999999999999999999999999999999 8899999999999
Q ss_pred cccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 247 TFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
...... ......||..|+|||++.+...++.++|||||||++|+|++|+.||.... .+....
T Consensus 188 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~--------- 249 (312)
T 2iwi_A 188 ALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAE--------- 249 (312)
T ss_dssp EECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTC---------
T ss_pred hhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhc---------
Confidence 876543 23456789999999999877655678999999999999999999996532 111100
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 250 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 250 --------------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred --------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 00113467788999999999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=367.51 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=209.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-------GKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-------g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 168 (457)
.++|.+.+.||+|+||+||+|++..+ +..||||++... ........+.+|+.+++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47899999999999999999997543 357999999765 3455567788999999999 89999999999877
Q ss_pred cCCceEEEEEecccCCHH-HHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 169 RMSCSLYLVFEYMEHDLA-GLAACQG---------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~-~~~~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
...+|+||||+.++.+ ..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 5568999999987544 4443332 359999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||+++....... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987643321 2233456789999999998766 7999999999999999999 99999998887776
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+...... .....+++++.+||.+||+.||++|||+.|++++
T Consensus 304 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 304 KLLKEGHRM----------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHTTCCC----------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 665432100 1123467889999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=368.01 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=179.2
Q ss_pred cCCccccc-eeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec--CCce
Q 036122 97 ANTFEKLD-KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR--MSCS 173 (457)
Q Consensus 97 ~~~y~~~~-~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~ 173 (457)
.++|.+.+ .||+|+||+||+|++..+|+.||||++... ... .......++.++||||+++++++... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 57899966 599999999999999999999999999643 121 22233446677999999999998652 2345
Q ss_pred EEEEEecccCC-HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCccc
Q 036122 174 LYLVFEYMEHD-LAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATF 248 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~ 248 (457)
+|+||||+.++ +...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 89999999884 544444332 36999999999999999999999999999999999999986 45699999999986
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...........+.......
T Consensus 181 ~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------- 248 (336)
T 3fhr_A 181 TTQN---ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG-------- 248 (336)
T ss_dssp C-------------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred cccc---ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc--------
Confidence 5432 234567899999999987665 7899999999999999999999998765543322211110000
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. .......+..+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 249 ---~----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 249 ---Q----------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ---c----------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0 000111234578889999999999999999999999999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=363.86 Aligned_cols=252 Identities=22% Similarity=0.296 Sum_probs=203.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcE----EEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKI----VALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~----vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++.+.||+|+||+||+|++..+++. ||+|.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~ 87 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---S 87 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---S
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---C
Confidence 47899999999999999999999888876 7777765432 22223446689999999999999999998864 4
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..++||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 589999999864 5454544445799999999999999999999999999999999999999999999999999997754
Q ss_pred CCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.... ......+|..|+|||++.+.. ++.++|||||||++|+|+| |..||.+.+..+....+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~----------- 235 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER----------- 235 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-----------
T ss_pred ccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------
Confidence 4322 234456788999999998766 7999999999999999999 9999998877666555532110
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......++.++.+||.+||+.||.+|||+.++++|
T Consensus 236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 -----------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp -----------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred -----------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01112367789999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=359.96 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=207.4
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 98 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--D 98 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--C
Confidence 478999999999999999999873 456899999997543 45566778999999999999999999999876 5
Q ss_pred ceEEEEEecccCCHHHHHHhcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQG------------------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKG 227 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 227 (457)
..+|+||||+.++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 5689999999865444444332 2389999999999999999999999999999999
Q ss_pred CCEEecCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 036122 228 SNLLIDNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRT 305 (457)
Q Consensus 228 ~NILl~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~ 305 (457)
+|||++.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999986643321 1223345688999999998766 7899999999999999999 999999887
Q ss_pred hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 306 EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 306 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+....+..... ......+++++.+||.+||+.||++|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHR----------------------------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCc----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7665554432110 01123577889999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=357.99 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=200.6
Q ss_pred cCCccccceeeccCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 4789999999999999999998 5678999999998743 455567789999999999999999999998765455
Q ss_pred eEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
.+++||||+++ ++...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 68999999977 45555544455699999999999999999999999999999999999999999999999999987643
Q ss_pred CCC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......+|..|+|||++.+.. ++.++|||||||++|+|+||..||...... .. ...+...........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-~~----~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE-FM----RMIGNDKQGQMIVFH 240 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-HH----HHHCTTCCTHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH-HH----hhhcCccccchhHHH
Confidence 321 1223345678899999998766 799999999999999999999988654221 11 111111000000000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
...... . .........+++++.+||.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~--~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLK--N-----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHH--T-----TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHh--c-----cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000000 0 0000112357788999999999999999999999984
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=354.06 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=196.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|++. ..||+|+++.........+.+.+|+.++++++||||++++++... ..+++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~l 96 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 96 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC---CccEE
Confidence 478999999999999999999743 359999998777677777889999999999999999999996543 45799
Q ss_pred EEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC-CC
Q 036122 177 VFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG-LK 254 (457)
Q Consensus 177 v~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~-~~ 254 (457)
||||+.++.+ ..+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred EEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 9999987544 444445567999999999999999999999999999999999999999999999999999865432 12
Q ss_pred CCcccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 245 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP----------- 245 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-----------
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-----------
Confidence 22344578999999999862 33378899999999999999999999998776665555443211100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.+......+++.+.+||.+||+.||.+|||+.++++
T Consensus 246 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 ------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 011223457788999999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=354.19 Aligned_cols=246 Identities=18% Similarity=0.227 Sum_probs=200.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG-------KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g-------~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 169 (457)
.++|.+.+.||+|+||+||+|++..++ ..||+|++... .....+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-
Confidence 578999999999999999999988777 47999998653 23445678899999999999999999999987
Q ss_pred CCceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc--------EEE
Q 036122 170 MSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI--------LKI 240 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~--------vkl 240 (457)
....|+||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++. +||
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred -CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 45679999999864 54544444445999999999999999999999999999999999999998887 999
Q ss_pred eeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCC
Q 036122 241 ADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 241 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++| .+||...+........ ...
T Consensus 163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~~-- 234 (289)
T 4fvq_A 163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-EDR-- 234 (289)
T ss_dssp CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HTT--
T ss_pred ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hcc--
Confidence 99999975432 23356789999999998755589999999999999999995 5666555554433322 110
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.......++++.+||.+||+.||.+|||+.++++|
T Consensus 235 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 ---------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ---------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01112357889999999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=368.60 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=196.7
Q ss_pred cCCccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCc
Confidence 468999999999999999999876 467789999997643 45556778999999999999999999999876 567
Q ss_pred EEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+|+||||++++ +...+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 89999999765 54444444557999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcc--cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 253 LKQPMT--SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 253 ~~~~~~--~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
...... ...+|+.|+|||++.+.. ++.++|||||||++|||++ |..||...+..+....+......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~---------- 269 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL---------- 269 (373)
T ss_dssp -------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC----------
T ss_pred CccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 222111 223477899999998766 7999999999999999998 99999988887776665432110
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 270 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 ------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 011246778899999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=349.33 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=195.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC--hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE--PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
.++|++.+.||+|+||.||+|.+ +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 81 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNL 81 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--C
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCce
Confidence 47899999999999999999986 4889999998765332 2335678899999999999999999999877 4568
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCCCCEEecC--------CCcEEEeec
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG---VLHRDIKGSNLLIDN--------DGILKIADF 243 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NILl~~--------~~~vkl~DF 243 (457)
|+||||++++.+..+.. ...+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999998876665554 447999999999999999999999999 899999999999986 778999999
Q ss_pred cCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 244 GLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
|++....... .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+.......+......
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---- 232 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA---- 232 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC----
T ss_pred Cccccccccc---ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC----
Confidence 9998664332 23457899999999998766 799999999999999999999999988877665554321100
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 -----------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 01123467789999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=350.49 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=206.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.++|++++..+.++... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEE
Confidence 57899999999999999999999999999999998765433 2477899999999998887777666543 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---cCCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~ 253 (457)
||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999777777776566689999999999999999999999999999999999999 488899999999998765432
Q ss_pred CC------CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhh
Q 036122 254 KQ------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 254 ~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~~ 324 (457)
.. ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+. .+.+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 21 124567899999999998766 79999999999999999999999986432 223333322111110
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......+|+++.+||.+||+.||++|||++++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11223457889999999999999999999999885
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=354.04 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=209.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+..++..||+|++..+. ...+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 86 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 86 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCEEE
Confidence 578999999999999999999999999999999997543 345668899999999999999999999876 567899
Q ss_pred EEecccC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEH-DLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~-~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+.+ ++...+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 9999996 454444432 34599999999999999999999999999999999999999999999999999987754433
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......+|+.|+|||++.+.. ++.++||||||+++|+|++ |.+||.+.+.......+.....
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~--------------- 230 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------------- 230 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------
T ss_pred ccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC---------------
Confidence 3334455688999999998766 7999999999999999999 9999998877666555432110
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+++.+.+||.+||..||.+|||++++++
T Consensus 231 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 -------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 0112346788999999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=351.36 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=202.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHH-----HHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESV-----KFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~-----~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||+||+|++..+++.||+|++.......... +.+.+|+.++++++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 478999999999999999999999999999999997654332211 5788999999999999999999988652
Q ss_pred ceEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEecCCCc-----EEEeec
Q 036122 172 CSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLIDNDGI-----LKIADF 243 (457)
Q Consensus 172 ~~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~-----vkl~DF 243 (457)
.++||||+.+ ++...+......+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+||
T Consensus 96 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 --PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp --TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred --CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 2799999985 555666666668999999999999999999999999 999999999999988776 999999
Q ss_pred cCccccCCCCCCCcccccccCccCchHhhhC-CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCC
Q 036122 244 GLATFYDPGLKQPMTSRVVTLWYRPPELLLG-ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ--LHKIFKLCGSP 320 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~--~~~i~~~~~~~ 320 (457)
|+++.... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.... ...+... +.
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~- 247 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GL- 247 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CC-
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CC-
Confidence 99985432 3345678999999999843 33378899999999999999999999987654332 2222211 00
Q ss_pred ChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 321 SEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......+++++.+||.+||+.||.+|||++|+++
T Consensus 248 -------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 -------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00112357788999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=351.08 Aligned_cols=254 Identities=22% Similarity=0.254 Sum_probs=202.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++.++|++++..++.+... ....++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEE
Confidence 47899999999999999999999999999999997654432 2367899999999998888877766543 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---cCCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~~ 253 (457)
||||+++++...+......+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999777777776566679999999999999999999999999999999999999 788999999999998765432
Q ss_pred C------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChhh
Q 036122 254 K------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV---EQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 254 ~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~---~~~~~i~~~~~~~~~~~ 324 (457)
. .......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.. ..+..+.......+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred cCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch---
Confidence 2 1223567899999999998776 799999999999999999999999875432 22222222110000
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......+|+++.+||..||+.||++|||++++++
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 239 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ---------------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11223567889999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=362.17 Aligned_cols=270 Identities=22% Similarity=0.257 Sum_probs=200.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC--CceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM--SCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~~ 174 (457)
.++|++.+.||+|+||+||+|++ +++.||||++... ........+|+.++++++||||+++++++.... ...+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 47899999999999999999986 4899999999653 233345567999999999999999999988743 3358
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeccCCCCCEEecCCCcEEEeecc
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN----------GVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
|+||||++++.+..+.... .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 98 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 9999999885554444443 599999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCC-CCcccccccCccCchHhhhCC----cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 036122 245 LATFYDPGLK-QPMTSRVVTLWYRPPELLLGA----TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 245 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~----~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
+++....... .......||+.|+|||++.+. ..++.++|||||||++|||+||++||.+................
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987654322 223446789999999999863 23567889999999999999999999875432221111112222
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhccc--CCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETF--KDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+....+........ ..+. +...+ ...++++.+||.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~--~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 257 PSLEDMQEVVVHKK--KRPV------LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCHHHHHHHHTTSC--CCCC------CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cchhhhhhhhhccc--CCCC------ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22222111100000 0000 00000 011234889999999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=348.52 Aligned_cols=250 Identities=22% Similarity=0.338 Sum_probs=207.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++.. ...+|+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEE
Confidence 468999999999999999999975 6788999999765433 2567899999999999999999999877 456899
Q ss_pred EEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||++++ +...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999875 55555555567999999999999999999999999999999999999999999999999999866432222
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
......+|..|+|||++.+.. ++.++||||||+++|+|++ |.+||...+..+....+......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~--------------- 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------- 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------
T ss_pred ccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC---------------
Confidence 223456688999999998666 7899999999999999999 89999998887777666432100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+++.+.+||.+||+.||++|||+.+++++
T Consensus 225 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 -------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112356788999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=351.80 Aligned_cols=252 Identities=21% Similarity=0.259 Sum_probs=205.0
Q ss_pred cCCccccc-eeeccCceEEEEEEE--cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLD-KIGQGTYSNVYKARD--LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~-~LG~G~fg~Vy~~~~--~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|.+.+ .||+|+||+||+|.+ ..+++.||||++..........+.+.+|+.+++.++||||+++++++. ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~ 91 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AES 91 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CCC
Confidence 46799988 999999999999954 566789999999876555555678999999999999999999999984 356
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||+.++.+..+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCC
Confidence 89999999976555555556679999999999999999999999999999999999999999999999999998765432
Q ss_pred CC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 254 KQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 254 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
.. ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------ 238 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------------ 238 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------------
T ss_pred CcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 21 112234578899999998766 7899999999999999999 9999999888776655533110
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 ----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112357788999999999999999999999984
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=360.26 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=198.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIV----ALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~v----AiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++.+.||+|+||+||+|++..+++.+ |+|.+.... .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 478999999999999999999988887754 777765432 334456788999999999999999999999862
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..++||||+.++ +...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 378899999875 5555555567799999999999999999999999999999999999999999999999999987754
Q ss_pred CCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.... ......+|+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---------- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred CcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC----------
Confidence 3222 223345688999999998766 7999999999999999999 99999988776655544321100
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....++.++.+||.+||+.||.+|||+.+++++
T Consensus 239 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 ------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0123356788999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=351.58 Aligned_cols=252 Identities=19% Similarity=0.258 Sum_probs=203.6
Q ss_pred cCCccccceeeccCceEEEEEEEcC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|.+.+.||+|+||+||+|++.. ++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CC
Confidence 5789999999999999999998653 34469999987653 44556778999999999999999999998765 34
Q ss_pred EEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.|+||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 68999999875 54555455567999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.........+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~------------ 233 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL------------ 233 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC------------
T ss_pred cccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC------------
Confidence 322334456788999999997666 7899999999999999998 99999887776666555332110
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+++.+.+||.+||+.||++|||+.|++++
T Consensus 234 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 ----------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 0112367789999999999999999999999964
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=355.18 Aligned_cols=256 Identities=20% Similarity=0.264 Sum_probs=200.6
Q ss_pred cCCccccceeeccCceEEEEEEEcC---CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc-
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC- 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~- 172 (457)
.++|.+.+.||+|+||.||+|.+.. ++..||+|++............+.+|+.++++++||||+++++++......
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 5789999999999999999998764 456899999987766777778899999999999999999999998764322
Q ss_pred --eEEEEEecccCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 173 --SLYLVFEYMEHDLAGLAA------CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 173 --~~~lv~E~~~~~l~~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
..|+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 469999999975554443 234569999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 036122 245 LATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSE 322 (457)
Q Consensus 245 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~ 322 (457)
++........ .......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 267 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR---- 267 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC----
T ss_pred cceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC----
Confidence 9986643321 1223345688999999998766 7999999999999999999 8999998887766665543210
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 268 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123577889999999999999999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.34 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=202.6
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++++ +||||+++++++..
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 478999999999999999999973 456789999997543 233446788999999999 89999999999877
Q ss_pred CceEEEEEecccCC-HHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 036122 171 SCSLYLVFEYMEHD-LAGLAACQG----------------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKG 227 (457)
Q Consensus 171 ~~~~~lv~E~~~~~-l~~~~~~~~----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 227 (457)
...+|+||||++++ +...+.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 45689999999874 444443332 2379999999999999999999999999999999
Q ss_pred CCEEecCCCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 036122 228 SNLLIDNDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRT 305 (457)
Q Consensus 228 ~NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~ 305 (457)
+||||+.++.+||+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|+| |.+||.+..
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999866433221 123345688999999998766 7999999999999999998 999998876
Q ss_pred hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCC
Q 036122 306 EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382 (457)
Q Consensus 306 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp 382 (457)
.......+......+ .....+++++.+||.+||+.||.+|||+.++++|-
T Consensus 280 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 280 VDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 555544443311000 01134678899999999999999999999999763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=365.59 Aligned_cols=262 Identities=20% Similarity=0.184 Sum_probs=200.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-----CcEEEEEEeecCCCChHH---------HHHHHHHHHHHHhcCCCCceeE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-----GKIVALKKVRFDNLEPES---------VKFMAREILVLRKLDHPNVIKL 162 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-----g~~vAiK~~~~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l 162 (457)
.++|.+.+.||+|+||.||+|.+..+ ++.||||++......... ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 56899999999999999999998764 578999998765311000 0123345667778889999999
Q ss_pred eeeEEecCC--ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec--CCCcE
Q 036122 163 EGLVTSRMS--CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID--NDGIL 238 (457)
Q Consensus 163 ~~~~~~~~~--~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~v 238 (457)
++++..... ..+|+||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 999876322 55899999996667776666657899999999999999999999999999999999999999 88999
Q ss_pred EEeeccCccccCCCCC------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH-HHHH
Q 036122 239 KIADFGLATFYDPGLK------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV-EQLH 311 (457)
Q Consensus 239 kl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~-~~~~ 311 (457)
||+|||+++.+..... .......||+.|+|||++.+.. ++.++|||||||++|||+||+.||.+.... ....
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999986643211 1123456999999999998776 799999999999999999999999864332 2222
Q ss_pred HHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhccc--CCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 312 KIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETF--KDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 312 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
............ .+...+ ..+|+++.+||..||+.||.+|||+.++++
T Consensus 273 ~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIAS---------------------LMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHH---------------------HHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHH---------------------HHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 221111000000 011111 457889999999999999999999998875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=352.26 Aligned_cols=269 Identities=22% Similarity=0.353 Sum_probs=201.7
Q ss_pred cCCccccceeeccCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
...|++.+.||+|+||.||+|+ +..+++.||+|++.... .......+.+|+.+++.++||||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3569999999999999999998 56789999999997553 233456788999999999999999999999876557
Q ss_pred eEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
.+++||||+++ ++...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 79999999987 45555545566799999999999999999999999999999999999999999999999999987754
Q ss_pred CCC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......||..|+|||++.+.. ++.++|||||||++|+|+||..|+..... ......+..........
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~- 251 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPMA-----LFLKMIGPTHGQMTVTR- 251 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHH-----HHHHHHCSCCGGGHHHH-
T ss_pred CCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchhh-----HHhhccCCcccccCHHH-
Confidence 322 1233456788899999998766 78999999999999999999988643211 11111111111000000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+..... ..........+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLK-------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHH-------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHh-------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 000000 00000122457788999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=380.11 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=208.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..+|++.+.||+|+||.||+|++..++..||||+++.... ..+.+.+|+.+|++++|||||++++++.. ...+||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l 293 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 293 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEEE
Confidence 5679999999999999999999998899999999976543 24568899999999999999999999977 456899
Q ss_pred EEecccCC-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHD-LAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+.++ |...+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999865 54444432 34699999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+.....
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------- 437 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------------- 437 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---------------
T ss_pred eecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 2233445678999999998766 7999999999999999999 9999998887666555432110
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+++.+.+||.+||+.||++|||+.++++
T Consensus 438 -------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 438 -------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 0112347788999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=354.55 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=206.7
Q ss_pred cCCccccceeeccCceEEEEEEE-----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARD-----LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 47899999999999999999985 4567899999997553 344557788999999999 89999999999877
Q ss_pred CceEEEEEecccC-CHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 171 SCSLYLVFEYMEH-DLAGLAACQGV-----------------KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 171 ~~~~~lv~E~~~~-~l~~~~~~~~~-----------------~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
....++||||+++ ++...+..... .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 4568999999987 45544443322 48999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCCCC-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLKQP-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||++.......... .....+|+.|+|||++.+.. ++.++|||||||++|+|+| |.+||.+.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 999999999999998765432211 22345688999999998766 7999999999999999999 99999887665554
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+......+ .....+++++.+||.+||+.||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 4443321100 0113467789999999999999999999999964
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.99 Aligned_cols=253 Identities=21% Similarity=0.316 Sum_probs=206.7
Q ss_pred cCCccccceeeccCceEEEEEEEc-------CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-------LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-------~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 168 (457)
.++|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 478999999999999999999975 456789999997543 445567788999999999 89999999999876
Q ss_pred cCCceEEEEEecccCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 169 RMSCSLYLVFEYMEHDLAGLAACQG----------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
...+|+||||+.++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 56789999999875544444332 248999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 9999999999999987653321 1123345688999999998766 7899999999999999999 99999998877776
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+...... .....+++++.+||.+||+.||.+|||+.|++++
T Consensus 270 ~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 270 KLLKEGHRM----------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 665432100 1123467789999999999999999999999964
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=357.55 Aligned_cols=251 Identities=26% Similarity=0.321 Sum_probs=202.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEE--EEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIV--ALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~v--AiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .......+.+|+.+++++ +||||+++++++.. ...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~ 100 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 100 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCc
Confidence 578999999999999999999998888865 999987432 334446688999999999 89999999999987 567
Q ss_pred EEEEEecccCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc
Q 036122 174 LYLVFEYMEHDLAGLAACQG----------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 237 (457)
+|+||||++++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 99999999875444443332 36999999999999999999999999999999999999999999
Q ss_pred EEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 036122 238 LKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKL 316 (457)
Q Consensus 238 vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~ 316 (457)
+||+|||+++..... .......+++.|+|||++.+.. ++.++|||||||++|+|+| |.+||.+.+..+....+...
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 257 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 257 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence 999999999744321 1223345688999999998765 7899999999999999998 99999998877766554221
Q ss_pred cCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.. ......+++.+.+||.+||+.||.+|||++|++++
T Consensus 258 ~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 258 YR----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CC----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 01123467789999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=357.02 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=187.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEe------c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTS------R 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~------~ 169 (457)
..+|++.+.||+|+||.||+|++..+|+.||||++... .......+.+|+.+++++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 46899999999999999999999999999999998654 3455567889999999996 9999999998853 2
Q ss_pred CCceEEEEEecccCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEecCCCcEEEeeccC
Q 036122 170 MSCSLYLVFEYMEHDLAGLAAC--QGVKFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLIDNDGILKIADFGL 245 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~~~~~vkl~DFGl 245 (457)
....+++||||+.+++...+.. ....+++.+++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 2456899999999988776644 3457999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCCC-----------CcccccccCccCchHhhh--CCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 036122 246 ATFYDPGLKQ-----------PMTSRVVTLWYRPPELLL--GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHK 312 (457)
Q Consensus 246 a~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~--~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~ 312 (457)
+......... ......||+.|+|||++. ....++.++|||||||++|+|++|..||........+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876533211 112446899999999983 233378899999999999999999999976544322211
Q ss_pred HHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCC
Q 036122 313 IFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382 (457)
Q Consensus 313 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp 382 (457)
... .......+..+.+||.+||+.||.+|||+.|+++|-
T Consensus 265 ~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 265 KYS-------------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -CC-------------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccc-------------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 100 001123566789999999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=358.22 Aligned_cols=262 Identities=18% Similarity=0.252 Sum_probs=212.2
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.++++++||||+++++++.. .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 100 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 100 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--C
Confidence 478999999999999999999876 357889999997543 34455678899999999999999999999876 4
Q ss_pred ceEEEEEecccCC-HHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEe
Q 036122 172 CSLYLVFEYMEHD-LAGLAACQ---------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~~-l~~~~~~~---------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 241 (457)
...|+||||+.++ +...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 5689999999874 44433321 1457999999999999999999999999999999999999999999999
Q ss_pred eccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 036122 242 DFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 242 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
|||++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~- 258 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 258 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-
Confidence 9999986532211 1123345688999999998766 7899999999999999999 8999999887777666543110
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC------CCCCCCCCC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS------EFFNTEPYA 390 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h------p~f~~~~~~ 390 (457)
......+++.+.+||.+||+.||.+|||+.|+++| ++|+...+.
T Consensus 259 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 259 ---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 01123467789999999999999999999999987 777654443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=346.47 Aligned_cols=253 Identities=20% Similarity=0.253 Sum_probs=207.9
Q ss_pred cCCccccc-eeeccCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLD-KIGQGTYSNVYKARDL--LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~-~LG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 83 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 83 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CC
Confidence 35677777 9999999999999854 467889999997653 45566778999999999999999999999843 45
Q ss_pred EEEEEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+++||||++++.+ ..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 8999999998544 444445567999999999999999999999999999999999999999999999999999876433
Q ss_pred CC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 253 LK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 253 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.. .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~----------- 231 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----------- 231 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----------
T ss_pred cceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc-----------
Confidence 22 1123345688999999998666 7899999999999999998 9999998887776665533110
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSE 382 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp 382 (457)
......+++++.+||.+||+.||++|||+.++++|.
T Consensus 232 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 232 -----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -----------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 011235788899999999999999999999999763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=357.73 Aligned_cols=258 Identities=20% Similarity=0.312 Sum_probs=205.3
Q ss_pred cCCccccceeeccCceEEEEEE-----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKAR-----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~-----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|.+.+.||+|+||.||+|+ +..++..||||++.... .......+.+|+.++++++||||+++++++.. .
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--S 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--C
Confidence 5789999999999999999998 55678899999997443 44555678899999999999999999999877 4
Q ss_pred ceEEEEEecccC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEe
Q 036122 172 CSLYLVFEYMEH-DLAGLAACQG------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~-~l~~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~ 241 (457)
..+|+||||+++ ++...+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++. +..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 567999999976 4544444332 34899999999999999999999999999999999999994 4469999
Q ss_pred eccCccccCCCC-CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 036122 242 DFGLATFYDPGL-KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 242 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
|||++....... ........+|+.|+|||++.+.. ++.++|||||||++|+|+| |.+||...+..+....+......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 999998553221 12233456789999999998766 7999999999999999998 99999988887776665432100
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....+++.+.+||.+||+.||.+|||+.++++|.|+-.
T Consensus 265 ----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 265 ----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 112346778999999999999999999999999988743
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=372.82 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=205.6
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
..++|.+.+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.+|++++|||||++++++.. ..+|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---~~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC---CccE
Confidence 3578999999999999999999974 577899999976442 34678899999999999999999998863 4589
Q ss_pred EEEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 176 LVFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+||||+.++.+..+... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999987544444332 2368999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
........+|..|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.+..+......+
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~------------ 405 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP------------ 405 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC------------
T ss_pred eeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 11223345678899999998666 7999999999999999999 999999998888777765421110
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....+++++.+||.+||+.||++|||++++++
T Consensus 406 ----------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 406 ----------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11346788999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=370.42 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=194.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 175 (457)
..+|.+.+.||+|+||+||.. ...+|+.||||++..... ..+.+|+.+|+++ +|||||++++++.+ ...+|
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~ 94 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQY 94 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEE
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEE
Confidence 357999999999999996643 357899999999965432 1245799999999 79999999999877 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-----CCcEEEeeccCccccC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-----DGILKIADFGLATFYD 250 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-----~~~vkl~DFGla~~~~ 250 (457)
+||||+++++...+......+.+.++..++.||+.||.|||++||+||||||+||||+. ...+||+|||+++...
T Consensus 95 lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 95 IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 99999999888877766666777788899999999999999999999999999999953 2368899999998765
Q ss_pred CCCC--CCcccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 251 PGLK--QPMTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 251 ~~~~--~~~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
.... .......||+.|+|||++.+ ...++.++|||||||++|||+| |.+||.......... + .+......
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~---~~~~~~~~- 249 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L---LGACSLDC- 249 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H---TTCCCCTT-
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H---hccCCccc-
Confidence 3321 22345679999999999974 2336789999999999999999 899996654433221 1 11100000
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.. .....+..+.+||.+||+.||.+|||++|+|+||||..
T Consensus 250 ----------~~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 250 ----------LH-----------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp ----------SC-----------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ----------cC-----------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 00 00112334688999999999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=375.36 Aligned_cols=275 Identities=24% Similarity=0.350 Sum_probs=205.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|.+.+.||+|+||+||+|++..+|+.||||++..... ......+.+|+.++++++||||+++++++.......+|+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 4689999999999999999999999999999999975432 223456778999999999999999999998765667899
Q ss_pred EEecccCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe----cCCCcEEEeeccCcccc
Q 036122 177 VFEYMEHDLAGLAACQG---VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI----DNDGILKIADFGLATFY 249 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl----~~~~~vkl~DFGla~~~ 249 (457)
||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++..
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 99999875555444332 239999999999999999999999999999999999999 77888999999999876
Q ss_pred CCCCCCCcccccccCccCchHhhhCC-------cCCCccchhhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGA-------TYYGVGVDLWSAGCILAELLAGKPIMPGR----TEVEQLHKIFKLCG 318 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~-------~~~~~~~DvwslG~vl~elltG~~pf~~~----~~~~~~~~i~~~~~ 318 (457)
... .......||+.|+|||++.+. ..++.++|||||||++|||++|+.||... ...+.+.++.. +
T Consensus 167 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~ 242 (396)
T 4eut_A 167 EDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--G 242 (396)
T ss_dssp CCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--S
T ss_pred cCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--C
Confidence 543 223456799999999998641 33688999999999999999999999643 33444444433 2
Q ss_pred CCChhhhhhc-CCCCcc-cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 319 SPSEEYWKKS-KLPNAT-LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 319 ~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.|. ..+... ...... .+....+. .......++..+.+||++||+.||++|||++|+++
T Consensus 243 ~p~-~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPS-GAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCT-TCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCc-ccchhheeccCCCcccCccCCc---ccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 221 111110 000000 00000000 00111223456788999999999999999999854
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.13 Aligned_cols=248 Identities=21% Similarity=0.356 Sum_probs=205.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++.. ...++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 84 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEE
Confidence 478999999999999999999964 6778999999765433 3568899999999999999999998764 35799
Q ss_pred EEecccCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAACQG--VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+.++.+..+.... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999875555444332 2699999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCC--------------
Confidence 2233445688999999998665 7899999999999999999 89999998887776665332100
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++++.+||.+||+.||++|||++++++
T Consensus 230 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 230 --------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 011346788999999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=353.44 Aligned_cols=253 Identities=21% Similarity=0.330 Sum_probs=201.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG----KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
..+|.+.+.||+|+||+||+|.+..++ ..||||++.... .......+.+|+.++++++||||+++++++.. ..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--CC
Confidence 578999999999999999999876553 459999997543 44555678899999999999999999999876 56
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
.+++||||++++ +...+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 799999999874 5555555556799999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCC--cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 252 GLKQP--MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 252 ~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
..... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~--------- 269 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--------- 269 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred ccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---------
Confidence 32111 12234578899999998766 7899999999999999999 99999988887776665432110
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 270 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 -------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112467788999999999999999999999854
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=355.48 Aligned_cols=255 Identities=21% Similarity=0.321 Sum_probs=204.7
Q ss_pred cCCccccceeeccCceEEEEEEE-----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARD-----LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~-----~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|.+.+.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.++.++ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 47899999999999999999985 3567899999997553 444556788999999999 699999999998763
Q ss_pred CceEEEEEecccCCHHHHHHhcCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVK----------------FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN 234 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~----------------l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~ 234 (457)
...+|+||||++++.+..+...... +++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3458999999997544444443322 899999999999999999999999999999999999999
Q ss_pred CCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 036122 235 DGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHK 312 (457)
Q Consensus 235 ~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~ 312 (457)
++.+||+|||+++........ ......+|+.|+|||++.+.. ++.++|||||||++|+|+| |.+||.+....+.+..
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~ 262 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence 999999999999866433221 123346788999999998766 7999999999999999998 9999987764443333
Q ss_pred HHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 313 IFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 313 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.......+ .....+++.+.+||.+||+.||.+|||+.|+++|
T Consensus 263 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 263 RLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32211000 0112367789999999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=356.03 Aligned_cols=272 Identities=21% Similarity=0.301 Sum_probs=206.6
Q ss_pred cCCccccceeeccCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 4789999999999999999998 4678899999999754 445567789999999999999999999998866677
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
.+|+||||++++ +...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 899999999765 4444444355699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC--hhhhhh
Q 036122 252 GLKQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPS--EEYWKK 327 (457)
Q Consensus 252 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~ 327 (457)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.............. .... ......
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 256 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE--RDVPALSRLLEL 256 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHHHH
T ss_pred CCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc--cccccHHHHHHH
Confidence 3221 223446788899999998766 78999999999999999999999875433211100000 0000 000000
Q ss_pred cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc---CCCCCC
Q 036122 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN---SEFFNT 386 (457)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~---hp~f~~ 386 (457)
.. ..........+++++.+||.+||+.||++|||+.|+++ ..|...
T Consensus 257 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LE-------------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hh-------------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 00 00000112457888999999999999999999999954 444443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=361.40 Aligned_cols=268 Identities=22% Similarity=0.271 Sum_probs=202.6
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.+++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.. ...+|
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 111 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMI 111 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCCE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEE
Confidence 468999999999999999999995 578999999887543 3345678899999999999999999999876 56789
Q ss_pred EEEecccCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 176 LVFEYMEHDLAGLAACQG----VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
+||||++++.+....... ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999875554443322 2589999999999999999999999999999999999999999999999999986543
Q ss_pred CC-CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 252 GL-KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 252 ~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
.. ........||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+....+....+... ........+
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~ 265 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNNGQL 265 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHHTTTCC
T ss_pred ccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhccccccH
Confidence 22 12234456899999999998766 799999999999999999999999765432211110000 000000000
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
... ..+. .........+..+.+||.+||+.||++|||+.|+++|
T Consensus 266 ~~~--~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 266 EQI--VDPN-----LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp CSS--SSSS-----CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHh--cChh-----hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 0000 0001112234567899999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=346.61 Aligned_cols=253 Identities=32% Similarity=0.460 Sum_probs=193.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC-CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN-LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.++++++||||+++++++.. ...++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 108 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELN 108 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEE
Confidence 578999999999999999999999999999999997643 345566778899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 176 LVFEYMEHDLAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999854433332 356799999999999999999999999999999999999999999999999999986643
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE--VEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+... ......+... ..+
T Consensus 189 ~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~--------- 256 (310)
T 2wqm_A 189 KT-TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYP--------- 256 (310)
T ss_dssp -----------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT-CSC---------
T ss_pred CC-ccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc-cCC---------
Confidence 32 2233457899999999998766 78999999999999999999999976432 2222222111 000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+++++.+||.+||+.||.+|||+.++++
T Consensus 257 -----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 257 -----------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -----------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011346778999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=356.85 Aligned_cols=269 Identities=20% Similarity=0.261 Sum_probs=201.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+ .+|+.||||++...... .....+.+|+.+++.++||||+++++++.. ....++
T Consensus 29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 104 (326)
T 3uim_A 29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLL 104 (326)
T ss_dssp TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCCEE
T ss_pred hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec--CCceEE
Confidence 57899999999999999999984 57899999999764322 112357899999999999999999999977 456799
Q ss_pred EEecccCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 177 VFEYMEHDLAGLAACQG----VKFSEPQVKCYMKQLLSGLEHCHNN---GVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
||||+.++.+..+.... ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 99999886555444432 3499999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC----ChHHHHHHHHHhcCCCChhhh
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR----TEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~----~~~~~~~~i~~~~~~~~~~~~ 325 (457)
............||+.|+|||++.+.. ++.++|||||||++|+|++|.+||... ...........
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------- 253 (326)
T 3uim_A 185 DYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK---------- 253 (326)
T ss_dssp CSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT----------
T ss_pred CcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH----------
Confidence 644444445567999999999998766 799999999999999999999999521 00000111100
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
............. ...........++.+.+||..||+.||.+|||+.|+|+|-.-
T Consensus 254 --~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 --GLLKEKKLEALVD--VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp --TTTSSCCSTTSSC--TTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred --HHhhchhhhhhcC--hhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000000000000 000000111223568899999999999999999999988654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=354.52 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=198.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEE----EEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIV----ALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~v----AiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++++.||+|+||+||+|++..+++.| |+|.+.... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence 478999999999999999999998888765 666664332 334456788999999999999999999998862
Q ss_pred eEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..++||||+.++ +...+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 378899998874 5555555566799999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---------- 238 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---------- 238 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----------
T ss_pred ccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence 322 1223345688999999998766 7999999999999999999 99999988777665554332100
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++.++.+||.+||..||.+|||+.|+++
T Consensus 239 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 ------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 012336678899999999999999999999996
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=368.29 Aligned_cols=245 Identities=22% Similarity=0.380 Sum_probs=201.8
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
..++|++.+.||+|+||.||+|.+ +|+.||||+++... ..+.+.+|+.+|++++||||+++++++... ...+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceE
Confidence 357899999999999999999985 47899999997543 335688999999999999999999998763 34689
Q ss_pred EEEecccCC-HHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 176 LVFEYMEHD-LAGLAACQGV-KFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 176 lv~E~~~~~-l~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+||||+.++ |...+...+. .+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 999999874 5554444433 3799999999999999999999999999999999999999999999999999855322
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....+++.|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..+....+.....
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------------- 404 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------------- 404 (450)
T ss_dssp -------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC--------------
T ss_pred ---ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------
Confidence 12335688999999998766 8999999999999999998 9999998877766665533210
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
......+++++.+||.+||+.||++|||+.++++
T Consensus 405 --------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 --------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp --------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112357888999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=347.63 Aligned_cols=255 Identities=20% Similarity=0.263 Sum_probs=203.1
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTG---KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
....+|++.+.||+|+||+||+|++..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++... .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-E 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-S
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-C
Confidence 34567999999999999999999865433 46899998753 3455567788999999999999999999987653 4
Q ss_pred ceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 172 CSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 172 ~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...|+||||++++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 5689999999985 445444445679999999999999999999999999999999999999999999999999998664
Q ss_pred CCCC---CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 251 PGLK---QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 251 ~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
.... .......+|+.|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+......
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------- 251 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------- 251 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC-------
T ss_pred ccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC-------
Confidence 3221 1223456788999999998766 7899999999999999999 67888877766665555332110
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++.+.+||.+||+.||++|||+.|+++
T Consensus 252 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 ---------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011236778999999999999999999999985
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.77 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=205.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK-----IVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~-----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|.+.+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+++++ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 5789999999999999999999876664 79999997543 445567788999999999 89999999999876
Q ss_pred CceEEEEEecccC-CHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC
Q 036122 171 SCSLYLVFEYMEH-DLAGLAACQ-------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG 236 (457)
Q Consensus 171 ~~~~~lv~E~~~~-~l~~~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~ 236 (457)
...+|+||||+++ ++...+... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 4568999999987 444444322 34589999999999999999999999999999999999999999
Q ss_pred cEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 036122 237 ILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIF 314 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~ 314 (457)
.+||+|||++......... ......+|+.|+|||++.+.. ++.++|||||||++|+|+| |.+||.+.........+.
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 9999999999865433211 123345688999999998766 7999999999999999999 899998876655554443
Q ss_pred HhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 315 KLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+ ......++.+.+||.+||+.||.+|||+.|+++
T Consensus 281 ~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 281 KDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 321100 011235678899999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=356.94 Aligned_cols=261 Identities=20% Similarity=0.156 Sum_probs=196.7
Q ss_pred cCCccccceeeccCceEEEEEEEcC---CCcEEEEEEeecCCCChH---------HHHHHHHHHHHHHhcCCCCceeEee
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNLEPE---------SVKFMAREILVLRKLDHPNVIKLEG 164 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~---~g~~vAiK~~~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~l~~ 164 (457)
.++|.+.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 788999999986532111 1123567889999999999999999
Q ss_pred eEEec--CCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC--cEEE
Q 036122 165 LVTSR--MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG--ILKI 240 (457)
Q Consensus 165 ~~~~~--~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~--~vkl 240 (457)
++... ....+|+||||+++++.. +......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQK-ISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHH-HCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEeccCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 98762 246789999999445544 444444799999999999999999999999999999999999999877 9999
Q ss_pred eeccCccccCCCC------CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 036122 241 ADFGLATFYDPGL------KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR--TEVEQLHK 312 (457)
Q Consensus 241 ~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~--~~~~~~~~ 312 (457)
+|||+++.+.... ........||+.|+|||++.+.. ++.++|||||||++|||++|..||.+. +.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 9999998764321 11224567899999999998766 799999999999999999999999652 32222222
Q ss_pred HHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhccc--CCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 313 IFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETF--KDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 313 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
........+... .... ..+++++.+||.+||+.||++|||++++++.
T Consensus 274 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSV----------------------LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHH----------------------HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHH----------------------HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 222211111111 1111 1578899999999999999999999998853
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=368.78 Aligned_cols=256 Identities=24% Similarity=0.383 Sum_probs=204.2
Q ss_pred CcCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 96 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
..++|++.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+|++++||||+++++++.. ..+|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceE
Confidence 3578999999999999999999975 4567999999865433 3568899999999999999999999865 4579
Q ss_pred EEEecccCC-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 176 LVFEYMEHD-LAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 176 lv~E~~~~~-l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+||||+.++ +...+.. .+..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999875 4444432 23469999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
........++..|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.+..+......
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------- 400 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------- 400 (452)
T ss_dssp --------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------
T ss_pred eecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 22233445688999999998766 7999999999999999999 99999999888877766432110
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc--CCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN--SEFFNTE 387 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~--hp~f~~~ 387 (457)
.....+++.+.+||.+||+.||++|||++++++ ..+|...
T Consensus 401 ---------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 401 ---------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 011346788999999999999999999999987 4677653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=344.52 Aligned_cols=255 Identities=23% Similarity=0.284 Sum_probs=204.1
Q ss_pred cCcCCccccceeeccCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 95 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.....|.+.+.||+|+||+||+|.+..++. .||+|++... ......+.+.+|+.++++++||||+++++++... .
T Consensus 18 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~ 95 (298)
T 3pls_A 18 HERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-E 95 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-S
T ss_pred ccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-C
Confidence 345567888999999999999999765554 7999998753 3445567788999999999999999999998764 3
Q ss_pred ceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 172 CSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 172 ~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...++||||+.++ +...+......+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 3458999999764 555554446679999999999999999999999999999999999999999999999999998654
Q ss_pred CCC---CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 036122 251 PGL---KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326 (457)
Q Consensus 251 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 326 (457)
... ........+|+.|+|||.+.+.. ++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------- 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------- 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-------
T ss_pred CCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-------
Confidence 321 12223456789999999998766 7999999999999999999 56677766666655554332110
Q ss_pred hcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 ---------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 012346778999999999999999999999885
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.41 Aligned_cols=258 Identities=27% Similarity=0.365 Sum_probs=191.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~~ 175 (457)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+ ..+.+.+|+.+|+++ +|||||++++++.. ...+|
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~ 85 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLY 85 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEE
Confidence 3556777889999999998754 578999999998753 234567899999886 89999999998876 57799
Q ss_pred EEEecccCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC-------------C
Q 036122 176 LVFEYMEHDLAGLAACQGVK------FSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND-------------G 236 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~------l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~-------------~ 236 (457)
+||||+++++...+...... .++..++.++.||+.||.|||++||+||||||+||||+.+ +
T Consensus 86 lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 86 IALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 99999998776665543211 1333467899999999999999999999999999999754 4
Q ss_pred cEEEeeccCccccCCCCCC---CcccccccCccCchHhhhC------CcCCCccchhhhHHHHHHHHHh-CCCCCCCCCh
Q 036122 237 ILKIADFGLATFYDPGLKQ---PMTSRVVTLWYRPPELLLG------ATYYGVGVDLWSAGCILAELLA-GKPIMPGRTE 306 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~------~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~ 306 (457)
.+||+|||+++........ ......||+.|+|||++.+ ...++.++|||||||++|||+| |.+||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999977543221 1234579999999999975 2347899999999999999999 8999976654
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 307 VEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 307 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.+ ..+....... +.. .. .....+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus 246 ~~--~~i~~~~~~~----------~~~------~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 246 RE--SNIIRGIFSL----------DEM------KC------LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HH--HHHHHTCCCC----------CCC------TT------CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred hH--HHHhcCCCCc----------ccc------cc------cccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 43 2222211000 000 00 000123467899999999999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=346.31 Aligned_cols=248 Identities=27% Similarity=0.422 Sum_probs=201.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEe--------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTS-------- 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------- 168 (457)
..+|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 367999999999999999999999899999999997643 235689999999999999999998754
Q ss_pred ------cCCceEEEEEecccCC-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEE
Q 036122 169 ------RMSCSLYLVFEYMEHD-LAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKI 240 (457)
Q Consensus 169 ------~~~~~~~lv~E~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl 240 (457)
.....+|+||||++++ +...+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 1134589999999985 44444332 357999999999999999999999999999999999999999999999
Q ss_pred eeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 036122 241 ADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP 320 (457)
Q Consensus 241 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~ 320 (457)
+|||++....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||... ......+..
T Consensus 164 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~----- 233 (284)
T 2a19_B 164 GDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD----- 233 (284)
T ss_dssp CCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT-----
T ss_pred Ccchhheeccccc--cccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc-----
Confidence 9999998765432 234457899999999998766 799999999999999999999877421 111111100
Q ss_pred ChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 321 SEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
. .....+++.+.+||.+||+.||.+|||+.|+++|.+.-.
T Consensus 234 -------~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -------G-------------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -------T-------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -------c-------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0 011236777899999999999999999999999987643
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=382.52 Aligned_cols=245 Identities=21% Similarity=0.270 Sum_probs=202.4
Q ss_pred ceeeccCceEEEEEEE--cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARD--LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~--~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
++||+|+||.||+|.+ ..+++.||||+++.........+.+.+|+.+|++++|||||++++++.. ..+++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 4799999999999954 4567899999998765555666789999999999999999999999864 3489999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC--CCccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK--QPMTS 259 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~--~~~~~ 259 (457)
.++.+..+......+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... .....
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9876666666667899999999999999999999999999999999999999999999999999987754322 12233
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
..+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 532 ~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~------------------- 591 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------------------- 591 (635)
T ss_dssp ---CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred CCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 45678999999998766 7999999999999999998 99999999888877766432100
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++++.+||..||+.||++|||++++++
T Consensus 592 ---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 112347888999999999999999999999974
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.70 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=193.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|++ +++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEE
Confidence 46899999999999999999985 5789999998632 344678899999999999999999998753 3689
Q ss_pred EEecccCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCCCCEEecCCCc-EEEeeccCcccc
Q 036122 177 VFEYMEHDLAGLAACQGV---KFSEPQVKCYMKQLLSGLEHCHN---NGVLHRDIKGSNLLIDNDGI-LKIADFGLATFY 249 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NILl~~~~~-vkl~DFGla~~~ 249 (457)
||||++++.+..+..... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999998765555544433 47899999999999999999999 89999999999999998886 799999999765
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhhhhh
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEV--EQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~ 327 (457)
... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... .....+... .
T Consensus 157 ~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~-------- 221 (307)
T 2eva_A 157 QTH----MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG--T-------- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTT--C--------
T ss_pred ccc----cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcC--C--------
Confidence 422 23456899999999998766 799999999999999999999999754322 222221110 0
Q ss_pred cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc-----CCCCCCC
Q 036122 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN-----SEFFNTE 387 (457)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~-----hp~f~~~ 387 (457)
.......+++.+.+||.+||+.||.+|||++++++ .++|...
T Consensus 222 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 222 ------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp ------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred ------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 00123457788999999999999999999999997 4666553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=360.46 Aligned_cols=257 Identities=20% Similarity=0.262 Sum_probs=196.4
Q ss_pred CcCcCCccccceeeccCceEEEEEEEcCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC
Q 036122 94 PRRANTFEKLDKIGQGTYSNVYKARDLLTG---KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM 170 (457)
Q Consensus 94 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 170 (457)
+.....|.+.+.||+|+||+||+|.+..++ ..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~- 162 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS- 162 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-
Confidence 334567889999999999999999875432 468999986532 345567789999999999999999999987653
Q ss_pred CceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 171 SCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 171 ~~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
....|+||||++++ +...+......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 34678999999875 55555444566899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCC---CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 036122 250 DPGLKQ---PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325 (457)
Q Consensus 250 ~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 325 (457)
...... ......+|+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~------ 315 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------ 315 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC------
T ss_pred cccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC------
Confidence 432211 123345688999999998766 7999999999999999999 68899877665555444321100
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+++.+.+||.+||+.||++|||+.|++++
T Consensus 316 ----------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 ----------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0112467789999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=349.69 Aligned_cols=267 Identities=24% Similarity=0.316 Sum_probs=201.7
Q ss_pred CCc-cccceeeccCceEEEEEEE----cCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 98 NTF-EKLDKIGQGTYSNVYKARD----LLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 98 ~~y-~~~~~LG~G~fg~Vy~~~~----~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
++| ++++.||+|+||+||++.. ..+|+.||||++... ........+.+|+.++++++||||+++++++......
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 345 9999999999999988753 457899999999865 3455567789999999999999999999999886667
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+++||||++++.+..+.... .+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 899999999886555555443 4999999999999999999999999999999999999999999999999999877543
Q ss_pred CC--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LK--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
.. .......+|..|+|||++.+.. ++.++|||||||++|+|+||..||......... ..+......... .+
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~~~~~~-~~ 260 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-----LIGIAQGQMTVL-RL 260 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HHCSCCHHHHHH-HH
T ss_pred ccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-----hhcccccchhHH-HH
Confidence 21 1123446788899999998766 789999999999999999999999754321100 000000000000 00
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
... .. ..........+++++.+||++||+.||++|||+.|+++
T Consensus 261 ~~~--~~-----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TEL--LE-----RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHH--HH-----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH--Hh-----cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 00 00000112457788999999999999999999999984
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=357.64 Aligned_cols=255 Identities=16% Similarity=0.179 Sum_probs=198.5
Q ss_pred cCCccccceeeccCceEEEEEEEcC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCcee-------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL--------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK------- 161 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~--------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~------- 161 (457)
.++|.+.+.||+|+||.||+|++.. .++.||||++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4789999999999999999999887 4889999999754 24678999999999999988
Q ss_pred --------EeeeEEecCCceEEEEEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 162 --------LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 162 --------l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
+++++... ...+|+||||+.++|...+... ...+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQ-DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEET-TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccC-CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 45565542 4678999999955666655543 3579999999999999999999999999999999999999
Q ss_pred cCCC--cEEEeeccCccccCCCCC------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 036122 233 DNDG--ILKIADFGLATFYDPGLK------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR 304 (457)
Q Consensus 233 ~~~~--~vkl~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~ 304 (457)
+.++ .+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 9998 999999999986643211 1223457899999999998766 799999999999999999999999876
Q ss_pred C-hHHHHHHHHH-hcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 305 T-EVEQLHKIFK-LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 305 ~-~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
. ..+.+..... ....+. .. .........+++++.+||.+||+.||++|||++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~-~~-------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPG-PF-------------------VGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCC-CE-------------------ECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CcCHHHHHHHHHhccCChh-hh-------------------hhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 4 3333322222 111110 00 0000112356889999999999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=344.31 Aligned_cols=255 Identities=25% Similarity=0.299 Sum_probs=193.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCceeEeeeEEec--CCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK--LDHPNVIKLEGLVTSR--MSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~--~~~ 172 (457)
.++|++.+.||+|+||+||+|++ +|+.||||++... ....+.+|.+++.. ++||||+++++++... ...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 47899999999999999999985 7899999998643 23445567777766 7999999999987542 235
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCEEecCCCcEEEeecc
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH--------NNGVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
.+|+||||++++.+..+.. ...+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 6899999999865555543 346999999999999999999999 9999999999999999999999999999
Q ss_pred CccccCCCCCC---CcccccccCccCchHhhhCCcC-----CCccchhhhHHHHHHHHHhC----------CCCCCCCC-
Q 036122 245 LATFYDPGLKQ---PMTSRVVTLWYRPPELLLGATY-----YGVGVDLWSAGCILAELLAG----------KPIMPGRT- 305 (457)
Q Consensus 245 la~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DvwslG~vl~elltG----------~~pf~~~~- 305 (457)
+++........ ......||+.|+|||++.+... ++.++|||||||++|||+|| .+||....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 99866433221 1234578999999999986532 45789999999999999999 88886432
Q ss_pred ---hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 306 ---EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 306 ---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....+..+....+. .+..+. .......++++.+||.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 239 NDPSFEDMRKVVCVDQQ-----------------RPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SSCCHHHHHHHHTTSCC-----------------CCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcchhhhhHHHhccCC-----------------CCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22222222111000 000000 0001123456889999999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=370.65 Aligned_cols=252 Identities=17% Similarity=0.213 Sum_probs=195.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCC-CCceeE------------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDH-PNVIKL------------ 162 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h-pniv~l------------ 162 (457)
...|...+.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+++.+.| .|...+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4568899999999999999999999999999999874432 23335678899999999987 322111
Q ss_pred ---------eeeEEecC---CceEEEEEecccCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecc
Q 036122 163 ---------EGLVTSRM---SCSLYLVFEYMEHDLAGLAA------CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRD 224 (457)
Q Consensus 163 ---------~~~~~~~~---~~~~~lv~E~~~~~l~~~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrD 224 (457)
..++.... ...++++|+++.+++...+. .....+++..+..++.||+.||.|||++||+|||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111111 23478999999888776653 2244578889999999999999999999999999
Q ss_pred CCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccccCccCchHhhh---------CCcCCCccchhhhHHHHHHHHH
Q 036122 225 IKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL---------GATYYGVGVDLWSAGCILAELL 295 (457)
Q Consensus 225 lkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~~~DvwslG~vl~ell 295 (457)
|||+||||+.++.+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999999865432 345577 9999999993 3334788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCH
Q 036122 296 AGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375 (457)
Q Consensus 296 tG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta 375 (457)
||+.||.+.+..+....+ ......+|+++.+||.+||+.||++|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHHH---------------------------------HhhcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999765432211111 11223578899999999999999999999
Q ss_pred HHHhcCCCCCC
Q 036122 376 TAALNSEFFNT 386 (457)
Q Consensus 376 ~elL~hp~f~~ 386 (457)
.++|+||||+.
T Consensus 359 ~~~l~~~~~~~ 369 (413)
T 3dzo_A 359 LQAMETPEYEQ 369 (413)
T ss_dssp HHHTTSHHHHH
T ss_pred HHHHhCHHHHH
Confidence 99999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=365.45 Aligned_cols=253 Identities=23% Similarity=0.263 Sum_probs=203.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCcee-EeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIK-LEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~~~~~~~~~ 175 (457)
.++|++.++||+|+||.||+|++..+++.||||++....... .+.+|+.+++.|+|++++. +..++.. ....|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVE--GDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEE
Confidence 578999999999999999999999999999999987654332 3678999999998755444 4444443 56789
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe---cCCCcEEEeeccCccccCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl---~~~~~vkl~DFGla~~~~~~ 252 (457)
|||||+.++|...+......+++.+++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+...
T Consensus 80 lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 80 LVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 999999777777776666789999999999999999999999999999999999999 58899999999999876543
Q ss_pred CCC------CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChh
Q 036122 253 LKQ------PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 253 ~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~~ 323 (457)
... ......||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+... .+.+.++.....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-----
T ss_pred ccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-----
Confidence 221 123567899999999998776 79999999999999999999999987543 333333322110
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
...+......+++++.+||..||+.||++||+++++++
T Consensus 234 -------------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 -------------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -------------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -------------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01122334568889999999999999999999887754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=344.02 Aligned_cols=253 Identities=26% Similarity=0.366 Sum_probs=197.5
Q ss_pred cCCccccceeeccCceEEEEEEEcC-CCc--EEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-TGK--IVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~g~--~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++.+.||+|+||+||+|++.. +++ .||+|+++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4689999999999999999998643 333 699999876543 345567789999999999999999999998763
Q ss_pred eEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
..++||||+.+ ++...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.....
T Consensus 94 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 94 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 37899999986 55555555456799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 252 GLKQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 252 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+.+..+......+
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-------- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--------
T ss_pred cccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC--------
Confidence 3221 122345688899999998766 7899999999999999999 999999988877776664321100
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++++.+||.+||+.||.+|||+.++++
T Consensus 245 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 245 -------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112357788999999999999999999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=371.50 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=208.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.+|++++||||+++++++.. ..+||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceE
Confidence 578999999999999999999975 4567999999865433 3568899999999999999999999865 45899
Q ss_pred EEecccCC-HHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHD-LAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+.++ |...+.. .+..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999874 5444433 234699999999999999999999999999999999999999999999999999986643211
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......++..|+|||++.+.. ++.++|||||||+||||++ |..||.+.+..+.+..+......
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~-------------- 483 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 483 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 1123345678899999998766 7999999999999999999 89999999888877766432100
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC--CCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS--EFFNT 386 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h--p~f~~ 386 (457)
.....+++.+.+||.+||+.||++|||++++++. .+|..
T Consensus 484 --------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0123467789999999999999999999999874 66654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=349.93 Aligned_cols=255 Identities=22% Similarity=0.352 Sum_probs=199.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec--CCceE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR--MSCSL 174 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~ 174 (457)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++... ....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 46899999999999999999999999999999998754 345567788999999999999999999998642 23578
Q ss_pred EEEEecccCC-HHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 175 YLVFEYMEHD-LAGLAAC---QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 175 ~lv~E~~~~~-l~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
|+||||+.++ +...+.. ....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 9999999985 4443333 35679999999999999999999999999999999999999999999999999987553
Q ss_pred CCCCC--------CcccccccCccCchHhhhCCc--CCCccchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcC
Q 036122 251 PGLKQ--------PMTSRVVTLWYRPPELLLGAT--YYGVGVDLWSAGCILAELLAGKPIMPGRTEV--EQLHKIFKLCG 318 (457)
Q Consensus 251 ~~~~~--------~~~~~~gt~~y~aPE~l~~~~--~~~~~~DvwslG~vl~elltG~~pf~~~~~~--~~~~~i~~~~~ 318 (457)
..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||...... .....+...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-- 263 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ-- 263 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc--
Confidence 21100 012345699999999987543 2688999999999999999999999531100 000111000
Q ss_pred CCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 319 SPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. .......+++++.+||.+||+.||.+|||+.+++++
T Consensus 264 ---------~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 264 ---------L-----------------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------C-----------------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0 001123467889999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=341.58 Aligned_cols=244 Identities=22% Similarity=0.377 Sum_probs=193.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||++.+ +|+.||+|+++... ..+.+.+|+.++++++||||+++++++... ...+|+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEE
Confidence 47899999999999999999985 58899999987543 345688999999999999999999987653 346899
Q ss_pred EEecccC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEH-DLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||+++ ++...+.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 9999987 4544443322 23899999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.....+++.|+|||++.+.. ++.++||||||+++|+|+| |.+||...+..+....+....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------------- 231 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 231 (278)
T ss_dssp -------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------
T ss_pred --ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 22345788999999998765 7899999999999999998 999998877666555442210
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.......+++.+.+||.+||+.||++|||+.|+++
T Consensus 232 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 00112357788999999999999999999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=344.77 Aligned_cols=261 Identities=25% Similarity=0.304 Sum_probs=198.6
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCC--CChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDN--LEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.|...+.||+|+||.||+|. .+++.||+|++.... ......+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 107 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCL 107 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEE--SSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred ccccCCccccCCCeEEEEEE--ECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEE
Confidence 35556999999999999998 478899999987542 234456778999999999999999999999876 456899
Q ss_pred EEecccCCHH-HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLA-GLAAC--QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~-~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
||||++++.+ ..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 9999987544 44332 23469999999999999999999999999999999999999999999999999998765432
Q ss_pred CCC-cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC--ChhhhhhcCC
Q 036122 254 KQP-MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSP--SEEYWKKSKL 330 (457)
Q Consensus 254 ~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~ 330 (457)
... .....||+.|+|||++.+. ++.++|||||||++|+|++|.+||........+..+....... .-..+....
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 264 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK- 264 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSS-
T ss_pred ccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccc-
Confidence 221 2345789999999988753 6889999999999999999999998765443333322211110 000000000
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
+.......+..+.+||.+||+.||.+|||+.+++++
T Consensus 265 ---------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 265 ---------------MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ---------------CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000111234567889999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=374.23 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=200.3
Q ss_pred CCccccc-eeeccCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLD-KIGQGTYSNVYKARDL--LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~-~LG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
++|.+.+ .||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|++++|||||++++++.. ..+
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCe
Confidence 4555555 7999999999999875 356679999997653 33445678899999999999999999999875 358
Q ss_pred EEEEecccCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
|+||||+.++.+.. +......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 99999999865544 44445679999999999999999999999999999999999999999999999999998764332
Q ss_pred CCC--cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 254 KQP--MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 254 ~~~--~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
... .....+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+.+..+.....
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------------ 557 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------------ 557 (613)
T ss_dssp -----------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC------------
T ss_pred ceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 211 12234568999999998666 8999999999999999998 9999999888887776643210
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
......+++++.+||..||+.||++|||+.+++
T Consensus 558 ----------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 558 ----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred ----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 011235788999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=346.45 Aligned_cols=251 Identities=18% Similarity=0.246 Sum_probs=200.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|.+.. .||+|++..........+.+.+|+.++++++||||+++++++.. ...+++
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~i 106 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLAI 106 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEEE
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceEE
Confidence 5789999999999999999998643 49999997655444444557789999999999999999999987 456999
Q ss_pred EEecccCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC---
Q 036122 177 VFEYMEHDLAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG--- 252 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~--- 252 (457)
||||+.++.+..+... ...+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 9999987555544443 44799999999999999999999999999999999999998 689999999998755321
Q ss_pred -CCCCcccccccCccCchHhhhC--------CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 036122 253 -LKQPMTSRVVTLWYRPPELLLG--------ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEE 323 (457)
Q Consensus 253 -~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~ 323 (457)
.........||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.......
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--- 262 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--- 262 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC---
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC---
Confidence 1122334568999999999975 2347889999999999999999999999888877766553321000
Q ss_pred hhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 324 YWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....++.++.+||.+||+.||++|||+.++++
T Consensus 263 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 ------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011247889999999999999999999999996
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=340.71 Aligned_cols=239 Identities=23% Similarity=0.323 Sum_probs=186.0
Q ss_pred cCCcccc-ceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHH-HhcCCCCceeEeeeEEe--cCCc
Q 036122 97 ANTFEKL-DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVL-RKLDHPNVIKLEGLVTS--RMSC 172 (457)
Q Consensus 97 ~~~y~~~-~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~--~~~~ 172 (457)
.++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4678887 7799999999999999999999999999642 3466788888 55689999999998865 2245
Q ss_pred eEEEEEecccC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCcc
Q 036122 173 SLYLVFEYMEH-DLAGLAACQG-VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLAT 247 (457)
Q Consensus 173 ~~~lv~E~~~~-~l~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~ 247 (457)
.+|+||||+++ ++...+.... ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 68999999987 4555444432 36999999999999999999999999999999999999998 7899999999987
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
.... ..++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus 169 ~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~----------- 213 (299)
T 3m2w_A 169 ETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----------- 213 (299)
T ss_dssp ECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS-----------
T ss_pred cccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH-----------
Confidence 4321 12678999999999999999999999776543321110000
Q ss_pred cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. ...........+..+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 214 -------~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 214 -------I---RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp -------S---CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred -------H---hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 0 0000001112335678899999999999999999999999999999874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=379.15 Aligned_cols=280 Identities=26% Similarity=0.332 Sum_probs=206.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEe----cCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTS----RMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~ 172 (457)
.++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.++++++||||+++++++.. ....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 46899999999999999999999999999999998754 355566778999999999999999999988654 1245
Q ss_pred eEEEEEecccCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc---EEEeeccCc
Q 036122 173 SLYLVFEYMEHDLAGLAACQG---VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI---LKIADFGLA 246 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~---vkl~DFGla 246 (457)
..|+||||+.++.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 679999999875555444432 25999999999999999999999999999999999999997764 999999999
Q ss_pred cccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh-h
Q 036122 247 TFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY-W 325 (457)
Q Consensus 247 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~-~ 325 (457)
...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+............ ...... .
T Consensus 172 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~---~~~~~~~~ 245 (676)
T 3qa8_A 172 KELDQG--ELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---EKSNEHIV 245 (676)
T ss_dssp CBTTSC--CCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---------CC
T ss_pred cccccc--cccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhh---cccchhhh
Confidence 876543 2335568899999999998766 79999999999999999999999987654322111000 000000 0
Q ss_pred hhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
..........+....+ ........+++.+.+||..||.+||++|||+.|+|+||||+.
T Consensus 246 ~~~~l~g~~~~~~~lp---~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLP---TPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCCCSSSCCCCSSSC---CSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhccccccccccC---CchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0000000000000000 011122335677899999999999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=345.04 Aligned_cols=269 Identities=22% Similarity=0.335 Sum_probs=201.9
Q ss_pred cCCccccceeeccCceEEEEEE----EcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKAR----DLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~----~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++++.||+|+||.||+|+ +..+|+.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 5679999999999999999998 4568999999999754 345567789999999999999999999998765455
Q ss_pred eEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
.+++||||+++ ++...+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 78999999987 55555555556799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 252 GLKQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 252 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
.... ......++..|+|||++.+.. ++.++|||||||++|+|+||..||...... ..+..+......+....
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-----HHHHHCTTCCTHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHHH-----HHHhhccccchhhhHHH
Confidence 3221 122345678899999998766 789999999999999999999888643211 11111111100000000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+........ .......+++++.+||.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 272 LIELLKNNG-------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHTTC-------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhcCC-------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000000 00112357788999999999999999999999984
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.75 Aligned_cols=251 Identities=20% Similarity=0.330 Sum_probs=204.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCC---CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~---g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 46799999999999999999998643 4579999986542 44555778899999999999999999998854 45
Q ss_pred EEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+|+||||+.++ +...+......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 89999999875 44444444557999999999999999999999999999999999999999999999999999876544
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.........+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------------ 611 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------ 611 (656)
T ss_dssp ---------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC------------
T ss_pred cceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------------
Confidence 333333455688999999998665 7999999999999999997 99999999888877776442110
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.....+++.+.+||.+||+.||++|||+.++++
T Consensus 612 ----------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 012347788999999999999999999999984
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=347.18 Aligned_cols=242 Identities=17% Similarity=0.158 Sum_probs=189.4
Q ss_pred cCCccccceeeccCceEEEEE-----EEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKA-----RDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD---HPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~-----~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~ 168 (457)
.++|.+.+.||+|+||+||+| .+..+++.||||++.... ...+.+|+.+++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 578999999999999999999 467889999999986432 345677888888887 9999999999887
Q ss_pred cCCceEEEEEecccCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---------
Q 036122 169 RMSCSLYLVFEYMEHDLAGLAAC-----QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN--------- 234 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~--------- 234 (457)
....|+||||++++.+..+.. ....+++..++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 139 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 139 --QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp --SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred --CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 567899999998754444433 3457999999999999999999999999999999999999998
Q ss_pred --CCcEEEeeccCccccCC-CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 036122 235 --DGILKIADFGLATFYDP-GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLH 311 (457)
Q Consensus 235 --~~~vkl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~ 311 (457)
++.+||+|||+++.... .........+||+.|+|||++.+.. ++.++|||||||++|||+||++||.......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999975431 1123345568999999999998877 8999999999999999999999985432200
Q ss_pred HHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccC--CCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 312 KIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFK--DFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 312 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
+. +...++ ..++.+.+++..||+.+|.+|++..+.|.+
T Consensus 293 -------------~~-------------------~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 293 -------------CK-------------------PEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp -------------EE-------------------ECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred -------------ee-------------------echhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 00 000000 123456789999999999999765555443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=344.27 Aligned_cols=278 Identities=24% Similarity=0.248 Sum_probs=189.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHH--HHhcCCCCceeEeeeEEe---cCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILV--LRKLDHPNVIKLEGLVTS---RMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~l~~~~~~---~~~ 171 (457)
.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|..+ +..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 57899999999999999999974 78999999997542 2223334444 556899999999876543 223
Q ss_pred ceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeccCCCCCEEecCCCcEEEee
Q 036122 172 CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN---------GVLHRDIKGSNLLIDNDGILKIAD 242 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~ivHrDlkp~NILl~~~~~vkl~D 242 (457)
..+|+||||++++.+..+.... .+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 4679999999875554444433 468999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCCC-------CCCcccccccCccCchHhhhCC------cCCCccchhhhHHHHHHHHHhCCCC-CCCCChHH
Q 036122 243 FGLATFYDPGL-------KQPMTSRVVTLWYRPPELLLGA------TYYGVGVDLWSAGCILAELLAGKPI-MPGRTEVE 308 (457)
Q Consensus 243 FGla~~~~~~~-------~~~~~~~~gt~~y~aPE~l~~~------~~~~~~~DvwslG~vl~elltG~~p-f~~~~~~~ 308 (457)
||+++...... ........||+.|+|||++.+. ..++.++|||||||++|||++|..| |.+....+
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99998764321 1222345799999999999763 2356789999999999999999654 44332211
Q ss_pred HHHHHHHhc-CCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHH------hcC
Q 036122 309 QLHKIFKLC-GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAA------LNS 381 (457)
Q Consensus 309 ~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el------L~h 381 (457)
....+.... ..+....+...... ....+..+ .. ......+++++.+||.+||+.||++|||+.|+ |.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSR--EKQRPKFP--EA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTT--SCCCCCCC--TT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcc--cccCCCCC--cc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 111111111 11111111100000 00000000 00 00001123358999999999999999999999 557
Q ss_pred CCCCCC
Q 036122 382 EFFNTE 387 (457)
Q Consensus 382 p~f~~~ 387 (457)
+|-++.
T Consensus 319 ~~~~~~ 324 (336)
T 3g2f_A 319 IWERNK 324 (336)
T ss_dssp CCCC--
T ss_pred HHHhcc
Confidence 888764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=350.10 Aligned_cols=250 Identities=17% Similarity=0.215 Sum_probs=192.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC------ChHHHHHHHHHHHHHHhcC---------CCCcee
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL------EPESVKFMAREILVLRKLD---------HPNVIK 161 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------hpniv~ 161 (457)
.++|++.+.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.+|+.++ |||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36799999999999999999996 789999999987642 2233466888999999885 888888
Q ss_pred EeeeEEec----------------------------CCceEEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 036122 162 LEGLVTSR----------------------------MSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGL 212 (457)
Q Consensus 162 l~~~~~~~----------------------------~~~~~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L 212 (457)
+.+++... ....+||||||+.++ ++..+.. ..+++.+++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 77765321 146799999999875 5554432 4689999999999999999
Q ss_pred HHHH-hCCceeccCCCCCEEecCCC--------------------cEEEeeccCccccCCCCCCCcccccccCccCchHh
Q 036122 213 EHCH-NNGVLHRDIKGSNLLIDNDG--------------------ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPEL 271 (457)
Q Consensus 213 ~~LH-~~~ivHrDlkp~NILl~~~~--------------------~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~ 271 (457)
.||| ++||+||||||+||||+.++ .+||+|||+|+.... ...+||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhh
Confidence 9999 99999999999999999887 999999999987643 23589999999999
Q ss_pred hhCCcCCCccchhhhHHHH-HHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcc
Q 036122 272 LLGATYYGVGVDLWSAGCI-LAELLAGKPIMPGRTE-VEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAET 349 (457)
Q Consensus 272 l~~~~~~~~~~DvwslG~v-l~elltG~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (457)
+.+.. +.++|||||+++ .+++++|..||..... ......+....... . ......
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------~-----~~~~~~ 304 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-----------------T-----KCNTPA 304 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-----------------S-----CCCSHH
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-----------------c-----ccchhh
Confidence 98654 789999998777 7789999999854221 11222222111000 0 000112
Q ss_pred cCCCCCCcHHHHHHhccCCCCCCcCHHHHh-cCCCCC
Q 036122 350 FKDFPSSSLPLIETLLSIDPDNRGTATAAL-NSEFFN 385 (457)
Q Consensus 350 ~~~~~~~~~~Li~~~L~~dP~~Rpta~elL-~hp~f~ 385 (457)
...+++++.+||++||+.| |++|+| +||||+
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 2346778999999999987 999999 999995
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=337.61 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=187.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc--CCCCceeEeeeEEecCC--c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL--DHPNVIKLEGLVTSRMS--C 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~~~--~ 172 (457)
.++|++.+.||+|+||.||+|++ +|+.||||++.... .....+|.+++..+ +||||+++++++..... .
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 36899999999999999999986 48999999986432 23344555665554 89999999999887432 5
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeccCCCCCEEecCCCcEEEeecc
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN--------GVLHRDIKGSNLLIDNDGILKIADFG 244 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------~ivHrDlkp~NILl~~~~~vkl~DFG 244 (457)
.+|+||||+.++.+..+.... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 789999999885444444333 699999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCCCCC---CcccccccCccCchHhhhCCcCCCc------cchhhhHHHHHHHHHhC----------CCCCCCCC
Q 036122 245 LATFYDPGLKQ---PMTSRVVTLWYRPPELLLGATYYGV------GVDLWSAGCILAELLAG----------KPIMPGRT 305 (457)
Q Consensus 245 la~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~------~~DvwslG~vl~elltG----------~~pf~~~~ 305 (457)
++......... ......||+.|+|||++.+.. ++. ++|||||||++|||+|| ..||....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 99866433221 123457999999999998665 333 38999999999999999 56664321
Q ss_pred ----hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 306 ----EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 306 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
....+........ ..+..+. ......+++++.+||.+||+.||++|||+.|+++|
T Consensus 267 ~~~~~~~~~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKK-----------------LRPSFPN----RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CSSCCHHHHHHHHTTSC-----------------CCCCCCG----GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCchhhhHHHHhhhc-----------------cCccccc----cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 1122222211000 0000000 00011345568899999999999999999999965
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=333.32 Aligned_cols=255 Identities=23% Similarity=0.266 Sum_probs=193.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHh--cCCCCceeEeeeEEecCC--ce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRK--LDHPNVIKLEGLVTSRMS--CS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~~--~~ 173 (457)
++|.+.+.||+|+||.||+|++ +|+.||||++... ....+.+|+.++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 5799999999999999999986 6899999998643 23556788999887 789999999999877432 27
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeccCCCCCEEecCCCcEEEeeccC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH--------NNGVLHRDIKGSNLLIDNDGILKIADFGL 245 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~ivHrDlkp~NILl~~~~~vkl~DFGl 245 (457)
+|+||||+.++.+..+... ..+++.+++.++.||+.||.||| +.||+||||||+||||+.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 8999999998544444443 35999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCCC---CcccccccCccCchHhhhCCcC-----CCccchhhhHHHHHHHHHhC----------CCCCCCCC--
Q 036122 246 ATFYDPGLKQ---PMTSRVVTLWYRPPELLLGATY-----YGVGVDLWSAGCILAELLAG----------KPIMPGRT-- 305 (457)
Q Consensus 246 a~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-----~~~~~DvwslG~vl~elltG----------~~pf~~~~-- 305 (457)
+......... ......||+.|+|||++.+... ++.++|||||||++|||+|| ..||....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9876543211 2344578999999999976532 23689999999999999999 67876542
Q ss_pred --hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 306 --EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 306 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
..+.+........ ..+..+. . + .....+..+.+||.+||+.||++|||+.++++|
T Consensus 274 ~~~~~~~~~~~~~~~-----------------~~~~~~~-~-~--~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQK-----------------LRPNIPN-R-W--QSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSC-----------------CCCCCCG-G-G--GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHH-----------------hCCCCcc-c-c--cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1122222111000 0000000 0 0 001233467889999999999999999999965
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=319.51 Aligned_cols=228 Identities=19% Similarity=0.127 Sum_probs=183.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.++.+++||||+++++++.. ...+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 107 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGL 107 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEE
Confidence 36899999999999999999999999999999999876543 4556778899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+..+...+ ....++..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999876555555433 4667889999999999999999999999999999999999999998543
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
|++| ++.++|||||||++|+|+||+.||.+.+..+.+...
T Consensus 175 ----------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---------------------- 214 (286)
T 3uqc_A 175 ----------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---------------------- 214 (286)
T ss_dssp ----------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----------------------
T ss_pred ----------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----------------------
Confidence 3332 688999999999999999999999876532211000
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.................+++++.+||.+||+.||++| |+.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 215 ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 0000000111223446788899999999999999999 9999985
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=369.20 Aligned_cols=243 Identities=23% Similarity=0.317 Sum_probs=197.4
Q ss_pred cCCccccceeeccCceEEEEEEEcC-CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC---c
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS---C 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---~ 172 (457)
.++|++.+.||+|+||+||+|++.. +|+.||||++.... .......+.+|+.++++++||||+++++++..... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4789999999999999999999876 78999999987543 44556678899999999999999999999886432 1
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
..||||||++++.+...... .+++.+++.|+.||+.||.|||++||+||||||+||||+.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 26999999998665554433 69999999999999999999999999999999999999885 9999999999876432
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... .++.
T Consensus 235 -----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------------~~~~ 286 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------------------GLPE 286 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------------------SCCT
T ss_pred -----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc---------------------cccc
Confidence 456799999999998754 478999999999999999999888642110 0000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
. ......++.+.+||.+||+.||.+||+..++|.|+|+.
T Consensus 287 ------~--------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 ------D--------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------T--------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------c--------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 00011345678999999999999999999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.14 Aligned_cols=188 Identities=17% Similarity=0.094 Sum_probs=135.6
Q ss_pred ceeeccCceEEEEEEEcCCCcEEEEEEeecCCC----C----hHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCceE
Q 036122 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----E----PESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~----~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~~ 174 (457)
..++.|++|.+..++....|+.||+|++..+.. . ....+.+.+|+++|+++ .|+||+++++++.+ +..+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEE
Confidence 346788888888888778899999999986532 1 23346789999999999 69999999999987 6789
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||||++|+.+...+...+++++. .|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~- 393 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC- 393 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-
Confidence 9999999998777777777788875 478999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP 299 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~ 299 (457)
....+.+||+.|||||++.+. +..++|+||+|+++++|.++..
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred ccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 334567899999999999764 4678999999999988876643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-29 Score=258.61 Aligned_cols=186 Identities=18% Similarity=0.131 Sum_probs=139.9
Q ss_pred cccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChH------HHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE------SVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 101 ~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
...+.||+|+||+||+|. ..+..+++|+......... ..+.+.+|+.+|++++||||+++..++.. ....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCcc
Confidence 446789999999999994 6788999998765433211 23457899999999999999955445444 3446
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||||++++.+..+... +..++.||+.||.|||++||+||||||+|||++. ++||+|||+++.......
T Consensus 415 ~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999987555544432 6689999999999999999999999999999998 999999999997754211
Q ss_pred CC------cccccccCccCchHhhhC--CcCCCccchhhhHHHHHHHHHhCCCCC
Q 036122 255 QP------MTSRVVTLWYRPPELLLG--ATYYGVGVDLWSAGCILAELLAGKPIM 301 (457)
Q Consensus 255 ~~------~~~~~gt~~y~aPE~l~~--~~~~~~~~DvwslG~vl~elltG~~pf 301 (457)
.. .....||+.|||||++.+ .. |+..+|+||..+-.++.+.++.+|
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~-Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEG-YKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHH-HHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 135678999999999975 33 677899999999999988877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=217.73 Aligned_cols=148 Identities=14% Similarity=0.102 Sum_probs=116.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----------------HHHHHHHHHHHHHHhcCCCCcee
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----------------ESVKFMAREILVLRKLDHPNVIK 161 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~hpniv~ 161 (457)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|++++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 4566779999999999999998 889999999997543211 23566889999999999 5 66
Q ss_pred EeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEe
Q 036122 162 LEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIA 241 (457)
Q Consensus 162 l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 241 (457)
+.+++.. ...|+||||++++.+..+ ...+...++.||+.||.|||++||+||||||+||||+ ++.+||+
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~l-------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGGC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec---cceEEEEEecCCCcHHHc-------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 6665544 346999999988544432 1134557999999999999999999999999999999 9999999
Q ss_pred eccCccccCCCCCCCcccccccCccCchHhhhC
Q 036122 242 DFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274 (457)
Q Consensus 242 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 274 (457)
|||+|+. +..|+|||++..
T Consensus 235 DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 235 DFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CCTTCEE--------------TTSTTHHHHHHH
T ss_pred ECCCCeE--------------CCCCCHHHHHHH
Confidence 9999963 334789998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.3e-22 Score=186.87 Aligned_cols=140 Identities=17% Similarity=0.223 Sum_probs=107.2
Q ss_pred CccccceeeccCceEEEEEEEcCCCcE--EEEEEeecCCCCh----------------------HHHHHHHHHHHHHHhc
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKI--VALKKVRFDNLEP----------------------ESVKFMAREILVLRKL 154 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~--vAiK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 154 (457)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 377889999999999999998778999 9999976532110 1123578899999999
Q ss_pred CCCCc--eeEeeeEEecCCceEEEEEecccC-C----HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeccCC
Q 036122 155 DHPNV--IKLEGLVTSRMSCSLYLVFEYMEH-D----LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH-NNGVLHRDIK 226 (457)
Q Consensus 155 ~hpni--v~l~~~~~~~~~~~~~lv~E~~~~-~----l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlk 226 (457)
.|++| +.++.+ ...+|||||+++ + .+...... +++..+..++.||+.+|.||| ++||+|||||
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 88764 333322 235899999953 2 33333221 345678899999999999999 9999999999
Q ss_pred CCCEEecCCCcEEEeeccCcccc
Q 036122 227 GSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 227 p~NILl~~~~~vkl~DFGla~~~ 249 (457)
|+|||++. .++|+|||+|...
T Consensus 199 p~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEET
T ss_pred HHHEEEcC--cEEEEECcccccC
Confidence 99999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6.9e-19 Score=173.42 Aligned_cols=139 Identities=18% Similarity=0.209 Sum_probs=99.3
Q ss_pred CccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC---------------ChHHH-----HHHHHHHHHHHhcCCCC
Q 036122 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL---------------EPESV-----KFMAREILVLRKLDHPN 158 (457)
Q Consensus 99 ~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~---------------~~~~~-----~~~~~E~~~l~~l~hpn 158 (457)
-|++.+.||.|+||.||+|.+ .+|+.||||+++.... ..... ....+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 489999999999999999996 5799999999864211 00000 11235677777775544
Q ss_pred ceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC--
Q 036122 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-- 236 (457)
Q Consensus 159 iv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-- 236 (457)
+... ..+... ..+|||||++|..+..+. .......++.||+.+|.+||++|||||||||.||||+++|
T Consensus 175 v~vp-~p~~~~---~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVP-EPIAQS---RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCC-CEEEEE---TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCC-eeeecc---CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 3221 112111 137999999986543221 2234567889999999999999999999999999999876
Q ss_pred --------cEEEeeccCccc
Q 036122 237 --------ILKIADFGLATF 248 (457)
Q Consensus 237 --------~vkl~DFGla~~ 248 (457)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 489999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-12 Score=123.04 Aligned_cols=139 Identities=14% Similarity=0.083 Sum_probs=107.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 176 (457)
..|.+...++.|+++.||++. ..+..+++|+....... ....+.+|+.+++.|. +.++.++++++.. ....|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEE--CCCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence 468888889999999999997 34788999998653211 1124778999999985 6778888888776 567899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN--------------------------------------- 217 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 217 (457)
||||++|..+.... .+......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 99999996655431 1223345778899999999998
Q ss_pred --------------------CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 218 --------------------NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 218 --------------------~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876667799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=7.8e-12 Score=116.90 Aligned_cols=134 Identities=12% Similarity=0.086 Sum_probs=96.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeeeEEecCCceEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN--VIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~~~ 175 (457)
..|.+....+.|..+.||++. ..+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++++... ....|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~ 91 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDW 91 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEE
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCE
Confidence 345544333456669999996 4567889999976431 134678999999886544 4567776655 45689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG------------------------------------ 219 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------ 219 (457)
+||||++|..+. .. ..+ ...++.+++..|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999986543 11 122 2356778888888888753
Q ss_pred ----------------------ceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 220 ----------------------VLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 220 ----------------------ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
++|+|++|.|||+++++.+.|+|||.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=4.1e-11 Score=118.04 Aligned_cols=143 Identities=16% Similarity=0.227 Sum_probs=103.6
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEee--cCCCChHHHHHHHHHHHHHHhcC--CCCceeEeeeEEecCC-ceEEE
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVR--FDNLEPESVKFMAREILVLRKLD--HPNVIKLEGLVTSRMS-CSLYL 176 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~--~~~~~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~-~~~~l 176 (457)
.++.|+.|.++.||++.. .+..+++|+.. .... ......+.+|+.+++.|. +..+++++.++.+... ...|+
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 467899999999999974 35678888765 3221 112345778999999997 4557888877765311 34789
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN--------------------------------------- 217 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 217 (457)
||||++|..+... .-..++..+...++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999998543211 11247788889999999999999997
Q ss_pred -------------------CCceeccCCCCCEEecCCCc--EEEeeccCcccc
Q 036122 218 -------------------NGVLHRDIKGSNLLIDNDGI--LKIADFGLATFY 249 (457)
Q Consensus 218 -------------------~~ivHrDlkp~NILl~~~~~--vkl~DFGla~~~ 249 (457)
..++|+|+++.|||++.++. +.|+||+.+..-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997753 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=2.1e-11 Score=117.32 Aligned_cols=183 Identities=16% Similarity=0.150 Sum_probs=120.0
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCC--ceeEeeeEEecCC-ceEEEEE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPN--VIKLEGLVTSRMS-CSLYLVF 178 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~~-~~~~lv~ 178 (457)
++.++.|.+..||++. ..+++|+... ......+.+|+.+|+.+. +.. +.+++........ ...|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4669999999999873 4588998642 234567889999999884 333 3344333222111 1348899
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN----------------------------------------- 217 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----------------------------------------- 217 (457)
|+++|..+..... ..++..+...++.+++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999854432221 247788888888999998888886
Q ss_pred -----------------CCceeccCCCCCEEecC--CCcEEEeeccCccccCCCCCCCcccccccCcc---CchHhhhC-
Q 036122 218 -----------------NGVLHRDIKGSNLLIDN--DGILKIADFGLATFYDPGLKQPMTSRVVTLWY---RPPELLLG- 274 (457)
Q Consensus 218 -----------------~~ivHrDlkp~NILl~~--~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~l~~- 274 (457)
..++|+|++|.||++++ ++.+.|+||+.+...++.. .......+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHH
Confidence 13799999999999998 5568999999987654321 11111111 23332210
Q ss_pred ---CcC---------CCccchhhhHHHHHHHHHhCCCCC
Q 036122 275 ---ATY---------YGVGVDLWSAGCILAELLAGKPIM 301 (457)
Q Consensus 275 ---~~~---------~~~~~DvwslG~vl~elltG~~pf 301 (457)
... ...-.+.|+++.++|.+.+|.++|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 012258999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.7e-07 Score=89.99 Aligned_cols=136 Identities=14% Similarity=0.164 Sum_probs=94.2
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---CceeEeeeEEecCCceEEEEEe
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP---NVIKLEGLVTSRMSCSLYLVFE 179 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~~lv~E 179 (457)
++.++.|....||+. |..+++|+.. .......+.+|+.+|+.|.+. .+.+.+.+.... ....|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-DGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-TSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC-CCceEEEEe
Confidence 456888999999988 5678888852 234456788999999999753 245555555422 345789999
Q ss_pred cccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 036122 180 YMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN----------------------------------------- 218 (457)
Q Consensus 180 ~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------------- 218 (457)
|++|..+...... .++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 9998544332111 245555556666666666666542
Q ss_pred -------------------CceeccCCCCCEEecC---CCc-EEEeeccCccccC
Q 036122 219 -------------------GVLHRDIKGSNLLIDN---DGI-LKIADFGLATFYD 250 (457)
Q Consensus 219 -------------------~ivHrDlkp~NILl~~---~~~-vkl~DFGla~~~~ 250 (457)
.++|+|+++.|||++. ++. +.|+||+.+...+
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999997 455 5899999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=3.8e-07 Score=85.55 Aligned_cols=134 Identities=15% Similarity=0.119 Sum_probs=91.1
Q ss_pred ceeeccCce-EEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYS-NVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg-~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
+.+..|..+ .||+......+..+.+|+-.. .....+.+|..+|+.|. +--+.++++++.+ ....|+|||++
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l 102 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAI 102 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECC
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEee
Confidence 345556555 699988666778899998653 23456788999999885 3336677777766 45689999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN------------------------------------------- 218 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------- 218 (457)
+|..+....... ......+..+++..|..||..
T Consensus 103 ~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 103 PGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp CSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred CCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 985443322211 122233445555555555531
Q ss_pred ---------------CceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 219 ---------------GVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 219 ---------------~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 278999999999999877778999998863
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2e-06 Score=85.46 Aligned_cols=77 Identities=18% Similarity=0.180 Sum_probs=47.9
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCC--C---hHHHHHHHHHHHHHHhcCC--CC-ceeEeeeEEecCCceE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL--E---PESVKFMAREILVLRKLDH--PN-VIKLEGLVTSRMSCSL 174 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--pn-iv~l~~~~~~~~~~~~ 174 (457)
.+.||.|.++.||++....++..|++|....... . ......+..|..+|+.+.. +. +.+++.+ +. ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~--~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cC--Ccc
Confidence 5789999999999997555678899998653211 0 0112345678888887742 33 3455433 22 234
Q ss_pred EEEEecccC
Q 036122 175 YLVFEYMEH 183 (457)
Q Consensus 175 ~lv~E~~~~ 183 (457)
++||||+++
T Consensus 111 ~lvmE~l~g 119 (397)
T 2olc_A 111 VTVMEDLSH 119 (397)
T ss_dssp EEEECCCTT
T ss_pred EEEEEeCCC
Confidence 799999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=2.7e-05 Score=75.20 Aligned_cols=30 Identities=17% Similarity=0.313 Sum_probs=27.5
Q ss_pred CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=2.3e-06 Score=83.63 Aligned_cols=82 Identities=10% Similarity=0.046 Sum_probs=51.1
Q ss_pred cccee-eccCceEEEEEEEc--C----CCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcC-C--CCceeEeeeEEecC
Q 036122 102 KLDKI-GQGTYSNVYKARDL--L----TGKIVALKKVRFDNL-EPESVKFMAREILVLRKLD-H--PNVIKLEGLVTSRM 170 (457)
Q Consensus 102 ~~~~L-G~G~fg~Vy~~~~~--~----~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~ 170 (457)
..+.| +.|....+|+.... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.++.+..
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 35667 88889999998642 0 266789997653220 0000123667888888874 2 34667776654421
Q ss_pred -CceEEEEEecccC
Q 036122 171 -SCSLYLVFEYMEH 183 (457)
Q Consensus 171 -~~~~~lv~E~~~~ 183 (457)
....|+||||++|
T Consensus 104 ~~g~~~~v~e~l~G 117 (357)
T 3ats_A 104 VLGTPFFLMDYVEG 117 (357)
T ss_dssp TTSSCEEEEECCCC
T ss_pred ccCCceEEEEecCC
Confidence 1346899999987
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.82 E-value=6.7e-05 Score=75.04 Aligned_cols=79 Identities=9% Similarity=0.080 Sum_probs=46.5
Q ss_pred HhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc--cCccCchHhhhCCc--CCCccchhhhHHHHH
Q 036122 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYRPPELLLGAT--YYGVGVDLWSAGCIL 291 (457)
Q Consensus 216 H~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~--~~~~~~DvwslG~vl 291 (457)
+...++|+|+++.|||++.++ +.|+||+.+..-++... ...... ...|++|+...... .-....++..+...+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 356799999999999999876 99999999875432110 000010 23355655443111 011223455677777
Q ss_pred HHHHhC
Q 036122 292 AELLAG 297 (457)
Q Consensus 292 ~elltG 297 (457)
|+++++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00026 Score=67.75 Aligned_cols=74 Identities=18% Similarity=0.147 Sum_probs=56.0
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC---CCCceeEeeeEEecCCceEEEEE
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD---HPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
-.+.|+.|.+..+|+.. .++..+++|+.... ....+..|...|+.|. ...+++++.+... ....|+||
T Consensus 40 ~~~~l~gG~~n~~y~v~--~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvm 110 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIN--DEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLL 110 (312)
T ss_dssp EEEEECCSSSSEEEEEE--SSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEE
T ss_pred eeEEeCCccceeeeEEE--ECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEE
Confidence 35679999999999997 35678899987632 2456788999998884 2457777776655 45689999
Q ss_pred ecccCC
Q 036122 179 EYMEHD 184 (457)
Q Consensus 179 E~~~~~ 184 (457)
||+++.
T Consensus 111 e~l~G~ 116 (312)
T 3jr1_A 111 EALNKS 116 (312)
T ss_dssp ECCCCC
T ss_pred EeccCC
Confidence 999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00076 Score=63.55 Aligned_cols=75 Identities=17% Similarity=0.213 Sum_probs=52.2
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCC---CceeEeeeEEecCCceEEE
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP---NVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~~~~~~~l 176 (457)
..-+..+|.|..+.||+... .+|+.|.+|+....... ....+..|+..|+.|.-. .+++++++ . . -++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~--~~l 87 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D--RTL 87 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T--TEE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C--ceE
Confidence 44578899999999999984 78899999986543222 223477899999888422 24445443 2 1 278
Q ss_pred EEecccC
Q 036122 177 VFEYMEH 183 (457)
Q Consensus 177 v~E~~~~ 183 (457)
||||+.+
T Consensus 88 v~e~l~~ 94 (288)
T 3f7w_A 88 AMEWVDE 94 (288)
T ss_dssp EEECCCC
T ss_pred EEEeecc
Confidence 9999875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00053 Score=65.06 Aligned_cols=68 Identities=16% Similarity=0.058 Sum_probs=41.5
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeeeEEecCCceEEEEEecc
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV-IKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~lv~E~~ 181 (457)
++.|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .+++++.. ..-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~~----~~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVDP----ATGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT----TTCCEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEEC----CCCEEEEeec
Confidence 688999999999999 45888987543111 0112457777777642222 45544321 1236899999
Q ss_pred -cC
Q 036122 182 -EH 183 (457)
Q Consensus 182 -~~ 183 (457)
++
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00088 Score=59.83 Aligned_cols=97 Identities=15% Similarity=0.033 Sum_probs=64.5
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcccccc
Q 036122 184 DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC-HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV 262 (457)
Q Consensus 184 ~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~~~g 262 (457)
+|...+...+.+++|+++|.++.|.+.+|.-+ +...-..+=+.|..|+|..+|.|.+.+ ..+. ..
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~ 99 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG 99 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence 46677777788999999999999999998876 222222344567999999999998764 2111 11
Q ss_pred cCccCchHhhhCCcCCCccchhhhHHHHHHHHHh
Q 036122 263 TLWYRPPELLLGATYYGVGVDLWSAGCILAELLA 296 (457)
Q Consensus 263 t~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt 296 (457)
...+.+||... ...+.+.=|||||+++|..+-
T Consensus 100 ~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 100 EPPPVAGKLGY--SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence 22356787653 124567789999999999885
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00013 Score=69.89 Aligned_cols=138 Identities=14% Similarity=0.113 Sum_probs=75.6
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeee------EEecCCce
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN--VIKLEGL------VTSRMSCS 173 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------~~~~~~~~ 173 (457)
-++.|+.|....+|++.. .+| .+++|+..... . ...+..|+.+++.|.... +.+++.. ... ...
T Consensus 26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~--~g~ 97 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL--SGR 97 (322)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE--TTE
T ss_pred EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE--CCE
Confidence 356688888899999974 344 68899886421 1 123556777777764212 2333211 111 245
Q ss_pred EEEEEecccCCHH---------------HHHHhc--C--CC----CCHHHHHHH---------------HHHHHHHHHHH
Q 036122 174 LYLVFEYMEHDLA---------------GLAACQ--G--VK----FSEPQVKCY---------------MKQLLSGLEHC 215 (457)
Q Consensus 174 ~~lv~E~~~~~l~---------------~~~~~~--~--~~----l~~~~~~~i---------------~~qi~~~L~~L 215 (457)
.+++|+|++|... ..+... . .+ ......... ...+...+.+|
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 6899999987311 111111 1 00 111100000 01133445555
Q ss_pred Hh-------CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 216 HN-------NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 216 H~-------~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
++ .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 42 369999999999999987666899999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00058 Score=68.44 Aligned_cols=72 Identities=17% Similarity=0.203 Sum_probs=48.0
Q ss_pred ccceeeccCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeeeEEecCCce
Q 036122 102 KLDKIGQGTYSNVYKARDLL-------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV-IKLEGLVTSRMSCS 173 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~ 173 (457)
.++.|+.|-...||++.... .+..|.+|+..... . ...+.+|..+++.|...++ .++++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 35678889999999998542 25789999874321 1 1234578998888853334 566654421
Q ss_pred EEEEEecccC
Q 036122 174 LYLVFEYMEH 183 (457)
Q Consensus 174 ~~lv~E~~~~ 183 (457)
.+||||++|
T Consensus 148 -g~v~e~l~G 156 (429)
T 1nw1_A 148 -GRLEEYIPS 156 (429)
T ss_dssp -EEEECCCCE
T ss_pred -CEEEEEeCC
Confidence 389999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0015 Score=64.14 Aligned_cols=141 Identities=14% Similarity=0.141 Sum_probs=82.1
Q ss_pred CCccccceeeccCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEec
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL-------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSR 169 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 169 (457)
+.++ ++.|..|-...+|++.... ++..|.+|+.-.. ......+.+|..+++.|. +.-..++++++..
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 3344 4678778888999997532 3578999985321 112344568999988875 3223556555432
Q ss_pred CCceEEEEEecccCCHHH------------------HHHhcC----CCC--CHHHHHHHHHHHHH---------------
Q 036122 170 MSCSLYLVFEYMEHDLAG------------------LAACQG----VKF--SEPQVKCYMKQLLS--------------- 210 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~------------------~~~~~~----~~l--~~~~~~~i~~qi~~--------------- 210 (457)
.+||||++|..+. .+.... ... -+.++..+..++..
T Consensus 126 -----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 126 -----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp -----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred -----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 2899999872110 011111 112 24566666655432
Q ss_pred ----HHHHHH----h----CCceeccCCCCCEEecCC----CcEEEeeccCccc
Q 036122 211 ----GLEHCH----N----NGVLHRDIKGSNLLIDND----GILKIADFGLATF 248 (457)
Q Consensus 211 ----~L~~LH----~----~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~ 248 (457)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 2 259999999999999876 7899999998863
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00063 Score=66.56 Aligned_cols=72 Identities=10% Similarity=0.029 Sum_probs=41.9
Q ss_pred cceeeccCceEEEEEEEcC--------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC-ceeEeeeEEecCCce
Q 036122 103 LDKIGQGTYSNVYKARDLL--------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN-VIKLEGLVTSRMSCS 173 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~--------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~ 173 (457)
+..|+.|....+|++.... .+..+++|+..... ........|..+++.|...+ ..++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF----NG- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TT-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec----CC-
Confidence 5678888888999997542 13678889865321 11112356888888775333 34565433 12
Q ss_pred EEEEEecccC
Q 036122 174 LYLVFEYMEH 183 (457)
Q Consensus 174 ~~lv~E~~~~ 183 (457)
++||||++|
T Consensus 110 -~~v~e~i~G 118 (369)
T 3c5i_A 110 -GRIEEWLYG 118 (369)
T ss_dssp -EEEEECCCS
T ss_pred -cEEEEEecC
Confidence 689999987
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0033 Score=60.14 Aligned_cols=137 Identities=15% Similarity=0.099 Sum_probs=77.6
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCC--ceeEeee-----EEecCCceEE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN--VIKLEGL-----VTSRMSCSLY 175 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~-----~~~~~~~~~~ 175 (457)
+..|+ |....||++.. .+|+.+++|+....... ...+..|..+++.|.... +++++.. ... .+..+
T Consensus 31 ~~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~--~g~~~ 103 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYF 103 (328)
T ss_dssp CEEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEE
T ss_pred EEeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE--CCEEE
Confidence 34566 88889998863 45678999998643222 234566888887774222 3444332 111 34568
Q ss_pred EEEecccCCHH---------------HHHHh--cC------CCCCHHHH----------------------HHHHHHHHH
Q 036122 176 LVFEYMEHDLA---------------GLAAC--QG------VKFSEPQV----------------------KCYMKQLLS 210 (457)
Q Consensus 176 lv~E~~~~~l~---------------~~~~~--~~------~~l~~~~~----------------------~~i~~qi~~ 210 (457)
+||+|++|... ..+.. .. ..++.... ...+.+++.
T Consensus 104 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 183 (328)
T 1zyl_A 104 AVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIA 183 (328)
T ss_dssp EEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHH
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHH
Confidence 89999987211 00110 00 01121111 011112222
Q ss_pred HHHHH----HhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 211 GLEHC----HNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 211 ~L~~L----H~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
.+.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 184 ~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 184 AVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 22222 223589999999999999 4 899999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0023 Score=61.85 Aligned_cols=33 Identities=24% Similarity=0.371 Sum_probs=28.9
Q ss_pred CCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
..++|+|+.+.||+++.++.+.|+||+.+...+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 369999999999999988899999999887543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.002 Score=61.98 Aligned_cols=33 Identities=27% Similarity=0.311 Sum_probs=28.4
Q ss_pred CCceeccCCCCCEEecCC----CcEEEeeccCccccC
Q 036122 218 NGVLHRDIKGSNLLIDND----GILKIADFGLATFYD 250 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~----~~vkl~DFGla~~~~ 250 (457)
..++|+|+.+.|||++.+ +.+.|+||+.+..-.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 469999999999999875 689999999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0074 Score=60.80 Aligned_cols=73 Identities=18% Similarity=0.123 Sum_probs=46.3
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeeeEEecCCceEEEEEec
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV-IKLEGLVTSRMSCSLYLVFEY 180 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~~lv~E~ 180 (457)
.++.|+.|-...+|++.....+..|++|+...... ... ...+|..+++.|...++ .++++.+. + .+||||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~----~--G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EII-NREREKKISCILYNKNIAKKIYVFFT----N--GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCS-CHHHHHHHHHHHTTSSSBCCEEEEET----T--EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC----C--eEEEEe
Confidence 35678889999999998644357899998743211 111 11478999998875455 46666552 2 259999
Q ss_pred ccC
Q 036122 181 MEH 183 (457)
Q Consensus 181 ~~~ 183 (457)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 986
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.061 Score=53.44 Aligned_cols=73 Identities=10% Similarity=-0.008 Sum_probs=45.5
Q ss_pred ccceeeccCceEEEEEEEcCC-------CcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCce
Q 036122 102 KLDKIGQGTYSNVYKARDLLT-------GKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~-------g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~ 173 (457)
.++.|..|-...+|++..... +..|.+|+..... +..-...+|..+++.|. +.-..++++.+ ..
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF----PE- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TT-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CC-
Confidence 356687788889999986421 5789999864321 11111346888888775 22234555432 11
Q ss_pred EEEEEecccC
Q 036122 174 LYLVFEYMEH 183 (457)
Q Consensus 174 ~~lv~E~~~~ 183 (457)
++||||++|
T Consensus 146 -~~I~efI~G 154 (424)
T 3mes_A 146 -GRIEEFIDG 154 (424)
T ss_dssp -EEEEECCCS
T ss_pred -CEEEEEeCC
Confidence 689999987
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.66 E-value=0.1 Score=51.33 Aligned_cols=29 Identities=24% Similarity=0.518 Sum_probs=25.2
Q ss_pred ceeccCCCCCEEe------cCCCcEEEeeccCccc
Q 036122 220 VLHRDIKGSNLLI------DNDGILKIADFGLATF 248 (457)
Q Consensus 220 ivHrDlkp~NILl------~~~~~vkl~DFGla~~ 248 (457)
++|+|+.+.|||+ +++..+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999999864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=92.18 E-value=0.016 Score=58.42 Aligned_cols=65 Identities=11% Similarity=0.170 Sum_probs=19.5
Q ss_pred cccceeeccCceEEEEEEEcCCCcEEEE------EEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEe
Q 036122 101 EKLDKIGQGTYSNVYKARDLLTGKIVAL------KKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTS 168 (457)
Q Consensus 101 ~~~~~LG~G~fg~Vy~~~~~~~g~~vAi------K~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 168 (457)
.+.+.|| ||.||++....+...||+ |..+......+....+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4566787 999999987655568899 7766544555555678889999999999999999887643
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.26 E-value=4.3 Score=35.96 Aligned_cols=84 Identities=15% Similarity=0.002 Sum_probs=57.2
Q ss_pred CCCCceeEeeeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCceeccCCCCCEEec
Q 036122 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE-HCHNNGVLHRDIKGSNLLID 233 (457)
Q Consensus 155 ~hpniv~l~~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~ivHrDlkp~NILl~ 233 (457)
.||++ .. .+-.. .+.+.+.++.-++........ .++..+.++++..|+.... ++ ..-+|--|.|+||+++
T Consensus 48 ~~~~f-~~-~I~~~--eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-VR-DIDVS--EDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-EE-EEEEC--SSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC-Ce-EEEEe--CCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 67887 32 12222 456677777665433322222 4788899988888887655 44 4456778999999999
Q ss_pred CCCcEEEeeccCcc
Q 036122 234 NDGILKIADFGLAT 247 (457)
Q Consensus 234 ~~~~vkl~DFGla~ 247 (457)
.++.++|.-.|+-.
T Consensus 119 ~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 119 RALEPFFLHVGVKE 132 (219)
T ss_dssp TTCCEEESCCEETT
T ss_pred CCCcEEEEEcCCcc
Confidence 99999999888654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 457 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-87 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-85 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-79 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-79 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-77 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-76 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-76 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-75 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-75 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-73 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-73 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-72 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-70 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-69 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-68 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-67 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-67 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-62 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-58 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-58 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-57 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-55 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-53 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-53 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-52 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-52 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-29 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (681), Expect = 5e-87
Identities = 132/311 (42%), Positives = 180/311 (57%), Gaps = 12/311 (3%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL 154
+ +EKL KIGQGT+ V+KAR TG+ VALKKV +N + REI +L+ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 155 DHPNVIKLEGLVTSRMS------CSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQL 208
H NV+ L + ++ S S+YLVF++ EHDLAGL + VKF+ ++K M+ L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG---LKQPMTSRVVTLW 265
L+GL + H N +LHRD+K +N+LI DG+LK+ADFGLA + T+RVVTLW
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
YRPPELLLG YG +DLW AGCI+AE+ PIM G TE QL I +LCGS + E W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 326 KK-SKLPNATLFKPQQPYKRCIAETFKDFPSSS--LPLIETLLSIDPDNRGTATAALNSE 382
+ + KR + + K + L LI+ LL +DP R + ALN +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 383 FFNTEPYACEP 393
FF ++P +
Sbjct: 307 FFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 260 bits (666), Expect = 5e-85
Identities = 118/301 (39%), Positives = 173/301 (57%), Gaps = 7/301 (2%)
Query: 101 EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL---EPESVKFMAREILVLRKLDHP 157
EKLD +G+G ++ VYKARD T +IVA+KK++ + + + REI +L++L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
N+I L + ++ LVF++ME DL + + + +K YM L GLE+ H
Sbjct: 61 NIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+ +LHRD+K +NLL+D +G+LK+ADFGLA + + T +VVT WYR PELL GA
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGARM 177
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
YGVGVD+W+ GCILAELL P +PG ++++QL +IF+ G+P+EE W +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLP 397
P + F L LI+ L +P R TAT AL ++F+ P LP
Sbjct: 238 KSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
Query: 398 K 398
+
Sbjct: 297 R 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 3e-79
Identities = 104/331 (31%), Positives = 162/331 (48%), Gaps = 13/331 (3%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
+ L IG+G Y V A D + VA+KK+ + + + REI +L + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRH 65
Query: 157 PNVIKLEGLV---TSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
N+I + ++ T +YLV M DL L Q S + ++ Q+L GL+
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLK 123
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP--MTSRVVTLWYRPPEL 271
+ H+ VLHRD+K SNLL++ LKI DFGLA DP +T V T WYR PE+
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 272 LLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331
+L + Y +D+WS GCILAE+L+ +PI PG+ ++QL+ I + GSPS+E
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 332 NATLFKPQQPYKRCI--AETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389
A + P+K + F + S +L L++ +L+ +P R AL +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY- 302
Query: 390 ACEPSSLPKYPPSKEMDVKLREEEARRQRGL 420
+PS P + D++L + + + L
Sbjct: 303 --DPSDEPIAEAPFKFDMELDDLPKEKLKEL 331
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 4e-79
Identities = 106/325 (32%), Positives = 161/325 (49%), Gaps = 13/325 (4%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ L +G G Y V A D TG VA+KK+ K RE+ +L+ + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 158 NVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
NVI L + T + YLV +M DL L + K E +++ + Q+L GL
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL--MKHEKLGEDRIQFLVYQMLKGLR 135
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ H G++HRD+K NL ++ D LKI DFGLA D MT VVT WYR PE++L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVIL 191
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y VD+WS GCI+AE++ GK + G ++QL +I K+ G+P E+ ++ + A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 334 TLFKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYAC 391
+ P K+ A + ++ L+E +L +D + R TA AL +F +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
Query: 392 EPSSLPKYPPSKEMDVKLREEEARR 416
+ + KY S + DV +E +R
Sbjct: 312 DEPQVQKYDDSFD-DVDRTLDEWKR 335
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 1e-77
Identities = 105/327 (32%), Positives = 157/327 (48%), Gaps = 18/327 (5%)
Query: 99 TFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
++ IG G++ VY+A+ +G++VA+KKV D +F RE+ ++RKLDH N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 159 VIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLA---ACQGVKFSEPQVKCYMKQLLSG 211
+++L S L LV +Y+ + +A + VK YM QL
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
L + H+ G+ HRDIK NLL+D D +LK+ DFG A G +P S + + +YR PE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRAPE 192
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330
L+ GAT Y +D+WSAGC+LAELL G+PI PG + V+QL +I K+ G+P+ E ++
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYA 390
PQ P ++ L LL P R T A FF+
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD--ELR 310
Query: 391 CEPSSLPKYPPSKEMDVKLREEEARRQ 417
LP + + +E +
Sbjct: 311 DPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 2e-76
Identities = 110/319 (34%), Positives = 157/319 (49%), Gaps = 12/319 (3%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++ L +G G Y +V A D TG VA+KK+ K RE+ +L+ + H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 160 IKLEGLVTSRMSC----SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
I L + T S +YLV M DL + CQ K ++ V+ + Q+L GL++
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI 137
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
H+ ++HRD+K SNL ++ D LKI DFGLA D MT V T WYR PE++L
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNW 193
Query: 276 TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
+Y VD+WS GCI+AELL G+ + PG ++QL I +L G+P E KK +A
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 336 FKPQQPY--KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
+ K A F ++ L+E +L +D D R TA AL +F +
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 394 SSLPKYPPSKEMDVKLREE 412
Y S E L +E
Sbjct: 314 PVADPYDQSFESRDLLIDE 332
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (607), Expect = 4e-76
Identities = 116/287 (40%), Positives = 169/287 (58%), Gaps = 4/287 (1%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
F+K++KIG+GTY VYKAR+ LTG++VALKK+R D REI +L++L+HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+KL ++ + LYLVFE++ DL + A P +K Y+ QLL GL CH++
Sbjct: 64 VKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
VLHRD+K NLLI+ +G +K+ADFGLA + ++ T VVTLWYR PE+LLG YY
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-YTHEVVTLWYRAPEILLGCKYY 180
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
VD+WS GCI AE++ + + PG +E++QL +IF+ G+P E W
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
+ ++ ++ L+ +L DP+ R +A AAL FF
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 2e-75
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 30/287 (10%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++ + +G+G Y V A + +T + VA+K V + + + +EI + + L+H NV
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENV 65
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
+K G R YL EY + EP + + QL++G+ + H G
Sbjct: 66 VKFYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELLLGATYY 278
+ HRDIK NLL+D LKI+DFGLAT + ++ + +++ TL Y PELL ++
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
VD+WS G +L +LAG+ ++ Q + +K +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--------------- 228
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
+K S+ L L+ +L +P R T ++N
Sbjct: 229 -----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 234 bits (598), Expect = 5e-75
Identities = 103/285 (36%), Positives = 161/285 (56%), Gaps = 4/285 (1%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ L+KIG+GTY VYKA++ G+ ALKK+R + + REI +L++L H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
+KL ++ ++ L LVFE+++ DL L K ++ QLL+G+ +CH+
Sbjct: 63 VKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
VLHRD+K NLLI+ +G LKIADFGLA + +++ +VTLWYR P++L+G+ Y
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWYRAPDVLMGSKKYS 179
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339
+D+WS GCI AE++ G P+ PG +E +QL +IF++ G+P+ + W
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
K S + L+ +L +DP+ R TA AL +F
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 2e-74
Identities = 110/287 (38%), Positives = 161/287 (56%), Gaps = 4/287 (1%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+EKL+KIG+GTY V+KA++ T +IVALK+VR D+ + REI +L++L H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
++L ++ S LVFE+ + DL VK ++ QLL GL CH+
Sbjct: 64 VRLHDVLHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
VLHRD+K NLLI+ +G LK+A+FGLA + + ++ VVTLWYRPP++L GA Y
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 280 VGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
+D+WSAGCI AEL P+ PG +QL +IF+L G+P+EE W P
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
P + ++ L++ LL +P R +A AL +F+
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 1e-73
Identities = 67/305 (21%), Positives = 126/305 (41%), Gaps = 23/305 (7%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
+ + FEK+ ++G G V+K +G ++A K + + ++P + RE+ VL + +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECN 62
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
P ++ G S + + E+M+ + + E + ++ GL +
Sbjct: 63 SPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 216 HN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
+ ++HRD+K SN+L+++ G +K+ DFG++ + S V T Y PE L G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQG 177
Query: 275 ATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCG----SPSEEYWKKSK 329
T+Y V D+WS G L E+ G+ PI P + +L ++ G +P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLP----------LIETLLSIDPDNRGTATAAL 379
L + + + + + P LP + L +P R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 380 NSEFF 384
F
Sbjct: 297 VHAFI 301
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 233 bits (594), Expect = 2e-73
Identities = 76/323 (23%), Positives = 127/323 (39%), Gaps = 35/323 (10%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ ++ +++G G + V++ + TG A K V + + + +EI + L HP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHP 83
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
++ L + +++E+M +L A + K SE + YM+Q+ GL H H
Sbjct: 84 TLVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 217 NNGVLHRDIKGSNLLI--DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
N +H D+K N++ LK+ DFGL DP KQ + T + PE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEG 199
Query: 275 ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
G D+WS G + LL+G G + E L + + + +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG------- 251
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPS 394
I+E KD I LL DP+ R T AL + S
Sbjct: 252 -----------ISEDGKD-------FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 395 SLPKYPPSKEMDVKLREEEARRQ 417
+P +K D + +A +
Sbjct: 294 QIPSSRYTKIRDSIKTKYDAWPE 316
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 231 bits (590), Expect = 2e-73
Identities = 81/321 (25%), Positives = 137/321 (42%), Gaps = 48/321 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPN 158
F L +IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L+KL HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
I+ G + +LV EY + L E ++ L GL + H++
Sbjct: 77 TIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY- 277
++HRD+K N+L+ G++K+ DFG A+ P S V T ++ PE++L
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMDEG 189
Query: 278 -YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
Y VD+WS G EL KP + + L+ I +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------------N 229
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSL 396
+ +E F++ +++ L P +R T+ L F E
Sbjct: 230 ESPALQSGHWSEYFRN-------FVDSCLQKIPQDRPTSEVLLKHRFVLRE--------- 273
Query: 397 PKYPPSKEMDVKLREEEARRQ 417
PP+ MD+ R ++A R+
Sbjct: 274 --RPPTVIMDLIQRTKDAVRE 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 229 bits (584), Expect = 5e-72
Identities = 72/322 (22%), Positives = 134/322 (41%), Gaps = 40/322 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
++ L+++G G + V++ + TG++ K + P + EI ++ +L HP +
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKL 88
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
I L + + L+ E++ +L A + K SE +V YM+Q GL+H H +
Sbjct: 89 INLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 219 GVLHRDIKGSNLLID--NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
++H DIK N++ + +KI DFGLAT +P + + T + PE++
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-E 203
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
G D+W+ G + LL+G G ++E L + + E+ +
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS--------- 254
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSL 396
++ KD I+ LL +P R T AL + + S+L
Sbjct: 255 ---------VSPEAKD-------FIKNLLQKEPRKRLTVHDALEHPWLKG-----DHSNL 293
Query: 397 PKYPPSKEMDVKLREEEARRQR 418
PS + ++ + +
Sbjct: 294 TSRIPSSRYNKIRQKIKEKYAD 315
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 8e-71
Identities = 81/306 (26%), Positives = 136/306 (44%), Gaps = 37/306 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ + +KIGQG VY A D+ TG+ VA++++ + + EILV+R+ +PN+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNI 79
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
+ L++V EY+ + E Q+ ++ L LE H+N
Sbjct: 80 VNYLDSYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYG 279
V+HRDIK N+L+ DG +K+ DFG P + ++ V T ++ PE++ YG
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTR-KAYG 194
Query: 280 VGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQ 339
VD+WS G + E++ G+P + L+ I G+P + +K
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEK------------ 241
Query: 340 QPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSL-PK 398
++ F+D + L +D + RG+A L +F A SSL P
Sbjct: 242 ------LSAIFRD-------FLNRCLDMDVEKRGSAKELLQHQFLKI---AKPLSSLTPL 285
Query: 399 YPPSKE 404
+KE
Sbjct: 286 IAAAKE 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 2e-70
Identities = 74/303 (24%), Positives = 129/303 (42%), Gaps = 38/303 (12%)
Query: 90 RDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREIL 149
RD P + +E + ++G G + VYKA++ T + A K + + E ++ EI
Sbjct: 6 RDLNPE--DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEID 61
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQL 208
+L DHPN++KL + L+++ E+ + + +E Q++ KQ
Sbjct: 62 ILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP 268
L L + H+N ++HRD+K N+L DG +K+ADFG++ + Q S + T ++
Sbjct: 120 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDSFIGTPYWMA 178
Query: 269 PELLLGATY----YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
PE+++ T Y D+WS G L E+ +P + L KI K P+
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEPPTLAQ 237
Query: 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ + FKD ++ L + D R T + L F
Sbjct: 238 PSR------------------WSSNFKD-------FLKKCLEKNVDARWTTSQLLQHPFV 272
Query: 385 NTE 387
+
Sbjct: 273 TVD 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 2e-69
Identities = 111/299 (37%), Positives = 158/299 (52%), Gaps = 13/299 (4%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLT-GKIVALKKVRFDNLEPESVKFMAREILVLRK 153
R +E + +IG+G Y V+KARDL G+ VALK+VR E RE+ VLR
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 154 L---DHPNVIKLEGLVT---SRMSCSLYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMK 206
L +HPNV++L + T + L LVFE+++ D L +K M
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
QLL GL+ H++ V+HRD+K N+L+ + G +K+ADFGLA Y + +TS VVTLWY
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWY 181
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
R PE+LL + Y VDLWS GCI AE+ KP+ G ++V+QL KI + G P EE W
Sbjct: 182 RAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
+ F + I + D L+ L+ +P R +A +AL+ +F
Sbjct: 241 RDVALPRQAFHSKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 3e-69
Identities = 86/296 (29%), Positives = 127/296 (42%), Gaps = 39/296 (13%)
Query: 90 RDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESV-KFMAREI 148
R W FE +G+G + NVY AR+ + I+ALK + LE V + RE+
Sbjct: 1 RQWALED---FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQL 208
+ L HPN+++L G + +YL+ EY + KF E + Y+ +L
Sbjct: 58 EIQSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 115
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP 268
+ L +CH+ V+HRDIK NLL+ + G LKIADFG + T+ TL Y P
Sbjct: 116 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLP 172
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328
PE++ G + VDLWS G + E L GKP T E +I ++
Sbjct: 173 PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219
Query: 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ + + E +D LI LL +P R L +
Sbjct: 220 ----------EFTFPDFVTEGARD-------LISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-68
Identities = 78/297 (26%), Positives = 127/297 (42%), Gaps = 39/297 (13%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
RA +E L IG G+Y K R GKI+ K++ + ++ + + E+ +LR+L
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL---AACQGVKFSEPQVKCYMKQLLSG 211
HPN+++ + R + +LY+V EY E DLA + + E V M QL
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 212 LEHCH-----NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
L+ CH + VLHRD+K +N+ +D +K+ DFGLA + + V T +Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYY 180
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
PE + Y D+WS GC+L EL A P ++ E KI + K
Sbjct: 181 MSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------GK 230
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
++P + +I +L++ +R + L +
Sbjct: 231 FRRIP-------------------YRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (557), Expect = 5e-68
Identities = 97/347 (27%), Positives = 163/347 (46%), Gaps = 23/347 (6%)
Query: 89 IRDWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREI 148
+ D T ++ L IG G V A D + + VA+KK+ K RE+
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAACQGVKFSEPQVKCY 204
++++ ++H N+I L + T + + +YLV E M+ L ++ ++
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYL 124
Query: 205 MKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTL 264
+ Q+L G++H H+ G++HRD+K SN+++ +D LKI DFGLA MT VVT
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTR 182
Query: 265 WYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324
+YR PE++LG Y VD+WS GCI+ E++ K + PGR ++Q +K+ + G+P E+
Sbjct: 183 YYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 325 WKKSKLPNATLFKPQQPYKR-------------CIAETFKDFPSSSLPLIETLLSIDPDN 371
KK + + + Y +E K S + L+ +L IDP
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 372 RGTATAALNSEFFNTEPYACEPSSLPKYPPSKEMDVKLREEEARRQR 418
R + AL + N E + P K++D + E ++
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKEL 348
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 217 bits (553), Expect = 9e-68
Identities = 88/301 (29%), Positives = 154/301 (51%), Gaps = 23/301 (7%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DH 156
+ ++ + K+G+G YS V++A ++ + V +K ++ P K + REI +L L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGG 89
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHC 215
PN+I L +V +S + LVFE++ + D L ++ ++ YM ++L L++C
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC 145
Query: 216 HNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLG 274
H+ G++HRD+K N++ID++ L++ D+GLA FY PG Q RV + +++ PELL+
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVD 203
Query: 275 ATYYGVGVDLWSAGCILAELLAGK-PIMPGRTEVEQLHKIFKLCGSPS-EEYWKKSKLPN 332
Y +D+WS GC+LA ++ K P G +QL +I K+ G+ +Y K +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 333 ATLFKPQQPY-------KRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385
F + +E +L ++ LL D +R TA A+ +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
Query: 386 T 386
T
Sbjct: 324 T 324
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 1e-67
Identities = 59/316 (18%), Positives = 118/316 (37%), Gaps = 36/316 (11%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ + +G+G + V++ + + K K V+ + VK +EI +L H N+
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNI 63
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+ L S L ++FE++ D+ + +E ++ Y+ Q+ L+ H++
Sbjct: 64 LHLHESFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 219 GVLHRDIKGSNLLIDND--GILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ H DI+ N++ +KI +FG A PG Y PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH-D 178
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
D+WS G ++ LL+G T + + I + EE +K+
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE--------- 229
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSL 396
I+ D ++ LL + +R TA+ AL + + +
Sbjct: 230 ---------ISIEAMD-------FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
Query: 397 PKYPPSKEMDVKLREE 412
+ ++++
Sbjct: 274 RTLKHRRYYHTLIKKD 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 214 bits (545), Expect = 4e-67
Identities = 79/299 (26%), Positives = 126/299 (42%), Gaps = 44/299 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPES-------VKFMAREILVLR 152
+E + +G+G S V + T K A+K + S + +E+ +LR
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 153 KL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLS 210
K+ HPN+I+L+ + +LVF+ M+ +L + SE + + M+ LL
Sbjct: 65 KVSGHPNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLE 121
Query: 211 GLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
+ H ++HRD+K N+L+D+D +K+ DFG + DPG + + T Y PE
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPE 179
Query: 271 LLLGAT-----YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
++ + YG VD+WS G I+ LLAG P R ++ L I W
Sbjct: 180 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 239
Query: 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
++T KD L+ L + P R TA AL FF
Sbjct: 240 DD------------------YSDTVKD-------LVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 5e-67
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 34/297 (11%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRK 153
+R F+ +G+G++S V AR+L T + A+K + ++ + V ++ RE V+ +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
LDHP +KL LY Y ++ + F E + Y +++S LE
Sbjct: 65 LDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPELL 272
+ H G++HRD+K N+L++ D ++I DFG A P KQ + V T Y PELL
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332
DLW+ GCI+ +L+AG P E KI KL E+++ K
Sbjct: 183 TE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPK----- 236
Query: 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389
+D L+E LL +D R P+
Sbjct: 237 -----------------ARD-------LVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 213 bits (543), Expect = 2e-66
Identities = 85/321 (26%), Positives = 137/321 (42%), Gaps = 36/321 (11%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ ++ D +G G +S V A D T K+VA+K + LE + EI VL K+ HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHP 67
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
N++ L+ + S LYL+ + + +L +G ++E + Q+L +++ H
Sbjct: 68 NIVALDDIYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 217 NNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
+ G++HRD+K NLL D D + I+DFGL+ DPG +++ T Y PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLA 182
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y VD WS G I LL G P + + +I K YW
Sbjct: 183 Q-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD------ 235
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEP 393
I+++ KD I L+ DP+ R T AL + + +
Sbjct: 236 ------------ISDSAKD-------FIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276
Query: 394 SSLPKYPPSKEMDVKLREEEA 414
K+ K + ++A
Sbjct: 277 IHQSVSEQIKKNFAKSKWKQA 297
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 9e-64
Identities = 71/313 (22%), Positives = 133/313 (42%), Gaps = 41/313 (13%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPE----SVKFMAREILVLRK 153
+ ++ +++G G ++ V K R+ TG A K ++ + S + + RE+ +L++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
+ HPNVI L + ++ + L+ E + + +E + ++KQ+L+G+
Sbjct: 70 IQHPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGI----LKIADFGLATFYDPGLKQPMTSRVVTLWYRPP 269
+ H+ + H D+K N+++ + + +KI DFGLA D G + T + P
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAP 185
Query: 270 ELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329
E++ G+ D+WS G I LL+G G T+ E L + + +EY+
Sbjct: 186 EIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN-- 242
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF---NT 386
+ KD I LL DP R T +L + +T
Sbjct: 243 ----------------TSALAKD-------FIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279
Query: 387 EPYACEPSSLPKY 399
+ S P++
Sbjct: 280 QQALSSAWSHPQF 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 4e-62
Identities = 61/295 (20%), Positives = 113/295 (38%), Gaps = 34/295 (11%)
Query: 91 DWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILV 150
DW +IG G++ VYK + VA+K + P+ ++ E+ V
Sbjct: 2 DWEIPDGQ-ITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGV 57
Query: 151 LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLL 209
LRK H N++ G T+ L +V ++ E L KF ++ +Q
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRP 268
G+++ H ++HRD+K +N+ + D +KI DFGLAT ++ ++ +
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 269 PELLLG--ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
PE++ Y D+++ G +L EL+ G+ +Q+ +
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------- 223
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381
+ +++ + P + L+ L D R L S
Sbjct: 224 ------------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 6e-62
Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 37/291 (12%)
Query: 100 FEKLD-KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPN 158
F K D +IG+G++ VYK D T VA +++ L + E +L+ L HPN
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 159 VIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
+++ T + + LV E M + ++ + +Q+L GL+ H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 217 NNG--VLHRDIKGSNLLI-DNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
++HRD+K N+ I G +KI D GLAT + + T + PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYE 186
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y VD+++ G + E+ + Q+++ P+
Sbjct: 187 EK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------------ 232
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384
+ + K+ +IE + + D R + LN FF
Sbjct: 233 -------SFDKVAIPEVKE-------IIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 191 bits (486), Expect = 2e-58
Identities = 63/297 (21%), Positives = 116/297 (39%), Gaps = 32/297 (10%)
Query: 93 TPRR-ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILV 150
TP ++ +E + +G G S V+ ARDL + VA+K +R D +P RE
Sbjct: 1 TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQN 60
Query: 151 LRKLDHPNVIKLEGLVTSR--MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQL 208
L+HP ++ + + Y+V EY++ + + +
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 120
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP--MTSRVVTLWY 266
L H NG++HRD+K +N++I +K+ DFG+A + + T Y
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
PE G + D++S GC+L E+L G+P G + V ++ + P +
Sbjct: 181 LSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEF 383
++ ++ L+ +P+NR A + ++
Sbjct: 240 G------------------LSADLDA-------VVLKALAKNPENRYQTAAEMRADL 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 193 bits (491), Expect = 4e-58
Identities = 71/296 (23%), Positives = 122/296 (41%), Gaps = 40/296 (13%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMA----REILVLRK 153
N F IG+G + VY R TGK+ A+K + ++ + + +A + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 154 LDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
D P ++ + + L + + M Q FSE ++ Y +++ GLE
Sbjct: 64 GDCPFIVCMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H HN V++RD+K +N+L+D G ++I+D GLA + K+ + V T Y PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQ 178
Query: 274 GATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333
Y D +S GC+L +LL G ++ H+I ++ + + E
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDS------ 231
Query: 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR-----GTATAALNSEFF 384
+ + L+E LL D + R A S FF
Sbjct: 232 ------------FSPELRS-------LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-57
Identities = 70/308 (22%), Positives = 112/308 (36%), Gaps = 48/308 (15%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLR 152
+ ++ +G G + +VY + VA+K V D + E + + E+++L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 153 KLD--HPNVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLAACQGVKFSEPQVKCYMKQLL 209
K+ VI+L S L+ E E + E + + Q+L
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120
Query: 210 SGLEHCHNNGVLHRDIKGSNLLID-NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP 268
+ HCHN GVLHRDIK N+LID N G LK+ DFG T T Y P
Sbjct: 121 EAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSP 177
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328
PE + Y+G +WS G +L +++ G E+ + F+
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR------------- 224
Query: 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388
+ S LI L++ P +R T N +
Sbjct: 225 ----------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262
Query: 389 YACEPSSL 396
E + +
Sbjct: 263 LPQETAEI 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 4e-57
Identities = 64/329 (19%), Positives = 120/329 (36%), Gaps = 41/329 (12%)
Query: 100 FEKLDK-IGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHP 157
++ + +G G V + + T + ALK ++ RE+ + + P
Sbjct: 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCP 65
Query: 158 NVIKLEGLVTSRMSC--SLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSGLE 213
+++++ + + + L +V E ++ +L + F+E + MK + ++
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 214 HCHNNGVLHRDIKGSNLLID---NDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPE 270
+ H+ + HRD+K NLL + ILK+ DFG A +T+ T +Y PE
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPE 183
Query: 271 LLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330
+L Y D+WS G I+ LL G P + +
Sbjct: 184 VLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--------- 233
Query: 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF-NTEPY 389
++ P ++E K LI LL +P R T T +N + +
Sbjct: 234 -----YEFPNPEWSEVSEEVKM-------LIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281
Query: 390 ACEPSSLPKYPPSKEMDVKLREEEARRQR 418
P + + + +EE
Sbjct: 282 PQTPLHTSRVLKEDKERWEDVKEEMTSAL 310
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 187 bits (477), Expect = 1e-56
Identities = 63/291 (21%), Positives = 118/291 (40%), Gaps = 42/291 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPN 158
F+ L +G G++ V+ R G+ A+K ++ + + + V+ E L+L + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 159 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
+I++ G ++++ +Y+E + +F P K Y ++ LE+ H+
Sbjct: 66 IIRMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
+++RD+K N+L+D +G +KI DFG A + + + T Y PE++ Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYTLCGTPDYIAPEVVSTKP-Y 178
Query: 279 GVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
+D WS G ++ E+LAG ++ KI
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI----------------------LNA 216
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR-----GTATAALNSEFF 384
+ + E KD L+ L++ D R N +F
Sbjct: 217 ELRFPPFFNEDVKD-------LLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-56
Identities = 69/289 (23%), Positives = 117/289 (40%), Gaps = 36/289 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDHP 157
F +G+G++ V+ A T + A+K ++ D + + + M + ++ +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
+ + ++ + L+ V EY+ KF + Y +++ GL+ H+
Sbjct: 64 FLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
G+++RD+K N+L+D DG +KIADFG+ G + T Y PE+LLG
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLGQ-K 179
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
Y VD WS G +L E+L G+ G+ E E H I
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI----------------------RM 217
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAA-LNSEFFN 385
Y R + + KD L+ L +P+ R F
Sbjct: 218 DNPFYPRWLEKEAKD-------LLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-55
Identities = 73/293 (24%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDH 156
N F+ L +G+GT+ V R+ TG+ A+K +R + + + V E VL+ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
P + L+ + L V EY + F+E + + Y +++S LE+ H
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 217 NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGAT 276
+ V++RDIK NL++D DG +KI DFGL M + T Y PE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED-N 180
Query: 277 YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
YG VD W G ++ E++ G+ + I
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----------------------L 218
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR-----GTATAALNSEFF 384
+ + R ++ K L+ LL DP R A + FF
Sbjct: 219 MEEIRFPRTLSPEAKS-------LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 1e-54
Identities = 65/329 (19%), Positives = 123/329 (37%), Gaps = 47/329 (14%)
Query: 69 PHSESQQGWPSWLMAVAGDAIRDWTPRRANT-----FEKLDKIGQGTYSNVYKARDLLTG 123
Q+ +L D ++ W NT F+++ +G G++ V + +G
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66
Query: 124 KIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYME 182
A+K + + + + ++ E +L+ ++ P ++KLE + + + +
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 183 HDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIAD 242
+ L + +FSEP + Y Q++ E+ H+ +++RD+K NLLID G +++ D
Sbjct: 127 EMFSHL--RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 243 FGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMP 302
FG A + T PE++L Y VD W+ G ++ E+ AG P
Sbjct: 185 FGFAKRVK----GRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF 239
Query: 303 GRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIE 362
++ KI + K L+
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLK-----------------------------DLLR 270
Query: 363 TLLSIDPDNR-----GTATAALNSEFFNT 386
LL +D R N ++F T
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-53
Identities = 62/303 (20%), Positives = 125/303 (41%), Gaps = 43/303 (14%)
Query: 91 DWTPRRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILV 150
+W R T + ++++G G + V+ VA+K ++ ++ P++ E +
Sbjct: 7 EWEVPR-ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFL---AEANL 61
Query: 151 LRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LAACQGVKFSEPQVKCYMKQL 208
+++L H +++L +VT +Y++ EYME+ L G+K + ++ Q+
Sbjct: 62 MKQLQHQRLVRLYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 209 LSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRP 268
G+ +HRD++ +N+L+ + KIADFGLA + + +
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178
Query: 269 PELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327
PE + + + D+WS G +L E++ G+ PG T E + + +
Sbjct: 179 PEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------ 225
Query: 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN--SEFFN 385
++ +P + P L+ P++R T + +FF
Sbjct: 226 -------GYRMVRP---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
Query: 386 -TE 387
TE
Sbjct: 270 ATE 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (451), Expect = 5e-53
Identities = 58/295 (19%), Positives = 98/295 (33%), Gaps = 36/295 (12%)
Query: 95 RRANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL 154
R N + KIG G++ ++Y D+ G+ VA+K P+ + E + + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMM 59
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
I + +V E + L L KFS V Q++S +E+
Sbjct: 60 QGGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 215 CHNNGVLHRDIKGSNLLI---DNDGILKIADFGLATFYDPG------LKQPMTSRVVTLW 265
H+ +HRD+K N L+ ++ I DFGLA Y + + T
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
Y LG DL S G +L G G + K ++
Sbjct: 179 YASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-------- 229
Query: 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
++ I K +PS + S+ D++ +
Sbjct: 230 -------------EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-52
Identities = 69/313 (22%), Positives = 123/313 (39%), Gaps = 49/313 (15%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
+ K+GQG + V+ T + VA+K ++ + PE+ +E V++KL H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHE 72
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA--ACQGVKFSEPQVKCYMKQLLSGLEHC 215
+++L +V+ +Y+V EYM G PQ+ Q+ SG+ +
Sbjct: 73 KLVQLYAVVSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 216 HNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGA 275
+HRD++ +N+L+ + + K+ADFGLA + + + PE L
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 188
Query: 276 TYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334
+ + D+WS G +L EL G+ PG E L ++ + P
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP----------- 237
Query: 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT--AALNSEFFNTEPYACE 392
+ P S L+ +P+ R T A ++F
Sbjct: 238 -----------------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT------- 273
Query: 393 PSSLPKYPPSKEM 405
S+ P+Y P + +
Sbjct: 274 -STEPQYQPGENL 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-52
Identities = 62/288 (21%), Positives = 105/288 (36%), Gaps = 37/288 (12%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNL-EPESVKFMAREILVLRKLD 155
L+K+G G++ V + VA+K ++ D L +PE++ RE+ + LD
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEH 214
H N+I+L G+V + + +V E L F + Y Q+ G+ +
Sbjct: 70 HRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLL 273
+ +HRD+ NLL+ ++KI DFGL M + L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 274 GATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332
+ D W G L E+ G+ G + LHKI K
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK----------------- 229
Query: 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+ +P +D P ++ + P++R T A +
Sbjct: 230 -EGERLPRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 175 bits (444), Expect = 4e-52
Identities = 52/287 (18%), Positives = 94/287 (32%), Gaps = 38/287 (13%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
++ +IG+G++ +++ +LL + VA+K + P+ + E + L
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAG 59
Query: 157 PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCH 216
I LV + + L L G KFS V KQ+L+ ++ H
Sbjct: 60 CTGIPNVYYFGQEGLH-NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 217 NNGVLHRDIKGSNLLIDN-----DGILKIADFGLATFYDPGL------KQPMTSRVVTLW 265
+++RDIK N LI ++ + DFG+ FY + + + T
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 266 YRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
Y LG DL + G + L G G K ++
Sbjct: 179 YMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-------- 229
Query: 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR 372
++ + E FP + ++ D
Sbjct: 230 -------------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 6e-52
Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 39/298 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNL--EPESVKFMAREILVLRKL 154
FE L +G G Y V+ R + TGK+ A+K ++ + + ++ + E VL +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 155 DH-PNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
P ++ L + L+L+ +Y+ Q +F+E +V+ Y+ +++ LE
Sbjct: 86 RQSPFLVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLL 273
H H G+++RDIK N+L+D++G + + DFGL+ + + T+ Y P+++
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 274 GA-TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332
G + + VD WS G ++ ELL G E +I + Y ++
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE----- 258
Query: 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNR-----GTATAALNSEFFN 385
++ KD LI+ LL DP R A FF
Sbjct: 259 -------------MSALAKD-------LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 3e-51
Identities = 55/303 (18%), Positives = 110/303 (36%), Gaps = 41/303 (13%)
Query: 92 WTPRRANTFEKLDKIGQGTYSNVYKA--RDLLTGKIVALKKVRFDNLEPESVKFMAREIL 149
+ R+ T E ++G G + V K + K VA+K ++ + +P + E
Sbjct: 2 YLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 150 VLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLL 209
V+++LD+P ++++ G+ + S LV E E Q + + + Q+
Sbjct: 61 VMQQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVS 117
Query: 210 SGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV--TLWYR 267
G+++ + +HRD+ N+L+ KI+DFGL+ + +
Sbjct: 118 MGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 268 PPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWK 326
PE + + D+WS G ++ E + G+ G E + K +
Sbjct: 178 APECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---------GE 227
Query: 327 KSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT---AALNSEF 383
+ P P L+ + D +NR L + +
Sbjct: 228 RMGCP-------------------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
Query: 384 FNT 386
++
Sbjct: 269 YDV 271
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-51
Identities = 60/283 (21%), Positives = 110/283 (38%), Gaps = 37/283 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ +IG G + V+ L VA+K +R + E E V+ KL HP +
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFI---EEAEVMMKLSHPKL 62
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
++L G+ + LVFE+MEH L+ Q F+ + + G+ +
Sbjct: 63 VQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
V+HRD+ N L+ + ++K++DFG+ F T + + PE+ + Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-Y 179
Query: 279 GVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
D+WS G ++ E+ + GK R+ E + I +T F+
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STGFR 220
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+P + + ++ P++R + L
Sbjct: 221 LYKP---------RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-51
Identities = 54/284 (19%), Positives = 105/284 (36%), Gaps = 43/284 (15%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ L IG+G + +V G VA+K ++ + + E V+ +L H N+
Sbjct: 9 LKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNL 62
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
++L G++ LY+V EYM L L + + + + +E+
Sbjct: 63 VQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
N +HRD+ N+L+ D + K++DFGL + + + + PE L
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-KK 176
Query: 278 YGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336
+ D+WS G +L E+ + G+ P + + ++ K +
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------------------GY 217
Query: 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
K P P + +++ +D R +
Sbjct: 218 KMDAP---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 7e-51
Identities = 53/283 (18%), Positives = 111/283 (39%), Gaps = 37/283 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
L ++G G + V + VA+K ++ ++ + E V+ L H +
Sbjct: 6 LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKL 61
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNN 218
++L G+ T + ++++ EYM + L +F Q+ K + +E+ +
Sbjct: 62 VQLYGVCTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 219 GVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYY 278
LHRD+ N L+++ G++K++DFGL+ + + + PPE+L+ + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 279 GVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
D+W+ G ++ E+ + GK T E I + L++
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ----------------GLRLYR 222
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
P ++ ++ + D R T L+
Sbjct: 223 PHLASEKVYT------------IMYSCWHEKADERPTFKILLS 253
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (431), Expect = 4e-50
Identities = 61/305 (20%), Positives = 128/305 (41%), Gaps = 42/305 (13%)
Query: 87 DAIRDWTPR-RANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVK 142
+A+R++ + + IG G + V L GK VA+K ++ E +
Sbjct: 14 EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD 73
Query: 143 FMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQV 201
F+ E ++ + DHPNVI LEG+VT S + ++ E+ME+ L +F+ Q+
Sbjct: 74 FL-SEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQL 130
Query: 202 KCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRV 261
++ + +G+++ + +HRD+ N+L++++ + K++DFGL+ F + P +
Sbjct: 131 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190
Query: 262 V----TLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKL 316
+ + + PE + + D+WS G ++ E+++ G+ T + ++ I +
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ- 248
Query: 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT 376
+ P L+ D ++R
Sbjct: 249 --------------------DYRLPPPMDCPSALHQ-------LMLDCWQKDRNHRPKFG 281
Query: 377 AALNS 381
+N+
Sbjct: 282 QIVNT 286
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 170 bits (430), Expect = 2e-49
Identities = 79/342 (23%), Positives = 140/342 (40%), Gaps = 51/342 (14%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV 159
+ + K+G G +S V+ A+D++ VA+K VR D + E+ + EI +L++++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADN 71
Query: 160 IKLEGLVTSRMSCSLYLVFEYMEHD---------------LAGLAACQGVKFSEPQVKCY 204
K + + + + L F + + LA + + VK
Sbjct: 72 TKEDSMGANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 205 MKQLLSGLEHC-HNNGVLHRDIKGSNLLIDNDGI------LKIADFGLATFYDPGLKQPM 257
KQLL GL++ G++H DIK N+L++ +KIAD G A +YD +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQLH 311
+R YR PE+LLGA +G G D+WS C++ EL+ G + + + +
Sbjct: 191 QTR----EYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 312 KIFKLCGSPSEEYWKKSK----------LPNATLFKPQQPYKRCIAETFKDFPSSS---L 358
+I +L G + K L P + + E +K +
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 359 PLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLPKYP 400
+ +L +DP R A +N + + E +P
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVNHPWLK-DTLGMEEIRVPDRE 346
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 3e-49
Identities = 53/290 (18%), Positives = 108/290 (37%), Gaps = 42/290 (14%)
Query: 105 KIGQGTYSNVYKARDLLTGK--IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKL 162
++G G + +V + + K VA+K ++ E + M RE ++ +LD+P +++L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 163 EGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVL 221
G+ + +L LV E L + + V + Q+ G+++ +
Sbjct: 75 IGVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 222 HRDIKGSNLLIDNDGILKIADFGLATFYDPG--LKQPMTSRVVTLWYRPPELLLGATYYG 279
HRD+ N+L+ N KI+DFGL+ ++ L + PE + +
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFS 190
Query: 280 VGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338
D+WS G + E L+ G+ E + I + K+ + P
Sbjct: 191 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------GKRMECP------- 234
Query: 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT---AALNSEFFN 385
+ P L+ ++R + + +++
Sbjct: 235 ------------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-49
Identities = 56/295 (18%), Positives = 115/295 (38%), Gaps = 39/295 (13%)
Query: 91 DWTPRRANTFEKLDKIGQGTYSNVYKARDLLT---GKIVALKKVRFDNLEPESVKFMARE 147
D+ +R E IG+G + +V++ + VA+K + + KF+ +E
Sbjct: 1 DYEIQRER-IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QE 58
Query: 148 ILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMK 206
L +R+ DHP+++KL G++T ++++ E +L + + Y
Sbjct: 59 ALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 207 QLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWY 266
QL + L + + +HRDI N+L+ ++ +K+ DFGL+ + + + + + +
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 175
Query: 267 RPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYW 325
PE + + D+W G + E+L G G + + +I
Sbjct: 176 MAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------G 225
Query: 326 KKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
++ +P + P + L+ + DP R T
Sbjct: 226 ERLPMP-------------------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 166 bits (422), Expect = 6e-49
Identities = 52/282 (18%), Positives = 103/282 (36%), Gaps = 31/282 (10%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHP 157
K+G G Y VY+ VA+K ++ D +E E +E V++++ HP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHP 73
Query: 158 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN 217
N+++L G+ T + F + L L C + S + Q+ S +E+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 218 NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATY 277
+HRD+ N L+ + ++K+ADFGL+ + + PE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 278 YGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337
+ + D+W+ G +L E+ ++ Q++++ +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------------------D 232
Query: 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379
+ E + L+ +P +R +
Sbjct: 233 YRMERPEGCPEKVYE-------LMRACWQWNPSDRPSFAEIH 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-48
Identities = 68/298 (22%), Positives = 105/298 (35%), Gaps = 33/298 (11%)
Query: 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH 156
A T + IG+G + V++ + G+ VA+K + E F EI L H
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRH 56
Query: 157 PNVIKLEGLVTSRMSC--SLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
N++ L+LV +Y EH L + + SGL
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY--LNRYTVTVEGMIKLALSTASGLA 114
Query: 214 HCH--------NNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG---LKQPMTSRVV 262
H H + HRD+K N+L+ +G IAD GLA +D + RV
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 263 TLWYRPPELLLGATYYGVG-----VDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLC 317
T Y PE+L + D+++ G + E+ I G E QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVP 233
Query: 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
PS E +K +P P + E + ++ + R TA
Sbjct: 234 SDPSVEEMRKVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTA 285
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-46
Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 62/312 (19%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGKI-----VALKKVRFDNLEPESVKFMAREILVLRKL 154
E +G G + V A K VA+K ++ E M E+ ++ +L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQL 97
Query: 155 -DHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEP------------- 199
H N++ L G T S +YL+FEY + DL + KFSE
Sbjct: 98 GSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 200 ---------QVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250
+ C+ Q+ G+E +HRD+ N+L+ + ++KI DFGLA
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 251 PGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVE 308
+ + + + PE L Y + D+WS G +L E+ + G PG
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 309 QLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSID 368
+K+ + FK QP+ E ++++ + D
Sbjct: 275 NFYKLIQ------------------NGFKMDQPFY--ATEEIYI-------IMQSCWAFD 307
Query: 369 PDNRGTATAALN 380
R + +
Sbjct: 308 SRKRPSFPNLTS 319
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-46
Identities = 56/291 (19%), Positives = 104/291 (35%), Gaps = 38/291 (13%)
Query: 96 RANTFEKLDKIGQGTYSNVYKARDLLTGKIVALK---KVRFDNLEPESVKFMAREILVLR 152
+ F+K+ +G G + VYK + G+ V + K + P++ K + E V+
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSG 211
+D+P+V +L G+ + ++ L+ + M L + + Q+ G
Sbjct: 67 SVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 212 LEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSRVV-TLWYRPPE 270
+ + + ++HRD+ N+L+ +KI DFGLA K+ + + E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 271 LLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329
+L Y D+WS G + EL+ G G E + K
Sbjct: 184 SILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------- 228
Query: 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+ QP ++ ID D+R +
Sbjct: 229 -----GERLPQP---------PICTIDVYMIMVKCWMIDADSRPKFRELII 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 8e-46
Identities = 58/251 (23%), Positives = 107/251 (42%), Gaps = 37/251 (14%)
Query: 94 PRRANTFEKLDKIGQGTYSNVYKAR-----DLLTGKIVALKKVRFDNLEPESVKFMAREI 148
PR N E + IG+G + V++AR +VA+K ++ + F RE
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REA 67
Query: 149 LVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL------------------- 188
++ + D+PN++KL G + + L+FEYM + DL
Sbjct: 68 ALMAEFDNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 189 ----AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFG 244
++ S + C +Q+ +G+ + +HRD+ N L+ + ++KIADFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 245 LAT-FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMP 302
L+ Y + + + + + PPE + Y D+W+ G +L E+ + G
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYY 244
Query: 303 GRTEVEQLHKI 313
G E ++ +
Sbjct: 245 GMAHEEVIYYV 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-44
Identities = 56/285 (19%), Positives = 104/285 (36%), Gaps = 39/285 (13%)
Query: 104 DKIGQGTYSNVYKARDLL---TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVI 160
+ IG+G + VY L A+K + E +F+ E ++++ HPNV+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVL 91
Query: 161 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG 219
L G + R S +V YM+H DL + + + + Q+ G++ +
Sbjct: 92 SLLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 220 VLHRDIKGSNLLIDNDGILKIADFGLATFYDPG---LKQPMTSRVVTLWYRPPELLLGAT 276
+HRD+ N ++D +K+ADFGLA T + + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-Q 209
Query: 277 YYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335
+ D+WS G +L EL+ G P P + + + L
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----------------GRRL 253
Query: 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
+P + P ++ + R + + ++
Sbjct: 254 LQP------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-42
Identities = 59/308 (19%), Positives = 100/308 (32%), Gaps = 57/308 (18%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLR 152
N +G G + V +A VA+K ++ E M E+ VL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLS 81
Query: 153 KL-DHPNVIKLEGLVTSRMSCSLYLVFEYMEH------------------DLAGLAACQG 193
L +H N++ L G T ++ EY + +
Sbjct: 82 YLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 194 VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253
+ + + Q+ G+ + +HRD+ N+L+ + I KI DFGLA
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 254 KQPMTSRVV-TLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLH 311
+ + + PE + Y D+WS G L EL + G PG + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 312 KIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDN 371
K+ K F+ P + P+ +++T DP
Sbjct: 259 KMIK------------------EGFRMLSP---------EHAPAEMYDIMKTCWDADPLK 291
Query: 372 RGTATAAL 379
R T +
Sbjct: 292 RPTFKQIV 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-42
Identities = 67/302 (22%), Positives = 113/302 (37%), Gaps = 54/302 (17%)
Query: 98 NTFEKLDKIGQGTYSNVYKARDLLTGKI--VALKKVRFDNLEPESVKFMAREILVLRKL- 154
N + D IG+G + V KAR G A+K+++ + + + A E+ VL KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 68
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEH----------------DLAGLAACQGVKFSE 198
HPN+I L G LYL EY H +A S
Sbjct: 69 HHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 199 PQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258
Q+ + + G+++ +HRD+ N+L+ + + KIADFGL+ + +K T
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLC 317
+ + + E L + Y D+WS G +L E+++ G G T E K+ +
Sbjct: 185 MGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-- 241
Query: 318 GSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATA 377
++ ++P + L+ P R +
Sbjct: 242 -----------------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 378 AL 379
L
Sbjct: 276 IL 277
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 9e-42
Identities = 54/288 (18%), Positives = 116/288 (40%), Gaps = 38/288 (13%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTG----KIVALKKVRFDNLEPESVKFMAREILVLRKLD 155
+ IG G + VYK + VA+K ++ E + V F+ E ++ +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFS 67
Query: 156 HPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LAACQGVKFSEPQVKCYMKQLLSGLEH 214
H N+I+LEG+++ + ++ EYME+ + +FS Q+ ++ + +G+++
Sbjct: 68 HHNIIRLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 215 CHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTS--RVVTLWYRPPELL 272
N +HRD+ N+L++++ + K++DFGL+ + + T+ + + + PE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 273 LGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332
+ D+WS G ++ E++ ++ K
Sbjct: 186 SYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----------------- 227
Query: 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380
F+ P D PS+ L+ + R ++
Sbjct: 228 -DGFRLPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-41
Identities = 58/335 (17%), Positives = 115/335 (34%), Gaps = 50/335 (14%)
Query: 78 PSWLMAVAGDAIRDWTPRRANTFEKLDKIGQGTYSNVYKARD-----LLTGKIVALKKVR 132
P + A +W R ++GQG++ VY+ VA+K V
Sbjct: 1 PEYFSAADVYVPDEWEVAREK-ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 59
Query: 133 FDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLAAC 191
E ++F+ E V+++ + +V++L G+V+ ++ E M DL
Sbjct: 60 EAASMRERIEFL-NEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRS 116
Query: 192 QG---------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIAD 242
S ++ ++ G+ + + N +HRD+ N ++ D +KI D
Sbjct: 117 LRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176
Query: 243 FGLAT-FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPI 300
FG+ Y+ + ++ + + PE L + D+WS G +L E+ +
Sbjct: 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQP 235
Query: 301 MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPL 360
G + + L + + + + L
Sbjct: 236 YQGLSNEQVLRFVME---------------------GGLLDKPDNCPDMLFE-------L 267
Query: 361 IETLLSIDPDNRGTATAALNSEFFNTEPYACEPSS 395
+ +P R + ++S EP E S
Sbjct: 268 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-41
Identities = 53/304 (17%), Positives = 97/304 (31%), Gaps = 52/304 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKL 154
+ +G+G + V +A T + VA+K ++ E M+ +++
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 155 DHPNVIKLEGLVTSRMSCSLYLVFEYMEHDL----------------AGLAACQGVKFSE 198
H NV+ L G T L ++ E+ + +
Sbjct: 75 HHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 199 PQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258
+ CY Q+ G+E + +HRD+ N+L+ ++KI DFGLA
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 259 SRVV-TLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKL 316
L + PE + Y + D+WS G +L E+ + PG E+ + K
Sbjct: 194 GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK- 251
Query: 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT 376
+ + P + +P R T +
Sbjct: 252 -----------------EGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFS 285
Query: 377 AALN 380
+
Sbjct: 286 ELVE 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-38
Identities = 58/304 (19%), Positives = 102/304 (33%), Gaps = 54/304 (17%)
Query: 100 FEKLDKIGQGTYSNVYKARDLLTGK-------IVALKKVRFDNLEPESVKFMAREILVLR 152
+G+G + V A + K VA+K ++ D E + ++ ++
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 153 KLDHPNVIKLEGLVTSRMSCSLYLVFEYMEH----------------DLAGLAACQGVKF 196
H N+I L G T LY++ EY + +
Sbjct: 75 IGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 197 SEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256
S + Q+ G+E+ + +HRD+ N+L+ D ++KIADFGLA
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 257 MT-SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFK 315
T + + + + PE L Y D+WS G +L E+ VE+L K+ K
Sbjct: 193 KTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251
Query: 316 LCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTA 375
+ +P + + ++ P R T
Sbjct: 252 EG------------------HRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTF 284
Query: 376 TAAL 379
+
Sbjct: 285 KQLV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 111 bits (278), Expect = 3e-29
Identities = 27/203 (13%), Positives = 67/203 (33%), Gaps = 30/203 (14%)
Query: 104 DKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFM--------AREILVLRKLD 155
+G+G S V+ +K + + + VK + + + +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 156 HPNVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLE 213
+ KL+G + ++ E ++ + + + +L +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVA 117
Query: 214 HCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMTSR---VVTLWYRPPE 270
++ G++H D+ N+L+ +GI I DF + + + R + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFSRT- 175
Query: 271 LLLGATYYGVGVDLWSAGCILAE 293
Y D+ SA + +
Sbjct: 176 -------YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 457 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.47 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.08 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.98 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.12 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-62 Score=472.59 Aligned_cols=291 Identities=41% Similarity=0.679 Sum_probs=242.4
Q ss_pred ccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh---HHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 102 KLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP---ESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
.++.||+|+||+||+|+++.+|+.||||+++...... ...+.+.+|+.+|++++|||||++++++.. .+.+|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehh
Confidence 4789999999999999999999999999997654322 123468899999999999999999999987 56799999
Q ss_pred ecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCcc
Q 036122 179 EYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPMT 258 (457)
Q Consensus 179 E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 258 (457)
||+.++++..+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~ 158 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT 158 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence 999999888887777889999999999999999999999999999999999999999999999999998765432 2334
Q ss_pred cccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC-cccCC
Q 036122 259 SRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN-ATLFK 337 (457)
Q Consensus 259 ~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~ 337 (457)
..+||+.|+|||++.+...|+.++|||||||++|||+||.+||.+.++.+++.+|.+.++.+..+.|....... .....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 56899999999999877778999999999999999999999999999999999999999999888776432211 11111
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSLP 397 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~~ 397 (457)
.. ....+...++.+++++.+||.+||+.||++|||++|+|+||||++.+.+..+..+|
T Consensus 239 ~~--~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p 296 (299)
T d1ua2a_ 239 SF--PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296 (299)
T ss_dssp CC--CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred cC--CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCC
Confidence 11 11223445567888999999999999999999999999999999987776665554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-62 Score=464.50 Aligned_cols=261 Identities=28% Similarity=0.422 Sum_probs=216.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .+..+.+.+|+.+|++++|||||++++++.+ ...+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEE
Confidence 4689999999999999999999999999999999986543 2334568899999999999999999999988 578999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-CC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL-KQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~~ 255 (457)
||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+||||++++.+||+|||+|+...... ..
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999986555555556689999999999999999999999999999999999999999999999999998764332 23
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
..+..+||+.|||||++.+..+++.++|||||||++|||+||++||...+..............
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---------------- 224 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---------------- 224 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT----------------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC----------------
Confidence 3456789999999999998876688999999999999999999999876554333332221100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
....+..+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 225 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 225 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ----------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 01122457888999999999999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-62 Score=459.23 Aligned_cols=255 Identities=32% Similarity=0.469 Sum_probs=221.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++.+.||+|+||+||+|+++.+|+.||+|++...... ......+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEE
Confidence 46899999999999999999999999999999999754321 2234668899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 99999998666655555567999999999999999999999999999999999999999999999999999866432
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+.+.++.+....
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------- 222 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT---------------- 222 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC----------------
T ss_pred cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 235568999999999998866 799999999999999999999999999888888776542100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
....+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 223 -------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 223 -------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 11246788999999999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-60 Score=457.77 Aligned_cols=256 Identities=27% Similarity=0.484 Sum_probs=221.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
.+|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEE
Confidence 5799999999999999999999999999999999865433 23568899999999999999999999988 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||++++.+..+...+ .+++.+++.++.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.+.... ...
T Consensus 96 mEy~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~ 173 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKR 173 (293)
T ss_dssp EECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCB
T ss_pred EEecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-ccc
Confidence 9999987666555543 69999999999999999999999999999999999999999999999999999775432 334
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
...+||+.|+|||++.+.. |+.++|||||||++|+|+||.+||.+.+..+.+..+..... +.
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~---------------- 235 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE---------------- 235 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC----------------
T ss_pred cccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC----------------
Confidence 5678999999999998766 79999999999999999999999999888887776654311 10
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
......+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 236 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 ---------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ---------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ---------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0112347888999999999999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-60 Score=458.30 Aligned_cols=289 Identities=40% Similarity=0.717 Sum_probs=240.6
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 58999999999999999999999999999999997665444455678899999999999999999999988 6789999
Q ss_pred EecccCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLAAC-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||+.++++..... ....+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...... ..
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~ 158 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT 158 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BC
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc-cc
Confidence 99999887766544 35569999999999999999999999999999999999999999999999999998775432 33
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
.....||+.|+|||++....+++.++|||||||++|+|++|++||.+.+..+.+.+++...+.+.+..|...........
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 238 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence 45568999999999998888788999999999999999999999999999999999999999888777654321111111
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
................+++++.+||++||..||++|||++|+|+||||++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 11111122334455678889999999999999999999999999999998643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-61 Score=455.31 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=211.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.+|++++|||||++++++.+.....+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 47899999999999999999999999999999999887777777788999999999999999999999997765677999
Q ss_pred EEecccCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 177 VFEYMEHDLAGLAAC----QGVKFSEPQVKCYMKQLLSGLEHCHNNG-----VLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 177 v~E~~~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
||||++++.+..+.. ....+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999998754443332 3567999999999999999999999976 9999999999999999999999999999
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
...... ......+||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+..+...++....-
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~--------- 231 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF--------- 231 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC---------
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 875432 2345678999999999998766 89999999999999999999999999988888777754210
Q ss_pred cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
......+++++.+||.+||+.||.+|||++|+|+|||+
T Consensus 232 -------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 -------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 01123478889999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-61 Score=460.58 Aligned_cols=263 Identities=29% Similarity=0.430 Sum_probs=221.7
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 4689999999999999999999999999999999975432 22344678899999999999999999999987 57899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-C
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL-K 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 254 (457)
+||||++++.+..+....+.+++.+++.++.||+.||.|||++||+||||||+||||+++|.+||+|||+|+.+.... .
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999986555555555679999999999999999999999999999999999999999999999999999775432 2
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
....+.+||+.|+|||++.+.. |+.++|||||||++|||+||.+||.+.+..+.+.+|.+.-..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--------------- 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--------------- 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC---------------
T ss_pred cccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC---------------
Confidence 2345578999999999998776 799999999999999999999999999988888877542100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHH------HhcCCCCCCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATA------ALNSEFFNTEPYAC 391 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~e------lL~hp~f~~~~~~~ 391 (457)
....+++++.+||.+||+.||++|||++| +++||||++..|..
T Consensus 229 --------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 229 --------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp --------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred --------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 11247888999999999999999999988 58899999876653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-59 Score=461.45 Aligned_cols=268 Identities=25% Similarity=0.396 Sum_probs=229.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 46899999999999999999999999999999999754 33445678899999999999999999999987 578999
Q ss_pred EEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec--CCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID--NDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~vkl~DFGla~~~~~~~ 253 (457)
|||||+++.+ ..+......+++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999987554 54445556799999999999999999999999999999999999996 4689999999999977543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|||||++.+.. |+.++|||||||++|+|+||++||.+.+..+.+.+|......++.
T Consensus 180 -~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 246 (350)
T d1koaa2 180 -QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD----------- 246 (350)
T ss_dssp -SCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-----------
T ss_pred -cccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 3345678999999999998876 799999999999999999999999999999988888664322221
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCCCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPYACEPSSL 396 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~~~~~~~~ 396 (457)
..+..+++++++||.+||+.||++|||++|+|+||||+....+..+..+
T Consensus 247 --------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~ 295 (350)
T d1koaa2 247 --------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295 (350)
T ss_dssp --------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCB
T ss_pred --------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhC
Confidence 1234578889999999999999999999999999999986554444333
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-60 Score=455.39 Aligned_cols=255 Identities=28% Similarity=0.458 Sum_probs=222.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC-hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE-PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
..|+.+++||+|+||+||+|++..+|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+ ...+|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEE
Confidence 3599999999999999999999999999999999876543 4455678999999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||||.++++..+......+++.+++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----- 167 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence 999999988877777777899999999999999999999999999999999999999999999999999986543
Q ss_pred cccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 036122 257 MTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNAT 334 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 334 (457)
....+||+.|||||++.+. ..|+.++|||||||++|||++|.+||.+.+..+.+.++......+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 233 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------------- 233 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 3456899999999999643 348899999999999999999999999988888777765421100
Q ss_pred cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 335 LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.....+++++.+||.+||+.||++|||++|+|+||||..
T Consensus 234 -------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 234 -------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 011346788999999999999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-60 Score=458.59 Aligned_cols=260 Identities=30% Similarity=0.446 Sum_probs=206.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.+.|++.+.||+|+||+||+|+++.+|+.||||++....... ....+.+|+.+|++++|||||++++++.+ ...+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 356999999999999999999999999999999998665432 23567899999999999999999999987 578999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec---CCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID---NDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~---~~~~vkl~DFGla~~~~~~~ 253 (457)
||||++|+.+..+......+++.++..++.||+.||.|||++||+||||||+|||+. +++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 999999765555555666899999999999999999999999999999999999995 5789999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
....+.+||+.|||||++.+.. |+.++|||||||++|||++|++||.+.+..+....+......++
T Consensus 164 -~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------ 229 (307)
T d1a06a_ 164 -SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------------ 229 (307)
T ss_dssp ----------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC------------
T ss_pred -CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC------------
Confidence 2345578999999999998776 79999999999999999999999999988888877765321111
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
....+++|+++.+||.+||+.||++|||++|+|+||||++.
T Consensus 230 -------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 230 -------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp -------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred -------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11234678899999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=452.15 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=225.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC----hHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE----PESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++.+.||+|+||+||+|+++.+|+.||||++...... ....+.+.+|+.+|++++|||||++++++.+ ..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~ 86 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KT 86 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CC
Confidence 35799999999999999999999999999999999865432 2235678899999999999999999999987 57
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC----cEEEeeccCccc
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG----ILKIADFGLATF 248 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~----~vkl~DFGla~~ 248 (457)
.+|||||||+++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 8999999999866655555556799999999999999999999999999999999999999776 599999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... .......||+.|+|||++.+.. ++.++|||||||++|||+||.+||.+.+..+.+.++......++..
T Consensus 167 ~~~~--~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----- 238 (293)
T d1jksa_ 167 IDFG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE----- 238 (293)
T ss_dssp CTTS--CBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH-----
T ss_pred cCCC--ccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch-----
Confidence 7543 3345668899999999998765 7999999999999999999999999999998888886543333222
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
....+++++.+||++||+.||++|||++|+|+||||+...+
T Consensus 239 --------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 239 --------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp --------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred --------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 23457888999999999999999999999999999987543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-59 Score=445.84 Aligned_cols=257 Identities=24% Similarity=0.303 Sum_probs=215.0
Q ss_pred CCc-cccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec--CCceE
Q 036122 98 NTF-EKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR--MSCSL 174 (457)
Q Consensus 98 ~~y-~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~~ 174 (457)
++| ++.++||+|+||+||+|++..+++.||+|++..........+.+.+|+++|++++|||||++++++... ....+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 345 667789999999999999999999999999987766677777899999999999999999999998653 24568
Q ss_pred EEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCCCCEEec-CCCcEEEeeccCccccCC
Q 036122 175 YLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNG--VLHRDIKGSNLLID-NDGILKIADFGLATFYDP 251 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NILl~-~~~~vkl~DFGla~~~~~ 251 (457)
|+||||++++.+..+......+++.+++.++.||+.||.|||+++ |+||||||+||||+ +++.+||+|||+|+....
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999998766666666667999999999999999999999998 99999999999997 578999999999986543
Q ss_pred CCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 252 GLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 252 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
......+||+.|||||++.+ . |+.++|||||||++|||++|++||.+..+...+.+.... +..+.
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~-~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~--------- 232 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA--------- 232 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG---------
T ss_pred ---CccCCcccCccccCHHHhCC-C-CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc---------
Confidence 23356789999999998865 3 899999999999999999999999876655444332211 11110
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFN 385 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~ 385 (457)
.....+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 233 ----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 ----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11234677899999999999999999999999999996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-59 Score=451.05 Aligned_cols=285 Identities=36% Similarity=0.655 Sum_probs=239.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|+++++||+|+||+||+|+++ +|+.||||+++.........+.+.+|+.+|++++|||||++++++.. ....|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEE
Confidence 68999999999999999999985 88999999997765444445778899999999999999999999987 5679999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
|||+.++++..+......+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY 157 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-ccc
Confidence 9999999998888888889999999999999999999999999999999999999999999999999998765432 223
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFK 337 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 337 (457)
....+++.|+|||.+.+...++.++|||||||++|||++|++||.+.+..+++.++....+.+....|............
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T d1ob3a_ 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237 (286)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence 44578999999999988777899999999999999999999999999999999999999999887777543211111111
Q ss_pred CCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 338 PQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
...............+++++.|||++||++||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 1111122234455678889999999999999999999999999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-60 Score=454.13 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=218.5
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
+.|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEE
Confidence 57999999999999999999999999999999997653 3344668899999999999999999999988 5679999
Q ss_pred EecccCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGLA-ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++++.+..+ ......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence 999998655544 4456679999999999999999999999999999999999999999999999999997543211 12
Q ss_pred cccccccCccCchHhhhC----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 257 MTSRVVTLWYRPPELLLG----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....+||+.|+|||++.. ...|+.++|||||||++|||+||++||.+.+..+.+.++.......
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------------ 234 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------------ 234 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 345689999999999852 3347899999999999999999999999988888877775421000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
......+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 235 --------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 235 --------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0112347888999999999999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-60 Score=463.23 Aligned_cols=283 Identities=23% Similarity=0.336 Sum_probs=214.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|+++++||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|++++|||||+++++|.+ ...+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~i 81 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 81 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 578999999999999999999999999999999998654 34445678899999999999999999999987 567999
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
||||+.++.+..+..+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+.....
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 158 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 158 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence 99999986666655555679999999999999999999997 59999999999999999999999999999876432
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhh----hcCC
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQ-LHKIFKLCGSPSEEYWK----KSKL 330 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~----~~~~ 330 (457)
...+.+||+.|+|||++.+.. |+.++|||||||++|||++|+.||.+.+..+. ...+....+.+...... ....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 234578999999999999876 89999999999999999999999987664432 22222222222111000 0000
Q ss_pred CC-cccCCCCCCcccchh----cc-----cCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 331 PN-ATLFKPQQPYKRCIA----ET-----FKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 331 ~~-~~~~~~~~~~~~~~~----~~-----~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
.. .....+......... .. ...+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00 000000000000000 00 1124667899999999999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.5e-59 Score=459.16 Aligned_cols=259 Identities=25% Similarity=0.450 Sum_probs=224.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|++..+|+.||||+++... ......+.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEE
Confidence 357999999999999999999999999999999997643 3344678899999999999999999999987 678999
Q ss_pred EEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEec--CCCcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLID--NDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~--~~~~vkl~DFGla~~~~~~~ 253 (457)
|||||+++.+ ..+...+..+++.+++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+|+.+...
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999997655 44444555799999999999999999999999999999999999998 6789999999999987654
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+.. |+.++|||||||++|+|+||++||.+.+..+.+.++......++.
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~----------- 249 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE----------- 249 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS-----------
T ss_pred -CceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----------
Confidence 3345678999999999998766 899999999999999999999999999999988888664322211
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
..+..+++++.+||.+||++||.+|||++|+|+||||++.
T Consensus 250 --------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 --------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1234578899999999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-59 Score=457.33 Aligned_cols=260 Identities=27% Similarity=0.400 Sum_probs=226.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .......+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccccc
Confidence 4789999999999999999999999999999999975432 22345668899999999999999999999987 67899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-Cc
Confidence 99999998777666666678999999999999999999999999999999999999999999999999999866432 23
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+...++.....
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~----------------- 222 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI----------------- 222 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------
T ss_pred ccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCC-----------------
Confidence 345678999999999998877 79999999999999999999999999998888877754211
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
.....+++++.+||++||++||.+|+ +++|+++||||++..|
T Consensus 223 ------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 223 ------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 11234788999999999999999999 4999999999987644
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-59 Score=453.75 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=226.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+.+|+.+|++++|||||++++++.+ ...+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeee
Confidence 4689999999999999999999999999999999975432 22335678899999999999999999999987 67899
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.|+.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+....
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999988777777778899999999999999999999999999999999999999999999999999987653
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
...+.+||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+..+.+.++......
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 219 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR---------------- 219 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCC----------------
Confidence 234678999999999998776 799999999999999999999999999998888887652110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPYA 390 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~~ 390 (457)
....+++++.+||.+||+.||.+|+ |++++|+||||++..|.
T Consensus 220 -------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 220 -------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred -------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 1134778899999999999999996 99999999999986543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=447.90 Aligned_cols=287 Identities=38% Similarity=0.635 Sum_probs=235.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCC-CcEEEEEEeecCCCChHHHHHHHHHHHHHHhc---CCCCceeEeeeEEec---
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLT-GKIVALKKVRFDNLEPESVKFMAREILVLRKL---DHPNVIKLEGLVTSR--- 169 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~-g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~--- 169 (457)
.++|+++++||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57899999999999999999999765 66799999976544333333455777777666 799999999998642
Q ss_pred CCceEEEEEecccCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccc
Q 036122 170 MSCSLYLVFEYMEHDLAGLAA-CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATF 248 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~ 248 (457)
....+|++|||+.++++.... .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 235789999999998765544 3455699999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... .......||+.|+|||++.+.. |+.++|||||||++|||+||++||.+.+..+++.++.+..+.+....|...
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hccc--ccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 5432 3345678999999999998776 899999999999999999999999999999999999999999988877653
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.......+... ...........+++.+.+||.+||++||++|||++|+|+||||++..
T Consensus 243 ~~~~~~~~~~~--~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 243 VALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CSSCGGGSCCC--CCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccchhhhhccc--cccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 32221111111 11223344567888999999999999999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.5e-58 Score=435.79 Aligned_cols=260 Identities=29% Similarity=0.440 Sum_probs=222.4
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh-------HHHHHHHHHHHHHHhcC-CCCceeEeeeEEec
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP-------ESVKFMAREILVLRKLD-HPNVIKLEGLVTSR 169 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~ 169 (457)
++|++.+.||+|+||+||+|++..+|+.||||++....... ...+.+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 68999999999999999999999999999999998764321 22346789999999997 9999999999987
Q ss_pred CCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCcccc
Q 036122 170 MSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFY 249 (457)
Q Consensus 170 ~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~ 249 (457)
...+||||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred -CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 6789999999987544444445567999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCcccccccCccCchHhhhC-----CcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLG-----ATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEY 324 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~ 324 (457)
... ...+..+||+.|+|||++.+ ...++.++||||+||++|+|+||++||.+.+..+....+......++
T Consensus 161 ~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 235 (277)
T d1phka_ 161 DPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG--- 235 (277)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---
T ss_pred cCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC---
Confidence 654 23456789999999999863 33478899999999999999999999999998888887765321111
Q ss_pred hhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCC
Q 036122 325 WKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNT 386 (457)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~ 386 (457)
......+|+++++||.+||+.||++|||++|+|+||||++
T Consensus 236 ----------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 ----------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ----------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ----------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1123458889999999999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-59 Score=455.84 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=224.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||++++++.. ...+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccccc
Confidence 4789999999999999999999999999999999975432 22334668899999999999999999999987 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||+.++.+.......+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999876666666666899999999999999999999999999999999999999999999999999997653
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
......||+.|||||++.+.. |+.++|||||||++|||+||++||.+.+....+.+|......
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~---------------- 256 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR---------------- 256 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC----------------
T ss_pred ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCC----------------
Confidence 234578999999999998776 799999999999999999999999999988888887653111
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEPY 389 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~~ 389 (457)
....+++++.+||++||+.||.+|+ |++++|+||||++..|
T Consensus 257 -------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 257 -------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 1234788899999999999999995 9999999999998655
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-58 Score=445.95 Aligned_cols=293 Identities=44% Similarity=0.699 Sum_probs=235.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC------
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM------ 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------ 170 (457)
.++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999999999999999776655555567889999999999999999999885522
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...+|+||||+.++++.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 34689999999999888887777889999999999999999999999999999999999999999999999999998765
Q ss_pred CCC---CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 251 PGL---KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 251 ~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
... .....+.+||+.|+|||++.+...|+.++|||||||++|||++|++||.+.++.+.+..+.+..+.+..+.+..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 322 22334467999999999998876789999999999999999999999999999999999999999887766544
Q ss_pred cCCCCc-ccCCCCCCcccchhccc--CCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 328 SKLPNA-TLFKPQQPYKRCIAETF--KDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 328 ~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
...... ................+ ...+++++|||.+||++||++|||++|+|+||||+..|.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 321110 00000000011111111 123567889999999999999999999999999997644
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-58 Score=449.93 Aligned_cols=287 Identities=34% Similarity=0.546 Sum_probs=236.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|+++++||+|+||+||+|+++.+|+.||||+++.........+.+.+|+.+|++++|||||+++++|.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999999999999999999876666667778899999999999999999999987642 23
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||++..+...... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~- 173 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS- 173 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-
T ss_pred eEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC-
Confidence 5799999997665554432 4699999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
..+..+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+....+.++.+++.......
T Consensus 174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence 34567899999999999887778999999999999999999999999999999999999999999988776533211
Q ss_pred cccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 333 ATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
.... .........+...+..+++++.+||.+||..||.+|||++|+|+||||+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 1000 00011122334455678889999999999999999999999999999997543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=448.53 Aligned_cols=282 Identities=36% Similarity=0.553 Sum_probs=233.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec----CCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR----MSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 173 (457)
.+|+.+++||+|+||+||+|++..+|+.||||++..+... ..+|+.+|++++|||||++++++... ....
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 3699999999999999999999999999999999765422 23699999999999999999998642 2346
Q ss_pred EEEEEecccCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCcccc
Q 036122 174 LYLVFEYMEHDLAGLAA---CQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFY 249 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~ 249 (457)
+||||||+++++...+. .....+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||+++..
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999988655443 3456799999999999999999999999999999999999999775 8999999999877
Q ss_pred CCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 250 DPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 250 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... ....+.+||+.|+|||.+.+...|+.++|||||||++|||++|++||.+.+..+++.++++.+|.+..+.|....
T Consensus 174 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 543 334567899999999999877778999999999999999999999999999999999999999999988887543
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
........+............+.+++++.+||.+||++||++|||+.|+|+||||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 2211111111111111222345678899999999999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=443.55 Aligned_cols=258 Identities=21% Similarity=0.352 Sum_probs=223.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+|++++|||||++++++.+ ...+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEE
Confidence 468999999999999999999999999999999997643 333557899999999999999999999988 578999
Q ss_pred EEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC--CcEEEeeccCccccCCCC
Q 036122 177 VFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND--GILKIADFGLATFYDPGL 253 (457)
Q Consensus 177 v~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~--~~vkl~DFGla~~~~~~~ 253 (457)
|||||.|+.+ ..+...+..+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999997544 4444445579999999999999999999999999999999999999854 58999999999876543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......+|+.|+|||.+.+.. |+.++|||||||++|+|++|.+||.+.+..+.+.+|.+....++...
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------- 226 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA--------- 226 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH---------
T ss_pred -CcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh---------
Confidence 3345567899999999998776 79999999999999999999999999999999998877544443333
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
++.+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 227 ----------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 227 ----------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ----------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ----------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 34578889999999999999999999999999999763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-57 Score=433.38 Aligned_cols=287 Identities=38% Similarity=0.665 Sum_probs=243.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|+++++||+|+||+||+|++..+|+.||||+++...........+.+|+.+|++++||||+++++++.. ...+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 58999999999999999999999999999999998876666677889999999999999999999999988 5678999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCCc
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQPM 257 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 257 (457)
||++.++.+..+....+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~ 158 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCY 158 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-ccc
Confidence 9999998888888888889999999999999999999999999999999999999999999999999998775432 233
Q ss_pred ccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccC
Q 036122 258 TSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPI-MPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLF 336 (457)
Q Consensus 258 ~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 336 (457)
....+++.|+|||++.+...++.++|||||||++|||++|+.| |.+.+..+.+.++....+.+....|...........
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence 4456789999999998877789999999999999999999765 677888888999999988887776654321111111
Q ss_pred CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 337 KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
.+..............+++.+.+||++||++||.+|||++|+|+||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 111222233444556778899999999999999999999999999999873
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-57 Score=449.67 Aligned_cols=262 Identities=26% Similarity=0.368 Sum_probs=214.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC----ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL----EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .........+|+.+++.++|||||++++++.+ ..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CC
Confidence 4789999999999999999999999999999999975432 11222233445777888899999999999987 56
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+||||++++.+..+......+++.+++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 79999999998766666556667999999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.....+||+.|+|||++.+...|+.++|||||||++|||+||++||.+.+..+... +........
T Consensus 161 ---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-~~~~~~~~~----------- 225 (364)
T d1omwa3 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMA----------- 225 (364)
T ss_dssp ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-HHHHSSSCC-----------
T ss_pred ---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhcccCC-----------
Confidence 23456899999999999866668999999999999999999999998765433322 111110000
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcC-----HHHHhcCCCCCCCCC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGT-----ATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 389 (457)
......+++++.+||.+||+.||++||| ++|+|+||||++..|
T Consensus 226 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 226 --------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp --------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred --------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 0112357889999999999999999999 899999999998654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-57 Score=438.31 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=220.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHH-hcCCCCceeEeeeEEecCCceEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLR-KLDHPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~~~ 175 (457)
++|++++.||+|+||+||+|+++.+|+.||||+++.+.. .......+..|+.++. .++|||||++++++.+ ...+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 579999999999999999999999999999999975421 1223344566777665 6899999999999988 56799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ 255 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~ 255 (457)
+||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++..... ..
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-cc
Confidence 99999998766666666678999999999999999999999999999999999999999999999999999866433 23
Q ss_pred CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 256 PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 256 ~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
..+...||+.|+|||++.+.. |+.++|||||||++|||+||++||.+.+..+.+.++... .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~--------------- 220 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP--------------- 220 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC---------------
T ss_pred cccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC---------------
Confidence 345578999999999998876 799999999999999999999999999988888777432 11
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHH-HHhcCCCCCCCCC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT-AALNSEFFNTEPY 389 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~-elL~hp~f~~~~~ 389 (457)
...+.+++++.+||++||+.||++|||+. |+++||||++..|
T Consensus 221 ------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 221 ------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp ------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 01134788899999999999999999995 8999999988643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=427.34 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=209.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCCh----HHHHHHHHHHHHHHhcC--CCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEP----ESVKFMAREILVLRKLD--HPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~----~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~ 170 (457)
.++|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 368999999999999999999999999999999997654321 11233568999999997 8999999999987
Q ss_pred CceEEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-CCcEEEeeccCccc
Q 036122 171 SCSLYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-DGILKIADFGLATF 248 (457)
Q Consensus 171 ~~~~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-~~~vkl~DFGla~~ 248 (457)
...+|+||||+.+ +.+.........+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 5679999999975 444444444567999999999999999999999999999999999999985 57999999999987
Q ss_pred cCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 249 YDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 249 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... ..++..||+.|+|||++.+..+++.++|||||||++|||+||++||.+.+ .+.+..
T Consensus 161 ~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~----------- 220 (273)
T d1xwsa_ 161 LKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ----------- 220 (273)
T ss_dssp CCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCC-----------
T ss_pred cccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcc-----------
Confidence 6432 34567899999999999887767888999999999999999999997632 121110
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
......+|+++.+||++||+.||++|||++|+|+||||++.
T Consensus 221 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 ------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 00113478899999999999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=430.16 Aligned_cols=290 Identities=33% Similarity=0.522 Sum_probs=232.1
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC---Cce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM---SCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---~~~ 173 (457)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+||||+++++++.... ...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 357999999999999999999999999999999997544 3455567889999999999999999999986532 234
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|++|++++++|...+.. ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 677777776677666543 359999999999999999999999999999999999999999999999999998664322
Q ss_pred --CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 254 --KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 254 --~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.......+||+.|+|||++.....++.++||||+||++|+|++|++||.+.+..++...+....+.+...........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 122355678999999999977766899999999999999999999999999999999988888888876654332111
Q ss_pred Ccc--cCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 332 NAT--LFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 332 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
... ...........+...++.+++++++||.+||+.||.+|||++|+|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 100 0001111122244556778889999999999999999999999999999997543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=439.98 Aligned_cols=285 Identities=31% Similarity=0.510 Sum_probs=226.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEec----CCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSR----MSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----~~~~ 173 (457)
++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||||++++++... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999999999999999999988776777777899999999999999999999998653 2468
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+|+||||+.++++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 97 ~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~- 172 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 172 (355)
T ss_dssp EEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred eEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc-
Confidence 99999999998877653 36999999999999999999999999999999999999999999999999999866543
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
...+..++|+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+....+.++....+.+..++|........
T Consensus 173 -~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 -FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ---------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred -cccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 3345567899999999998765 89999999999999999999999999999999999999999988888764321000
Q ss_pred -----ccCCCCCCcccc--------hhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 334 -----TLFKPQQPYKRC--------IAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 334 -----~~~~~~~~~~~~--------~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
............ .......+++++++||++||..||++||||+|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 000000000000 0011112356789999999999999999999999999998743
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=419.86 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=207.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|+.. ..||||+++.........+.+.+|+.+|++++|||||++++++.. ..+|+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~l 80 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAI 80 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEE
Confidence 478999999999999999999732 359999998776667777889999999999999999999998754 45799
Q ss_pred EEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC-C
Q 036122 177 VFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL-K 254 (457)
Q Consensus 177 v~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~-~ 254 (457)
||||++++ |...+......+++.++..++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+...... .
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999975 445454556679999999999999999999999999999999999999999999999999998764332 2
Q ss_pred CCcccccccCccCchHhhhCC--cCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGA--TYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~--~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
.......||+.|||||++.+. ..|+.++|||||||++|||+||+.||.+.+....+..+......++
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p----------- 229 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----------- 229 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-----------
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-----------
Confidence 234556899999999999743 2378999999999999999999999998877766555543211111
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
........+|+++.+||.+||+.||++|||++|++++
T Consensus 230 ------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 ------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0112334578899999999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=437.97 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=206.6
Q ss_pred cCCccccc-eeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe--cCCc
Q 036122 97 ANTFEKLD-KIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS--RMSC 172 (457)
Q Consensus 97 ~~~y~~~~-~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~ 172 (457)
.++|.+++ .||+|+||+||+|++..+|+.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46899886 499999999999999999999999999642 3467899987654 89999999999865 2346
Q ss_pred eEEEEEecccCC-HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCcc
Q 036122 173 SLYLVFEYMEHD-LAGLAACQ-GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLAT 247 (457)
Q Consensus 173 ~~~lv~E~~~~~-l~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~ 247 (457)
.+|+|||||+|+ |...+... ...|++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 689999999875 54544443 346999999999999999999999999999999999999985 5679999999998
Q ss_pred ccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 248 FYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 248 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
..... ......+||+.|||||++.+.. |+.++|||||||++|+|+||++||.+.+..+....+........
T Consensus 163 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------ 233 (335)
T d2ozaa1 163 ETTSH--NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------ 233 (335)
T ss_dssp ECCCC--CCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS------
T ss_pred eccCC--CccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC------
Confidence 77543 3345678999999999987766 89999999999999999999999988766555444432211000
Q ss_pred cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCC
Q 036122 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTE 387 (457)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~ 387 (457)
. . .....+..+++++.+||++||+.||++|||+.|+|+||||++.
T Consensus 234 --------~--~-----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 --------Y--E-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp --------S--S-----CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred --------C--C-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 0 0 0011223478889999999999999999999999999999763
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=432.80 Aligned_cols=286 Identities=36% Similarity=0.554 Sum_probs=231.4
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecC----Cc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRM----SC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~ 172 (457)
.++|+++++||+|+||+||+|+++.+|+.||||+++....+....+.+.+|+.+|++++|||||++++++.... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 36799999999999999999999999999999999877666667778899999999999999999999886421 23
Q ss_pred eEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 173 SLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+|+++++.+++|...+ . ...+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~-~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIV-K-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCEEEEECCSEEHHHHH-T-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred eEEEEEeecCCchhhhc-c-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 34555555444555444 3 3469999999999999999999999999999999999999999999999999997553
Q ss_pred CCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 253 LKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 253 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....+..||+.|+|||++.+..+++.++|||||||++|+|++|++||.+.+.......+.+..+.+..+.+.......
T Consensus 173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 334556889999999999887778999999999999999999999999999999999999999988877665322111
Q ss_pred cccC--CCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCC
Q 036122 333 ATLF--KPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEP 388 (457)
Q Consensus 333 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~ 388 (457)
.... .........+...+..+++++++||++||+.||.+|||++|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 1000 0011112223445667889999999999999999999999999999999754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.5e-55 Score=427.17 Aligned_cols=283 Identities=29% Similarity=0.515 Sum_probs=225.6
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLY 175 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~ 175 (457)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+.+. ||||+++++++.......++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 478999999999999999999999999999999986432 356789999999995 99999999999876667799
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCC-cEEEeeccCccccCCCCC
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDG-ILKIADFGLATFYDPGLK 254 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~-~vkl~DFGla~~~~~~~~ 254 (457)
+||||+.++.+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+.....
T Consensus 109 ~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-- 183 (328)
T d3bqca1 109 LVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-- 183 (328)
T ss_dssp EEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--
T ss_pred EEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC--
Confidence 99999998765443 34699999999999999999999999999999999999998654 6999999999877644
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhh-cCCCC
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKK-SKLPN 332 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~-~~~~~ 332 (457)
......++|+.|+|||.+.+...++.++|||||||++|+|++|+.||... +..++...+...++.+....+.. .....
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 23456788999999999988777899999999999999999999998654 55567777777777554333322 11111
Q ss_pred cccC------CCCCCccc-chhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCCCCCCC
Q 036122 333 ATLF------KPQQPYKR-CIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFFNTEPY 389 (457)
Q Consensus 333 ~~~~------~~~~~~~~-~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f~~~~~ 389 (457)
...+ ........ ........++++++|||++||.+||++|||++|+|+||||+...+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 1000 00111111 111223446788999999999999999999999999999998643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-55 Score=418.82 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=211.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC--ce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS--CS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~ 173 (457)
.++|++.+.||+|+||+||+|++..+|+.||||+++.... +......+.+|+.+|++++|||||++++++..... ..
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999999999999999999987654 35556779999999999999999999999876432 35
Q ss_pred EEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 174 LYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
+||||||++|+.+.......+.+++.+++.++.||+.||.|||++||+||||||+||||+.++.++|+|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999987666666666689999999999999999999999999999999999999999999999999987654322
Q ss_pred --CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 036122 254 --KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLP 331 (457)
Q Consensus 254 --~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 331 (457)
.......+||+.|+|||++.+.. ++.++|||||||++|||+||++||.+.+..+.+.++......++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~---------- 234 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP---------- 234 (277)
T ss_dssp -------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG----------
T ss_pred ccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC----------
Confidence 22345568999999999998766 79999999999999999999999999998888777655321111
Q ss_pred CcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcCCCC
Q 036122 332 NATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNSEFF 384 (457)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~hp~f 384 (457)
.....++|+++.+||.+||+.||.+||+..+.|.|+|+
T Consensus 235 ---------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 235 ---------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ---------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 12235688899999999999999999944444446554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-55 Score=412.15 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=199.0
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.++||+|+||+||+|++. +++.||||+++..... .+.+.+|+.++++++|||||+++|++.. ...+|+|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceecc--CCceEEE
Confidence 57999999999999999999974 6778999999765433 3468899999999999999999999987 4568999
Q ss_pred EecccCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||++++.+.. +......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.........
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999865544 44455679999999999999999999999999999999999999999999999999998775544334
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....||+.|+|||++.+.. |+.++|||||||++|||+| |.+||...+..+.+..+......+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--------------- 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY--------------- 222 (263)
T ss_dssp ------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCC---------------
T ss_pred ecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCC---------------
Confidence 44567899999999998776 8999999999999999999 578888888877777765421100
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
....+++++.+||.+||+.||++|||++|+|+|
T Consensus 223 -------------~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 223 -------------KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 112357789999999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=415.96 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=211.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.++||+|+||+||+|+++ ++..||||+++..... .+.+.+|+.+|++++|||||++++++.+ ..+|+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEE
Confidence 468999999999999999999974 6788999999765433 3568899999999999999999998754 35799
Q ss_pred EEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||++++.+...... ...+++.++..|+.||+.||.|||+++|+||||||+||||++++.+||+|||+|+.......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999998766553332 23599999999999999999999999999999999999999999999999999998765443
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+.. ++.++|||||||++|||+|| .+||...+..+.+..+......
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~-------------- 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred ccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 3445567899999999998766 79999999999999999995 6777777777777666432100
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc--CCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN--SEFFNT 386 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~--hp~f~~ 386 (457)
.....+++++.+||.+||+.||++|||++|+++ |+||+.
T Consensus 230 --------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 230 --------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 011347788999999999999999999999998 788853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-55 Score=419.16 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=206.5
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.++||+|+||+||+|++..+|+.||||+++.+... .+.+.+|+.+|++++|||||++++++.+ ...+||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee--CCeeEE
Confidence 36899999999999999999999999999999999765433 3568899999999999999999999977 567899
Q ss_pred EEecccCCHHHHHH-h-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAA-C-QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~-~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||++++.+.... . ....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999976544443 3 345799999999999999999999999999999999999999999999999999997755433
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKP-IMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
...+...||+.|+|||++.+.. |+.++|||||||++|||++|.. ||.+.+..+....+....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---------------- 233 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------------- 233 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------------
T ss_pred eeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC----------------
Confidence 3334456799999999998776 7999999999999999999654 555555554444332210
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
. ......+|+++.+||.+||+.||++|||++|+++
T Consensus 234 ---~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 234 ---R---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp ---C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---C---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0 0112357888999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=416.83 Aligned_cols=250 Identities=21% Similarity=0.287 Sum_probs=204.5
Q ss_pred ceeeccCceEEEEEEEc--CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEEecc
Q 036122 104 DKIGQGTYSNVYKARDL--LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 104 ~~LG~G~fg~Vy~~~~~--~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
++||+|+||+||+|.+. .+++.||||+++....+....+.+.+|+.+|++++|||||++++++.. ..+||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 46999999999999864 345789999997665556666789999999999999999999999864 3478999999
Q ss_pred cCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCC--Cccc
Q 036122 182 EHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQ--PMTS 259 (457)
Q Consensus 182 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~--~~~~ 259 (457)
+++.+..+......+++.++..|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++........ ....
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC---
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccc
Confidence 98766666666778999999999999999999999999999999999999999999999999999876543222 1233
Q ss_pred ccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccCCC
Q 036122 260 RVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKP 338 (457)
Q Consensus 260 ~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (457)
..||+.|||||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+.+... +
T Consensus 170 ~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-------------------~ 229 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------------------M 229 (277)
T ss_dssp -CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------C
T ss_pred cCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-------------------C
Confidence 56899999999998766 7999999999999999998 8999999888777766643110 0
Q ss_pred CCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHH---hcCCCCC
Q 036122 339 QQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAA---LNSEFFN 385 (457)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el---L~hp~f~ 385 (457)
.....+|+++.+||.+||+.||++|||++++ |+|+|++
T Consensus 230 ---------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 230 ---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1123578889999999999999999999998 5666653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=407.53 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=213.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.++||+|+||+||+|++ .+++.||||+++...... +.+.+|+.++++++|||||+++|++.+ ...+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEE
Confidence 6899999999999999999997 478899999998765443 468899999999999999999999987 5679999
Q ss_pred EecccCCH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCCCC
Q 036122 178 FEYMEHDL-AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLKQP 256 (457)
Q Consensus 178 ~E~~~~~l-~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~~~ 256 (457)
|||+.++. ..........+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.........
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99998654 44445556679999999999999999999999999999999999999999999999999998775544444
Q ss_pred cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 036122 257 MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNATL 335 (457)
Q Consensus 257 ~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 335 (457)
.....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+...++.+....+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--------------- 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---------------
T ss_pred ecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---------------
Confidence 45567899999999998776 7999999999999999998 899999999888887775421110
Q ss_pred CCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 336 FKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....++++.+||.+||+.||++|||++++|+|
T Consensus 222 -------------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 222 -------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 112467789999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-54 Score=416.86 Aligned_cols=253 Identities=23% Similarity=0.387 Sum_probs=199.9
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCc---EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGK---IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~---~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.++|++.+.||+|+||+||+|+++.+|+ .||||.+.... .....+.+.+|+.+|++++|||||+++|++.. ...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCE
Confidence 4679999999999999999999877664 58899886543 45556778999999999999999999999977 467
Q ss_pred EEEEEecccCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+|+|||||+++.+.. +......+++.++..++.||+.||.|||+++|+||||||+||||+.++++||+|||+|+.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 899999999866555 4444567999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCC----cccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 036122 253 LKQP----MTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKK 327 (457)
Q Consensus 253 ~~~~----~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 327 (457)
.... .....||+.|||||++.+.. |+.++|||||||++|||+| |.+||.+.+..+.+..+......+
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~------- 253 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP------- 253 (299)
T ss_dssp --------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------
T ss_pred CCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 2211 12245789999999998766 8999999999999999998 899999998888777764421110
Q ss_pred cCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 328 SKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
....+++++.+||.+||+.||++|||+.|++++
T Consensus 254 ---------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 254 ---------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 123477889999999999999999999998864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=411.97 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=211.6
Q ss_pred CCccccce-eeccCceEEEEEEEcC--CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDK-IGQGTYSNVYKARDLL--TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~-LG~G~fg~Vy~~~~~~--~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
++|.+.+. ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.+|++++|||||+++|++.. ..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeE
Confidence 57888884 9999999999998754 45579999997553 45566789999999999999999999999865 358
Q ss_pred EEEEecccCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLAGLA-ACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~~~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
||||||++++.+..+ ......+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999998655444 4455679999999999999999999999999999999999999999999999999999775432
Q ss_pred C--CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 254 K--QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 254 ~--~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
. .......||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.+..+.+...
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~------------ 230 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR------------ 230 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC------------
T ss_pred cccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 2 2223456899999999998766 7999999999999999998 8999999888877776643210
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHH---hcCCCCC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAA---LNSEFFN 385 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~el---L~hp~f~ 385 (457)
.+..+.+|+++.+||.+||+.||++|||+.++ |+|+|++
T Consensus 231 ----------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ----------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 01124578889999999999999999999887 6788874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-54 Score=418.17 Aligned_cols=253 Identities=21% Similarity=0.302 Sum_probs=204.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCc-----EEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCC
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGK-----IVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~-----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 171 (457)
++|++.+.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+|.++ +|||||++++++.+ .
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~ 113 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL--S 113 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--C
Confidence 689999999999999999999876543 69999986543 233345688999999998 89999999999987 5
Q ss_pred ceEEEEEecccCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQG-----------------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGS 228 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~~-----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~ 228 (457)
..+|+|||||+++.+..+.... ..+++.+++.|+.||+.||.|||+++||||||||+
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~ 193 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence 6789999999986554444322 24899999999999999999999999999999999
Q ss_pred CEEecCCCcEEEeeccCccccCCCCCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCCh
Q 036122 229 NLLIDNDGILKIADFGLATFYDPGLKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTE 306 (457)
Q Consensus 229 NILl~~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~ 306 (457)
|||++.++++||+|||+|+........ ......||+.|||||++.+.. |+.++|||||||++|||+| |.+||.+.+.
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999866433222 223456799999999998766 8999999999999999998 8999998777
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 307 VEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 307 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.+.+.++......+ .....+|+++.+||.+||+.||++|||++|+++|
T Consensus 273 ~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66666654421110 1123467889999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=407.45 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=204.8
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||+||+|++.. +..||||+++..... .+.+.+|+.+|++++|||||++++++.+ ..+|+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEE
Confidence 4689999999999999999999754 467999999765433 3568899999999999999999998854 34789
Q ss_pred EEecccCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAAC--QGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||++++.+..... ....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 999999875443332 234699999999999999999999999999999999999999999999999999987754444
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||++.+.. ++.++|||||||++|||+|| .+||.+....+.+..+......
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------------- 233 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------------- 233 (285)
T ss_dssp -------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--------------
T ss_pred eeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC--------------
Confidence 4445567899999999998766 79999999999999999995 6677777777777766432111
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc--CCCCCCC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN--SEFFNTE 387 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~--hp~f~~~ 387 (457)
.....+++++.+||.+||+.||++|||++++++ ++||+..
T Consensus 234 --------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 --------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 112357788999999999999999999999998 8999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=404.76 Aligned_cols=251 Identities=20% Similarity=0.317 Sum_probs=198.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTG---KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~ 174 (457)
++|++.+.||+|+||+||+|++..++ ..||||+++... .....+.+.+|+.+|++++|||||++++++.+ ..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~ 82 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPV 82 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSC
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeE
Confidence 68999999999999999999986543 468899886432 45556778999999999999999999999854 468
Q ss_pred EEEEecccCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCC
Q 036122 175 YLVFEYMEHDLA-GLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGL 253 (457)
Q Consensus 175 ~lv~E~~~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~ 253 (457)
|+||||+.++.+ .........+++.+++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999997544 4445556679999999999999999999999999999999999999999999999999998776544
Q ss_pred CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 036122 254 KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPN 332 (457)
Q Consensus 254 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 332 (457)
....+...||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+.+.++......
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------------- 228 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------------- 228 (273)
T ss_dssp --------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred ceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 44445567899999999998766 7999999999999999998 89999999888887776432100
Q ss_pred cccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 333 ATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
...+.+|+++.+||.+||+.||++|||++|+++|
T Consensus 229 ---------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 ---------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1224578899999999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=400.06 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=199.0
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC----cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCc
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG----KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSC 172 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g----~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 172 (457)
.+.|++.+.||+|+||+||+|.++.++ ..||||+++... .......+.+|+.+|++++|||||+++|++.. ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CC
Confidence 357999999999999999999877654 479999997543 44455678899999999999999999999977 56
Q ss_pred eEEEEEecccCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCC
Q 036122 173 SLYLVFEYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDP 251 (457)
Q Consensus 173 ~~~lv~E~~~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~ 251 (457)
.+++||||+.++++.. .......+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 7899999999865544 444556799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 252 GLKQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 252 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.... ......||+.|||||++.+.. ++.++|||||||++|||++| .+||...+..+.+..+......
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------- 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL--------- 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------
T ss_pred CCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---------
Confidence 3221 223356799999999998776 89999999999999999995 5666666766666555332100
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
....++++++.+||.+||+.||++|||+.|+++
T Consensus 233 -------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 -------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 112346778999999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=420.32 Aligned_cols=265 Identities=26% Similarity=0.403 Sum_probs=216.4
Q ss_pred cCCccccceeeccCceEEEEEEEc---CCCcEEEEEEeecCCC--ChHHHHHHHHHHHHHHhcCC-CCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL---LTGKIVALKKVRFDNL--EPESVKFMAREILVLRKLDH-PNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~---~~g~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~ 170 (457)
.++|++++.||+|+||+||+|++. .+|+.||||+++.... +....+.+.+|+.+|++++| |||+++++++.+
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 468999999999999999999874 4689999999865432 11223457789999999976 899999999888
Q ss_pred CceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccC
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYD 250 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~ 250 (457)
...+++||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 56799999999987666666666678999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCcccccccCccCchHhhhCCc-CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 251 PGLKQPMTSRVVTLWYRPPELLLGAT-YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 251 ~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
...........|++.|+|||.+.+.. .++.++|||||||+||+|+||++||.+.+..+...++.+....+.
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~-------- 252 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------- 252 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--------
Confidence 44334445678999999999997644 468899999999999999999999988765555554443211000
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCc-----CHHHHhcCCCCCCCC
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRG-----TATAALNSEFFNTEP 388 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 388 (457)
......+++++.+||++||++||++|| |++|+|+||||++..
T Consensus 253 -----------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 253 -----------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -----------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 011235788999999999999999999 589999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=408.17 Aligned_cols=251 Identities=23% Similarity=0.323 Sum_probs=202.7
Q ss_pred CCccccceeeccCceEEEEEEEcCCCc----EEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGK----IVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
.+|++++.||+|+||+||+|++..+|+ .||+|+++... .....+.+.+|+.+|++++|||||+++|++.+ . .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT--S-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--S-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--C-C
Confidence 579999999999999999999988876 57888876432 33445678999999999999999999999976 2 3
Q ss_pred EEEEEecccC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEH-DLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
.+++|||+.+ ++...+......+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 5677777765 566767767778999999999999999999999999999999999999999999999999999977543
Q ss_pred CCC-CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 036122 253 LKQ-PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKL 330 (457)
Q Consensus 253 ~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 330 (457)
... ......||+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+....+......
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~----------- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL----------- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCC-----------
T ss_pred cccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-----------
Confidence 322 223456899999999998776 8999999999999999998 79999988877766655432110
Q ss_pred CCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 331 PNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.....+++++.+||.+||+.||++|||+.|+++|
T Consensus 233 -----------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 -----------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -----------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 0113467789999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=397.77 Aligned_cols=254 Identities=20% Similarity=0.303 Sum_probs=195.2
Q ss_pred CCccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCC
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~ 171 (457)
++|++.++||+|+||+||+|++.. +++.||||+++... .....+.+.+|..++.++ +|+|||.+++++... .
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 689999999999999999998754 45689999987544 344456677788888777 689999999887654 3
Q ss_pred ceEEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDND 235 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~ 235 (457)
..+++|||||+++.+..+... ...+++.++..++.||+.||.|||++|||||||||+||||+.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 568999999997655544332 2348999999999999999999999999999999999999999
Q ss_pred CcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 036122 236 GILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKI 313 (457)
Q Consensus 236 ~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i 313 (457)
+++||+|||+|+....... ...+...||+.|+|||++.+.. ++.++|||||||++|||+|| .+||.+.+..+.+.++
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999987643322 2334567899999999998766 79999999999999999997 5789877655544444
Q ss_pred HHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 314 FKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
......+ .....+++++.+||.+||+.||++|||++|+++|
T Consensus 250 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 250 LKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3321100 1123467889999999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=393.92 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=198.7
Q ss_pred CCccccceeeccCceEEEEEEEc-CCC--cEEEEEEeecCCC-ChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCce
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDL-LTG--KIVALKKVRFDNL-EPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~-~~g--~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 173 (457)
++|++.+.||+|+||+||+|+.. .++ ..||||+++.+.. ..+..+.+.+|+.+|++++|||||+++|++.+ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~ 84 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PP 84 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cc
Confidence 57999999999999999999864 333 3689999876543 34455778999999999999999999999965 35
Q ss_pred EEEEEecccCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCC
Q 036122 174 LYLVFEYMEHD-LAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPG 252 (457)
Q Consensus 174 ~~lv~E~~~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~ 252 (457)
+++||||++++ +...+......+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 78999999864 45555555667999999999999999999999999999999999999999999999999999977543
Q ss_pred CCC--CcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 036122 253 LKQ--PMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSK 329 (457)
Q Consensus 253 ~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 329 (457)
... ......||..|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.+.++.+....+
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 234 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--------- 234 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC---------
T ss_pred CCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC---------
Confidence 222 123345788999999998766 8999999999999999998 899999999998888775421110
Q ss_pred CCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 330 LPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
.....+|+++.+||.+||+.||++|||+.|++
T Consensus 235 ------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 235 ------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 12245788899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-51 Score=395.82 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=208.1
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||+||+|+.+ .+++.||||+++... ..+..+.+.+|+.+|++++||||+++++++.. .
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--G 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc--C
Confidence 468999999999999999999875 356789999987543 45556779999999999999999999999987 5
Q ss_pred ceEEEEEecccCCHHHHHHhc------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCC
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ------------------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKG 227 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 227 (457)
..+++||||++++.+..+... ...+++.++..|+.||+.||+|||+++||||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 678999999987644443322 12489999999999999999999999999999999
Q ss_pred CCEEecCCCcEEEeeccCccccCCCC-CCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCC
Q 036122 228 SNLLIDNDGILKIADFGLATFYDPGL-KQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRT 305 (457)
Q Consensus 228 ~NILl~~~~~vkl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~ 305 (457)
+||||+.++.+||+|||+|+...... ....+...||+.|+|||++.+.. |+.++|||||||++|||++| .+||.+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 99999999999999999998664332 22334567899999999998766 89999999999999999998 58899999
Q ss_pred hHHHHHHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 306 EVEQLHKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 306 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
..+.+..+.+... ......+++++.+||.+||+.||++|||+.|+++
T Consensus 248 ~~e~~~~v~~~~~----------------------------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 248 HEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCC----------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888877643210 0112357788999999999999999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=385.83 Aligned_cols=245 Identities=21% Similarity=0.345 Sum_probs=196.3
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEE
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~l 176 (457)
.++|++.+.||+|+||.||+|++ +|..||||+++.+. ..+.+.+|+.++++++|||||+++|++.+. ...+|+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEE
Confidence 46899999999999999999986 57899999997543 235688999999999999999999988653 345799
Q ss_pred EEecccCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC
Q 036122 177 VFEYMEHDLAGLAACQ--GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~ 254 (457)
||||++++.+..+... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999988655444322 235899999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.....+|..|+|||++.+.. ++.++|||||||++|||+| |++||...+..+....+....
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~---------------- 217 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 217 (262)
T ss_dssp -------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------
T ss_pred --CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 23446789999999998766 7999999999999999998 789999888777766653210
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
+ .+....+++++.+||.+||+.||.+|||+.+++++
T Consensus 218 ---~---------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ---K---------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---C---------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0 01223477889999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=388.49 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=203.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCC-------cEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEe
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTG-------KIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTS 168 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g-------~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 168 (457)
.++|++.+.||+|+||.||+|++..++ ..||||+++.+. .......+.+|...+.++ +|||||++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 368999999999999999999876554 479999997654 445556788899999888 79999999999987
Q ss_pred cCCceEEEEEecccCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 169 RMSCSLYLVFEYMEHDLAGLAACQG----------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 169 ~~~~~~~lv~E~~~~~l~~~~~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
...+|+||||+.++.+..+.... ..+++.++..++.||+.||+|||+++||||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 56789999999986555544322 358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||+++....... .......+|+.|+|||++.+.. |+.++|||||||++|||+| |.+||.+.+..+..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999987754322 2334567899999999998766 8999999999999999998 79999988877666
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
..+.... .+ .....+++++.+||.+||+.||++|||+.|+|+
T Consensus 248 ~~i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGH-RM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTC-CC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCC-CC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5553211 00 112347788999999999999999999999985
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=392.40 Aligned_cols=251 Identities=26% Similarity=0.312 Sum_probs=204.2
Q ss_pred cCCccccceeeccCceEEEEEEEcCCCcE--EEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecCCce
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLLTGKI--VALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRMSCS 173 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~~g~~--vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~ 173 (457)
-++|++.++||+|+||+||+|+++.+|.. ||||+++... ..+..+.+.+|+.+|+++ +|||||++++++.. ...
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~ 85 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 85 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCe
Confidence 37899999999999999999999888874 6777775432 333456788999999999 79999999999987 568
Q ss_pred EEEEEecccCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCc
Q 036122 174 LYLVFEYMEHDLAGLAACQ----------------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGI 237 (457)
Q Consensus 174 ~~lv~E~~~~~l~~~~~~~----------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~ 237 (457)
+|+||||++++.+..+... ...+++.++..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999997655554432 356999999999999999999999999999999999999999999
Q ss_pred EEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHh
Q 036122 238 LKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKL 316 (457)
Q Consensus 238 vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~ 316 (457)
+||+|||+++...... ......||..|+|||.+.+.. |+.++|||||||++|||++| .+||.+.+..+.+..+.+.
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 9999999998654332 123456899999999998776 79999999999999999997 5789888887777665331
Q ss_pred cCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 317 CGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
. .+ .....+++++.+||.+||+.||++|||++|+|+|
T Consensus 243 ~-------------------~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 Y-------------------RL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp C-------------------CC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-------------------CC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1 00 1123477889999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=389.84 Aligned_cols=258 Identities=18% Similarity=0.225 Sum_probs=212.3
Q ss_pred cCCccccceeeccCceEEEEEEEcC-----CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDLL-----TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS 171 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~~-----~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 171 (457)
.++|++.+.||+|+||+||+|.+.. +++.||||+++... .......+.+|+.++++++|||||++++++.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--C
Confidence 3789999999999999999998752 35789999997543 44555678999999999999999999999976 4
Q ss_pred ceEEEEEecccCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEe
Q 036122 172 CSLYLVFEYMEHDLAGLAACQ----------GVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIA 241 (457)
Q Consensus 172 ~~~~lv~E~~~~~l~~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~ 241 (457)
..+++||||+.++.+..+... -..+++..+..++.||+.||.|||+++|+||||||+||||+.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 568999999987644443221 1347899999999999999999999999999999999999999999999
Q ss_pred eccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCC
Q 036122 242 DFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAG-KPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 242 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG-~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
|||+++....... .......||+.|+|||.+.+.. ++.++|||||||++|||+|| .+||.+.+..+.+..+.+...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~- 253 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 253 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC-
Confidence 9999986643322 1223446899999999998776 78999999999999999998 589999988888877644210
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc------CCCCCC
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN------SEFFNT 386 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~------hp~f~~ 386 (457)
......+++.+.+||.+||+.||++|||++|+++ +|+|++
T Consensus 254 ---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 254 ---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred ---------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 0112347788999999999999999999999998 676654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=386.79 Aligned_cols=253 Identities=22% Similarity=0.288 Sum_probs=207.9
Q ss_pred cCCccccceeeccCceEEEEEEEc-----CCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhc-CCCCceeEeeeEEecC
Q 036122 97 ANTFEKLDKIGQGTYSNVYKARDL-----LTGKIVALKKVRFDNLEPESVKFMAREILVLRKL-DHPNVIKLEGLVTSRM 170 (457)
Q Consensus 97 ~~~y~~~~~LG~G~fg~Vy~~~~~-----~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~ 170 (457)
.++|++.++||+|+||.||+|++. .+++.||||+++... .......+.+|+.+++++ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 478999999999999999999863 466789999997654 445556788999999999 69999999999987
Q ss_pred CceEEEEEecccCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEe
Q 036122 171 SCSLYLVFEYMEHDLAGLAACQG------------------VKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLI 232 (457)
Q Consensus 171 ~~~~~lv~E~~~~~l~~~~~~~~------------------~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl 232 (457)
...+|+||||++++.+..+.... ..+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 45689999999986554443322 258999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeccCccccCCCCC-CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 036122 233 DNDGILKIADFGLATFYDPGLK-QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLA-GKPIMPGRTEVEQL 310 (457)
Q Consensus 233 ~~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~ellt-G~~pf~~~~~~~~~ 310 (457)
+.++.+||+|||+++....... .......||+.|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+.+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999997754322 2234467899999999998766 7999999999999999998 67888887776666
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
.++......+ .....+++++.+||.+||+.||++|||++|+|+
T Consensus 258 ~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 258 YKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6654421110 111346788999999999999999999999984
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-49 Score=383.43 Aligned_cols=262 Identities=22% Similarity=0.248 Sum_probs=206.9
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLV 177 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv 177 (457)
++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|+|++.+++.+... ....++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEE
Confidence 5799999999999999999999999999999998765432 2367899999999888766665555433 5678999
Q ss_pred EecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC---CCcEEEeeccCccccCCCCC
Q 036122 178 FEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN---DGILKIADFGLATFYDPGLK 254 (457)
Q Consensus 178 ~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~---~~~vkl~DFGla~~~~~~~~ 254 (457)
|||+++++..........+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 999999988888777788999999999999999999999999999999999999864 45799999999997754321
Q ss_pred ------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 036122 255 ------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKKS 328 (457)
Q Consensus 255 ------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 328 (457)
.......||+.|||||++.+.. ++.++|||||||++|||+||.+||...........+...... ..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----~~--- 233 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KM--- 233 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH----HH---
T ss_pred ccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----cC---
Confidence 1234567999999999998776 899999999999999999999999877655444333221100 00
Q ss_pred CCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHH---HHhcCCCCCC
Q 036122 329 KLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTAT---AALNSEFFNT 386 (457)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~---elL~hp~f~~ 386 (457)
..........+|+++.+||..||+.||++||+++ ++|+|+|.+.
T Consensus 234 --------------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 234 --------------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp --------------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0011223456889999999999999999999987 5578887643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=380.34 Aligned_cols=249 Identities=19% Similarity=0.221 Sum_probs=197.2
Q ss_pred ccceeeccCceEEEEEEEcCCC---cEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCCceEEEEE
Q 036122 102 KLDKIGQGTYSNVYKARDLLTG---KIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMSCSLYLVF 178 (457)
Q Consensus 102 ~~~~LG~G~fg~Vy~~~~~~~g---~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~~~lv~ 178 (457)
..++||+|+||+||+|++..++ ..||||+++.. ......+.+.+|+++|++++|||||+++|++... ...+++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEE
Confidence 3578999999999999986543 36999998743 3556667899999999999999999999998764 35789999
Q ss_pred ecccCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeeccCccccCCCCC---
Q 036122 179 EYMEHDLAGL-AACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPGLK--- 254 (457)
Q Consensus 179 E~~~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DFGla~~~~~~~~--- 254 (457)
||++++.+.. .......+++..+..++.||+.||.|||+.+|+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 9999866654 444555688999999999999999999999999999999999999999999999999987643322
Q ss_pred CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 036122 255 QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGR-TEVEQLHKIFKLCGSPSEEYWKKSKLPNA 333 (457)
Q Consensus 255 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 333 (457)
.......||+.|+|||.+.+.. ++.++|||||||++|||+||..||... +..+....+....
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~---------------- 251 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---------------- 251 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC----------------
T ss_pred eecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC----------------
Confidence 1223457899999999998766 799999999999999999976666543 3333333332210
Q ss_pred ccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhcC
Q 036122 334 TLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALNS 381 (457)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~h 381 (457)
.+ .....+++++.+||.+||+.||++|||+.|+++|
T Consensus 252 ---~~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 252 ---RL---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ---CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CC---------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 00 0113467789999999999999999999999988
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-47 Score=368.32 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=205.8
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC-CCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH-PNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~~~l 176 (457)
++|++.++||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.|.| +|++.+++++.. ....|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEE
Confidence 6899999999999999999999999999999998754322 236678999999975 899999988877 677899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecC-----CCcEEEeeccCccccCC
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDN-----DGILKIADFGLATFYDP 251 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~-----~~~vkl~DFGla~~~~~ 251 (457)
||||+++++...+...+..+++..+..++.|++.||.|||++||+||||||+||||+. ++.+||+|||+|+.+..
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999998888887777778999999999999999999999999999999999999974 57899999999987643
Q ss_pred CCC------CCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCCh
Q 036122 252 GLK------QPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRTE---VEQLHKIFKLCGSPSE 322 (457)
Q Consensus 252 ~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~~---~~~~~~i~~~~~~~~~ 322 (457)
... ......+||+.|||||++.+.. ++.++|||||||++|||+||..||.+... .+...++......+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-- 235 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC--
Confidence 221 1234567999999999998766 89999999999999999999999986543 33333332211000
Q ss_pred hhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHh
Q 036122 323 EYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAAL 379 (457)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL 379 (457)
...+..+++|+++.+||..|+..+|++||+.+.+.
T Consensus 236 ----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 236 ----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp ----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred ----------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 12234466888999999999999999999876654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-47 Score=379.62 Aligned_cols=282 Identities=28% Similarity=0.444 Sum_probs=215.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-----------CCCceeEeeeE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-----------HPNVIKLEGLV 166 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~ 166 (457)
++|+++++||+|+||+||+|+++.+|+.||||+++.+ ....+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 5699999999999999999999999999999999754 233456778999988875 57899999988
Q ss_pred EecCCceEEEEEecccCC--H-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCCCCEEecCCC------
Q 036122 167 TSRMSCSLYLVFEYMEHD--L-AGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN-NGVLHRDIKGSNLLIDNDG------ 236 (457)
Q Consensus 167 ~~~~~~~~~lv~E~~~~~--l-~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NILl~~~~------ 236 (457)
........+++|+++... . ..........+++..++.++.||+.||.|||+ +||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 765556677777776542 2 23333445679999999999999999999998 8999999999999998665
Q ss_pred cEEEeeccCccccCCCCCCCcccccccCccCchHhhhCCcCCCccchhhhHHHHHHHHHhCCCCCCCCC------hHHHH
Q 036122 237 ILKIADFGLATFYDPGLKQPMTSRVVTLWYRPPELLLGATYYGVGVDLWSAGCILAELLAGKPIMPGRT------EVEQL 310 (457)
Q Consensus 237 ~vkl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DvwslG~vl~elltG~~pf~~~~------~~~~~ 310 (457)
.++|+|||.+..... .....+||+.|+|||++.+.. ++.++||||+||++++|++|++||.... ..+.+
T Consensus 170 ~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeeccccccccc----ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999986542 234568999999999998776 7899999999999999999999997543 45667
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcc-----c--C---CCCCCcccchhcc---cCCCCCCcHHHHHHhccCCCCCCcCHHH
Q 036122 311 HKIFKLCGSPSEEYWKKSKLPNAT-----L--F---KPQQPYKRCIAET---FKDFPSSSLPLIETLLSIDPDNRGTATA 377 (457)
Q Consensus 311 ~~i~~~~~~~~~~~~~~~~~~~~~-----~--~---~~~~~~~~~~~~~---~~~~~~~~~~Li~~~L~~dP~~Rpta~e 377 (457)
.+++..+|.++...+......... . . ....+........ ....++++.|||.+||.+||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 778888898877766443211100 0 0 0001111111111 1223567899999999999999999999
Q ss_pred HhcCCCCCCC
Q 036122 378 ALNSEFFNTE 387 (457)
Q Consensus 378 lL~hp~f~~~ 387 (457)
+|+||||+..
T Consensus 325 ~L~Hp~f~~~ 334 (362)
T d1q8ya_ 325 LVNHPWLKDT 334 (362)
T ss_dssp HHTCGGGTTC
T ss_pred HhcCcccCCC
Confidence 9999999964
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=367.53 Aligned_cols=270 Identities=23% Similarity=0.219 Sum_probs=188.1
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCceeEeeeEEecCC--ceEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNVIKLEGLVTSRMS--CSLY 175 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~--~~~~ 175 (457)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.+. ......+.|+..+.+++|||||++++++..... ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4688999999999999999984 78999999986432 222223446666678899999999999986433 3689
Q ss_pred EEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 176 LVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN--------NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 176 lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
+||||+.++.+..+.... .+++.++..++.|++.||.|||+ +|||||||||+||||+.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999986665555544 59999999999999999999996 599999999999999999999999999998
Q ss_pred ccCCCCC---CCcccccccCccCchHhhhCCc-----CCCccchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 036122 248 FYDPGLK---QPMTSRVVTLWYRPPELLLGAT-----YYGVGVDLWSAGCILAELLAGKPIMPGRTEVEQLHKIFKLCGS 319 (457)
Q Consensus 248 ~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-----~~~~~~DvwslG~vl~elltG~~pf~~~~~~~~~~~i~~~~~~ 319 (457)
....... ......+||+.|+|||++.+.. .++.++|||||||+||||+||.+||............ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~~~~ 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSD 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSS
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-ccccc
Confidence 7643321 1234568999999999987542 2567899999999999999999887543211000000 00000
Q ss_pred CChhhhhhcCCCCcccCCCCCCcccchhcccCCCCCCcHHHHHHhccCCCCCCcCHHHHhc
Q 036122 320 PSEEYWKKSKLPNATLFKPQQPYKRCIAETFKDFPSSSLPLIETLLSIDPDNRGTATAALN 380 (457)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~Rpta~elL~ 380 (457)
+......... .....+|..+.. ......+..+.+||.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~--~~~~~~p~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKVV--CEQKLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHH--TTSCCCCCCCGG----GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHH--hccccCCCCCcc----cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0000000000 000000100000 000112234788999999999999999999985
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.2e-26 Score=207.05 Aligned_cols=166 Identities=16% Similarity=0.094 Sum_probs=121.2
Q ss_pred ccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCC----------------hHHHHHHHHHHHHHHhcCCCCceeEe
Q 036122 100 FEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLE----------------PESVKFMAREILVLRKLDHPNVIKLE 163 (457)
Q Consensus 100 y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~hpniv~l~ 163 (457)
+.+.++||+|+||+||+|++ .+|+.||||+++..... ........+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45678999999999999997 57899999987642110 11123455789999999999999887
Q ss_pred eeEEecCCceEEEEEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeccCCCCCEEecCCCcEEEeec
Q 036122 164 GLVTSRMSCSLYLVFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHNNGVLHRDIKGSNLLIDNDGILKIADF 243 (457)
Q Consensus 164 ~~~~~~~~~~~~lv~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NILl~~~~~vkl~DF 243 (457)
++.. .+++|||+++.... .+++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~------~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG------NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET------TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC------CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 5421 27999999975432 25556677899999999999999999999999999999965 5899999
Q ss_pred cCccccCCCCCCCcccccccCccCc------hHhhhCCcCCCccchhhhHHHHH
Q 036122 244 GLATFYDPGLKQPMTSRVVTLWYRP------PELLLGATYYGVGVDLWSAGCIL 291 (457)
Q Consensus 244 Gla~~~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~~~~~~DvwslG~vl 291 (457)
|+|........ ..|.. .+.+. .. |+.++|+||+.--+
T Consensus 147 G~a~~~~~~~~---------~~~l~rd~~~~~~~f~-r~-y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW---------REILERDVRNIITYFS-RT-YRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH---------HHHHHHHHHHHHHHHH-HH-HCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc---------HHHHHHHHHHHHHHHc-CC-CCCcccHHHHHHHH
Confidence 99976532210 01111 12221 22 78899999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.47 E-value=4.5e-07 Score=82.30 Aligned_cols=139 Identities=14% Similarity=0.085 Sum_probs=86.3
Q ss_pred CCccccceeeccCceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcC-CCCceeEeeeEEecCCceEEE
Q 036122 98 NTFEKLDKIGQGTYSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLD-HPNVIKLEGLVTSRMSCSLYL 176 (457)
Q Consensus 98 ~~y~~~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~~~l 176 (457)
..|+.++..+.++.+.||+.. .++..+.+|+....... ....+.+|..+++.|. +--+.+++.+... ....|+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEE
Confidence 356666665555567899986 56667888887543221 1223567888887774 3335666666555 467899
Q ss_pred EEecccCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 036122 177 VFEYMEHDLAGLAACQGVKFSEPQVKCYMKQLLSGLEHCHN--------------------------------------- 217 (457)
Q Consensus 177 v~E~~~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~--------------------------------------- 217 (457)
||++++|.......... .....++.+++..|..||+
T Consensus 88 v~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred EEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 99999985443221111 1111122333333333331
Q ss_pred --------------C------CceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 218 --------------N------GVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 218 --------------~------~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
. .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 27999999999999987667799999886
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.08 E-value=3e-06 Score=81.77 Aligned_cols=77 Identities=18% Similarity=0.139 Sum_probs=46.7
Q ss_pred cceeeccCceEEEEEEEcCCCcEEEEEEeecC-----CCChHHHHHHHHHHHHHHhcC-C--CCceeEeeeEEecCCceE
Q 036122 103 LDKIGQGTYSNVYKARDLLTGKIVALKKVRFD-----NLEPESVKFMAREILVLRKLD-H--PNVIKLEGLVTSRMSCSL 174 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~~g~~vAiK~~~~~-----~~~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~~~~~ 174 (457)
.+.||.|....||++.+..+++.|++|.-... ....-...+...|..+|+.+. + ..+++++.+ +. ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~--~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT--EMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET--TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC--CCC
Confidence 45799999999999987777889999975321 001112233456888887663 2 345556543 32 234
Q ss_pred EEEEecccC
Q 036122 175 YLVFEYMEH 183 (457)
Q Consensus 175 ~lv~E~~~~ 183 (457)
++|||++++
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 789999976
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=2.8e-05 Score=69.66 Aligned_cols=135 Identities=13% Similarity=0.059 Sum_probs=78.0
Q ss_pred eeeccCc-eEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCC--CCceeEeeeEEecCCceEEEEEecc
Q 036122 105 KIGQGTY-SNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDH--PNVIKLEGLVTSRMSCSLYLVFEYM 181 (457)
Q Consensus 105 ~LG~G~f-g~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~~~lv~E~~ 181 (457)
.+..|.. +.||+.. ...+..+.+|....... ..+..|+..++.|.. -.+.+++.+..+ ....++||+++
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEee
Confidence 4455543 6899997 35677788897654321 235678888877743 235666666555 45689999999
Q ss_pred cCCHHH-----------H----HHhcC------CCC--CHHHHHHHHH--------------------HHHHHHHHHHhC
Q 036122 182 EHDLAG-----------L----AACQG------VKF--SEPQVKCYMK--------------------QLLSGLEHCHNN 218 (457)
Q Consensus 182 ~~~l~~-----------~----~~~~~------~~l--~~~~~~~i~~--------------------qi~~~L~~LH~~ 218 (457)
+|..+. . +..-+ ..+ .......-.. .....+..+.+.
T Consensus 89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 168 (255)
T d1nd4a_ 89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR 168 (255)
T ss_dssp SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence 863211 0 00000 000 0000000000 011223333332
Q ss_pred -------CceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 219 -------GVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 219 -------~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 38999999999999987677899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.00037 Score=64.78 Aligned_cols=67 Identities=16% Similarity=0.178 Sum_probs=42.5
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-----eeEee--eEEecCCceEEEEEecccC
Q 036122 111 YSNVYKARDLLTGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV-----IKLEG--LVTSRMSCSLYLVFEYMEH 183 (457)
Q Consensus 111 fg~Vy~~~~~~~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~~--~~~~~~~~~~~lv~E~~~~ 183 (457)
--.||++. ..+|..|++|+.+....+ ...+..|...+..|....| +..-+ .+.. ....+.++++++|
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~--~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEEEEECCCC
T ss_pred cceeEEEE-cCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee--eeEEEEEEeecCC
Confidence 35899997 468899999998755433 3446678888887742222 11111 1111 3557889999886
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.98 E-value=0.00092 Score=63.76 Aligned_cols=71 Identities=17% Similarity=0.199 Sum_probs=47.1
Q ss_pred cceeeccCceEEEEEEEcC-------CCcEEEEEEeecCCCChHHHHHHHHHHHHHHhcCCCCc-eeEeeeEEecCCceE
Q 036122 103 LDKIGQGTYSNVYKARDLL-------TGKIVALKKVRFDNLEPESVKFMAREILVLRKLDHPNV-IKLEGLVTSRMSCSL 174 (457)
Q Consensus 103 ~~~LG~G~fg~Vy~~~~~~-------~g~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~~ 174 (457)
++.|+.|-.-.+|++.... ..+.|.+++.- .... .....+|..+++.+.-.++ .++++++..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~------ 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG------ 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC------
Confidence 4678888888999998643 23567777764 2211 1234578999888853344 467666532
Q ss_pred EEEEecccC
Q 036122 175 YLVFEYMEH 183 (457)
Q Consensus 175 ~lv~E~~~~ 183 (457)
.+||||++|
T Consensus 117 g~I~efi~g 125 (395)
T d1nw1a_ 117 GRLEEYIPS 125 (395)
T ss_dssp EEEECCCCE
T ss_pred ceEEEEecc
Confidence 589999986
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.12 E-value=0.0029 Score=57.93 Aligned_cols=30 Identities=30% Similarity=0.486 Sum_probs=27.1
Q ss_pred CCceeccCCCCCEEecCCCcEEEeeccCcc
Q 036122 218 NGVLHRDIKGSNLLIDNDGILKIADFGLAT 247 (457)
Q Consensus 218 ~~ivHrDlkp~NILl~~~~~vkl~DFGla~ 247 (457)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 379999999999999988777899999875
|